Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.7677421596906544,-2.386623216508869,0.0,0.0,0.0,12/46,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.7677421596906544,-2.386623216508869,0.0,0.0,0.0,12/46,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.7677421596906544,-2.386623216508869,0.0,0.0,0.0,12/46,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.7677421596906544,-2.386623216508869,0.0,0.0,0.0,12/46,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.7677421596906544,-2.386623216508869,0.0,0.0,0.0,12/46,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.8322327697925329,-2.289542454671834,0.0,0.0,0.0,12/30,7.87%,THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96;RASAL3
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.7687560042234982,-2.2691190953059106,0.0,0.0,0.0,10/38,5.90%,THEMIS;ITK;IKZF3;NKG7;ZNF831;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.8839969740042255,-2.2344188271724614,0.0,0.0,0.0,11/24,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.8771323992518316,-2.2255898363041404,0.0,0.0,0.0,13/29,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;KLRC4-KLRK1;GZMB;CD96
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.8812129341974269,-2.217207960396082,0.0,0.0,0.0,12/24,5.90%,TRGC2;NKG7;SKAP1;CCL5;GRAP2;CST7;GNLY;CD2;KLRC4-KLRK1;GZMB;HCST;CD96
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.789240332878852,-2.2127852857734727,0.0,0.0,0.0,7/34,2.67%,THEMIS;ITK;IKZF3;ZNF831;GNLY;BIN2;CD2
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.8476120757266157,-2.212762350568015,0.0,0.0,0.0,12/32,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.8923180387752786,-2.196953428826492,0.0,0.0,0.0,11/23,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.8100432507226526,-2.178968113410339,0.0,0.0,0.0,11/39,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.7046924292330844,-2.1717891402728253,0.0,0.0,0.0,27/52,15.91%,THEMIS;ITK;IKZF3;NKG7;CCL5;CST7;GNLY;BIN2;CD2;GZMB;HCST;CD96;AOAH;CD226;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;CD247;IL12RB1;PYHIN1;PSTPIP1
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.6326775378053606,-2.1637702986174565,0.0,0.0,0.0,30/67,15.91%,ITK;NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PTPN7;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;CD247;IL12RB1;PYHIN1;PSTPIP1
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.8846332796516938,-2.1517161597325023,0.0,0.0,0.0,11/24,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.6893896964222201,-2.1301444829324763,0.0,0.0007295971254781323,0.01,27/59,14.51%,TRGC2;THEMIS;NKG7;CX3CR1;CST7;GNLY;GIMAP8;BIN2;CD2;MPEG1;GZMB;HCST;RASAL3;AOAH;MYO1F;HCK;ITGB2;CYTH4;LCP2;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.8429201126387289,-2.0853512998536936,0.0,0.0026265496517212765,0.04,8/23,5.90%,THEMIS;ITK;NKG7;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.8429201126387289,-2.0853512998536936,0.0,0.0026265496517212765,0.04,8/23,5.90%,THEMIS;ITK;NKG7;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.8683637876373995,-2.0625695285053602,0.0,0.002501475858782168,0.04,9/20,5.90%,THEMIS;ITK;IKZF3;SKAP1;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.6683403425280144,-2.0416984107397123,0.0,0.004775544821311412,0.06,26/63,14.51%,ITK;NKG7;GRAP2;CD37;CST7;GNLY;BIN2;SELPLG;CD2;SAMSN1;GZMB;HCST;CD96;RASAL3;AOAH;MYO1F;NCKAP1L;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP7;PIK3R5;CD247
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.6362282087532624,-2.0414461831572424,0.0,0.0045679124377761325,0.06,26/58,15.91%,NKG7;GRAP2;CD37;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;HCST;CD96;RASAL3;AOAH;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247;PYHIN1;PSTPIP1
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.7455003740709323,-2.0247885096477662,0.0,0.004377582752868794,0.06,9/34,4.90%,NKG7;GRAP2;ZNF831;CD37;GNLY;BIN2;CD2;CEACAM21;GZMB
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.6538725107438197,-2.0167193553751623,0.0,0.004040845618032733,0.06,21/49,14.74%,NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;HCST;RASAL3;MYO1F;NCKAP1L;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP7;PIK3R5;CD247;IL12RB1
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.6538725107438197,-2.0167193553751623,0.0,0.004040845618032733,0.06,21/49,14.74%,NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;HCST;RASAL3;MYO1F;NCKAP1L;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP7;PIK3R5;CD247;IL12RB1
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.8559722188903977,-1.9990394773812685,0.0,0.004221240511694908,0.07,10/25,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.8559722188903977,-1.9990394773812685,0.0,0.004221240511694908,0.07,10/25,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.8912890069747239,-1.989820802985182,0.0,0.004103983830814495,0.07,10/21,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.8912890069747239,-1.989820802985182,0.0,0.004103983830814495,0.07,10/21,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.8912890069747239,-1.989820802985182,0.0,0.004103983830814495,0.07,10/21,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.8912890069747239,-1.989820802985182,0.0,0.004103983830814495,0.07,10/21,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.7630766790151102,-1.9749357491208797,0.0,0.004775544821311412,0.07,11/35,6.16%,NKG7;SKAP1;GRAP2;CST7;RHOG;SELPLG;CD2;GZMB;ARHGDIB;HCST;GMIP
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.7405845019818006,-1.952081620288385,0.0,0.006952631431026908,0.13,9/43,2.67%,THEMIS;ITK;IKZF3;GRAP2;ZNF831;GNLY;GIMAP8;BIN2;CD2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.695251982423093,-1.9410939407139314,0.0,0.010506198606885106,0.21,23/58,14.51%,THEMIS;ITK;NKG7;CCL5;CST7;GNLY;BIN2;CD2;HAVCR1;HPGDS;GZMB;CD96;RASAL3;CYTH4;LCP2;PRF1;CD53;IL18R1;SNX20;GIMAP4;GIMAP7;HAVCR2;CD247
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7853837839388584,-1.9104833770293854,0.0,0.014956741072301714,0.27,9/29,5.90%,THEMIS;ITK;ZNF831;GNLY;GIMAP8;BCL11B;CD2;GZMB;CD96
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.6063242764945632,-1.9050883799337168,0.0,0.01703707882197585,0.28,23/83,9.16%,TRGC2;THEMIS;ITK;NKG7;CCL5;GRAP2;ITGAM;SAMD3;CST7;GNLY;BIN2;SELPLG;CD2;KLRG1;GZMB;HCST;CD96;TGFB1;RASAL3;ITGAX;AOAH;SERPINB9;MYO1F
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.6861051188316594,-1.903732753768145,0.0,0.016934333280834546,0.28,31/76,14.51%,TRGC2;NKG7;CD300LF;ITGAM;CST7;GNLY;GIMAP8;BIN2;SELPLG;CD2;MPEG1;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.8422372736344619,-1.895924368569368,0.0,0.017510331011475175,0.31,4/17,4.69%,KARS1;TARS2;DARS2;CARS2
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.8986269481197349,-1.895222686511546,0.0,0.016884962046779636,0.33,11/20,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.8986269481197349,-1.895222686511546,0.0,0.016884962046779636,0.33,11/20,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;CD2;GZMB;CD96
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.8986269481197349,-1.895222686511546,0.0,0.016884962046779636,0.33,11/20,5.90%,TRGC2;THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;CD2;GZMB;CD96
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.7878829631660108,-1.8709337415748375,0.0,0.024433020016011876,0.44,6/13,10.62%,MAF;YES1;WWTR1;CBFB;SRC;ABL1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7414480796457343,-1.870811861339245,0.0,0.02387772410655706,0.44,5/15,13.95%,LGALS9;HLA-E;NLRP3;SYK;HAVCR2
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.6384370525741484,-1.8677320566702058,0.0,0.023930785715682742,0.45,19/51,14.74%,NKG7;GRAP2;CD37;CST7;GNLY;BIN2;CD2;CEACAM21;GZMB;HCST;RASAL3;CYTH4;PTPN7;PRF1;CD53;SNX20;PIK3R5;CD247;IL12RB1
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.5870313676273463,-1.8470966364158465,0.0,0.034259343283320996,0.61,24/68,14.74%,ITK;NKG7;CD37;BIN2;CD2;SAMSN1;CEACAM21;GZMB;APOBEC3G;HCST;CD96;RASAL3;NCKAP1L;PLEK;CYTH4;LCP2;PTPN7;PRF1;CD53;SNX20;GIMAP7;PIK3R5;CD247;IL12RB1
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,-0.5715117830561722,-1.8397774113661602,0.0,0.03855998424867406,0.65,26/68,13.61%,NKG7;FCGR1CP;CD300LF;ITGAM;LY86;BIN2;P2RX1;SAMSN1;PIK3R6;LGALS9;HCST;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;BTK;ITGB2;CYTH4;LCP2;PTPN7;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.8666760644614306,-1.8263258277533487,0.0,0.04404942645074224,0.72,4/8,11.82%,INPP5K;SETDB1;APOBEC3G;TASOR
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,-0.6156863948238852,-1.8119601481315841,0.0,0.053056302964769785,0.79,29/69,14.51%,TRGC2;NKG7;CD300LF;ITGAM;CX3CR1;CST7;GNLY;BIN2;CD2;MPEG1;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,-0.6156863948238852,-1.8119601481315841,0.0,0.053056302964769785,0.79,29/69,14.51%,TRGC2;NKG7;CD300LF;ITGAM;CX3CR1;CST7;GNLY;BIN2;CD2;MPEG1;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.8160946502532482,-1.786407679518435,0.0,0.07261637272405881,0.88,8/16,15.72%,IL1B;IL1A;ZDHHC21;NOS1AP;EGFR;DDAH2;AKT1;LYPLA1
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.7300049417505304,-1.7821867526093886,0.0,0.07500819678473261,0.89,9/16,16.61%,BLNK;YES1;FYN;CRKL;HCK;CRK;SYK;CBL;RAPGEF1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.6340785915689783,-1.7764806566356262,0.0,0.07879648955163829,0.89,22/36,20.46%,NKG7;CST7;GNLY;BIN2;CD2;CEACAM21;GZMB;CD96;RASAL3;PRF1;CD53;SNX20;CD247;IL12RB1;PYHIN1;PSTPIP1;SCML4;ITGAL;ARHGAP30;NLRC3;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.6340785915689783,-1.7764806566356262,0.0,0.07879648955163829,0.89,22/36,20.46%,NKG7;CST7;GNLY;BIN2;CD2;CEACAM21;GZMB;CD96;RASAL3;PRF1;CD53;SNX20;CD247;IL12RB1;PYHIN1;PSTPIP1;SCML4;ITGAL;ARHGAP30;NLRC3;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,-0.4990257053241525,-1.7590182693792256,0.0,0.09789866883688393,0.93,20/69,10.03%,ADGRG5;NKG7;CCL5;TGFBR3;CX3CR1;SAMD3;CST7;GNLY;A2M;KLRG1;C12ORF75;GZMB;ABI3;RUNX3;LLGL2;EFHD2;MYBL1;MYO1F;AGPAT4;PLEK
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.6520920171477295,-1.7567238396299283,0.0,0.10060623219539533,0.95,24/48,15.91%,ITK;NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;HCST;CD96;RASAL3;MYO1F;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP7;PIK3R5;CD247;IL12RB1;PYHIN1;PSTPIP1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.6370421847545483,-1.753966586015318,0.0,0.10344919242305729,0.97,29/73,14.51%,TRGC2;NKG7;CD37;CST7;GNLY;GIMAP8;BIN2;SELPLG;CD2;CEACAM21;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;PLEK;ITGB2;CYTH4;LCP2;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,-0.5743535941046067,-1.7525576623616612,0.0,0.10024664504069539,0.97,24/72,14.51%,TRGC2;NKG7;CD37;LY86;BIN2;CD2;SAMSN1;CEACAM21;HCST;SH2D3C;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;ST8SIA4;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,-0.5743535941046067,-1.7525576623616612,0.0,0.10024664504069539,0.97,24/72,14.51%,TRGC2;NKG7;CD37;LY86;BIN2;CD2;SAMSN1;CEACAM21;HCST;SH2D3C;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;ST8SIA4;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,-0.5743535941046067,-1.7525576623616612,0.0,0.10024664504069539,0.97,24/72,14.51%,TRGC2;NKG7;CD37;LY86;BIN2;CD2;SAMSN1;CEACAM21;HCST;SH2D3C;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;ST8SIA4;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.7051184196488093,-1.7515159080661828,0.0,0.10011029410249127,0.97,11/25,15.26%,NKG7;GRAP2;GNLY;LYL1;FAM78A;S100Z;MYO1F;ARRB2;PRF1;TMIGD2;LILRA2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6318958848879295,-1.747410254175441,0.0,0.10336743790645024,0.97,28/75,13.92%,THEMIS;ITK;NKG7;SKAP1;GRAP2;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;ITGB5;HCST;CD96;RAPGEF6;ARHGEF1;RASAL3;ENPP1;CYTH4;APBB1IP;LCP2;PRF1;CD53;SNX20;GIMAP4;BCL2;GIMAP7
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,-0.960197694385091,-1.7327887682000471,0.0,0.12090466650780479,0.98,3/7,0.82%,RNASEL;FLNA;PDE12
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7993988406044965,-1.7275525685247752,0.0,0.12722349875524933,0.98,3/17,4.64%,SMDT1;MAIP1;MICU3
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.5504800007851708,-1.7236702765223506,0.0,0.13152952486696545,0.99,27/85,14.46%,NKG7;ITGAM;CD37;LY86;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;MPEG1;CEACAM21;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.5558073276422737,-1.721632301973608,0.0,0.13411321706516216,0.99,25/72,15.91%,THEMIS;ITK;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;CD96;RASAL3;AOAH;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247;IL12RB1;PYHIN1;PSTPIP1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,-0.6394845137436136,-1.7204942385711082,0.0,0.1330915830984139,0.99,14/39,15.91%,NKG7;CD37;CD2;CEACAM21;GZMB;HCST;RASAL3;PTPN7;PRF1;CD53;SNX20;PIK3R5;CD247;PSTPIP1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,-0.5414573569106684,-1.72023220189731,0.0,0.13152061123692568,0.99,20/71,9.22%,ITGA5;ZNF185;RALB;ARAP3;FLNA;MYH9;BCL2L1;LRP10;FLII;ARAP1;ETS1;RNPEPL1;LASP1;TLN1;TGFB1;ILK;SIPA1;TFE3;CAP1;HLA-E
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,-0.5773069793509737,-1.7148507422240447,0.0,0.13894066998235738,0.99,23/69,14.77%,THEMIS;ITK;NKG7;PPP1R16B;CX3CR1;SAMD3;GNLY;CD2;EVL;KLRC4-KLRK1;GZMB;SH2D3C;FYN;AOAH;P2RY14;RASGRP2;ZMAT1;PRF1;GIMAP4;GIMAP7;CD247;SPOCK2;GLT1D1
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.6305694594858989,-1.7067332547705567,0.0,0.15177704773160805,0.99,9/28,14.14%,RALB;BCL11B;MAPK13;SRC;CRKL;CRK;RIT2;MAPKAPK2;RAP1A
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,-0.6047121452817614,-1.701348730345765,0.0,0.15944266195660142,0.99,28/78,14.46%,NKG7;CD300LF;ITGAM;CD37;CST7;LY86;BIN2;SELPLG;CD2;MPEG1;CEACAM21;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.5690921659274331,-1.701019320062428,0.0,0.15777537838464611,0.99,9/37,2.67%,THEMIS;ITK;IKZF3;CCL5;GRAP2;ZNF831;GNLY;BIN2;CD2
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.8760363006822662,-1.696147423747562,0.0,0.16424930356311815,1.0,2/9,0.84%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.6658899538047395,-1.695344116272342,0.0,0.16486923151682878,1.0,4/23,3.32%,ITK;CX3CR1;GNLY;KLRG1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.8822738264338503,1.6931474989112334,0.0,0.25668413453826,0.22,5/26,4.63%,KLF4;LRP2;ACVR1B;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.9509725874860416,-1.6831934295760316,0.0,0.1894617815441614,1.0,2/5,0.45%,SKAP1;CCL5
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,-0.824462856053635,-1.6787864236595489,0.047619047619047616,0.19630002660232698,1.0,3/10,4.90%,NKG7;GNLY;GZMB
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5492692943447794,-1.6752124895347031,0.0,0.20279009973354528,1.0,27/72,14.51%,NKG7;CD37;CST7;GNLY;GIMAP8;BIN2;SELPLG;CD2;CEACAM21;GZMB;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;IL6R;PIK3R5;CD247
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,-0.5988719438554955,-1.672755566321195,0.0,0.20709333792417758,1.0,12/67,2.72%,TRGC2;STAT4;NKG7;CX3CR1;BTG2;CST7;GNLY;LY86;BIN2;CCL3L3;CD2;MAF
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.9103641619513481,-1.669705837775067,0.0425531914893617,0.2102902094574313,1.0,2/6,0.84%,FLNA;LOXL3
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.8760660047475035,-1.6657357521421206,0.0,0.2173469836799356,1.0,4/6,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.7909191489816498,-1.6637041690469307,0.0,0.21936553572709178,1.0,3/9,8.14%,TP53;CHTOP;SSBP1
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,-0.8684141647523056,-1.6622501466655315,0.0,0.2185099439172941,1.0,2/7,8.40%,TGFB1;ZFYVE9
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,-0.8684141647523056,-1.6622501466655315,0.0,0.2185099439172941,1.0,2/7,8.40%,TGFB1;ZFYVE9
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8804327672718681,-1.6601379620379069,0.0,0.2209115867787002,1.0,1/8,0.03%,PHLDB2
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.5587151399779876,-1.658812749349985,0.0,0.2220206970307926,1.0,26/82,14.46%,NKG7;ITGAM;CD37;LY86;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;MPEG1;CEACAM21;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,0.819341928841565,1.658703646667711,0.0,0.33918974921127215,0.42,11/41,6.89%,ASPN;OMD;SVEP1;RBMS3;ECM2;NTN4;OSMR;NFIB;LAMA2;STEAP2;PDZD2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.9107928468645878,-1.6576814728139542,0.0,0.22157695027020768,1.0,3/9,4.64%,SMDT1;MAIP1;MICU3
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.6015353244740514,-1.6558315126953262,0.0,0.22355862265512702,1.0,23/50,20.46%,NKG7;CD37;GNLY;BIN2;CD2;CEACAM21;GZMB;HCST;RASAL3;CYTH4;PRF1;CD53;SNX20;CD247;PYHIN1;PSTPIP1;CD72;IL16;ITGAL;ARHGAP30;ALOX5AP;NCF1;TBC1D10C
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.7676438880169378,1.6514766039864843,0.0,0.29335329661515425,0.47,55/91,15.84%,PCDH17;LRRC4C;AMER2;GRIA4;GFAP;PTPRD;NCAN;LHFPL3;GPM6B;PLPPR4;NRXN1;SLC1A2;PCDH15;RAB3C;CADM2;PHYHIPL;RFTN2;KIF1B;CA10;ROBO2;RUNX1T1;PTPRZ1;ANK2;GRIN2A;MEGF11;CSRNP3;GRIA2;SCD5;NTRK3;CADPS;NOVA1;SCN1A;ADCY8;PPFIA2;GABRB2;PLP1;ZNF536;CLASP2;GRIA3;NTRK2;MAGI2;CSMD2;GRID2;TMEM132B;NFASC;DLGAP1;STMN2;CTNNA2;GRIN2B;LSAMP;MAPK10;FAM135B;SCN2A;ST8SIA3;SYNPR
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,-0.8662645504751214,-1.6469038001713494,0.0,0.24385125743821398,1.0,1/10,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.776475123512512,-1.6432658881277553,0.0,0.2501124527903125,1.0,3/18,4.51%,IL1B;LGALS9;APPL2
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.5095484677564727,-1.6431548041616373,0.0,0.2474793449621825,1.0,31/84,14.46%,CD37;LY86;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;MPEG1;LGALS9;ABI3;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;HLA-DPA1;ITGB2;CYTH4;APBB1IP;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.9573531241524291,1.6417037121256792,0.0,0.25668413453826,0.52,2/12,0.84%,NAMPT;NUDT12
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.9613665619905212,-1.6412947632497106,0.0,0.2498108487433807,1.0,2/11,1.05%,RING1;DNMT3A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.744337989608194,-1.6386827333099157,0.0,0.2525199094508118,1.0,5/12,13.95%,LGALS9;HLA-E;NLRP3;SYK;HAVCR2
prerank,KEGG_2021_Human__Pertussis,-0.5685238217224127,-1.63790872360339,0.0,0.25192282681025574,1.0,9/51,6.21%,ITGA5;CASP7;ITGAM;TICAM1;IL1B;IL1A;IRAK4;C3;MAPK13
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.8162041436474057,-1.6375460788635519,0.0,0.24980163708923628,1.0,3/7,8.14%,GTF2H2;CHTOP;SSBP1
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.9137613103334196,1.634984284265718,0.0,0.24935030212288115,0.57,1/13,0.08%,TOP2A
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.8759308949063574,-1.6347054323779846,0.034482758620689655,0.25463707676161007,1.0,4/7,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.746478797356833,-1.6332865089596729,0.041666666666666664,0.2562253905038516,1.0,5/17,8.31%,SMDT1;MAIP1;MICU3;STOML2;PHB2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7757569823967281,1.632106797440855,0.0,0.22765438122738535,0.62,49/91,15.84%,PCSK1;FAM13C;PCDH17;LRP4;SULT4A1;GRIA4;PTPRD;KCTD16;BRINP1;MAPK4;PLPPR4;NRXN1;RAB3C;TTLL7;PHYHIPL;LIFR;ASXL3;KIF1B;CNTN1;SYT4;ANK2;SNAP25;CSRNP3;ARNT2;UNC13A;GRIA2;AKAP12;ERC2;FAIM2;MAP2;FAM171B;TAGLN3;MAP1B;UNC5D;CADPS;CRMP1;CACNA1B;KALRN;NFASC;STMN2;ITSN1;LSAMP;MAPK10;CHGB;NDRG4;CPE;ST8SIA3;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.8708892196807503,-1.6282817892850765,0.0,0.269018255565473,1.0,3/7,3.78%,NEDD4;HHEX;DAB2IP
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.6925458218399332,-1.6251678310178865,0.0,0.27739580505423683,1.0,8/21,13.23%,GRAP2;FYN;HLA-E;BTK;TREM2;LCP2;TYROBP;SYK
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.7781950586071793,-1.624124850695514,0.0,0.2775122157273187,1.0,3/13,2.97%,NPC2;ARV1;NPC1
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.8826729818315244,-1.6149648246632018,0.0,0.30100259008725827,1.0,4/8,7.43%,LGALS9;RUNX3;CD274;CBFB
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.7587183783934593,1.61374621416433,0.0,0.3378801362799545,0.81,24/90,9.17%,TOP2A;CENPF;PLPP3;PLIN2;KNSTRN;APOLD1;VIM;CKS2;TGIF1;HMGB2;MAPT;CREB5;OIP5;NRXN1;CLSPN;RTN1;KIF15;SMC4;RUNX1T1;RBFOX2;SNAP25;CHL1;PAICS;ATAD2
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.9137872180725829,1.6123968895862673,0.0,0.3082501437088926,0.81,1/12,0.08%,TOP2A
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.6679577699596726,-1.6123935313701918,0.03571428571428571,0.30504383578901556,1.0,1/15,0.45%,CCL5
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.9386998058543242,-1.611042402229782,0.0,0.3066882975686314,1.0,2/8,0.45%,IKZF3;CCL5
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,0.8268261357696753,1.6081838945158209,0.0,0.2550173544438557,0.82,20/30,14.97%,TOP2A;DIAPH3;BRIP1;CENPF;DTL;CENPE;ANLN;RACGAP1;CLSPN;KIF15;SMC4;WDHD1;ATAD2;FANCI;GINS1;POLQ;BRCA1;CENPI;E2F7;KIF11
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,0.8268261357696753,1.6081838945158209,0.0,0.2550173544438557,0.82,20/30,14.97%,TOP2A;DIAPH3;BRIP1;CENPF;DTL;CENPE;ANLN;RACGAP1;CLSPN;KIF15;SMC4;WDHD1;ATAD2;FANCI;GINS1;POLQ;BRCA1;CENPI;E2F7;KIF11
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,0.8268261357696753,1.6081838945158209,0.0,0.2550173544438557,0.82,20/30,14.97%,TOP2A;DIAPH3;BRIP1;CENPF;DTL;CENPE;ANLN;RACGAP1;CLSPN;KIF15;SMC4;WDHD1;ATAD2;FANCI;GINS1;POLQ;BRCA1;CENPI;E2F7;KIF11
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.8339548434631888,-1.6072333939687946,0.0,0.3173534991812746,1.0,5/7,16.52%,KMT2B;SETD1B;SETD1A;KMT2D;KMT2A
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.863904145476674,1.6053627176911798,0.014492753623188406,0.2521004892786482,0.85,3/14,5.04%,LRP2;TGFB2;VEGFA
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.6945536550318657,-1.6040277245229884,0.06666666666666667,0.32326764944261865,1.0,6/18,10.04%,ITGA5;FLNA;DDR1;ARHGAP35;LCP1;COL5A1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.7847935309791699,1.6032997114536152,0.0,0.24046508208117212,0.86,9/41,7.65%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.886759038985287,-1.602549783206062,0.0,0.3248166402628645,1.0,1/7,0.03%,PHLDB2
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.5387748237849315,-1.6024464025569598,0.0,0.32212401389034523,1.0,15/60,14.97%,STAT4;MAF;CHUK;RUNX3;NFKBIE;MAPK13;NFATC3;IKBKB;HLA-DPA1;NFKBIA;PPP3CC;MAML1;CD247;IL12RB1;JAG2
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.7144733797435759,-1.598183501044893,0.0,0.3221664280016683,1.0,8/17,15.51%,NKG7;CD2;CEACAM21;HCST;RASAL3;PRF1;CD247;PYHIN1
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.7144733797435759,-1.598183501044893,0.0,0.3221664280016683,1.0,8/17,15.51%,NKG7;CD2;CEACAM21;HCST;RASAL3;PRF1;CD247;PYHIN1
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.7144733797435759,-1.598183501044893,0.0,0.3221664280016683,1.0,8/17,15.51%,NKG7;CD2;CEACAM21;HCST;RASAL3;PRF1;CD247;PYHIN1
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.7144733797435759,-1.598183501044893,0.0,0.3221664280016683,1.0,8/17,15.51%,NKG7;CD2;CEACAM21;HCST;RASAL3;PRF1;CD247;PYHIN1
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.7144733797435759,-1.598183501044893,0.0,0.3221664280016683,1.0,8/17,15.51%,NKG7;CD2;CEACAM21;HCST;RASAL3;PRF1;CD247;PYHIN1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.9500636692807553,1.5954801246071608,0.0,0.2743639091110483,0.93,6/12,4.08%,TGFB2;METRN;RELN;NFIB;ANXA1;CDH2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.7757925512454397,1.5907767851720205,0.024390243902439025,0.29396444931643584,0.95,9/41,7.65%,KCNE1;LRP2;COL11A1;LHFPL3;NDUFB9;PCDH15;CEMIP;SLC26A5;TIMM13
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.5404364465363458,-1.589748849046274,0.0,0.34637623532074335,1.0,30/74,14.55%,ADGRG5;PPP1R16B;BTG2;BIN2;DENND1C;CD2;SAMSN1;MPEG1;SH2D3C;RASAL3;AOAH;CCDC88C;ALOX5;ST6GAL1;INPP5D;PLEK;SEMA4D;KIF21B;HLA-DPA1;LCP2;SORL1;TYROBP;MMRN1;ZMAT1;CD53;GIMAP4;GIMAP7;PIK3R5;CD247;SPOCK2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.8877815128781061,-1.5870835826796643,0.0,0.3520273847373339,1.0,2/7,3.88%,TARS2;DARS2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6888590896496566,-1.5864561167939004,0.0,0.35216501251368165,1.0,5/13,10.62%,IKZF3;CD2;IL4I1;NCKAP1L;ABL1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8672396561044857,-1.5864004675369772,0.0,0.3491027080570409,1.0,2/6,8.31%,ITGA5;PHB2
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,-0.6528536557967092,-1.584597880113846,0.0,0.35390492290003056,1.0,5/18,5.01%,CCL5;PTAFR;IL1B;IL1A;ICAM1
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,-0.8774177887955166,-1.5842125032045238,0.04,0.3534617458662521,1.0,3/8,5.36%,P2RX1;STIM1;ITPR2
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,-0.5269040551784597,-1.582290522873099,0.0,0.35370132914986097,1.0,20/49,17.79%,ADGRG5;SKAP1;SUSD3;DENND1C;CD2;TC2N;EML4;MAPK13;LLGL2;CCDC88C;LCP1;ATP2A3;PSD4;DEF6;CD247;CARD11;RPS6KA1;ZNF600;CASP8;ELF1
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,-0.5269040551784597,-1.582290522873099,0.0,0.35370132914986097,1.0,20/49,17.79%,ADGRG5;SKAP1;SUSD3;DENND1C;CD2;TC2N;EML4;MAPK13;LLGL2;CCDC88C;LCP1;ATP2A3;PSD4;DEF6;CD247;CARD11;RPS6KA1;ZNF600;CASP8;ELF1
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,-0.8685102870930723,-1.581232602992619,0.0,0.3510025443663887,1.0,2/6,8.40%,TGFB1;ZFYVE9
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,-0.8685102870930723,-1.581232602992619,0.0,0.3510025443663887,1.0,2/6,8.40%,TGFB1;ZFYVE9
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7481398251883956,1.5811921845127777,0.0,0.3661186651114914,0.98,43/79,15.35%,PCDH17;DENND2A;SULT4A1;GRIA4;PTPRD;SCN3B;NCAN;BRINP1;GPM6B;MAPK4;NRXN1;RAB3C;ASXL3;CNTN1;ROBO2;RUNX1T1;ANK2;FMN2;SNAP25;CSRNP3;UNC13A;GRIA2;GABRB3;MAP1B;UNC5D;NTRK3;CADPS;CRMP1;NOVA1;CACNA1B;PNMA2;PLP1;MAGI2;GRID2;SH3GL2;TMEM132B;NFASC;STMN2;CTNNA2;LSAMP;NEFL;NDRG4;ST8SIA3
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,-0.7984607386611862,-1.58116458849367,0.027777777777777776,0.34823311980812827,1.0,1/8,1.84%,BCL2L1
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.7418825075423912,1.5808861823215585,0.0,0.3472785349635282,0.98,29/58,15.35%,DENND2A;GRIA4;PREX2;PTPRD;PPP1R9A;GPM6B;NRXN1;RAB3C;ASXL3;ROBO2;RUNX1T1;LRRN1;PTPRZ1;SEMA6A;CSRNP3;UNC5D;CADPS;CNTNAP2;PLP1;KALRN;HIF3A;MAGI2;SORBS1;GRID2;TMEM132B;SHROOM4;LSAMP;DAB1;ST8SIA3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.8718663718919968,-1.5806885736369922,0.0,0.34700351089813614,1.0,1/9,0.13%,STAT4
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,0.8157283553956438,1.5799757582151572,0.0,0.3189252122740411,0.98,13/32,9.20%,TOP2A;DIAPH3;CENPF;DTL;CENPE;ANLN;CIT;RACGAP1;CLSPN;KIF15;SMC4;WDHD1;FANCI
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,0.8157283553956438,1.5799757582151572,0.0,0.3189252122740411,0.98,13/32,9.20%,TOP2A;DIAPH3;CENPF;DTL;CENPE;ANLN;CIT;RACGAP1;CLSPN;KIF15;SMC4;WDHD1;FANCI
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.7438546858292672,1.5784818022525149,0.0,0.3144380648093685,0.98,50/85,19.66%,FAM13C;NCAN;KCTD16;ENAH;BRINP1;MAPK4;PLPPR4;CADM2;TTLL7;PHYHIPL;LIFR;KIF1B;CNTN1;CTNND2;PTPRZ1;ANK2;RBFOX2;SNAP25;CSRNP3;ARNT2;GRIA2;TMEFF2;NLGN1;MAP2;FAM171B;PTN;TAGLN3;MAP1B;CRMP1;GPRC5B;FIGN;PPFIA2;ADGRL2;SYT1;NFASC;LRP1B;STMN2;LIMCH1;GLRB;ITSN1;MAPK10;NDRG4;CPE;HSPA12A;MPDZ;APBB2;NMNAT2;TMEM59L;GUCY1A2;SNAP91
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.552981951043654,-1.5775255217004667,0.0,0.35649056966507325,1.0,23/63,14.51%,NKG7;GRAP2;CST7;GNLY;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;GZMB;CD96;RASAL3;HLA-E;PLEK;CYTH4;LCP2;PRF1;CD53;IL18R1;SNX20;GIMAP4;GIMAP7;CD247
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7348582978703622,1.5771713784183277,0.0,0.31212441529737395,0.98,40/81,15.35%,FAM13C;PCDH17;PTPRD;PPP1R9A;MAPK4;AGT;NFIB;PLPPR4;NRXN1;PHYHIPL;LIFR;ASXL3;SYBU;CNTN1;SYT4;ANK2;SNAP25;CSRNP3;PTPRT;GRIA2;MAP2;PXK;SHC2;THSD7A;NOVA1;UNC5C;PPFIA2;LMO3;FGF14;KALRN;NTRK2;ADGRL2;NFASC;PAK5;STMN2;LIMCH1;LONRF2;MAPK10;CPE;ST8SIA3
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,0.826718338622015,1.5768093397395049,0.012048192771084338,0.2983536368983672,0.98,9/30,5.30%,CRISPLD2;ASPN;C1QTNF7;ADAMTS2;OGN;TNS1;FILIP1L;DAAM2;LAMA2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7310149844625993,1.5767098218949842,0.0,0.28697605103656393,0.98,54/104,16.46%,FAM13C;SULT4A1;AMER2;GRIA4;PTPRD;SCN3B;NCAN;KCTD16;BRINP1;MAPK4;PLPPR4;NRXN1;RAB3C;CADM2;PHYHIPL;ASXL3;KIF1B;CA10;SYT4;ANK2;TCEAL2;SNAP25;CSRNP3;GRIA2;ERC2;FAIM2;MAP2;OLFM3;TAGLN3;MAP1B;CRMP1;NOVA1;CACNA1B;ADCY8;PPFIA2;PLP1;ZNF536;NKAIN2;MAGI2;SH3GL2;NFASC;PAK5;LY6H;STMN2;LSAMP;MAPK10;NDRG4;SCN2A;ST8SIA3;PIEZO2;KIF5A;ASIC2;SYNPR;CCDC92
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,-0.7622821858986549,-1.5756298386266452,0.0,0.3601524882440214,1.0,2/12,8.22%,ITGAM;ITGAX
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7553352714666123,1.5744817072669823,0.0,0.2910614739853484,0.99,37/69,18.52%,PCSK1;DEPP1;FAM13C;PCDH17;KCNT2;PTPRD;AGT;PLPPR4;RAB3C;PHYHIPL;ASXL3;RUNX1T1;SYT4;CAMK2N1;SNAP25;CSRNP3;PTPRT;MAFB;SHC2;CADPS;GRIA3;FGF14;SH3GL2;NFASC;STMN2;ALDH1A1;MAPK10;CHGB;CPE;ST8SIA3;PEMT;LDB2;EDIL3;SORBS2;KCNB2;CNTN3;SCG5
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.8411866159713094,1.5740040147152425,0.0,0.28271923961285494,0.99,1/19,0.01%,KCNE1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.8223790337057166,1.5722883555010858,0.024096385542168676,0.28101271322389176,0.99,6/20,6.69%,FA2H;SHROOM3;COBL;ARFGEF3;PTPRZ1;OVOL2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.8483595011748759,-1.5720175042182236,0.09375,0.36938460181350014,1.0,2/5,9.02%,ACTA2;ENG
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.855131282075156,-1.5717144047943694,0.0,0.36813058110739144,1.0,5/9,11.55%,CORO1B;WHAMM;ARFIP1;WASHC5;GSN
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.8766402190953883,1.570450553479607,0.0,0.2845255353744205,1.0,5/25,4.70%,PCSK1;FA2H;AANAT;NMRAL1;DMD
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.9457049804536339,1.5701806070485866,0.0,0.2760009252751954,1.0,2/9,0.30%,THBS1;KLF4
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5583745652125564,-1.5695870366955462,0.0,0.37335992900834863,1.0,26/64,14.51%,ITK;CCL5;GNLY;GIMAP8;BIN2;SELPLG;CD2;MAF;GZMB;HCST;CD96;RASAL3;AOAH;HLA-E;PLEK;ITGB2;CYTH4;LCP2;ENTPD1;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;CD247
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8152951289820505,1.5694349392820734,0.0,0.2702770135840053,1.0,5/21,7.71%,THBS1;PLPP3;PRKCE;ANXA1;KANK1
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,-0.787626486716054,-1.5691111400900242,0.034482758620689655,0.37239994674404764,1.0,5/10,9.74%,CCND1;RUNX3;CBFB;TGFB1;EP300
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.46806577272892874,-1.5689109316835619,0.0,0.3647322357276591,1.0,16/58,13.61%,NKG7;GRAP2;ZNF831;CD37;GNLY;BIN2;CD2;RASAL3;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;PRF1;CD53;SNX20
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.46806577272892874,-1.5689109316835619,0.0,0.3647322357276591,1.0,16/58,13.61%,NKG7;GRAP2;ZNF831;CD37;GNLY;BIN2;CD2;RASAL3;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;PRF1;CD53;SNX20
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.46806577272892874,-1.5689109316835619,0.0,0.3647322357276591,1.0,16/58,13.61%,NKG7;GRAP2;ZNF831;CD37;GNLY;BIN2;CD2;RASAL3;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;PRF1;CD53;SNX20
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.7533289203788233,1.568262491530438,0.0,0.2689071885638914,1.0,22/56,12.61%,DENND2A;ZNF793;PREX2;SLCO1A2;ZNF483;CDH8;LRRTM4;ZNF814;FSIP2;SEMA6A;MGAT4C;POU5F1;CNTNAP2;TYRO3;ZNF850;HIF3A;ASTN2;MAGI2;ADAMTSL3;L2HGDH;GRID2;TMEM132B
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",0.91250434290115,1.5665529924340165,0.0,0.27324440128266386,1.0,1/10,0.62%,LRP2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.9599722241722719,1.5664519344762884,0.0,0.26556494722875784,1.0,1/7,0.08%,TOP2A
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.955425933633494,1.5654002993426248,0.0,0.2619622715038736,1.0,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.8847241059891437,-1.5649324471154002,0.0,0.37680125830708233,1.0,3/7,9.33%,BIN2;WHAMM;BIN3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.862394261329145,1.5641312302831574,0.0,0.2639640417152905,1.0,4/19,5.04%,THBS1;KLF4;ANXA1;VEGFA
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,-0.9079990812083059,-1.5608223762142523,0.0,0.38888615738918003,1.0,5/6,9.19%,ADORA1;P2RY13;P2RY6;P2RY12;P2RY14
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.8309034896644288,-1.5607236836038498,0.0,0.3862973580364885,1.0,4/8,12.54%,ITGAM;TICAM1;ITGB2;TYROBP
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.7781112657401361,1.5603281029584364,0.0,0.28366216092340363,1.0,20/38,13.01%,LRP2;COL11A1;ZDHHC15;CDH8;NRXN1;PCDH15;DMD;ASXL3;RUNX1T1;GRIN2A;ERC2;RYR2;UNC5D;CADPS;GABRB2;GRIA3;HIF3A;MAGI2;GRID2;DLGAP1
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,-0.7871183062688696,-1.5598917205889586,0.10344827586206896,0.3861607373982862,1.0,5/10,11.43%,PLA2G4C;ACOX1;ACAA1;PLA2G12A;PLB1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6655357979310937,-1.5586450873214268,0.0,0.38909361446484164,1.0,4/20,12.50%,NCOA4;NEDD4;M6PR;SORL1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.7749494941474783,1.5583924229337627,0.0,0.28775106352007324,1.0,5/41,2.92%,THBS1;RAB7B;HMGB2;WDR5;FAXDC2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.7382738402731059,1.5577417725999447,0.0,0.2841860060959307,1.0,55/118,16.43%,FA2H;ST18;OPALIN;MOBP;AMER2;NFE2L3;ASPA;ENPP2;OMG;GFAP;TMEM163;NCAN;CREB5;ANLN;GPM6B;MAPK4;MYRF;NRXN1;SLC1A2;HEPACAM;PHYHIPL;KIF1B;CA10;MOG;GRM3;OLIG1;SRCIN1;PEX5L;TTYH1;PTPRT;GRIA2;MAG;ERMN;FAIM2;NDRG2;MPPED1;GPRC5B;ADCY8;TYRO3;PLP1;VSTM2B;NTRK2;GALC;SORBS1;ZDHHC9;TPPP;LY6H;FASN;BCAS1;PLLP;ST8SIA3;SYNPR;NINJ2;KLHL2;SLC39A12
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.865738795586761,1.5576979494465788,0.0,0.27718991596283904,1.0,2/15,0.84%,NAMPT;NUDT12
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,-0.7981320816688189,-1.5576829493665951,0.0,0.3904613485874056,1.0,2/10,7.92%,FLNA;ILK
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.5422425540328263,-1.557586866675665,0.0,0.38784123454373526,1.0,26/75,14.74%,NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;SAMSN1;CEACAM21;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;IL12RB1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7870800995008406,1.5572698329114631,0.0,0.2724330695328236,1.0,9/37,5.92%,ASPN;SPARC;SVEP1;ADAMTS2;RBMS3;ECM2;DAAM2;LAMA2;RUNX1T1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7705852141082078,1.5561064905453192,0.0,0.27203934615795944,1.0,26/57,17.45%,KCNE1;GRIA4;CACNB2;JPH1;RELN;NETO1;DMD;PRRT1;ANK3;ANK2;DAPK1;GRIN2A;GRIA2;NLGN1;CACNG2;CAMK2B;GRIA3;FGF14;LRRC7;AHNAK;GRIN2B;NEFL;SHISA9;CACNG8;GRIA1;APP
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.8483188121412183,-1.5556554005719467,0.0625,0.3925753675876265,1.0,2/8,11.62%,METAP1D;NAA20
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.7242607996134232,1.555608411289477,0.010526315789473684,0.2703232740912511,1.0,37/69,19.39%,FAM13C;TUB;KCNT2;PREX2;PTPRD;BRINP1;PLPPR4;NRXN1;FBXL7;UBE2QL1;ASXL3;DAAM2;ROBO2;RUNX1T1;ANK2;CSRNP3;NLGN1;PTN;MAP1B;NOVA1;PLP1;ZNF536;GRIA3;MAGI2;CSMD2;GRID2;TMEM132B;NFASC;STMN2;LSAMP;THY1;LDB2;AMPH;OLFM1;LRFN5;PTPN5;GUCY1A2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.810074178334932,1.5554236892246118,0.02631578947368421,0.26519661859182475,1.0,6/24,9.85%,DIAPH3;COBL;SPIRE2;MICALL2;PSTPIP2;WASF1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.7538154560296898,1.5545942473402792,0.0,0.2643590754380751,1.0,43/78,16.47%,FGF1;OPALIN;AMER2;GRIA4;GFAP;SCN3B;NCAN;KCTD16;IL1RAPL1;DGKI;TTLL7;GRIK2;SYT16;GABRB1;GRM3;FRMPD4;ANK2;AKAP6;GRIN2A;PEX5L;FMN2;SNAP25;GRIA2;PDE1C;FAM171B;MAP1B;NTRK3;TMEM130;PNMA2;GRIA3;FGF14;MAGI2;NALCN;GAD2;SYT1;TMEM132B;EPHA5;GRIN2B;SLC17A7;NDRG4;SCN2A;SYNPR;APLP1
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,-0.8078486255649526,-1.5544127277821027,0.06060606060606061,0.39482070828533655,1.0,3/7,17.28%,CASP10;TNFSF10;CASP8
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.5850932963974369,-1.5543370653589275,0.0,0.3921327649048666,1.0,15/33,20.79%,BLNK;YES1;FYN;CRKL;CSF2RA;INPP5D;HCK;CRK;SYK;CBL;RAPGEF1;PRKCA;PTPN6;CSF2RB;GAB2
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.5170271507594878,-1.5541435949575213,0.0,0.39003343954056857,1.0,13/68,11.22%,CCL5;TICAM1;IL1B;CCL3L3;CHUK;IRAK4;MAPK13;MAP2K3;TLR3;IRF5;IKBKB;NFKBIA;TLR7
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.8349203803809866,1.5536240579974256,0.0,0.2646013399866804,1.0,9/26,5.86%,ASPN;SPARC;LRP4;TGFB2;NCAN;ITGA2;VCAN;LAMA2;LAMB1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.7978445468400253,1.5532741256900404,0.0,0.26055476831304325,1.0,4/37,5.04%,THBS1;KLF4;BEX3;VEGFA
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,-0.9061295894333509,-1.5531109746638547,0.02857142857142857,0.39051686141217035,1.0,2/5,9.02%,ITGAM;ENG
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.7401972630450926,1.5530279618387555,0.0,0.2572820013112528,1.0,39/80,15.32%,FAM13C;PCDH17;LRP4;LRRC4C;GFAP;PTPRD;NCAN;BRINP1;GPM6B;MAPK4;PLPPR4;FBXL7;PHYHIPL;ASXL3;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;GRIA2;NLGN1;SPRY1;FAIM2;MAP2;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ZNF536;NTRK2;NFASC;LY6H;STMN2;MAPK10;NDRG4;CPE
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.6265611775040132,-1.552708822735431,0.07692307692307693,0.3891822018429767,1.0,8/36,10.80%,TNFAIP8L3;PTAFR;CSF1R;PIK3C2B;ADAP2;IGF1;PLCL2;PI4KB
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.5079224202972716,-1.5523585243610745,0.0,0.3878658252815802,1.0,26/80,14.74%,NKG7;CD37;BIN2;SELPLG;CD2;SAMSN1;CEACAM21;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;APBB1IP;LCP2;PTPN7;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;IL12RB1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,0.8874933141402982,1.5520786231390544,0.0,0.25629403706935683,1.0,4/17,3.33%,TOP2A;CENPF;ANLN;RACGAP1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.7395414572525196,1.5515400028055926,0.0,0.24476665686326937,1.0,29/67,14.25%,TUB;COL11A1;KCNT2;PTPRD;SPOCK1;ENAH;SLC6A15;DZIP1;FBXL7;PTPRG;CDH2;ANK2;RBFOX2;FMN2;CHN1;NLGN1;AKAP12;ROBO1;FAM171B;PTN;MAP1B;TRPC4;CRMP1;FIGN;NR2F1;SGCE;ADGRL2;PEG10;GLRB
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.7395414572525196,1.5515400028055926,0.0,0.24476665686326937,1.0,29/67,14.25%,TUB;COL11A1;KCNT2;PTPRD;SPOCK1;ENAH;SLC6A15;DZIP1;FBXL7;PTPRG;CDH2;ANK2;RBFOX2;FMN2;CHN1;NLGN1;AKAP12;ROBO1;FAM171B;PTN;MAP1B;TRPC4;CRMP1;FIGN;NR2F1;SGCE;ADGRL2;PEG10;GLRB
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.7395414572525196,1.5515400028055926,0.0,0.24476665686326937,1.0,29/67,14.25%,TUB;COL11A1;KCNT2;PTPRD;SPOCK1;ENAH;SLC6A15;DZIP1;FBXL7;PTPRG;CDH2;ANK2;RBFOX2;FMN2;CHN1;NLGN1;AKAP12;ROBO1;FAM171B;PTN;MAP1B;TRPC4;CRMP1;FIGN;NR2F1;SGCE;ADGRL2;PEG10;GLRB
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,0.8105782533954922,1.5515384737414701,0.0,0.23996731065026408,1.0,10/31,5.92%,ASPN;OMD;C1QTNF7;ADAMTS2;OGN;ECM2;TNS1;DAAM2;LAMA2;RUNX1T1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.8756440550975381,1.5501690107636248,0.013888888888888888,0.24152284637185173,1.0,2/14,3.16%,FGF1;PIGU
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.9406539262655413,1.5475536980570275,0.0,0.2501113602037223,1.0,2/10,0.30%,PCSK1;KLF4
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.7440059137241023,1.5474966584994378,0.0,0.24632849154432224,1.0,32/100,13.55%,FA2H;OPALIN;MOBP;ASPA;DPYD;MAL;TM7SF2;GRIA4;OMG;LHFPL3;TUBB4A;GRIK2;DAAM2;KCNH8;GRM3;LRRN1;MARCKSL1;OLIG1;GRIA2;TMEFF2;MAG;ERMN;MAP2;TAGLN3;PHACTR3;PLP1;COX7C;EIF3E;ZDHHC9;EEF1B2;UGT8;SCD
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,0.747662234616594,1.545403188163191,0.0,0.25451732041553443,1.0,13/41,14.97%,TOP2A;DTL;CKS2;HMGB2;OIP5;CLSPN;KIF15;SMC4;FANCI;LMNB1;CENPK;RFC4;KIF11
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.725695098871343,1.5453782926331427,0.0,0.249972368265257,1.0,50/100,17.39%,LRRC4C;OPALIN;VIM;AMER2;GRIA4;GFAP;METRN;NCAN;GPM6B;PLPPR4;GRIN3A;NRXN1;SLC1A2;CADM2;HEPACAM;PHYHIPL;RFTN2;KIF1B;CA10;GRM3;PTPRZ1;AKAP6;BAALC;GRIN2A;CDH20;GRIA2;NRXN3;SEPTIN4;CHL1;FAIM2;NTRK3;SCN1A;ADCY8;PPFIA2;PLP1;GRIA3;NTRK2;MAGI2;NFASC;CTNNA2;GRIN2B;LSAMP;MAPK10;SCN2A;ST8SIA3;SYNPR;SLC39A12;LRRTM2;DPP6;GRIA1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.871787481359395,-1.5449803633228576,0.041666666666666664,0.41354756251080915,1.0,2/10,6.70%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.843499305256787,1.5444726519367151,0.0,0.2483209923101964,1.0,7/26,7.51%,GLRA1;ANO4;RACGAP1;SLC4A10;SLC11A1;SLC13A4;TTYH1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6950393830730417,-1.5441583206128273,0.0,0.41377030493163214,1.0,1/20,0.09%,RNASEL
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.8478417613617539,1.5439554066323882,0.0,0.24814907095139668,1.0,2/20,0.84%,NAMPT;NUDT12
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.8795902845038639,-1.5434536687764284,0.0,0.41451889302164974,1.0,4/8,6.94%,CX3CR1;TMEM106A;SIRPA;NOS1AP
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.9704065278144802,1.5424374780745163,0.0,0.25248893379217463,1.0,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.6504589328170064,-1.5422342251026029,0.0,0.4161330164877075,1.0,8/24,16.32%,CPSF1;LSM11;WDR33;SNRPB;CSTF1;CPSF2;CPSF4;TTF2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.8098325139738405,1.5417836979157258,0.012987012987012988,0.2521004892786482,1.0,8/24,10.47%,KCNE1;SCN3B;GNA11;DMD;ANK3;AKAP6;SCN3A;SCN1A
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9092784725553248,-1.5412539375816754,0.0,0.41807364820609855,1.0,2/6,8.33%,COL18A1;CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.8928633366340056,-1.5402855242691955,0.06666666666666667,0.41972954631782766,1.0,2/6,4.52%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.8698635946586897,-1.5401029016686816,0.029411764705882353,0.41479017876533397,1.0,1/6,0.13%,STAT4
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,-0.8698635946586897,-1.5401029016686816,0.029411764705882353,0.41479017876533397,1.0,1/6,0.13%,STAT4
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.7309400302736051,1.5398049209651685,0.0,0.2605915042677651,1.0,57/89,21.44%,LRRC4C;AMER2;PCDH9;GRIA4;GPM6A;SCN3B;GPM6B;NRXN1;RAB3C;DOK6;CADM2;ASXL3;RORB;SLC24A2;CTNND2;CA10;GRM3;FRRS1L;CDH20;GRIA2;OLFM3;RYR2;UNC5D;NTRK3;CADPS;SLITRK5;NOVA1;SCN1A;PPFIA2;PPP2R2B;GABRB2;ZNF536;MAGI2;GRID2;XKR4;VWC2;ANKS1B;NEGR1;CTNNA2;LSAMP;DAB1;SYNPR;CRB1;DPP6;GRIA1;AMPH;ATP1B2;NTNG1;PTPN5;NLGN4X;SNAP91;NCAM1;ATP1A2;CNTN2;KIF5C;SORCS3;PAK3
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,-0.8168909345556155,-1.539568776754874,0.0,0.4148253901557216,1.0,3/7,13.67%,PANK1;PPCDC;PPCS
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.8715490899430314,-1.5392434816817806,0.0,0.413429017294974,1.0,5/8,9.42%,LILRB4;RUNX3;CBFB;HLA-E;NCKAP1L
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.716190813600501,-1.5387348696132086,0.07692307692307693,0.4123013768577762,1.0,4/19,3.82%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7343410216173086,1.5378395020236837,0.0,0.2673300203025196,1.0,47/87,16.25%,LRRC4C;SULT4A1;AMER2;GRIA4;GFAP;PDE10A;SPOCK1;SCN3B;NCAN;BRINP1;PLPPR4;NRXN1;RAB3C;CADM2;PHYHIPL;GABRB1;CA10;GRM3;SYT4;TCEAL2;SNAP25;CSRNP3;GRIA2;FAIM2;OLFM3;TAGLN3;FXYD7;PPFIA2;PLP1;ZNF536;CLASP2;VSTM2B;GAD2;SH3GL2;NFASC;CCK;PAK5;LY6H;STMN2;NEGR1;LSAMP;SCN2A;ST8SIA3;ASIC2;SYNPR;CCDC85C;NRGN
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),-0.7829754319670879,-1.537692364464693,0.0,0.413681570146101,1.0,4/8,10.32%,ITGAM;CX3CR1;C3;TREM2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.8885502965942544,1.5364711875243886,0.034482758620689655,0.2710898767827542,1.0,1/8,0.28%,THBS1
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7374413267101517,1.5361734398372588,0.0,0.26828648660165233,1.0,33/69,16.12%,PLPP3;FAM13C;LRP4;TGFB2;COL11A1;KCNT2;PTPRD;BRINP1;VCAN;MAPK4;PLPPR4;FBXL7;LIFR;ASXL3;COL23A1;RUNX1T1;ANK2;CSRNP3;MAP2;PTN;SHC2;MAP1B;CRMP1;GPRC5B;CCDC3;ADGRL2;NFASC;STMN2;MAPK10;CPE;THY1;LDB2;EDIL3
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,0.9754578929079638,1.535907191664218,0.0,0.2657103898187263,1.0,1/5,0.62%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.9420289279458488,1.5358140080528437,0.0,0.2618233731626732,1.0,1/7,0.08%,TOP2A
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7363293605682503,1.535681568767597,0.0,0.2584628625494526,1.0,25/60,11.45%,LRP4;LRRC4C;SULT4A1;NCAN;MAPK4;CASKIN1;DPYSL5;CADM2;PHYHIPL;SRRM3;CTNND2;PTPRZ1;GALNT13;ANK2;LINGO1;CSRNP3;UNC13A;GRIA2;ERC2;TAGLN3;MAP1B;UNC5D;CSPG5;CACNA1B;ZNF536
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.7663887948215647,-1.5355937257758256,0.08,0.41917419756243646,1.0,3/9,9.42%,RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.9594201858039646,1.5354150464520757,0.0,0.25668413453825994,1.0,1/10,0.01%,KCNE1
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),-0.9375886799186359,-1.533767040978218,0.0,0.4241877687529862,1.0,1/5,2.40%,HPS4
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.7418523808512922,1.533732042989575,0.0,0.2626628022681884,1.0,41/100,14.20%,SOCS3;AANAT;FGF1;OPALIN;VIM;AMER2;GFAP;NCAN;BRINP1;GPM6B;MAPK4;AGT;PLPPR4;NRXN1;SLC1A2;CADM2;PHYHIPL;DAAM2;CA10;PTPRZ1;LUZP2;BAALC;GRIN2A;TCEAL2;SNAP25;CDH20;GRIA2;FAIM2;PTN;GPRC5B;ADCY8;SLC25A28;PLP1;GRIA3;VSTM2B;NTRK2;SORBS1;NFASC;LY6H;STMN2;PLXNB1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7090352130018851,1.5333304786251638,0.0,0.26074393462534473,1.0,64/119,21.39%,SULT4A1;INSYN2A;TMEM163;NCAN;RELN;BRINP1;GPM6B;MAPK4;NRG1;DPYSL5;CADM2;KIF1B;SYT4;GALNT13;ANK2;CNR1;LINGO1;SNAP25;CSRNP3;CHN1;GRIA2;NLGN1;MAP9;ERC2;MAP2;FAM171B;OLFM3;TAGLN3;DNM3;MAP1B;SLITRK5;CRMP1;NOVA1;CACNA1B;PPFIA2;CNTNAP2;EPHA7;PNMA2;ZNF536;KCNH7;GRID2;SH3GL2;SYT1;LINGO2;PAK5;STMN2;NEFL;NDRG4;ST8SIA3;KIF5A;PREPL;EDIL3;APLP1;SMAD1;PTPN5;TMEM59L;SNAP91;DYNC1I1;CLSTN2;REEP2;CNTN2;RNF138;KIF5C;ELAVL3
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.7882084004386459,1.5323015814333885,0.0,0.26365644000358496,1.0,1/26,0.04%,GLRA1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.8056227161622483,1.5320080193842562,0.01098901098901099,0.26101313283900446,1.0,10/30,7.86%,CENPF;LRP4;TGFB2;GREB1L;ZBTB16;AGT;VEGFA;SOX4;ROBO2;PAX8
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.6696434536173667,-1.5318675582977594,0.0,0.42864964036631387,1.0,8/24,13.23%,GRAP2;FYN;HLA-E;BTK;TREM2;LCP2;TYROBP;SYK
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,-0.8723180513728558,-1.5317389406591386,0.0,0.4263279203210553,1.0,3/5,8.84%,ST6GALNAC3;GALNT1;ST6GAL1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.7573871264156121,1.5315470121650192,0.010869565217391304,0.25969803827060745,1.0,10/53,4.30%,HS3ST5;OMD;HS3ST2;OGN;CHST7;NCAN;VCAN;B4GAT1;GPC5;CEMIP
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.7779391743698534,1.5313790478180875,0.0,0.25730354605982914,1.0,14/31,15.42%,RAP1GAP;FAAH;COL26A1;PHYHIPL;SYT4;LINGO1;SHC2;PTOV1;SYT1;STMN2;CALY;KLC4;ST8SIA3;CPLX1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7262875109759678,1.5313625156657082,0.0,0.25399506265262106,1.0,45/96,15.84%,LRRC4C;SULT4A1;AMER2;GRIA4;SCN3B;NCAN;GPM6B;MAPK4;NRXN1;DPYSL5;RAB3C;CADM2;PHYHIPL;KIF1B;CTNND2;ROBO2;GRM3;SYT4;ANK2;EPHA3;BSN;SNAP25;CSRNP3;UNC13A;GRIA2;ROBO1;ERC2;OLFM3;NTRK3;NOVA1;CACNA1B;PPFIA2;EPHA7;ZNF536;CLASP2;GAD2;PAK5;STMN2;CTNNA2;HIVEP2;LSAMP;NDRG4;ST8SIA3;KIF5A;SYNPR
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8522909473775888,1.5313496513431015,0.03076923076923077,0.2506530223545603,1.0,2/8,2.26%,TOP2A;HMGB2
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.8959507107348486,1.5307954104869723,0.013513513513513514,0.2506122927657872,1.0,2/11,3.16%,FGF1;PIGU
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.8025827539791286,-1.5303815040014914,0.07407407407407407,0.4303996392483147,1.0,1/10,0.45%,CCL5
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,-0.5497514258090503,-1.530327169250149,0.0,0.42277955839754516,1.0,9/46,2.32%,TRGC2;ITK;NKG7;CCL5;GRAP2;CD37;CST7;GNLY;BIN2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,-0.5497514258090503,-1.530327169250149,0.0,0.42277955839754516,1.0,9/46,2.32%,TRGC2;ITK;NKG7;CCL5;GRAP2;CD37;CST7;GNLY;BIN2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,-0.5497514258090503,-1.530327169250149,0.0,0.42277955839754516,1.0,9/46,2.32%,TRGC2;ITK;NKG7;CCL5;GRAP2;CD37;CST7;GNLY;BIN2
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.8716439619214711,1.5303082135020698,0.012345679012345678,0.2497499019660268,1.0,8/14,6.68%,METRN;RELN;MYRF;NFIB;CDH2;SOX4;PTPRZ1;ADGRG6
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.8778081717522653,1.5289468423081078,0.014084507042253521,0.2537830932347082,1.0,2/13,3.16%,FGF1;PIGU
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.8427570709201093,1.5288350415321612,0.0,0.2514129424897064,1.0,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.7799878393495727,-1.5288189871921873,0.0,0.425595410632202,1.0,7/10,19.63%,CX3CR1;NMI;TREM2;TYROBP;SYK;PLCG2;GRN
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.8825133266525691,1.5286553089256394,0.028985507246376812,0.24898813755915872,1.0,2/13,3.16%,FGF1;PIGU
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.7316972330740757,-1.5282551334800145,0.1,0.424625527028273,1.0,1/10,0.14%,COL18A1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.76587164546751,1.5273837680664732,0.010526315789473684,0.25075893456851794,1.0,33/51,18.88%,ZPBP;OPALIN;MOBP;AMER2;ZNF804B;NCAN;KCTD16;NRXN1;PCDH15;GABRB1;CA10;GRM3;GRIN2A;RALYL;TMEM232;PEX5L;PTPRT;GRIA2;ERC2;CNTN5;DGKB;GABRB2;GAD2;DNAH7;DLGAP1;PAK5;CTNNA2;GRIN2B;CRB1;KIF3A;DLGAP2;GRM7;GABRG2
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5143065704323211,-1.5264299979188218,0.0,0.428096509802737,1.0,7/49,5.85%,BUD23;DDX52;DDX49;RRP7A;FBL;FCF1;THUMPD1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.7408690715608542,1.5261892626380908,0.0,0.2500269354707286,1.0,27/60,16.12%,TNC;PLPP3;FGF1;PTPRD;PLPPR4;FBXL7;LAMA2;PTPRZ1;BAALC;TCEAL2;CHL1;PTN;TAGLN3;ITGB8;SEMA5A;GPRC5B;PLP1;SGIP1;FGF14;NTRK2;NFASC;SHROOM4;STMN2;MAPK10;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.7408690715608542,1.5261892626380908,0.0,0.2500269354707286,1.0,27/60,16.12%,TNC;PLPP3;FGF1;PTPRD;PLPPR4;FBXL7;LAMA2;PTPRZ1;BAALC;TCEAL2;CHL1;PTN;TAGLN3;ITGB8;SEMA5A;GPRC5B;PLP1;SGIP1;FGF14;NTRK2;NFASC;SHROOM4;STMN2;MAPK10;THY1;LDB2;EDIL3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7151303465477954,1.5255353787048278,0.0,0.25183086308690633,1.0,49/114,15.69%,FAM13C;TUB;PCDH17;LRRC4C;SULT4A1;NCAN;KCTD16;PPP2R5B;BRINP1;MAPK4;PLPPR4;NRXN1;CADM2;PHYHIPL;TTBK2;ASXL3;KIF1B;CNTN1;CA10;SYT4;ANK2;AKAP6;SNAP25;CSRNP3;GRIA2;FAIM2;MAP2;OLFM3;TAGLN3;SCN3A;MAP1B;CRMP1;NOVA1;CACNA1B;PPFIA2;ZNF536;KALRN;NTRK2;NFASC;CCK;PAK5;LY6H;STMN2;LSAMP;MAPK10;NDRG4;CPE;ST8SIA3;ASIC2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.864825340838403,-1.525434647265037,0.037037037037037035,0.42959537097711814,1.0,4/8,10.73%,CD300LF;HAVCR1;MILR1;CD226
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.7222226462404767,1.5252609813382068,0.0,0.25039494685646707,1.0,36/76,16.47%,SULT4A1;AMER2;GRIA4;NCAN;GPM6B;MAPK4;DPYSL5;CADM2;PHYHIPL;CNTN1;CTNND2;TMEM178B;SYT4;PTPRZ1;GALNT13;BSN;SNAP25;CSRNP3;GRIA2;ERC2;MAP2;TAGLN3;MAP1B;CSPG5;CACNA1B;PNMA2;SH3GL2;SYT1;PPM1E;LRP1B;PAK5;MAPK10;NDRG4;ST8SIA3;KIF5A;APLP1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.9655797297452671,1.524890285165326,0.0,0.2494135248161172,1.0,2/8,0.84%,NAMPT;NUDT12
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.74087280166395,1.5235273919198893,0.0,0.2540797906407533,1.0,41/71,19.66%,SULT4A1;MAPT;NCAN;MAPK4;NR4A2;NRXN1;CASKIN1;DPYSL5;PHYHIPL;CTNND2;SYT4;SRCIN1;LINGO1;BSN;SYP;SNAP25;CSRNP3;UNC13A;GRIA2;ERC2;OLFM3;CACNA1B;HS6ST3;GAD2;PAK5;LY6H;STMN2;CALY;LONRF2;SCN2A;ST8SIA3;KIF5A;APLP1;KCNJ6;CHD5;KCNB2;GABRG2;PTPN5;TMEM59L;MAPK8IP2;SNAP91
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.7578608368815282,1.5234948518032776,0.0,0.2513279647966912,1.0,22/36,20.46%,SULT4A1;GRM8;VGF;NCAN;CASKIN1;DPYSL5;SYT4;LINGO1;KLHL23;UNC13A;CSPG5;CRMP1;CACNA1B;PPM1E;BRCA1;STMN2;KIF5A;APLP1;KCNB2;TMEM59L;SNAP91;REEP2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),-0.8494777729603202,-1.5233075026833278,0.03333333333333333,0.4351470855746419,1.0,3/6,13.23%,IL1B;LGALS9;SYK
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.8979421118758034,-1.5229535623463142,0.043478260869565216,0.4339151648468609,1.0,3/7,8.37%,RUBCNL;PIP4K2B;PLEKHM1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.7498853106971909,1.5228439941887568,0.012048192771084338,0.25169305414446047,1.0,14/47,6.89%,PLPP3;ASPN;SPARC;SVEP1;ADAMTS2;ECM2;PDE5A;VIM;TNS1;VEGFA;DAAM2;LAMA2;INPP4B;PDZD2
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,0.810121872162799,1.5224363583087372,0.0,0.24095499396317113,1.0,7/27,5.30%,ASPN;SPARC;SVEP1;ADAMTS2;ECM2;FILIP1L;LAMA2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,0.810121872162799,1.5224363583087372,0.0,0.24095499396317113,1.0,7/27,5.30%,ASPN;SPARC;SVEP1;ADAMTS2;ECM2;FILIP1L;LAMA2
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,0.810121872162799,1.5224363583087372,0.0,0.24095499396317113,1.0,7/27,5.30%,ASPN;SPARC;SVEP1;ADAMTS2;ECM2;FILIP1L;LAMA2
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,0.810121872162799,1.5224363583087372,0.0,0.24095499396317113,1.0,7/27,5.30%,ASPN;SPARC;SVEP1;ADAMTS2;ECM2;FILIP1L;LAMA2
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,0.810121872162799,1.5224363583087372,0.0,0.24095499396317113,1.0,7/27,5.30%,ASPN;SPARC;SVEP1;ADAMTS2;ECM2;FILIP1L;LAMA2
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.7278246739520605,1.5218224778398295,0.022727272727272728,0.2266657518576652,1.0,19/47,16.12%,SPARC;FGF1;COL11A1;CLIP3;SPOCK1;DZIP1;PLPPR4;FBXL7;RUNX1T1;ANK2;PTN;MAP1B;TRPC4;CRMP1;SEMA5A;NFASC;THY1;LDB2;EDIL3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.8622203707224816,-1.521700956698169,0.034482758620689655,0.4355821358837192,1.0,1/6,4.25%,CSF1R
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.7203513864726575,1.521179436746826,0.010869565217391304,0.22677918682506462,1.0,25/59,16.12%,SPARC;COL11A1;KCNT2;CLIP3;BRINP1;DZIP1;PLPPR4;FBXL7;CDH2;DGKI;RUNX1T1;ANK2;CSRNP3;CHN1;NLGN1;PTN;MAP1B;TRPC4;CRMP1;GRIA3;CSMD2;ADGRL2;STMN2;THY1;EDIL3
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.9702623470394781,1.521098952616587,0.0,0.225039352842094,1.0,1/9,0.01%,KCNE1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.8600172399573323,1.5210559668239167,0.0,0.22315804349652807,1.0,5/23,7.48%,KCNE1;CACNB2;SCN3B;ANK2;PKP2
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.8398827621550026,-1.5207728820097601,0.03225806451612903,0.43541853278103576,1.0,1/7,0.82%,PDE12
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.5679464761206667,-1.520490211309044,0.0,0.4340560910158818,1.0,30/78,15.91%,ITK;NKG7;CD37;CST7;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PTPN7;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;IL12RB1;PYHIN1;PSTPIP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.9032451928532754,-1.520334332000442,0.023809523809523808,0.4296708766417489,1.0,1/5,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.9032451928532754,-1.520334332000442,0.023809523809523808,0.4296708766417489,1.0,1/5,0.03%,PHLDB2
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.4940692309587309,-1.519533953564247,0.0,0.43028195418085624,1.0,23/74,15.91%,NKG7;CD37;BIN2;SELPLG;CD2;SAMSN1;CEACAM21;HCST;RASAL3;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PTPN7;PRF1;CD53;SNX20;PIK3R5;IL12RB1;PYHIN1;PSTPIP1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7286081841003536,1.5188578214717652,0.0,0.23212271465656661,1.0,41/81,15.84%,AMER2;GRIA4;SCN3B;NCAN;KCTD16;MEIS2;NRXN1;SLC1A2;PHYHIPL;DIRAS2;CA10;GRM3;GRIN2A;BSN;FRRS1L;SNAP25;CSRNP3;UNC13A;GRIA2;GABRA2;OLFM3;NTRK3;CADPS;TMEM130;SCN1A;CACNA1B;PPFIA2;MAGI2;GAD2;TMEM132B;PAK5;STMN2;CTNNA2;GRIN2B;LSAMP;SLC17A7;NDRG4;SCN2A;ST8SIA3;ASIC2;SYNPR
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.8719041246186368,1.5183227944048312,0.0,0.2332946923723905,1.0,3/16,4.13%,KCNE1;KCNT2;SLC11A1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.7638956942389736,-1.5182527150531144,0.07692307692307693,0.43242691752081575,1.0,3/11,9.74%,TAL1;CEBPA;EP300
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8570722577587292,1.5179909740030535,0.013333333333333334,0.23223802648699712,1.0,4/17,6.41%,KCNE1;FHL1;ANK3;ANK2
prerank,CellMarker_Augmented_2021__Monocyte Derived Dendritic cell:Peripheral Blood,-0.8842449733872726,-1.5179306057427382,0.038461538461538464,0.4311189414450284,1.0,2/7,8.22%,ITGAM;ITGAX
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.7610089841778327,-1.5168236990413584,0.05714285714285714,0.43396114549571696,1.0,5/12,19.43%,KARS1;DARS2;SARS1;TRPT1;RPP30
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.9039671599245419,1.5162899958193108,0.0125,0.23977931440648073,1.0,1/9,0.38%,PLPP3
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.7756108669233404,1.5158755726383124,0.012048192771084338,0.2392662825517352,1.0,7/24,8.46%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2;PAX8;MAFB
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.6742035989424471,-1.5151713608035586,0.04,0.43756585406697307,1.0,5/15,8.31%,SMDT1;MAIP1;MICU3;STOML2;PHB2
prerank,KEGG_2021_Human__Other glycan degradation,-0.7192426647214492,-1.5151018315742355,0.0,0.4352465474778564,1.0,5/14,17.41%,HEXD;MAN2B2;MAN2B1;MANBA;AGA
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.5596269506761944,-1.514846092056337,0.0,0.43395168158873265,1.0,31/80,14.74%,NKG7;CD37;CST7;LY86;GIMAP8;BIN2;SELPLG;CD2;SAMSN1;MPEG1;GZMB;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PTPN7;TYROBP;PRF1;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5;IL12RB1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.7262221168667558,1.5135264320295478,0.025,0.24875566706217475,1.0,5/41,4.63%,THBS1;ACVR1B;TGFB2;ACVR2A;BMPR1B
prerank,CellMarker_Augmented_2021__Neuron:Brain,0.8034131309658484,1.5135107229800027,0.012658227848101266,0.2465346343205482,1.0,11/20,12.79%,COBL;GFAP;RELN;DPYSL5;LNX1;ENO2;SYP;MAP2;TMEM130;GRIA3;NFASC
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.7159873955588449,1.5133265175454769,0.0,0.2452453030054235,1.0,44/72,22.90%,SULT4A1;NCAN;KCTD16;BRINP1;CASKIN1;DPYSL5;SRRM3;SYT4;TTC9B;BSN;SNAP25;ARNT2;UNC13A;CHN1;GRIA2;ERC2;MAP2;FAM171B;TAGLN3;MAP1B;CRMP1;CACNA1B;DNM1;PNMA2;TYRO3;SH3GL2;SYT1;STMN2;NDRG4;ST8SIA3;KIF5A;APLP1;CHD5;NMNAT2;GABRG2;TMEM59L;MAPK8IP2;SNAP91;REEP2;CNTN2;ELAVL3;KCNQ2;DCLK1;MAPK8IP1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.8340959590466474,-1.512593957423507,0.027777777777777776,0.4392016944648523,1.0,5/6,16.52%,KMT2B;SETD1B;SETD1A;KMT2D;KMT2A
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.7343059101991266,1.5120092471206117,0.021052631578947368,0.2498488740634003,1.0,11/41,13.36%,DIAPH3;COBL;MAPT;HDGFL3;SPIRE2;MICALL2;PSTPIP2;MID1IP1;WASF1;CKAP5;TPPP
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.8123217921610032,1.5113842038381489,0.05128205128205128,0.25022717338993733,1.0,5/17,11.28%,OMD;OGN;B4GAT1;GNS;B4GALT5
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,0.7127271483080645,1.5112773528746573,0.010869565217391304,0.24886032625030197,1.0,16/62,9.80%,TNC;P4HA3;RBMS3;ENAH;DZIP1;PTPRG;LAMB1;FBXL2;CLMP;RND3;MYO10;FMN2;FN1;PPFIBP1;MAP1B;TRPC4
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.8934991183342466,1.5100087979497376,0.0,0.25323660647974855,1.0,3/11,1.30%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.6904922463083475,-1.5098492159217158,0.0,0.44651344079261696,1.0,2/17,3.60%,CCL5;LGALS9
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.8230281640077062,1.5097203898693135,0.025,0.2522558670840588,1.0,10/20,13.96%,NAMPT;SH3PXD2B;ZBTB16;CHI3L1;ARID5B;ITGB8;SOX6;SULF2;SPTLC2;PKD1
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.8006996234378752,-1.509475541846369,0.10256410256410256,0.44553024038822936,1.0,1/6,4.68%,BAP1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.9189792553112068,1.5094704413397417,0.014705882352941176,0.25183086308690633,1.0,2/8,2.53%,THBS1;PRKCE
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.729842163410659,1.508622079147923,0.023255813953488372,0.2536283710318521,1.0,11/51,11.07%,THBS1;ACVR1B;TGFB2;THSD4;TGIF1;ACVR2A;BMPR1B;RPS6KB2;ID2;LTBP1;RBX1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.7138869203872193,-1.508588606679827,0.05263157894736842,0.4467230059244033,1.0,3/21,5.87%,RING1;DDB2;LEO1
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,0.8964342199204396,1.5080782163711053,0.029411764705882353,0.25365362527570673,1.0,1/9,0.82%,FGF1
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,0.9052962850152191,1.5066943672617912,0.01282051282051282,0.25901352803084954,1.0,1/9,0.14%,SOCS3
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.794528592425904,1.5049910465844027,0.0,0.2665222024125487,1.0,10/31,14.45%,CLDN18;CADM1;CDH8;CDH2;CADM2;CDH9;CLDN20;CDH12;PARD3;CDH10
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.7884903825968066,1.5038097071313596,0.02631578947368421,0.2713961572263688,1.0,2/22,0.30%,THBS1;KLF4
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,-0.8563131510803591,-1.5032446439620917,0.08,0.4657609078171353,1.0,2/6,7.43%,ITGA5;CBFB
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8504471619718084,1.5028899855112663,0.01282051282051282,0.2739186407144003,1.0,7/16,6.83%,HTR2B;TSHR;HTR7;CHRM5;AGT;ANXA1;CNR1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.8725399158571879,1.5027359271477445,0.0136986301369863,0.2723267334401097,1.0,3/16,3.16%,FGF1;FLRT1;PIGU
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7351649068215503,1.5024756064430143,0.0,0.2715539128607801,1.0,39/86,15.39%,PCSK1;FAM13C;COL11A1;KCNT2;GNRHR;GRIA4;PTPRD;KCTD16;PLPPR4;NRXN1;RAB3C;CADM2;ASXL3;ROBO2;RUNX1T1;SYT4;FMN2;CSRNP3;GRIA2;OLFM3;SCN3A;UNC5D;CADPS;TMEM130;NOVA1;ZNF536;GRIA3;SGIP1;FGF14;MAGI2;NREP;GAD2;NFASC;STMN2;LSAMP;MAPK10;CHGB;ST8SIA3;THY1
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.7071025529685847,1.5023719512992861,0.0,0.2695756368309181,1.0,29/84,15.54%,HHIP;FGF1;PCDH9;GFAP;CLIP3;SPOCK1;KCTD16;CDH2;DOK6;DGKI;GABRB1;FRMPD4;FMN2;SNAP25;CHN1;PDE1C;DNM3;MAP1B;SPTAN1;DNM1;PNMA2;GRIA3;NALCN;NEGR1;EPHA5;ZC3H12B;SCN8A;SCN2A;KIF5A
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,0.9725074717160941,1.50223102935194,0.0,0.26819654588798264,1.0,1/6,0.24%,TNC
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.8791046233894879,-1.502071857458271,0.08108108108108109,0.4675258380063872,1.0,2/5,8.55%,TICAM1;TLR3
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,-0.4942035787054453,-1.5011366625638016,0.125,0.4683784352755323,1.0,33/82,14.29%,CD300LF;ITGAM;LY86;LYL1;P2RX1;SH2B3;PIK3R6;UBA7;FOLR2;LGALS9;CSF1R;IL4I1;LILRB4;ICAM1;ARHGDIB;ITGAX;TRPV2;MILR1;ENG;MAN2B1;NCKAP1L;WDFY4;PLEK;HCK;PTGS1;BTK;ITGB2;CYTH4;TYROBP;CD53;CTSZ;SCARF1;SLC15A3
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.26950455586589595,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.26950455586589595,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.26950455586589595,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.8836843252427338,1.5005495453970592,0.012048192771084338,0.26950455586589595,1.0,2/11,3.61%,CENPF;TEX14
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.7389302581791035,-1.500346966688,0.0,0.46840135455696097,1.0,2/16,4.08%,RING1;DDB2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.7663551831658132,1.5003141557075865,0.0,0.26872475492171777,1.0,4/30,4.57%,GLRA1;GRAMD1C;ADCY3;ADAM15
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.7487313862198219,1.4999713333813711,0.0,0.26843184757400573,1.0,19/46,15.39%,TNC;PLPP3;SPARC;ADAMTS2;COL11A1;PREX2;PTPRD;DZIP1;FBXL7;RUNX1T1;PTPRZ1;ANK2;PTN;CRMP1;PLTP;NFASC;TIMP3;WNT5A;THY1
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.48371774100488835,-1.4993227588363935,0.0,0.4697168975604138,1.0,11/62,5.90%,THEMIS;ITK;NKG7;CCL5;ZNF831;CST7;GNLY;BIN2;CD2;GZMB;CD96
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7239850813924273,1.4985529565835212,0.0,0.27387280426180416,1.0,41/90,15.35%,PCSK1;PCDH17;LRRC4C;SULT4A1;GRIA4;SCN3B;MAPK4;NRXN1;RAB3C;CADM2;UBE2QL1;PHYHIPL;ASXL3;CNTN1;CTNND2;CA10;ROBO2;SYT4;TCEAL2;SYP;SNAP25;CSRNP3;PTPRT;GRIA2;MAFB;GABRB3;UNC5D;CADPS;NOVA1;CACNA1B;CAMK2B;GAD2;SH3GL2;NFASC;PAK5;LY6H;STMN2;LSAMP;MAPK10;CHGB;ST8SIA3
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5445217760073863,-1.498446006742509,0.0,0.4714250457367775,1.0,15/85,5.90%,THEMIS;ITK;NKG7;SKAP1;CCL5;GRAP2;CST7;GNLY;CYTL1;BIN2;SELPLG;CD2;GZMB;HCST;CD96
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7063105755756733,1.498328684112082,0.0,0.27361351046062177,1.0,55/124,19.52%,GLRA1;HTR2B;HTR7;PRKAR2B;CHRM5;GRIA4;CACNB2;NRXN1;SLC1A2;NRXN2;GRIK2;GAD1;GABRB1;GRM3;GRIN2A;GRIK1;BSN;NLGN3;SNAP25;GRIA2;NLGN1;GABRB3;GABRA2;KCNMB1;NOVA1;CACNA1B;CHRM3;GABRB2;PLP1;RPS6KA2;GRIA3;PMP22;GAD2;SYT1;DLGAP1;GABRA4;UNC13C;GLRB;GRIN2B;SDCBP;HTR1F;CPLX1;KIF5A;ASIC2;NRGN;CACNA1A;GRIA1;AMPH;GABRD;SPG11;GRM7;GRIK4;GABRG2;DLG4;NLGN4X
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,0.9041085445918714,1.4981879198066586,0.013888888888888888,0.27242795956040483,1.0,1/10,0.14%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.9027154818083578,-1.4976581818169012,0.04,0.4713646413435183,1.0,2/8,6.70%,RALB;PIP4K2B
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.9031319298897712,1.4972642343106637,0.02857142857142857,0.2751506190374154,1.0,2/10,3.16%,FGF1;PIGU
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.7354386548202106,1.4968485328440821,0.0,0.27613188656832716,1.0,41/69,19.66%,SULT4A1;VGF;NCAN;KCTD16;FRMD5;CASKIN1;DPYSL5;SRRM3;STXBP5L;GRM3;SYT4;TTC9B;SYP;SNAP25;UNC13A;GRIA2;ERC2;FAM171B;OLFM3;TAGLN3;RIMS2;CSPG5;WASF1;CACNA1B;PNMA2;SH3GL2;SYT1;PAK5;STMN2;CTNNA2;NDRG4;ST8SIA3;KIF5A;APLP1;CHD5;SYT14;TMEM145;GABRG2;TMEM59L;MAPK8IP2;SNAP91
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.6997534932351351,1.4966354497443228,0.0,0.2752787805559759,1.0,30/65,19.52%,IL1RAPL2;SHANK3;GRIA4;PTPRD;IL1RAPL1;NRXN1;BEGAIN;NRXN2;LRRTM4;SHANK2;GRIN2A;SIPA1L1;NLGN3;NLGN1;NRXN3;PPFIBP1;NTRK3;SLITRK5;PPFIA2;GRIA3;SYT1;DLGAP1;GRIN2B;LRRTM2;DLGAP2;GRIA1;EPB41L5;PPFIA4;RTN3;NLGN4X
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.6613524915809353,-1.4965527671381587,0.0,0.47244391822160003,1.0,7/24,13.23%,ITK;GRAP2;ITPR2;NFATC3;BTK;LCP2;SYK
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7466219171413978,1.496167184115457,0.012195121951219513,0.2759870913357801,1.0,9/30,14.25%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.6931562185654674,-1.495534869443337,0.07407407407407407,0.4734455742772717,1.0,5/14,10.52%,CX3CR1;FFAR4;LILRB4;IGF1;NLRP3
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.8817816844740485,-1.4946203687112924,0.03571428571428571,0.47384016949234337,1.0,4/7,10.03%,SKAP1;SRC;P2RY12;PLEK
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.8966084089559256,1.4940627622761153,0.013333333333333334,0.2851476099965486,1.0,1/12,0.38%,PLPP3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6995314018805107,1.4939780676470882,0.0,0.2837403739179129,1.0,57/104,19.66%,SULT4A1;PDE5A;AMER2;GRIA4;NCAN;BRINP1;PDE1A;NRXN1;RAB3C;CADM2;NRXN2;GAD1;SLC24A2;CTNND2;CA10;GRM3;SYT4;SHANK2;BSN;TCEAL2;SYP;SNAP25;GRIA2;SLC22A15;FAIM2;OLFM3;CACNG2;CADPS;CACNA1B;CNTNAP2;PLP1;GRIA3;VSTM2B;GAD2;GRID2;PPM1E;DLGAP1;PAK5;LY6H;STMN2;CALY;CTNNA2;HCN1;HIVEP2;ST8SIA3;CPLX1;KIF5A;ASIC2;SLC24A3;SYNPR;KCNMA1;PKP4;ATP1B2;GABRG2;PTPN5;DLG4;SNAP91
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.7021310380967911,1.493270559067764,0.0,0.28513434649447106,1.0,34/77,15.69%,PCSK1;FAM13C;PCDH17;KCNT2;PTPRD;MAPK4;AGT;PLPPR4;NRXN1;RAB3C;PHYHIPL;ASXL3;CNTN1;SYT4;SNAP25;CSRNP3;PTPRT;GRIA2;GABRB3;SHC2;UNC5D;CADPS;GRIA3;KALRN;SORBS1;GAD2;NFASC;LY6H;STMN2;MAPK10;CHGB;CPE;ST8SIA3;ASIC2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.8259228221890804,-1.4930537635166383,0.0625,0.4746175220660347,1.0,3/8,6.50%,RPS6KA6;TFAP4;TP53
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.8259228221890804,-1.4930537635166383,0.0625,0.4746175220660347,1.0,3/8,6.50%,RPS6KA6;TFAP4;TP53
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.7258835093837203,1.492949838478459,0.0,0.2853790096566516,1.0,48/91,19.26%,AMER2;SLCO1A2;SCN3B;KCTD16;ZNF483;IL1RAPL1;CDH8;FRMD5;PCDH15;TTLL7;SYT16;LRRTM4;KIF1B;SLC24A2;STXBP5L;GRM3;FBXL2;ANK2;AKAP6;MGAT4C;FRRS1L;PEX5L;CSRNP3;UNC13A;ERC2;GABRB3;RIMS2;MAP1B;DGKB;CADPS;SCN1A;CACNA1B;CLASP2;MAGI2;GAD2;GRID2;TMEM132B;CTNNA2;HCN1;GRIN2B;NDRG4;ST8SIA3;SYNPR;KIF3A;PRKAA2;SYT14;GABRG2;PTPN5
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.698139964140009,1.492519489051918,0.010752688172043012,0.2856203440683262,1.0,40/67,21.39%,AMER2;NCAN;GPM6B;GALNT8;NRXN1;NELL2;RAB3C;UBE2QL1;NRXN2;ASXL3;CTNND2;KCNH8;PTPRZ1;CNR1;TCEAL2;NLGN3;GRIA2;UNC5D;KHDRBS2;CACNA1B;CNTNAP2;ZNF536;PAK5;LY6H;STMN2;CTNNA2;LSAMP;NEFL;ST8SIA3;KIF5A;ATP1B2;PTPN5;B3GAT1;SNAP91;NCAM1;CNTN2;PDZD4;KIF5C;SORCS3;ELAVL3
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.7393246351842461,1.492464402160097,0.011235955056179775,0.2843098884002445,1.0,20/48,12.36%,LRP4;FRAS1;ENAH;COL4A5;DZIP1;FBXL7;PTPRG;CDH2;LIFR;LAMB1;RBFOX2;LINGO1;AKAP12;ROBO1;TUSC3;MAP1B;CRMP1;FIGN;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Kidney,-0.9226648418890225,-1.4918008326494676,0.0,0.4774178682867504,1.0,2/6,1.47%,TRGC2;GNLY
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.8865251258588408,1.4917874071116715,0.014705882352941176,0.28578566752881535,1.0,1/10,0.82%,FGF1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.70854705156072,1.4917589108557685,0.0,0.28406377555567436,1.0,34/82,15.46%,FAM13C;FGF1;LRP4;ASPA;GFAP;CLIP3;MAPK4;AGT;PLPPR4;PHYHIPL;DAAM2;NDRG1;SEMA3B;ANK2;OLIG1;ARNT2;GRIA2;MAG;FAIM2;PTN;SHC2;GPRC5B;CTHRC1;PLP1;NTRK2;PMP22;SORBS1;NFASC;RGS11;BCAS1;NDRG4;CPE;THY1;BAG3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.7088839053988794,1.4911578948255075,0.0,0.2852180851610089,1.0,11/60,12.39%,THBS1;PLPP3;RHOB;SPARC;FGF1;AGT;VEGFA;HIF1A;SEMA5A;SASH1;GPI
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.7854774639327349,-1.491021649312769,0.12121212121212122,0.47758994409763605,1.0,3/5,21.14%,AKNA;TRPV4;SPI1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.7543357063262168,1.4897554582421266,0.025,0.29148365183820735,1.0,9/21,16.77%,SHROOM3;ARFGEF3;EYA2;SHANK2;SLC9A7;MROH9;DNAH7;NEBL;KCNMA1
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.8936225034919866,1.4897033831331916,0.028169014084507043,0.28975828072526266,1.0,2/11,3.16%,FGF1;PIGU
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.7374790144790189,1.488965023916897,0.0,0.28986381183686916,1.0,16/40,12.85%,SPON1;PCDH17;ENPP2;PREX2;PTPRD;ASXL3;RUNX1T1;SEMA6A;PTPRT;CHL1;THSD7A;FLT1;KALRN;NTRK2;SORBS1;SHROOM4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.7374790144790189,1.488965023916897,0.0,0.28986381183686916,1.0,16/40,12.85%,SPON1;PCDH17;ENPP2;PREX2;PTPRD;ASXL3;RUNX1T1;SEMA6A;PTPRT;CHL1;THSD7A;FLT1;KALRN;NTRK2;SORBS1;SHROOM4
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,0.7353981104430435,1.4881292632186116,0.03296703296703297,0.29247182637292124,1.0,15/42,16.12%,TNC;FGF1;NTN4;OSMR;FBXL7;LAMA2;LAMB1;CLMP;RND3;FN1;PTN;SGCE;SERPINE2;THY1;EDIL3
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.9595898034485513,1.4874829354788401,0.0,0.29411237162630016,1.0,3/8,2.92%,RAB7B;HMGB2;FAXDC2
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.6279862906517911,-1.4870948610327461,0.0,0.49005205940366187,1.0,4/20,9.25%,FLNA;MYH9;NF2;PKN1
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,-0.8313276381621035,-1.4870508306297474,0.08333333333333333,0.48784297207705474,1.0,2/8,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.7090030903177729,1.4868989978490486,0.0,0.29509392139728535,1.0,22/53,15.99%,LRRC4C;COL11A1;PREX2;PTPRD;BRINP1;GPM6B;FBXL7;CTNND2;RUNX1T1;LRRN1;SEMA6A;LINGO1;TCEAL2;CSRNP3;PTN;CRMP1;GPRC5B;PLP1;NTRK2;STMN2;THY1;LDB2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8148843345781791,1.4863599416204938,0.0,0.29594781279984017,1.0,3/21,5.73%,TOP2A;KNSTRN;SMC4
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,-0.6569268286054029,-1.4858997920781634,0.043478260869565216,0.49026791425909577,1.0,6/18,10.62%,MAF;YES1;WWTR1;CBFB;SRC;ABL1
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,-0.8373856999044827,-1.4857524995341334,0.0,0.48871673859454623,1.0,1/5,7.71%,TRAK2
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.8660887223468166,-1.484877739616556,0.10714285714285714,0.48786897016467073,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.8660887223468166,-1.484877739616556,0.10714285714285714,0.48786897016467073,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.9087441255716446,1.4842590836952516,0.0,0.30658857230228326,1.0,3/9,1.30%,GLRA1;HHIP;NLRP12
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.8171453684412837,1.4836146188334196,0.0,0.3082714960936423,1.0,7/23,7.86%,CENPF;LRP4;TGFB2;GREB1L;AGT;VEGFA;PAX8
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,-0.8609772559518183,-1.482809059384433,0.13793103448275862,0.4934520194968226,1.0,2/5,9.02%,ABCG2;ENG
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,0.9167189634090519,1.4822517344855817,0.0,0.3138948179637849,1.0,1/12,0.14%,SOCS3
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.9104012482664106,1.4822276993405008,0.015625,0.31225028811490346,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7579577254349412,-1.4820726452503314,0.030303030303030304,0.49429162969535634,1.0,3/11,9.22%,IDE;ERAP2;HLA-E
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7702502949533225,1.4818482457638145,0.012658227848101266,0.31241455312158867,1.0,3/23,6.30%,GLRA1;VEGFA;NSMF
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7141113001404947,-1.4815378934835763,0.037037037037037035,0.4937539902157556,1.0,2/15,1.82%,BUD23;FBL
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.710212931888273,1.4814912905944828,0.0,0.31196567433600214,1.0,35/55,22.72%,FAM13C;PCDH17;ENPP2;PREX2;PTPRD;PLPPR4;FBXL7;ASXL3;RUNX1T1;BAALC;PTPRT;CHL1;PTN;THSD7A;GPRC5B;PLP1;SGIP1;KALRN;NTRK2;SORBS1;NFASC;SHROOM4;STMN2;MAPK10;THY1;LDB2;SORBS2;TMEM178A;TCF4;ATP1A2;CX3CL1;TSPAN7;RCAN2;SPARCL1;PDZRN4
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.45729231607780685,-1.481404020220757,0.0,0.4894877390848642,1.0,28/83,14.46%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SELPLG;CD2;PIK3R6;MPEG1;CSF1R;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.45729231607780685,-1.481404020220757,0.0,0.4894877390848642,1.0,28/83,14.46%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SELPLG;CD2;PIK3R6;MPEG1;CSF1R;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2;PIK3R5
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7436738767161132,1.4811700130880685,0.0,0.31240579799546836,1.0,38/72,15.69%,PCSK1;SULT4A1;ENPP2;GRIA4;NCAN;NRXN1;RAB3C;PHYHIPL;ASXL3;VEGFA;CTNND2;CA10;SYT4;SYP;SNAP25;CSRNP3;PTPRT;UNC13A;GRIA2;ALCAM;OLFM3;TAGLN3;SCN3A;UNC5D;CADPS;CACNA1B;GAD2;SH3GL2;NFASC;CCK;PAK5;LY6H;STMN2;CALY;CHGB;CPE;ST8SIA3;ASIC2
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.5112366977535483,-1.4809645953823813,0.0,0.488857348729245,1.0,15/71,12.54%,GBP3;LY86;PTAFR;IL1B;UBA7;MPEG1;LGALS9;CSF1R;ICAM1;TNFSF10;HLA-E;PLEK;HCK;OAS2;TYROBP
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.7646982233558391,1.4809287205327142,0.0375,0.3117427716088063,1.0,11/34,10.26%,TNC;ASPN;SPARC;SVEP1;ADAMTS2;COL11A1;FBXL7;LAMA2;RUNX1T1;FN1;SEMA5A
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8099529751017641,1.4805770415677184,0.047058823529411764,0.3118515792700161,1.0,4/14,7.49%,GLRA1;INSYN2A;GRIN2A;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.6936444905101977,-1.4795410317730426,0.05263157894736842,0.4897420704771963,1.0,7/18,17.28%,GZMB;TP53;BID;PPP1R13B;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.6936444905101977,-1.4795410317730426,0.05263157894736842,0.4897420704771963,1.0,7/18,17.28%,GZMB;TP53;BID;PPP1R13B;PPP3CC;BCL2;CASP8
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.9071120664928116,1.4792909031322963,0.03076923076923077,0.31619015642931475,1.0,1/8,0.50%,NFIL3
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.7181512994136893,1.478803751871233,0.010869565217391304,0.3179432053020128,1.0,24/63,15.06%,TNC;PLPP3;SVEP1;LRP4;ENAH;COL4A5;PTPRG;LIFR;DMD;PTPRZ1;ANK2;RND3;MYO10;PALLD;ROBO1;TUSC3;PTN;FIGN;SH3D19;ADGRL2;COL21A1;ITSN1;TIMP3;WNT5A
prerank,KEGG_2021_Human__Nicotine addiction,0.7841232602467161,1.478008840689838,0.013157894736842105,0.32042628908420634,1.0,17/22,18.88%,GRIA4;GRIN3A;GABRB1;GRIN2A;GRIA2;GABRB3;GABRA2;CACNA1B;GABRB2;GRIA3;GABRA4;GRIN2B;SLC17A7;CACNA1A;GRIA1;GABRD;GABRG2
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,0.8579655992887415,1.4777901841384953,0.025,0.31984250235965495,1.0,5/11,7.93%,ITGA2;OVOL2;BAIAP2L1;RND3;PPP1R13L
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,0.8378715832006989,1.4777435601021534,0.011494252873563218,0.3182586523610218,1.0,4/19,3.87%,THBS1;KLF4;ITGA2;ANXA1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.8232881205076226,-1.477579466222592,0.09375,0.49595793538838384,1.0,3/11,2.39%,CCL5;INPP5K;TFAP4
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.8321019363499753,-1.477465486525529,0.10344827586206896,0.49440580256138794,1.0,1/8,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.8523064864549813,-1.4774630604200578,0.1111111111111111,0.49214824181909855,1.0,2/6,8.55%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.7080994213095052,1.477438613469887,0.0,0.3179574613995072,1.0,15/72,12.87%,KCNE1;GLRA1;AANAT;TSHR;EGR1;GABRB1;NSMF;AKAP6;RAPGEF3;GABRB3;PDE2A;IMPACT;GABRB2;RYR3;BRCA1
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.8833255755548287,1.4768604896206003,0.029411764705882353,0.31970270879326546,1.0,1/10,0.82%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.725200148011071,1.4754827280892215,0.010869565217391304,0.32611594284578854,1.0,14/63,7.22%,THBS1;RHOB;SPARC;FGF1;TGFB2;ENPP2;PRKCE;DOCK1;GLIPR2;AGT;ARF6;DOCK5;VEGFA;HIF1A
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,0.7493772583392636,1.4752500973025362,0.03529411764705882,0.3251021615207139,1.0,8/32,5.92%,ASPN;SPARC;ADAMTS2;ECM2;TNS1;DAAM2;LAMA2;RUNX1T1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.750773601895063,-1.474806900995391,0.027777777777777776,0.5002383200323703,1.0,4/9,18.76%,GZMB;PLEKHM2;LYST;CEBPG
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.7364137151707288,1.4740382213182017,0.0,0.3241472890775185,1.0,42/70,18.88%,OPALIN;MOBP;AMER2;GRIA4;GFAP;GPM6A;MAPT;NCAN;SLC1A2;CADM2;DIRAS2;SLC24A2;GABRB1;CA10;MOG;GRM3;FRRS1L;SYP;TTYH1;CDH20;GRIA2;MAG;FAIM2;NTRK3;TMEM130;SCN1A;ADCY8;PLP1;VSTM2B;GAD2;ANKS1B;CTNNA2;SNTG1;GRIN2B;ST8SIA3;SYNPR;SLC39A12;DPP6;GRIA1;RPH3A;ATP1B2;GABRG2
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.7364137151707288,1.4740382213182017,0.0,0.3241472890775185,1.0,42/70,18.88%,OPALIN;MOBP;AMER2;GRIA4;GFAP;GPM6A;MAPT;NCAN;SLC1A2;CADM2;DIRAS2;SLC24A2;GABRB1;CA10;MOG;GRM3;FRRS1L;SYP;TTYH1;CDH20;GRIA2;MAG;FAIM2;NTRK3;TMEM130;SCN1A;ADCY8;PLP1;VSTM2B;GAD2;ANKS1B;CTNNA2;SNTG1;GRIN2B;ST8SIA3;SYNPR;SLC39A12;DPP6;GRIA1;RPH3A;ATP1B2;GABRG2
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.7364137151707288,1.4740382213182017,0.0,0.3241472890775185,1.0,42/70,18.88%,OPALIN;MOBP;AMER2;GRIA4;GFAP;GPM6A;MAPT;NCAN;SLC1A2;CADM2;DIRAS2;SLC24A2;GABRB1;CA10;MOG;GRM3;FRRS1L;SYP;TTYH1;CDH20;GRIA2;MAG;FAIM2;NTRK3;TMEM130;SCN1A;ADCY8;PLP1;VSTM2B;GAD2;ANKS1B;CTNNA2;SNTG1;GRIN2B;ST8SIA3;SYNPR;SLC39A12;DPP6;GRIA1;RPH3A;ATP1B2;GABRG2
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.7364137151707288,1.4740382213182017,0.0,0.3241472890775185,1.0,42/70,18.88%,OPALIN;MOBP;AMER2;GRIA4;GFAP;GPM6A;MAPT;NCAN;SLC1A2;CADM2;DIRAS2;SLC24A2;GABRB1;CA10;MOG;GRM3;FRRS1L;SYP;TTYH1;CDH20;GRIA2;MAG;FAIM2;NTRK3;TMEM130;SCN1A;ADCY8;PLP1;VSTM2B;GAD2;ANKS1B;CTNNA2;SNTG1;GRIN2B;ST8SIA3;SYNPR;SLC39A12;DPP6;GRIA1;RPH3A;ATP1B2;GABRG2
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.9184743326568154,1.47324023542713,0.0,0.32710101446064765,1.0,1/11,0.01%,KCNE1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.8351929586050909,1.4729692419878984,0.01282051282051282,0.3268164117345059,1.0,7/20,10.47%,KCNE1;SCN3B;ANK2;PKP2;CAV3;RYR2;SCN1A
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7020675750010328,1.4729162484941793,0.0,0.3252395245081058,1.0,38/71,21.39%,SULT4A1;NCAN;MAPK4;CASKIN1;DPYSL5;B4GALNT4;SYT4;CNR1;LINGO1;CSRNP3;UNC13A;ERC2;ADGRB2;TAGLN3;MAP1B;UNC5D;CSPG5;CRMP1;CACNA1B;EPHA7;GRID2;EPHA4;PPM1E;PAK5;STMN2;DAB1;KIF5A;APLP1;EZH2;NTNG1;TMEM59L;SNAP91;NCAM1;POU6F2;REEP2;TACC3;KIF5C;ELAVL3
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.9335292309320706,1.4727543717760854,0.014492753623188406,0.3243734256153378,1.0,1/6,0.30%,KLF4
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.7797221875509858,1.4726365534453385,0.012048192771084338,0.32327020707305054,1.0,9/28,12.57%,THBS1;SPON1;ADAMTS2;THSD4;B4GAT1;THSD7A;SEMA5A;ADAMTSL3;THSD7B
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.8200000568502601,1.4726268660560395,0.029850746268656716,0.32159051233212094,1.0,8/14,14.65%,PRLR;TSHR;CYP3A5;TG;SLC5A9;FMO5;SLC10A1;DIO1
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.7903484388145017,1.4723329666616023,0.0136986301369863,0.3214403143761797,1.0,4/20,5.43%,DKK2;FZD6;PPP2R5B;PPP2R5A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7407206542021543,1.4721463456787474,0.011627906976744186,0.3205156388943352,1.0,20/31,20.68%,GRM8;SHANK3;RELN;NRXN1;TSHZ3;CDH2;DGKI;GRM3;GRIK1;NLGN3;UNC13A;NLGN1;CACNG2;SYT1;CACNG8;GRM7;MAPK8IP2;TNF;ATP1A2;LRRK2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.8485183542535957,1.4718665681404868,0.0,0.3205656747880074,1.0,2/15,0.90%,HHIP;FBN2
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.757254279548357,1.471814207881942,0.012658227848101266,0.3194632758950371,1.0,14/26,12.36%,PCDH17;PREX2;PTPRD;CACHD1;ASXL3;CGNL1;RUNX1T1;LINGO1;SHC2;RYR2;CCDC3;EPHA7;FLT1;ADGRL2
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.7082635469201345,1.4716040824329695,0.0,0.3187543307621696,1.0,37/80,15.11%,SCRG1;SPARC;LRRC4C;OMG;LHFPL3;GPM6B;PCDH15;CADM2;ENC1;RTN1;RFTN2;SOX4;CNTN1;CA10;PTPRZ1;LUZP2;OLIG1;RND3;TTYH1;KANK1;ALCAM;SPRY1;SCD5;PTN;CSPG5;ITGB8;SEMA5A;NOVA1;SCN1A;PDE4B;SOX6;GRID2;SYT1;STMN2;SERPINE2;LSAMP;PLLP
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.7148460274186605,1.4715382578350764,0.011111111111111112,0.31748274523570125,1.0,29/65,15.39%,PCDH17;GFAP;PTPRD;GPM6B;MAPK4;PLPPR4;NRXN1;PHYHIPL;DAAM2;CNTN1;PTPRZ1;ANK2;LINGO1;PTPRT;CHL1;FAIM2;NDRG2;PTN;SHC2;GPRC5B;CCDC3;PLP1;ZNF536;NTRK2;SORBS1;NFASC;STMN2;ALDH1A1;THY1
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.7260667472789593,1.4713373800177751,0.011764705882352941,0.31650779328742,1.0,26/59,16.38%,TNC;PLPP3;SPARC;FGF1;ADAMTS2;COL11A1;DZIP1;PLPPR4;FBXL7;DAAM2;LAMA2;RUNX1T1;ANK2;BAALC;ARNT2;PDE1C;PTN;PLP1;PMP22;NFASC;TIMP3;COL5A3;THY1;LDB2;EDIL3;ZBTB47
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.6674696097452,1.471181932099389,0.0,0.3157778995775627,1.0,46/131,16.75%,CRISPLD2;C1QTNF7;FBN2;PLIN2;RBMS3;OGN;PDE5A;VIM;PCDH9;RPL23;CERCAM;GULP1;COL4A5;ENC1;LIFR;LAMA2;RBFOX2;RND3;NLGN1;NDRG2;RPS6;TSC22D3;RIMS2;RPS27A;SEMA5A;PPFIA2;HIF3A;PMP22;RPL9;SYT1;RPS18;INSIG1;NEGR1;SERPINE2;LSAMP;NEFL;TIMP3;WNT5A;SCN2A;THY1;ANGPT2;PLOD1;TSHZ2;CCND3;LITAF;RPS24
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.7804548559283718,1.470610794648985,0.023529411764705882,0.3178149952965519,1.0,8/25,9.47%,PLPP3;CYP3A5;PLPPR4;ALOX12;DGKI;ALOX15B;MBOAT2;DGKB
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,0.8855707108429842,1.4705750220755758,0.012345679012345678,0.3163413246176743,1.0,6/15,7.48%,FA2H;TOM1L1;LSR;OVOL2;BAIAP2L1;PKP2
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.8131506599522138,1.4698685614508655,0.05263157894736842,0.3180772013488179,1.0,5/16,11.28%,OMD;OGN;B4GAT1;GNS;B4GALT5
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.7683206061290584,1.4695112940213972,0.0125,0.31790689383498427,1.0,6/26,6.04%,FBN2;TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.8682320928285105,1.469074939035117,0.06349206349206349,0.31893003716378804,1.0,3/7,12.26%,THBS1;SPRY1;SULF2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.7431440754464695,1.4690466005031073,0.0,0.3175713626137001,1.0,23/48,14.79%,PTPRD;PPP1R9A;NCAN;GPM6B;MAPK4;NRXN1;ASXL3;CTNND2;LRRN1;PTPRZ1;SEMA6A;LINGO1;CSRNP3;PTPRT;PTN;TAGLN3;UNC5D;GPRC5B;EPHA7;PLP1;GRID2;LY6H;MAPK10
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.6692140459032694,-1.4685194989477246,0.06666666666666667,0.5216850541280789,1.0,6/10,16.89%,SETD1B;SETD1A;KMT2D;TET2;KMT2A;ZNF335
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.7860990924118013,-1.4685018480599474,0.06666666666666667,0.5193351214518263,1.0,4/6,18.72%,NBN;TERF2;SMG6;ERCC4
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.7333958476312812,1.468224968515398,0.04938271604938271,0.3204013419094971,1.0,7/25,5.86%,THBS1;NTN4;ITGA2;NRXN1;DMD;LAMA2;LAMB1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.690893643232199,-1.4680021282329212,0.030303030303030304,0.5194208055646112,1.0,4/14,3.56%,CEBPA;TFAP4;HHEX;LATS2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.858094670736665,-1.4672208777305815,0.14285714285714285,0.5199161230237562,1.0,1/5,0.21%,ITGA5
prerank,PanglaoDB_Augmented_2021__Neurons,0.6691298753164922,1.466771409722742,0.0,0.32695164216344164,1.0,78/199,16.33%,SCRG1;MAP7D2;SULT4A1;AMER2;VGF;GRIA4;PPP1R9A;PNMA8A;SCN3B;NCAN;BRINP1;PDE1A;PQBP1;NRXN1;SLC11A1;RAB3C;CADM2;PHYHIPL;GAD1;CA10;GRM3;ENO2;SYT4;LUZP2;CAMK2N1;BSN;TCEAL2;FRRS1L;SYP;SNAP25;CSRNP3;UNC13A;CHN1;GRIA2;BEX2;ERC2;FAIM2;OLFM3;TAGLN3;DNM3;RYR2;DGKB;CACNG2;CADPS;TMEM130;SCN1A;CACNA1B;PPFIA2;CNTNAP2;GRIA3;SGIP1;VSTM2B;GAD2;SH3GL2;GNAI1;CCK;DLGAP1;PAK5;SPOCK3;NWD2;LY6H;STMN2;CALY;CTNNA2;RGS17;RASGRF1;SLC17A7;AIM2;SCN8A;RIMS3;NDRG4;SCN2A;ST8SIA3;CPLX1;KIF5A;SYNPR;NRGN;GPR162
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.7224067208787845,1.4664141161163708,0.0,0.327056570582888,1.0,11/42,14.25%,GLRA1;ANO4;SLC4A10;GABRB1;TTYH1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7475717613503485,1.4661108027018983,0.0,0.32675800889739826,1.0,23/42,19.42%,GRIA4;RELN;BEGAIN;NETO1;PRRT1;DAPK1;GRIN2A;GRIA2;NLGN1;CACNG2;CAMK2B;GRIA3;DLGAP1;LRRC7;GRIN2B;NEFL;SHISA9;CACNG8;DLGAP2;GRIA1;APP;DLG4;MAPK8IP2
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8498269628551895,-1.4660611229002785,0.07142857142857142,0.521282554211616,1.0,1/7,3.98%,ZNF675
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.7995299864618852,1.4659569890837214,0.024691358024691357,0.3257503233044492,1.0,3/19,3.24%,SLC38A4;SLC16A10;SLC6A15
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.7110481390471418,1.4651851245716623,0.02247191011235955,0.32829528801451363,1.0,11/44,8.46%,TNC;VIM;OSMR;ANXA1;SYNC;LAMB1;TUBB6;ARHGAP23;CLMP;RND3;FN1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.778213507022103,1.464881967510505,0.036585365853658534,0.32799507713491255,1.0,5/20,9.26%,LRP4;TGFB2;ZBTB16;PTN;RBPJ
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.7112185835966284,1.4646898056100317,0.0,0.32761001381856864,1.0,27/69,13.71%,SULT4A1;GFAP;NCAN;GPM6B;MAPK4;DPYSL5;PHYHIPL;SRRM3;CTNND2;RBM3;PTPRZ1;LINGO1;RND3;CSRNP3;ARNT2;GRIA2;MAP2;PTN;TAGLN3;IGF1R;CSPG5;CRMP1;PLP1;ZNF536;PAK5;LY6H;STMN2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5922808151280613,-1.4646404468615237,0.0625,0.5245545067718576,1.0,4/28,3.76%,TCF3;LYL1;HHEX;BLNK
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.7293924163421383,1.464569834257941,0.024390243902439025,0.3266611188349999,1.0,17/40,12.85%,PLPP3;SPARC;PCDH17;PREX2;PTPRD;FBXL7;CGNL1;LAMA2;RUNX1T1;PTN;GPRC5B;FLT1;KALRN;SORBS1;ADGRL2;COL21A1;SHROOM4
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.8401195696981003,1.4640416975549282,0.05172413793103448,0.32745909309662585,1.0,2/10,4.44%,THBS1;PIAS4
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8735403423041481,1.4637013711877613,0.0,0.3275576683165969,1.0,6/11,9.36%,KCNE1;SCN3B;ANK2;PKP2;CAV3;RYR2
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.8806955316969333,-1.4636994829382046,0.04878048780487805,0.5226603407833084,1.0,3/5,9.65%,INPP5K;PASK;ENPP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.8806955316969333,-1.4636994829382046,0.04878048780487805,0.5226603407833084,1.0,3/5,9.65%,INPP5K;PASK;ENPP1
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,0.8898222446385148,1.4635470226713863,0.029850746268656716,0.32653630595938604,1.0,1/8,0.82%,FGF1
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.6904292732376841,1.462585618788928,0.03225806451612903,0.33006529649821315,1.0,12/69,6.20%,HS3ST5;OMD;HS3ST2;OGN;CHST7;NCAN;VCAN;B4GAT1;GPC5;CEMIP;PAPSS2;GNS
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,0.7874879879803889,1.4619173526135654,0.0684931506849315,0.3316000854325661,1.0,5/20,5.30%,ASPN;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,0.7236602149167483,1.4618696355607537,0.047058823529411764,0.33036198797053834,1.0,7/34,5.30%,ASPN;SPARC;ADAMTS2;ECM2;TNS1;FILIP1L;LAMA2
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),-0.8672135484618433,-1.4618143324418977,0.03125,0.5283493873648061,1.0,3/5,11.90%,FOLR2;SLC46A1;SLC19A1
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.7210850374218599,1.4617019484425102,0.022988505747126436,0.32972673964304133,1.0,14/41,9.38%,TNC;LRP4;ADAMTS2;COL11A1;ENAH;DZIP1;FBXL7;PTPRG;LAMB1;ANK2;PTK7;ROBO1;FN1;MAP1B
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8525349554090992,1.4616791650017347,0.07575757575757576,0.32829833524577257,1.0,3/10,12.26%,THBS1;SPRY1;SULF2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.7977347408030669,1.4615404742536384,0.03225806451612903,0.3276364515706068,1.0,5/20,9.87%,KCNE1;AANAT;AKAP6;RAPGEF3;PDE2A
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8059562912930347,1.4613924654718842,0.028169014084507043,0.32702225452212086,1.0,6/14,9.12%,SHANK3;RELN;NRXN1;NLGN3;NLGN1;RIMS2
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.7757272161691299,1.461338253837863,0.02564102564102564,0.32570843962417867,1.0,2/22,1.62%,PDE5A;VIM
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,-0.9073568017310454,-1.46127692239369,0.027777777777777776,0.5275367876576711,1.0,4/5,9.19%,P2RY13;P2RY6;P2RY12;P2RY14
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7691064624489984,1.4611771635495339,0.023529411764705882,0.3250258724180573,1.0,8/20,14.52%,GLRA1;INSYN2A;GRIN2A;NLGN3;GABRA2;GRID2;GABRA4;GRIN2B
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.5820868810004522,-1.4608537909425396,0.0625,0.5268449268939626,1.0,4/24,12.50%,NCOA4;NEDD4;M6PR;SORL1
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.7314913588706214,1.4605835430116723,0.0,0.3266104178261492,1.0,20/44,15.99%,SPARC;COL11A1;KCNT2;CLIP3;PTPRD;BRINP1;DZIP1;PLPPR4;FBXL7;CDH2;RUNX1T1;ANK2;PTN;MAP1B;CRMP1;GRIA3;NREP;STMN2;THY1;LDB2
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.7043492117438425,1.4603451634352353,0.0,0.326421023130925,1.0,16/73,12.57%,THBS1;OMD;SPON1;ADAMTS2;OGN;THSD4;NCAN;VCAN;B4GAT1;GPC5;PAPSS2;THSD7A;CSPG5;SEMA5A;ADAMTSL3;THSD7B
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.8824293525465351,1.4601674495673609,0.0375,0.32574438978307757,1.0,1/9,0.36%,DAPK2
prerank,KEGG_2021_Human__Bladder cancer,0.7655330334253148,1.460152613955884,0.011235955056179775,0.3244652958551741,1.0,5/28,6.52%,THBS1;DAPK2;ARAF;VEGFA;DAPK1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.6544833430185916,-1.4594534341947671,0.08333333333333333,0.5301214975941757,1.0,2/21,1.31%,TNFAIP8L3;NPC2
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.7336003756150677,1.4590077347248185,0.011363636363636364,0.32961861329472597,1.0,3/35,1.33%,HS3ST5;HS3ST2;CHST7
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.7264068319623075,1.4584295504163736,0.011627906976744186,0.3313090959579045,1.0,18/49,17.60%,CORO6;HMGB2;CKMT2;LDB3;PDE1A;DMD;LAMA2;CAV3;RYR2;CKB;CPT1A;SORBS1;COL21A1;ATP2A2;IL11RA;HAMP;SLC25A4;SORBS2
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6819532248900361,1.4581155019241105,0.0,0.3315436684725311,1.0,31/79,16.54%,PLPP3;FAM13C;SPARC;PCDH17;LRP4;COL11A1;PTPRD;BRINP1;AGT;PLPPR4;FBXL7;LIFR;VEGFA;ANK2;CA2;PTN;GLUL;SEMA5A;GPRC5B;PLP1;NTRK2;ADGRL2;NFASC;MAPK10;TIMP3;CPE;THY1;SYNPR;LDB2;EDIL3;CRB1
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,0.9330120411971525,1.4579840689551675,0.0,0.33081961438937235,1.0,2/7,4.44%,LRP2;PIAS4
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.8497955576640323,1.457774389137184,0.02666666666666667,0.3304193110954782,1.0,2/12,4.70%,VIM;DMD
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.8013831419888158,1.4575409841863114,0.027777777777777776,0.3298644019589585,1.0,4/15,8.95%,PRKCE;ANXA1;KANK1;PTN
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5834016009626057,-1.4570292307100816,0.13043478260869565,0.5378790413385438,1.0,1/29,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.7499698745423594,1.4568296641325043,0.022727272727272728,0.33352412760282496,1.0,4/35,5.04%,THBS1;KLF4;BEX3;VEGFA
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,0.7598346910593683,1.456501252892436,0.0,0.3339792806682946,1.0,10/29,9.63%,THBS1;SH2D4A;ITGA2;OSMR;ANXA1;RND3;HIF1A;ATP8B1;ALCAM;PLK2
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.6898049034679159,1.4562932024043327,0.011235955056179775,0.3341184821155314,1.0,13/72,5.79%,PLPP3;ASPN;SVEP1;ADAMTS2;ECM2;ACSL1;METRN;ZBTB16;GULP1;TNS1;AGT;LAMA2;TRIP10
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6997912511581127,1.4562742547945602,0.0,0.33274157028673346,1.0,48/96,20.82%,PIANP;CDK14;SULT4A1;GALNTL6;TMEM163;NCAN;BRINP1;MAPK4;SYT16;SRRM3;CA10;SYT4;KCTD8;LINGO1;BSN;TCEAL2;SNAP25;GRIA2;ERC2;OLFM3;NARF;TAGLN3;CRMP1;CACNA1B;FXYD7;VSTM2B;SH3GL2;PAK5;LY6H;STMN2;CALY;ABLIM3;NEFL;NDRG4;ST8SIA3;KIF5A;ASIC2;APLP1;DCTN1;PTPN5;TMEM59L;LHFPL5;SNAP91;POU6F2;REEP2;CNTN2;NELL1;MTUS2
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.8043041729088019,1.4559417718669967,0.023529411764705882,0.33303954164774235,1.0,7/20,9.58%,OMD;OGN;NCAN;VCAN;GPC5;PAPSS2;CSPG5
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.8414599382616512,1.455895913565597,0.028169014084507043,0.33202539611641674,1.0,2/14,3.16%,FGF1;PIGU
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.6656771382880252,1.4551439913767603,0.0,0.33451021179141743,1.0,39/121,19.36%,GLRA1;PRKAR2B;GRIA4;MAPT;NRG1;GRIN3A;GABRB1;GRIN2A;GRIK1;GRIA2;GABRB3;GABRA2;CACNG2;ADCY8;CAMK2B;GABRB2;PRKAG2;RPS6KA2;GRIA3;PPM1E;GNAI1;NSF;GABRA4;LRRC7;GNAL;GLRB;RASGRF1;GRIN2B;NEFL;NRGN;KCNJ6;CACNG8;PLCB1;GRIA1;PRKAA2;KCNJ3;GRIK4;GABRG2;AP2A2
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,-0.6533849845589763,-1.4550271509754544,0.038461538461538464,0.5424274013650884,1.0,1/14,0.13%,STAT4
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.847332571024982,1.4543504716332498,0.012987012987012988,0.33655415318699533,1.0,3/10,11.07%,PRLR;GHR;RBX1
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.8581930239553442,1.4543209295141486,0.013513513513513514,0.3353098171242978,1.0,3/9,12.90%,ACVR1B;ACVR2A;DRAP1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.7460654549013254,1.4542792475795683,0.0,0.33400000209914965,1.0,10/31,11.11%,NLRP12;TOM1L1;PPP2R5B;VEGFA;GPNMB;PPP2R5A;CALM3;ERRFI1;IMPACT;EPHA7
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.7071127552748806,1.4541962689001129,0.0,0.3330782221984564,1.0,40/84,18.50%,FAM13C;LRP4;COBL;FRAS1;KCNT2;PTPRD;PPP1R9A;ENAH;MAPK4;DZIP1;AGT;PTPRG;CDH2;PHYHIPL;LIFR;DMD;ASXL3;CGNL1;RUNX1T1;ANK2;ACSS3;CSRNP3;MAP1B;FIGN;SH3D19;ZNF385B;EPHA7;KALRN;SORBS1;ADGRL2;LRP1B;LIMCH1;ITSN1;CPE;EPB41L4B;HSPA12A;MPDZ;SORBS2;PRKAA2;ESRRG
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.7794165498186068,-1.453846408413413,0.06666666666666667,0.5453164149254514,1.0,2/7,9.39%,POMK;IPPK
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.7637014965163672,1.4536124522060243,0.06756756756756757,0.3350193834422811,1.0,5/20,5.91%,DIAPH3;RGS20;ANLN;MTCL1;TUBB6
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.46108207411065577,-1.453462167779054,0.0,0.5444525803483257,1.0,17/84,14.04%,RALB;GRAP2;SETDB1;BCR;TP53;RAPGEF6;KRAS;USP28;IGF1;CCDC88C;CRKL;PLD2;RASGRP2;RIN2;RIT2;ABR;RGS19
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.8187979561155745,1.453303146190593,0.012987012987012988,0.3354854154912593,1.0,6/15,7.94%,LRP4;SHANK3;NRXN1;NRXN2;NLGN3;NLGN1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.7180706934881874,1.4531774028228195,0.0,0.3335483396609807,1.0,23/54,13.71%,SPON1;ENPP2;PREX2;PTPRD;GPM6B;GALNT8;PLPPR4;NRXN1;RAB3C;ASXL3;ROBO2;RUNX1T1;BAALC;SEMA6A;CHL1;CELF2;RNF144A;PLP1;SGIP1;FLT1;NTRK2;EPHA4;STMN2
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.7180706934881874,1.4531774028228195,0.0,0.3335483396609807,1.0,23/54,13.71%,SPON1;ENPP2;PREX2;PTPRD;GPM6B;GALNT8;PLPPR4;NRXN1;RAB3C;ASXL3;ROBO2;RUNX1T1;BAALC;SEMA6A;CHL1;CELF2;RNF144A;PLP1;SGIP1;FLT1;NTRK2;EPHA4;STMN2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.9325991514719486,1.4530413488181957,0.0,0.33283178965761706,1.0,1/9,0.30%,KLF4
prerank,PanglaoDB_Augmented_2021__Interneurons,0.6574184995521,1.4530148199919932,0.0,0.3316423815147226,1.0,84/199,19.66%,PIANP;SULT4A1;AMER2;VGF;GRIA4;TACR1;TMEM163;NCAN;RELN;BRINP1;MAPK4;PDE1A;NRXN1;RAB3C;CADM2;PHYHIPL;RORB;GAD1;CTNND2;CA10;SV2B;GRM3;SYT4;LINGO1;BSN;TCEAL2;FRRS1L;SYP;DNAJC6;SNAP25;CSRNP3;UNC13A;CHN1;GRIA2;RAB15;ERC2;SLC22A15;MAP2;OLFM3;TAGLN3;DEPTOR;DNM3;CACNG2;TRIM9;CACNA1B;FAM81A;ADCY8;PPFIA2;LMO3;VSTM2B;GAD2;ADGRL2;SH3GL2;SYT1;CCK;DLGAP1;PAK5;GABRA4;SPOCK3;LY6H;TMEM132D;STMN2;CTNNA2;RGS17;HIVEP2;SLC17A7;SCN8A;NDRG4;ST8SIA3;CPLX1;KIF5A;SYNPR;NRGN;SHISA9;KCNMA1;HSPA12A;SLC16A1;NTNG1;GABRG2;PARM1;PTPN5;TMEM59L;TIMELESS;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.8556716053755855,-1.4520414708191234,0.10344827586206896,0.548693979986162,1.0,2/6,5.66%,NEXMIF;ACER2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.6191393199785282,-1.4519506540022316,0.037037037037037035,0.5466092615535917,1.0,3/17,5.01%,COL18A1;PPP1R16B;ICAM1
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.8254608165016815,1.4518812871874023,0.0273972602739726,0.33528178074291787,1.0,3/13,3.62%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.8254608165016815,1.4518812871874023,0.0273972602739726,0.33528178074291787,1.0,3/13,3.62%,OMD;OGN;B4GAT1
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",0.9513819750154638,1.4518732840134483,0.0,0.33402405375996364,1.0,1/6,0.06%,PCSK1
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.7096842044045466,-1.4516917037398611,0.07142857142857142,0.5454761170007764,1.0,1/15,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.678304196324638,1.45168383601063,0.020833333333333332,0.33389953412903245,1.0,18/89,12.38%,THBS1;KLF4;NAMPT;PRR16;TGFB2;NLRP12;VIM;EIF4A3;SOX4;RBM3;INSR;DNA2;IRS2;NOD2;EIF3E;SORBS1;NMD3;UPF3A
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.7556137283605235,-1.4512002647064308,0.09375,0.5451184923009866,1.0,2/6,17.33%,RABEP1;RAB29
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.7100378474581452,1.451145245210267,0.010638297872340425,0.33558057971551486,1.0,22/60,10.80%,TNC;FGF1;LRP4;TGFB2;SEMA3A;NCAN;LHFPL3;GPM6B;IL1RAPL1;FRMD5;GAD1;CNTN1;PTPRZ1;GRIA2;MAP2;SCD5;PTN;TAGLN3;MAP1B;CSPG5;ITGB8;NR2F1
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.7030198468628127,1.4510724027970479,0.0,0.3346600291900087,1.0,38/73,19.66%,LRP4;SULT4A1;VGF;ENAH;MTCL1;CASKIN1;TTLL7;SRRM3;ARFGEF3;STXBP5L;RBFOX2;SPIRE2;SRCIN1;BSN;SNAP25;ARNT2;UNC13A;MAP2;MAP1B;CSPG5;TMEM132A;NR2F1;PNMA2;TYRO3;HS6ST3;KIAA1549;SYT1;CHGB;NDRG4;CPE;EPB41L4B;APLP1;HSPA12A;PRKAA2;NMNAT2;TMEM59L;MAPK8IP2;SNAP91
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6612727826789522,-1.4509407933542873,0.045454545454545456,0.5438374590078494,1.0,6/19,9.02%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.6886967308240322,1.4507699803051444,0.0,0.33482096232320463,1.0,20/52,20.52%,MACC1;COBL;CYP3A5;TFRC;LARP1B;INSR;PDZD2;ATP5MK;ITGB8;TRHDE;CLMN;MAP7;NEBL;ATP10B;FGD4;ESRRG;PPARA;TRPM7;PLD1;CPEB4
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,0.729319914849191,1.4502241578880708,0.0379746835443038,0.33658581065911913,1.0,6/31,8.46%,TNC;THBS1;SPARC;ADAMTS2;LAMA2;FN1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.7025254270774475,1.4487161792348906,0.022988505747126436,0.3428850911259979,1.0,8/43,9.85%,DIAPH3;COBL;ENAH;SPIRE2;MICALL2;SVIL;PSTPIP2;WASF1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7322444784840209,-1.448217798943265,0.05263157894736842,0.5525522428476454,1.0,2/13,3.04%,CCL5;SH2B3
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,-0.856217060462338,-1.4477797980171463,0.07692307692307693,0.5516835153245019,1.0,1/8,0.13%,STAT4
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.8270056809050853,1.4476752288850205,0.0273972602739726,0.3474721661282541,1.0,2/11,4.13%,CADM1;SLC11A1
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.7209250705195557,1.446379022742047,0.02127659574468085,0.3536106023742046,1.0,15/50,10.63%,TNC;PLPP3;TGFB2;NTN4;ITGA2;DOCK1;OSMR;KITLG;ARHGAP23;RND3;MYO10;PALLD;PLK2;ERRFI1;SH3D19
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.725563883776146,1.4463103465958675,0.0,0.3525016385093018,1.0,20/57,12.85%,SPARC;PCDH17;KCNT2;ENPP2;PREX2;PTPRD;TNS1;VCAN;NRXN1;ASXL3;DAAM2;LAMA2;RUNX1T1;GRIN2A;THSD7A;SEMA5A;GRIA3;SGIP1;FLT1;SHROOM4
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.7058280276321878,1.446251537117403,0.011235955056179775,0.3514011400174134,1.0,6/40,9.12%,ANXA1;RAB3C;TVP23A;RAB15;ABCA1;RIMS2
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7973011504592096,-1.446244880688811,0.1,0.5553968413137674,1.0,3/9,6.25%,EHHADH;ACOX1;ACAA1
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.8471937212156636,1.4458312875526163,0.013157894736842105,0.35292325668113556,1.0,4/15,9.54%,SOCS3;PRLR;IRS2;GHR
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,0.8364172360784627,1.4452362131940175,0.0821917808219178,0.35453801591391154,1.0,4/9,13.75%,SLC51A;SLCO1A2;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.5984027409965749,-1.4449949252295997,0.10344827586206896,0.5579541903013626,1.0,2/15,4.08%,RING1;DDB2
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.7276720847113495,1.4448735747226706,0.0,0.3527518456722957,1.0,23/51,16.59%,PLPP3;RAP1GAP;COBL;SH2D4A;NTN4;DOCK1;KITLG;LIFR;PTPRK;PAPSS2;ADGRG6;CAMK2N1;NGEF;ERRFI1;SH3D19;NCEH1;PMP22;MAP7;TIMP3;GIPC2;EPB41L4B;MTUS1;EPAS1
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.7276720847113495,1.4448735747226706,0.0,0.3527518456722957,1.0,23/51,16.59%,PLPP3;RAP1GAP;COBL;SH2D4A;NTN4;DOCK1;KITLG;LIFR;PTPRK;PAPSS2;ADGRG6;CAMK2N1;NGEF;ERRFI1;SH3D19;NCEH1;PMP22;MAP7;TIMP3;GIPC2;EPB41L4B;MTUS1;EPAS1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.7276720847113495,1.4448735747226706,0.0,0.3527518456722957,1.0,23/51,16.59%,PLPP3;RAP1GAP;COBL;SH2D4A;NTN4;DOCK1;KITLG;LIFR;PTPRK;PAPSS2;ADGRG6;CAMK2N1;NGEF;ERRFI1;SH3D19;NCEH1;PMP22;MAP7;TIMP3;GIPC2;EPB41L4B;MTUS1;EPAS1
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.9037278027680017,1.444653829690216,0.013888888888888888,0.3525302092952169,1.0,2/7,4.25%,ACVR1B;ACVR2A
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,0.6959860101799665,1.4443568056563194,0.010638297872340425,0.3531962785919445,1.0,13/73,10.84%,FA2H;KLF4;GDPD1;RPL23;CACHD1;GULP1;CNIH4;PPP2R5A;DAPK1;AKAP12;TXN;RPS27A;IBTK
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.6963470627820232,-1.4442084032192242,0.041666666666666664,0.558942578323613,1.0,2/10,2.17%,LRIG1;POLD3
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.9516907996770463,1.4439375938570638,0.014925373134328358,0.35440066088761346,1.0,1/6,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.866981881323089,1.4436362475132334,0.014705882352941176,0.35471663610545523,1.0,2/11,0.82%,THBS1;FGF1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),-0.838517325562868,-1.443619788785518,0.06896551724137931,0.5590722588633447,1.0,2/5,10.29%,IL1B;SEMA4D
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.8306370378049893,1.443138489838304,0.01282051282051282,0.3566817484005259,1.0,8/17,12.57%,THBS1;SPON1;ADAMTS2;THSD4;THSD7A;SEMA5A;ADAMTSL3;THSD7B
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.8703264696361912,1.442748480719003,0.014285714285714285,0.35792728807474006,1.0,3/7,4.94%,NAMPT;SH3PXD2B;ARID5B
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),-0.8471756631191434,-1.442707892927485,0.027777777777777776,0.5605777139742224,1.0,2/5,10.32%,KHSRP;TREM2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6841640252159066,1.4425622972310406,0.0,0.3577250738377315,1.0,45/83,20.69%,LRRC4C;GFAP;CLIP3;NCAN;LHFPL3;BRINP1;VCAN;MAPK4;PLPPR4;PCDH15;NRXN2;PHYHIPL;CTNND2;CA10;ANK2;OLIG1;LINGO1;SNAP25;ARNT2;GRIA2;FAIM2;MAP2;PTN;TAGLN3;CSPG5;CRMP1;GPRC5B;ADCY8;PLP1;ZNF536;VSTM2B;NFASC;LY6H;STMN2;NDRG4;ST8SIA3;APLP1;ATP1B2;NKX6-2;PTPN5;TMEM59L;SNAP91;TMEM178A;ATP1A2;CNTN2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.7632062054752239,-1.4425027995611235,0.030303030303030304,0.559170269227891,1.0,4/10,20.12%,FSCN1;OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.7158397017615414,1.442399495070132,0.0,0.35729098103650264,1.0,14/39,16.65%,IL1RAPL1;ANXA1;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;CADPS;CLASP2;SYT1;NSF;CPLX1;STXBP6;RAB2B
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.7803684855232759,1.4422732060690013,0.011627906976744186,0.3567936041938391,1.0,4/33,6.15%,FA2H;PLPP3;ALDH3B1;VAPB
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,0.8998048835464652,1.442139216102881,0.03076923076923077,0.35620053378484945,1.0,1/7,0.82%,FGF1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.6846267150541331,1.4415172061775121,0.02197802197802198,0.35605101570198694,1.0,51/77,25.14%,LRRC4C;AMER2;GRIA4;SCN3B;NCAN;GPM6B;MAPK4;NRXN1;GNAO1;RAB3C;CADM2;UBE2QL1;RTN1;NRXN2;ASXL3;CTNND2;TCEAL2;CDH20;GRIA2;CADPS;TRIM9;PLP1;ZNF536;VSTM2B;PAK5;STMN2;CTNNA2;LSAMP;NEFL;ST8SIA3;AMPH;ATP1B2;PTPN5;B3GAT1;SNAP91;NCAM1;ATP1A2;CNTN2;PDZD4;KIF5C;SORCS3;ELAVL3;PAK3;SYT11;ADGRB3;MEGF10;CLVS2;SLC6A1;JPH4;ADGRL3;CACNA1C
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.6846267150541331,1.4415172061775121,0.02197802197802198,0.35605101570198694,1.0,51/77,25.14%,LRRC4C;AMER2;GRIA4;SCN3B;NCAN;GPM6B;MAPK4;NRXN1;GNAO1;RAB3C;CADM2;UBE2QL1;RTN1;NRXN2;ASXL3;CTNND2;TCEAL2;CDH20;GRIA2;CADPS;TRIM9;PLP1;ZNF536;VSTM2B;PAK5;STMN2;CTNNA2;LSAMP;NEFL;ST8SIA3;AMPH;ATP1B2;PTPN5;B3GAT1;SNAP91;NCAM1;ATP1A2;CNTN2;PDZD4;KIF5C;SORCS3;ELAVL3;PAK3;SYT11;ADGRB3;MEGF10;CLVS2;SLC6A1;JPH4;ADGRL3;CACNA1C
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.6846267150541331,1.4415172061775121,0.02197802197802198,0.35605101570198694,1.0,51/77,25.14%,LRRC4C;AMER2;GRIA4;SCN3B;NCAN;GPM6B;MAPK4;NRXN1;GNAO1;RAB3C;CADM2;UBE2QL1;RTN1;NRXN2;ASXL3;CTNND2;TCEAL2;CDH20;GRIA2;CADPS;TRIM9;PLP1;ZNF536;VSTM2B;PAK5;STMN2;CTNNA2;LSAMP;NEFL;ST8SIA3;AMPH;ATP1B2;PTPN5;B3GAT1;SNAP91;NCAM1;ATP1A2;CNTN2;PDZD4;KIF5C;SORCS3;ELAVL3;PAK3;SYT11;ADGRB3;MEGF10;CLVS2;SLC6A1;JPH4;ADGRL3;CACNA1C
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.6971053721238974,1.4413379574945282,0.0,0.35569739690780994,1.0,44/86,17.30%,FAM13C;LRRC4C;TGFB2;PDE10A;CADM1;PPP1R9A;GULP1;ENAH;DZIP1;NFIB;TTLL7;LIFR;BMPR1B;CNTN1;ARFGEF3;MYO10;CSRNP3;ARNT2;TMEFF2;NLGN1;NPHP1;KCTD1;TUSC3;MAP2;SCD5;FAM171B;MAP1B;ENOX1;SLITRK5;FIGN;NOVA1;UNC5C;KIAA1549;LRP1B;ANKS1B;LIMCH1;GLRB;EPHA5;LONRF2;MAPK10;CC2D2A;HSPA12A;KIF3A;MPDZ
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.9434183575956193,1.4410670876884824,0.0,0.3558339078844724,1.0,2/7,1.81%,CENPF;CENPE
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.8635233039592987,-1.440917410521608,0.12903225806451613,0.5629746523499384,1.0,1/5,6.81%,JMJD6
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.9102245531828419,1.4406645483329723,0.05,0.35532934519582066,1.0,3/7,4.32%,FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.9102245531828419,1.4406645483329723,0.05,0.35532934519582066,1.0,3/7,4.32%,FA2H;LSR;ALOX12
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6777389595662072,1.4405409528527962,0.06741573033707865,0.3546937282648362,1.0,16/50,15.39%,PLPP3;FAM13C;SVEP1;LRP4;FBXL7;LIFR;LAMB1;RUNX1T1;ANK2;PTN;MAP1B;GPRC5B;ADGRL2;TIMP3;CPE;THY1
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.8298863803996044,1.440403996731986,0.012658227848101266,0.354062556207495,1.0,8/18,12.57%,THBS1;SPON1;ADAMTS2;THSD4;THSD7A;SEMA5A;ADAMTSL3;THSD7B
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.668361195589153,1.4401692562075163,0.0,0.354394035926082,1.0,65/166,19.52%,GLRA1;HTR2B;HTR7;PRKAR2B;CHRM5;GRIA4;CACNB2;NAPA;CDH8;NRXN1;SLC1A2;NRXN2;GRIK2;GAD1;KIF1B;GABRB1;GRM3;GRIN2A;GRIK1;BSN;NLGN3;SNAP25;UNC13A;GRIA2;NLGN1;ERC2;GABRB3;GABRA2;KCNMB1;NOVA1;CACNA1B;CHRM3;GABRB2;PLP1;RPS6KA2;GRIA3;PMP22;GAD2;GRID2;SYT1;DLGAP1;GABRA4;CBLN2;UNC13C;GLRB;GRIN2B;SLC17A7;SDCBP;HTR1F;CPLX1;KIF5A;ASIC2;NRGN;CACNA1A;DLGAP2;GRIA1;AMPH;GABRD;STXBP2;SPG11;GRM7;GRIK4;GABRG2;DLG4;NLGN4X
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.9131375652165105,1.4397984093783958,0.0,0.35539166196920546,1.0,1/6,1.51%,APOLD1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.8853017125373547,1.4395997775072056,0.0,0.3553355999873441,1.0,1/11,0.04%,GLRA1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.9050202209190743,1.439584729028818,0.013888888888888888,0.35423675020144596,1.0,3/8,4.44%,LRP2;CBR1;PIAS4
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8677203439862495,-1.439169521027251,0.03125,0.5649687455220309,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8677203439862495,-1.439169521027251,0.03125,0.5649687455220309,1.0,1/6,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.8275824978714471,1.4390768704892105,0.014285714285714285,0.35576017812230853,1.0,5/16,11.27%,PTPRD;RELN;IL1RAPL1;SS18L1;CAMK2B
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.7446627224170705,-1.4387830436767515,0.11428571428571428,0.5638257374900495,1.0,4/8,14.75%,CYP19A1;SRD5A1;DHRS9;MED1
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,-0.7021901408257969,-1.438484373950025,0.08333333333333333,0.5630019519211217,1.0,6/10,20.36%,ITGAM;ICAM1;CSF2RA;IL6R;CSF3R;CD81
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,-0.8062981101974824,-1.438429272345088,0.03571428571428571,0.5609486040499636,1.0,4/10,13.29%,RALB;MAPK13;SRC;MAPKAPK2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7337164123718566,-1.4383649391052564,0.10344827586206896,0.5567876460146892,1.0,2/6,12.04%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7337164123718566,-1.4383649391052564,0.10344827586206896,0.5567876460146892,1.0,2/6,12.04%,TMEM119;UBASH3B
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.8185527205339533,1.438254159649285,0.025,0.3581208320300797,1.0,5/19,8.38%,KCNE1;NETO1;FHL1;ANK2;CAV3
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.7884817350637463,1.438186613644682,0.022222222222222223,0.35739917952590733,1.0,6/25,9.87%,KCNE1;AANAT;VGF;AKAP6;RAPGEF3;PDE2A
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.8469276324168733,1.438147034324225,0.04,0.35646416740055736,1.0,7/13,7.93%,SHROOM3;SH2D4A;NTN4;ITGA2;OVOL2;BAIAP2L1;PPP1R13L
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.8215960186639366,1.4381307352580333,0.0125,0.3553179654128892,1.0,2/16,0.94%,SOCS3;ST18
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8629609034586512,1.4380917647097362,0.029850746268656716,0.35433436091363807,1.0,3/9,6.66%,GLRA1;GRIN3A;GRIN2A
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.8026166614111818,1.4377504132933798,0.02631578947368421,0.35499329381006833,1.0,6/22,9.28%,RAP1GAP;SHANK3;PIGU;DOK6;GRB10;IRS2
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.6645178546873856,-1.4373855023321638,0.16,0.558956234991305,1.0,6/12,23.04%,HLA-DPA1;CD247;HLA-DRB5;CSK;CD4;PAG1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.7339682048757848,-1.4372684974363406,0.09375,0.5571023363602637,1.0,3/11,8.55%,TICAM1;MLKL;TLR3
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,0.936131909551882,1.4365663716002135,0.0,0.36063136495589904,1.0,1/6,1.91%,FOLH1
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.6398087464703545,-1.436273733100715,0.10526315789473684,0.5584448644121237,1.0,5/20,8.31%,SMDT1;MAIP1;MICU3;STOML2;PHB2
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.9042513191793515,1.4358207850693914,0.030303030303030304,0.3632883791380605,1.0,2/6,4.18%,NRXN1;PCDH15
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,-0.720770533572945,-1.4356261054421455,0.1724137931034483,0.558821081073113,1.0,2/9,8.79%,ITPR2;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5562011958237282,-1.43500687111593,0.08333333333333333,0.559745800778082,1.0,6/37,6.48%,RNASEL;CCL5;INPP5K;SETDB1;APOBEC3G;BANF1
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.747155928077228,1.4349337579193389,0.024096385542168676,0.36650827495855837,1.0,2/28,3.16%,FGF1;PIGU
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),0.9773231842780402,1.4337786598058937,0.0,0.3707727401363048,1.0,1/6,0.04%,GLRA1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.7255177942074357,-1.4337494923832095,0.0,0.5614125044544166,1.0,6/16,9.02%,TGFBR3;ZNF703;LATS2;BCL9;TGFB1;ENG
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,0.9332780669714755,1.4333194898480994,0.014084507042253521,0.3721252134939131,1.0,3/5,6.20%,OMD;OGN;GNS
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.6916966325754279,1.433313739073072,0.0,0.37092733256000326,1.0,41/72,22.61%,PIANP;AMER2;SCN3B;NCAN;TUBB4A;NRXN1;CA10;GRM3;TCEAL2;FRRS1L;SYP;TTYH1;POU6F1;GRIA2;TMEM130;CACNA1B;FXYD7;PNMA2;VSTM2B;PAK5;RUNDC3A;CALY;CTNNA2;NEFL;ST8SIA3;KIF5A;CACNG8;ATP1B2;PTPN5;B3GAT1;SNAP91;REEP2;CNTN2;PDZD4;KIF5C;SORCS3;ELAVL3;HPCAL4;KCNQ2;MYT1L;SYT11
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.7489174514303107,1.4332411278134847,0.03571428571428571,0.3701896658354887,1.0,12/23,13.71%,NCAN;BRINP1;DPYSL5;COL26A1;CTNND2;SYT4;LINGO1;TCEAL2;UNC5D;EPHA7;GRID2;STMN2
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,-0.9112336902567113,-1.4330958981224764,0.0,0.5622209121923081,1.0,2/5,8.79%,FLNA;SRC
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.7264237781287609,1.4329112598357026,0.036585365853658534,0.37062904718867495,1.0,9/30,18.04%,THBS1;SOX4;IRS2;IGF1R;ADCY8;EIF2B2;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.7641017820657381,1.4327544071776182,0.06172839506172839,0.3705263043848272,1.0,3/22,2.25%,HTR2B;TGFB2;GPM6A
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,0.8352975948311655,1.432484027552524,0.02531645569620253,0.37069297884573754,1.0,7/15,7.93%,SH2D4A;NTN4;ITGA2;OSMR;BAIAP2L1;RND3;PPP1R13L
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,-0.6702409266792414,-1.432399819429739,0.03571428571428571,0.5628249885773309,1.0,5/12,20.89%,CRKL;CRK;RAP1A;RAPGEF1;KIDINS220
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.7174859014705178,1.432352291911193,0.036585365853658534,0.3704418759813525,1.0,15/33,15.99%,FAM13C;KCNT2;PTPRD;MAPK4;FBXL7;RUNX1T1;ANK2;PTN;GPRC5B;CCDC3;SORBS1;ADGRL2;COL21A1;THY1;LDB2
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.8578638915340782,1.4322990725479852,0.05128205128205128,0.3695693786342007,1.0,3/10,12.63%,CLDN18;CLDN20;PARD3
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.747817290929895,1.4321593509345114,0.023255813953488372,0.36778226304936495,1.0,13/36,10.44%,ASPN;FAM13C;SVEP1;ADAMTS2;RBMS3;ENAH;FBXL7;PTPRG;RUNX1T1;ANK2;EPHA3;MAP1B;NOVA1
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.747817290929895,1.4321593509345114,0.023255813953488372,0.36778226304936495,1.0,13/36,10.44%,ASPN;FAM13C;SVEP1;ADAMTS2;RBMS3;ENAH;FBXL7;PTPRG;RUNX1T1;ANK2;EPHA3;MAP1B;NOVA1
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.5884943570262753,-1.4320324398254904,0.07692307692307693,0.562190242183274,1.0,6/34,5.90%,ITK;CCL5;CD2;GZMB;APOBEC3G;CD96
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.7053943670859735,1.4315570691566983,0.0,0.37018811939646723,1.0,12/39,14.90%,DDIT4;SEMA3A;GPM6A;SPOCK1;RELN;NR4A2;VEGFA;MAP1B;NTRK2;ASTN2;CCK;TUBB2A
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.6859518800979195,1.430901947460806,0.03225806451612903,0.37222714124221207,1.0,11/59,5.30%,TNC;SCRG1;PLPP3;SPARC;ADAMTS2;COL11A1;GADD45B;FBXL7;VEGFA;DAAM2;LAMA2
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.6373416866078593,1.4307013888957187,0.0,0.3722095121961188,1.0,82/240,19.52%,GLRA1;IL1RAPL2;SHANK3;PRKAR2B;GRIA4;PTPRD;CACNB2;MAPT;NRG1;IL1RAPL1;GRIN3A;NRXN1;SLC1A2;BEGAIN;NRXN2;GAD1;LRRTM4;GABRB1;KCNH8;SHANK2;GRIN2A;GRIK1;SIPA1L1;NLGN3;SNAP25;GRIA2;NLGN1;NRXN3;PPFIBP1;GABRB3;GABRA2;KCNH5;GLUL;NTRK3;CACNG2;SLITRK5;KCNMB1;CACNA1B;CACNA2D3;ADCY8;PPFIA2;CAMK2B;GABRB2;PRKAG2;RPS6KA2;GRIA3;KCNH7;GAD2;SYT1;PPM1E;GNAI1;NSF;DLGAP1;GABRA4;LRRC7;HCN1;GNAL;GLRB;RASGRF1;GRIN2B;SLC17A7;NEFL;CPLX1;NRGN;CACNA1A;KCNJ6;KCNMA1;CACNG8;PLCB1;LRRTM2;DLGAP2;GRIA1;KCNB2;EPB41L5;PRKAA2;KCNJ3;PPFIA4;GRIK4;GABRG2;AP2A2;RTN3;NLGN4X
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.610482273844519,-1.4306989637394973,0.07142857142857142,0.5650032930584701,1.0,1/16,0.05%,TNFAIP8L3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8493331281974087,-1.4306052778810743,0.058823529411764705,0.5632870941517923,1.0,2/7,5.42%,IDE;ERAP2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.9320806291037429,1.430533855275947,0.0,0.3717845599462893,1.0,3/6,6.20%,OMD;OGN;GNS
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8916699361871503,1.4304949592546352,0.08333333333333333,0.3708981306590929,1.0,1/5,2.79%,MAPT
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.8144421788011673,1.4304890928865817,0.02531645569620253,0.36972810501032605,1.0,5/21,7.48%,SHROOM3;FRAS1;SHANK2;OVOL2;PKP2
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.795685907594988,-1.430153380301951,0.2,0.5632435563551741,1.0,2/6,5.35%,PSAT1;PSPH
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",-0.8108052217209626,-1.4300976574537807,0.1,0.5612061089177794,1.0,4/6,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5799400483924987,-1.429849950912031,0.043478260869565216,0.5596198409239355,1.0,5/22,9.18%,TNFAIP8L3;WDR91;DAB2IP;TGFB1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.856018491688495,1.4295273102633543,0.0,0.3738697822132405,1.0,6/16,8.42%,GLRA1;ACVR1B;TACR1;RNASE10;VEGFA;POMZP3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.6431219275621493,-1.4293505097908714,0.0,0.5594454193840888,1.0,6/21,13.78%,ITK;BLNK;NCKAP1L;BTK;SYK;BCL2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.9811768560305002,1.4291697538236778,0.028169014084507043,0.3735957364412331,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.9811768560305002,1.4291697538236778,0.028169014084507043,0.3735957364412331,1.0,1/5,0.30%,KLF4
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.6722427175871223,1.4290453475317935,0.0,0.3684968718250361,1.0,38/78,15.32%,FAM13C;PTPRD;ENAH;BRINP1;GPM6B;DZIP1;PLPPR4;FBXL7;PTPRG;LIFR;KIF1B;CNTN1;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;CHN1;NLGN1;ERC2;MAP2;FAM171B;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ADGRL2;TMEM132B;NFASC;STMN2;ITSN1;LSAMP;MAPK10;NDRG4;CPE
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.6722427175871223,1.4290453475317935,0.0,0.3684968718250361,1.0,38/78,15.32%,FAM13C;PTPRD;ENAH;BRINP1;GPM6B;DZIP1;PLPPR4;FBXL7;PTPRG;LIFR;KIF1B;CNTN1;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;CHN1;NLGN1;ERC2;MAP2;FAM171B;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ADGRL2;TMEM132B;NFASC;STMN2;ITSN1;LSAMP;MAPK10;NDRG4;CPE
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.6722427175871223,1.4290453475317935,0.0,0.3684968718250361,1.0,38/78,15.32%,FAM13C;PTPRD;ENAH;BRINP1;GPM6B;DZIP1;PLPPR4;FBXL7;PTPRG;LIFR;KIF1B;CNTN1;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;CHN1;NLGN1;ERC2;MAP2;FAM171B;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ADGRL2;TMEM132B;NFASC;STMN2;ITSN1;LSAMP;MAPK10;NDRG4;CPE
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.6722427175871223,1.4290453475317935,0.0,0.3684968718250361,1.0,38/78,15.32%,FAM13C;PTPRD;ENAH;BRINP1;GPM6B;DZIP1;PLPPR4;FBXL7;PTPRG;LIFR;KIF1B;CNTN1;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;CHN1;NLGN1;ERC2;MAP2;FAM171B;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ADGRL2;TMEM132B;NFASC;STMN2;ITSN1;LSAMP;MAPK10;NDRG4;CPE
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.6722427175871223,1.4290453475317935,0.0,0.3684968718250361,1.0,38/78,15.32%,FAM13C;PTPRD;ENAH;BRINP1;GPM6B;DZIP1;PLPPR4;FBXL7;PTPRG;LIFR;KIF1B;CNTN1;RUNX1T1;PTPRZ1;ANK2;CSRNP3;ARNT2;CHN1;NLGN1;ERC2;MAP2;FAM171B;PTN;MAP1B;CRMP1;GPRC5B;NOVA1;PPFIA2;PLP1;ADGRL2;TMEM132B;NFASC;STMN2;ITSN1;LSAMP;MAPK10;NDRG4;CPE
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.8126873205859401,1.428083060312105,0.0,0.37245632799728895,1.0,3/17,3.60%,GDPD1;ENPP2;ABHD12B
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",0.8743421874603524,1.4280431760044525,0.04225352112676056,0.370297049052418,1.0,1/10,0.06%,PCSK1
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.8743421874603524,1.4280431760044525,0.04225352112676056,0.370297049052418,1.0,1/10,0.06%,PCSK1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.9161180502758405,1.4280419462334397,0.015384615384615385,0.3691993902118915,1.0,2/7,7.07%,HSPA5;COPS5
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.7415139787449874,-1.4278095361113194,0.1111111111111111,0.5628320682259877,1.0,1/7,0.83%,MYH9
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.8048089998855851,1.42780051899939,0.01282051282051282,0.36930290958350953,1.0,7/26,10.27%,KCNE1;FA2H;COBL;SLC2A9;OVOL2;CELSR2;GPRC5B
prerank,KEGG_2021_Human__Linoleic acid metabolism,-0.8058565660057815,-1.42750459687985,0.125,0.5623596179497397,1.0,3/6,11.43%,PLA2G4C;PLA2G12A;PLB1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.7419348654313611,-1.426842727440065,0.12121212121212122,0.562893468087976,1.0,2/7,10.48%,SMARCD1;ZMIZ1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7140630712088513,1.426483556385061,0.02531645569620253,0.37522190922791826,1.0,18/28,20.52%,GRM8;GRIA4;GRIN3A;GRIK2;GRM3;GRIN2A;GRIK1;GRIA2;GRIA3;GRID2;GRIN2B;PLCB1;APP;GRM7;GNAQ;GRIK4;CDK5R1;CPEB4
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.9107159184351711,1.426434413425875,0.05405405405405406,0.3745059075669557,1.0,2/5,7.78%,CLDN18;CLDN20
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.7167032180122477,-1.426380592058367,0.0,0.5629000431134547,1.0,3/8,19.10%,ZDHHC21;PDE4D;ADRB2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.7150468602367096,1.426217601754294,0.046511627906976744,0.3744273824383177,1.0,8/42,8.38%,CKMT2;LDB3;DOCK1;DOCK5;DMD;LAMA2;LAMB1;CAV3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.8444132639467676,1.4258945788805149,0.013157894736842105,0.3750629489376949,1.0,5/20,7.48%,KCNE1;SCN3B;DMD;ANK2;PKP2
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,-0.8402737683646346,-1.4258431583413804,0.1111111111111111,0.563333266457621,1.0,1/7,2.86%,AP1B1
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,0.9168483238868003,1.4256445637276383,0.03125,0.37506532494471123,1.0,1/6,0.82%,FGF1
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,0.9042840818252321,1.4254308501237785,0.045454545454545456,0.37392752367135673,1.0,1/6,0.82%,FGF1
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,0.9042840818252321,1.4254308501237785,0.045454545454545456,0.37392752367135673,1.0,1/6,0.82%,FGF1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.7789778989303033,-1.425284416626136,0.05714285714285714,0.5624878903425403,1.0,3/6,15.53%,DCP1B;EDC3;ZFP36
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.7076186476793674,1.4237601196257836,0.0,0.38133758787066097,1.0,36/61,24.23%,PIANP;SULT4A1;CLIP3;NCAN;BRINP1;CASKIN1;B4GALNT4;GAD1;SRRM3;LINGO1;BSN;GRIA2;FAIM2;ADGRB2;TAGLN3;CSPG5;CKB;CELSR2;VSTM2B;LY6H;STMN2;NDRG4;KIF5A;ASIC2;APLP1;NCDN;TMEM59L;SNAP91;CNTN2;ELAVL3;KCNQ2;DNER;MAPK8IP1;BRSK1;PPFIA3;CLVS2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.7543655576937123,-1.4235967368905853,0.125,0.5669205018876533,1.0,4/10,12.78%,LGALS9;SERPINB9;HLA-E;ARRB2
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,-0.5199908364129533,-1.4235878281358076,0.0,0.5628854805219048,1.0,18/51,13.44%,CD37;LYL1;P2RX1;STAC3;MAP4K2;GRK2;FAM78A;GMIP;TLN1;ARHGEF1;TGFB1;NBEAL2;MYO1F;IL17RA;TREML1;ZNF592;ARRB2;C19ORF38
prerank,CellMarker_Augmented_2021__Platelet:Liver,-0.5199908364129533,-1.4235878281358076,0.0,0.5628854805219048,1.0,18/51,13.44%,CD37;LYL1;P2RX1;STAC3;MAP4K2;GRK2;FAM78A;GMIP;TLN1;ARHGEF1;TGFB1;NBEAL2;MYO1F;IL17RA;TREML1;ZNF592;ARRB2;C19ORF38
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.9085182980723733,1.423455500090989,0.0,0.38142959520250286,1.0,3/7,5.89%,FAAH;ABHD12B;DGAT1
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.8602497702794344,1.421937110126819,0.056338028169014086,0.3875337253905894,1.0,2/11,3.16%,FGF1;PIGU
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.716319571866559,-1.4218483968465092,0.041666666666666664,0.5677817970529397,1.0,2/12,1.00%,CCL5;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7773380051367815,-1.4213576470541172,0.14814814814814814,0.5678173416689317,1.0,5/10,11.55%,MYH9;PLGRKT;HPN;KLKB1;GSN
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.7265804380045617,1.4212806565616234,0.0379746835443038,0.3900803091904223,1.0,2/19,1.70%,SPARC;CD163
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,-0.7865382251131195,-1.4212784308193058,0.1388888888888889,0.5660029531174018,1.0,3/6,13.78%,BCL2L1;BID;BCL2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.526193340185514,-1.4206639590426104,0.06666666666666667,0.5664592082212221,1.0,8/54,6.02%,PHLDB2;INPP5K;SERPINF2;PFN1;EVL;ARAP1;LPAR1;NF2
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,0.8865991196789215,1.4206490461733747,0.03076923076923077,0.39237075619998435,1.0,1/8,0.82%,FGF1
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.7090277798800888,1.4205861260122097,0.02197802197802198,0.39176135402559503,1.0,17/43,16.59%,PLPP3;FGF1;SVEP1;FRAS1;NTN4;DOCK1;OSMR;RND3;PALLD;FN1;SH3D19;THBD;UACA;TIMP3;PCSK6;GBP2;EPAS1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.7101741827780232,1.4204868615986526,0.060240963855421686,0.3911021966864103,1.0,11/46,8.46%,PLPP3;SPARC;SVEP1;ADAMTS2;GFAP;RELN;FBXL7;VEGFA;LAMA2;SYP;FN1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.7386074570697763,1.4204733773190916,0.013333333333333334,0.3900482827005299,1.0,3/27,1.28%,LRP2;COBL;TGFB2
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,0.9295160290517468,1.4204596906012688,0.014084507042253521,0.3890799458809195,1.0,2/8,2.72%,KCNE1;CACNB2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.6773441823257424,1.4204428893158307,0.0,0.388117190253353,1.0,23/92,11.16%,KLF4;ASPN;HHIP;SPARC;SVEP1;ADAMTS2;VIM;EGR1;TNS1;NR4A2;NR4A1;VEGFA;LAMA2;CD55;LAMB1;HIF1A;PALLD;FOSL2;FN1;FGR;P4HA1;CKAP4;CTHRC1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5859085775053244,-1.420418136440694,0.14285714285714285,0.5655347117237629,1.0,5/20,8.92%,NEDD4;IDE;SNX25;TGFB1;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7904844557510777,1.4202470526525874,0.02666666666666667,0.38850344993537134,1.0,4/21,7.49%,SHANK3;RELN;HIF1A;NLGN3
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.6820964593361126,1.4201415595727729,0.011363636363636364,0.3878893383878925,1.0,27/53,15.35%,PTPRD;NCAN;BRINP1;GPM6B;MAPK4;NRXN1;DPYSL5;CTNND2;SYT4;PTPRZ1;ANK2;LINGO1;TCEAL2;CSRNP3;NLGN1;ERC2;PTN;TAGLN3;UNC5D;CRMP1;EPHA7;PLP1;GRID2;TMEM132B;PAK5;MAPK10;ST8SIA3
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.7502187329140619,1.4198790553090732,0.011764705882352941,0.38803831154942064,1.0,4/23,6.56%,KCNE1;ANK3;ANK2;AKAP6
prerank,KEGG_2021_Human__ECM-receptor interaction,0.7488101753876212,1.4194929679622839,0.0125,0.38907443551246024,1.0,12/33,9.84%,TNC;THBS1;FRAS1;ITGA2;RELN;COL4A5;LAMA2;SV2B;LAMB1;FN1;ITGB8;GP6
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,0.6824127421964693,1.4191858115236664,0.01098901098901099,0.3893754561162262,1.0,16/60,15.17%,SLC38A4;VGF;CERCAM;HMGB2;PRKCE;RAB3C;FAM110B;ASXL3;MBOAT2;PALLD;PDE4DIP;SGCZ;GRIA3;SPOCK3;ASPH;HTR1F
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,-0.4648456283291195,-1.4187552191572377,0.0,0.5681281616457532,1.0,23/60,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;RASAL3;NCKAP1L;PLEK;CYTH4;HVCN1;PTPN7;PRF1;CD53;SNX20;IL12RB1;PSTPIP1;IL16;ITGAL;ARHGAP30;NLRC3;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,-0.4648456283291195,-1.4187552191572377,0.0,0.5681281616457532,1.0,23/60,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;RASAL3;NCKAP1L;PLEK;CYTH4;HVCN1;PTPN7;PRF1;CD53;SNX20;IL12RB1;PSTPIP1;IL16;ITGAL;ARHGAP30;NLRC3;NCF1;GPR174;TBC1D10C
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.7471046267438929,-1.4182179262558658,0.12903225806451613,0.5685253061018147,1.0,4/9,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,0.9139902315923183,1.41807360878975,0.03333333333333333,0.3946609462341094,1.0,1/6,0.82%,FGF1
prerank,CellMarker_Augmented_2021__Neutrophil:Peripheral Blood,-0.7826594280686434,-1.4177169783628214,0.14285714285714285,0.5677875781600236,1.0,2/8,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__T cell:Undefined,-0.5280774605352123,-1.4173430228039374,0.05,0.5667841421987545,1.0,13/34,14.74%,ITGAM;CD2;KLRG1;GZMB;CD200R1;ITGAX;IL17RA;CD83;ENTPD1;IL18R1;IL6R;IL6ST;IL12RB1
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",-0.8725744453209459,-1.4172085884967915,0.03333333333333333,0.565292852268574,1.0,4/5,9.42%,LILRB4;RUNX3;CBFB;NCKAP1L
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.7362415465526325,1.4170049874630333,0.012658227848101266,0.39947633771057295,1.0,2/25,6.30%,GLRA1;NSMF
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.7683961574494034,1.416884687992415,0.075,0.3987642259094377,1.0,9/16,19.42%,SHANK3;RELN;PRRT1;NLGN3;NLGN1;CACNG2;SHISA9;CACNG8;MAPK8IP2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.7007145573391818,1.4157448020807428,0.011494252873563218,0.40330928121370674,1.0,27/64,18.07%,TNC;TGFB2;NTN4;SH3PXD2B;ENAH;DOCK1;DZIP1;OSMR;PTPRG;KITLG;LAMB1;RBFOX2;RND3;PALLD;ALCAM;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2;EDIL3;ITGAV;MPDZ;APP;APBB2;STARD13
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.5558063466101478,-1.4157028308457122,0.09090909090909091,0.5695040934261184,1.0,8/30,7.87%,NKG7;GNLY;SELPLG;CD2;GZMB;HCST;CD96;RASAL3
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.694270369872473,1.4154511007473654,0.0,0.4041568220785988,1.0,30/69,15.84%,AMER2;GRIA4;SCN3B;NCAN;NRXN1;RAB3C;CADM2;DIRAS2;CA10;GRM3;SYT4;RALYL;BSN;SYP;SNAP25;UNC13A;GRIA2;OLFM3;CACNA1B;VSTM2B;GAD2;PAK5;LY6H;STMN2;CTNNA2;HCN1;SLC17A7;ST8SIA3;KIF5A;SYNPR
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,0.9352205974204666,1.415235730223249,0.027777777777777776,0.4044618819864142,1.0,1/6,0.14%,SOCS3
prerank,KEGG_2021_Human__Basal cell carcinoma,0.7190190963003541,1.4151805239729083,0.022988505747126436,0.40364167475589685,1.0,5/27,7.98%,HHIP;FZD6;GADD45B;TCF7;TCF7L1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.9336229195667147,1.4149856398442213,0.04225352112676056,0.40364089450059115,1.0,1/5,0.30%,KLF4
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,-0.7471411926605518,-1.4148788519255313,0.08695652173913043,0.570783187919974,1.0,2/5,18.21%,SENP1;SENP5
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.9590452372285445,1.4147847510624278,0.0,0.40389406013365897,1.0,2/6,1.92%,KCNE1;KCNT2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Blood,-0.8562864611453578,-1.414537906373255,0.17142857142857143,0.5700948277956384,1.0,2/5,2.67%,ITGAM;CD2
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,-0.7526114150759038,-1.4141311118040265,0.07407407407407407,0.5692336491821617,1.0,3/10,6.98%,PIDD1;TP53;CASP10
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.6781273565643936,1.4137927767980745,0.04597701149425287,0.407817808070653,1.0,2/46,3.57%,DIAPH3;TFRC
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8490011421858749,1.41346349790902,0.04838709677419355,0.40736517623198143,1.0,3/10,3.77%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8490011421858749,1.41346349790902,0.04838709677419355,0.40736517623198143,1.0,3/10,3.77%,IL1RAPL2;PTPRD;IL1RAPL1
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.686635907532568,1.4130186646671736,0.010526315789473684,0.40871046197075384,1.0,29/64,12.79%,FAM13C;LRP4;FRAS1;PTPRD;CACHD1;ENAH;DZIP1;PLPPR4;FBXL7;PTPRG;PHYHIPL;LIFR;CNTN1;ANK2;RBFOX2;LINGO1;CSRNP3;ARNT2;MAP2;PTN;SHC2;MAP1B;CRMP1;GPRC5B;FIGN;CCDC3;PLP1;ADGRL2;NFASC
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.45892940174579366,-1.4124138353572657,0.0,0.5734191226182073,1.0,27/70,14.74%,THEMIS;ITK;NKG7;GRAP2;ZNF831;CST7;GNLY;BIN2;SELPLG;CD2;GZMB;CD96;RASAL3;AOAH;MYO1F;IL17RA;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247;IL12RB1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.8514007930501891,1.4122409186997005,0.038461538461538464,0.41165141990010756,1.0,2/14,2.89%,KCNE1;SCN3B
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8350448961682705,1.4121345741413134,0.0379746835443038,0.4109793757841564,1.0,7/11,9.88%,SHANK3;RELN;NRXN1;TSHZ3;NLGN3;NLGN1;CACNG2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",-0.8260805564661236,-1.4120182298607835,0.125,0.572640707625273,1.0,2/5,7.43%,RUNX3;CBFB
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.6976151633624289,1.4118939238963868,0.023255813953488372,0.4103418360596632,1.0,16/46,18.26%,TNC;THBS1;PLPP3;NTN4;OSMR;RND3;ALCAM;FN1;TNFRSF11B;PDCD1LG2;TGFBI;TIMP3;THY1;EPAS1;STARD13;IGFBP7
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.6976151633624289,1.4118939238963868,0.023255813953488372,0.4103418360596632,1.0,16/46,18.26%,TNC;THBS1;PLPP3;NTN4;OSMR;RND3;ALCAM;FN1;TNFRSF11B;PDCD1LG2;TGFBI;TIMP3;THY1;EPAS1;STARD13;IGFBP7
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.7544225193645344,1.4114832905164851,0.05333333333333334,0.41185910892176597,1.0,4/18,7.02%,GLRA1;GRIN3A;GRIN2A;ABCA2
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.8108161735484433,1.4114068095058552,0.02631578947368421,0.41114433139989487,1.0,3/15,4.53%,SOCS3;OSMR;LIFR
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.7292766391073638,1.4109251705875934,0.011111111111111112,0.4126020031273125,1.0,7/42,13.49%,FA2H;PLPP3;ALDH3B1;VAPB;ELOVL4;PPM1L;SPTLC2
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8443162353280347,1.4109031957560765,0.012345679012345678,0.41156956309629467,1.0,3/10,4.08%,HTR2B;NRG1;CDH2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.665637697987084,-1.410746293778777,0.21428571428571427,0.5748102891651562,1.0,5/15,3.78%,ITGA5;NEDD4;IL1B;HHEX;DAB2IP
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.6882328709863215,1.4100273350002117,0.04819277108433735,0.41593516796979885,1.0,17/42,17.66%,SHANK3;NRXN1;BEGAIN;NRXN2;LRRTM4;SHANK2;GRIN2A;SIPA1L1;NLGN3;NLGN1;NRXN3;SYT1;DLGAP1;GRIN2B;LRRTM2;DLGAP2;EPB41L5
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5402359554882612,-1.4098051203740485,0.0,0.5750485782339938,1.0,6/25,11.56%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5402359554882612,-1.4098051203740485,0.0,0.5750485782339938,1.0,6/25,11.56%,CD300LF;TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.7259425298207974,-1.409657602029635,0.0967741935483871,0.5736662749256138,1.0,3/12,8.55%,TICAM1;MLKL;TLR3
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.8655962258698056,1.4091605180393236,0.07692307692307693,0.4203019357253623,1.0,1/6,0.98%,COBL
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7633871555595628,1.4089743097837153,0.060240963855421686,0.419988687457833,1.0,8/26,13.57%,FA2H;FAAH;AATK;SLC5A9;OVOL2;ST14;CHRM3;MAP7
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.7967210449005757,1.4087191061121667,0.05128205128205128,0.4191003901129696,1.0,3/15,5.51%,SHROOM3;TOM1L1;SEMA3B
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.7967210449005757,1.4087191061121667,0.05128205128205128,0.4191003901129696,1.0,3/15,5.51%,SHROOM3;TOM1L1;SEMA3B
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.7807720650394112,1.4083352064497696,0.036585365853658534,0.41949424663560525,1.0,5/22,12.63%,CLDN18;LSR;CLDN20;MICALL2;PARD3
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.7211342045718272,1.4081708074880592,0.010869565217391304,0.4193794168057436,1.0,17/44,12.76%,SHROOM3;FRAS1;TOM1L1;JPH1;GULP1;ENAH;SLC6A15;MEIS2;KITLG;GOLM1;RBFOX2;RND3;TUSC3;TMEM132A;KIAA1549;ADGRL2;GNAI1
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,-0.7531744907816089,-1.4077714947753222,0.14285714285714285,0.5802680979743309,1.0,3/7,14.51%,FYN;HCK;CD247
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),0.9439799976864303,1.4076436761059703,0.0,0.42119008015487824,1.0,2/6,1.81%,CENPF;CENPE
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6758904560208625,1.4066938813762064,0.0,0.4253190834350768,1.0,55/97,21.44%,AMER2;GRIA4;SCN3B;NRXN1;SLC1A2;PCDH15;RAB3C;CADM2;AP3B2;KIF1B;SLC24A2;CA10;SV2B;SYT4;FRRS1L;SYP;SNAP25;CDH20;GRIA2;OLFM3;NTRK3;CADPS;TMEM130;SCN1A;CACNA1B;CACNA2D3;PPFIA2;CNTNAP2;ZNF536;SGIP1;VSTM2B;MAGI2;GAD2;PAK5;STMN2;CTNNA2;HCN1;LSAMP;FAM135B;SCN2A;ST8SIA3;SYNPR;KCNMA1;HSPA12A;GRIA1;AMPH;ATP1B2;NTNG1;GABRG2;PTPN5;SNAP91;NCAM1;CNTN2;ELAVL3;PAK3
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.8113214698530327,-1.40603437937662,0.041666666666666664,0.5841912983589937,1.0,3/7,17.71%,MAGED2;GSN;KCNQ1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.7569373801115261,1.4059144036808224,0.011363636363636364,0.42856484790260585,1.0,2/27,0.38%,FA2H;PLPP3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.9171362631793873,1.4047637064611285,0.01639344262295082,0.43406165682427855,1.0,3/5,4.46%,SHANK3;NRXN1;NRXN2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7161369129591731,1.4044598013733671,0.02197802197802198,0.4346486263322262,1.0,26/44,18.16%,PCSK1;PLPP3;FAM13C;FGF1;DENND2A;ENPP2;PTPRD;AGT;PHYHIPL;GRIN2A;GABRA2;PDE1C;CADPS;SEMA5A;GRIA3;SGIP1;FGF14;KALRN;NFASC;LSAMP;THY1;PIEZO2;GIPC2;SORBS2;CNTN3;SGCD
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.7151776194375956,1.4031484950972248,0.034482758620689655,0.44036243732498304,1.0,9/34,17.16%,RHOB;ANLN;CIT;RACGAP1;ANK3;SPAST;INCENP;SPTBN1;ROCK1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.8794628587712847,1.4027695256492403,0.02857142857142857,0.4415933588097308,1.0,2/6,11.07%,FBXL7;RBX1
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.5338953206351844,-1.4020608490453843,0.058823529411764705,0.5977338076261436,1.0,9/28,14.48%,CCL5;CX3CR1;CCL3L3;CSF1R;TNFSF10;CXCL12;IL18R1;IL6R;IL6ST
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.822618120731754,1.4018918517629775,0.0625,0.4460548394650046,1.0,2/13,2.08%,GDPD1;ENPP2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.9324591840940927,1.4015612176128427,0.014492753623188406,0.4468170391888918,1.0,1/5,6.52%,DAPK1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.770911763519403,-1.4010175440352233,0.16,0.5996430021870862,1.0,4/7,17.87%,TP53;TGFB1;EGFR;DDX5
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.7093071148700943,1.4009912510977207,0.05,0.44875062385255693,1.0,15/31,19.52%,LRP4;PTPRD;IL1RAPL1;NRXN1;NRXN2;ANK3;NLGN3;NLGN1;SPAST;PICALM;UGCG;UBXN2B;SPTBN1;STX2;NLGN4X
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,0.95289761075778,1.4009652361885996,0.0136986301369863,0.4477670443379329,1.0,4/5,4.08%,TNC;VIM;GFAP;CDH2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.7019243497299331,1.4009607015820873,0.01282051282051282,0.44664816741492597,1.0,11/41,8.95%,PLPP3;SPARC;SVEP1;GFAP;TNS1;FBXL7;DAAM2;LAMA2;PALLD;FN1;PTN
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.7826988501492367,-1.4008100785060553,0.125,0.5983314328766366,1.0,1/6,0.93%,TICAM1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.6794278442652305,1.4007775925000596,0.011363636363636364,0.44646804208127006,1.0,18/45,15.99%,PLPP3;PREX2;PTPRD;VEGFA;CGNL1;RUNX1T1;INSR;SEMA6A;PTN;GPRC5B;FLT1;SORBS1;ADGRL2;COL21A1;SHROOM4;PLXNB1;TIMP3;LDB2
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,0.671752781527517,1.400777119218486,0.03488372093023256,0.4453581416965949,1.0,14/51,7.98%,LRP2;GREB1L;PLAC8;GLIPR2;TFRC;ADAM15;SYBU;SH3GL3;ARHGAP23;NIM1K;DNAJC6;ATP8B1;PALLD;TCF7L1
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.5652465904970237,-1.4006705035595068,0.05263157894736842,0.5967725474917367,1.0,10/37,16.05%,KARS1;TARS2;DARS2;CARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.802132683630153,1.400429044511821,0.075,0.4460641108341191,1.0,4/13,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.6327608218126758,-1.4002342214313441,0.11764705882352941,0.596328772868952,1.0,8/22,16.92%,IL1B;IL1A;GZMB;HLA-E;HLA-DPA1;PRF1;FAS;HLA-DRB5
prerank,CellMarker_Augmented_2021__Immature Myeloid cell:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__CD16+ Dendritic cell:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__Classical monocyte:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__Suppressive monocyte:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Peripheral Blood,-0.8923061698043219,-1.400184310518409,0.038461538461538464,0.585053512104836,1.0,2/6,8.22%,ITGAM;ITGAX
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.8719776158312422,1.399834598643496,0.0,0.44868794152422037,1.0,5/8,7.94%,ZDHHC15;NRXN1;NRXN2;BSN;NLGN1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.7242055149178546,1.3995868435312413,0.05952380952380952,0.4488508642636468,1.0,5/28,5.30%,ASPN;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7845970576963038,1.3982739267872255,0.07058823529411765,0.45562355216271727,1.0,8/21,8.65%,SHANK3;RELN;ANTKMT;ANK3;ANK2;AKAP6;NLGN3;CALM3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6655169760591335,1.398263800112991,0.010526315789473684,0.45455056549453415,1.0,48/89,21.39%,AMER2;GRIA4;GFAP;NCAN;BRINP1;NR4A2;NRXN1;RAB3C;CADM2;CA10;GRM3;SYT4;GRIN2A;TCEAL2;SNAP25;CDH20;GRIA2;FAIM2;MAP2;OLFM3;TAGLN3;PDE2A;CACNA1B;ADCY8;GRIA3;VSTM2B;GAD2;CCK;PAK5;LY6H;STMN2;CALY;CTNNA2;GRIN2B;DAB1;ST8SIA3;ASIC2;SYNPR;NRGN;GRIA1;KCNB2;GABRG2;PTPN5;DLG4;SNAP91;CNTN2;SORCS3;ELAVL3
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7558431211837185,1.398164245862904,0.03571428571428571,0.45391839005935514,1.0,15/26,19.42%,GRIA4;RELN;DAPK1;GRIN2A;GRIA2;NLGN1;CAMK2B;GRIA3;LRRC7;GRIN2B;NEFL;GRIA1;APP;DLG4;MAPK8IP2
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.6964770551755083,1.3980481663273179,0.045454545454545456,0.45326650654525125,1.0,5/51,3.57%,DIAPH3;RHOB;ANLN;RACGAP1;TFRC
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.915436368456286,1.3980396490291216,0.05714285714285714,0.45218458633254777,1.0,1/5,3.07%,RELN
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6895908566458062,1.3980270552144236,0.0641025641025641,0.4511535306892335,1.0,24/44,24.85%,LRP4;LRRC4C;OMG;METRN;CDH2;ROBO2;LINGO1;SIPA1L1;CHN1;MAG;ROBO1;NTRK2;EPHA4;PLXNB1;THY1;ARHGDIA;PLXNC1;CHODL;PAK3;RTN4;GDI1;PTEN;BRSK1;RUFY3
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,0.7001341077619774,1.397407448554007,0.0449438202247191,0.45418932433856185,1.0,4/38,8.40%,DIAPH3;SLC2A3;TCF7;TMEM183A
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6933254106642034,1.3973571401033331,0.011363636363636364,0.45331685735429744,1.0,20/39,22.96%,VEGFA;SUV39H2;NDRG1;HIF1A;FMN2;BNIP3L;FAM162A;BNIP3;PINK1;CPEB2;SCN2A;HYOU1;EPAS1;EGLN3;RGCC;NOP53;PGK1;CPEB4;P4HB;RORA
prerank,CellMarker_Augmented_2021__Macrophage:Brain,0.6819130353597534,1.397102731293259,0.044444444444444446,0.45384861930146253,1.0,17/45,19.06%,NFIL3;PLAC8;BHLHE40;FOSL2;MXD1;FGR;CD93;PDE4B;GPR65;THBD;PLTP;ARG2;CYRIA;TGFBI;IQGAP1;SPINT2;SLC66A3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.7217487111816153,1.3969292785763108,0.04819277108433735,0.4539047630058806,1.0,17/41,16.59%,SHROOM3;LRP4;COBL;JPH1;ENAH;MAPK4;MFNG;ARFGEF3;LINGO1;SHC2;RPL23A;CKB;NR2F1;PLXNB1;CPE;EPB41L4B;EPAS1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8657597503908354,1.3967569845072954,0.058823529411764705,0.4539606314960613,1.0,1/5,1.30%,NLRP12
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8484069884019421,1.396617461761571,0.04477611940298507,0.4534558789594428,1.0,5/8,11.82%,SHANK3;NRXN1;NRXN2;NLGN1;TMEM108
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.8134575532593366,-1.3966173654999432,0.16129032258064516,0.5961685878788244,1.0,3/5,18.50%,TRIB1;LILRA2;SIGIRR
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,0.7017188225223016,1.3963528057864427,0.023255813953488372,0.4540939101339305,1.0,10/56,5.92%,ASPN;SPARC;ADAMTS2;PLIN2;OGN;ENPP2;RELN;TFRC;FILIP1L;RUNX1T1
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.7761786521616221,1.3960704506553843,0.012345679012345678,0.45461731231828423,1.0,6/20,9.37%,CADM1;CDH8;CDH2;CADM2;CDH9;CDH12
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.8277647532870773,1.396044817872987,0.08,0.45366962717584797,1.0,1/11,3.04%,IL15
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.7380602724087502,1.3957807084247236,0.06666666666666667,0.4539917505803382,1.0,7/24,14.03%,CENPF;CENPE;OIP5;CENPP;CENPK;CENPV;CENPI
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,0.9002111523698249,1.3957621795602482,0.029850746268656716,0.4530058682180575,1.0,2/5,9.59%,CKMT2;CKB
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.7117711695484721,1.3955279710796475,0.03529411764705882,0.45306296035969984,1.0,14/47,12.57%,THBS1;SPON1;ADAMTS2;THSD4;GALNTL6;GCNT7;GALNT8;B4GAT1;THSD7A;GALNT18;SEMA5A;B4GALT5;ADAMTSL3;THSD7B
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.7681889434644117,1.3954601009440497,0.06172839506172839,0.4523705283139939,1.0,4/24,3.84%,HS3ST5;HS3ST2;B4GAT1;GPC5
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,0.924520553861022,1.395443294073811,0.017241379310344827,0.45141761036387723,1.0,1/5,0.82%,FGF1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.7733430367851412,-1.395409882955076,0.1111111111111111,0.5984307526674107,1.0,2/6,11.56%,ZDHHC5;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.7497345967676474,1.3951020094092137,0.011904761904761904,0.45209216929013085,1.0,4/24,6.56%,KCNE1;FHL1;ANK2;AKAP6
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6577778153758174,-1.3950455909898256,0.07142857142857142,0.5977052375685854,1.0,3/12,7.51%,ZNF675;IGF1;TGFB1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.7400316020601954,1.3949820158542385,0.0684931506849315,0.45065963654859303,1.0,3/24,1.28%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.7400316020601954,1.3949820158542385,0.0684931506849315,0.45065963654859303,1.0,3/24,1.28%,LRP2;COBL;TGFB2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.8196577173541346,-1.3949743979143452,0.07142857142857142,0.5960785643773098,1.0,2/7,12.16%,LGALS9;CXCL12
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,0.8164897717940865,1.3948689628985125,0.025974025974025976,0.45039486246940696,1.0,4/16,7.48%,DAPK2;SLC38A4;ITPKC;PKP2
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.8067047150361353,-1.3941611157142075,0.0967741935483871,0.5972527668984334,1.0,4/7,10.15%,EHHADH;ACOX1;ACAA1;MLYCD
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5484100104716128,-1.3941481754567402,0.058823529411764705,0.5954330783668451,1.0,8/27,10.62%,FGL1;CCL5;CD2;DUSP3;IL4I1;SIRPA;HLA-DPA1;ABL1
prerank,KEGG_2021_Human__Primary immunodeficiency,-0.668805711633313,-1.3940954038570896,0.1111111111111111,0.5937470470459371,1.0,3/15,10.31%,RFX5;BLNK;BTK
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.6602429826318286,1.3939032814095953,0.010526315789473684,0.45510601037377674,1.0,24/73,19.55%,DDIT4;TGFB2;PTPRD;SPOCK1;MANF;ERCC2;NR4A2;IL1RAPL1;RORB;VEGFA;SOX4;OLIG1;ID2;ALK;NTRK2;EPHA5;WNT5A;CASP3;UGCG;NRBP2;ERCC6;CDK5R1;NLGN4X;ACSL3
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.8019452433502613,1.3938819170818015,0.06172839506172839,0.45409512588484985,1.0,4/14,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,0.8507874277479859,1.3934531292712515,0.03125,0.4553159694441726,1.0,2/10,6.34%,PCSK1;RGS2
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,0.9105916078055627,1.393321628604158,0.016666666666666666,0.4550643013742581,1.0,1/6,0.82%,FGF1
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,-0.7903281677092112,-1.3933209944582337,0.1935483870967742,0.5953241486145964,1.0,5/6,19.40%,GPX4;ALOX5;LTC4S;GPX1;ALOX5AP
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.6330346996160225,1.3931493175330714,0.0,0.4549859705350797,1.0,53/164,19.36%,GLRA1;PRKAR2B;GRIA4;CACNB2;MAPT;NRG1;GRIN3A;SLC1A2;GAD1;GABRB1;GRIN2A;GRIK1;SNAP25;GRIA2;GABRB3;GABRA2;GLUL;CACNG2;CACNA1B;CACNA2D3;ADCY8;PPFIA2;CAMK2B;GABRB2;PRKAG2;RPS6KA2;GRIA3;GAD2;SYT1;PPM1E;GNAI1;NSF;GABRA4;LRRC7;GNAL;GLRB;RASGRF1;GRIN2B;SLC17A7;NEFL;CPLX1;NRGN;CACNA1A;KCNJ6;CACNG8;PLCB1;GRIA1;PRKAA2;KCNJ3;PPFIA4;GRIK4;GABRG2;AP2A2
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.7660463523652933,1.3931152284885546,0.06666666666666667,0.4540492440071646,1.0,7/15,10.97%,IL1RAPL2;PTPRD;IL1RAPL1;PPFIBP1;NTRK3;SLITRK5;PPFIA2
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.7855963167187646,1.392993519322352,0.08108108108108109,0.4536737861861552,1.0,3/13,9.26%,LRP4;SRGN;RBPJ
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.7683429759584073,1.3927264458566886,0.04878048780487805,0.45430442060301424,1.0,9/17,14.37%,VIM;CKS2;HMGB2;GAD1;PTPRZ1;NRXN3;PDE4DIP;GAD2;FDFT1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6936484363512093,1.392672142647653,0.02197802197802198,0.4535250493382396,1.0,8/54,8.38%,GLRA1;VIM;MYOT;CKMT2;GNAO1;DMD;LTB4R;CAV3
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,-0.46892722625929734,-1.3923936823811307,0.1,0.5976616452875033,1.0,30/82,14.46%,CD300LF;ITGAM;LY86;BIN2;CCL3L3;SAMSN1;PIK3R6;MPEG1;P2RY13;HCST;ITGAX;AOAH;NCKAP1L;WDFY4;CLEC9A;IGSF6;PLEK;HCK;BTK;NLRP3;ITGB2;CYTH4;TLR7;LCP2;CD83;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.6798486862815478,1.3919481618199454,0.010638297872340425,0.45668421052958075,1.0,46/82,22.53%,ST18;MOBP;AMER2;ASPA;GRIA4;CACNB2;SCN3B;NRXN1;SLC1A2;SLC4A10;AP3B2;SLC24A2;SV2B;MOG;KCNT1;FRRS1L;SYP;GRIA2;UNC80;CACNG2;CADPS;SCN1A;GAD2;XKR4;CCK;RUNDC3A;UNC13C;CTNNA2;HCN1;FAM135B;ST8SIA3;SYNPR;CACNA1A;KCNJ6;DLGAP2;DPP6;RPH3A;ATP1B2;B3GAT1;CYP46A1;CNTN2;SLC24A4;SEZ6;CNDP1;MYT1L;PRKCB
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7269828770031648,1.3917535380545751,0.03488372093023256,0.4566032178290129,1.0,7/22,10.26%,HTR2B;SEMA3A;NRG1;CDH2;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.7695312773927652,1.3915657741967973,0.07792207792207792,0.4566496286585063,1.0,3/13,6.03%,TOP2A;HMGB2;MTERF1
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,0.9169834627959512,1.3903219381437666,0.047619047619047616,0.46349736374037515,1.0,1/5,0.82%,FGF1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.7692095605512871,1.390110201977664,0.04938271604938271,0.46361200949976855,1.0,7/21,7.93%,PRLR;LSR;RARRES1;OVOL2;BAIAP2L1;KDM3A;PPP1R13L
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.7295997043577129,1.3900817845539977,0.05194805194805195,0.4627379122639274,1.0,8/33,8.46%,TNC;SVEP1;ADAMTS2;COL11A1;FBXL7;LAMA2;LAMB1;FN1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.8955158370173009,-1.3898041914362174,0.06896551724137931,0.6051166313004018,1.0,1/5,7.98%,DDX23
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6785696000259465,1.389696297594219,0.010416666666666666,0.46446906038015806,1.0,25/56,22.34%,KCNE1;KCNJ13;SLC24A2;KCNH8;SLC9A7;KCNH5;KCNMB1;SLC24A1;SLC9A6;NALCN;KCNH7;HCN1;SLC24A3;ATP1B3;KCNJ6;KCNMA1;KCNB2;KCNJ3;TMEM175;ATP1A2;SLC24A4;SLC9A1;KCNQ5;CHP1;KCNQ2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7513850347192882,1.3896431238588058,0.04819277108433735,0.46363885749278666,1.0,9/23,15.83%,FGF1;NRG1;INSR;TXN;NTRK3;PRR5;PINK1;WNT5A;IL18
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6739082537900681,1.3889187827139222,0.02197802197802198,0.4664877059429052,1.0,20/63,18.37%,KCNE1;KCNT2;KCNJ13;SLC24A2;KCNH8;SLC9A7;KCNH5;SLC24A1;SLC9A6;NALCN;KCNH7;SLC12A8;HCN1;SLC24A3;ATP1B3;KCNJ6;KCNB2;KCNJ3;ATP1B2;TMEM175
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.8816156812605521,1.3885427328097715,0.029411764705882353,0.46780266824574285,1.0,1/6,0.35%,CLEC4E
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),0.7267045460545237,1.3882443884973295,0.02564102564102564,0.46861276683641034,1.0,1/25,0.72%,MDH1
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8421600339579453,1.3881925605722367,0.04054054054054054,0.4681955117216129,1.0,5/8,7.94%,LRP4;NRXN1;NRXN2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.9061135473140827,1.3881570884618217,0.06349206349206349,0.4672834925837189,1.0,2/5,7.86%,FGF1;PAX8
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,0.8911406969085701,1.3881526356743665,0.029411764705882353,0.46623105228510686,1.0,1/7,1.00%,ARAF
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,-0.7949112052211113,-1.3881108758921528,0.037037037037037035,0.6086182843282982,1.0,4/7,14.66%,RUNX3;TP53;TGFB1;ZFHX3
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.779090308560381,1.3879300419555793,0.1038961038961039,0.466419381226384,1.0,5/13,13.75%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,-0.5205185531970434,-1.387924899300755,0.05,0.6071185181203447,1.0,12/33,14.74%,ITGAM;CD2;KLRG1;GZMB;CD200R1;ITGAX;IL17RA;CD83;ENTPD1;IL6R;IL6ST;IL12RB1
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.6372470499750922,-1.387911592214896,0.08,0.6053476247617984,1.0,5/16,11.00%,TICAM1;CHUK;TLR3;IKBKB;NFKBIA
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.648252580060821,1.387537168758818,0.031914893617021274,0.4676551432586876,1.0,14/56,14.50%,PCSK1;GPM6A;CADM1;MXRA7;ENTPD3;ROBO2;ALCAM;SCD5;ELOVL4;SEMA5A;PIK3IP1;SUSD4;ENPP4;RASGRF1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.8969498038667958,1.3874686080099914,0.031746031746031744,0.46699859600277394,1.0,1/7,0.28%,THBS1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,0.8265902094961274,1.3873264630929723,0.0125,0.4666928456962768,1.0,5/12,7.48%,TOM1L1;LSR;OVOL2;BAIAP2L1;PKP2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.6986178101415274,1.3872108816100566,0.023809523809523808,0.4664292915627227,1.0,7/38,8.46%,TNC;SPARC;FBXL7;LAMA2;LAMB1;ARHGAP23;FN1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7754162693454218,1.3870904465145157,0.0641025641025641,0.4659631912137794,1.0,2/13,9.54%,PRLR;GHR
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7902466157012014,1.386468530942211,0.07792207792207792,0.469137616815255,1.0,4/13,9.87%,VEGFA;ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.7620887218589223,1.3863094449627462,0.07058823529411765,0.46895152961391023,1.0,4/22,6.39%,KCNE1;MTCL1;CEMIP;ANK3
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.6847306832507247,1.3856098718991452,0.03333333333333333,0.4723279486063535,1.0,17/62,17.30%,PLPP3;SHROOM3;COBL;PRLR;AGT;SLC4A10;PHYHIPL;CGNL1;SHANK2;SLC13A4;SHC2;GPRC5B;ADGRL2;PLXNB1;CPE;EPB41L4B;MPDZ
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.5670161359157183,-1.3855403216397348,0.0,0.6120499363197922,1.0,5/18,9.24%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.8794708819229251,1.385462228748234,0.045454545454545456,0.4723375767085414,1.0,3/6,8.46%,SEMA3A;SOX4;FN1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.7574722814839484,1.3854101498569245,0.03614457831325301,0.47172257786061866,1.0,2/23,2.79%,AANAT;MAPT
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.800586652898053,-1.3853813652410625,0.09375,0.6106727940251967,1.0,1/5,2.93%,FLII
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.4776729652799435,-1.3853467090574165,0.0,0.6090262409957944,1.0,18/74,15.14%,ITK;GRAP2;CHUK;NFKBIE;MAP3K14;MAPK13;KRAS;FYN;NFATC3;IKBKB;NFKBIA;LCP2;PPP3CC;NCK1;BCL10;AKT1;CD247;CARD11
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,0.8382032067072068,1.3851064357332763,0.057971014492753624,0.4723366025200829,1.0,1/10,0.82%,FGF1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.4484254697539066,-1.3849257353730227,0.0,0.6088136399042494,1.0,24/86,13.61%,NKG7;CCL5;CD300LF;ITGAM;CST7;LY86;BIN2;SELPLG;PIK3R6;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2;LTC4S;TYROBP;CD53;SNX20
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.8464644680841086,1.3844801268989875,0.057971014492753624,0.4749739713658112,1.0,1/8,3.16%,PIGU
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,-0.7223986614247002,-1.3843785828294761,0.038461538461538464,0.609430507027761,1.0,2/9,2.17%,LRIG1;POLD3
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,0.7556790066945965,1.3842028887230153,0.02631578947368421,0.47535804048262137,1.0,5/23,5.56%,FA2H;CBR1;FAAH2;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.7007057382217577,1.3834487995223732,0.01098901098901099,0.47819703028708055,1.0,10/50,16.95%,FA2H;PLPP3;ALDH3B1;VAPB;ELOVL4;PPM1L;SPTLC2;ST6GALNAC5;ST8SIA3;PRKD3
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.7201344411022298,1.3833492503755704,0.05063291139240506,0.4776158360515481,1.0,9/23,14.46%,HTR2B;NUDT4;AKAP6;ADGRG6;RAPGEF3;RIMS2;PDE2A;GUCY1B1;EPHA5
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6578445826785159,1.3831118805834992,0.030927835051546393,0.478011560739905,1.0,24/80,11.79%,OPALIN;CD163;ENPP2;GFAP;TNS1;CHI3L1;NRXN1;SLC1A2;RTN1;PDK4;CA10;BAALC;GRIN2A;PTPRT;CDH20;GRIA2;CHL1;FAIM2;NDRG2;GLUL;PLP1;GRIA3;KIAA0513;NTRK2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.707454134518956,1.38286843265183,0.06896551724137931,0.47852462805540186,1.0,5/23,3.87%,TGFB2;SPOCK1;MAPT;CIT;ANXA1
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.6536793616237945,1.3828535566825375,0.021052631578947368,0.4775900963589455,1.0,33/94,13.03%,GLRA1;HTR2B;PRLR;TSHR;GRM8;GNRHR;HTR7;CHRM5;GRIA4;TACR1;AGT;GRIN3A;GRIK2;GABRB1;GRM3;MCHR2;LTB4R;GRIN2A;CNR1;GRIK1;GRIA2;GABRB3;GABRA2;GHR;C5AR1;RXFP1;CHRM3;GABRB2;GRIA3;GRID2;PARD3;CCK;GABRA4
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6710406072385278,1.382835258141505,0.06896551724137931,0.4767781353661708,1.0,9/43,14.25%,GLRA1;ANO4;GABRB1;GABRB3;GABRA2;GABRB2;GABRA4;SLC12A8;GLRB
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.7522473288350133,-1.3828338433429495,0.17142857142857143,0.6144081565538423,1.0,2/5,7.43%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.5572552485874367,-1.3827180895983702,0.14285714285714285,0.6130837313920753,1.0,3/24,1.70%,PHLDB2;RPS6KA6;RBM19
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7856877106672675,1.3825141303988884,0.047058823529411764,0.4777636955760517,1.0,6/16,14.09%,CACNB2;JPH1;DMD;ANK2;CAV3;AHNAK
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.7770815405357245,1.3821346851968883,0.06578947368421052,0.4791187995615667,1.0,5/12,10.16%,PDE5A;PDE10A;PDE1A;PDE2A;KCNMB1
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.7029868618253431,1.3816867747997261,0.011111111111111112,0.4804288397590528,1.0,17/39,16.85%,ZNF382;AANAT;PDE10A;SCN3B;AP3B2;TVP23A;SLC24A2;SV2B;MGAT4C;FRRS1L;XKR4;UNC13C;HCN1;CACNA1A;CRB1;KCNJ6;SV2C
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.7744805820094052,1.3815975678134225,0.025974025974025976,0.47989198809926975,1.0,10/24,10.63%,SHROOM3;TOM1L1;SH2D4A;THSD4;ADGRG6;OVOL2;BAIAP2L1;PKP2;ERRFI1;SH3D19
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.6686797655518251,-1.3815576834111871,0.043478260869565216,0.6156366601824677,1.0,6/15,15.78%,TAPT1;WRAP73;ARHGAP35;MARK4;KCTD17;CROCC
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.8092959287710058,1.3807737728490301,0.1,0.4820044325767082,1.0,1/13,0.36%,DAPK2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.8092959287710058,1.3807737728490301,0.1,0.4820044325767082,1.0,1/13,0.36%,DAPK2
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8740782959884985,-1.3807646179231565,0.02857142857142857,0.6175898943691215,1.0,1/5,4.41%,RPIA
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.7507253028741699,1.380361589242992,0.08641975308641975,0.4829663417070354,1.0,9/18,19.88%,PRKCE;CIT;RACGAP1;SVIL;SPAST;CENPV;PKP4;CDC25B;ECT2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.7401056923401053,1.380009766474795,0.024691358024691357,0.4843903083674488,1.0,5/21,7.71%,TNC;NTN4;OSMR;RND3;PALLD
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.8288365906185868,-1.3798296663334653,0.07692307692307693,0.6194538623874601,1.0,4/6,14.75%,TAL1;SH2B3;ZNF385A;MED1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7960178150790318,1.3789632197731545,0.12658227848101267,0.4891805765437694,1.0,1/14,0.36%,DAPK2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.7874626242686369,1.3788101678493265,0.047619047619047616,0.48919292488025523,1.0,2/16,2.26%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.8672529921498903,1.3782115984379566,0.02531645569620253,0.4916369656562131,1.0,3/10,8.38%,KCNE1;ANK2;CAV3
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,-0.501184022095102,-1.377877397995059,0.0,0.6259168543194787,1.0,15/47,13.10%,LYL1;BIN2;P2RX1;SAMSN1;PIK3R6;LGALS9;ARHGDIB;HCST;NCKAP1L;PLEK;BTK;LCP2;PTPN7;TYROBP;CD53
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7742381971973917,1.3777197115534678,0.06666666666666667,0.493358153846534,1.0,9/16,14.60%,NAPA;CDH8;GRIK2;GRIK1;UNC13A;GRIA2;GRID2;UNC13C;SLC17A7
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.9083152629337201,1.3775800023127114,0.06666666666666667,0.4932847919432104,1.0,1/6,0.31%,CENPF
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.6769778852959847,1.3774738018387227,0.036585365853658534,0.49300077424092276,1.0,4/30,9.03%,RAB3C;TVP23A;RAB15;ABCA1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.6753775614853557,1.3773712536466078,0.031578947368421054,0.4926031120548966,1.0,24/58,12.36%,LRP4;FRAS1;PTPRD;PPP1R9A;CACHD1;ENAH;MAPK4;FBXL7;LIFR;PTPRZ1;ANK2;RBFOX2;SEMA6A;LINGO1;CSRNP3;PTN;MAP1B;UNC5D;CRMP1;GPRC5B;FIGN;EPHA7;PLP1;ADGRL2
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.6592423199659208,-1.377301651181439,0.043478260869565216,0.626084460363973,1.0,8/16,22.10%,EHHADH;ACOX1;ACAA1;MLYCD;PECR;ACBD5;SLC25A17;SYCP2
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8472319033849945,1.3772116311725662,0.08695652173913043,0.4925699787110315,1.0,2/6,6.41%,TGFB2;ANK2
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,-0.7312568445148421,-1.376851487800726,0.2,0.6262895958400498,1.0,4/7,24.19%,C3;C1QC;C1QB;PIKFYVE
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6648961543280181,-1.3765241033057887,0.06896551724137931,0.6236332467527136,1.0,4/13,14.14%,MAP4K4;RAPGEF6;STK26;RAP1A
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6648961543280181,-1.3765241033057887,0.06896551724137931,0.6236332467527136,1.0,4/13,14.14%,MAP4K4;RAPGEF6;STK26;RAP1A
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.8611459990197214,1.376424463067543,0.056338028169014086,0.49659651095403196,1.0,2/7,7.86%,TG;PAX8
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6587543508249156,1.3761753185379901,0.03260869565217391,0.4972018853807938,1.0,15/64,8.46%,SOCS3;TNC;PLPP3;SPARC;SVEP1;LRP4;ADAMTS2;COL11A1;ITGA2;OSMR;LAMA2;INSR;HIF1A;PALLD;FN1
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.7146867553942767,1.375932566867139,0.05813953488372093,0.49772883349092945,1.0,8/30,7.79%,TNC;SHROOM3;ITGA2;ENAH;PTPRK;ARFGEF3;GOLM1;PTK7
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.6563831469741686,1.3758905528558238,0.0,0.4969277563271686,1.0,16/102,11.38%,KCNE1;CACNB2;PPP2R3B;ADCY3;CREB5;PPP2R5B;AGT;PPP2R5A;RAPGEF3;CALM3;RYR2;CACNG2;CACNA2D3;ADCY8;CAMK2B;PPP2R2B
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.8284086866694305,1.3747557020852474,0.04225352112676056,0.5026321432725633,1.0,1/12,0.14%,SOCS3
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.8953730743001647,1.3743225675984572,0.03076923076923077,0.5043330177211536,1.0,3/6,5.04%,MANF;NR4A2;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.9231939458066842,1.3738343857619586,0.03125,0.5058198430021695,1.0,1/5,0.01%,KCNE1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7911037533778065,1.3730956774450858,0.08695652173913043,0.5091039761505697,1.0,6/14,7.94%,LRP4;PTPRD;IL1RAPL1;BSN;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.904857658549761,1.3730161163082741,0.10294117647058823,0.508625274186206,1.0,2/5,5.16%,TGFB2;SOX4
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6659882562247731,1.3727900099787254,0.03125,0.5090652551593333,1.0,20/85,13.26%,FGF1;PRLR;TGFB2;TOM1L1;PRKAR2B;ADCY3;NRG1;CHI3L1;CLSPN;SLC11A1;VEGFA;TRAF2;INSR;TXN;GHR;NTRK3;PRR5;ADCY8;PAK5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.8358315524240612,-1.3724883034883009,0.20512820512820512,0.6369382905424096,1.0,3/5,15.04%,CD200R1;RIPOR2;LRCH1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.6935546078569912,1.3721975263068538,0.047619047619047616,0.5121173353396808,1.0,16/39,13.55%,SH3PXD2B;VGF;RGS20;ANLN;ENAH;MTCL1;FRMD5;B4GALNT4;SRRM3;RBFOX2;ADGRB2;MAP1B;WASF1;TMEM132A;PEG10;SCD
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.7249607111421974,1.3713815578417072,0.047619047619047616,0.5153806011417154,1.0,4/31,5.23%,THBS1;FGF1;MAPT;IER5
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7590201347789934,1.3712915685275169,0.14285714285714285,0.5147442923998923,1.0,3/10,9.23%,CIT;SHANK2;LIMD1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6458983011586373,1.3711902245125194,0.08791208791208792,0.5141847888798516,1.0,24/71,18.07%,TNC;PLPP3;SH3PXD2B;DOCK1;OSMR;FILIP1L;SYNC;GPNMB;LAMB1;RND3;BMI1;PALLD;FN1;PPFIBP1;PTN;MLANA;SASH1;PMP22;UACA;TIMP3;ITGAV;EPAS1;HSPB1;STARD13
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.6811661916042672,1.3708582440112131,0.056818181818181816,0.5152943260744982,1.0,23/48,20.39%,SHANK3;RELN;NRXN1;TSHZ3;GRIK2;SLC24A2;SHANK2;GRIN2A;NLGN3;NLGN1;RIMS2;PLK2;CACNG2;SLC24A1;ADCY8;SYT1;GRIN2B;RIMS3;CACNG8;APP;DLG4;TNF;CLSTN2
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.7222528168638843,1.3704780989652448,0.034482758620689655,0.5167690381401029,1.0,14/44,15.06%,FAM13C;SVEP1;ADAMTS2;RBMS3;PDE10A;LIFR;RUNX1T1;MYO10;ENOX1;NR2F1;CCDC3;UACA;LIMCH1;WNT5A
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,-0.7919776831787777,-1.370002921022684,0.1935483870967742,0.6450273021509715,1.0,1/5,2.58%,PLA2G4C
prerank,KEGG_2021_Human__Fat digestion and absorption,0.7736399586017411,1.3699740319957632,0.05263157894736842,0.5185513850441293,1.0,4/14,9.03%,PLPP3;DGAT1;ACAT1;ABCA1
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.7003644743752819,1.3699717207740185,0.04597701149425287,0.5175285254165692,1.0,13/39,12.63%,SHROOM3;LRP4;FRAS1;SH3PXD2B;ENAH;ADGRA3;LAMB1;ASAP2;RBFOX2;PTK7;TUSC3;TMEM132A;PARD3
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.9070124640858349,1.3698156184696202,0.0273972602739726,0.5171895044031704,1.0,3/6,6.56%,KCNE1;ANK3;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7037303480753757,1.3696851442576605,0.011904761904761904,0.5172001965135554,1.0,3/30,6.56%,KCNE1;ANK2;AKAP6
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.5956661950044775,-1.3693937214709109,0.08695652173913043,0.6453265488231957,1.0,8/21,14.51%,ITK;GRAP2;EVL;PKN1;HLA-DPA1;LCP2;NCK1;CD247
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,0.6658289692151295,1.3693577848942045,0.06315789473684211,0.5180708512390758,1.0,10/49,5.30%,ASPN;SPON1;SPARC;SVEP1;ADAMTS2;OGN;CERCAM;VCAN;VASN;LAMA2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.6362310889249766,1.3691590467627082,0.010309278350515464,0.5185910680575916,1.0,19/93,6.19%,TNC;THBS1;SPARC;FBN2;ADAMTS2;ECM2;THSD4;COL11A1;NCAN;ITGA2;MMP21;COL4A5;VCAN;TEX14;ADAM15;COL23A1;LAMA2;LAMB1;COL24A1
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.7487465501976522,1.3689135245005641,0.024390243902439025,0.519163892108554,1.0,9/22,18.67%,TUBA4A;TUBB4A;VBP1;TUBA1A;TUBB6;TUBB2A;PFDN4;TCP1;TUBA1C
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.7716456266188705,1.3687275235090888,0.04819277108433735,0.519243338198959,1.0,6/19,7.48%,SHROOM3;COBL;TOM1L1;CAMK2N1;NGEF;PKP2
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5459288025889764,-1.3682861075928148,0.10526315789473684,0.6481219421574476,1.0,6/25,12.77%,MYH9;PLEKHM2;PLEKHM1;LAMTOR1;MILR1;DEF8
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7291308232187441,1.3680216850714508,0.06493506493506493,0.5220091211302832,1.0,14/20,25.86%,SHANK3;RELN;NRXN1;NLGN3;NLGN1;RIMS2;TMEM108;APP;DLG4;NLGN4X;LRRK2;PTEN;RIMS1;PTK2B
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.8621644996215491,1.367617895978672,0.02564102564102564,0.5240392851156953,1.0,1/12,0.14%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.7659960450692789,1.3675066962116096,0.013888888888888888,0.523638527488589,1.0,4/17,8.65%,TOM1L1;VEGFA;GPNMB;CALM3
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.6467765367847801,1.3673972640854024,0.020833333333333332,0.523257393494895,1.0,26/77,14.79%,PCDH17;LRRC4C;ENPP2;CADM1;PTPRD;VCAN;NRXN1;UBE2QL1;RTN1;PHYHIPL;ASXL3;INSR;BAALC;PTPRT;CHL1;NDRG2;PTN;SCN3A;THSD7A;ZNF536;NTRK2;NFASC;LY6H;STMN2;LSAMP;MAPK10
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,0.811769229226879,1.3672305508295541,0.024691358024691357,0.523147912989955,1.0,4/10,9.56%,KLF4;TFRC;ALCAM;POU5F1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.8888759882965982,1.3669435074900032,0.07017543859649122,0.5227687783369371,1.0,4/5,11.01%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.8888759882965982,1.3669435074900032,0.07017543859649122,0.5227687783369371,1.0,4/5,11.01%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.779340766642715,1.366216012767114,0.057971014492753624,0.5253232736717648,1.0,1/16,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.779340766642715,1.366216012767114,0.057971014492753624,0.5253232736717648,1.0,1/16,0.28%,THBS1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8255914578429657,1.3661546525190797,0.058823529411764705,0.5246579478677039,1.0,5/9,7.94%,LRP4;PTPRD;IL1RAPL1;NLGN3;NLGN1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7965153953520109,1.366019106592614,0.0273972602739726,0.5245292227766233,1.0,7/14,7.17%,SHROOM3;TOM1L1;SH2D4A;ENAH;OVOL2;BAIAP2L1;RND3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.7057854291887463,1.365482735549806,0.01098901098901099,0.5266217549822192,1.0,4/36,1.28%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.7896158316426919,1.3652431825384488,0.0684931506849315,0.5268266317536779,1.0,3/16,8.05%,SLC4A10;FHL1;UNC80
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7825910805972569,-1.3649172884665708,0.16216216216216217,0.6588262043067534,1.0,3/5,21.14%,ZDHHC3;CASP8;SPI1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8063254262557715,1.3647493721025463,0.1111111111111111,0.5288712545877938,1.0,1/9,1.28%,TGFB2
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.7298905736010424,1.3645950058214094,0.07317073170731707,0.5233387888602851,1.0,10/29,9.46%,COBL;FRAS1;PTPRD;PPP1R9A;ASXL3;LRRN1;PTPRZ1;SEMA6A;PTPRT;UNC5D
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.8061496997402717,-1.3636067315437113,0.07317073170731707,0.662281860605938,1.0,2/5,12.16%,CALCR;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6854682969260881,1.3631004074809123,0.031578947368421054,0.5307617214304841,1.0,4/43,1.28%,THBS1;KLF4;SPARC;TGFB2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.9017768168132517,1.3629158238979255,0.047619047619047616,0.5309200643970068,1.0,2/5,7.22%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.8519202458370427,1.3626044519265132,0.09230769230769231,0.531650763237017,1.0,2/6,8.25%,BSN;ERC2
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.8036453927753294,1.3625795830774223,0.1111111111111111,0.5308190470592385,1.0,3/9,5.86%,ITGA2;LAMA2;LAMB1
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,0.8411533267805102,1.362220897644674,0.058823529411764705,0.5317720372132254,1.0,1/8,0.82%,FGF1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.7970484097017227,1.361914836328553,0.06578947368421052,0.5325487959444246,1.0,1/10,0.75%,AANAT
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,0.8422532186747065,1.3618468112894515,0.08974358974358974,0.5320474850968928,1.0,1/6,0.75%,AANAT
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.5513548610455979,-1.3618209321862824,0.09090909090909091,0.6664682130553331,1.0,4/18,12.06%,SERGEF;IL1B;NR1H3;REST
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.7624245724832568,1.361604373421668,0.04,0.5326660175991632,1.0,3/13,14.41%,THBS1;IRS2;EIF2B2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.7909879763766211,1.3615944931755695,0.12162162162162163,0.5317028501149671,1.0,3/10,10.26%,VEGFA;GPNMB;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.7605693758945363,1.3614446366814794,0.05063291139240506,0.5318742013396255,1.0,1/19,0.01%,KCNE1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5501278053626426,-1.361311875330209,0.13333333333333333,0.666776942212605,1.0,10/38,16.05%,KARS1;TARS2;DARS2;CARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,-0.6976050314378517,-1.3609022892596603,0.07142857142857142,0.6665989009560234,1.0,2/9,2.17%,LRIG1;POLD3
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.6235404092167575,-1.3608886952196586,0.1111111111111111,0.664784925306055,1.0,3/13,9.02%,ITGA5;ICAM1;ENG
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.8262778212793206,1.3603895687860421,0.056338028169014086,0.5369193120708685,1.0,4/7,16.85%,SV2B;SNAP25;SYT1;SV2C
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,-0.6595941851120818,-1.3601107037223423,0.10714285714285714,0.6654667747539019,1.0,3/10,16.61%,CRKL;RAP1A;RAPGEF1
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.8952611981406047,1.3596240272620732,0.07246376811594203,0.5404262867170588,1.0,1/7,0.14%,SOCS3
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,0.8627410983534646,1.3595326239390417,0.07936507936507936,0.5397966475064749,1.0,1/6,0.82%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.8115767254362012,-1.35918755136012,0.13333333333333333,0.6665147193670737,1.0,1/5,5.75%,TMEM106A
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,0.9135627845235688,1.358997808021933,0.08196721311475409,0.5420436898843325,1.0,1/5,0.82%,FGF1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8412504637936372,1.358989739056067,0.06756756756756757,0.5411078111291335,1.0,3/7,9.87%,ROBO2;ROBO1;PDE2A
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.7827258041546307,1.3585996056626732,0.09333333333333334,0.5425646490480952,1.0,4/12,5.91%,TUBA4A;TUBB4A;TUBA1A;TUBB6
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.6578810124813336,-1.358450969501507,0.16,0.6680732330431505,1.0,3/10,11.00%,FLNA;NFKBIE;NFKBIA
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.6547181427646944,1.358376893391293,0.10344827586206896,0.5428659714114386,1.0,5/34,8.46%,TNC;THBS1;SPARC;CLMP;FN1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.8237262763372767,1.358179297319471,0.08955223880597014,0.543014239890068,1.0,3/9,8.14%,TGFB2;ROBO2;ROBO1
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.6449917787108211,1.3575606069676163,0.05263157894736842,0.5459761866403023,1.0,38/79,26.86%,EEF1A2;RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;EEF1B2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;EEF1A1;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.7163900384915655,1.3573845931955013,0.09302325581395349,0.5461518456305874,1.0,2/19,0.68%,THBS1;SPARC
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.7413235794938925,1.3573155520501194,0.05263157894736842,0.5458399538094474,1.0,4/19,8.81%,PDE5A;GFAP;GAD1;PDE1C
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6306392207266641,1.3570840819042762,0.011363636363636364,0.5463168854582267,1.0,35/82,21.44%,LRP4;LRRC4C;SHANK3;MYOT;GPM6A;PTPRD;CACNB2;MAPT;NRXN1;CDH2;NRXN2;CTNND2;SHANK2;ANK3;NLGN3;UNC13A;NLGN1;PPFIBP1;DNM3;C5AR1;PPFIA2;CBLN2;UNC13C;APP;APBB2;DCTN1;PPFIA4;NTNG1;LRFN5;NLGN4X;PTPRS;LRRK2;CNTN2;CX3CL1;PAK3
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,0.7357937237691263,1.3565223091807308,0.07228915662650602,0.5491675422720281,1.0,12/29,11.71%,TGFB2;SH2D4A;NTN4;OSMR;ADGRG6;RND3;FN1;TNFRSF11B;PLK2;ERRFI1;NR2F1;SGCE
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.7014382428245896,1.3564514660987104,0.08433734939759036,0.5487516727381497,1.0,1/28,0.04%,GLRA1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.8066379554966745,1.3564227642273885,0.07352941176470588,0.5479372882344649,1.0,4/9,11.64%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,Reactome_2022__Fertilization R-HSA-1187000,-0.8158742295622248,-1.3561785218399987,0.09090909090909091,0.6749202585452417,1.0,3/6,17.93%,CATSPER2;HVCN1;CATSPERG
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.6987829131128038,1.3560208146354076,0.10810810810810811,0.549122365856577,1.0,1/19,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.9575395337090917,1.3554282462632508,0.015873015873015872,0.5519306759345582,1.0,1/5,0.30%,KLF4
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.8332523520790429,-1.3552398840776707,0.08333333333333333,0.677033524750948,1.0,2/5,9.94%,BUD23;METTL16
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.8547290630349356,1.3552248359438337,0.05128205128205128,0.5521593356497264,1.0,2/8,9.56%,KLF4;POU5F1
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.734508668998563,1.3551657680935083,0.1,0.551493607264771,1.0,8/15,19.39%,PDE5A;PDE10A;PDE1A;PDE2A;KCNMB1;GUCY1B1;KCNMA1;GUCY1A2
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.6488847528759641,1.355021594461499,0.043478260869565216,0.551689195210932,1.0,39/69,24.09%,PIANP;CLIP3;NCAN;PNMA1;TUBB4A;ENO2;PRRT1;TTC9B;STMN3;TCEAL2;SYP;SNAP25;CHN1;PCBP4;ADGRB2;TAGLN3;TRIM9;VSTM2B;CALY;NEFL;TMCC2;CA11;DTX3;KIF5A;APLP1;NCDN;PPFIA4;TMEM59L;DLG4;SNAP91;CNTNAP1;REEP2;PDZD4;KIF5C;KCNQ2;GDI1;ATP6V0E2;SYNGR3;BRSK1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.8074140346000888,1.3548828646051876,0.06666666666666667,0.5515543209515592,1.0,3/10,9.72%,ASPA;GAD1;GLUL
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.715075245286886,1.3546864849547693,0.060240963855421686,0.5517326392745633,1.0,7/33,7.94%,IL1RAPL2;PTPRD;IL1RAPL1;NRXN1;ROBO2;NLGN3;NLGN1
prerank,KEGG_2021_Human__Gastric cancer,0.6336358753232773,1.3544948493410336,0.07368421052631578,0.5517788877753457,1.0,14/78,15.06%,FGF1;ARAF;TGFB2;FZD6;GADD45B;RXRB;TCF7;RPS6KB2;TCF7L1;SHC2;GAB1;APC2;CTNNA2;WNT5A
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.5493564947693548,-1.3542821499291327,0.13333333333333333,0.6781473181561145,1.0,5/41,10.83%,RING1;NUP42;NUP155;NUP188;NUP214
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,0.7446303913786934,1.35363085633965,0.08333333333333333,0.5560888268628839,1.0,6/26,10.63%,SHROOM3;COBL;TOM1L1;ARFGEF3;OVOL2;SH3D19
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7562308906760238,1.3535603454065501,0.03896103896103896,0.555455954656741,1.0,10/26,16.42%,CLIP3;TUBB4A;TTBK2;HDGFL3;MAP2;MID1IP1;CLASP2;STMN2;APC2;EML2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.560912454371188,-1.3530177133558559,0.09523809523809523,0.6811518763463844,1.0,2/18,4.50%,EGFL7;ALG1
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.7412479942868532,1.3529833377509684,0.047619047619047616,0.5577013513914104,1.0,4/25,12.63%,CLDN18;CLDN20;MICALL2;PARD3
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.45940784893219505,-1.352913695760972,0.0,0.6795924382798499,1.0,26/75,14.51%,NKG7;CD37;CST7;GNLY;BIN2;SELPLG;CD2;CEACAM21;GZMB;UCP2;HCST;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PRF1;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5;CD247
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.6924403351726093,1.3527381743002689,0.047619047619047616,0.5584054383355525,1.0,7/22,15.68%,RGS2;ANK2;CAV3;CALM3;RYR2;PDE4B;ATP2A2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.629620353898369,1.3526396357455983,0.020618556701030927,0.5581951799103076,1.0,21/91,9.79%,TNC;THBS1;SPARC;FBN2;ADAMTS2;ECM2;THSD4;COL11A1;NCAN;ITGA2;MMP21;COL4A5;VCAN;ADAM15;COL23A1;LAMA2;LAMB1;COL24A1;FN1;ITGAE;ITGB8
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.8667865960536898,1.3521732304705036,0.1,0.5598548841208097,1.0,1/7,0.27%,HTR2B
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6965653448974408,1.3516076231711103,0.06976744186046512,0.562303752626924,1.0,13/30,16.10%,FA2H;LSR;ANXA1;ALOX12;ST14;TXNIP;ERRFI1;PKD1;WNT5A;COL5A3;CASP3;UGCG;CLIC4
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.6987150698665984,1.3512925542817051,0.023255813953488372,0.5630919119988104,1.0,19/38,21.02%,SCN3B;SLC6A15;SLC24A2;SLC9A7;SCN3A;SCN1A;SLC24A1;SLC9A6;NALCN;HCN1;SCN8A;SCN2A;ASIC2;SLC24A3;ATP1B3;ATP1B2;ATP1A2;SLC24A4;SLC9A1
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,0.9397957173006143,1.3511985956810475,0.0273972602739726,0.5626808547619379,1.0,1/5,2.03%,ACSL1
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.8497956841902011,1.3511704347227076,0.04411764705882353,0.561916173798042,1.0,3/8,7.35%,HSPA5;EIF2AK3;HERPUD1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6790176277618472,1.3510902634751643,0.04878048780487805,0.5615086277257996,1.0,15/39,15.06%,SHANK3;GPM6A;NRXN1;CDH2;NRXN2;SHANK2;NLGN3;NLGN1;GABRB3;GABRA2;DNM3;GABRB2;GRID2;PLXNB1;WNT5A
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,0.8831247400819434,1.3510694014674796,0.07246376811594203,0.5606200226650794,1.0,2/5,8.46%,SPARC;FN1
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7833379831504041,1.3509569249436655,0.12,0.560216174041659,1.0,9/12,21.58%,GRIA4;PTPRD;GRIN2A;GRIA3;GRIN2B;GRIA1;RTN3;PTPRS;FLOT2
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.6855252608936414,1.3508479630907064,0.11494252873563218,0.56003811171984,1.0,2/40,0.30%,PCSK1;KLF4
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6950004894829915,1.3508301784758514,0.09210526315789473,0.5591407266253833,1.0,6/19,11.27%,SHANK3;ARF6;GRIN3A;NLGN1;PPFIA2;CAMK2B
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7556561870538607,-1.3506472595599857,0.15,0.6863493489076634,1.0,2/7,11.93%,DNAJB12;DNAJB14
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.7018962485144132,1.3505347862105785,0.05,0.5602588003734545,1.0,4/22,9.72%,MDH1;AFMID;ACAT1;GLUL
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.8171222040664456,1.3504508374214061,0.04285714285714286,0.5598583893444433,1.0,2/11,1.28%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.693231465456856,-1.3503545836737965,0.10526315789473684,0.6855801088170549,1.0,5/14,11.90%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,CellMarker_Augmented_2021__Osteoclast:Bone,-0.7510248179050115,-1.3502381083216817,0.15625,0.6842378316606319,1.0,1/5,0.98%,CALCR
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8880032219067314,1.3499405090826007,0.05970149253731343,0.5621968234393289,1.0,5/7,10.68%,SLC24A2;PRRT1;SHANK2;PLK2;SLC24A1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.829572465335545,1.3498654322658372,0.11428571428571428,0.561842105080248,1.0,3/7,9.26%,TGFB2;NRG1;RBPJ
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.715591551904609,1.349742305038435,0.07228915662650602,0.5606613550539307,1.0,5/23,13.06%,BRIP1;DNA2;EME2;BRCA1;XRCC3
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.715591551904609,1.349742305038435,0.07228915662650602,0.5606613550539307,1.0,5/23,13.06%,BRIP1;DNA2;EME2;BRCA1;XRCC3
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7894632939293336,1.3496251844617968,0.12162162162162163,0.5604533698640493,1.0,9/15,17.39%,GRIA4;GRIN2A;GRIA2;CAMK2B;GRIA3;LRRC7;GRIN2B;NEFL;GRIA1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.6418042505010919,1.3495767800894605,0.13186813186813187,0.5596622972751464,1.0,15/50,16.75%,RIOK2;WDR12;WDR74;PES1;RPL38;XPO1;RPS6;GLUL;RPS25;RRP36;HEATR3;RPL14;SHQ1;RPL11;RPS24
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.708128898707861,1.3492317828213398,0.09195402298850575,0.5608743656503659,1.0,14/31,15.12%,MAL;MYRF;ADGRG6;B4GALT5;PLP1;PMP22;PARD3;NFASC;TPPP;BCAS1;EIF2B2;SCN8A;PLLP;SCN2A
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.8484935636038438,1.3489889936808908,0.1076923076923077,0.5607587657846295,1.0,2/7,5.71%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.8484935636038438,1.3489889936808908,0.1076923076923077,0.5607587657846295,1.0,2/7,5.71%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.772679214615225,1.3488015077074127,0.06944444444444445,0.5598930506536034,1.0,7/15,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.772679214615225,1.3488015077074127,0.06944444444444445,0.5598930506536034,1.0,7/15,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.7520346575911243,1.3484567376508052,0.08536585365853659,0.5610475500904715,1.0,4/20,12.63%,CLDN18;CLDN20;MICALL2;PARD3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7969326519153067,-1.3484394380814364,0.04,0.6898110948328809,1.0,3/7,13.85%,NEDD4;COMMD1;WNK3
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.7947501680128597,1.3478114065255098,0.06578947368421052,0.5640845889048095,1.0,4/11,16.17%,ACVR1B;ACVR2A;DRAP1;PCSK6
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.6908295323000126,1.347770207400339,0.10588235294117647,0.563407045000635,1.0,9/26,12.37%,SLCO1A2;ABHD12B;PTPRZ1;TTYH1;GABRB3;FLVCR1;POU5F1;CNTNAP2;GRID2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6733193379701881,1.3472646933614967,0.0,0.5654042961085195,1.0,10/52,12.39%,THBS1;RHOB;SPARC;FGF1;AGT;VEGFA;PTN;GLUL;SASH1;GPI
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.8675200039004693,1.3471293140246134,0.09836065573770492,0.5652231797461721,1.0,1/5,3.16%,PIGU
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.863856529625115,-1.3470083889176785,0.07317073170731707,0.6939903936330766,1.0,1/5,0.57%,TGFBR3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.6736760188282023,1.346701552620723,0.03333333333333333,0.5653625481325203,1.0,5/43,3.87%,TNC;THBS1;SPARC;OSMR;ANXA1
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.6736760188282023,1.346701552620723,0.03333333333333333,0.5653625481325203,1.0,5/43,3.87%,TNC;THBS1;SPARC;OSMR;ANXA1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.6736760188282023,1.346701552620723,0.03333333333333333,0.5653625481325203,1.0,5/43,3.87%,TNC;THBS1;SPARC;OSMR;ANXA1
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,0.775865125604977,1.3463301952754418,0.13043478260869565,0.5666926261975834,1.0,2/8,7.85%,KMO;AFMID
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7107399704617468,1.3462631919358337,0.07228915662650602,0.5660955709219871,1.0,11/27,15.33%,SHANK3;ZDHHC15;RELN;SRCIN1;SIPA1L1;NGEF;NLGN1;PPFIA2;CAMK2B;EPHA4;CFL1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.6818648319714384,1.3460889025578915,0.09195402298850575,0.5660993840564424,1.0,8/31,9.58%,OMD;OGN;NCAN;VCAN;GPC5;CEMIP;GNS;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.7195990089711981,-1.3458585150129676,0.1111111111111111,0.6965724185341468,1.0,1/11,1.65%,TAL1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.6642536910898758,1.3457357326994694,0.05747126436781609,0.5673908974874629,1.0,23/45,22.84%,LRP4;SEMA3A;OMG;DCC;SPOCK1;LINGO1;NGEF;KANK1;PAQR3;NLGN1;MAG;CRMP1;EPHA4;STMN2;THY1;DENND5A;ARHGDIA;PTPN9;PTPRS;BCL11A;RTN4RL1;RTN4;GDI1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8184604642301149,1.3455948461555993,0.04225352112676056,0.567224187836366,1.0,7/12,14.52%,TSHZ3;SLC24A2;SHANK2;GRIN2A;PLK2;SLC24A1;GRIN2B
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.7282591113369549,1.3455330376283228,0.09523809523809523,0.5666607846282731,1.0,9/23,18.67%,TUBA4A;TUBB4A;VBP1;TUBA1A;TUBB6;TUBB2A;PFDN4;TCP1;TUBA1C
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.8926470668396375,1.3453503770040034,0.0967741935483871,0.5666331251382981,1.0,3/5,9.26%,VEGFA;HIF1A;RBPJ
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,-0.6994343251392374,-1.3453315327731428,0.175,0.696820767656381,1.0,1/8,0.57%,TGFBR3
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,0.7768973236818211,1.3452328048004225,0.04938271604938271,0.5663162244508395,1.0,6/20,10.63%,SHROOM3;TOM1L1;OVOL2;BAIAP2L1;PKP2;SH3D19
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,0.8351378237637701,1.3451544029384013,0.043478260869565216,0.565817941201431,1.0,2/8,1.93%,RHOBTB3;HTR7
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.46942056782919217,-1.3449630404569297,0.16666666666666666,0.696605099365048,1.0,31/138,15.36%,THEMIS;ITK;SKAP1;GRAP2;BTN3A2;PSMB3;CD276;PSME3;CHUK;BLNK;PSMC4;PSMD12;SPG21;FYN;STOML2;PSME4;NCKAP1L;INPP5D;BTK;IKBKB;HLA-DPA1;LCP2;NCK1;SYK;PSMA1;BCL2;BCL10;CD247;CARD11;PSMA7;BTN3A1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.7851679825240521,1.3448202268350882,0.056338028169014086,0.5667631830610043,1.0,4/11,10.79%,HSPA5;EIF2AK3;HERPUD1;IMPACT
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.8386935220295162,-1.3447708591635796,0.0625,0.6952902855076768,1.0,3/6,12.41%,FBL;PIH1D1;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6496421217434399,1.3445125257700972,0.042105263157894736,0.5675234695983465,1.0,31/70,19.39%,PLPP3;FAM13C;LRP4;VIM;PLPPR4;FBXL7;LIFR;SRRM3;ANK2;RBFOX2;ARNT2;PTN;SHC2;MAP1B;CRMP1;GPRC5B;FIGN;NR2F1;ADGRL2;NFASC;LIMCH1;NDRG4;CPE;THY1;EDIL3;EPAS1;HSPA12A;MPDZ;TNFRSF1A;TMEM59L;GUCY1A2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.7296651296032821,-1.3442266110555547,0.1,0.6957170735165763,1.0,3/10,8.55%,TICAM1;SCIMP;TLR3
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,0.7868612945516417,1.3438871297096506,0.1044776119402985,0.5700814244503966,1.0,1/12,0.84%,SKIC2
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,-0.7773066937739849,-1.343872479046584,0.2,0.6955767175788213,1.0,5/9,5.90%,THEMIS;ITK;GRAP2;CD2;CD96
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.709471377093012,-1.343792374493702,0.09523809523809523,0.6921730846889012,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.709471377093012,-1.343792374493702,0.09523809523809523,0.6921730846889012,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.8106910591851666,-1.343393212930656,0.10526315789473684,0.6917281162773153,1.0,4/7,18.05%,REST;EIF2AK4;MED1;CNTN4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.6596017851739703,1.3433913841881968,0.010638297872340425,0.5725403353933536,1.0,12/57,9.48%,TNC;PLPP3;NTN4;SPOCK1;OSMR;KITLG;PTPRK;RND3;PALLD;ALCAM;FN1;TNFRSF11B
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,-0.4711015954442049,-1.3433645813509918,0.07692307692307693,0.6898884138404076,1.0,19/48,15.96%,TDRD10;A2M;FOLR2;LGALS9;HPGDS;CSF1R;OLFML2B;SLCO2B1;SLC7A8;ENG;TMEM119;CH25H;GSN;CXCL12;PLVAP;SCARF1;CMKLR1;MYO15B;C1QC
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.6352590506968532,-1.3432149548711352,0.125,0.6883371501062655,1.0,3/10,10.21%,SETDB1;BAHD1;POLE3
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.5710320292769476,1.0,1/10,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.5710320292769476,1.0,1/10,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7791158243899748,1.3431664987739462,0.1232876712328767,0.5710320292769476,1.0,1/10,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.848050235314142,1.3423793080352289,0.11940298507462686,0.5749436541679988,1.0,1/6,5.33%,RXRB
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5262479297201784,-1.3420541514126434,0.05263157894736842,0.6920055021558781,1.0,1/28,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.8250813203602282,1.3420325774482804,0.08955223880597014,0.5765057356427411,1.0,1/7,5.04%,VEGFA
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.7134353695293919,-1.3420206020370689,0.13043478260869565,0.6903182343217844,1.0,5/13,11.90%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.759382532636583,1.3417950529989566,0.08450704225352113,0.5766270600982422,1.0,7/16,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;PGK1;ENO1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7356137269495544,1.3416909683211966,0.15853658536585366,0.5761657021772599,1.0,7/17,9.58%,OMD;OGN;NCAN;VCAN;GNS;ACAT1;CSPG5
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.6211563363505256,-1.341482644472044,0.12,0.6907825584026956,1.0,3/16,12.07%,ITGA5;PKN1;EGFR
prerank,CellMarker_Augmented_2021__Natural Killer cell:Kidney,-0.8143068635743439,-1.3411295975440432,0.14814814814814814,0.6901414321097559,1.0,1/5,0.35%,NKG7
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.6644017854745298,1.341103295685977,0.043010752688172046,0.5745525403161121,1.0,24/67,15.48%,FAM13C;LRP4;FRAS1;PTPRD;ENAH;ADGRA3;DZIP1;PTPRG;PHYHIPL;LIFR;LAMB1;ANK2;RBFOX2;CSRNP3;ROBO1;SH3D19;NR2F1;CCDC3;KALRN;SORBS1;ADGRL2;FAM171A1;CPE;STXBP6
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.7741271087273255,1.3410699121939889,0.03896103896103896,0.5737454320775255,1.0,11/20,10.80%,FGF1;VGF;ENAH;SRRM3;RBFOX2;LINGO1;ADGRB2;CSPG5;CKB;TMEM132A;NR2F1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.7163524329594254,1.3410015716136467,0.1,0.5732209488169813,1.0,6/22,8.44%,LRP4;OMG;DCC;LINGO1;MAG;MAP2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.7231801420768479,1.3406673424936733,0.0963855421686747,0.5745227785434432,1.0,5/23,3.33%,HTR2B;FGF1;PRKCE;CIT;RACGAP1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.8880322575315331,1.3406352186711952,0.05,0.5738077453522985,1.0,2/5,9.72%,GAD1;GLUL
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.9392183046052305,1.340588465661465,0.0,0.5731683385915192,1.0,2/5,3.60%,FAAH;ABHD12B
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6562451109638459,-1.3403878157984088,0.21052631578947367,0.6914288821389832,1.0,5/17,15.04%,CCL5;SH2B3;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.59811849769619,-1.3403803425196796,0.13636363636363635,0.6897607414363602,1.0,4/13,9.24%,FLNA;DDR1;ARHGAP35;LCP1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.84962291698636,1.340276598831312,0.04285714285714286,0.5739514653672994,1.0,2/8,6.27%,RACGAP1;SLC13A4
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.7973688779083661,1.3402586606870703,0.07317073170731707,0.5731237975487157,1.0,6/11,16.36%,KLF4;VIM;ALCAM;POU5F1;THY1;ITGAV
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6172503869316158,-1.3401166564195575,0.07692307692307693,0.6892298845200376,1.0,3/17,5.85%,BUD23;FBL;THUMPD1
prerank,KEGG_2021_Human__Renin-angiotensin system,0.8108213100372237,1.3399731837088695,0.08108108108108109,0.5740358795827193,1.0,1/8,3.59%,AGT
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.65139277710895,1.3398257743343938,0.08602150537634409,0.5740414494128121,1.0,10/50,16.18%,MOBP;FKBP5;SLC2A3;GAD1;GRIN2A;GRIA2;CAMK2B;GAD2;GRIN2B;TBL1XR1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.6568767511845438,-1.339722156298244,0.09523809523809523,0.6871217197689495,1.0,3/8,12.19%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.6568767511845438,-1.339722156298244,0.09523809523809523,0.6871217197689495,1.0,3/8,12.19%,TRIM38;LGALS9;TRIM11
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.5966426015249643,-1.3396488123797703,0.16,0.6855837546992887,1.0,4/21,3.82%,PHLDB2;INPP5K;PFN1;ARAP1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.6104386720956947,-1.3396281514357535,0.09375,0.6838506335486684,1.0,4/16,9.60%,CCND1;CBFB;SRC;AGO1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.6539084468015182,1.3396223611793332,0.0,0.5743525779115454,1.0,9/76,7.42%,THBS1;KLF4;PRR16;VIM;EIF4A3;AGT;SOX4;RBM3;VPS11
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.7109548054484647,-1.3394796285633566,0.1111111111111111,0.6832742725088293,1.0,3/7,17.68%,MMAA;MCEE;PCCB
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8588165641321722,1.3392232081588684,0.06153846153846154,0.5760283705177422,1.0,1/8,0.14%,SOCS3
prerank,KEGG_2021_Human__Olfactory transduction,0.7181138980975847,1.3390340397829612,0.05952380952380952,0.5764078966026998,1.0,9/28,14.14%,OR3A2;ADCY3;PDE1A;RGS2;CALM3;PDE1C;PDE2A;CAMK2B;GNAL
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.7875366627644416,1.3389526918672128,0.0759493670886076,0.5760476266866299,1.0,4/10,9.36%,TGFB2;SCN3B;RGS2;RYR2
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.8783873392870456,1.3389100108841692,0.05714285714285714,0.5753848448445797,1.0,3/6,9.28%,THBS1;ACSL1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8042188629687903,1.3388538269066859,0.10606060606060606,0.5747818972163263,1.0,2/7,8.38%,RGS2;CAV3
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.7253153419773569,-1.3385751310943597,0.2,0.684855984829581,1.0,1/8,2.54%,ACTA2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6624092615877238,1.338511832279939,0.05952380952380952,0.5762708725763497,1.0,5/30,7.98%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.8229187775813492,1.3383193281232382,0.13432835820895522,0.5765031254467458,1.0,1/8,0.27%,HTR2B
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.6603712016146621,1.3382898240896999,0.045454545454545456,0.5759012602045152,1.0,20/64,18.69%,KCNE1;CACNB2;SCN3B;SCN3A;RYR2;SCN1A;FXYD7;CAMK2B;FGF14;RYR3;ASPH;SCN8A;SCN2A;ATP2A2;ATP1B3;KCNIP4;CACNG8;NPRL2;ATP1B2;CLIC2
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.9128113054871717,1.337926011693437,0.09230769230769231,0.5771949913300812,1.0,1/5,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.8355856675521023,-1.3379139684675336,0.2,0.6851196904835114,1.0,3/5,14.21%,MTLN;STOML2;AKT1
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8761398176291791,1.3378693611504493,0.1323529411764706,0.5765223064191085,1.0,5/5,12.42%,MAPT;WASF1;NTRK2;TMEM108;SH3GL2
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,-0.4747268568313927,-1.3377431413802527,0.14285714285714285,0.684041974347513,1.0,3/44,0.98%,PHLDB2;COL18A1;CALCR
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6794087038240012,1.3375741008917323,0.07777777777777778,0.5771674625340182,1.0,12/49,17.16%,RHOB;ANLN;CIT;RACGAP1;ANK3;SPIRE2;SEPTIN4;SEPTIN8;SPAST;INCENP;SPTBN1;ROCK1
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,0.6952608281446235,1.3372196767045246,0.05,0.5783103832220478,1.0,10/28,20.42%,CLEC4E;NAMPT;RGS2;MXD1;SOD2;SDCBP;PELI1;FOS;BASP1;SELL
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.6505270809085352,1.3369937071756184,0.031578947368421054,0.5784374975831085,1.0,30/74,17.45%,LRP4;SH3PXD2B;GFAP;DOCK1;DZIP1;MTCL1;GNA11;LIFR;SRRM3;SEMA3B;SLC13A4;RBFOX2;CAMK2N1;KAZN;NGEF;ARNT2;ALCAM;ADGRB2;MAP1B;GPRC5B;TMEM132A;NR2F1;TYRO3;PLXNB1;NDRG4;CPE;APLP1;HSPA12A;MPDZ;APP
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.8850405825294461,1.3369744667790537,0.08955223880597014,0.5776674170195834,1.0,1/6,4.12%,SLC4A10
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.7313326423378377,1.3367906240773495,0.10666666666666667,0.5777382826603394,1.0,2/23,2.84%,SLC51A;SLCO1A2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7618945458400813,1.3367183343793694,0.07317073170731707,0.5773122490759338,1.0,8/16,13.71%,MAPT;NTRK3;WASF1;NTRK2;TMEM108;MAGI2;SH3GL2;STMN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.7198216561790769,1.3366097066162606,0.13095238095238096,0.577057559468962,1.0,2/23,0.94%,SOCS3;ST18
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.619138645804428,1.3364931642715896,0.030303030303030304,0.576916832367187,1.0,22/95,15.15%,DDIT4;TGFB2;SEMA3A;GPM6A;HMGB2;PTPRD;SPOCK1;MAPT;RELN;CIT;RACGAP1;NR4A2;IL1RAPL1;OLIG1;BHLHE40;MAP1B;NTRK2;ASTN2;CCK;TUBB2A;WNT5A;CASP3
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.7191629923200132,-1.3364322943871367,0.08823529411764706,0.6867124089423947,1.0,2/8,2.23%,SKAP1;IL1B
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.6259319439435596,1.3359589296838854,0.030303030303030304,0.5791637070403772,1.0,31/98,18.88%,FAAH;NDUFA2;GRIA4;ADCY3;NDUFB9;GNAO1;GABRB1;CNR1;GRIA2;GABRB3;GABRA2;NDUFA3;CACNA1B;ADCY8;NDUFS8;GABRB2;GRIA3;GNAI1;GABRA4;SLC17A7;MAPK10;NDUFB6;CACNA1A;NAPEPLD;KCNJ6;PLCB1;GRIA1;GABRD;KCNJ3;GNAQ;GABRG2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.8533672193492936,1.3359388238079228,0.058823529411764705,0.5784842388107587,1.0,2/8,2.24%,EEF1A2;GFAP
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.6058778987346195,1.3358996209930571,0.020618556701030927,0.5777927761816626,1.0,42/106,24.09%,LRP2;LRP4;FLRT1;SHANK3;GPM6A;DCC;PLPPR4;CTNND2;NYAP2;ANK3;NLGN1;ALCAM;MAP2;MAP1B;CELSR2;SLITRK5;IMPACT;CNTNAP2;SLC9A6;PARD3;CCK;CTNNA2;PLXNB1;IQGAP1;ROCK1;APP;KLF7;NTNG1;UBB;SPTBN4;DLG4;MAPK8IP2;CNTNAP1;LRRK2;FGFR2;PAK3;CTTN;DCLK1;MAP1A;TMEM106B;PTEN;BRSK1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.7576112172643956,-1.3355512822488804,0.25,0.6885359918224163,1.0,3/6,12.78%,LGALS9;HLA-E;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.7584252043750772,1.3354349692078358,0.14864864864864866,0.5796764624640328,1.0,3/17,5.44%,THBS1;AGT;TRAF2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.803516471419073,1.3353491502369164,0.11940298507462686,0.5792941439283942,1.0,2/8,2.68%,LRRC4C;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.773335976348404,1.3352551429128996,0.07692307692307693,0.5789270118263803,1.0,2/13,4.57%,ASPN;SRGN
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.7061978745340718,1.33503933986763,0.08,0.5793307732247653,1.0,5/21,12.48%,HMGB2;ANXA1;MTERF1;DNA2;DDX1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.9021347710863508,1.3349425748700248,0.07692307692307693,0.5790765008164426,1.0,2/5,5.04%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.8516591455181723,-1.3347843809250883,0.11904761904761904,0.6894859073088079,1.0,1/6,1.84%,BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.7723121116535367,1.334542453813757,0.1,0.5804276271212513,1.0,6/16,13.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.7927055925565597,1.3342842832697952,0.08450704225352113,0.5809944517213698,1.0,1/10,0.08%,TOP2A
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.6615713546347755,1.334058620884799,0.07954545454545454,0.5814760905971855,1.0,16/35,28.90%,GABRB1;GABRB3;GABRA2;ADCY8;GABRB2;GNAI1;GABRA4;GNAL;KCNJ6;KCNJ3;GABRG2;GNB5;GABRG3;ADCY1;GABBR2;ADCY2
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.6895451402749057,-1.3338782877255864,0.14705882352941177,0.6909616413334949,1.0,4/10,18.76%,GZMB;PLEKHM2;LYST;CEBPG
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),0.8836939285848211,1.333575135051683,0.05970149253731343,0.5836230500556606,1.0,1/5,1.30%,NLRP12
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.7842600405987401,1.3334075450629748,0.10256410256410256,0.5826076234513203,1.0,2/13,4.70%,VIM;DMD
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.7842600405987401,1.3334075450629748,0.10256410256410256,0.5826076234513203,1.0,2/13,4.70%,VIM;DMD
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.7464628536863369,1.3329101820403955,0.03896103896103896,0.5841209471864249,1.0,4/18,13.06%,BRIP1;DNA2;BRCA1;XRCC3
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.8066292261704947,1.3328976415389098,0.13924050632911392,0.5833240839272817,1.0,1/11,0.30%,KLF4
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.6379705826234983,1.3328776654248815,0.042105263157894736,0.5825709734472001,1.0,13/72,13.19%,KCNE1;CD163;CCPG1;OMG;ANKUB1;CHL1;ABCA1;CPM;FGL2;FAM20A;FMO5;SOD2;CLMN
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.9186229751071485,1.332373345980014,0.04918032786885246,0.5846556528588907,1.0,1/5,0.82%,FGF1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7359772123573944,1.3319697749675,0.14285714285714285,0.5861155984891891,1.0,6/16,17.45%,MYRF;SOX4;CSPG5;TPPP;EIF2B2;APP
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.6584888132321444,-1.331838233524803,0.14814814814814814,0.6966641771442077,1.0,2/10,0.95%,CCL5;ZNF703
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7478821472317485,1.331808349742381,0.0273972602739726,0.5863086120550728,1.0,6/18,10.26%,HTR2B;SEMA3A;SEMA3B;SEMA6A;FN1;SEMA5A
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7383610673200778,1.3315115709965422,0.0759493670886076,0.5872273062941807,1.0,6/17,14.68%,GRIN3A;GRIN2A;CAMK2B;LRRC7;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8583890253631445,1.3308717652529984,0.07575757575757576,0.5901409065442266,1.0,2/7,5.16%,SEMA3A;SOX4
prerank,CellMarker_Augmented_2021__Leukocyte:Undefined,-0.7869420496317381,-1.3308408141826162,0.20512820512820512,0.6987084029547491,1.0,2/5,10.78%,CX3CR1;FCGR1A
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.6675962085283647,1.3301955845611029,0.10126582278481013,0.5938245639613302,1.0,14/29,23.76%,LRP4;SHANK3;CTNND2;MAP2;PTN;CELSR2;CTNNA2;PHACTR1;KLF7;DLG4;MAPK8IP2;PAK3;TMEM106B;PTEN
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.5427788219379162,-1.3297991958335207,0.043478260869565216,0.7009727811116294,1.0,7/28,12.38%,ELOA;GTF2F1;CTDP1;ELOC;SUPT16H;TCEA1;POLR2C
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.690061262997449,1.3297145511421025,0.06756756756756757,0.5959284509550037,1.0,3/21,7.71%,PRKCE;ANXA1;KANK1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.8440446035963568,1.3295182172701168,0.06349206349206349,0.5960918282492462,1.0,1/6,2.03%,ACSL1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8787387641370767,1.3292832753152142,0.14754098360655737,0.5965947537755245,1.0,1/5,0.62%,LRP2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7505490681692373,1.3289145093560986,0.0375,0.5975851113131205,1.0,10/22,12.37%,SPOCK1;MAPT;NR4A2;SOX4;MDGA2;AGTPBP1;FAIM2;MAP2;NTRK2;GRID2
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.70859607461428,1.3288633637199205,0.05747126436781609,0.596918086959562,1.0,5/29,9.28%,FGF1;PIGU;INSR;GRB10;IRS2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.8410212482984504,1.3288027664699877,0.1044776119402985,0.5963613615319429,1.0,1/6,5.63%,CD55
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,-0.619641394715122,-1.3287859691230175,0.09523809523809523,0.7029303505419067,1.0,2/15,1.22%,MEI4;ASB8
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,-0.7934911684179546,-1.3287407252413874,0.2,0.6994985216748255,1.0,3/6,19.66%,HLCS;PCCB;MCCC1
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,-0.7934911684179546,-1.3287407252413874,0.2,0.6994985216748255,1.0,3/6,19.66%,HLCS;PCCB;MCCC1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.8113081328733396,1.328318662840741,0.13043478260869565,0.5979831718336013,1.0,3/8,5.04%,PRLR;NRG1;VEGFA
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",0.8466807647627107,1.3280853791328335,0.06944444444444445,0.5986281212545713,1.0,1/7,2.58%,TACR1
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.4389923857444291,-1.3278653969952245,0.2,0.7010541272640176,1.0,18/81,13.67%,IDNK;GBP3;FMO4;DHRS4;UBA7;TMEM9B;ARHGDIB;ANXA4;ACAA1;MPC1;NMRK1;TNFSF10;CTBS;NMI;PHF11;ARL6IP5;VPS29;PPCS
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6272114786816785,1.3276828741055375,0.010638297872340425,0.5997969448393764,1.0,23/86,9.89%,CLDN18;LRRC4C;TGFB2;MYOT;CADM1;PTPRD;IL1RAPL1;CDH8;CDH2;IGSF11;CDH9;ROBO2;PTPRT;PALLD;CLDN20;CDH20;NLGN1;ALCAM;MAG;ROBO1;CDH12;UNC5D;CELSR2
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7976366344224672,1.3276799243007285,0.07352941176470588,0.5989161857426959,1.0,5/10,12.72%,OPALIN;DAAM2;PTPRZ1;PTN;TNFRSF1B
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.6219771142258487,1.3269673535393436,0.08421052631578947,0.602151192653458,1.0,16/83,14.54%,DIAPH3;CENPF;RHOB;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,0.8460327315181911,1.3268309099036313,0.12195121951219512,0.6022628007146134,1.0,3/8,9.75%,ITGA2;OVOL2;ST14
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.4415847823816686,-1.3267641632207217,0.0,0.7030896338747461,1.0,14/85,8.92%,ITGA5;PSMB3;CCND1;MAF;PSME3;YES1;WWTR1;PSMC4;PSMD12;CBFB;HIVEP3;PSME4;SRC;SMURF1
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.6342735676629775,1.3267564247936794,0.06451612903225806,0.6019854107623479,1.0,36/76,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;EEF1A1;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.731641546917325,-1.3267277684668206,0.125,0.7014833162430417,1.0,4/7,10.10%,CYP2S1;HPGDS;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.6606729114434633,1.3266433953883696,0.07865168539325842,0.601922957201633,1.0,7/46,7.22%,HTR2B;THBS1;SPARC;HMGB2;NR4A1;VEGFA;HIF1A
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6438184138314272,1.3266364966660629,0.0425531914893617,0.6010989720775444,1.0,24/83,13.05%,KLF4;SHROOM3;LRP4;FRAS1;SH3PXD2B;GULP1;ENAH;COL4A5;DOCK1;ADGRA3;PTPRG;KITLG;LIFR;LAMB1;RBFOX2;RND3;MYO10;PTK7;POU5F1;SH3D19;ADGRL2;PARD3;UACA;BNIP3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.6949256276584681,1.326195185941852,0.05555555555555555,0.6029595187796744,1.0,16/34,20.96%,THSD4;NTN4;ITGA2;DOCK1;OSMR;NFIB;ATP8B1;PPFIBP1;SH3D19;UACA;SHROOM4;TIMP3;EPAS1;IGFBP7;NPAS2;COL16A1
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9143510169526026,1.3261712757266477,0.031746031746031744,0.6022296941821915,1.0,3/5,7.94%,NRXN1;NRXN2;NLGN1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.6762056559220846,-1.3260572944959053,0.18181818181818182,0.7017610184001613,1.0,3/11,2.97%,NPC2;ARV1;NPC1
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.6541843518693924,1.325956198021598,0.06741573033707865,0.6027925935753613,1.0,9/45,7.71%,SHROOM3;LRP4;SH3PXD2B;ENAH;COL4A5;DOCK1;RBFOX2;RND3;PALLD
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,0.6814502133905073,1.325447034101772,0.06097560975609756,0.6054530380457064,1.0,8/37,5.30%,SPARC;ADAMTS2;COL11A1;ENPP2;TNS1;FBXL7;DAAM2;LAMA2
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,-0.44491167862931447,-1.3253511780472043,0.0,0.7028763029907195,1.0,22/84,11.39%,NKG7;CD300LF;ITGAM;CD37;CST7;LY86;BIN2;SELPLG;CD2;PIK3R6;CEACAM21;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;PLEK;HCK;ITGB2;CYTH4;LCP2
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,0.6303619507431002,1.325248948228112,0.06451612903225806,0.6057973762363328,1.0,35/77,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6112338305572736,-1.3251518876998323,0.08,0.701829517231994,1.0,6/17,14.21%,CCL5;IL1B;IGF1;TGFB1;PLK3;AKT1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),0.8256388803748395,1.3251371530345053,0.13846153846153847,0.6056108180437941,1.0,1/6,6.48%,INSR
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.7861289116952056,1.325118473896747,0.08695652173913043,0.6048030628266979,1.0,1/12,0.75%,AANAT
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.6606236240224417,1.3249792816021666,0.11494252873563218,0.6048958713930908,1.0,12/31,21.34%,ARAF;PPP2R5B;PPP2R5A;PAQR3;RPS27A;PEBP1;DUSP10;UBA52;UBB;DUSP16;DUSP6;DUSP12
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8866526135386283,1.3249698821892657,0.06451612903225806,0.6040914693516563,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.7535418106191059,1.3249501924949285,0.09210526315789473,0.6033947499657343,1.0,1/16,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7998902377872541,1.324921367957023,0.08695652173913043,0.6026868772774486,1.0,5/10,7.94%,LRP4;PTPRD;IL1RAPL1;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.7147917168023171,1.3248049234066739,0.0989010989010989,0.6025983146175014,1.0,2/28,3.76%,SOCS3;ITPKC
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.4829286777941169,-1.324652386241522,0.07142857142857142,0.7017832419073377,1.0,14/32,21.97%,WIPF3;NCKAP1L;WASF3;BTK;ABL1;CYFIP1;ARPC2;NCK1;ARPC3;CDC42;WIPF2;ACTR3;WASF2;ACTR2
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.8168402616135655,1.3245611803933188,0.0684931506849315,0.6032575526512817,1.0,4/8,8.46%,THBS1;ANXA1;F13A1;FN1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.9177821875696466,1.3245544128523372,0.028985507246376812,0.6024088522768073,1.0,1/5,0.82%,FGF1
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,0.7372673668132265,1.3244118053957668,0.06896551724137931,0.6022426005581797,1.0,8/27,14.82%,PAPPA2;ENPP2;LAMA2;SEMA5A;PDCD1LG2;ANTXR2;SERPINE2;TGFBI
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.7087908978133225,1.3242708405678252,0.10714285714285714,0.6020245872175582,1.0,6/19,18.04%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7184599860261199,1.3242043885065204,0.08974358974358974,0.601702872173562,1.0,3/21,6.00%,KLF4;GPNMB;FHL1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.7063246738980121,1.324074011608841,0.08536585365853659,0.6016294837630219,1.0,13/22,22.05%,SLC4A10;NETO1;GRIK2;NSMF;SYP;CAMK2B;MCTP1;SHISA9;APP;NCDN;DLG4;SYNGR1;RAB5A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.6242487160150101,1.3238988640903127,0.053763440860215055,0.6018163685258232,1.0,7/66,6.43%,KCNE1;CLEC4E;NAMPT;DPYD;DOCK5;SLC2A9;SIRPB2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.5325255366734483,-1.3238740910901754,0.041666666666666664,0.7028582805819508,1.0,5/19,9.24%,BAIAP2L2;FSCN1;CORO1B;LIMA1;LCP1
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.7001509724760615,1.323744578583993,0.09210526315789473,0.6018469059008676,1.0,6/31,8.46%,ASPN;SPARC;SVEP1;ADAMTS2;LAMA2;FN1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.8643690419331204,1.3237126602047833,0.09090909090909091,0.6011901342628019,1.0,1/6,0.72%,MDH1
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.5175232402982635,-1.3236928086651623,0.11764705882352941,0.7019150389216701,1.0,7/22,16.26%,CPSF1;LSM11;WDR33;SNRPB;CSTF1;CPSF2;CPSF4
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.6658995434965989,-1.3232659900081691,0.2,0.7017732661686361,1.0,4/13,14.21%,BID;PPP3CC;BCL2;AKT1
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,0.8220209395146452,1.3232366445809178,0.08450704225352113,0.6031118998515744,1.0,2/9,3.08%,BRIP1;ERCC2
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.6276215253029445,1.3231554301405823,0.010309278350515464,0.6028430933262057,1.0,43/111,19.93%,SPON1;RHOB;NHSL1;GFAP;TACR1;SPOCK1;GADD45B;ANLN;TNS1;AGT;SLC1A2;HEPACAM;BMPR1B;GABRB1;SEMA6A;RND3;HIF1A;KIF21A;MAFB;NDRG2;ABCA1;GLUL;PER1;C5AR1;FXYD7;HIF3A;NTRK2;PLTP;KCNH7;DGKG;TIMP3;CPE;IL11RA;EPAS1;EGLN3;GRIA1;IGFBP7;FTH1;ATP1B2;LHFPL6;FOS;SORCS2;PAPLN
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.7142887003451276,1.322995316004573,0.12345679012345678,0.6029623943059459,1.0,1/23,0.82%,FGF1
prerank,KEGG_2021_Human__Serotonergic synapse,0.6369446037314299,1.3227538653320434,0.044444444444444446,0.6034552716894808,1.0,20/57,18.82%,HTR2B;ARAF;HTR7;GNAO1;ALOX12;GABRB1;ALOX15B;RAPGEF3;GABRB3;CACNA1B;GABRB2;GNAI1;CASP3;HTR1F;CACNA1A;KCNJ6;PLCB1;APP;KCNJ3;GNAQ
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.6384015059173335,1.3227294407243735,0.047058823529411764,0.6027879778630477,1.0,12/42,19.69%,PPP2R5B;HSPA5;VAPB;ARFGAP1;SERP1;DNAJB9;HYOU1;SYVN1;GFPT1;CXXC1;DCTN1;SRPRA
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.7696710728572268,1.3226544464990992,0.10126582278481013,0.6024182748775614,1.0,2/13,0.65%,KLF4;ACVR1B
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,-0.46386415805772324,-1.3225835521124536,0.16666666666666666,0.7030631089534798,1.0,30/82,14.46%,ITGAM;CD37;LY86;BIN2;CCL3L3;SAMSN1;PIK3R6;MPEG1;LILRB4;HCST;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;BTK;ITGB2;CYTH4;TLR7;LCP2;PTPN7;CD83;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,-0.7432648955738065,-1.3222825474956024,0.17857142857142858,0.702379980536383,1.0,2/9,8.22%,ITGAM;ITGAX
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.6966562441693441,1.3220615044098618,0.10843373493975904,0.6049769775564362,1.0,13/26,19.12%,MAPT;AP3B2;SYBU;KIF1B;HIF1A;TMEM108;DYNC1H1;SPAST;NEFL;KIF3A;DCTN1;SOD1;RAB21
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,0.6612611945395587,1.3220509136501728,0.08433734939759036,0.604194962836212,1.0,5/34,4.13%,CLEC4E;NLRP12;CLEC12A;CR1;SLC11A1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.6735632199216287,-1.3217801573082162,0.1111111111111111,0.7024279833645443,1.0,5/15,14.80%,BANF1;TP53;CDAN1;M1AP;RBBP4
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6092259088450054,-1.321696539916544,0.20833333333333334,0.6992794780194151,1.0,1/14,1.05%,DNMT3A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6092259088450054,-1.321696539916544,0.20833333333333334,0.6992794780194151,1.0,1/14,1.05%,DNMT3A
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.6663861702951949,1.321504814951207,0.06818181818181818,0.6067312334147578,1.0,2/39,3.10%,RHOBTB3;NAA38
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.8638926611962041,1.3213609909611017,0.11940298507462686,0.606639376939471,1.0,3/7,11.78%,TGFB2;PTN;SOX6
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.7783159901257398,1.3210841188699676,0.07792207792207792,0.6072627739210467,1.0,2/13,8.38%,FA2H;CAV3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),-0.6884337663873648,-1.3209192205904345,0.16666666666666666,0.7005598580631701,1.0,2/8,3.60%,IL1B;LGALS9
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.7973645298540848,-1.3204522764876154,0.19444444444444445,0.7003923450759385,1.0,2/5,5.35%,PSAT1;PSPH
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,-0.8314947638884401,-1.3204267387049933,0.14285714285714285,0.6987872811507986,1.0,1/5,0.91%,ITGAM
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.8010012289764175,1.3204213591512215,0.08860759493670886,0.6105491986141027,1.0,1/12,0.34%,GDPD1
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.6376071684549032,-1.320170211073922,0.07692307692307693,0.6978449199365402,1.0,5/14,11.00%,TICAM1;CHUK;TLR3;IKBKB;NFKBIA
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.6089831803649405,1.3200525249207953,0.061224489795918366,0.6121585567690973,1.0,22/93,15.09%,DDIT4;CENPF;SHANK3;RELN;NFIB;MEIS2;CDH2;AATK;CA10;ROBO2;GRIN2A;ARNT2;POU6F1;MFSD2A;CNTNAP2;EPHA7;SOX6;ADGRL2;SHROOM4;CTNNA2;GRIN2B;NDRG4
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.6949348335646719,1.3200115207650878,0.10465116279069768,0.6116019536139975,1.0,12/39,12.31%,CLDN18;SHROOM3;THSD4;NTN4;DOCK1;OSMR;VEGFA;SEMA3B;RND3;PALLD;SH3D19;CRLF1
prerank,KEGG_2021_Human__Fructose and mannose metabolism,0.7328250645403734,1.3199808621111149,0.10975609756097561,0.610983406904485,1.0,6/17,19.51%,PFKM;AKR1B1;PFKFB4;FBP1;ENOSF1;SORD
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.9000633561874466,1.3198660796550332,0.06349206349206349,0.6108864314324652,1.0,1/5,1.63%,SHANK3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.8603996761841272,1.3195665388289255,0.1,0.6117520361129386,1.0,2/6,9.36%,HTR2B;RYR2
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.7344803421015426,1.3194313162888405,0.14102564102564102,0.6115910452880078,1.0,5/15,14.62%,CR1;CD22;FCGR2B;GPI;DNAJB9
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7208709649743563,1.3194263593489555,0.08974358974358974,0.6107865147456796,1.0,6/21,11.53%,SEMA3A;NLGN3;ALCAM;MAP1B;SEMA5A;SLC9A6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8513054548637324,1.319189002704452,0.08695652173913043,0.6113208313231894,1.0,2/8,9.03%,KLF4;ABCA1
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.6850593701036909,1.3183229923679405,0.1125,0.6157195566318073,1.0,11/28,15.39%,TNC;SVEP1;COL4A5;ARHGAP23;RND3;PALLD;SH3D19;ADGRL2;TIMP3;WNT5A;THY1
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.6638036763296827,1.3181818703610497,0.07058823529411765,0.6156294576942511,1.0,13/44,12.78%,CLDN18;SVEP1;ENAH;DOCK1;FBXL7;PTPRG;LAMB1;RBFOX2;RND3;PALLD;FN1;SH3D19;UACA
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.7790991016356693,1.318143942844739,0.14864864864864866,0.6149870565855023,1.0,5/11,20.66%,MDH1;CA2;ATP1B3;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.77972240841946,-1.3180783946246122,0.22727272727272727,0.703504519275014,1.0,1/7,1.60%,TCF3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.49501192834903385,-1.3180584348399431,0.0,0.7018724347099633,1.0,18/49,21.93%,CCND1;CSF1R;TP53;CBFB;MED12;MED24;AGO1;MECP2;MED4;MED1;MED27;PAXIP1;MED30;MED10;CDKN1A;ZNF45;MOV10;MED23
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,0.6872542714615172,1.3177964931029842,0.08045977011494253,0.6163153113094971,1.0,10/37,8.95%,TNC;SPARC;ADAMTS2;RBMS3;VIM;FBXL7;LAMA2;FHL1;FN1;PTN
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,0.6767400208813287,1.317202910488705,0.08333333333333333,0.6188547281522305,1.0,14/36,13.89%,SULT4A1;NCAN;DPYSL5;NRXN2;PHYHIPL;CTNND2;SYT4;LINGO1;OLFM3;SHC2;CACNA1B;LY6H;STMN2;CALY
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.49894223509879154,-1.3171991923949666,0.11764705882352941,0.7032215010929229,1.0,7/27,9.25%,GRAP2;YES1;MAP3K14;TRIB3;FYN;SRC;PKN1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7811553475131696,1.3170926869920165,0.07058823529411765,0.6187983633153394,1.0,1/18,0.14%,SOCS3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.7101090632299298,1.316972497559676,0.056818181818181816,0.6186672150813891,1.0,7/30,13.31%,SLF1;RPA2;FIGNL1;SPIRE2;FMN2;KDM1A;ZCWPW1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.8390118846369105,1.3169181028499932,0.13559322033898305,0.6181123585737166,1.0,2/5,10.41%,FBN2;LTBP1
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,0.8009349948230594,1.316700587428907,0.09333333333333334,0.6177161661806808,1.0,4/10,6.73%,SHROOM3;TOM1L1;OVOL2;BAIAP2L1
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,0.8009349948230594,1.316700587428907,0.09333333333333334,0.6177161661806808,1.0,4/10,6.73%,SHROOM3;TOM1L1;OVOL2;BAIAP2L1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.6424125168290105,1.3163838554832235,0.054945054945054944,0.6186927356246184,1.0,9/54,9.91%,SLC51A;SLC38A4;SLC16A10;ACSL1;SLCO1A2;SLC6A15;SLC13A3;ATP8B1;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),0.8925971256451668,1.316246742281846,0.05555555555555555,0.6186246426294455,1.0,3/5,5.61%,CR1;CD22;FCGR2B
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,0.6764028116230927,1.3158795882652874,0.10344827586206896,0.6198451096342585,1.0,17/30,21.39%,DCC;NCAN;DPYSL5;NRXN2;SYT4;GRIA2;OLFM3;ALK;ZNF536;PAK5;STMN2;CHGB;KCNB2;SNAP91;CNTN2;NELL1;ELAVL3
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.8482811292675905,1.3156353866798323,0.058823529411764705,0.6204313354103401,1.0,1/7,1.62%,VIM
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.8134835569165522,-1.315510079772231,0.22580645161290322,0.7077469790944013,1.0,4/5,14.22%,CTDP1;RPRD1B;RPAP2;RPRD1A
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.6207331662994842,1.3154651849669672,0.0898876404494382,0.6205835616989218,1.0,31/62,25.20%,PIANP;SULT4A1;CLIP3;NCAN;CDH2;NRXN2;ENO2;TCEAL2;FMN2;CHN1;ADGRB2;TAGLN3;CRMP1;PNMA2;STMN2;NEFL;SCN8A;KIF5A;APLP1;TMEM59L;GDF11;BEX1;CNTNAP1;REEP2;KIF5C;SYT11;BRSK1;CLVS2;JAM3;JPH4;USP11
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.6862462829598523,1.315400576682635,0.10588235294117647,0.6202665262212751,1.0,11/33,10.63%,TOM1L1;SH2D4A;NTN4;ITGA2;PTPRK;LAMB1;ADGRG6;BAIAP2L1;RND3;ERRFI1;SH3D19
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7957360686009262,-1.3153413052964313,0.15789473684210525,0.7067021621603115,1.0,2/5,14.53%,UBA7;UBE2E2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.796539652303456,1.3145012152896467,0.10606060606060606,0.6243368422164762,1.0,1/8,2.03%,ACSL1
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.6257556803549842,1.3143573402683522,0.05434782608695652,0.6245324335740579,1.0,36/79,26.86%,RPL23;SEPSECS;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7800487898102766,1.314078934303766,0.1388888888888889,0.6252681986583561,1.0,9/10,22.05%,SHANK3;NETO1;SYP;CAMK2B;NEURL1;APP;DLG4;SYNGR1;RAB5A
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6815557904488534,1.3138226355358777,0.10714285714285714,0.6257688231134259,1.0,6/23,8.65%,JPH1;CEMIP;DMD;ANK2;AKAP6;CALM3
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.7275916728323326,1.3136582261515428,0.1,0.6257901352968914,1.0,6/14,22.91%,ABCA2;EPHA4;PICALM;CASP3;TNF;ABCG1
prerank,Reactome_2022__Insulin Processing R-HSA-264876,0.697944382681198,1.3134450041738044,0.15789473684210525,0.6263132048727752,1.0,2/23,5.71%,PCSK1;MYRIP
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,0.721264344724617,1.3129566638040018,0.13580246913580246,0.6284849918899168,1.0,4/17,13.58%,NFIX;NFIB;POLR3F;POLR3H
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6297563301127792,1.312719445829818,0.03571428571428571,0.6290152868915987,1.0,16/52,17.93%,LRP2;SHANK3;METRN;PTPRD;IL1RAPL1;VEGFA;ROBO2;ROBO1;SS18L1;KDM1A;NTRK2;PLXNB1;SMARCD3;NEURL1;ARHGDIA;PLXNC1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.677053378387958,-1.3127117296623094,0.11764705882352941,0.7149812617513409,1.0,3/11,10.59%,SPIN1;NIFK;RPAP2
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.7629189467644715,1.312537969735132,0.09411764705882353,0.6291540740653304,1.0,3/15,11.42%,GPR18;ROBO1;GPR65
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.7129101910607718,1.3124287069905327,0.075,0.6289150875598545,1.0,7/26,12.23%,KLF4;CD55;BHLHE40;PPP1R13L;FOSL2;MLANA;NFKBIZ
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.6690682884009201,1.3123666481539162,0.0425531914893617,0.6283727797148964,1.0,26/64,19.27%,SHROOM3;LRP4;SH3PXD2B;ENAH;COL4A5;GNA11;LIFR;B4GALNT4;SRRM3;RBFOX2;RND3;ARNT2;MAP2;ADGRB2;CELSR2;GPRC5B;TMEM132A;LIMCH1;PLXNB1;NDRG4;CPE;EPB41L4B;HSPA12A;APP;NMNAT2;TMEM59L
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6540784649749617,1.3122835198392313,0.07228915662650602,0.6279533295134906,1.0,9/42,12.78%,PLPP3;ASPN;SVEP1;TNS1;LAMA2;KCNMB1;SH3D19;PMP22;UACA
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.7932286410061806,1.3119790746155824,0.1323529411764706,0.6288931060826615,1.0,5/9,15.12%,ANK3;SCN3A;SCN1A;SCN8A;SCN2A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4381639864924061,-1.3116114663902507,0.07142857142857142,0.7171769276831939,1.0,17/49,21.93%,CCND1;CSF1R;TP53;CBFB;MED12;MED24;AGO1;MECP2;MED4;MED1;MED27;MED30;MED10;CDKN1A;ZNF45;MOV10;MED23
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.7259628070683251,-1.31122487841317,0.2777777777777778,0.7166684603315479,1.0,1/6,0.41%,SKAP1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8746190826075999,1.311186209109696,0.06349206349206349,0.6324946057180024,1.0,1/5,1.64%,SEMA3A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,0.7392901682884596,1.3105663940692114,0.12345679012345678,0.6351674548536974,1.0,11/16,20.58%,CADM1;SLC2A3;NFIB;SOX4;BMI1;POU5F1;SCAMP3;ALDH1A1;THY1;SLC16A1;TCF4
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.6248753209590687,1.310407273456899,0.06521739130434782,0.6354055594668163,1.0,36/78,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;GNL3;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.7004078089218784,1.310102525980844,0.07228915662650602,0.6368854465986902,1.0,3/29,6.47%,TOP2A;SMC4;NCAPH2
prerank,KEGG_2021_Human__Glutamatergic synapse,0.6215994824686032,1.3097318950688808,0.054945054945054944,0.6381927951740163,1.0,29/77,19.94%,GRM8;SHANK3;GRIA4;ADCY3;GRIN3A;SLC1A2;GNAO1;GRIK2;GRM3;SHANK2;GRIN2A;GRIK1;GRIA2;GLUL;ADCY8;GRIA3;GNAI1;DLGAP1;GRIN2B;SLC17A7;CACNA1A;PLCB1;GRIA1;KCNJ3;GRM7;GNAQ;GRIK4;DLG4;PLD1
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.7400555340648137,1.3096516760157249,0.09090909090909091,0.6378725861151614,1.0,3/17,12.87%,BRIP1;DNA2;BRCA1
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.8517447616893778,1.309646733031109,0.07228915662650602,0.6370846392946656,1.0,3/8,6.52%,KLF4;RBMS3;DAPK1
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.544778852738769,-1.3092920740407066,0.07692307692307693,0.7218430350980508,1.0,7/26,12.38%,ELOA;GTF2F1;CTDP1;ELOC;SUPT16H;TCEA1;POLR2C
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.618115602701791,1.309284820773332,0.053763440860215055,0.6384345898643043,1.0,35/81,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8332140208130288,-1.309214905255275,0.16216216216216217,0.7208385743708845,1.0,4/5,16.71%,DNMT3A;KDM1B;MECP2;CTCF
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.6463538940635595,1.3091349681894617,0.1,0.6384628386584479,1.0,20/60,14.87%,PLPP3;NTN4;SH3PXD2B;ENAH;DOCK1;GNA11;KITLG;LIFR;DMD;LAMB1;RBFOX2;RND3;BMI1;PALLD;SPRY1;ERRFI1;SH3D19;UACA;LIMCH1;TIMP3
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.6121569440362291,1.3091084366173615,0.0625,0.6377609814222247,1.0,38/87,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;EIF3A;RPL36AL;RPL21;RPL7;RPL12;EIF3D;RPL10A;FAU;RPS12
prerank,KEGG_2021_Human__Nitrogen metabolism,0.8606918868971123,1.3088320860698572,0.14084507042253522,0.6385191152652944,1.0,2/5,9.72%,CA2;GLUL
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.7293319726617691,1.3087665045350527,0.10526315789473684,0.638165173215169,1.0,4/19,5.86%,ITGA2;PIGU;LAMA2;LAMB1
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.6683010643350192,-1.3085694056535329,0.23333333333333334,0.7212675582955903,1.0,2/8,10.48%,SMARCD1;ZMIZ1
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.6497505055553899,1.3084988432573084,0.06593406593406594,0.6349473868799179,1.0,17/56,12.36%,LRP4;ENAH;MXRA7;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;ARHGAP23;RBFOX2;AKAP12;FN1;PPFIBP1;MAP1B;SH3D19;SGCE;ADGRL2
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7968670234992827,1.308454517705153,0.09333333333333334,0.6344356477400726,1.0,5/9,7.94%,LRP4;NRXN1;NRXN2;NLGN3;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.6740539721979216,1.3083120550483731,0.136986301369863,0.634161497889743,1.0,3/15,7.82%,DDIT4;DMD;PAQR3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.6260912246659096,1.3082939198852506,0.010416666666666666,0.633427919428668,1.0,14/101,13.49%,PCSK1;FA2H;PLPP3;ALDH3B1;NMRAL1;DMD;VAPB;MFSD2A;ELOVL4;B4GALT5;ARG2;SLC44A5;PPM1L;SPTLC2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6609727384022995,1.3082148445133188,0.07142857142857142,0.6331557696143437,1.0,12/39,11.93%,TGFB2;ENPP2;PRKCE;DOCK1;GLIPR2;PTPRG;DOCK5;HIF1A;PTN;GLUL;CLASP2;SASH1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.8636963403299062,1.3081882278748536,0.11666666666666667,0.6325195097788803,1.0,4/5,13.64%,ADGRG6;BAIAP2L1;PPP1R13L;TRIM16
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.701695883491826,-1.3076486648279322,0.2,0.7225134619319197,1.0,2/10,8.65%,CCL5;ALOX5
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7255559141294563,-1.3073590289096204,0.20689655172413793,0.7219077769713651,1.0,4/8,15.48%,ZPR1;ETS1;SERBP1;HABP4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7299367459845324,1.307295472713665,0.15384615384615385,0.636774102989145,1.0,8/15,21.02%,DMD;ANK2;CALM3;RYR2;ATP2A2;CLIC2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6475984254734527,1.307257416312702,0.11904761904761904,0.6361935289909316,1.0,4/36,7.22%,THBS1;ANXA1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),-0.7599046354143317,-1.3068994080131737,0.2,0.7219388715127687,1.0,3/6,10.32%,CX3CR1;P2RY12;TREM2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.6455936193835468,1.306539947465723,0.08045977011494253,0.6395416039338132,1.0,5/63,10.66%,PCSK1;AANAT;SRGN;CPM;TYSND1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.7616110030268866,1.3062390467467595,0.11267605633802817,0.6404458824809295,1.0,6/12,20.17%,TGFB2;ROBO2;ROBO1;TNFRSF1B;TNFRSF1A;NOTCH2
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,-0.4570735245028448,-1.3062273231696526,0.05555555555555555,0.7195726608636862,1.0,4/35,2.32%,NKG7;CD37;LY86;BIN2
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,-0.4570735245028448,-1.3062273231696526,0.05555555555555555,0.7195726608636862,1.0,4/35,2.32%,NKG7;CD37;LY86;BIN2
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,-0.4570735245028448,-1.3062273231696526,0.05555555555555555,0.7195726608636862,1.0,4/35,2.32%,NKG7;CD37;LY86;BIN2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.7145730953047504,1.3061175458656005,0.1411764705882353,0.6403422585513271,1.0,3/17,7.02%,THBS1;TGFB2;ABCA2
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.7543525464327265,1.306100092922502,0.12048192771084337,0.6397133851624816,1.0,2/18,2.08%,FAAH;ENPP2
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),-0.7349194982872198,-1.3059749502098112,0.14285714285714285,0.7190404035167723,1.0,1/5,1.00%,CX3CR1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.8331335966908363,1.3059694688348737,0.19696969696969696,0.639727589032332,1.0,1/5,1.63%,SHANK3
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.7787352616760728,1.3057904899882407,0.1791044776119403,0.6400912087952407,1.0,2/6,3.98%,KMO;FAH
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,0.6580218050784277,1.3057676010643435,0.07058823529411765,0.6393836128636136,1.0,9/41,8.46%,TNC;FZD6;ITGA2;OSMR;LAMB1;TUBB6;RND3;PALLD;FN1
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.6999581500059151,1.3056193799796931,0.0759493670886076,0.639235516471639,1.0,5/29,12.69%,ARAF;PPP2R5B;PPP2R5A;CAMK2B;PHB1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.626038094559676,1.3055777907991353,0.06976744186046512,0.6386352325638851,1.0,15/71,8.95%,PLPP3;SPARC;FGF1;SVEP1;TNS1;NR4A2;FBXL7;FILIP1L;ARID5B;LAMA2;NOCT;PALLD;AKAP12;FN1;PTN
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),0.8915896934739476,1.305106865842522,0.07462686567164178,0.6406093343237458,1.0,4/5,10.87%,THBS1;SLC11A1;FCGR2B;NOD2
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.7459239788207656,1.304166899497793,0.08108108108108109,0.6450554713962252,1.0,5/15,14.52%,FKBP5;SLC2A3;GRIN2A;GRIA2;GRIN2B
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.6836229314353055,-1.303589265957974,0.19230769230769232,0.7266289917176645,1.0,3/12,18.44%,LGALS9;TREM2;BATF3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.7599108625325849,1.3033989583278094,0.11267605633802817,0.6490626651857839,1.0,9/16,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;ENO4;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.48087974532100575,-1.3031736459942886,0.07142857142857142,0.7267382959252384,1.0,9/36,13.97%,ACSM5;ALOX5;CH25H;LPL;MLYCD;LIPG;NDUFAB1;OSBPL6;ABCD3
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.8018268160246382,1.303119758419489,0.12121212121212122,0.6499193332715543,1.0,5/10,14.41%,MYRF;PTPRZ1;SOX6;TPPP;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.7975447051166149,-1.3030684099948115,0.2413793103448276,0.7254506368374058,1.0,2/6,5.98%,LGALS9;CD274
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7991343344369206,1.3029646010530231,0.0958904109589041,0.6499205386723006,1.0,2/7,9.26%,RHOB;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.8349946178963659,1.30279855614067,0.140625,0.6501520749770456,1.0,2/6,8.38%,GLA;CAV3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.7675471172613917,1.3025485873120122,0.11688311688311688,0.6508776268648736,1.0,4/13,8.65%,JPH1;DMD;AKAP6;CALM3
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.732172104169832,1.3025338393285288,0.06172839506172839,0.6502343082319456,1.0,8/28,16.34%,SOCS3;PRKCE;INSR;IRS2;CACNA1B;PKM;MAPK10;CACNA1A
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.6561291355559861,1.302519366738906,0.14285714285714285,0.6495581795435835,1.0,12/37,17.16%,PTPRD;AGT;IL1RAPL1;NRXN1;VEGFA;NLGN3;NLGN1;NPHP1;CNTNAP2;GRID2;THY1;ROCK1
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6295842852908015,1.3024831413772193,0.07608695652173914,0.6489983323084327,1.0,10/60,11.28%,OMD;OGN;CHST7;NCAN;VCAN;B4GAT1;PAPSS2;MAT2A;CSPG5;B4GALT5
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.47830390659442446,-1.3024301165016883,0.0,0.7258585578148471,1.0,11/49,14.21%,PLA2G4C;MAPK13;KRAS;MAP2K3;FYN;ALOX5;INPP5D;BTK;LCP2;SYK;AKT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8628787465028942,1.3024284938534585,0.10606060606060606,0.6484742173654516,1.0,4/6,11.64%,DPYD;DPYSL5;CRMP1;ALDH6A1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.6454126216452684,-1.3023053600088519,0.16129032258064516,0.7246674151708475,1.0,2/9,11.60%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6856811599670464,1.3023052208309984,0.12195121951219512,0.648477214135401,1.0,3/23,6.00%,KLF4;GPNMB;FHL1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.6100562624492532,1.3022226025776618,0.06315789473684211,0.6480920491728555,1.0,16/98,9.76%,RHOBTB3;RHOB;SHROOM3;COBL;GAS2L3;CORO6;PPP1R9A;ENAH;CGNL1;MARCKSL1;BAIAP2L1;SPIRE2;RND3;ERMN;SVIL;CARMIL1
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.6392321057759097,1.3022190914293423,0.10465116279069768,0.6473201708424883,1.0,12/45,12.36%,TNC;SH3PXD2B;ENAH;DOCK1;FBXL7;LAMB1;RBFOX2;RND3;PALLD;FN1;SH3D19;ADGRL2
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6151086764478135,1.3020823847172922,0.07526881720430108,0.6471879347801177,1.0,34/105,18.07%,PLPP3;SH2D4A;THSD4;NTN4;MAPT;ENAH;COL4A5;DOCK1;NFIB;PTPRG;KITLG;DOCK5;LIFR;VEGFA;LAMB1;RBFOX2;EMC7;RND3;PALLD;KANK1;MAFB;THSD7A;SH3D19;MAGI2;ADGRL2;UACA;LIMCH1;CPE;NEBL;HSPA12A;MPDZ;APBB2;EPB41L5;STARD13
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.6579527630994699,1.3019651425776528,0.08888888888888889,0.646930914941585,1.0,5/37,10.16%,KCNE1;FHL1;AKAP6;CAV3;KCNMB1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.6366463209437673,1.3015111953680019,0.10843373493975904,0.6482308131214051,1.0,6/44,5.30%,TNC;SPARC;SVEP1;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8606485107709473,1.3014415149908718,0.05,0.6477802626176606,1.0,4/7,12.53%,THBS1;ANK3;RYR3;FBP1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6584677015935881,1.3012656130407736,0.1282051282051282,0.6478747443091328,1.0,7/35,8.95%,SPARC;SVEP1;ADAMTS2;TNS1;DAAM2;LAMA2;PTN
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.639980168598033,1.3011562161743846,0.04395604395604396,0.6478105457158494,1.0,25/70,17.60%,RAP1GAP;COBL;FAAH;PPP1R9A;MAPK4;PHYHIPL;SYBU;ARFGEF3;MYRIP;SHANK2;ANK3;SRCIN1;BMI1;PTPRT;NDRG2;SHC2;KALRN;SORBS1;TPPP;PLXNB1;NEBL;EPB41L4B;MTUS1;HAMP;SORBS2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.6601869014630204,1.301116381159552,0.06521739130434782,0.6472039284447162,1.0,21/72,15.06%,HHIP;TGFB2;SH3PXD2B;ZBTB16;NCAN;VCAN;CHI3L1;BMPR1B;SOX4;EIF2AK3;PAPSS2;TRPS1;TNFRSF11B;ITGB8;DEAF1;SOX6;ETS2;SULF2;COL10A1;PKD1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8005672303686209,1.3008692935546404,0.18571428571428572,0.647705202436423,1.0,4/8,10.17%,COBL;ZDHHC15;PTN;ALK
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.8572656695748256,1.3008139898983404,0.1724137931034483,0.6463277676882564,1.0,2/5,5.04%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.8572656695748256,1.3008139898983404,0.1724137931034483,0.6463277676882564,1.0,2/5,5.04%,PRLR;VEGFA
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.6823272689145716,1.3007647446579462,0.10256410256410256,0.645793436294703,1.0,2/21,2.73%,TSHR;TG
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.6223456960407832,1.3006282004358618,0.08045977011494253,0.6458446046190254,1.0,19/78,13.89%,LRP4;TGFB2;SHANK3;CLIP3;RELN;TFRC;NRG1;NRXN1;SLF1;VEGFA;FRMPD4;INSR;RAPGEF3;IGF1R;CAMK2B;BNIP3;TPPP;PPP1R15A;CALY
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.6874221716497076,1.3004291974482187,0.12345679012345678,0.6462883712683468,1.0,1/26,0.14%,SOCS3
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.7877876192161534,1.3003949525589038,0.14705882352941177,0.6456439781210137,1.0,3/9,6.41%,CACNB2;SCN3B;ANK2
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.6858604429509193,1.2998392689314155,0.13580246913580246,0.6482360144564038,1.0,4/31,9.93%,DIAPH3;BAIAP2L1;AKAP12;LMNB1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.6441046791871454,-1.299100547535367,0.16,0.7359946265649092,1.0,8/11,25.20%,CD226;BCL10;CARD11;RAB29;CD81;PRKD2;RELA;IKBKG
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,-0.4664987587661673,-1.2989005095685535,0.0,0.7349922181234841,1.0,28/82,16.24%,NKG7;CD300LF;ITGAM;LY86;BIN2;SELPLG;PIK3R6;MPEG1;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5;FERMT3;PSTPIP1;PLCB2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.6154777297923504,1.29873304215142,0.1111111111111111,0.6538514064723291,1.0,23/47,25.50%,SLC6A15;NRXN1;SLC1A2;NRXN2;GAD1;SNAP25;UNC13A;GABRA2;GLUL;PPFIA2;GAD2;SYT1;SLC17A7;CPLX1;STXBP2;PPFIA4;ATP1A2;TSPOAP1;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7441509986688255,-1.2986885774745973,0.21052631578947367,0.7342293327311681,1.0,2/6,7.34%,ARHGDIB;IGF1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.702124918489071,1.2986224004501845,0.11267605633802817,0.653680294246512,1.0,7/18,20.66%,KCNJ13;SLC12A8;ATP1B3;KCNJ6;KCNJ3;ATP1B2;ATP1A2
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,0.7311263828827504,1.29836141611229,0.10526315789473684,0.6545802308215429,1.0,4/15,9.56%,KLF4;TFRC;CD55;POU5F1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.8530918833601892,1.2982337070799899,0.0547945205479452,0.654675981745864,1.0,2/7,6.68%,THBS1;SEMA6A
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,-0.47887939163274357,-1.298128362152054,0.0,0.7349941899286558,1.0,26/81,13.65%,NKG7;CD300LF;ITGAM;LY86;BIN2;P2RX1;SAMSN1;PIK3R6;MPEG1;HCST;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;BTK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.6476952265696434,1.2979938386318373,0.10126582278481013,0.6554723974770572,1.0,10/31,19.47%,METRN;MAPT;ROBO2;ROBO1;NTRK2;PLXNB1;ARHGDIA;MAP3K13;PLXNC1;CHODL
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4531304441777273,-1.2976176258867749,0.0,0.7355508980121009,1.0,25/93,11.22%,CYSLTR1;ITGAM;LY86;TRIM38;PTAFR;IL1B;MPEG1;LGALS9;CSF1R;LILRB4;TMEM106A;ITGAX;MILR1;HLA-E;CSF2RA;WDFY4;APOL6;IGSF6;PLEK;HCK;TREM2;NLRP3;ITGB2;CYTH4;TLR7
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8741827125713295,1.2971937191664076,0.109375,0.6599337987111368,1.0,3/5,10.22%,DPYD;DPYSL5;CRMP1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6907512336302799,1.2970858317565621,0.05813953488372093,0.6596675712852428,1.0,11/34,19.33%,CLIP3;MAPT;TUBB4A;CAV3;MAP2;STMN2;TOGARAM1;EML2;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.8231582219226021,1.2968673416304524,0.20634920634920634,0.660155767329916,1.0,4/7,13.55%,ALOX12;ALOX15B;SCD5;SCD
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,0.6393245805574497,1.2967043204513116,0.06451612903225806,0.6601445618462626,1.0,13/49,16.89%,KLF4;ANKRD22;ANXA1;DOCK5;CD55;FOSL2;ST14;NFKBIZ;VMP1;AHNAK;TGFBI;IL18;IQGAP1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.792026430000778,1.2966467396943375,0.11392405063291139,0.659657878580511,1.0,3/11,6.41%,CACNB2;SCN3B;ANK2
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.8370526153459398,1.2965322315516516,0.07575757575757576,0.6596583448923226,1.0,2/5,11.79%,PIGU;NTRK2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.733068627797797,1.2963721623062239,0.1506849315068493,0.6597801580911231,1.0,4/16,11.25%,HS3ST5;TRIM5;TRIM25;TYRO3
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.6572118048721891,-1.2961387922898504,0.18181818181818182,0.7393737269595394,1.0,5/17,15.06%,PKIB;MAP3K4;NBN;TERF2;SMG6
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.8784219333578536,1.2961312046927551,0.08196721311475409,0.6603975054809903,1.0,1/6,3.16%,PIGU
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6630285991066528,1.296018643626279,0.10843373493975904,0.6603420564525473,1.0,8/31,10.17%,COBL;DCC;ZDHHC15;CSMD3;NSMF;PTN;MFSD2A;ALK
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7126269807776976,1.2959373559878296,0.13513513513513514,0.6600888852043331,1.0,1/18,1.31%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7772242004552075,1.2958499013375284,0.14473684210526316,0.6597924051901544,1.0,2/11,3.87%,KLF4;ANXA1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7184646593407413,1.2956881188539244,0.09090909090909091,0.6598365698722966,1.0,4/19,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,-0.7517421089483763,-1.2955337947688803,0.2,0.7393941103825571,1.0,2/6,5.35%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.6963622929239184,1.2954430524233191,0.12790697674418605,0.66043920944944,1.0,4/21,11.25%,HTR2B;NYAP2;IGF1R;TYRO3
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.6878884635071708,1.2954107786386608,0.13580246913580246,0.6598151881467418,1.0,11/25,22.53%,GRIA4;GRIA2;CACNG2;CAMK2B;GRIA3;NSF;CACNG8;GRIA1;AP2A2;TSPAN7;PRKCB
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.6542080784410618,1.2950976561701857,0.06666666666666667,0.6607988423493253,1.0,13/59,7.97%,SHROOM3;COBL;FRAS1;TOM1L1;PPP1R9A;ENAH;COL4A5;ADGRA3;LIFR;ARFGEF3;RBFOX2;PKP2;KIF21A
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.6954709152241941,1.2950030793163747,0.10975609756097561,0.6606888104086616,1.0,1/22,0.14%,SOCS3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.6853017231220624,1.294789857271416,0.14864864864864866,0.6612112670696582,1.0,2/23,0.62%,SOCS3;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7694586033573242,-1.2944839505730654,0.15625,0.7417097290834154,1.0,3/5,18.72%,TP53;SRC;ERCC4
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.6717119343623359,1.2941026367128337,0.16666666666666666,0.6645523500146892,1.0,6/33,8.46%,TNC;SVEP1;ADAMTS2;SYNC;LAMA2;FN1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.47589252010741767,-1.2940306542142037,0.15384615384615385,0.7416668845473005,1.0,4/47,5.91%,BUD23;ALKBH8;FBL;METTL8
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6254854168529542,1.2939464435057781,0.07368421052631578,0.6645796269291935,1.0,25/64,18.04%,DENND2A;RBMS3;PDE10A;ENAH;DZIP1;FBXL7;PTPRG;LIFR;LAMB1;RUNX1T1;ANK2;AKAP12;PPFIBP1;MAP1B;FIGN;TYRO3;ADGRL2;NFASC;LIMCH1;ITSN1;THY1;MPDZ;APBB2;FLRT2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.6439658071302949,-1.2935774424843078,0.14285714285714285,0.7420870568860972,1.0,3/13,7.34%,CCL5;TRIB1;IGF1
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.6296821561605098,1.2935447294609081,0.06818181818181818,0.6663012673119084,1.0,20/62,18.04%,PRKAR2B;GRIA4;MAPT;NRG1;GRIN3A;GRIN2A;GRIA2;ADCY8;CAMK2B;PRKAG2;RPS6KA2;GRIA3;PPM1E;LRRC7;RASGRF1;GRIN2B;NEFL;NRGN;GRIA1;PRKAA2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.6224307485188602,1.2929244420624493,0.07692307692307693,0.6689409862903258,1.0,45/84,31.36%,RPL23;RPL37A;FTSJ1;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;DRG2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL24;RPL27A;RPL3;RPS16;EIF4A2;RPL30;RPL21;RPL7;RPL12;RPL10A;RPS12;DRG1;RPL6;RPLP0;RPL8;RWDD1;RPL18A;RPL15;RPS23
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7784273280222993,1.2928920683554075,0.1111111111111111,0.6683561606798943,1.0,2/10,9.54%,PRLR;GHR
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.7891537778402836,1.2927647986811321,0.12307692307692308,0.6682272923929908,1.0,3/9,7.86%,AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8020626959932267,1.2927159560328105,0.17142857142857143,0.6676987401289205,1.0,2/7,8.65%,ANK3;CALM3
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.7363604802624398,1.2925445959048423,0.1625,0.6678624890400663,1.0,9/17,17.39%,NRG1;GRIN2A;GRIA2;CAMK2B;LRRC7;GRIN2B;NEFL;NRGN;GRIA1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7946696095663197,1.2924355730168144,0.14285714285714285,0.6676915161818965,1.0,3/8,11.99%,ACVR1B;ACVR2A;MAGI2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.6391660171318985,1.2921856766518385,0.08602150537634409,0.668490458826014,1.0,10/58,14.63%,THBS1;KLF4;NLRP12;BEX3;VEGFA;DAPK1;EPHA7;CYCS;UACA;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.6910664033643548,1.2920567965451515,0.11688311688311688,0.668340669720155,1.0,6/17,22.91%,ABCA2;EPHA4;PICALM;CASP3;TNF;ABCG1
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.6206691612243961,1.2918392583479161,0.06521739130434782,0.6689650242199183,1.0,27/102,18.69%,KCNE1;PDE5A;VIM;CACNB2;SCN3B;ANXA1;DMD;CAV3;SCN3A;RYR2;SCN1A;FXYD7;CAMK2B;FGF14;SORBS1;RYR3;GUCY1B1;ASPH;SCN8A;SCN2A;ATP2A2;ATP1B3;KCNIP4;CACNG8;NPRL2;ATP1B2;CLIC2
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.715045583411702,1.2916711360823472,0.11688311688311688,0.669158535242201,1.0,10/27,12.42%,FLRT1;SEMA3A;NLGN3;ALCAM;MAP1B;SEMA5A;IMPACT;SLC9A6;TMEM108;SH3GL2
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.6263706790801167,-1.29156095174689,0.13043478260869565,0.7465750911145334,1.0,3/15,11.96%,SPIN1;NIFK;GTF3C2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.6010962063752405,1.291216903888867,0.06315789473684211,0.6709491682122262,1.0,37/102,25.39%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;UPF3A;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;PYM1;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.8202880548337089,1.2911470084886778,0.13333333333333333,0.6705401798944232,1.0,2/7,13.05%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7938262263929561,1.2910398259226126,0.19402985074626866,0.6704102668743277,1.0,2/5,8.38%,ANK2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.6621297144076118,-1.2910115773672062,0.2222222222222222,0.7471842561870262,1.0,1/10,0.45%,CCL5
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.5958118767555097,1.290945348648551,0.0625,0.6701524428283693,1.0,39/96,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;EIF4A2;RPL30;EIF3A;RPL36AL;RPL21;RPL7;RPL12;EIF3D;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.6040040840141004,1.2906043981819144,0.021739130434782608,0.6712825855060324,1.0,41/128,22.94%,PCSK1;EEF1A2;RPL23;CARNS1;DMD;RPL37A;RPS6KB2;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;MRPL43;RPL37;RPL14;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;RPL36;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;TNIP1;EEF1A1;RPL24;RPL27A;RPL3
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6805268363741043,-1.290574989193165,0.25,0.7469861230507971,1.0,1/7,0.41%,SKAP1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.8318452892672905,1.2905470821530125,0.15384615384615385,0.6709070906853631,1.0,2/6,5.16%,TGFB2;SOX4
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.6268213976779754,1.2903889027185222,0.07777777777777778,0.6710541838148487,1.0,12/46,11.69%,SPON1;COBL;PPP1R9A;ASXL3;LRRN1;ANK3;SEMA6A;BMI1;PTPRT;NDRG2;SHC2;KALRN
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.7134527636775694,-1.290296027180922,0.20833333333333334,0.746129350299556,1.0,5/12,11.90%,FOLR2;SLC46A1;MTHFD2L;MTHFD1L;SLC19A1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.6522105379994964,-1.2902527325956148,0.13333333333333333,0.7448471359832243,1.0,4/7,10.32%,APPL2;C3;NCKAP1L;TREM2
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,0.8909971979866792,1.290158906177503,0.09722222222222222,0.6717007763273326,1.0,3/5,9.58%,NCAN;VCAN;CSPG5
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,0.7823518393676976,1.289941142727472,0.14102564102564102,0.67232462519432,1.0,2/8,9.75%,ANKRD22;ST14
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.4720517341384863,-1.2896519715752974,0.21428571428571427,0.7459401010888425,1.0,7/45,4.79%,PHLDB2;IL17RD;ZNF703;IL1B;BCL9L;DAB2IP;WWTR1
prerank,KEGG_2021_Human__Histidine metabolism,0.7623858725266525,1.2895657288384665,0.1643835616438356,0.6735836473638763,1.0,3/11,3.25%,ALDH3B1;ASPA;CARNS1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.8537615454398526,1.2895441026177177,0.10294117647058823,0.6729321142296183,1.0,1/5,0.75%,AANAT
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6440947709666918,1.2895438127564034,0.07368421052631578,0.6721550563609929,1.0,29/65,17.30%,FAM13C;LRP4;DENND2A;GULP1;ENAH;DZIP1;FBXL7;PTPRG;LIFR;SEMA3B;RUNX1T1;ANK2;RBFOX2;CSRNP3;ARNT2;TUSC3;PTN;MAP1B;GPRC5B;FIGN;PLP1;ADGRL2;NFASC;ITSN1;CPE;THY1;EDIL3;HSPA12A;MPDZ
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6678802397406258,-1.2893663141155756,0.15384615384615385,0.7454330231734343,1.0,3/10,20.16%,IPPK;PIH1D1;NOL11
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.6462088855020022,1.2893088675994697,0.06315789473684211,0.672733208760185,1.0,17/62,20.52%,NAMPT;NFIL3;BMAL2;NOCT;HIF1A;BHLHE40;RPS27A;PER1;CRTC3;CPT1A;SMARCD3;TBL1XR1;UBA52;UBB;PPARA;NR1D1;NPAS2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4625508714344244,-1.2892368035446948,0.18181818181818182,0.744416474883948,1.0,6/50,6.48%,RNASEL;CCL5;PDE12;ADARB1;APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.7122820312996438,1.2892026293935972,0.18181818181818182,0.672570731388474,1.0,2/16,11.73%,FKBP5;PPID
prerank,KEGG_2021_Human__Glutathione metabolism,-0.520257043149623,-1.28863609556752,0.07692307692307693,0.7453331014933045,1.0,8/28,13.98%,GCLC;HPGDS;GPX4;GSTM4;GGT7;GCLM;GPX1;SMS
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.6163820842674936,1.2883523744351055,0.07368421052631578,0.6773456727943694,1.0,21/94,16.18%,SLC51A;LRP2;TM7SF2;IDI1;SLCO1A2;CD163L1;PIAS4;MVD;AKR1B1;SH3D19;SEC24C;SLC10A1;FASN;INSIG1;SCD;STARD5;HSD17B12;FDFT1;HMGCS1;SMARCD3;TBL1XR1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.766786492289752,1.288322320287987,0.15714285714285714,0.6766724857051716,1.0,3/10,4.14%,LRP2;TGFB2;KITLG
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.84661900502645,1.2881176866125554,0.13333333333333333,0.6770849212309662,1.0,1/5,4.08%,CDH2
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.7930727866101807,1.2879220345710831,0.12307692307692308,0.6774123072209748,1.0,1/7,2.27%,GLA
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.8627866445729608,1.2876573943181722,0.07936507936507936,0.6782744893673412,1.0,3/7,9.28%,INSR;GRB10;IRS2
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.8687798876926962,1.2875721776897526,0.15,0.6779914094646365,1.0,4/5,13.15%,CR1;FCGR2B;CD55;SUSD4
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6696353682640581,1.2874550498068702,0.11235955056179775,0.6778242225396656,1.0,14/38,14.56%,SYCP2L;PREX2;CKMT2;CACNB2;MAPT;LDB3;ZNF483;CADM2;RYR2;HIF3A;SORBS1;L2HGDH;LRP1B;TMEM266
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7916165382258356,1.2874123792687275,0.08860759493670886,0.6772911442969743,1.0,3/12,8.38%,KCNE1;ANK2;CAV3
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.6672504195653032,1.2873196014470323,0.0975609756097561,0.6770937780874651,1.0,3/37,6.24%,TOP2A;PIAS4;NUP133
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.5432731660018458,-1.287238152850905,0.16666666666666666,0.7484534373935068,1.0,6/23,14.21%,TP53;BID;PPP1R13B;PPP3CC;BCL2;AKT1
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,0.865410447078226,1.287162299576461,0.14285714285714285,0.6754105463793866,1.0,1/5,0.82%,FGF1
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,0.865410447078226,1.287162299576461,0.14285714285714285,0.6754105463793866,1.0,1/5,0.82%,FGF1
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,0.865410447078226,1.287162299576461,0.14285714285714285,0.6754105463793866,1.0,1/5,0.82%,FGF1
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.5964132973841714,1.2868043157007598,0.06315789473684211,0.6768706935130239,1.0,39/97,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;EIF4A2;RPL30;EIF3A;RPL36AL;RPL21;RPL7;RPL12;EIF3D;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.7991587456268429,1.28678536806291,0.136986301369863,0.6761448414365657,1.0,3/8,15.15%,DDIT4;NTRK2;CASP3
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.7641925786859473,1.2864393103223477,0.15853658536585366,0.6774139740530224,1.0,4/11,9.58%,NCAN;VCAN;GPC5;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7760985224987467,1.286181383620037,0.0759493670886076,0.6782135746122415,1.0,4/12,5.04%,TGFB2;IL15;ANXA1;VEGFA
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.6298314809744465,1.2860952275489592,0.031578947368421054,0.677965157608116,1.0,20/68,14.87%,THBS1;KLF4;PLPP3;RAB7B;TNS1;FILIP1L;PAPSS2;GNS;FCHO2;FOSL2;FN1;SVIL;ABCA1;PDCD1LG2;SASH1;PMP22;THBD;ABLIM3;TGFBI;TIMP3
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,-0.45457215361863607,-1.2860865039701914,0.07692307692307693,0.751277927800405,1.0,14/78,9.04%,ITGA5;ATRAID;NPC2;DHRS4;RHOG;PFN1;LRP10;SH3BGRL3;ILK;LAMTOR1;CCDC107;ENG;CYB5R3;MAN2B1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.7853821794569258,-1.286039192609908,0.11764705882352941,0.7498630164484948,1.0,1/8,0.45%,CCL5
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,0.8057855744204594,1.2858157945804871,0.1791044776119403,0.6789796145061955,1.0,1/7,4.81%,MASTL
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,0.7867917130147727,1.285614119447468,0.16455696202531644,0.6792579873674529,1.0,3/6,17.69%,NEIL1;POLG2;NEIL2
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.6199709960802001,1.2855025665958382,0.052083333333333336,0.6790814981469893,1.0,19/66,20.20%,THBS1;PRR16;VIM;EIF4A3;SOX4;RBM3;ABCA2;EIF3E;UPF3A;EPHA4;PICALM;CASP3;RPS4X;TNFRSF1A;PYM1;SIRT3;PLD1;SAMD4A;TNF
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.641121375494813,1.2854435400764173,0.14772727272727273,0.6787094796335849,1.0,3/32,3.16%,FGF1;FLRT1;PIGU
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.8638985850290424,1.2852860195313769,0.11290322580645161,0.6788945147438489,1.0,2/7,3.33%,KNSTRN;RACGAP1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7390922038768855,1.2850761874194445,0.19718309859154928,0.6793877974919987,1.0,2/9,3.87%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.896416782529529,1.2849039481434599,0.0684931506849315,0.6796949840575898,1.0,2/5,3.66%,TGFB2;NRG1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.6515478776542527,1.2847383385308484,0.08641975308641975,0.6799398882981568,1.0,7/35,15.59%,THBS1;CBR1;AGT;SIRT5;BRCA1;PINK1;PDK3
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.7030201033521315,1.2847202149297372,0.09090909090909091,0.6792818715385305,1.0,2/24,0.84%,NAMPT;NUDT12
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.771647095502395,-1.2846290884501756,0.20930232558139536,0.7528692427824626,1.0,2/6,10.19%,HHEX;BHLHE41
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.6185154569357555,-1.2845925859088547,0.21739130434782608,0.7514850392424763,1.0,5/15,9.25%,EFNB2;FYN;SRC;EPHB3;PKN1
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,0.5974000833301846,1.284259088652645,0.07526881720430108,0.6813601481891298,1.0,40/95,26.86%,RPL23;SEPSECS;RPL37A;PAPSS2;RPL38;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;AHCY;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;TXNRD1;RPL12;RPL10A;FAU;RPS12
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.5526270629444255,-1.2841898238681406,0.13793103448275862,0.7513108070931084,1.0,5/13,17.53%,BCKDHB;GOT2;NDUFAB1;PDHX;DHTKD1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.6478276358094286,1.2841513431489688,0.05813953488372093,0.681203351305698,1.0,4/38,5.61%,KLF4;HHIP;NLRP12;FCGR2B
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.7311237762799823,1.284142341839625,0.09210526315789473,0.680505246948741,1.0,3/14,9.26%,ACVR2A;BMPR1B;RBPJ
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.7242252675707143,1.2841055219490125,0.0958904109589041,0.6799924515428531,1.0,6/16,18.84%,PIGU;NRG1;NRG3;CDC37;NRG4;NRG2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6617202867501789,1.284037485316845,0.10588235294117647,0.679562374618573,1.0,6/34,6.22%,GPR18;HTR2B;TACR1;AGT;GNA11;LTB4R
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.7147156924586152,1.283953918592238,0.16216216216216217,0.679286041596112,1.0,8/14,22.53%,GRIA4;GRIA2;GRIA3;NSF;GRIA1;AP2A2;TSPAN7;PRKCB
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.6339569230451155,1.2839187758402335,0.11764705882352941,0.6786542119009228,1.0,10/28,24.85%,SEMA3A;MAPT;MAG;MAP2;MAP3K13;OLFM1;PTPRS;CTTN;RTN4;RUFY3
prerank,KEGG_2021_Human__Tryptophan metabolism,0.6643328011357332,1.2838927507392621,0.13580246913580246,0.6780644363315288,1.0,4/22,7.92%,AANAT;KMO;AFMID;ACAT1
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.6665793518186504,1.2837355752183763,0.08235294117647059,0.6781256974668626,1.0,9/32,4.92%,NLRP12;CD163;CREB5;SLC2A3;VCAN;NR4A2;ANXA1;ADAM15;F13A1
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.6742217199410078,-1.2836096961666157,0.21875,0.7518079247788582,1.0,4/7,28.13%,TREM2;PLCG2;CDH13;P2RX4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.7838962026616684,1.2833796156049,0.10144927536231885,0.6790690733731053,1.0,1/8,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6961874434015892,1.2831071710392108,0.0821917808219178,0.6798786796345277,1.0,4/18,11.27%,SHANK3;RELN;NLGN1;CAMK2B
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,0.7619613346620351,1.2830170511059102,0.08860759493670886,0.6796443011983754,1.0,5/11,18.81%,BRIP1;RPS27A;RBX1;UBA52;UBB
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.8287740628166159,1.2828041368837277,0.16393442622950818,0.6803302008152787,1.0,5/5,17.16%,LRP2;NLGN1;PTN;PHACTR1;ROCK1
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,-0.6084867967660681,-1.282297517449514,0.14814814814814814,0.7544220162061845,1.0,4/16,12.40%,ITGAM;ITGAX;TLR7;CD83
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8041054137185304,1.2822961406321514,0.11764705882352941,0.6822564142368415,1.0,2/9,5.04%,ACVR1B;VEGFA
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,-0.712451818508258,-1.2820613965892715,0.21875,0.7537418439102688,1.0,2/6,7.62%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7325847032159827,1.2819468855529503,0.11764705882352941,0.683401842403373,1.0,2/18,2.53%,THBS1;PRKCE
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.6432476919145644,1.2818557886481794,0.14444444444444443,0.6832754359965472,1.0,2/33,3.19%,THBS1;COL4A5
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),0.8411685884016528,1.2816058547091502,0.09230769230769231,0.6837832690140075,1.0,1/5,2.02%,EGR1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.689609622113587,1.2814133720091758,0.12345679012345678,0.6842799365089305,1.0,6/30,7.22%,ACVR1B;RAB7B;HMGB2;FAXDC2;ACVR2A;HIF1A
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.7401323397959845,1.281263104617324,0.08,0.6843035963484391,1.0,3/16,12.87%,BRIP1;DNA2;BRCA1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.8302845199669656,1.2811809560206728,0.08823529411764706,0.6840764579574666,1.0,2/6,6.59%,RAB7B;RAB20
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.6531151675978157,1.2811363832630787,0.12941176470588237,0.6836193814187781,1.0,5/38,3.09%,TOP2A;CENPF;KNSTRN;APOLD1;ANLN
prerank,Reactome_2022__Regulation Of HMOX1 Expression And Activity R-HSA-9707587,0.9068625829941988,1.2809878933026912,0.034482758620689655,0.683773788367808,1.0,1/5,0.26%,BRIP1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.6601221185590803,1.2809445967804736,0.14457831325301204,0.6832980446989434,1.0,7/25,8.95%,FBN2;TGFB2;ZBTB16;GPM6B;ACVR2A;BMPR1B;PTN
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.596861082169457,1.280713909509729,0.06315789473684211,0.6839817315176253,1.0,37/99,26.86%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;UPF3A;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7815412371004589,1.280135037932441,0.1527777777777778,0.6867587411169379,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7331331891293307,1.2797870047031419,0.1375,0.68820444239206,1.0,3/12,9.61%,HS3ST5;TRIM5;TRIM25
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.5898344669202968,1.2796894869413855,0.061224489795918366,0.6880942384298865,1.0,29/135,10.41%,THBS1;ASPN;P4HA3;SPARC;FBN2;LRP4;ADAMTS2;TGFB2;COL11A1;NTN4;NCAN;ITGA2;COL4A5;VCAN;NRXN1;COL26A1;ADAM15;DMD;COL23A1;LAMA2;COLGALT2;LAMB1;COL24A1;ERC2;FN1;ITGAE;ITGB8;P4HA1;LTBP1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.7204334593782432,1.2796638753245633,0.13580246913580246,0.6874771891222076,1.0,4/16,18.25%,FGF1;ABCA2;ERLIN1;SOD1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.7715120416370433,1.2796523239653335,0.15853658536585366,0.6868217486298466,1.0,2/10,2.27%,ENPP2;GLA
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.6894654942386246,1.2790622552890534,0.11842105263157894,0.6895409722690016,1.0,7/25,13.75%,SLC51A;SLC16A4;SLCO1A2;ATP8B1;SLCO3A1;SLC10A1;STARD5
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.8254025772205322,1.2787624485260318,0.07936507936507936,0.690529874829645,1.0,1/6,3.16%,PIGU
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,-0.7017009957405327,-1.278457241179099,0.18181818181818182,0.7649756448649536,1.0,2/7,7.36%,ALDH9A1;ALDH7A1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.71164576126193,1.2784271758910914,0.11392405063291139,0.6918037381029624,1.0,8/19,20.77%,ACSL1;MID1IP1;MFSD2A;CPT1A;PRKAG2;PRKAA2;ACSL3;ACACB
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.7053620282741883,-1.2784058997719245,0.16666666666666666,0.7635280095161914,1.0,5/7,15.15%,FSCN1;LCP1;HCK;GSN;CAPG
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.7659277972998184,-1.278328014843462,0.22580645161290322,0.7621141173652314,1.0,3/6,12.78%,GTF2H2;GRK2;ARRB2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.7415386019563966,1.2781361872036794,0.11538461538461539,0.6928177337602642,1.0,6/12,22.29%,SVIL;SGCZ;IGSF8;ZBTB18;SGCD;MYL6
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6196509870146328,1.2780163966105742,0.11235955056179775,0.6927330254962856,1.0,13/54,13.23%,THBS1;RHOB;FGF1;CHI3L1;VEGFA;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,0.7731130487011189,1.2779586609221045,0.22535211267605634,0.6922833868419049,1.0,4/7,11.08%,MEIS2;ID2;THSD7A;LMO3
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.5975432278027173,1.2777295545812681,0.10416666666666667,0.6927908734108291,1.0,37/86,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;IMPACT;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;ATF3;RPL32;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6891429849010289,1.2775710714538733,0.18666666666666668,0.6930511019388098,1.0,6/19,9.36%,LRP2;TGFB2;NRG1;PKP2;RBPJ;RYR2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.6648588498557162,1.2775383335383843,0.14606741573033707,0.6925140439977849,1.0,5/29,10.87%,TGFB2;ROBO2;ROBO1;RBPJ;NOD2
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.8106928253912331,-1.2775106980018691,0.16666666666666666,0.7631340689770011,1.0,2/5,12.50%,PLEKHJ1;SORL1
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),-0.7992202885315709,-1.277324571594442,0.19444444444444445,0.7621949744051553,1.0,4/5,12.54%,ITGAM;CX3CR1;TREM2;TYROBP
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.706413045614923,1.2772848121519476,0.1095890410958904,0.6931179076174374,1.0,1/22,0.15%,FA2H
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.7106902802472742,1.277261043623064,0.15584415584415584,0.6925230376497403,1.0,5/16,8.63%,LAMA2;LAMB1;ADGRG6;MAG;SCD5
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,0.5919212878755025,1.2770375680996005,0.0,0.692968726542977,1.0,75/213,20.74%,TNC;SCRG1;SPON1;RAP1GAP;LRP4;VIM;CBR1;TM7SF2;GFAP;RGS20;IDI1;NCAN;GULP1;GPM6B;AGT;SLC1A2;RTN1;PHYHIPL;LIFR;BMPR1B;SOX4;GRM3;PTPRZ1;LUZP2;RBFOX2;SEMA6A;MYO10;NLGN3;TTYH1;ALCAM;SPRY1;NDRG2;ID2;PTN;TAGLN3;CSPG5;IFITM3;GLUL;P4HA1;GPRC5B;DARS1;PRR5;CRYL1;ALDH6A1;NTRK2;SASH1;PMP22;PLTP;SYT1;TMEM132B;SCD;SERPINE2;HSD17B12;MAGT1;TIMP3;HMGCS1;ITGAV;SLC39A12;LITAF;HSPB1;APBB2;RGCC;ATP1B2;PLEC;TMSB10;MSMO1;SPATA6;TECPR2;BEX1;SLC3A2;NOTCH2;ATP13A4;UCHL1;ATP1A2;BCL11A
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7458797327335116,1.2765181207435656,0.12857142857142856,0.6954800211218651,1.0,7/14,24.36%,CGNL1;BSN;NLGN1;KIF3A;DLG4;TJP1;JAM3
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.7420285094201583,1.2763260372965541,0.13114754098360656,0.6958824682612752,1.0,4/11,10.95%,TOP2A;FANCM;EME2;SHOC1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6536261493779437,1.2759327199164776,0.1411764705882353,0.6974568450041267,1.0,10/31,25.32%,SOX4;HIF1A;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;NR1D1;KCNB1;PPARGC1A
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.63020907153493,1.2758253769913765,0.11956521739130435,0.6975146309227339,1.0,14/47,20.52%,THBS1;TNS1;OSMR;SYNC;PAPSS2;RARRES1;FN1;ABLIM3;TGFBI;EPAS1;IGFBP7;CD151;SAMD4A;NPAS2
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.7881479398818743,1.2756814422226874,0.16666666666666666,0.6975137792722428,1.0,2/8,8.98%,NDUFA2;GSDMD
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7548341038125971,1.2756812986813364,0.14084507042253522,0.6967725318978832,1.0,6/12,19.70%,SYNE3;DYNC1H1;CLMN;HOOK3;DCTN1;SUN2
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6361800755550373,-1.2755200071589883,0.23076923076923078,0.7661777211040924,1.0,3/10,10.89%,ZDHHC21;ETS1;ITGB2
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,-0.755604868064118,-1.2754702967567864,0.3448275862068966,0.7647152702067833,1.0,4/7,15.58%,CHUK;IKBKB;NFKBIA;NFKB2
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.6295623097660973,1.2752125772033205,0.12631578947368421,0.6987772064143623,1.0,22/61,25.44%,SKIC2;TUBA4A;TUBB4A;GNA11;VBP1;TUBA1A;TUBB6;PDCL;RGS11;TUBB2A;PFDN4;TCP1;TUBA1C;GNAQ;FBXL5;GNB5;TUBA1B;KIFC3;CCT8;USP11;GNA15;CCT6B
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.7914318367075337,1.2750379752823273,0.15492957746478872,0.6989597253888181,1.0,1/9,3.86%,ARF6
prerank,KEGG_2021_Human__Amphetamine addiction,0.6210771915093397,1.2748992065689644,0.14772727272727273,0.6991030132191788,1.0,15/40,25.14%,GRIA4;CREB5;GRIN3A;GRIN2A;GRIA2;CALM3;CAMK2B;GRIA3;GRIN2B;GRIA1;FOS;PRKCB;JUN;PRKACB;CACNA1C
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.700659078465988,-1.2748580978012103,0.21621621621621623,0.7650373058482327,1.0,3/8,14.75%,SH2B3;NCKAP1L;MED1
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.6127999586632895,1.2747392106685533,0.12903225806451613,0.6992945019775135,1.0,15/62,15.76%,CENPF;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;SEH1L
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.8326512601022659,1.2745328490740808,0.16923076923076924,0.6996503257900872,1.0,1/6,8.25%,XPO1
prerank,KEGG_2021_Human__Dopaminergic synapse,0.6046047714250594,1.2742305887591185,0.08695652173913043,0.7006152601148953,1.0,28/90,19.53%,GRIA4;PPP2R3B;CREB5;PPP2R5B;GNAO1;PPP2R5A;GRIN2A;GRIA2;CALM3;SCN1A;CACNA1B;CAMK2B;PPP2R2B;GRIA3;GNAI1;CALY;GNAL;GRIN2B;MAPK10;KIF5A;CACNA1A;KCNJ6;PLCB1;GRIA1;PPP2R3A;KCNJ3;GNAQ;FOS
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.7463812042758312,1.2742103510231735,0.13333333333333333,0.6999825859963263,1.0,3/18,3.84%,HS3ST5;HS3ST2;GPC5
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.776267110204069,1.2739265761151741,0.11392405063291139,0.7008775169886893,1.0,2/12,7.91%,KLF4;PCBP4
prerank,KEGG_2021_Human__Selenocompound metabolism,0.7421372517487371,1.273720290943091,0.19718309859154928,0.7016258172233965,1.0,2/11,5.87%,SEPSECS;PAPSS2
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.7771608700356482,1.2735211891346958,0.13114754098360656,0.7021893907279935,1.0,1/9,1.35%,NDUFA2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6252681368625228,1.2734904747273765,0.17857142857142858,0.7016058689397366,1.0,9/48,11.25%,NTN4;RELN;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.6395103911863971,-1.2733519501241675,0.18518518518518517,0.7687435758197948,1.0,3/9,10.89%,ETS1;ALOX5;ITGB2
prerank,KEGG_2021_Human__Circadian entrainment,0.6038220083923289,1.2732150390050112,0.13541666666666666,0.7023702880919499,1.0,23/64,19.53%,GRIA4;ADCY3;GNAO1;GRIN2A;ADCY10;GRIA2;CALM3;RYR2;PER1;ADCY8;CAMK2B;GRIA3;RYR3;GNAI1;GUCY1B1;GRIN2B;KCNJ6;PLCB1;GRIA1;KCNJ3;GNAQ;GUCY1A2;FOS
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.7027530060765255,-1.273177161338817,0.19047619047619047,0.7676935994491565,1.0,5/8,15.53%,CX3CR1;CD274;SIRPA;MAPKAPK2;ZFP36
prerank,KEGG_2021_Human__Cocaine addiction,0.6780750556886959,1.2731325175605597,0.125,0.7022394380024521,1.0,11/23,23.72%,CREB5;GRIN3A;GRM3;GRIN2A;GRIA2;GNAI1;GRIN2B;CDK5R1;DLG4;JUN;PRKACB
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.8113321482313101,1.2730685691162642,0.1527777777777778,0.7018112849748214,1.0,3/7,15.68%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8043033965087211,1.2729149512898816,0.18333333333333332,0.7019114345461578,1.0,1/6,9.54%,GHR
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.85862915304521,1.2726039083862228,0.14285714285714285,0.7028160272778622,1.0,4/5,13.99%,SHANK3;FRMPD4;CAMK2B;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.839315742581942,1.2725844854683026,0.125,0.7021685216279616,1.0,1/6,3.87%,ANXA1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.6654274391474924,-1.2721950765656895,0.27586206896551724,0.769856385495199,1.0,4/11,15.04%,SH2B3;RIPOR2;CXCL12;LRCH1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.7260727618657781,-1.2721720846840847,0.24242424242424243,0.7683471744606547,1.0,1/8,5.38%,KRI1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7164869041777123,1.2721653415178547,0.14666666666666667,0.7039312894109536,1.0,4/23,7.22%,KLF4;TGFB2;EGR1;HIF1A
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7553026037334725,1.2720892859201982,0.17333333333333334,0.7035990966113665,1.0,4/13,15.15%,DDIT4;NTRK2;MAGI2;CASP3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.619143680554098,1.2720598683972035,0.07777777777777778,0.703000494083435,1.0,7/52,10.66%,DEPP1;DAPK2;MAPT;FBXL2;DAPK1;BOK;TYSND1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.7395895818691502,1.27193435250097,0.1518987341772152,0.7030797240211175,1.0,2/13,5.16%,TGFB2;SOX4
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.4992240264786494,-1.2717690243345494,0.08333333333333333,0.7681168450554378,1.0,10/33,12.03%,ITGAM;PTAFR;SELPLG;KRT10;C3;ICAM1;HLA-DPA1;FCGR1A;ITGB2;CFD
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),-0.7991243804324133,-1.2714549769419106,0.2702702702702703,0.7678063971605797,1.0,1/5,11.62%,NAA20
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5593141328095633,-1.2713699475155156,0.058823529411764705,0.7664185590510308,1.0,7/21,16.04%,NEDD4;CLTA;SNX25;TGFB1;SMURF1;ZNRF3;BECN1
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,-0.7125446336048142,-1.2712587816864611,0.24242424242424243,0.7652516997576456,1.0,3/6,14.21%,MAP4K2;PDHX;AKT1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.6220425478453083,1.2711593041306524,0.06741573033707865,0.7062807747538741,1.0,23/60,17.53%,LRP4;SH3PXD2B;ENAH;DOCK1;FBXL7;PTPRG;LIFR;LAMB1;ANK2;RBFOX2;RND3;AKAP12;MAP1B;CRMP1;GPRC5B;FIGN;NR2F1;ADGRL2;ITSN1;CPE;HSPA12A;MPDZ;APBB2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.6220425478453083,1.2711593041306524,0.06741573033707865,0.7062807747538741,1.0,23/60,17.53%,LRP4;SH3PXD2B;ENAH;DOCK1;FBXL7;PTPRG;LIFR;LAMB1;ANK2;RBFOX2;RND3;AKAP12;MAP1B;CRMP1;GPRC5B;FIGN;NR2F1;ADGRL2;ITSN1;CPE;HSPA12A;MPDZ;APBB2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.7500274276121317,1.2710901614944374,0.16176470588235295,0.7060143669411155,1.0,3/11,8.20%,SYT4;NLGN1;RAB15
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.6339794134613461,1.2709910450582433,0.13793103448275862,0.7058244302875489,1.0,9/43,11.93%,HTR2B;FGF1;DIRAS2;VEGFA;TRAF2;ROBO1;NOD2;FLT1;SASH1
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,0.862711856506988,1.2707502695320054,0.0821917808219178,0.7065828999682424,1.0,3/6,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.7688578504254318,-1.2706110303556897,0.3125,0.7658084183929672,1.0,1/6,0.57%,TGFBR3
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.637701441405813,1.2704838745304345,0.12048192771084337,0.7073871542700461,1.0,18/37,21.00%,SCN3B;SLC6A15;SLC5A9;SLC24A2;SLC9B2;SCN3A;SCN1A;SLC24A1;NALCN;HCN1;SCN8A;SCN2A;ASIC2;SLC24A3;ATP1B3;ATP1A2;SLC24A4;SLC5A6
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.7469099567171864,1.2704147237785255,0.16666666666666666,0.7070923227010205,1.0,5/10,19.68%,SLC2A3;POU5F1;IFITM3;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.8199867343160832,1.270365168660397,0.109375,0.7067413941423276,1.0,2/8,6.59%,RAB7B;RAB20
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.658103284792636,1.2703499520081691,0.05813953488372093,0.7061457202732513,1.0,12/42,19.51%,TULP2;WDR5;CREB5;SMC1B;POU5F1;GGNBP1;BRCA1;MRPL14;OSBP2;AQP11;SPAG6;SORD
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,0.6119540175606096,1.2703044463972266,0.1368421052631579,0.7056455857590415,1.0,10/57,10.74%,TNC;PLPP3;SPARC;TNS1;DOCK1;GPNMB;RARRES1;ALCAM;SEMA5A;PDCD1LG2
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8001411221120096,1.2702177125143979,0.18181818181818182,0.7053725994889117,1.0,3/8,10.81%,ADCY3;ADCY10;ADCY8
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,-0.7040501699416583,-1.2699461492489894,0.17647058823529413,0.7666844830320289,1.0,2/5,9.02%,ITGAM;ENG
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.6677363815358953,1.26991824288648,0.16666666666666666,0.7065402101612679,1.0,7/27,12.63%,DDIT4;CHI3L1;CEMIP;CALM3;PRKAG2;RIPK2;PARD3
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7582455077986384,1.2698393835889812,0.15714285714285714,0.706191647505481,1.0,2/10,5.87%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.7651689166830045,1.2698330807791756,0.14666666666666667,0.7054868759209861,1.0,2/10,12.11%,XPO1;NMD3
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.6115693701878094,1.2697477800478807,0.0851063829787234,0.705346533174078,1.0,38/87,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;RPL32;SRP19;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,0.7237645063863977,1.2692796738316967,0.14666666666666667,0.707334263671912,1.0,4/12,9.84%,TULP2;TEX14;PP2D1;GP6
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8420804220731686,1.2692270784939381,0.0847457627118644,0.7062181275911252,1.0,2/7,7.99%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8420804220731686,1.2692270784939381,0.0847457627118644,0.7062181275911252,1.0,2/7,7.99%,SEMA3A;ALCAM
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6677336749024506,1.2691282075135937,0.13636363636363635,0.7060308874606508,1.0,8/26,11.60%,PRKCE;SCN3B;NETO1;DMD;ANK3;CAV3;FXYD7;FGF14
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.794217510499593,1.269083232033263,0.17142857142857143,0.7056573221467513,1.0,2/8,11.27%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6670495169087577,-1.2688858917659753,0.08823529411764706,0.7689210731943306,1.0,5/12,15.60%,PPP1R16B;INPP5K;SRC;SMG6;MTMR1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.5202362069422519,-1.2688292747233096,0.125,0.7677319215732454,1.0,11/36,15.78%,RALB;FSCN1;TAPT1;ARHGAP35;PIP4K2B;LCP1;CNOT6L;CAPG;MARK4;KCTD17;CROCC
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,0.6069308497726247,1.2685514699091591,0.07692307692307693,0.7059464521644284,1.0,22/65,24.36%,DTL;RACGAP1;TFRC;FIGNL1;PUS7;XPO1;WDHD1;ATAD2;FANCI;POLQ;NUDCD1;CENPI;KIF11;GTPBP4;HSPD1;ECT2;IPO7;NDC1;CSE1L;PSMD14;CCT8;MELK
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,0.6069308497726247,1.2685514699091591,0.07692307692307693,0.7059464521644284,1.0,22/65,24.36%,DTL;RACGAP1;TFRC;FIGNL1;PUS7;XPO1;WDHD1;ATAD2;FANCI;POLQ;NUDCD1;CENPI;KIF11;GTPBP4;HSPD1;ECT2;IPO7;NDC1;CSE1L;PSMD14;CCT8;MELK
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,0.6069308497726247,1.2685514699091591,0.07692307692307693,0.7059464521644284,1.0,22/65,24.36%,DTL;RACGAP1;TFRC;FIGNL1;PUS7;XPO1;WDHD1;ATAD2;FANCI;POLQ;NUDCD1;CENPI;KIF11;GTPBP4;HSPD1;ECT2;IPO7;NDC1;CSE1L;PSMD14;CCT8;MELK
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,0.6069308497726247,1.2685514699091591,0.07692307692307693,0.7059464521644284,1.0,22/65,24.36%,DTL;RACGAP1;TFRC;FIGNL1;PUS7;XPO1;WDHD1;ATAD2;FANCI;POLQ;NUDCD1;CENPI;KIF11;GTPBP4;HSPD1;ECT2;IPO7;NDC1;CSE1L;PSMD14;CCT8;MELK
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.6207041859366144,1.2685159095017553,0.11458333333333333,0.7055005605462857,1.0,22/64,25.44%,SKIC2;TUBA4A;TUBB4A;GNA11;VBP1;TUBA1A;TUBB6;PDCL;RGS11;TUBB2A;PFDN4;TCP1;TUBA1C;GNAQ;FBXL5;GNB5;TUBA1B;KIFC3;CCT8;USP11;GNA15;CCT6B
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6973238791314784,1.2683608574109309,0.1282051282051282,0.7056679613952532,1.0,4/18,9.23%,RORB;NOCT;RANBP3L;LIMD1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.7763004339874404,1.268295106929515,0.1643835616438356,0.7052695993287804,1.0,5/11,11.78%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.6333293146598343,1.2682064149752625,0.14444444444444443,0.7050294601541862,1.0,2/46,1.11%,SOCS3;PRLR
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.5864282982501687,-1.267769556814329,0.2916666666666667,0.7694245450336445,1.0,7/13,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,0.7322297728765215,1.2677628058116126,0.1891891891891892,0.7068896794318752,1.0,4/13,7.93%,LSR;OVOL2;BAIAP2L1;PPP1R13L
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6103719243558416,1.2677326129984652,0.07526881720430108,0.7063157073334443,1.0,18/71,14.46%,EEF1A2;CENPE;MAPT;RELN;SPDYA;INSR;EPHA3;IGF1R;NTRK3;ALK;EPHA7;TYRO3;PRKAG2;FLT1;NTRK2;EPHA4;EPHA6;EPHA5
prerank,CellMarker_Augmented_2021__B cell:Spleen,-0.3823780875347376,-1.2677309181683842,0.0,0.767920174490089,1.0,19/75,14.74%,NKG7;CD37;LY86;BIN2;SAMSN1;CEACAM21;RASAL3;MYO1F;NCKAP1L;WDFY4;PLEK;BTK;CYTH4;LCP2;PTPN7;CD53;SNX20;PIK3R5;IL12RB1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.8309129673896815,1.26733482736271,0.14516129032258066,0.7079862463532088,1.0,3/5,12.72%,PTPRZ1;PTN;TNFRSF1B
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.7285421655462014,1.267186111444974,0.09333333333333334,0.7082239170545437,1.0,10/18,25.44%,TUBA4A;TUBB4A;TUBA1A;TUBB6;TUBB2A;TCP1;TUBA1C;TUBA1B;CCT8;CCT6B
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.7183209051576216,1.2671001831541064,0.11392405063291139,0.7080188688751495,1.0,3/13,13.49%,PLPP3;ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.72212202276833,1.2669644060938172,0.07894736842105263,0.708274437786438,1.0,4/16,18.25%,SH3PXD2B;ALOX12;SOD2;SOD1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6740722513013637,-1.2669481177147814,0.16666666666666666,0.7689157778402629,1.0,1/10,4.46%,LILRB4
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.6947196488998124,1.266905674826638,0.11904761904761904,0.7079318271374736,1.0,3/23,5.53%,ANXA1;SOX4;TCF7
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6630339196873243,1.2668775371467,0.1724137931034483,0.7073694471987663,1.0,8/30,7.86%,COBL;LSR;TG;NRG1;ANXA1;ARID5B;ALOX15B;PAX8
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.4524768065537101,-1.2667777519630028,0.14285714285714285,0.7678421360878731,1.0,17/96,15.17%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;NFATC3;BTK;IKBKB;LCP2;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.6067164120382751,1.2667142763291874,0.08791208791208792,0.7075514869717052,1.0,6/72,6.73%,DIAPH3;RACGAP1;DOCK1;TFRC;VAPB;BAIAP2L1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7698495838695634,1.2667131314955198,0.1917808219178082,0.7068439354847336,1.0,1/6,1.43%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7830305361983575,1.2666957162964572,0.19444444444444445,0.706220220878528,1.0,4/8,12.37%,SHANK3;MAPT;ADCY8;GRID2
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.7605252031005841,1.2664398875731908,0.14705882352941177,0.7070432920320527,1.0,2/10,5.87%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.769064873635261,1.2663129130886919,0.15492957746478872,0.7071426721653126,1.0,3/9,4.14%,LRP2;TGFB2;KITLG
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,0.7245496959253045,1.2661770452797296,0.14634146341463414,0.7072692466325278,1.0,12/19,18.98%,SCN3B;ANK3;ANK2;SCN3A;SCN1A;SPTAN1;NFASC;SCN8A;SPTBN5;SCN2A;SPTBN1;SPTBN4
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.7606759174587641,1.2661746183455262,0.12857142857142856,0.7065654961383661,1.0,4/8,18.84%,NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.8081493566910298,1.2660781539911532,0.1388888888888889,0.7064190142551993,1.0,1/7,1.25%,NEK11
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.6370154180995155,1.266054560626025,0.0989010989010989,0.7058904735457753,1.0,20/52,24.41%,CENPF;SUV39H2;WDHD1;DNA2;PAICS;FANCI;KDM1A;POU5F1;GINS1;RFC4;KIF11;PFAS;ZGRF1;SMARCC1;KNTC1;HELLS;HNRNPU;ATAD5;MCM3;NASP
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.8371199307110977,1.2658237613205254,0.13636363636363635,0.7064088529664402,1.0,1/6,8.25%,XPO1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5991821149976484,1.265751291630436,0.11956521739130435,0.7061448500843354,1.0,38/84,26.86%,RPL23;RPL37A;SEC61B;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;SRP19;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,KEGG_2021_Human__Cushing syndrome,0.5943789741630399,1.2655792549526395,0.03125,0.706271660566677,1.0,15/82,15.06%,FZD6;WDR5;ADCY3;CREB5;AGT;NR4A1;GNA11;TCF7;TCF7L1;ADCY8;CAMK2B;NCEH1;GNAI1;APC2;WNT5A
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.6376399317431206,1.2654619088605144,0.09876543209876543,0.7062259367850919,1.0,2/30,2.71%,ECM2;SPOCK1
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.5852376322763617,1.2654371221285523,0.10638297872340426,0.7056730224684145,1.0,25/63,15.99%,LRRC4C;PREX2;GPM6B;GALNT8;NRXN1;RAB3C;KCNH8;SYT4;CNR1;TCEAL2;CDH20;CHL1;CELF2;CADPS;KHDRBS2;PDE4B;PPP2R2B;PLP1;TMEM132D;STMN2;CTNNA2;CNKSR2;ST8SIA3;PHACTR1;LDB2
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,0.7984746668280296,1.26538913879811,0.16,0.7052297955306749,1.0,4/9,15.17%,HTR7;CHRM5;CHRM3;HTR1F
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,-0.44722536612870956,-1.2652379994132357,0.05263157894736842,0.7625609908332338,1.0,20/42,20.46%,NKG7;CD37;LY86;BIN2;CEACAM21;HCST;RASAL3;PRF1;CD53;SNX20;GPSM3;CD247;PSTPIP1;IL16;ITGAL;TLR10;ARHGAP30;NCF1;GPR174;TBC1D10C
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.8363666924545635,1.265168566354275,0.140625,0.705827125657616,1.0,2/5,9.03%,SRGN;ABCA1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.7640000590112952,1.2648563981852272,0.19444444444444445,0.7067032649922834,1.0,2/8,10.25%,CHST7;OGA
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.7277143146113672,1.264199155084245,0.2328767123287671,0.7098243876543299,1.0,6/15,14.68%,GRIN2A;CAMK2B;PPM1E;LRRC7;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7354637504960666,-1.2641643401249174,0.17142857142857143,0.7646959586216696,1.0,3/7,8.55%,PDE12;TICAM1;TLR3
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.84264399764216,1.2641192082960278,0.11594202898550725,0.709505018740026,1.0,1/7,2.08%,ENPP2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.7564534806574941,-1.264058709648596,0.3055555555555556,0.7635457853880039,1.0,4/5,24.37%,ARHGAP12;LRP6;PHACTR4;NOTCH1
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.6623767057303352,1.2640455301586093,0.17045454545454544,0.7091592616786407,1.0,5/39,9.93%,DIAPH3;RACGAP1;VAPB;AKAP12;LMNB1
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.660003605845219,1.2639211535475696,0.13157894736842105,0.7091110631072034,1.0,8/28,16.59%,PLPP3;SVEP1;LAMA2;GPNMB;FN1;PMP22;TIMP3;EPAS1
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.6036228464560732,1.2637487460960217,0.06382978723404255,0.7093685353934098,1.0,24/60,25.54%,PRKCE;ADCY3;CREB5;NR4A2;AGT;NR4A1;GNA11;CALM3;PDE2A;ADCY8;LIPE;CAMK2B;ATP1B3;PRKD3;PLCB1;ATP1B2;GNAQ;ATP1A2;PRKCB;PRKACB;ATP2B2;CACNA1C;ATP2B4;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6503521539506844,1.2637316573303372,0.13095238095238096,0.708736608359366,1.0,4/29,3.59%,THBS1;CBR1;MAPT;AGT
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5823456538137267,1.263446761278019,0.01,0.7097025693551555,1.0,77/254,18.00%,SCRG1;ACVR1B;IL1RAPL2;MOBP;SHANK3;MAL;GPM6A;ZBTB16;SPOCK1;NCAN;RELN;GPM6B;VCAN;NRG1;NRXN1;CDH2;DPYSL5;NRXN2;VEGFA;ROBO2;MOG;SH3GL3;SHANK2;PTPRZ1;MARCKSL1;RBFOX2;SEMA6A;ADGRG6;GRIK1;STMN3;NLGN3;ARNT2;PAX8;NLGN1;ROBO1;FN1;SCD5;ADGRB2;PTN;TAGLN3;ADAM23;DNM3;CSPG5;CRMP1;RAPGEFL1;SEMA5A;BTBD2;CHRM3;TYRO3;KALRN;SOX6;PMP22;IGSF8;SH3GL2;PRPS1;NFASC;LY6H;UGT8;APC2;PKD1;GLRB;EIF2B2;LSAMP;DPF3;SCN8A;SCN2A;ASIC2;NINJ2;NR2C2;LDB2;NRGN;APLP1;NEURL1;GMFB;GSTP1;ERCC6;DCTN1
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.6177507368763103,1.263276869996598,0.15476190476190477,0.7100124754830127,1.0,14/45,24.78%,BRIP1;SCO2;BLVRB;TXNIP;COX7C;CYCS;SMARCD3;TBL1XR1;SCO1;PPARA;COX4I1;COX6C;COX6B1;COX20
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5926404624304429,1.2632034493847093,0.12631578947368421,0.7097130109394219,1.0,5/48,8.46%,THBS1;WDR5;ZBTB16;MEIS2;MAFB
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.6684302658869195,1.2630472843379785,0.1839080459770115,0.7098523719222006,1.0,5/20,6.04%,TGFB2;SH3PXD2B;MEIS2;BMPR1B;SCO2
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.5776001581801482,1.2629838002781084,0.030612244897959183,0.7095089722714477,1.0,33/189,11.99%,TNC;THBS1;DDIT4;FGF1;PRLR;PPP2R3B;CREB5;PPP2R5B;ITGA2;RELN;COL4A5;OSMR;NR4A1;KITLG;MTCP1;VEGFA;LAMA2;PHLPP1;PPP2R5A;IL7;LAMB1;RPS6KB2;INSR;FN1;RPS6;IGF1R;MCL1;GHR;ITGB8;PPP2R2B;FLT1;NTRK2;MAGI2
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,0.7719917073398556,1.2626494704049103,0.17333333333333334,0.7107997507748519,1.0,4/8,15.39%,VIM;ALCAM;POU5F1;THY1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.6043428660184481,1.2625338662459267,0.05263157894736842,0.7109198127266754,1.0,44/80,19.66%,SULT4A1;GFAP;NCAN;KCTD16;GADD45B;BRINP1;MAPK4;PLPPR4;CADM2;UBE2QL1;PHYHIPL;GAD1;CTNND2;CA10;ANK2;SNAP25;PTPRT;GRIA2;FAIM2;MAP2;OLFM3;PPFIA2;CAMK2B;ZNF536;HS6ST3;VSTM2B;NTRK2;NKAIN2;GAD2;SH3GL2;PAK5;LY6H;STMN2;NDRG4;ST8SIA3;ASIC2;SYNPR;GABRG2;SPTBN4;PARM1;LRFN5;PTPN5;TMEM59L;SNAP91
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.8569379401965,1.2625095097431966,0.12307692307692308,0.7104160161165463,1.0,1/5,3.59%,AGT
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6522149863788269,1.2624547858068682,0.13953488372093023,0.7099933002907793,1.0,1/20,0.41%,HHIP
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.7444791472196981,1.262330972722244,0.19444444444444445,0.7101404700371579,1.0,7/12,18.81%,MAPT;SYBU;HIF1A;SPAST;NEFL;UXT;UBB
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5885276471188013,1.2618875540483578,0.030303030303030304,0.7121794406954568,1.0,24/139,6.19%,TNC;THBS1;P4HA3;SPARC;FBN2;ADAMTS2;TGFB2;ECM2;THSD4;COL11A1;SH3PXD2B;NCAN;ITGA2;MMP21;COL4A5;GPM6B;VCAN;COL26A1;ADAM15;COL23A1;LAMA2;COLGALT2;LAMB1;COL24A1
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8809327072525532,1.261789223238711,0.078125,0.7122620881634888,1.0,1/5,3.87%,ANXA1
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.6212375440663543,1.2616960688804788,0.10588235294117647,0.7121140636310992,1.0,11/38,19.69%,PPP2R5B;HSPA5;ARFGAP1;SERP1;DNAJB9;HYOU1;SYVN1;GFPT1;CXXC1;DCTN1;SRPRA
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.6333142513092627,1.2615257267557285,0.14444444444444443,0.7124446185548475,1.0,19/57,20.52%,TGFB2;PTPRZ1;NSMF;MAG;FAIM2;RETREG1;EPHA7;TYRO3;NTRK2;CRLF1;GRID2;SOD2;PINK1;NRBP2;EGLN3;SOD1;CDK5R1;TNF;CPEB4
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.721740298631554,1.2612686713259773,0.2125,0.7132612158229105,1.0,3/12,5.64%,MANF;FCGR2B;EIF2AK3
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.6672046658069858,-1.2605936825089317,0.17142857142857143,0.7742871122509963,1.0,4/8,11.22%,CHUK;DAB2IP;TLR3;TLR7
prerank,KEGG_2021_Human__Insulin secretion,0.6187494861883654,1.2604398425646475,0.18085106382978725,0.7174266751085717,1.0,22/52,26.81%,ADCY3;CREB5;GNA11;SNAP25;RIMS2;RYR2;KCNMB1;ADCY8;CHRM3;CAMK2B;CCK;ATP1B3;KCNMA1;PLCB1;ATP1B2;GNAQ;ATP1A2;PRKCB;PRKACB;CACNA1C;ABCC8;ADCY1
prerank,KEGG_2021_Human__Melanogenesis,0.6154622543612248,1.2603969122038527,0.05434782608695652,0.7169474730829002,1.0,13/54,18.82%,FZD6;ADCY3;GNAO1;KITLG;TCF7;TCF7L1;CALM3;ADCY8;CAMK2B;GNAI1;WNT5A;PLCB1;GNAQ
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6590432692159247,1.260284271787135,0.1125,0.7169809382893423,1.0,12/29,19.66%,DNAJC6;NLGN3;FCHO2;NLGN1;DNM3;DNM1;SYT1;ITSN1;PICALM;AMPH;NLGN4X;SNAP91
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.7387240577577894,1.2602139823449752,0.1506849315068493,0.7166617510427251,1.0,2/11,3.98%,FAAH;FAH
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.6396022523507093,1.260177344676024,0.1728395061728395,0.7161582460954252,1.0,5/39,8.41%,NUDT12;NUDT16;RIDA;RNASEH2C;DNA2
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,0.8206483309962779,1.2597098720932487,0.1323529411764706,0.7180487047096643,1.0,1/6,3.57%,TFRC
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6424034674828957,1.2596441545880297,0.1111111111111111,0.7176590970135415,1.0,10/40,9.37%,TGFB2;CADM1;CDH8;CDH2;CADM2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7450822779110471,-1.2594018790288497,0.2926829268292683,0.7769043757798446,1.0,2/5,20.96%,TYMS;DCTD
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,0.6783880171000862,1.2592886819633,0.12643678160919541,0.7190176406859222,1.0,7/25,10.63%,FZD6;ITGA2;TFRC;OSMR;ADGRG6;ERRFI1;SH3D19
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.7776096451761815,-1.2591915452006643,0.2727272727272727,0.7762798517902214,1.0,1/6,0.45%,CCL5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6650569258864529,1.2585696292983453,0.13580246913580246,0.7224351280756932,1.0,3/27,3.24%,SLC38A4;SLC16A10;SLC6A15
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6187484166957717,-1.258482153468274,0.1891891891891892,0.7774380560477948,1.0,3/8,9.11%,ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7894154058541912,-1.2584673823176842,0.2222222222222222,0.7759136677026031,1.0,2/6,16.68%,TREM2;PRKCA
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7025042562439502,1.258405977886221,0.16666666666666666,0.7226033492447259,1.0,10/25,15.33%,SHANK3;ZDHHC15;IL1RAPL1;FCGR2B;SRCIN1;SIPA1L1;PPFIA2;EPHA4;WNT5A;CFL1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.8149795472817809,1.257874770812399,0.21739130434782608,0.7250127260303615,1.0,2/5,13.26%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.7152142449029327,-1.257609921566239,0.1891891891891892,0.7760376925080783,1.0,3/6,22.94%,AKAP8L;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.7152142449029327,-1.257609921566239,0.1891891891891892,0.7760376925080783,1.0,3/6,22.94%,AKAP8L;NSUN2;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.6261632198020854,-1.257551831504858,0.13636363636363635,0.7747297476612182,1.0,5/14,4.42%,FGL1;SAMSN1;BANK1;DUSP3;IL4I1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6080571427260913,1.257464432147362,0.043478260869565216,0.726507773648468,1.0,36/81,20.68%,LRRC4C;GRM8;RELN;CDH2;BEGAIN;DGKI;GRIK2;GRM3;IQSEC2;GRIK1;NLGN3;UNC13A;NLGN1;PXK;RIMS2;CACNA1B;NRG3;TMEM108;GRID2;SYT1;DLGAP1;RIMS3;CPLX1;MCTP1;CACNA1A;DLGAP2;APP;GRM7;GRIK4;DLG4;MAPK8IP2;NLGN4X;TNF;CLSTN2;ATP1A2;LRRK2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.6659598824683921,1.2572318422029245,0.18072289156626506,0.7272309321713143,1.0,5/18,13.75%,SLC51A;SLCO1A2;ATP8B1;SLC10A1;STARD5
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.795579864870631,1.257200406264715,0.11428571428571428,0.7266780233295392,1.0,3/6,19.88%,ITGA2;TBX19;KDM6B
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.4997298818678466,-1.2569978086743574,0.06666666666666667,0.775470899604985,1.0,4/32,9.60%,CCND1;CSF1R;TP53;AGO1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.6735689741157117,1.2564703982257033,0.14606741573033707,0.7300861570314474,1.0,1/34,0.30%,KLF4
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.7236718909644685,-1.2563900282805047,0.21875,0.7761326718426094,1.0,2/5,20.26%,EDA;LRP6
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.8251264332290607,1.2562393464787782,0.19047619047619047,0.730646997029296,1.0,3/5,15.66%,SEMA3A;PTN;PHACTR1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6209134923548565,1.2562057267753084,0.10989010989010989,0.7301707722106363,1.0,10/64,12.75%,CENPF;TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A;KCNH5;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7010577606739676,1.2561218530489802,0.14473684210526316,0.730008565331568,1.0,6/20,12.37%,PTPRD;IL1RAPL1;NRXN1;NLGN3;NLGN1;GRID2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6120647624937758,1.2559913087495933,0.12941176470588237,0.7301073472006844,1.0,4/52,6.35%,ACVR1B;GALNTL6;CIT;GALNT13
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.6488969128605312,1.2556279875691263,0.14457831325301204,0.7313431721515053,1.0,6/32,9.49%,GALNTL6;GALNT8;MFNG;COLGALT2;GALNT13;GALNT18
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.39736100712929395,-1.2555841929885367,0.0,0.7773263513844111,1.0,22/75,13.92%,NKG7;GRAP2;BIN2;CD2;SAMSN1;MPEG1;CD96;RASAL3;AOAH;MYO1F;LCP1;NCKAP1L;PLEK;ITGB2;CYTH4;LCP2;PTPN7;TYROBP;PRF1;CD53;SNX20;GIMAP7
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.618716314209632,1.255574077571181,0.14606741573033707,0.7310588954081298,1.0,15/56,16.42%,SHANK3;CLIP3;TUBB4A;VBP1;TTBK2;HDGFL3;KANK1;CAV3;MAP2;MID1IP1;CLASP2;STMN2;APC2;PFDN4;EML2
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.6418701970707096,1.2553291536367002,0.12048192771084337,0.7317716006715571,1.0,8/43,10.81%,LRP2;TSHR;TG;ADCY3;CREB5;HSPA5;PAX8;ADCY8
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.7861179644225615,1.2552350933061516,0.20833333333333334,0.7317558094154927,1.0,3/8,18.00%,NRXN1;AGTPBP1;DCTN1
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.8108046649318077,1.2546849886345084,0.21739130434782608,0.7340664641331862,1.0,4/7,15.99%,OR3A2;ADCY8;GNAL;LDB2
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.8208078141754972,1.2545570437864784,0.11290322580645161,0.7340053385382477,1.0,4/7,14.68%,VIM;GFAP;PKP2;NEFL
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.7823535130822318,1.254552214814133,0.16455696202531644,0.7333487131366834,1.0,3/11,10.84%,FAAH;ABHD12B;LIPE
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.41237664463839724,-1.2544160918008873,0.1111111111111111,0.7798109067523353,1.0,23/72,15.39%,INPP5K;GIMAP8;TSC22D4;LRP10;SELPLG;UBA7;NLRP1;ARAP1;STIM1;RNPEPL1;PPM1M;AKNA;RASAL3;HLA-E;TECPR1;GIMAP4;GIMAP7;ITM2B;SPOCK2;TBC1D17;ZNF862;BTN3A1;ITPKB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.8136950388241657,1.2542162110311854,0.16666666666666666,0.7346078466683934,1.0,3/5,13.15%,CR1;CD55;SUSD4
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,0.8248261435917992,1.2542098826229342,0.14864864864864866,0.7339346575089667,1.0,1/6,6.69%,OVOL2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,0.7885589880131519,1.2541624633024884,0.1625,0.7334693193831365,1.0,6/7,18.03%,LAMA2;OVOL2;ADCY8;TRHDE;CLMN;PCED1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.707343492591076,1.253921735446816,0.16455696202531644,0.7339852212155081,1.0,6/18,15.68%,ANK2;PKP2;CAV3;RYR2;PDE4B;ATP2A2
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.6760831173622425,1.2536827397802188,0.1686746987951807,0.7345345226340205,1.0,6/24,15.56%,SPARC;GFAP;NRG1;NRG3;NRG4;ESR1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.674477215534587,1.25348714562844,0.1566265060240964,0.7348682052643142,1.0,8/24,14.52%,HTR2B;SLC24A2;GRIN2A;RYR2;SLC24A1;IBTK;RYR3;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.6301942024745728,1.253451460886928,0.18292682926829268,0.7343780083294945,1.0,6/41,10.26%,HTR2B;HMGB2;NR4A1;VEGFA;HIF1A;SEMA5A
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.7763473374287202,1.2532905525195344,0.11864406779661017,0.734616970355426,1.0,1/7,1.28%,TGFB2
prerank,KEGG_2021_Human__Ether lipid metabolism,0.669920110030507,1.2531943413000397,0.13580246913580246,0.7344959845514235,1.0,3/26,2.08%,GDPD1;PLPP3;ENPP2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.7621021284738249,1.252715434282544,0.17647058823529413,0.7365387734423572,1.0,2/8,5.56%,APOLD1;ALOX15B
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.7642010515087049,1.252608858491797,0.1728395061728395,0.7365016581637166,1.0,4/10,9.58%,NCAN;VCAN;GPC5;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.586105729450067,1.2525946422649235,0.1276595744680851,0.7359354015613938,1.0,22/72,21.14%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;INSR;GRB10;KDM3A;IGF1R;KDM1A;DYNC1H1;FASN;SCD;PEMT;IL18;EPAS1;ESRRG;KDM6B;TNF;ACACB;LEPR;MFN2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7429283356602563,1.2525274789971295,0.09333333333333334,0.735702779232052,1.0,4/15,15.66%,HS3ST5;HS6ST3;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5774859854568474,-1.2524813285220708,0.2857142857142857,0.7847704432372625,1.0,7/15,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7229820959677279,1.252412357941947,0.16666666666666666,0.7357261828880589,1.0,2/13,7.02%,GRAMD1C;ABCA2
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.6894110796084656,1.2520328750518952,0.1411764705882353,0.7372901926505353,1.0,12/24,23.73%,FANCB;FANCM;FANCI;RPS27A;EME2;FAN1;FANCL;FANCA;UBA52;UBB;RPA3;SLX4
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),0.8233946971648032,1.251785451968713,0.14705882352941177,0.7379328708772035,1.0,2/5,9.68%,HMGB2;NEIL1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6822119745328725,1.251757593399973,0.19736842105263158,0.7374188884300369,1.0,5/17,8.95%,RACGAP1;TDG;ALOX15B;INSR;PTN
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5973099588763358,1.2516333057185431,0.06593406593406594,0.7373132929364047,1.0,40/95,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;SRPRA;RPS3A;RPL35;RPL4;RPL32;SRP19;SPCS3;RPL24;RPL27A;RPL3;RPS16;RPL30;MAN1A1;RPL21;RPL7;RPL12;SRP54;RPL10A;RPS12
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.7985603954385836,1.2514530192306723,0.16923076923076924,0.7378184801517191,1.0,4/7,15.06%,SHANK3;NLGN1;GRID2;WNT5A
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7972203612624169,1.2512196722786393,0.21739130434782608,0.7384498216954603,1.0,3/7,16.64%,PFKM;FBP1;GFPT1
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.8280224847141198,1.250760288607555,0.203125,0.7403073815607156,1.0,2/6,5.04%,NFIB;VEGFA
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6811247913767677,1.2506902376333797,0.2222222222222222,0.7399880883049645,1.0,6/21,13.71%,MAPT;STMN3;MAP2;MAP1B;CLASP2;STMN2
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.8172033949198474,1.2506776235467967,0.16393442622950818,0.7394074610219469,1.0,1/5,1.06%,SLC16A10
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.6306415180769926,1.250636022284745,0.1566265060240964,0.7389882884115178,1.0,6/36,8.46%,TNC;SPARC;ADAMTS2;FBXL7;LAMA2;FN1
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,0.618661869960126,1.2504100959550952,0.15555555555555556,0.7396746847093123,1.0,14/47,16.57%,COBL;CLIP3;PPP2R3B;PDE1A;STXBP5L;ALOX15B;ARFGAP1;NKAIN2;SNX10;SSC4D;KLHL6;FGD6;LDB2;MTUS1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.8366703622609963,1.250143102385738,0.1111111111111111,0.7405199098005533,1.0,3/7,9.91%,RORB;VEGFA;MFSD2A
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6363201177203004,-1.2500785520217967,0.16666666666666666,0.7910519769952846,1.0,5/13,10.10%,CYP2S1;HPGDS;ACOX1;DAGLB;PTGS1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.6186587444602848,1.2500444099585397,0.10588235294117647,0.7405049383048857,1.0,20/58,18.26%,KLF4;CRISPLD2;NAMPT;ACSL1;TNS1;RNF144B;SIRPB2;FCHO2;FOSL2;MAFB;IFITM3;CD93;THBD;PPP1R3B;TGFBI;SLC31A2;CEBPD;BCL6;TNFRSF1A;IGFBP7
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5806537193458585,1.2499903507480377,0.05102040816326531,0.7401451695905974,1.0,46/128,21.81%,LRRC4C;SHANK3;SEMA3A;DCC;SPOCK1;ZDHHC15;RELN;IL1RAPL1;CDH2;CSMD3;ZNF804A;EPHA3;SRCIN1;SIPA1L1;KANK1;CHN1;PTK7;PAQR3;MAG;PTN;NTRK3;MFSD2A;CRMP1;PPFIA2;CAMK2B;NTRK2;MAGI2;EPHA4;LRRC7;STMN2;CTNNA2;WNT5A;NDRG4;CFL1;DENND5A;PTPN9;ATP1B2;FES;NTNG1;CDK5R1;FBXO7;PTPRS;LRRK2;CX3CL1;PAK3;RTN4RL1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7205522368721312,1.2499662151381654,0.17073170731707318,0.7395591888629355,1.0,3/14,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.7015137668077895,-1.2499610473434561,0.26666666666666666,0.7899853183253993,1.0,2/7,5.35%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.7723228994442293,1.2498779951900814,0.17391304347826086,0.7394611887319495,1.0,3/9,18.98%,NFIB;EPHA4;SPTBN4
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7398107359787414,1.2498243982935098,0.1044776119402985,0.739094975155078,1.0,4/16,8.14%,LRP2;TGFB2;ROBO2;ROBO1
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.6099739752484543,-1.2496451722396626,0.19230769230769232,0.7896537518183535,1.0,2/9,11.56%,MAP3K14;BIRC2
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,-0.6072892634744645,-1.2494732109515168,0.21875,0.7885687000340199,1.0,4/11,19.28%,SIRPA;SRC;TYROBP;PTPN6
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7733323138312931,1.2494722628025452,0.16666666666666666,0.7404975282388189,1.0,2/8,7.69%,SOCS3;PTPRT
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.645015005223514,1.249457181174283,0.12222222222222222,0.7398798784720569,1.0,10/45,14.45%,CLDN18;CADM1;CDH8;CDH2;CADM2;CDH9;CLDN20;CDH12;PARD3;CDH10
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.875348860751684,1.2492752404927157,0.15151515151515152,0.7403674455374767,1.0,1/5,2.08%,ENPP2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.7383763690837507,1.249246155009413,0.21739130434782608,0.7398262506448331,1.0,10/14,19.52%,NCAM2;NRXN1;NRXN2;NLGN3;NLGN1;NRXN3;ASTN2;NINJ2;CDK5R1;NLGN4X
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.7743152978638542,1.2490195063117677,0.19444444444444445,0.7396310127834712,1.0,4/6,18.88%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.7743152978638542,1.2490195063117677,0.19444444444444445,0.7396310127834712,1.0,4/6,18.88%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7703770787125337,1.2489841582744525,0.17391304347826086,0.7391753023659405,1.0,5/11,16.42%,CLIP3;TUBB4A;MAP2;STMN2;EML2
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,0.8159647047373348,1.248975793862089,0.09722222222222222,0.7385289141454062,1.0,3/7,12.37%,SLCO1A2;ABHD12B;GRID2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.8464615498247581,1.2489625882759179,0.171875,0.7379169741449426,1.0,2/5,9.54%,PRLR;GHR
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6272917937553502,1.2487500946678003,0.2222222222222222,0.7385029613564186,1.0,4/28,16.96%,FZD6;GNAO1;WNT5A;PLCB1
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.3897400965605095,-1.2486127086004015,0.0,0.7899486184847001,1.0,17/77,12.09%,ITK;IKZF3;NKG7;CD37;BIN2;CD2;SAMSN1;CEACAM21;CD96;RASAL3;AOAH;MYO1F;NCKAP1L;PLEK;CYTH4;LCP2;PTPN7
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.7739016872365143,1.2486093765012174,0.11475409836065574,0.7386727017378363,1.0,2/11,5.43%,PPP2R5B;PPP2R5A
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.64932304250923,-1.248280565836637,0.1875,0.7895939578003704,1.0,3/8,11.90%,FOLR2;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8377131229628991,1.248085524360512,0.23809523809523808,0.7408166282394462,1.0,1/5,6.84%,SPIRE2
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.7552592417433585,1.2480353581636476,0.2835820895522388,0.7403788954241648,1.0,2/5,7.29%,SHANK3;FRRS1L
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.5725222491519187,1.247945600508739,0.05154639175257732,0.7401489835019377,1.0,45/133,20.17%,RAP1GAP;SHANK3;SEMA3A;NTN4;DCC;RELN;ENAH;NFIB;NRXN1;DOK6;VEGFA;LAMA2;SEMA3B;ROBO2;SEMA6A;EPHA3;GRB10;PALLD;CHN1;ALCAM;NRXN3;ROBO1;IRS2;UNC5D;SEMA5A;SPTAN1;UNC5C;EPHA7;EPHA4;GAB1;EPHA6;PLXNB1;EPHA5;WNT5A;SPTBN5;DAB1;KIF5A;SPTBN1;KLF7;PLXNC1;RHOH;SPTBN4;CDK5R1;NCAM1;NOTCH2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7260550115046,1.2478200958638372,0.1875,0.7401676984203435,1.0,3/13,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5714191538444408,1.247716622000384,0.08247422680412371,0.7400623855771395,1.0,19/103,13.23%,THBS1;KLF4;RHOB;SPARC;FGF1;TGFB2;CHI3L1;VEGFA;GPNMB;SEMA6A;HIF1A;RAPGEF3;GLUL;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.7943006616097334,1.2475382301686833,0.171875,0.7402463211968721,1.0,5/7,15.01%,UNC13A;RIMS2;SYT1;UNC13C;RIMS3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),0.8184392689418423,1.2475310921273568,0.19117647058823528,0.7396212898119928,1.0,1/5,1.97%,RPL23
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5921029260122834,1.2473510617028176,0.11827956989247312,0.7399454387081212,1.0,14/74,15.02%,TSHR;PRKAR2B;ADCY3;NR4A2;NR4A1;INSR;RAB15;IRS2;ADCY8;SORBS1;NR4A3;PKM;INSIG1;CPEB2
prerank,KEGG_2021_Human__Breast cancer,0.5860553843856656,1.2473203064793101,0.12087912087912088,0.7394288760761697,1.0,13/76,15.56%,FGF1;ARAF;FZD6;GADD45B;TCF7;RPS6KB2;TCF7L1;SHC2;IGF1R;BRCA1;APC2;WNT5A;ESR1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7212290626754612,1.2470599593983853,0.18292682926829268,0.7400735532004789,1.0,3/15,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.8117271926958703,1.247011736257715,0.11764705882352941,0.7396729072304471,1.0,1/7,0.30%,KLF4
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.5949304906479106,1.246853904306728,0.15217391304347827,0.7398890606160443,1.0,13/55,10.22%,TUB;SPARC;VIM;CLIP3;TSHZ3;NRXN2;TUBA1A;COLGALT2;FHL1;STMN3;ADAM23;ELOVL4;CRMP1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.8253041017128616,1.246656696408713,0.11428571428571428,0.7389458780549124,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.8253041017128616,1.246656696408713,0.11428571428571428,0.7389458780549124,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.8253041017128616,1.246656696408713,0.11428571428571428,0.7389458780549124,1.0,1/5,3.94%,SLF1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8257651973974405,1.2466125072509313,0.16129032258064516,0.7385234722933075,1.0,1/6,2.49%,GRAMD1C
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,0.5983924970495759,1.2464541517774217,0.07368421052631578,0.7386415535841486,1.0,18/113,13.78%,KCNE1;ALDH3B1;VIM;PLAC8;AMZ2;PNMA1;IQCH;DALRD3;TUBA1A;RUVBL2;DYNC2LI1;CKB;DNAJB2;GALC;PRPS1;TPPP;NSMCE1;ANKRD37
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.56032557774488,-1.2463528127333354,0.13636363636363635,0.7955693821270807,1.0,2/14,0.82%,RALB;PDE12
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7347794220196654,1.2463005170594201,0.1518987341772152,0.738832958807335,1.0,9/19,16.91%,CACNB2;SCN3B;SCN3A;SCN1A;CAMK2B;FGF14;SCN8A;SCN2A;CACNG8
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,0.6069241874715252,1.2462371422688006,0.07692307692307693,0.7385342302445911,1.0,15/59,20.92%,SOCS3;TNC;ANXA1;RARRES1;FOSL2;GSDMD;ITGB8;NFKBIZ;TGFBI;IL18;IGFBP7;SNTB1;FOS;DUSP6;CLCA4
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6853454486517773,1.2460684126316646,0.16883116883116883,0.7387498582297443,1.0,7/21,10.26%,THBS1;SEMA3A;SEMA3B;ROBO2;SEMA6A;ROBO1;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.734083730262008,1.2459529399729732,0.18181818181818182,0.7387043443903772,1.0,6/12,20.66%,DMD;ANK2;CALM3;RYR2;CLIC2;ATP1A2
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6971429402764144,1.245914134864586,0.17073170731707318,0.7382681210330315,1.0,1/17,0.36%,DAPK2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5682732773022184,1.2455083579175894,0.12371134020618557,0.7397767556000949,1.0,10/88,10.63%,DIAPH3;RHOBTB3;RHOB;SYNE3;SEMA6A;RND3;PALLD;LIMD1;CSPG5;SH3D19
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.6342685868941531,1.2454494776290377,0.19230769230769232,0.7394297523058843,1.0,15/32,25.50%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;RIMS2;GAD2;SYT1;CPLX1;STXBP2;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.4075563700012178,-1.2454150409806148,0.07142857142857142,0.7976272026952436,1.0,6/45,11.60%,PDE12;NT5C3B;DCP1B;LSM6;CNOT6L;EDC3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7759549162082016,1.2454023917924955,0.19718309859154928,0.7390021653990928,1.0,3/7,20.93%,NR4A3;UGCG;LEPR
prerank,KEGG_2021_Human__Cell adhesion molecules,0.5700779152324059,1.2453899292386834,0.12121212121212122,0.7384779835255604,1.0,21/88,11.01%,CLDN18;LRRC4C;CADM1;CD22;VCAN;NCAM2;NRXN1;CDH2;IGSF11;NRXN2;CNTN1;NLGN3;CLDN20;NLGN1;ALCAM;NRXN3;MAG;ITGB8;PDCD1LG2;CD99L2;CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6601947277438386,1.2453389148892196,0.189873417721519,0.7381897873185219,1.0,7/18,19.39%,ARF6;ABCA2;SDCBP;PICALM;ITGAV;APP;DLG4
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.6247969921524703,-1.2450897472523106,0.23076923076923078,0.7968612733689872,1.0,2/12,9.50%,CCL5;CH25H
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.8070454831721728,1.2450265039378385,0.13043478260869565,0.7392302236535037,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7038792382782638,-1.244786619043639,0.25,0.796471334729344,1.0,4/6,22.31%,UQCC2;DDX5;NR1D2;MEF2C
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.5657794038742596,1.2447376332337539,0.09375,0.7402364587221596,1.0,11/82,8.46%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;HSPA5;ENDOD1;FN1
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.753802731334065,1.2447283509212477,0.30158730158730157,0.7396402810986257,1.0,2/6,9.80%,DCC;TRPC4
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.6995156051566653,1.2446966390924834,0.1875,0.7392147690752244,1.0,7/20,13.90%,TTBK2;HDGFL3;MID1IP1;MAP1B;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.6124313003345805,-1.244674242389959,0.25,0.7951146715059457,1.0,5/13,15.04%,CCL5;CD200R1;RIPOR2;CXCL12;LRCH1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.5978117323336418,1.2442947721295305,0.08888888888888889,0.7407186879128631,1.0,13/76,13.82%,CENPF;LRP2;SLC38A4;SLC16A10;ARRDC3;SLC6A15;SLC11A1;SLC19A2;FLVCR1;TXNIP;SLC35F3;LRP1B;SCAMP3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.7355492902199696,1.244096685294773,0.18571428571428572,0.7411879356650699,1.0,9/12,24.37%,ADGRG6;ADGRB2;PMP22;NFASC;UGT8;SCN8A;ASIC2;GSTM3;SERPINI1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5641365856431169,1.2440806342277504,0.06060606060606061,0.7405849618579085,1.0,30/166,13.23%,THBS1;ACVR1B;FGF1;TGFB2;SEMA3A;ENPP2;PRKCE;DOCK1;GLIPR2;CEMIP;DOCK5;VEGFA;HSPA5;GPNMB;SEMA3B;LAMB1;NSMF;INSR;SEMA6A;HIF1A;FN1;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;CLASP2;FLT1;SOD2;GAB1
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,0.7682671515597601,1.243984725727865,0.18571428571428572,0.740474007953545,1.0,4/8,19.96%,VIM;CASP3;THY1;NCAM1
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.7401636203945103,1.243958191408919,0.18840579710144928,0.7399129256621045,1.0,2/9,3.86%,PIGU;ARF6
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.47048089367394264,-1.2439358737217485,0.0,0.7960923321745393,1.0,11/35,15.48%,BUD23;IL1B;ZPR1;TP53;RIOK1;TGFB1;ZC3H18;EGFR;HSPA1A;GRSF1;HABP4
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8037441506948256,1.2438072298610752,0.15714285714285714,0.7400678915922188,1.0,2/6,10.75%,SEMA3A;UNC5C
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,0.6095564647251892,1.2437882516988492,0.07692307692307693,0.739532229749554,1.0,8/44,10.74%,TNC;THBS1;SPARC;OSMR;ANXA1;CLMP;FN1;PDCD1LG2
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.8344020227739837,1.2437247070386,0.19672131147540983,0.7391579127310974,1.0,3/5,7.86%,ANXA1;ALOX15B;PAX8
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.5955041805043029,1.2436717670470268,0.10526315789473684,0.7388403436738921,1.0,11/76,9.56%,KLF4;ACVR1B;FZD6;ACVR2A;LIFR;BMPR1B;TCF7;BMI1;ID2;IGF1R;POU5F1
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.8851366571871059,1.2434146602942848,0.11864406779661017,0.7395081124961443,1.0,1/5,3.16%,PIGU
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.620726509559217,-1.2432031124010445,0.21212121212121213,0.7963985436447912,1.0,3/11,10.83%,NEDD4;TGFB1;NUP214
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.6649761505480452,1.2431331558353846,0.2028985507246377,0.7404306961168002,1.0,10/20,26.06%,OIP5;CENPP;CENPK;CENPV;CENPI;HELLS;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.8734436045205403,1.2431300939010415,0.15873015873015872,0.7397851593285554,1.0,1/6,0.31%,CENPF
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.5742571271656198,1.243075597235363,0.11702127659574468,0.7394441940675814,1.0,40/104,26.86%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPL9;RPLP2;RPL37;EIF2B2;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;RPL27A;RPL3;RPS16;EIF4A2;RPL30;EIF3A;RPL36AL;RPL21;RPL7;RPL12;EIF3D;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.8376441084283185,1.2429418278899789,0.10714285714285714,0.7396064674778287,1.0,3/6,14.10%,HS3ST5;THBD;SERPINE2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.44041836825431885,-1.2429260781416727,0.0,0.7961358347524707,1.0,16/71,10.31%,GRAP2;TAL1;LYL1;RHOG;P2RX1;SH2B3;HHEX;RPIA;ETS1;ARHGDIB;FAM78A;SIPA1;EPOR;ENG;NMI;BTK
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.64523227974331,1.2427368403299393,0.24096385542168675,0.740294581433683,1.0,6/31,9.56%,KLF4;TGFB2;EGR1;NFIB;HIF1A;POU5F1
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,0.6021807842801586,1.242719611795779,0.14893617021276595,0.7397469818722555,1.0,7/54,5.36%,TNC;SPARC;SVEP1;VIM;OSMR;ANXA1;GPNMB
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.4125607445741022,-1.242380714788645,0.125,0.7893318730302901,1.0,19/79,11.06%,CD300LF;ITGAM;LY86;PTAFR;IL1B;SELPLG;UBA7;MPEG1;LGALS9;CSF1R;LILRB4;MLKL;ITGAX;MILR1;HLA-E;IGSF6;HCK;ITGB2;CYTH4
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.7104704141523734,1.2423272470925752,0.21052631578947367,0.741189762370662,1.0,5/13,18.84%,NRG1;NRG3;CDC37;NRG4;NRG2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.5899454845968854,1.2422337200351066,0.13333333333333333,0.7410875819655766,1.0,15/62,13.35%,THBS1;KLF4;RHOB;FGF1;CHI3L1;VEGFA;HIF1A;RAPGEF3;ITGB8;SEMA5A;FLT1;SASH1;BRCA1;GAB1;PKM
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.6184436733568853,1.2421815062400388,0.17777777777777778,0.7407393169458588,1.0,14/43,18.88%,SPARC;GFAP;NRG1;GABRB1;GABRB3;RPS27A;NRG3;GABRB2;NRG4;ESR1;UBA52;UBB;NRG2;GABRG2
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5919250835108414,1.2419661372585407,0.0625,0.7413441007506831,1.0,33/113,16.87%,FLRT1;METRN;GRAMD1C;SPOCK1;CARNS1;B4GAT1;NRG1;CASKIN1;SYBU;SRRM3;ARFGEF3;SRCIN1;LINGO1;ENDOD1;KCTD1;MAP2;RETREG1;PDE1C;ADGRB2;CSPG5;CKB;CELSR2;FAM81A;TTC5;IFT74;OSCP1;GNAL;NDRG4;CPE;EPB41L4B;EML2;APLP1;HSPA12A
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.65205788015704,-1.2417942120813108,0.25,0.7896217171890828,1.0,2/12,9.48%,PKIB;MAP3K4
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.7779210961735616,1.2416260286335934,0.15789473684210525,0.742518811328669,1.0,4/9,16.20%,OSMR;LIFR;CRLF1;IL11RA
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.605236068926997,1.2414427730586848,0.10752688172043011,0.7428120018817715,1.0,17/60,18.54%,RHOB;COBL;TLE1;TNS1;AATK;PDK4;IQSEC2;MAFB;NDRG2;CAMK2B;PINK1;ABLIM3;SLC24A3;CCDC92;OLFM1;GABRD;PNKD
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.7657378202262481,-1.2412339227128404,0.24242424242424243,0.7900564072760871,1.0,1/6,4.59%,STIM1
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.6826703253267172,1.241181244408299,0.13253012048192772,0.7435717587211678,1.0,9/25,18.67%,TUBB4A;TTLL7;TUBA1A;AGBL3;TUBB6;AGTPBP1;TUBB2A;TPGS1;TUBA1C
prerank,KEGG_2021_Human__Ribosome,0.5890397154039314,1.240979533807023,0.0851063829787234,0.7439742700152285,1.0,45/106,26.86%,RPL23;RPL36A-HNRNPH2;MRPL33;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPS18;MRPL20;RPL37;RPL14;MRPL14;MRPL27;RPS4X;RPL11;RPS24;RPS9;MRPL19;RPL36;UBA52;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.6595650086772817,-1.240852152481272,0.2727272727272727,0.7899068915620178,1.0,4/8,21.91%,HLA-DPA1;CD247;HLA-DRB5;CD4
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.5218694586652654,-1.2407231166655854,0.12,0.7888371813785782,1.0,8/18,18.30%,PSMC4;TP53;MED12;MED24;MED4;MED1;PAXIP1;MED30
prerank,KEGG_2021_Human__GABAergic synapse,0.5947296355341454,1.2405861076472466,0.16483516483516483,0.7455536099858203,1.0,26/56,26.81%,ADCY3;GNAO1;GAD1;GABRB1;GABRB3;GABRA2;GLUL;CACNA1B;ADCY8;GABRB2;GAD2;GNAI1;NSF;GABRA4;CACNA1A;KCNJ6;GABRD;GABRG2;GABBR1;GNB5;PRKCB;PRKACB;SLC6A1;CACNA1C;GABRG3;ADCY1
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.6043071363078563,1.2405120006343,0.14285714285714285,0.7453694146715474,1.0,17/39,26.20%,SYCP2L;WDR12;CDH9;TVP23A;TTYH1;ZNF850;TMEM266;HIC2;ORC6;PLCXD1;EMC3-AS1;TRIM24;ZNF519;ATAD5;GABRG3;JARID2;RBM28
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.6466930172024301,1.240435483562098,0.18518518518518517,0.7451934256233226,1.0,10/33,12.09%,PLPP3;THSD4;ACSL1;FAXDC2;AGT;CGNL1;ACSS3;FAM124A;KALRN;SORBS1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.7905931550451943,1.2403287655586128,0.1917808219178082,0.7450886812808324,1.0,2/8,9.50%,HMGB2;KDM1A
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7161967256277402,-1.240151510380988,0.2857142857142857,0.7895853267011465,1.0,3/6,23.15%,C1QC;CD81;C1QB
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6353515412396341,1.240122725185636,0.1875,0.7456614253174987,1.0,8/31,11.25%,NTN4;LAMB1;SRCIN1;TMEFF2;FN1;MICALL2;MEGF9;TYRO3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.6012462380575248,-1.2400816754873725,0.12,0.788495999306253,1.0,3/12,4.42%,FGL1;DUSP3;IL4I1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.568038307611459,1.2400068027022986,0.04040404040404041,0.745524983401544,1.0,34/188,15.59%,KCNE1;GLRA1;AANAT;TSHR;VIM;EGR1;HMGB2;MAPT;BRINP1;RORB;PTPRK;PDK4;NSMF;DAPK1;AKAP6;EPHA3;RUVBL2;PTK7;RAPGEF3;PDE2A;PDE4B;PDCD1LG2;IMPACT;NOD2;RYR3;TNFRSF1B;NR4A3;GUCY1B1;INSIG1;HCN1;PYCARD;WNT5A;ESR1;PDK3
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.793545635532745,1.2398850210683254,0.19672131147540983,0.744867884844745,1.0,1/6,2.27%,GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.793545635532745,1.2398850210683254,0.19672131147540983,0.744867884844745,1.0,1/6,2.27%,GLA
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.6030268522485949,1.239581735497108,0.18823529411764706,0.7457606534803647,1.0,3/51,5.79%,DIAPH3;TFRC;TRIP10
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.8030403578704568,1.2394831899352312,0.16417910447761194,0.7449559664070251,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.8030403578704568,1.2394831899352312,0.16417910447761194,0.7449559664070251,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5560569812085331,1.239463674150719,0.10309278350515463,0.7444137388406918,1.0,20/116,10.44%,HS3ST5;LRP4;NLRP12;ARRDC3;IL15;NFIB;PTPRG;SLC11A1;SRGN;VASN;GPNMB;FCGR2B;RGS2;SFMBT1;OVOL2;ACOT13;ROBO1;SPRY1;RBPJ;NOVA1
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,0.7879299900039923,1.2393964961952197,0.09210526315789473,0.7441305599452348,1.0,3/9,6.52%,DAPK2;DCC;DAPK1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.6755641844664543,-1.2392979148772756,0.17857142857142858,0.789868541594236,1.0,3/6,21.06%,CHMP2B;LYST;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5752472173664096,1.2391487995848545,0.1326530612244898,0.7449967059126225,1.0,28/88,19.47%,METRN;PTPRD;RELN;IL1RAPL1;ROBO2;ZNF804A;EPHA3;PTK7;ROBO1;PTN;SS18L1;CARMIL1;NTRK3;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;PLXNB1;WNT5A;NDRG4;ARHGDIA;MAP3K13;PLXNC1;ATP1B2;FES;DLG4;CHODL
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.5799612638110392,-1.2387565674806265,0.11538461538461539,0.7899853183253993,1.0,3/15,14.46%,PIK3R6;AKT1;PIK3R5
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.3659238893216107,-1.238405814242571,0.0,0.789837572598963,1.0,20/114,14.46%,ITK;CCL5;CX3CR1;CCL3L3;PIK3R6;CHUK;GRK2;KRAS;SRC;CRKL;HCK;RASGRP2;IKBKB;CRK;NFKBIA;CXCL12;ARRB2;RAP1A;AKT1;PIK3R5
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7491453958131801,1.2380802401851116,0.21875,0.7503669356429208,1.0,4/9,14.33%,THBS1;THBD;SERPINE2;ENPP4
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5686359045856815,1.2380202157045328,0.14444444444444443,0.7500716112575616,1.0,21/71,21.98%,LRP2;KCNJ13;SCN3B;SLC5A9;SLC9B2;SCN3A;KCNMB1;SCN1A;SCN8A;SCN2A;PIEZO2;KCNJ6;KCNMA1;KCNB2;KCNJ3;TAF7;TRPM7;SLC3A2;ATP1A2;SLC5A6;CHP1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.744818342968268,1.2379113257717056,0.17721518987341772,0.7500963970423205,1.0,2/12,1.97%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6752011248353751,1.2377215471523946,0.1282051282051282,0.7503937449312452,1.0,5/24,12.80%,TULP2;TUB;FSIP2;TULP3;SNX10
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.6856023298413486,1.237651536421582,0.1527777777777778,0.7501458423684524,1.0,2/14,3.02%,THBS1;ITGA2
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.5567588349369261,1.237458549375219,0.1134020618556701,0.7506059289849427,1.0,11/86,8.46%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;HSPA5;ENDOD1;FN1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.7348390172871884,1.2371378736075505,0.2702702702702703,0.7518732003817434,1.0,3/11,12.87%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.8189969652490674,1.2364559482713315,0.21428571428571427,0.7547295996478474,1.0,2/8,15.76%,CENPE;SEH1L
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.4117409083468482,-1.2364482031704365,0.16666666666666666,0.7949386724201319,1.0,5/56,3.78%,CCL5;GBP3;INPP5K;CHUK;DAB2IP
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,0.8180333255348756,1.2362844576809031,0.18309859154929578,0.7550062584309444,1.0,2/5,14.15%,DGAT1;GK
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.5718015785302208,1.236143927404199,0.061855670103092786,0.7550964689553534,1.0,55/162,21.44%,RAP1GAP;SHANK3;SEMA3A;NTN4;DCC;RELN;ENAH;PLPPR4;NRXN1;DOK6;LAMA2;SEMA3B;ROBO2;ANK3;SEMA6A;EPHA3;GRB10;NLGN3;PALLD;NRXN3;ROBO1;IRS2;MAP1B;UNC5D;SLITRK5;SEMA5A;SPTAN1;UNC5C;EPHA7;B4GALT5;SLC9A6;EPHA4;PARD3;CCK;GAB1;CTNNA2;EPHA6;EPHA5;WNT5A;SPTBN5;DAB1;KIF5A;SPTBN1;APP;KLF7;SPG11;NTNG1;SPTBN4;CDK5R1;NCAM1;NOTCH2;CNTN2;FGFR2;KIF5C;PAK3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7928963804637942,1.2358825290840747,0.2318840579710145,0.7557981959746697,1.0,1/6,7.03%,SYCP3
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5950744890565933,1.2358744417629843,0.16470588235294117,0.7552532249115945,1.0,15/41,18.98%,LRP2;VEGFA;CTNND2;ANK2;LINGO1;ARNT2;GALNT18;CRMP1;NTRK2;SH3GL2;CPE;APP;STARD13;SCG5;SPTBN4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.7255732472457967,1.2357261813235203,0.1590909090909091,0.7553198102508338,1.0,6/12,15.39%,KLF4;BMI1;ALCAM;POU5F1;ALDH1A1;THY1
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,0.7374435610576638,1.2355915163424882,0.14285714285714285,0.7554094526253546,1.0,5/13,9.56%,ABHD12B;LRRN1;SEMA6A;UNC5D;POU5F1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.7603387838332473,-1.2354471842754393,0.28125,0.7969353519771797,1.0,1/5,0.84%,LOXL3
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.5986067127463939,-1.2351432891265477,0.19444444444444445,0.796369854401891,1.0,2/11,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.8576546237685501,1.2349850744150146,0.14516129032258066,0.7580531302499713,1.0,3/6,7.57%,FOLH1;AGBL3;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8121379295436599,1.2349433808739303,0.17647058823529413,0.7576083271656405,1.0,1/7,3.87%,ANXA1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.746078776887932,1.2348063597115415,0.21621621621621623,0.7572058814681938,1.0,2/10,16.96%,IL15;PLCB1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.746078776887932,1.2348063597115415,0.21621621621621623,0.7572058814681938,1.0,2/10,16.96%,IL15;PLCB1
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.6166942088633091,1.234677083471976,0.17777777777777778,0.7554537811393971,1.0,14/38,16.87%,LRP4;SRRM3;LINGO1;PCBP4;PTN;SHC2;CELSR2;CRMP1;GPRC5B;CCDC3;ADGRL2;PLXNB1;CPE;HSPA12A
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.6166942088633091,1.234677083471976,0.17777777777777778,0.7554537811393971,1.0,14/38,16.87%,LRP4;SRRM3;LINGO1;PCBP4;PTN;SHC2;CELSR2;CRMP1;GPRC5B;CCDC3;ADGRL2;PLXNB1;CPE;HSPA12A
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.6166942088633091,1.234677083471976,0.17777777777777778,0.7554537811393971,1.0,14/38,16.87%,LRP4;SRRM3;LINGO1;PCBP4;PTN;SHC2;CELSR2;CRMP1;GPRC5B;CCDC3;ADGRL2;PLXNB1;CPE;HSPA12A
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.6166942088633091,1.234677083471976,0.17777777777777778,0.7554537811393971,1.0,14/38,16.87%,LRP4;SRRM3;LINGO1;PCBP4;PTN;SHC2;CELSR2;CRMP1;GPRC5B;CCDC3;ADGRL2;PLXNB1;CPE;HSPA12A
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.6998025474773071,-1.234646325940326,0.3684210526315789,0.7965452755038571,1.0,2/6,11.08%,NBDY;CNOT6L
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.39373205318974996,-1.2346279129911029,0.0,0.7908517338723288,1.0,31/86,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SAMSN1;MPEG1;CSF1R;LILRB4;ABI3;ARHGDIB;P2RY13;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;SCARF1;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.39373205318974996,-1.2346279129911029,0.0,0.7908517338723288,1.0,31/86,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SAMSN1;MPEG1;CSF1R;LILRB4;ABI3;ARHGDIB;P2RY13;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;SCARF1;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.39373205318974996,-1.2346279129911029,0.0,0.7908517338723288,1.0,31/86,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SAMSN1;MPEG1;CSF1R;LILRB4;ABI3;ARHGDIB;P2RY13;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;SCARF1;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.39373205318974996,-1.2346279129911029,0.0,0.7908517338723288,1.0,31/86,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;SAMSN1;MPEG1;CSF1R;LILRB4;ABI3;ARHGDIB;P2RY13;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;SCARF1;GIMAP7;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.6281141441990554,-1.2345779026197747,0.20689655172413793,0.7895946790232964,1.0,1/7,0.45%,CCL5
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.6956392883929143,1.2345746731560947,0.25333333333333335,0.7553970027178273,1.0,6/11,27.38%,BRCA1;RLIM;LRIF1;PCGF5;HNRNPU;PCGF3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.73984305729319,1.2345465575464605,0.1780821917808219,0.7549037815203571,1.0,4/10,15.86%,GRIN2A;RIPK2;ASPH;CIDEB
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.8181407353383768,1.234421336022777,0.17142857142857143,0.75494703509646,1.0,1/6,1.87%,TBRG4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.7704380816148997,-1.2342072472583594,0.25,0.7890966224758319,1.0,2/5,12.15%,ADARB1;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.8381462672423161,1.234118000387351,0.20270270270270271,0.7560988546593311,1.0,2/5,13.05%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.8085589091260099,1.2338180380559023,0.1935483870967742,0.7571265239826747,1.0,3/7,7.48%,SCN3B;ANK3;PKP2
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.6549171949493149,1.2335431731049082,0.17647058823529413,0.7579998209920871,1.0,3/25,1.94%,KMO;FOLH1;ASPA
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.6671313582275551,1.2335372735838257,0.21951219512195122,0.75738445889562,1.0,7/24,12.09%,GADD45B;GPM6B;TFRC;AKAP12;ALCAM;SVIL;PLTP
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,-0.44783543469276466,-1.2332770467765841,0.16666666666666666,0.7911421733208844,1.0,20/61,15.91%,NKG7;CD37;BIN2;CD2;SAMSN1;CEACAM21;HCST;RASAL3;NCKAP1L;PLEK;CYTH4;LCP2;PTPN7;PRF1;CD53;SNX20;PIK3R5;IL12RB1;PYHIN1;PSTPIP1
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.6000744398615597,1.2331861470499088,0.14893617021276595,0.7585685243026686,1.0,22/53,26.85%,VGF;VCAN;CDH2;LAMB1;GOLM1;FN1;CKAP4;LTBP1;TMEM132A;FAM20A;TRIM26;CHGB;CXXC1;APP;IGFBP7;P4HB;HSP90B1;SPARCL1;GPC3;TF;PRKCSH;FBN1
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.5896999966695079,1.2331276297362683,0.11702127659574468,0.7582506591755802,1.0,23/78,19.68%,SHROOM3;NUDT12;TGFB2;FZD6;ADGRA3;KITLG;FNDC3A;GOLM1;RND3;BMI1;ALCAM;FAM171B;SH3D19;IBTK;ADGRL2;GNAI1;HSD17B12;CPE;ITGAV;APP;TNFRSF21;ACSL3;SMAD5
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5974273537515103,1.2330574572903779,0.11494252873563218,0.7580170064351852,1.0,16/56,9.37%,SHANK3;GPM6A;CDH8;NRXN1;CDH2;NRXN2;CDH9;CTNND2;SHANK2;PKP2;NLGN3;CDH20;NLGN1;FN1;DNM3;CDH12
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.7112561193725286,-1.2329713596198517,0.2857142857142857,0.7905726505373225,1.0,1/5,0.68%,FLNA
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.7057300163024873,1.2328851370903793,0.22857142857142856,0.7583310421051259,1.0,1/15,0.28%,THBS1
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.5685639185415695,-1.2328415734221703,0.15384615384615385,0.7896533917210609,1.0,4/13,19.66%,HLCS;MMAB;PCCB;MCCC1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.7707019222780147,1.2326909511171413,0.23684210526315788,0.7587508888735996,1.0,3/9,10.81%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7483155900302173,1.2326673465284133,0.24615384615384617,0.7582593825329311,1.0,4/7,24.75%,MYRF;SOD1;PTEN;EPB41L3
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.4717082502901341,-1.23245356390172,0.08333333333333333,0.7894865151898401,1.0,4/29,9.59%,STAT4;LGALS9;CSF2RA;INPP5D
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.6004263584146636,-1.2322197507149288,0.2,0.788689299779758,1.0,3/14,8.79%,RALB;MAPK13;SRC
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.6386687323794671,1.2321186143431535,0.16883116883116883,0.7604680734110589,1.0,5/26,10.26%,THBS1;VEGFA;PTN;NTRK3;SEMA5A
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.584831351753292,1.2318570849333101,0.1875,0.7605217522822428,1.0,13/73,11.93%,PLPP3;SPARC;CDK14;ENPP2;TNS1;VCAN;GPNMB;ALCAM;FN1;ABCA1;PDCD1LG2;RPS6KA2;SASH1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.584831351753292,1.2318570849333101,0.1875,0.7605217522822428,1.0,13/73,11.93%,PLPP3;SPARC;CDK14;ENPP2;TNS1;VCAN;GPNMB;ALCAM;FN1;ABCA1;PDCD1LG2;RPS6KA2;SASH1
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.852289702716283,1.2317295618132522,0.15151515151515152,0.760635508650726,1.0,1/5,3.87%,ANXA1
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,0.7611370704136823,1.2314423081095924,0.16417910447761194,0.761587963893815,1.0,1/10,2.78%,PPP2R3B
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.7004925774844247,-1.2311417997156526,0.3,0.790880692199022,1.0,3/6,17.23%,AMPD3;NUDT2;AK9
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6849118634183005,1.2307454816985997,0.1951219512195122,0.7649250640245387,1.0,7/21,19.33%,MAPT;CAV3;STMN2;TOGARAM1;DCTN1;FES;CDK5R1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.6449939441029622,1.2307294699264562,0.15,0.7643709470213845,1.0,10/27,12.61%,FRAS1;PREX2;CGNL1;PTPRZ1;SEMA6A;FAM124A;UNC5D;POU5F1;GRID2;TMEM132B
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.6321179163562157,1.2306749884375365,0.16304347826086957,0.763968519199473,1.0,6/34,11.27%,PRKAR2B;PRKCE;PDE1A;PDE1C;ADCY8;CAMK2B
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.7155199095490455,-1.2306596650326733,0.21875,0.7912480825810345,1.0,2/6,11.55%,WHAMM;GSN
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.8053278939158486,-1.2305319453724965,0.14814814814814814,0.7901963005302347,1.0,4/6,6.50%,CCL5;LGALS9;CD274;TP53
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.7399001340768316,-1.2302778173057174,0.30303030303030304,0.7895194787908115,1.0,2/5,10.21%,BAHD1;POLE3
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.7081308129076394,1.2300478519764875,0.22666666666666666,0.7663086539121882,1.0,4/12,21.59%,IL7;IRS2;IL7R;BRWD1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.7019144717009911,1.2296926155858607,0.16,0.7676890791295287,1.0,5/13,21.87%,CR1;CD55;CD300A;SLAMF8;APPL1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7897633565917344,1.2296312339006361,0.16666666666666666,0.7674202857462581,1.0,3/7,13.42%,MAPT;BNIP3;PRELID1
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.6774723117205202,1.2295482427617197,0.2222222222222222,0.767242103078559,1.0,8/24,20.52%,NAMPT;BMAL2;NOCT;BHLHE40;SMARCD3;TBL1XR1;PPARA;NPAS2
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.6973664656261878,1.2294924447449316,0.1643835616438356,0.7669440839792692,1.0,3/15,6.22%,GLRA1;MCHR2;LTB4R
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.5958766618714015,1.2292863879632019,0.13636363636363635,0.7674192456996838,1.0,23/73,20.05%,CENPE;TFRC;CLSPN;CEP152;SMC4;FANCB;WDHD1;DNA2;FANCM;ATAD2;POLQ;BRCA1;MPHOSPH9;CENPI;CCDC18;POLE2;ZGRF1;KIAA1586;SUZ12;TBC1D31;TRPM7;DPY19L1P1;KNTC1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.6010372540214268,1.2291717833589466,0.18681318681318682,0.7674213987315032,1.0,11/59,15.70%,GLRA1;SLC1A2;SLC24A2;GABRB1;SLC9A7;SLC24A1;SLC9A6;GLRB;SLC17A7;PIEZO2;SLC24A3
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,0.8186163456734976,1.2287143681573134,0.125,0.7690487950121853,1.0,2/7,1.94%,FOLH1;ASPA
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.8112955864909781,1.2283788267868434,0.19444444444444445,0.7701945901616087,1.0,3/7,9.58%,NCAN;VCAN;CSPG5
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,0.6326003058358456,1.228284434278082,0.16455696202531644,0.7694472279570317,1.0,9/29,17.61%,ABHD12B;ZNF814;MGAT4C;FLVCR1;POU5F1;ZNF850;SHISA9;ORC6;ZNF665
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,0.6326003058358456,1.228284434278082,0.16455696202531644,0.7694472279570317,1.0,9/29,17.61%,ABHD12B;ZNF814;MGAT4C;FLVCR1;POU5F1;ZNF850;SHISA9;ORC6;ZNF665
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.7875743964263071,1.2281746694289046,0.30666666666666664,0.7694925120928404,1.0,2/7,16.37%,ENPP2;PNPLA8
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.5791629009746427,1.2280890195475704,0.16129032258064516,0.7693587030303309,1.0,12/64,13.49%,THBS1;KLF4;CBR1;AGT;VEGFA;INSR;PAX8;IFNLR1;MAGI2;NSF;PRELID1;FASN
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.8101098620209275,1.2280675877051663,0.08695652173913043,0.7688524574573857,1.0,1/7,1.28%,TGFB2
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,0.5893780168770238,1.2280593670652045,0.16129032258064516,0.7683246932975909,1.0,15/74,15.76%,CENPF;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;SEH1L
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.7232901034611474,1.227876425085837,0.20270270270270271,0.7685270021890975,1.0,5/15,9.36%,DMD;ANK2;AKAP6;CALM3;RYR2
prerank,KEGG_2021_Human__Yersinia infection,-0.40418428677427926,-1.2277043309790676,0.16666666666666666,0.7967895464626423,1.0,21/113,11.39%,ITGA5;TICAM1;RPS6KA6;RHOG;IL1B;CHUK;ACTB;WIPF3;IRAK4;MAPK13;MAP2K3;ARHGEF1;NFATC3;SRC;CRKL;PKN1;IKBKB;NLRP3;CRK;NFKBIA;LCP2
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,0.8068906602891505,1.2275486709235524,0.21333333333333335,0.76947991264156,1.0,4/6,14.58%,VIM;GFAP;GLUL;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.7023687411257888,1.227363138754447,0.22666666666666666,0.7698369648586556,1.0,2/15,4.53%,KLF4;LIFR
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.83665114759938,1.2271656878819606,0.16666666666666666,0.7704680864237488,1.0,2/5,9.10%,EGR1;SIRT5
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.6976856146778935,1.227099248354966,0.17567567567567569,0.7703490796833633,1.0,3/15,9.71%,PPP2R5B;PPP2R5A;FGR
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.6094949034450964,1.2270044142420238,0.14444444444444443,0.7703117853190425,1.0,11/45,18.25%,PCSK1;DMD;GLRX2;CPM;BACE2;TRHDE;CPE;LTA4H;CARNMT1;GSTP1;SOD1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7468066516094845,1.2269815534595985,0.19444444444444445,0.769859875704037,1.0,3/10,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.7318617577797752,-1.2269586668384167,0.3548387096774194,0.7975138832466724,1.0,2/5,14.14%,RIN2;RAP1A
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.7388816288979766,1.226693590196379,0.15384615384615385,0.7702224420679591,1.0,2/12,5.43%,PPP2R5B;PPP2R5A
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.7388816288979766,1.226693590196379,0.15384615384615385,0.7702224420679591,1.0,2/12,5.43%,PPP2R5B;PPP2R5A
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.6366658002087805,1.2265588687436344,0.16483516483516483,0.7702666271643831,1.0,22/47,25.14%,CACNB2;SLC9A7;RYR2;COX7A2;CACNG2;CACNA2D3;SLC9A6;COX7C;ASPH;ATP2A2;UQCRFS1;ATP1B3;UQCRC1;CACNG8;ATP1B2;CYC1;COX4I1;ATP1A2;SLC9A1;COX6C;COX6B1;CACNA1C
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.6375049980570379,1.2264521375513802,0.2125,0.7701188332562237,1.0,4/31,6.20%,HS3ST5;HS3ST2;GPC5;GNS
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.6148595899312468,-1.2264465720268336,0.16666666666666666,0.7977740660083121,1.0,2/12,5.51%,ARV1;TECR
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.8431699059536659,1.2261863894397702,0.23076923076923078,0.770878418528821,1.0,2/5,9.28%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.5887901299083738,1.2261829788559568,0.1348314606741573,0.7702734797527033,1.0,13/66,13.26%,DDIT4;ARAF;TFRC;MTCP1;DMD;VEGFA;PAQR3;RAPGEF3;TXN;NTRK3;HCLS1;RIPK2;PINK1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.8390181180800386,1.2261749042654002,0.15625,0.7696916026224571,1.0,3/5,12.22%,H2BC11;IFNLR1;OTUD7B
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.767080984369663,1.2261634461157125,0.22388059701492538,0.7691474463644874,1.0,3/8,12.06%,OMG;PTN;NREP
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.6065558234021042,1.2261131261406335,0.14285714285714285,0.7688247071298479,1.0,13/48,20.77%,TM7SF2;IDI1;MVD;SEC24C;FASN;INSIG1;SCD;FDFT1;HMGCS1;SMARCD3;TBL1XR1;PPARA;ACACB
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.5929230665042156,1.2260424666917005,0.16842105263157894,0.7685759409590397,1.0,16/58,18.26%,PAPPA2;VGF;VCAN;CDH2;LAMB1;GOLM1;FN1;CKAP4;LTBP1;TMEM132A;FAM20A;TRIM26;CHGB;CXXC1;APP;IGFBP7
prerank,KEGG_2021_Human__Phototransduction,0.8075867832934172,1.2259496223802637,0.3103448275862069,0.7683789510620314,1.0,2/5,10.68%,CALM3;SLC24A1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7320790076291398,1.225856016151554,0.2571428571428571,0.7682116116785199,1.0,4/9,18.33%,DMD;ANK3;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.6394568181692059,1.2258085996152235,0.19047619047619047,0.767795388842661,1.0,3/24,10.79%,RHOB;ANXA1;IMPACT
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,0.7467452876907412,1.22525624342055,0.21333333333333335,0.7700597257318081,1.0,3/12,10.46%,CR1;FCGR2B;FCGR2C
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6696007312570816,1.2252100854724306,0.15294117647058825,0.7696207434865803,1.0,3/20,9.06%,PRR16;CAV3;DEPTOR
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.6896864941248833,1.225080629423086,0.15384615384615385,0.7698184695664425,1.0,11/24,11.25%,FRAS1;GULP1;ENAH;COL4A5;COL26A1;B4GALNT4;PTK7;TUSC3;PAICS;KDM1A;TYRO3
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7202463503026013,1.2250355575251206,0.21052631578947367,0.7693730745165427,1.0,2/9,5.04%,IL15;VEGFA
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,0.8623173304526158,1.2249839528569604,0.13432835820895522,0.769052468263559,1.0,3/5,9.72%,GFAP;SLC1A2;GLUL
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.6720007122418916,-1.2248330660024251,0.25925925925925924,0.8017888410517582,1.0,1/12,1.84%,BCL2L1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.6683863385646756,1.2247700841412763,0.203125,0.7697971489066074,1.0,5/13,15.05%,CIT;SHANK2;MOB3B;LIMD1;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),-0.7627487858698305,-1.2247153120435745,0.275,0.8005456543560636,1.0,3/5,15.53%,LGALS9;MAP2K3;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.7071032120256766,-1.2246189422587896,0.2,0.7993756925173049,1.0,5/7,22.20%,PLEKHM1;DEF8;SYK;PRKCA;ATP6AP1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,0.6276256500789709,1.224481914429455,0.1839080459770115,0.7705989431926352,1.0,6/40,6.68%,KLF4;ITGA2;DOCK1;KITLG;ASAP2;ADGRG6
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.5948994334062794,1.224297709560818,0.15853658536585366,0.7710062678387818,1.0,2/51,1.00%,DDIT4;ARAF
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6283241094188494,1.2242610955781383,0.21428571428571427,0.7705980756694957,1.0,6/31,7.94%,LRP2;PTPRD;IL1RAPL1;NRXN1;NLGN3;NLGN1
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.4400306246311073,-1.2240495890099738,0.058823529411764705,0.8000662761107008,1.0,4/25,13.23%,GRAP2;PKN1;LCP2;SYK
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.63806809481538,1.2239882500601562,0.13095238095238096,0.7714264067140134,1.0,8/27,15.06%,BRINP1;TMEM161A;RORB;RXRB;EPHA3;PTK7;TRIM16;WNT5A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.7811926825167205,1.2239596712575154,0.2,0.7709749439443689,1.0,1/8,1.54%,CR1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,0.5927961244052874,1.223832534111727,0.14285714285714285,0.7704875598103127,1.0,12/51,14.82%,TNC;OSMR;ANXA1;FILIP1L;CEMIP;LAMA2;NDRG1;FOSL2;PDCD1LG2;AHNAK;SERPINE2;TGFBI
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,0.5927961244052874,1.223832534111727,0.14285714285714285,0.7704875598103127,1.0,12/51,14.82%,TNC;OSMR;ANXA1;FILIP1L;CEMIP;LAMA2;NDRG1;FOSL2;PDCD1LG2;AHNAK;SERPINE2;TGFBI
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7599767066041939,-1.223715559113756,0.29411764705882354,0.7998392793948093,1.0,2/5,5.78%,PMEPA1;SNX25
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.610292415306233,-1.2235275182250738,0.2702702702702703,0.7989050458048567,1.0,4/9,22.80%,LEO1;RNF8;RNF20;CDC73
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.6993164607275648,1.223378368565051,0.14285714285714285,0.7721612427777002,1.0,6/17,18.84%,PIGU;NRG1;NRG3;CDC37;NRG4;NRG2
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.6250314379583424,1.223364947825932,0.23809523809523808,0.7716526968254818,1.0,15/37,20.85%,SOCS3;DOCK1;NRG1;GPNMB;HIF1A;RPS27A;KHDRBS2;NRG3;NRG4;EPAS1;UBA52;UBB;NRG2;LRRK2;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.6586098856554342,1.2232354602780051,0.1566265060240964,0.7718106132408031,1.0,11/24,26.37%,ABCA2;SIRT5;BRCA1;PINK1;SDCBP;ITGAV;AP1AR;DLG4;TRAP1;BTN2A2;LRPAP1
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.6942325482933814,1.2232135839549196,0.26136363636363635,0.7713320648307913,1.0,8/18,16.34%,SCN3B;SCN3A;CACNG2;SCN1A;CACNA1B;SCN8A;SCN2A;CACNA1A
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7339294547031405,1.222765236311523,0.225,0.7731081671211878,1.0,4/12,13.87%,CALM3;MAGI2;CD300A;PPP1R15A
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.7094371156984546,1.222531090510645,0.17567567567567569,0.7736832281275118,1.0,5/19,13.87%,TGFB2;SH2D4A;MASTL;PPP4R4;PPP1R15A
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,0.804860616693479,1.2224090091997786,0.2222222222222222,0.7736587334807216,1.0,3/6,4.98%,SLC2A3;SLC2A9;SLC5A9
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.5925425764554366,1.222336973265712,0.14432989690721648,0.7734613096018811,1.0,27/71,28.92%,NDUFA2;NDUFB9;ETFB;SCO2;NDUFA3;NDUFS8;COX7C;ACAD9;CYCS;NDUFB6;UQCRFS1;UQCRC1;TIMMDC1;SCO1;NDUFAF4;COX4I1;ECSIT;COX6C;TRAP1;COX6B1;COX20;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.734841717200729,1.222221103873633,0.2328767123287671,0.773365014485827,1.0,5/10,17.54%,ACSL1;ALOX12;ALOX15B;PNPLA8;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.745883404428193,1.2221410499905543,0.18666666666666668,0.7732544791886061,1.0,2/10,5.04%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.7765205927489338,1.2216266387905927,0.16393442622950818,0.7752076564008845,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),-0.7304464451545517,-1.221531780976975,0.2727272727272727,0.8043580309294697,1.0,2/5,3.60%,CX3CR1;LGALS9
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.7226142638680912,1.2214006873541978,0.17647058823529413,0.775706524021229,1.0,2/10,11.68%,PLIN2;VSTM2B
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7456090034233958,1.2210120117782604,0.19444444444444445,0.7770158114484893,1.0,2/9,12.87%,TGFB2;BRCA1
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.6921857061754568,1.2207518641023427,0.15789473684210525,0.7778065828411341,1.0,2/17,5.43%,PPP2R5B;PPP2R5A
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8009645177056068,-1.220514763739812,0.27586206896551724,0.805187426969711,1.0,3/5,15.53%,NPR2;PDE1B;ZFP36
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8009645177056068,-1.220514763739812,0.27586206896551724,0.805187426969711,1.0,3/5,15.53%,NPR2;PDE1B;ZFP36
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.6411344533196827,1.2202836275319262,0.14814814814814814,0.7794633906763441,1.0,5/33,3.84%,HS3ST5;HS3ST2;NCAN;VCAN;GPC5
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.8152029654329738,1.2201112113344026,0.13846153846153847,0.7797496781171461,1.0,3/5,17.16%,IL15;IL18;ROCK1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.7058567350038648,1.2198752572803429,0.2375,0.7801786456793399,1.0,6/14,14.69%,NLRP12;BEX3;EPHA7;GRIN2B;PYCARD;AIM2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.8586111233531197,1.21987406402547,0.1780821917808219,0.7795843835384344,1.0,2/5,12.41%,BOK;CYCS
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.6051359858974167,1.2196576212651555,0.13953488372093023,0.7801485700244939,1.0,17/58,18.26%,THBS1;PLPP3;TNS1;DOCK1;ENC1;CGNL1;LAMA2;KCNT1;SASH1;SHROOM4;TIMP3;SMARCD3;LDB2;NRGN;EPAS1;SORBS2;IGFBP7
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.4742391795567462,-1.219528424276523,0.25,0.8067680877553893,1.0,2/48,0.81%,RING1;NUP42
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.7832000211451363,1.2193198137784345,0.18666666666666668,0.781340165539151,1.0,2/8,1.97%,PKIA;PRKAR2B
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5915728311635973,1.2192246873665011,0.14736842105263157,0.7812814427410506,1.0,5/57,10.66%,PCSK1;MYRF;SRGN;CPM;TYSND1
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5984271386619834,1.2191682743918653,0.10752688172043011,0.7809020273863649,1.0,17/78,17.64%,FA2H;PLPP3;ALDH3B1;ENPP2;GLA;VAPB;ABCA2;ELOVL4;ARSA;GALC;PPM1L;UGT8;SPTLC2;UGCG;SUMF2;PRKD3;SUMF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7356978439066483,1.2189991574129693,0.2191780821917808,0.7808495928365673,1.0,4/10,21.59%,IL7;IRS2;IL7R;BRWD1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7356978439066483,1.2189991574129693,0.2191780821917808,0.7808495928365673,1.0,4/10,21.59%,IL7;IRS2;IL7R;BRWD1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8434014423469466,1.2187359545342973,0.20967741935483872,0.7815452984782907,1.0,2/5,5.04%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7568514452370024,1.218454180921999,0.25,0.7824673311629067,1.0,3/9,8.38%,SCN3B;FHL1;CAV3
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.6237079961106516,1.21830411873313,0.2073170731707317,0.7827133478407874,1.0,11/32,19.28%,GFAP;RFX2;TMEM232;PTPRT;CELSR2;CFAP54;PLTP;DNAH7;ENKUR;HSPA2;SPAG6
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,0.6358809257402817,1.218299820253518,0.19480519480519481,0.7821430096865732,1.0,9/29,12.63%,SHROOM3;TOM1L1;SH2D4A;GNA11;ADGRG6;BAIAP2L1;RND3;ERRFI1;PARD3
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.7048003388210293,1.21814653919292,0.2,0.7824314362880702,1.0,4/15,12.36%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.5661504608730641,1.217931694899672,0.13402061855670103,0.7827619238554964,1.0,28/96,17.73%,TGFB2;GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;ALK;CNTNAP2;B4GALT5;PLP1;NTRK2;TMEM108;SH3GL2;STMN2;EPHA5;RASGRF1;UGCG;ROCK1;APP;ERCC6;NCDN
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.7831035690970658,1.2177984951669723,0.19230769230769232,0.7828370574199675,1.0,2/8,9.13%,ANTKMT;MID1IP1
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.780030699445111,1.217688820555952,0.2153846153846154,0.7828484132978628,1.0,2/6,8.39%,ITGA2;CHL1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.43280702910070423,-1.2168979226982748,0.14285714285714285,0.813211471910083,1.0,17/97,15.17%,ITK;GRAP2;PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;NFATC3;BTK;IKBKB;LCP2;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,-0.6073712695602529,-1.2168630852059967,0.24242424242424243,0.8119248148866459,1.0,2/9,2.98%,MAF;HAVCR1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7322173291772168,1.2166277049430085,0.20512820512820512,0.7881749424669691,1.0,4/11,9.36%,CDH2;DMD;CAV3;RYR2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7040862099665426,1.216394291137852,0.18055555555555555,0.7886977402640483,1.0,5/14,9.36%,DMD;ANK2;CAV3;CALM3;RYR2
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8242166518476469,1.2163855563599597,0.2222222222222222,0.788125868603026,1.0,3/6,15.32%,RBPJ;RYR2;CPE
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.44600481851304974,-1.2159060527245091,0.06666666666666667,0.8132826679324591,1.0,3/39,2.67%,ITK;CD276;CD2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.650958371307819,1.2157038103421383,0.20512820512820512,0.7907916354740389,1.0,6/20,12.37%,CADM1;PTPRD;IL1RAPL1;NLGN1;ALCAM;GRID2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.6972566407859851,1.2156794748581805,0.1891891891891892,0.7902824505638121,1.0,3/14,8.68%,B4GAT1;SDF2L1;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7643450113929322,-1.2156247800199078,0.34375,0.8127436658156403,1.0,4/6,21.44%,NCKAP1L;BTK;SYK;PPP2R3C
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.5723202673585998,1.215487595080399,0.0707070707070707,0.7905907956613046,1.0,17/123,10.26%,THBS1;OMD;SPON1;ADAMTS2;OGN;THSD4;NCAN;VCAN;TALDO1;B4GAT1;GPC5;PAPSS2;GNS;THSD7A;RPS27A;CSPG5;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.8129332928901666,1.2154210129371341,0.16176470588235295,0.7903076832808157,1.0,3/5,18.04%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.816187340757252,1.2153973545167505,0.140625,0.7898211313295473,1.0,2/5,15.46%,MAPT;BAG3
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.7281767687059988,1.2153534137436617,0.24,0.7894477209508538,1.0,5/13,14.68%,CAMK2B;LRRC7;RASGRF1;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.7478158832127659,1.2153433112807435,0.3230769230769231,0.7888783401940738,1.0,1/7,0.28%,THBS1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7642912752993003,1.215328892432024,0.26865671641791045,0.7883659426703981,1.0,3/8,4.98%,SLC2A3;SLC2A9;SLC5A9
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.4630984309838363,-1.2151980283298547,0.0,0.8131060129018656,1.0,6/73,3.24%,RNASEL;FLNA;NUP42;PDE12;NEDD4;UBA7
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.5848817377863348,1.2150266251570694,0.1134020618556701,0.7891158823703519,1.0,27/100,20.41%,RHOB;TUBA4A;VIM;ACSL1;IDI1;FKBP5;OSMR;FILIP1L;MRPL33;CARHSP1;GLRX2;MCL1;IFITM3;CPM;GNAI1;SOD2;ABLIM3;CDC37L1;TGFBI;KLHL2;HSPB1;FTH1;NDUFAF4;HPRT1;ECT2;CPNE8;CSRP1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5131704431618004,-1.214448008132638,0.2222222222222222,0.8142528411759181,1.0,6/38,7.51%,FLNA;NEDD4;IL1B;ZPR1;TP53;TGFB1
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7130393390293785,-1.2144117785132789,0.2608695652173913,0.8129977962072761,1.0,2/9,3.45%,ZNF703;ACTB
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.576722131130319,1.2142925664366737,0.0707070707070707,0.7923158234471801,1.0,42/160,15.09%,DDIT4;IL1RAPL2;LSR;MAL;ZBTB16;SPOCK1;NCAN;RELN;VCAN;MYRF;NR4A2;NFIB;MEIS2;CDH2;AATK;SOX4;CA10;ROBO2;MOG;SH3GL3;PTPRZ1;MARCKSL1;GRIN2A;GRIK1;ARNT2;POU6F1;PAX8;TAGLN3;ADAM23;MFSD2A;CNTNAP2;EPHA7;SOX6;ADGRL2;SH3GL2;SHROOM4;TPPP;UGT8;PKD1;EIF2B2;GRIN2B;NDRG4
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.5923800159331063,1.2142490325569224,0.125,0.7919139422270353,1.0,5/58,6.15%,DIAPH3;ANLN;RACGAP1;TFRC;VAPB
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.7218442203189017,1.2141490898997258,0.2602739726027397,0.7918413260082968,1.0,3/8,17.45%,ATOX1;SLC31A2;APP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5659638281522021,-1.2141336569861807,0.17857142857142858,0.8125524429375216,1.0,2/13,2.97%,NPC2;NPC1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.6482477505580051,1.214050921077313,0.22077922077922077,0.7916570242591697,1.0,5/23,9.36%,HTR2B;TGFB2;VEGFA;INSR;RYR2
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.8084480785899251,1.213879498827502,0.203125,0.7919128656221592,1.0,2/6,7.63%,CLDN18;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.7427565293393282,1.2137703000448499,0.234375,0.7917566964650878,1.0,3/6,7.94%,GRIN3A;NGEF;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.7633125128196161,1.2137127263124028,0.2,0.791454367032283,1.0,4/6,21.81%,EPHA4;THY1;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.7646370786812916,1.213676477469605,0.23529411764705882,0.7911455310404707,1.0,2/6,15.68%,VMP1;ATP2A2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.6702920144020966,1.2136293129705291,0.18604651162790697,0.7908162818371367,1.0,7/29,10.42%,DAPK2;SYNE3;SLC11A1;GHR;KCNMB1;CPM;C5AR1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7438951326070924,1.2135535494028926,0.24,0.7905501313538936,1.0,1/10,0.17%,GPR18
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.8009714155204966,-1.2134467057652818,0.2,0.8136050230689001,1.0,3/5,15.80%,STIM1;STIM2;CRACR2A
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,0.7805699666120474,1.213406539788622,0.2571428571428571,0.7907569968344668,1.0,5/8,19.80%,SCO2;UCKL1;DCK;UPP2;UCK2
prerank,KEGG_2021_Human__Melanoma,0.5907798033698605,1.2133500727837323,0.26881720430107525,0.7904704597712325,1.0,3/43,2.91%,FGF1;ARAF;GADD45B
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.6059912634391581,1.2129950153536775,0.14285714285714285,0.7917943575865646,1.0,14/61,18.79%,FA2H;PLPP3;ALDH3B1;VAPB;ARSA;GALC;PPM1L;UGT8;SPTLC2;UGCG;SUMF2;PRKD3;SUMF1;GBA3
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7046067969073976,1.2128938711158335,0.1891891891891892,0.791777911327887,1.0,5/17,15.66%,HS3ST5;HS6ST3;SULF2;HS2ST1;NDST3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.7358173468620828,-1.2128576669719915,0.36363636363636365,0.8141412052882061,1.0,3/6,14.21%,TICAM1;TREM2;AKT1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5840660109701996,1.2127781539200715,0.1595744680851064,0.7918584982965612,1.0,24/79,22.86%,GLRA1;SYT4;ANK3;NLGN1;ADCY8;RYR3;SYT1;FBP1;BNIP3;WNT5A;CLIC4;IQGAP1;PRKAA2;DLG4;FOS;ECT2;CPNE8;CPNE2;LRRK2;CDKN1B;HFE;SYT11;CPNE3;JUN
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,0.655780349782445,1.212302187614448,0.2823529411764706,0.7939607526803985,1.0,8/17,15.42%,VGF;STXBP5L;PDIA2;SYT4;SYP;CKB;CHGB;CPLX1
prerank,KEGG_2021_Human__Malaria,0.6710526597900712,1.2120886582182668,0.16666666666666666,0.7943094002641368,1.0,3/22,1.54%,THBS1;TGFB2;CR1
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.704513637297165,1.2120566221701938,0.20270270270270271,0.7938901243615997,1.0,5/15,16.84%,IDI1;MVD;ACAT1;HMGCS1;DHDDS
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.623028057201601,1.211985770827107,0.17582417582417584,0.793706361970335,1.0,7/35,11.82%,ADCY3;CREB5;AGT;NR4A1;GNA11;ADCY8;NCEH1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.6070519591076041,1.2119697867642363,0.23333333333333334,0.7932122377201979,1.0,11/35,20.77%,TM7SF2;IDI1;MVD;FASN;SCD;FDFT1;HMGCS1;SMARCD3;TBL1XR1;PPARA;ACACB
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.6113823155818725,1.211597535978605,0.16666666666666666,0.7943605539456633,1.0,12/43,17.30%,TNC;SPARC;FBXL7;LAMB1;AKAP12;FN1;MAP1B;ADGRL2;TIMP3;THY1;EDIL3;MPDZ
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6904521770439673,1.2115197059768736,0.18292682926829268,0.7941010326535551,1.0,2/16,3.05%,MAPT;CD22
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.6261450174550176,1.2114949916582414,0.14772727272727273,0.7936559382574391,1.0,9/41,14.15%,PLPP3;GLA;DGKI;MBOAT2;DGAT1;DGKB;AKR1B1;DGKG;GK
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.6256772611044842,1.2114251207272306,0.23076923076923078,0.793390453277458,1.0,14/31,25.50%,NRXN1;NRXN2;GAD1;SNAP25;UNC13A;GAD2;SYT1;CPLX1;STXBP2;SYN2;BRSK1;PPFIA3;RIMS1;PTPRN2
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.8097354956099247,1.2111754552694867,0.21875,0.793314231506513,1.0,1/5,0.28%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.8097354956099247,1.2111754552694867,0.21875,0.793314231506513,1.0,1/5,0.28%,THBS1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.7398195515268843,1.2106504378232636,0.23943661971830985,0.7954804761186638,1.0,5/10,18.84%,PIGU;NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.7488215087405601,1.210362265902176,0.16901408450704225,0.7963534699023429,1.0,2/12,7.22%,HTR2B;HIF1A
prerank,KEGG_2021_Human__Salivary secretion,0.594094013542198,1.2102245199700927,0.2159090909090909,0.7965394965659847,1.0,21/43,26.81%,AMY2B;ADCY3;CALM3;ADCY8;CHRM3;RYR3;GUCY1B1;ATP1B3;KCNMA1;PLCB1;ATP1B2;GNAQ;GUCY1A2;ATP1A2;SLC9A1;PRKCB;PRKACB;ATP2B2;ATP2B4;PRKG1;ADCY1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.780311524406379,1.2100702736938669,0.2112676056338028,0.7966772847490871,1.0,1/7,6.90%,CA2
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6067020383493041,1.2098348351640835,0.16279069767441862,0.7973831159021142,1.0,12/29,22.91%,RTN1;ABCA2;NTRK2;EPHA4;PICALM;CASP3;TMED10;ROCK1;RTN3;TNF;RTN4;ABCG1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.40769595870561404,-1.2097881543035072,0.16666666666666666,0.8224661833144167,1.0,26/91,12.54%,MATK;NKG7;CD300LF;ITGAM;CST7;GNLY;BIN2;SELPLG;P2RX1;PIK3R6;MPEG1;HCST;TGFB1;EPOR;ITGAX;AOAH;MAFG;MYO1F;PLEK;HCK;ITGB2;CYTH4;TREML1;LCP2;PLK3;TYROBP
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.6003079852563754,1.2097076586518054,0.1590909090909091,0.7975063863413802,1.0,8/44,12.93%,HTR2B;PPP1R9A;NUDT4;AGT;EIF2AK3;RYR2;CHRM3;GUCY1B1
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.6670600794628259,1.2096320035471584,0.26582278481012656,0.7972671564537278,1.0,8/13,25.30%,SNAP25;PPFIA2;SYT1;CPLX1;PPFIA4;TSPOAP1;PPFIA3;RIMS1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5738704788332741,1.209380465299069,0.14893617021276595,0.7981144225812259,1.0,18/101,11.99%,KLF4;LRP2;ACVR1B;KNSTRN;MAPT;NR4A1;ANXA1;ACVR2A;BMPR1B;VEGFA;SEMA6A;OVOL2;NTRK3;PDE2A;FLT1;SOX6;NTRK2;MAGI2
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.4227814626232381,-1.2093145626676134,0.2,0.8226522390556122,1.0,31/91,14.46%,CD300LF;ITGAM;LY86;PTAFR;BIN2;PIK3R6;MPEG1;LGALS9;CSF1R;LILRB4;ITGAX;AOAH;ALOX5;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;HLA-DPA1;HLA-DRB6;FCGR1A;ITGB2;CYTH4;TLR7;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.5862390239353429,1.2092291097810652,0.20987654320987653,0.7982778290034542,1.0,16/50,21.00%,LRP2;SLC2A3;TFRC;SLC1A2;INSR;SLC13A3;ABCA2;SLCO3A1;MFSD2A;SLC24A3;SLC16A1;ATP1B2;SLC44A1;ATP1A2;LEPR;SLC5A6
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.679633000953059,1.2091421416223422,0.13414634146341464,0.7980385591210108,1.0,9/19,27.66%,PLIN2;GFAP;RPS27A;UBA52;UBB;EEF1A1;CFTR;HSP90AB1;HSPA8
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),-0.7261892529975228,-1.209090024433982,0.34210526315789475,0.8221277879458657,1.0,2/7,16.01%,IPPK;ISYNA1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.5594003067601948,-1.209052222945914,0.23076923076923078,0.82094071702914,1.0,3/13,4.42%,SKAP1;SAMSN1;IL4I1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.7740340051698384,1.2089653885157379,0.208955223880597,0.7984880437978289,1.0,2/6,13.42%,MAPT;PRELID1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.6464041492756937,1.2088360328721555,0.2375,0.7986031330773248,1.0,9/23,28.90%,ADCY8;GNAI1;GNAL;KCNJ6;KCNJ3;GNB5;ADCY1;GABBR2;ADCY2
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.8052899032281909,1.208615248395077,0.25396825396825395,0.7992420910958118,1.0,2/5,19.38%,CCDC39;SPATA6
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7766236977567339,1.2085561457520895,0.19672131147540983,0.7989076066363421,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7869798458126501,1.208502901128848,0.22580645161290322,0.7985396399799284,1.0,1/5,2.79%,MAPT
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.7284293355244382,1.208163516184524,0.28125,0.7997476343114945,1.0,1/8,2.27%,GLA
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.6100414730011108,-1.2079017255484041,0.21739130434782608,0.8234719556229854,1.0,4/13,13.33%,CYP19A1;GCLC;SLC35D1;GCLM
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,0.7836700537256766,1.2078689806409724,0.19696969696969696,0.8000698556329773,1.0,3/7,8.14%,OMG;LINGO1;MAG
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,0.7836700537256766,1.2078689806409724,0.19696969696969696,0.8000698556329773,1.0,3/7,8.14%,OMG;LINGO1;MAG
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.598614956736861,1.20781734715332,0.22826086956521738,0.7997766486316563,1.0,11/66,17.12%,PLPP3;CENPE;RACGAP1;NAPA;KIF15;ARFGAP1;NSF;KIF11;TMED10;KIF5A;KIF3A
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7974014236745126,1.2075477297906156,0.19718309859154928,0.8004452892431364,1.0,3/6,18.25%,SOD2;ADPRS;SOD1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.6360395297822661,1.2074787654104964,0.25301204819277107,0.8002537208677792,1.0,6/22,9.72%,THBS1;KLF4;FGF1;VEGFA;SEMA6A;GLUL
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.67534498209572,1.207381497980178,0.19540229885057472,0.8001097588127652,1.0,3/23,9.28%,FGF1;PIGU;IRS2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6966930414820295,1.207370847301567,0.2125,0.7995944533130591,1.0,2/17,4.63%,LRP4;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.8427295218417693,1.2071974232721652,0.1774193548387097,0.79996423298936,1.0,3/5,7.86%,EGR1;HIF1A;PAX8
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.5871595709151551,1.2070663872955567,0.19540229885057472,0.8000299158056774,1.0,14/47,16.59%,PLPP3;SVEP1;PRLR;LIFR;LAMA2;MAFB;SH3D19;MLANA;SASH1;COL21A1;ALDH1A1;TIMP3;CPE;EPAS1
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,-0.5781896864982748,-1.2068280008362953,0.2857142857142857,0.825950542160184,1.0,2/8,14.48%,IL6R;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7056061108076861,1.2067362753164244,0.1794871794871795,0.8009448245336047,1.0,6/15,17.45%,CHI3L1;CEMIP;CALM3;PRKAG2;RIPK2;APP
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6535824919017139,-1.2066369641991825,0.2222222222222222,0.825313902728359,1.0,2/7,3.78%,ATRAID;DAB2IP
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.7072371210472446,1.2065229054288253,0.23809523809523808,0.8014946608842404,1.0,3/11,7.98%,TLE1;TCF7;TCF7L1
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,0.6286266418332046,1.2064825018600813,0.15853658536585366,0.801141768452,1.0,12/33,17.60%,PCDH17;PREX2;PTPRD;CGNL1;RUNX1T1;FLT1;SORBS1;ADGRL2;SHROOM4;LDB2;GIPC2;SORBS2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5730657475598345,1.2062759436057802,0.13829787234042554,0.8016233953222162,1.0,20/83,18.16%,HTR2B;TGFB2;SH3PXD2B;LDB3;MMP21;VEGFA;SOX4;INSR;PKP2;POU6F1;FN1;ID2;NTRK3;SGCZ;PKD1;NDRG4;TBX19;CACYBP;FLRT2;SGCD
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6965282058749762,1.2060107977144767,0.25757575757575757,0.8022925008440436,1.0,5/14,25.31%,ANK3;TMTC2;FAM20A;TRPM7;CNNM2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7703460194362866,-1.2058699639450376,0.4,0.826153255611761,1.0,3/5,17.46%,NR1H3;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5891866582606221,1.2055577129939554,0.23404255319148937,0.8038404172427754,1.0,11/56,13.26%,ARRDC3;BMI1;SEPTIN4;FANCM;FANCI;KDM1A;RBX1;PRICKLE1;RIPK2;BRCA1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.584073570958752,1.2053544789622574,0.17582417582417584,0.8043995433493233,1.0,18/62,21.14%,PRLR;TSHR;ACSL1;PLAC8;VEGFA;GRB10;KDM3A;IGF1R;KDM1A;DYNC1H1;SCD;PEMT;IL18;EPAS1;ESRRG;KDM6B;LEPR;MFN2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7307592422571596,1.205323538595626,0.23684210526315788,0.8038781632189963,1.0,5/11,11.78%,ZBTB16;BMPR1B;MBOAT2;TRPS1;SOX6
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.7512612258947253,1.2051373541754336,0.18666666666666668,0.8043158220539541,1.0,2/7,6.35%,GALNTL6;GALNT13
prerank,KEGG_2021_Human__Bile secretion,0.6105649089152639,1.204674585156738,0.2111111111111111,0.8061322877035868,1.0,12/38,21.68%,SLC51A;ADCY3;SLCO1A2;CA2;ADCY8;NCEH1;SLC10A1;ATP1B3;ATP1B2;ATP1A2;SLC9A1;ABCB4
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.664277722946889,1.2043736064600252,0.21176470588235294,0.8070360639795601,1.0,3/25,9.28%,FGF1;PIGU;IRS2
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.7884781370741405,1.2043607821578204,0.2,0.8065075953805035,1.0,2/6,12.11%,XPO1;NMD3
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6716900610619616,1.2043575389420147,0.20987654320987653,0.8059331252534321,1.0,4/17,9.91%,LSR;DMD;LAMA2;MFSD2A
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.6235024249655907,1.2042483273827531,0.19101123595505617,0.8059604068284612,1.0,16/40,20.74%,DCC;MAPT;TFRC;NFIB;GRIN3A;SFMBT1;KANK1;RAPGEF3;BNIP3;PINK1;THY1;ROCK1;KLF7;SUZ12;PTPRS;BCL11A
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7338619604589873,1.2038743094329192,0.24,0.8075155304455226,1.0,5/10,19.63%,SLC4A10;GRIK2;SYP;SHISA9;SYNGR1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.627439905987328,1.2036375305154103,0.2073170731707317,0.8083016732211695,1.0,13/34,21.03%,PFKM;ENO2;PGAM1;GPI;NR4A3;PKM;ENO4;SLC16A3;SLC16A1;PGK1;PGM1;ENO1;PDHB
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.6013303624995755,1.2036190410624044,0.18681318681318682,0.8077808674304509,1.0,16/51,18.04%,PRKAR2B;MAPT;NRG1;GRIN2A;GRIA2;ADCY8;CAMK2B;PRKAG2;RPS6KA2;LRRC7;RASGRF1;GRIN2B;NEFL;NRGN;GRIA1;PRKAA2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.698611635599156,1.2034651306844544,0.25316455696202533,0.8079598489426368,1.0,5/16,13.21%,DGKI;DGAT1;DGKB;LIPE;DGKG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6539566427481662,1.2034344196270916,0.21621621621621623,0.8075198783638853,1.0,1/15,1.54%,CR1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.8168606691083904,1.2033281562422005,0.27419354838709675,0.8074594694245486,1.0,2/5,12.55%,PAICS;PRPS1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5900953134947593,1.203170136051323,0.25882352941176473,0.8077844399547727,1.0,6/48,8.27%,THBS1;LRP2;AGT;ACVR2A;BMPR1B;SPRY1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6672135937737459,-1.2031632474496956,0.2702702702702703,0.8329632252519756,1.0,4/7,17.87%,ZNF385A;SPRED2;PYHIN1;DDX5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.674518359263755,1.2031631477178408,0.3108108108108108,0.8072592561565961,1.0,6/15,27.75%,RUVBL2;NHP2;SHQ1;TCP1;CCT8;DKC1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.6346746430801864,1.2030048611891395,0.18823529411764706,0.8075242011134007,1.0,8/28,10.80%,VIM;GFAP;METRN;CDH2;BMI1;SLAIN1;ID2;NR2F1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,0.8137665742834925,1.2027524646204495,0.23076923076923078,0.8081599619625864,1.0,3/5,16.02%,ANXA1;PAPSS2;TSHZ2
prerank,KEGG_2021_Human__Calcium signaling pathway,0.5544866020074333,1.2027238474075712,0.1368421052631579,0.8077283779452307,1.0,29/121,17.42%,HTR2B;FGF1;HTR7;CHRM5;TACR1;ADCY3;PDE1A;ITPKC;GNA11;VEGFA;GRIN2A;CALM3;PDE1C;RYR2;NTRK3;CACNA1B;ADCY8;CHRM3;CAMK2B;FLT1;NTRK2;RYR3;GNAL;ASPH;PHKG1;ATP2A2;CACNA1A;PLCB1;SLC25A4
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5407738723153172,1.2026455407530998,0.18556701030927836,0.8075224625529205,1.0,39/120,22.37%,SHANK3;OMG;GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;CTNND2;NYAP2;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;CNTNAP2;PLP1;SLC9A6;TMEM108;SH3GL2;EPHA4;STMN2;PLXNB1;RASGRF1;ROCK1;APP;ERCC6;NCDN;GRM7;UBB;CDK5R1;DLG4;CNTNAP1;UHMK1;LRRK2;PAK3;CTTN;DCLK1
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.6022185473616531,1.2025733159316063,0.1744186046511628,0.8072837732631996,1.0,19/53,23.12%,SPARC;ENPP2;PREX2;RFTN2;DAAM2;CELF2;CD93;SGIP1;FLT1;SORBS1;SHROOM4;LDB2;SGCD;NCAM1;TCF4;ATP1A2;SYT11;SPARCL1;MRC1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7366256789797989,1.20217999042155,0.2647058823529412,0.8086911782185153,1.0,3/10,17.22%,VEGFA;SEMA5A;HSPB1
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.4613420358165529,-1.2021103037810223,0.2857142857142857,0.8352120950110352,1.0,23/70,15.58%,TICAM1;CARD14;PIDD1;BCL2L1;IL1B;CHUK;EDA2R;BLNK;IRAK4;ICAM1;MAP3K14;EDA;BTK;IKBKB;NFKBIA;BIRC2;CXCL12;SYK;BCL2;BCL10;CARD11;TIRAP;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),0.8007846163400083,1.2020672931623984,0.2857142857142857,0.8087029685416506,1.0,3/5,13.83%,CD22;FCGR2B;CD300A
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.47832577606670146,-1.201855121081231,0.11764705882352941,0.8346518155757285,1.0,5/16,11.56%,TICAM1;CHUK;TLR3;IKBKB;BIRC2
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.6492057195516844,1.2017700976600971,0.25287356321839083,0.8095859314838577,1.0,10/23,16.79%,KCNT2;GNAO1;SYT16;SV2B;ZNF385B;GABRB2;GAD2;HCN1;CC2D2A;CHD5
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6232826118001183,-1.2017047029360044,0.22727272727272727,0.8337437767173486,1.0,5/11,21.82%,KHSRP;ZFP36;UPF1;MOV10;ZC3H12D
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6382722558117223,1.2015522708377366,0.29545454545454547,0.8100653184206286,1.0,11/28,12.37%,LRRC4C;RELN;GRIK2;IQSEC2;GRIK1;NLGN3;NLGN1;PXK;CACNA1B;NRG3;GRID2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7457422137686542,1.2015317223611799,0.21212121212121213,0.8096279460791491,1.0,2/6,5.04%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.7218480306293487,1.2013344904164314,0.2911392405063291,0.8101329568475348,1.0,2/11,3.26%,CENPE;RIOK2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.5915428612447825,1.2012533042613083,0.18681318681318682,0.8098935929926546,1.0,16/51,12.78%,LRP4;ENAH;DOCK1;GNA11;PTPRG;KITLG;LIFR;LAMB1;RBFOX2;RND3;FN1;ERRFI1;FIGN;SH3D19;ADGRL2;UACA
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),-0.6687660928528086,-1.201068381166444,0.24242424242424243,0.8344530791361342,1.0,2/8,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.566453326503129,1.2010450792903817,0.13541666666666666,0.8103713836530582,1.0,22/76,14.46%,ACVR1B;PTPRD;PTPRG;ACVR2A;LIFR;INSR;EPHA3;PTPRT;PTN;SHC2;IGF1R;FGR;NTRK3;GP6;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;EPHA6;EPHA5
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.5756604900516433,1.201006931082483,0.17391304347826086,0.8099613321619088,1.0,15/70,15.76%,CENPF;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;SEH1L
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.6521993012306846,1.2009756634187672,0.19753086419753085,0.8095453013100598,1.0,5/25,10.26%,THBS1;NR4A1;VEGFA;ROBO1;SEMA5A
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.6006739767646263,1.2009352414720966,0.2638888888888889,0.8091692388224333,1.0,7/22,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;TECPR2;SURF4;HSP90B1
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,-0.7388431581578656,-1.200832818544098,0.2972972972972973,0.8338750668748277,1.0,2/5,7.96%,TP53;PPP1R13B
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.7738639846384161,1.2006107026969182,0.22580645161290322,0.8102560217645366,1.0,2/6,20.16%,PAICS;CTPS1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.5634905753398047,-1.200367941945639,0.16,0.8341686869891289,1.0,3/10,16.26%,CPSF1;CPSF2;CPSF4
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7276210074970328,1.2003661534700203,0.17721518987341772,0.8111381159489699,1.0,2/12,4.63%,TGFB2;BMPR1B
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6764461792529606,1.200358104702146,0.17333333333333334,0.810624212227001,1.0,5/17,13.96%,COBL;TGFB2;CLMP;CCDC39;PKD1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6592659056992123,-1.200348860458055,0.2222222222222222,0.8328333098147951,1.0,2/9,4.46%,IL4I1;LILRB4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.7952070753298213,1.2002646396897463,0.18055555555555555,0.8104905587959375,1.0,2/5,8.38%,CDH2;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.5484735427454679,-1.2002441837112914,0.20689655172413793,0.8318274078520584,1.0,4/16,3.56%,CEBPA;TFAP4;HHEX;LATS2
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.6186597010694148,1.2002249475980211,0.17647058823529413,0.8101217019755518,1.0,2/33,1.62%,PDE5A;VIM
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.6970979949311086,1.2002135573130561,0.27419354838709675,0.8095900193894212,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.6825758129049433,1.2000387562352122,0.2625,0.8098556821085029,1.0,6/18,15.68%,ANK2;PKP2;CAV3;CALM3;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6602744017433544,1.2000149172581658,0.2236842105263158,0.8094358666567967,1.0,7/17,20.17%,NRG1;SGCZ;SMAD1;SGCD;SMAD5;KDM6B;NOTCH2
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7865183198415168,-1.1999827574398072,0.3611111111111111,0.8312791657202213,1.0,3/5,15.48%,ETS1;SERBP1;HABP4
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.6409130397523568,-1.1998705923568513,0.2962962962962963,0.8301495293141761,1.0,5/8,25.35%,SVIP;DERL2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.5531876685736827,1.199712977209702,0.09090909090909091,0.8103989140934111,1.0,42/201,15.60%,RHOBTB3;P4HA3;RHOB;SHROOM3;ADAMTS2;TGFB2;COL11A1;VIM;CORO6;GFAP;CLIP3;PPP1R9A;MAPT;COL4A5;COL26A1;FIGNL1;COL23A1;CGNL1;COLGALT2;COL24A1;HDGFL3;MARCKSL1;STMN3;RND3;ERMN;RPS27A;CARMIL1;P4HA1;FIGN;DYNC1H1;COL21A1;SPAST;CKAP5;SHROOM4;TPPP;COL10A1;STMN2;HOOK3;NEFL;TGFBI;COL5A3;PLOD1
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.6521459559821274,1.1996894573928631,0.2857142857142857,0.8099402163785941,1.0,10/18,25.30%,SLC1A2;SNAP25;PPFIA2;SYT1;SLC17A7;CPLX1;PPFIA4;TSPOAP1;PPFIA3;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.8245192873810151,1.1995862626447154,0.15625,0.8099053761063763,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.7200074596530579,1.199486268803037,0.2857142857142857,0.8099226351987416,1.0,3/10,5.86%,NTN4;GPM6B;LAMB1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7461545439146664,-1.1994203522658955,0.41935483870967744,0.8300155672803936,1.0,2/5,5.98%,CCL5;CD274
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,0.6849201075627499,1.1993971218985093,0.21686746987951808,0.8098618503163445,1.0,3/17,2.19%,ALDH3B1;CBR1;CYP3A5
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.804040166883287,1.1993515137181532,0.23880597014925373,0.8094633067257723,1.0,1/5,3.08%,ERCC2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.6760904272580397,1.198732161759008,0.1951219512195122,0.8119804221510023,1.0,7/20,22.85%,MAPT;INF2;BNIP3;PINK1;DDHD1;LRRK2;STAT2
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.5732289856267629,1.1987148650161552,0.12631578947368421,0.8114836260180084,1.0,10/81,9.85%,PLPP3;PRKCE;DOCK1;ARF6;FCGR2B;ASAP2;RPS6KB2;MARCKSL1;MYO10;WASF1
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.748122068198934,1.198672271743685,0.2807017543859649,0.8111107139812884,1.0,2/5,15.28%,PRPS1;DCK
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.631129432746279,1.198625125751642,0.2222222222222222,0.8107448076792628,1.0,11/23,30.92%,TFRC;STEAP2;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;ATP6V1E2;ATP6V0A1;MCOLN1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.6703135860409363,1.1985537117642246,0.25316455696202533,0.810495951548106,1.0,4/18,15.06%,AGT;BMI1;FN1;WNT5A
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,0.5919888585842004,1.1981093305268034,0.16091954022988506,0.8122853411655856,1.0,17/48,20.65%,TUB;PIANP;CLIP3;B4GAT1;COLGALT2;CHN1;WASF1;CRMP1;PPM1E;DTX3;NAT8L;APLP1;NCDN;DCTN1;DLG4;REEP2;UCHL1
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.7421548998689618,1.198108713501973,0.21333333333333335,0.8117189673640014,1.0,3/15,3.19%,CACNB2;NCAN;COL4A5
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5820747385454056,1.1981036110811827,0.18888888888888888,0.8111663126100856,1.0,13/39,22.61%,KCNJ13;SYT4;ANK3;CA2;PXK;PER1;NKAIN2;SYT1;KCNJ6;KCNJ3;SPTBN4;HFE;SYT11
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.7636249923357886,1.198052776598717,0.18571428571428572,0.8109049489708693,1.0,4/7,18.84%,NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.5531407997383653,1.19778954830454,0.1368421052631579,0.8116568065412211,1.0,10/81,8.46%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;ENDOD1;FN1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.40710986197599813,-1.197553879847955,0.0,0.8348337364327536,1.0,13/67,11.56%,ITGAM;TICAM1;CHUK;LGALS9;IRAK4;SCIMP;TLR3;NMI;BTK;IKBKB;ITGB2;TLR7;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.8017504787043671,1.197452907320736,0.22857142857142856,0.8128008589122284,1.0,1/5,6.34%,RGS2
prerank,KEGG_2021_Human__Insulin signaling pathway,0.5693184297158878,1.19732962084609,0.12371134020618557,0.8129061046224224,1.0,18/101,14.79%,SOCS3;ARAF;PRKAR2B;TRIP10;RPS6KB2;INSR;CALM3;RPS6;SHC2;IRS2;LIPE;PRKAG2;SORBS1;PPP1R3B;FBP1;FASN;PHKG1;MAPK10
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5855876023516057,1.1972293430559116,0.2,0.8126700042027435,1.0,6/37,16.50%,ARAF;RPL23;XPO1;CAV3;RNF139;RPL11
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.5848749881052698,1.1970593828153497,0.25,0.8130067887353805,1.0,16/51,21.00%,LRP2;SLC2A3;TFRC;SLC1A2;INSR;SLC13A3;ABCA2;SLCO3A1;MFSD2A;SLC24A3;SLC16A1;ATP1B2;SLC44A1;ATP1A2;LEPR;SLC5A6
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.6187207024635882,1.1969954196830237,0.18181818181818182,0.8128030922212575,1.0,6/28,13.44%,HTR2B;SEMA3A;SEMA3B;SEMA6A;SEMA5A;CENPV
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7494673989955977,1.1969373790013729,0.2,0.8124840461371847,1.0,3/10,9.76%,COBL;SPIRE2;CARMIL1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.6897067922772266,1.1969236391488263,0.2625,0.8120370534717282,1.0,3/13,14.50%,ARF6;STMN3;RASGRF1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.6870223975376243,1.1969190662559832,0.2236842105263158,0.8114880435473657,1.0,1/16,0.50%,NFIL3
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.6300033221589648,1.1964554114778663,0.25301204819277107,0.8132989363719003,1.0,2/26,3.16%,FGF1;PIGU
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7434811516565698,1.196250823722959,0.26153846153846155,0.8137363687095288,1.0,2/8,7.69%,PIGU;PTPRT
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.6001465300434271,1.196240644207776,0.24719101123595505,0.8132193309689171,1.0,11/45,10.30%,LRP4;ENAH;COL4A5;MTCL1;GNA11;LAMB1;FHL1;RBFOX2;RND3;BOK;FIGN
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6835461648920133,1.1961227421296863,0.3076923076923077,0.813163618415232,1.0,4/11,21.98%,DMD;ANK3;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6778598765206008,-1.1960291076209493,0.30303030303030304,0.8377661683726694,1.0,1/7,3.45%,ACTB
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.6320562932647071,1.1957579346215486,0.17721518987341772,0.8142331182440365,1.0,5/28,14.02%,RGS20;PRKCE;ADCY8;GNAI1;RGS17
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.7292842548219842,1.1957480961070959,0.2602739726027397,0.8137359803189269,1.0,2/10,5.86%,TGFB2;LAMB1
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.6532382616636131,1.195703555365986,0.19540229885057472,0.8122104649524888,1.0,4/27,9.30%,FGF1;PIGU;IRS2;IGF1R
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.6532382616636131,1.195703555365986,0.19540229885057472,0.8122104649524888,1.0,4/27,9.30%,FGF1;PIGU;IRS2;IGF1R
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.6532382616636131,1.195703555365986,0.19540229885057472,0.8122104649524888,1.0,4/27,9.30%,FGF1;PIGU;IRS2;IGF1R
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8218151342754271,1.1956307488712046,0.2112676056338028,0.8119836796380805,1.0,4/5,13.76%,THBS1;PDE10A;PDE2A;RUNDC3A
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6350485575459018,1.1956181176292155,0.2,0.811483463822493,1.0,8/25,17.63%,ZBTB16;NFIB;CHI3L1;ITGB8;SOX6;SULF2;PKD1;SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7626636507689237,1.1954025134201902,0.2222222222222222,0.812192675925215,1.0,4/5,23.76%,CAV3;DEPTOR;RDX;PTEN
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.803677414516613,1.1953809931314006,0.22058823529411764,0.811775654431468,1.0,1/5,1.28%,TGFB2
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,-0.7283104463398292,-1.1952963732280868,0.21951219512195122,0.8383714733913279,1.0,3/5,20.89%,CRK;RAP1A;KIDINS220
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7215586681208481,1.1951609120276963,0.32098765432098764,0.8122168576522621,1.0,2/10,14.47%,NUDT16;ZC3H12B
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5718613261391108,1.1951473403178634,0.17647058823529413,0.8117559572302783,1.0,11/50,16.61%,KMO;ASPA;CARNS1;FAH;GAD1;ACAT1;GLUL;ALDH6A1;BLMH;SLC25A21;CARNMT1
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.8129398882828198,1.195070172350965,0.19047619047619047,0.8115367722688996,1.0,1/6,5.04%,VEGFA
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.591675211824431,1.1949788154195848,0.15555555555555556,0.8114066470842788,1.0,9/44,21.28%,FGF1;FLRT1;RBFOX2;HNRNPH1;POLR2D;FLRT2;FIBP;FGFR2;POLR2G
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.6218422271018484,1.1948399514685202,0.189873417721519,0.8114794338187903,1.0,15/38,26.86%,GEMIN2;RPS6;RPS27A;RPS25;RPS27;RPS11;RPS20;RPS4X;RPS24;RPS9;RPS3A;SNRPD2;RPS16;FAU;RPS12
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6251664816957253,1.1947411929780223,0.24175824175824176,0.8114381619878217,1.0,10/26,20.64%,SH3BP5;RELN;AGT;SRCIN1;GPRC5B;EPHA4;THY1;APP;DLG4;SH3BP5L
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,0.7666540340817829,1.1944268649883238,0.26865671641791045,0.812320635470496,1.0,3/6,17.50%,AMY2B;MGAM;GUCY2C
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7441851337782245,1.1942397610244722,0.25,0.8127593328957146,1.0,4/8,17.56%,NLRP12;ANXA1;TMED10;FOXP1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7781983294115733,1.1942201512500366,0.3,0.8122939642016365,1.0,2/6,10.87%,NAMPT;NOD2
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,0.5990852559665543,1.1940004824013302,0.29347826086956524,0.8127825842167806,1.0,3/31,1.44%,ASPN;OMD;ECM2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6143770498478883,-1.193986754797576,0.2777777777777778,0.8413099904004449,1.0,2/10,1.86%,NEXMIF;SERPINF2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6914921710714661,1.1938627713343641,0.2191780821917808,0.8128667418552832,1.0,5/15,19.55%,DGAT1;SCD5;FASN;SCD;ACSL3
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.708053487751223,-1.1938460413526895,0.26666666666666666,0.8403247778243119,1.0,1/5,3.85%,WRAP73
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.7139313075248823,1.1936797229524467,0.2361111111111111,0.8132218934257316,1.0,6/15,13.71%,MAPT;HDGFL3;STMN3;CKAP5;TPPP;STMN2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.620190235098434,1.193544976847672,0.2236842105263158,0.8133056334529036,1.0,4/23,16.92%,ANK3;NSF;PREPL;SPTBN1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.7072797063596832,1.1934433200533765,0.17142857142857143,0.8133011114283422,1.0,3/15,5.83%,WDR12;MAK16;PES1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.6856531696995487,1.1933346716328561,0.2597402597402597,0.8132148009805135,1.0,2/17,3.26%,CENPE;RIOK2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4062414794177394,-1.1931862586535624,0.15384615384615385,0.8414781754124278,1.0,11/58,12.38%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.6682927574628693,1.1929807099357381,0.25882352941176473,0.8147193664738774,1.0,9/18,20.39%,GRIK2;CDKN2AIP;ANK3;RIMS2;SYT1;RIMS3;DLG4;TNF;CLSTN2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6021463149692832,1.1929237112779585,0.2,0.8144939703334011,1.0,13/41,19.12%,ANXA1;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;SYT1;NSF;DISP1;CPLX1;MCTP1;SCG5;RAB21
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.6180848654712271,1.1927454033509814,0.23809523809523808,0.8148591057690123,1.0,16/28,30.45%,NAPA;DNM3;DNM1;NSF;SNAP29;UBXN2B;NAPG;CHP1;HACE1;RIMS1;VAPA;OPA1;GCA;NSFL1C;MX2;MX1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.47476037910964214,-1.1923955022824673,0.07692307692307693,0.8428623415649404,1.0,2/32,0.57%,STAT4;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.6191823643768316,1.1921959877235024,0.2222222222222222,0.8169869231793195,1.0,9/30,17.40%,MAPT;SYT4;INSR;UNC13A;RIMS2;GHR;SYT1;PLCB1;MAP3K13
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.5727752670500967,1.192177428605992,0.12903225806451613,0.8166162198909457,1.0,9/81,6.56%,KLF4;LRP2;ACVR1B;NLRP12;IL1RAPL1;ACVR2A;BMPR1B;ROBO2;AKAP6
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.5631267169624842,-1.1921724784042962,0.15,0.8422199608505606,1.0,3/16,5.36%,P2RX1;STIM1;ITPR2
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.4457732336472393,-1.1921090019057914,0.0,0.841218402209049,1.0,17/81,9.59%,ITGA5;ITGAM;SELPLG;GYPC;CD2;YES1;CEACAM21;SDC3;OLR1;SIRPA;TGFB1;SLC7A8;FYN;ITGAX;BSG;SRC;INPP5D
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.45773442577392137,-1.1920795532947175,0.2,0.8399230546203038,1.0,17/123,10.55%,THEMIS;ITK;SKAP1;GRAP2;BTN3A2;PSMB3;CD276;PSME3;CHUK;PSMC4;PSMD12;FYN;STOML2;PSME4;INPP5D;IKBKB;HLA-DPA1
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation In TLR7/8 Or 9 Signaling R-HSA-975110,-0.729615844291911,-1.1919539537731678,0.32432432432432434,0.8389284315005877,1.0,4/7,23.64%,IRAK4;TLR7;MYD88;IRF7
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,-0.6347024368292054,-1.1918470844799745,0.22580645161290322,0.8378735684476407,1.0,4/10,9.59%,YES1;FYN;SRC;INPP5D
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.6375259208496832,-1.1918140104934718,0.3170731707317073,0.8365898460623162,1.0,3/6,10.32%,CRKL;P2RY12;TREM2
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.6148302810381303,1.1915989763768808,0.25,0.8189467084141658,1.0,5/33,13.86%,NFIX;NFIB;POLR3F;POLR3H;ZNF143
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.7707171658886033,1.191176416382017,0.18055555555555555,0.8205539050065409,1.0,2/7,9.84%,ITGA2;GP6
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,-0.6666813790850699,-1.1909467204892517,0.23076923076923078,0.8375447091668519,1.0,3/10,7.76%,DUSP3;PPP2R5D;DUSP7
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.6858316906572006,-1.1908628715622596,0.22857142857142856,0.8366865497129755,1.0,1/6,2.28%,CYP19A1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.78635880852545,1.1908343949770055,0.23214285714285715,0.8218773183452985,1.0,3/5,18.79%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.7368254770379896,-1.1907101823248154,0.3055555555555556,0.8358521487665653,1.0,2/6,8.79%,NEDD4;SRC
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.7488100374309559,1.1906568939315283,0.24,0.8222046566368294,1.0,1/6,5.25%,SUV39H2
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.6190448369651591,1.1905052210485838,0.23255813953488372,0.8223003354697414,1.0,13/43,14.49%,NTN4;ITGA2;DOCK1;OSMR;NFIB;LAMB1;ADGRG6;RND3;PLK2;ERRFI1;SH3D19;UACA;ASPH
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.640927329769865,1.1904819174766998,0.2441860465116279,0.821902548833522,1.0,8/25,12.13%,EEF1A2;VGF;JPH1;ENAH;PAICS;WASF1;TMEM132A;KIAA1549
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.7428014136088901,1.1903526453235775,0.22388059701492538,0.8219858220633699,1.0,2/8,11.44%,VEGFA;ZSWIM4
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.6619315856214653,1.1903108522372305,0.2625,0.8215700818319949,1.0,5/20,8.58%,LRP4;CACNB2;ANK3;UNC13A;PPFIBP1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6697311055111657,1.1896355180727431,0.21176470588235294,0.8242397530808907,1.0,1/19,1.28%,TGFB2
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.6592300252995984,1.1895538437874862,0.23255813953488372,0.8241468910128614,1.0,4/18,11.07%,FN1;RPS6;ALK;RBX1
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.6589980048396978,1.189280487151024,0.20481927710843373,0.8250001347717555,1.0,4/22,6.52%,DAPK2;NDUFA2;DCC;DAPK1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,0.7499651189863347,1.1892738835340972,0.24324324324324326,0.82450262647489,1.0,5/8,21.58%,VEGFA;KDM1A;POU5F1;ALDH1A1;FLOT2
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.5913827146932851,1.1891836609100355,0.17073170731707318,0.8243227634885836,1.0,10/36,19.69%,PPP2R5B;ARFGAP1;SERP1;DNAJB9;HYOU1;SYVN1;GFPT1;CXXC1;DCTN1;SRPRA
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.6114710251361883,1.1891495427585663,0.2247191011235955,0.8239443953731153,1.0,5/30,14.80%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;NDUFB6
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.6226457877141154,1.189130088715699,0.25287356321839083,0.8234982659445256,1.0,5/29,11.27%,PRKAR2B;PDE1A;PDE1C;ADCY8;CAMK2B
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.5655675996147507,1.189034308006944,0.16129032258064516,0.8234186875304765,1.0,41/98,26.86%,RPL23;RPL37A;SEC61B;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;RPL11;RPS24;RPS9;RPL36;SSR3;UBA52;SRPRA;RPS3A;RPL35;RPL4;RPL32;SRP19;SPCS3;RPL27A;RPL3;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;SRP54;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6507588920520335,1.189030456706231,0.22666666666666666,0.8228743439831527,1.0,6/19,14.89%,TM7SF2;IDI1;MVD;INSIG1;FDFT1;HMGCS1
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,0.7101243785058391,1.1890153274187576,0.22666666666666666,0.8223802889569426,1.0,2/10,12.78%,CYCS;UACA
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5524792687155756,1.1889444709699122,0.21052631578947367,0.8221592581663154,1.0,13/79,12.53%,ACVR1B;TGFB2;DCC;ADAM15;TP53TG5;CDKN2AIP;FHL1;MAG;MAP2;TCHP;ING1;DNAJB2;FBP1
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.6112740966131468,1.1889394034595084,0.2682926829268293,0.8216230521024769,1.0,12/26,22.80%,MAL;NELL2;TCF7;CD55;SVIL;EEF1B2;GPR183;TSHZ2;TXK;IL7R;SERINC5;LRRN3
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.7540683583690935,1.1887613373455719,0.26666666666666666,0.8219035383924249,1.0,5/10,16.34%,CACNB2;CACNG2;CACNA1B;CACNA2D3;CACNA1A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.680318389348971,1.1887080964373051,0.24285714285714285,0.8215782595587448,1.0,4/16,15.39%,SH3BP5;SRCIN1;ERRFI1;THY1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.6122474251559857,-1.1886782908662474,0.21212121212121213,0.8393648384615505,1.0,2/10,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.6122474251559857,-1.1886782908662474,0.21212121212121213,0.8393648384615505,1.0,2/10,10.33%,INPP5K;OCRL
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.558969168109126,1.1885503711822687,0.2,0.8218151854354464,1.0,18/57,22.61%,VEGFA;HSPA5;EPHA3;TMEFF2;RAPGEF3;TFIP11;CARMIL1;IMPACT;DNAJB2;MCTP1;AIDA;HSPA1B;HSPA2;NOP53;TNF;IRAK3;RDX;SYT11
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,-0.7048712795581362,-1.1885335124369434,0.37777777777777777,0.8384465106378411,1.0,1/5,1.36%,BTN3A2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6390610745833483,1.1883841761822018,0.2235294117647059,0.8220394542241318,1.0,8/24,19.33%,MAPT;CAV3;CKAP5;TOGARAM1;HSPA1B;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.5190098372713826,-1.187878314647953,0.1,0.8393684348052366,1.0,4/16,8.55%,RALB;TICAM1;CGAS;TLR3
prerank,KEGG_2021_Human__Autophagy,0.5681229041896727,1.1877290811835992,0.125,0.8247910535947303,1.0,14/114,14.79%,DDIT4;DAPK2;RAB7B;EIF2AK3;RPS6KB2;DAPK1;HIF1A;DEPTOR;IRS2;IGF1R;SNAP29;BNIP3;VMP1;MAPK10
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6696882048862058,1.1876859755058409,0.20481927710843373,0.824458547818586,1.0,5/18,18.33%,DMD;ANK3;ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7492281863321172,1.1875717320164212,0.21739130434782608,0.8243665990214895,1.0,5/9,19.70%,SYNE3;DYNC1H1;CLMN;DCTN1;SUN2
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,0.7492211000925901,1.1874189372482167,0.22972972972972974,0.8246131635640918,1.0,4/8,8.14%,DCC;NELL2;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.824920285917523,1.187012096112478,0.2413793103448276,0.8259907061928458,1.0,1/5,7.48%,PKP2
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,0.7577566744540266,1.1869931972275898,0.32432432432432434,0.8255354018645044,1.0,2/8,6.04%,DPYD;SCO2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6998812223524714,1.186873818260867,0.208955223880597,0.825467538869966,1.0,3/9,8.14%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7498510382878538,-1.186294342842148,0.39285714285714285,0.8434559683170341,1.0,3/5,18.50%,IL6R;APOL2;SIGIRR
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6681791984412377,1.186273971095468,0.24050632911392406,0.827989188810569,1.0,6/18,14.14%,OR3A2;PCDH15;NIPSNAP1;RETREG1;C5AR1;GNAL
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.7320071142206951,1.1860276770137144,0.18055555555555555,0.8286372154011761,1.0,3/10,9.36%,FBN2;ID2;RYR2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,-0.7248367691704476,-1.185864066444996,0.3235294117647059,0.8435761528016384,1.0,1/5,0.91%,ITGAM
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.7113422946369101,1.1854118909105051,0.25609756097560976,0.830914388532513,1.0,4/11,9.58%,NCAN;VCAN;GPC5;CSPG5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.5786051477083499,1.1852682410081379,0.19318181818181818,0.8311493024192513,1.0,8/59,8.46%,TNC;THBS1;SPARC;VIM;ANXA1;TUBB6;CLMP;FN1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,0.7360212681724808,1.1848326774575748,0.2236842105263158,0.8327975502727234,1.0,4/9,14.58%,BMI1;ALCAM;POU5F1;ALDH1A1
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,0.7187326910197189,1.184752088114982,0.2676056338028169,0.8325355305226567,1.0,2/8,10.06%,CD163L1;AKR1B1
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,0.7636404179798328,1.1846255390132123,0.21212121212121213,0.832530544266795,1.0,2/8,6.18%,NR4A1;RPS6KB2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,0.7576524120100083,1.1845423172554135,0.21621621621621623,0.8323118037166888,1.0,2/7,16.36%,POU5F1;ITGAV
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.43843418670687084,-1.1843208019875566,0.14285714285714285,0.8473531779896377,1.0,11/55,12.03%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4;ABL1;SETD1A
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.5728786056217872,1.1840337432927863,0.17894736842105263,0.8341990236927025,1.0,30/83,28.92%,NDUFA2;NDUFB9;COX7A2;NDUFA3;NDUFS8;COX7C;PPA1;ATP5ME;NDUFB6;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;ATP5MC1;ATP6V0B;CYC1;COX4I1;ATP6V1B2;ATP5PB;ATP5F1E;COX6C;ATP6V0E2;ATP6V1D;COX6B1;NDUFS5;ATP6V1E2;NDUFV1;NDUFS7;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.5752096394214324,1.1839979554673083,0.21428571428571427,0.8338330802345544,1.0,9/32,24.95%,HHIP;PDCL;TULP3;TXNDC15;FGFR2;IFT122;RORA;IFT81;GPC3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.6673166297733479,1.1838765289778082,0.2375,0.8339186736017643,1.0,5/20,14.11%,ACSL1;SCD5;FASN;SCD;HSD17B12
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.574294302359127,1.1837221507152822,0.17391304347826086,0.8340467917841906,1.0,15/66,15.76%,CENPF;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;SEH1L
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5254612380534684,-1.1836476803991698,0.18181818181818182,0.8481722184965973,1.0,1/12,0.87%,SMPD3
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.5840237756714532,1.1834639865332914,0.23255813953488372,0.8349234627538009,1.0,2/47,3.13%,ACVR1B;CIT
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.7516443085627635,1.1833681244909164,0.22727272727272727,0.8348013354572589,1.0,3/8,12.29%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7119555736697621,-1.1833291168468747,0.3333333333333333,0.847807970783124,1.0,3/9,10.03%,SKAP1;SRC;PLEK
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.7519589686055157,1.183274436328304,0.24242424242424243,0.8346793701332585,1.0,2/7,10.68%,ANK2;PDE4B
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,-0.6880101161571053,-1.1832087925577868,0.2571428571428571,0.846845107000245,1.0,2/5,14.93%,PPP2R5D;MLXIPL
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,-0.651135913971118,-1.1829335659255864,0.3333333333333333,0.8465047403483784,1.0,4/7,30.30%,SLC39A7;PURA;NFX1;TSPAN15
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5715347908376675,1.182524476679746,0.1134020618556701,0.8377044561144975,1.0,31/124,15.99%,PLPP3;SPARC;COBL;ENPP2;GPM6A;ENAH;TNS1;RIOK2;MEIS2;DGKI;RGS1;GRIK2;CDH9;LAMA2;PDK4;CD55;ENO2;PAPSS2;TCF7L1;PDE1C;ABCA1;DNM3;SGCE;NCEH1;GNAI1;SHROOM4;LSAMP;ALDH1A1;HS2ST1;SLC31A2;LDB2
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.5657722699822536,1.182496542863265,0.17525773195876287,0.8373075323379314,1.0,33/87,28.92%,NDUFA2;NDUFB9;ETFB;SCO2;NDUFA3;NDUFS8;COX7C;ACAD9;CYCS;ATP5ME;NDUFB6;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;TIMMDC1;SCO1;NDUFAF4;ATP5MC1;COX4I1;ECSIT;ATP5PB;ATP5F1E;COX6C;TRAP1;COX6B1;COX20;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.7527287141096249,1.1824800034591056,0.2711864406779661,0.8369050669048691,1.0,1/5,0.28%,THBS1
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.5811446714011278,1.1824125317408019,0.17708333333333334,0.8367517177695276,1.0,16/70,19.94%,ARAF;EGR1;ADCY3;CREB5;NR4A2;GNA11;RXRB;MAFB;PDE4B;ADCY8;GNAI1;NACA;PLCB1;GNAQ;FOS;PLD1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7510584395253475,1.1823600760446704,0.25316455696202533,0.836404682845459,1.0,2/7,4.91%,CACNB2;SESTD1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.6571651097719292,1.1822377898606358,0.23076923076923078,0.8365122323723744,1.0,9/22,15.39%,LRP4;NRXN1;NRXN2;NLGN1;SAV1;PTN;MAGI2;LRRC7;THY1
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,0.7246523567553511,1.182182597706793,0.26865671641791045,0.8362323748416765,1.0,4/7,15.39%,ALCAM;POU5F1;FLT1;THY1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.5823759355206687,1.1821807322168312,0.20454545454545456,0.8345857807481285,1.0,22/71,18.07%,TGFB2;FZD6;SH3PXD2B;ITGA2;DOCK1;KITLG;PAPSS2;RND3;HIF1A;PALLD;ALCAM;FN1;PLK2;CKAP4;SLC41A2;ASPH;REEP3;CLIC4;ITGAV;APP;APBB2;STARD13
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.5823759355206687,1.1821807322168312,0.20454545454545456,0.8345857807481285,1.0,22/71,18.07%,TGFB2;FZD6;SH3PXD2B;ITGA2;DOCK1;KITLG;PAPSS2;RND3;HIF1A;PALLD;ALCAM;FN1;PLK2;CKAP4;SLC41A2;ASPH;REEP3;CLIC4;ITGAV;APP;APBB2;STARD13
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.5823759355206687,1.1821807322168312,0.20454545454545456,0.8345857807481285,1.0,22/71,18.07%,TGFB2;FZD6;SH3PXD2B;ITGA2;DOCK1;KITLG;PAPSS2;RND3;HIF1A;PALLD;ALCAM;FN1;PLK2;CKAP4;SLC41A2;ASPH;REEP3;CLIC4;ITGAV;APP;APBB2;STARD13
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,0.5825605858942732,1.1821364858548202,0.29213483146067415,0.8342475775798762,1.0,13/44,16.36%,SEMA3A;ITGA2;OSMR;LAMB1;RND3;MYO10;FN1;PPFIBP1;PLK2;ERRFI1;SERPINE2;ASPH;ITGAV
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5893880543121163,1.1821189229458693,0.2247191011235955,0.8337590416112001,1.0,22/57,24.09%,LRP4;DCC;PLPPR4;ANK3;MAP2;MAP1B;CELSR2;MFSD2A;SLITRK5;PARD3;CCK;CTNNA2;APP;KLF7;NTNG1;SPTBN4;MAPK8IP2;FGFR2;PAK3;MAP1A;TMEM106B;BRSK1
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5413989706055629,-1.1820827678896515,0.21052631578947367,0.8482683313977387,1.0,1/17,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5451603581937322,1.18206021694735,0.05,0.8334459352920933,1.0,44/236,12.31%,HTR2B;THBS1;NAMPT;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;TBC1D8;IL15;AGT;OSMR;NRG1;MEIS2;KITLG;LIFR;VEGFA;SPDYA;SOX4;IL7;LAMB1;SHANK2;MVD;INSR;BMI1;FN1;ID2;RPS6;PTN;RBPJ;IRS2;IGF1R;KDM1A;NTRK3;C5AR1;NOD2;SAAL1;FLT1;NTRK2;HCLS1;CRLF1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.6333669022773519,1.182024818052148,0.20224719101123595,0.8330489157964878,1.0,9/26,25.73%,VIM;RPS27A;DYNC1H1;UBA52;UBB;DYNC1I1;ATG5;CFTR;DYNLL1
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.5794971993658378,1.1816912687682932,0.2111111111111111,0.8342655718741872,1.0,3/42,2.98%,THBS1;WDR5;H2BC11
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.41103591180361204,-1.1814535891159998,0.25,0.848461991334634,1.0,23/112,15.17%,ITK;GRAP2;PSMB3;PSME3;CHUK;ITPR2;PSMC4;PSMD12;SLC7A8;FYN;PSME4;NFATC3;PKN1;RASGRP2;BTK;IKBKB;NFKBIA;LCP2;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.6952614020697956,1.181378518396022,0.25675675675675674,0.835318218663058,1.0,4/14,12.36%,HTR2B;RYR2;IBTK;RYR3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.6688500044068512,1.1813509076278175,0.2619047619047619,0.8348786730962928,1.0,5/15,9.87%,NUDT16;NUDT4;HINT1;ACAT1;PDE2A
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.6211093949130674,1.1812829278276025,0.25842696629213485,0.834728058745816,1.0,13/31,12.37%,FRAS1;DPYSL5;COL26A1;SEMA6A;LINGO1;GABRB3;UNC5D;POU5F1;CRMP1;CACNA1B;CNTNAP2;EPHA7;GRID2
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6780319897211051,-1.1812698219052824,0.3548387096774194,0.8476479955836644,1.0,3/5,21.84%,APH1A;ADAM10;PSEN1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.6026467511619875,1.181170384845889,0.24096385542168675,0.8347157213505738,1.0,3/27,3.23%,THBS1;SPARC;TNS1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.5596475217786749,1.181142676664126,0.20212765957446807,0.8343854247127082,1.0,20/83,19.68%,ACVR1B;TGFB2;TGIF1;ACVR2A;BMPR1B;XPO1;RPS27A;ITGB8;LTBP1;CCNC;PARD3;DRAP1;PPP1R15A;UBE2M;ITGAV;SMAD1;UBA52;UBB;CDK9;SMAD5
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.5662506945119299,1.18097939367086,0.16494845360824742,0.8346371344670209,1.0,9/98,5.22%,CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;TUBA1A
prerank,CellMarker_Augmented_2021__Stem cell:Liver,0.6977450563508141,1.1809305977505749,0.325,0.8344091797369894,1.0,5/8,22.37%,POU5F1;THY1;GSTP1;NCAM1;DCLK1
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.5759350840588224,1.1808035493473357,0.17582417582417584,0.8344509728729443,1.0,24/50,26.87%,NAPA;SLC1A2;SNAP25;UNC13A;DNM3;CACNA1B;DNM1;SYT1;NSF;UNC13C;SLC17A7;CPLX1;CACNA1A;AP2A2;STX2;ATP6V0B;CLTCL1;ATP6V1B2;ATP6V0E2;ATP6V1D;SLC6A1;RIMS1;AP2S1;ATP6V1E2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.7002198892171435,1.1807642329253332,0.3287671232876712,0.8341157275696152,1.0,3/11,20.93%,PRKAG2;GFPT1;LEPR
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.7213450363169044,1.1806446600044909,0.2571428571428571,0.8342712769911284,1.0,1/8,0.81%,RAB7B
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,-0.7756526355642405,-1.180589838638836,0.358974358974359,0.8480882586378152,1.0,2/6,10.49%,TXN2;GOT2
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.7909247946753627,1.1805434237623869,0.24193548387096775,0.834217461179906,1.0,2/6,5.76%,GRM8;GRM3
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6923622978092838,-1.180350414731472,0.37142857142857144,0.8476051922103037,1.0,1/6,3.62%,NLRP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.5694595933155207,1.1801264776229974,0.25263157894736843,0.8358120361275948,1.0,5/47,7.17%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7166323566426078,-1.18006999346333,0.3157894736842105,0.8471440866568007,1.0,3/5,26.08%,IDH3B;IDH3G;IDH3A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.6788933415722377,1.1799259635634218,0.2328767123287671,0.8361810357456375,1.0,4/10,20.22%,HIF1A;NR4A3;PINK1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6741616477543663,1.1797768544336515,0.3026315789473684,0.8363467654372718,1.0,6/14,22.92%,CEMIP;AKAP6;CALM3;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5545481701898978,1.179767298201855,0.17708333333333334,0.8358327795381554,1.0,46/128,25.81%,KCNE1;SCN3B;SLC6A15;SLC11A1;SLC24A2;KCNH8;SLC9A7;SCN3A;KCNH5;TRPC4;SCN1A;SLC24A1;SLC9A6;NALCN;KCNH7;RYR3;PKD1;HCN1;SCN8A;SCN2A;ATP2A2;ASIC2;SLC24A3;ATP1B3;CACNA1A;ITGAV;KCNB2;SLC39A14;TMEM175;TRPM7;ATP1A2;SLC24A4;SLC9A1;KCNQ5;KCNQ2;TRPC1;KCNK10;ATP6V0E2;KCNB1;SLC6A1;CACNA1C;KCNC2;ATP2B4;SLC11A2;SLC39A6;ABCC8
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.5364350003243337,1.1796089431269383,0.06,0.8360342600679569,1.0,57/256,19.36%,DDIT4;NAMPT;FGF1;FLRT1;PRLR;DOCK1;NRG1;PTPRG;VEGFA;PDK4;EIF2AK3;INSR;RBFOX2;EPHA3;SIPA1L1;GRB10;NGEF;PTPRT;CHN1;SHC2;IRS2;IGF1R;GHR;FGR;NTRK3;ALK;DNM1;EPHA7;TYRO3;FLT1;KALRN;NTRK2;SORBS1;SULF2;EPHA4;NR4A3;GAB1;ANKS1B;EPHA6;ITSN1;EPHA5;GRIN2B;SDCBP;CASP3;ANGPT2;HNRNPH1;RASGRP4;ITGAV;POLR2D;PLCB1;ROCK1;SLC39A14;FLRT2;FES;FIBP;CDK5R1;AP2A2
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.7160971613457836,1.1795688261414525,0.2835820895522388,0.8357473504785146,1.0,3/8,15.49%,STEAP2;ATOX1;SLC31A2
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.4678240869977735,-1.1792536844457204,0.23529411764705882,0.8485021674269729,1.0,13/31,21.14%,H2BC4;TAL1;CEBPA;CBFB;EP300;H2BC26;IL6R;KMT2A;CSF3R;H2BC21;H2AC6;CDKN1A;SPI1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.705195243536248,1.1792009994664852,0.25333333333333335,0.8370491757286642,1.0,3/10,10.81%,SHANK3;RELN;ADCY8
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.6885723230766226,1.1791594014853728,0.2804878048780488,0.8367144195629342,1.0,3/17,14.79%,NOD2;RIPK2;MAPK10
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.6731549133587144,-1.1790917805131755,0.34375,0.8478167839309944,1.0,2/5,12.16%,TREM2;CXCL12
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.6263910889046536,1.1790715504710958,0.2,0.8366415106397039,1.0,5/33,7.94%,RHOBTB3;RHOB;ARF6;RND3;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5578208137104168,1.1790274118594117,0.15463917525773196,0.8362955773990918,1.0,18/119,12.38%,THBS1;KLF4;PRR16;VIM;EGR1;EIF4A3;SOX4;RBM3;INSR;HIF1A;DNA2;MID1IP1;IRS2;MFSD2A;EIF3E;SORBS1;NMD3;UPF3A
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.5983174016069012,1.17890543523973,0.2235294117647059,0.8363832390286312,1.0,12/39,17.74%,SEMA3A;DCC;SPOCK1;KANK1;PAQR3;MAG;CRMP1;EPHA4;STMN2;GRIN2B;DENND5A;PTPN9
prerank,KEGG_2021_Human__Pancreatic secretion,0.570974310850648,1.1787203903949117,0.23863636363636365,0.8367554120564009,1.0,25/52,26.81%,AMY2B;ADCY3;CA2;RYR2;ADCY8;CHRM3;CCK;ATP2A2;ATP1B3;KCNMA1;PLCB1;ATP1B2;GNAQ;ATP1A2;CLCA4;SLC9A1;SLC26A3;PRKCB;TRPC1;ATP2B2;CFTR;ATP2B4;RAB11A;RAB27B;ADCY1
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.5608482690544261,1.1786807459706128,0.15789473684210525,0.8363863726336478,1.0,21/136,14.54%,CENPF;TUBA4A;CENPE;PRKAR2B;HAUS6;PPP2R5B;TUBB4A;CEP152;TUBA1A;PPP2R5A;SMC4;NUP133;XPO1;CENPP;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP
prerank,KEGG_2021_Human__Axon guidance,0.5447719113028602,1.1784888644600755,0.1134020618556701,0.8366988425704274,1.0,29/130,15.33%,LRRC4C;SEMA3A;NTN4;DCC;ENAH;DPYSL5;BMPR1B;SEMA3B;ROBO2;SEMA6A;EPHA3;NGEF;ROBO1;UNC5D;TRPC4;SEMA5A;UNC5C;EPHA7;CAMK2B;EPHA4;PARD3;GNAI1;PAK5;ABLIM3;EPHA6;PLXNB1;EPHA5;WNT5A;CFL1
prerank,Reactome_2022__Digestion R-HSA-8935690,0.7774786481792879,1.178350795810656,0.21311475409836064,0.8367682628938033,1.0,3/5,17.50%,AMY2B;MGAM;GUCY2C
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.733113930439069,1.1782939312963174,0.23076923076923078,0.8364768164027799,1.0,5/11,18.84%,NRG1;RPS27A;UBA52;UBB;NRG2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.5165074882391346,-1.1781017283039088,0.3157894736842105,0.8501062097571065,1.0,5/26,6.02%,PHLDB2;NEXMIF;MAP4K4;ACER2;NF2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.5762452595369705,1.1779323569152074,0.23404255319148937,0.8374919811933362,1.0,14/58,21.72%,SLC38A4;SLC16A10;SLC6A15;SLC1A2;SLC4A10;SLC9A7;SLC24A1;SLC17A7;SLC24A3;SLC3A2;SLC24A4;SLC9A1;SLC20A2;SLC26A3
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.7014164108687415,-1.1779293016371741,0.36363636363636365,0.8491765131737572,1.0,2/5,13.10%,RIPOR2;CD53
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,-0.6323291527505764,-1.17776775326468,0.24,0.8482090946377797,1.0,3/7,21.84%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.76191511793768,1.1776253309981728,0.30434782608695654,0.8385058377818431,1.0,2/6,15.06%,VEGFA;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.6986239520552975,1.1775895576624702,0.24324324324324326,0.8380898733665962,1.0,1/10,0.30%,KLF4
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.7580866190531811,1.1775190194204113,0.2463768115942029,0.8379163097493668,1.0,1/7,5.61%,FCGR2B
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.6163543689100291,1.1772869949096088,0.18181818181818182,0.8384445176427623,1.0,2/38,0.62%,HHIP;LRP2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.575584470183323,-1.1770230972627729,0.25,0.8493523869906401,1.0,3/10,20.36%,SORL1;EDEM2;CD81
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.6257498195201749,1.176933421921277,0.25301204819277107,0.8395494209443181,1.0,5/23,9.87%,TGFB2;SOX4;ROBO2;ROBO1;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6914832799433313,1.1768073165803203,0.27941176470588236,0.8397108584207749,1.0,2/9,8.38%,RGS2;CAV3
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6489654706381832,1.1766485438945964,0.2727272727272727,0.8398603206366467,1.0,7/19,15.57%,DMD;VEGFA;ANK2;CAV3;KDM1A;SGCZ;NEBL
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.5651431876484773,-1.1766447938270614,0.2608695652173913,0.8492173284575255,1.0,8/14,23.60%,SERGEF;PKDCC;PPM1F;SNX3;CSK;HMGCR;WWP2;RHBDF2
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.740396259697143,-1.1763414898890385,0.34375,0.8491230939453084,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.7065557986101645,1.1763313498274683,0.273972602739726,0.84076226153246,1.0,5/10,21.58%,ABCA2;PICALM;TMED10;ROCK1;FLOT2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.584763303945309,1.1761667201006478,0.2111111111111111,0.8410166345828209,1.0,10/49,13.26%,ARAF;TFRC;MTCP1;VEGFA;RAPGEF3;TXN;NTRK3;HCLS1;RIPK2;PINK1
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.7460020499197018,1.176072287435865,0.22972972972972974,0.8409887919438648,1.0,3/6,21.05%,PRPS1;GUK1;MACROD1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.6990984045395809,1.176032276656213,0.2638888888888889,0.8406499309231925,1.0,2/13,1.28%,THBS1;TGFB2
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.5516193267688967,1.1758567904882364,0.15306122448979592,0.8408862920349097,1.0,34/136,22.76%,TGFB2;NDUFA2;AGT;NDUFB9;PDK4;INSR;RYR2;COX7A2;NDUFA3;NDUFS8;CAMK2B;COX7C;MAPK10;NDUFB6;PDK3;ATP2A2;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;GFPT1;PLCB1;SLC25A4;MPC2;PPARA;ATP5MC1;CYC1;COX4I1;PDHB;ATP5PB;ATP5F1E;PRKCB;COX6C;GYS1
prerank,Reactome_2022__Methylation R-HSA-156581,0.7280719260566848,1.1757687172364688,0.275,0.8407472188017081,1.0,2/8,20.69%,MAT2A;AHCY
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6219273894063333,-1.1757341987262397,0.15789473684210525,0.8497150374819653,1.0,1/13,1.27%,BTG2
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7896403749553156,-1.1755126737097639,0.3170731707317073,0.8491771991328013,1.0,2/5,16.68%,TREM2;PRKCA
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.652442097526475,1.1753775415773273,0.2835820895522388,0.8415760023145715,1.0,8/18,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.652442097526475,1.1753775415773273,0.2835820895522388,0.8415760023145715,1.0,8/18,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.748838274867107,1.1753700876736675,0.3287671232876712,0.841097442584436,1.0,2/7,7.02%,ALG10B;ABCA2
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.44620003323654583,-1.175363732144967,0.125,0.8483393369747847,1.0,8/39,9.73%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;SUPT16H;TCEA1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,-0.4421861918009289,-1.1752923458933704,0.2,0.8474036338122161,1.0,25/71,13.86%,CD300LF;CD37;LY86;PTAFR;BIN2;P2RX1;PIK3R6;MPEG1;LGALS9;CEACAM21;ARHGDIB;DAPP1;RASAL3;ALOX5;NCKAP1L;WDFY4;INPP5D;PLEK;HCK;BTK;CYTH4;CD53;SYK;SNX20;GPSM3
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.7272704580476831,1.1751759674707536,0.2911392405063291,0.8414438478304936,1.0,4/10,20.77%,ACSL1;FASN;ACSL3;ACACB
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.4884314992979474,-1.1751579345866818,0.32,0.8463905877691753,1.0,5/17,15.48%,TFAP4;ZNF675;NFKBIA;ILRUN;HABP4
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7368158453437337,1.1751448539233218,0.2361111111111111,0.8410594665084218,1.0,2/11,4.44%,EGR1;PIAS4
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.6983044092019932,1.1750938309191863,0.28169014084507044,0.8408040336921252,1.0,2/10,5.04%,FBN2;VEGFA
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.6400270192394703,1.175074600488427,0.25316455696202533,0.8403680310855909,1.0,8/23,14.89%,TM7SF2;IDI1;FAXDC2;MVD;PRKAG2;INSIG1;FDFT1;HMGCS1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.7505331520531031,1.1750740471768975,0.2753623188405797,0.8398392774338312,1.0,4/7,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,KEGG_2021_Human__Gap junction,0.5754032896641983,1.174200572042677,0.1935483870967742,0.8434023835734245,1.0,15/62,19.39%,HTR2B;TUBA4A;ADCY3;TUBB4A;GNA11;TUBA1A;TUBB6;ADCY8;GNAI1;GUCY1B1;TUBB2A;PLCB1;TUBA1C;GNAQ;GUCY1A2
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.7393286898241792,1.1741979084109355,0.2753623188405797,0.842866549784623,1.0,1/7,5.76%,GRM3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.5704052925360185,1.174012164410175,0.20430107526881722,0.8432568562244782,1.0,19/71,17.28%,CENPF;LRP2;ARRDC3;SLCO1A2;SLC19A2;ABCA2;FLVCR1;ABCA1;TXNIP;MFSD2A;PLTP;SLC35F3;LRP1B;SCAMP3;ABCA5;DISP1;PEX3;KIF3A;ARRDC2
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.7583318139481945,1.1738959536189149,0.28125,0.8433151092554024,1.0,5/8,17.97%,KAZN;PKP2;ST14;PCSK6;PKP4
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.5768269869750771,1.1737574823584738,0.23863636363636365,0.8434895508115785,1.0,8/63,5.30%,HHIP;SVEP1;OGN;TNS1;FBXL7;VASN;DAAM2;LAMA2
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.45216218802005953,-1.1736092444122719,0.26666666666666666,0.8495446724119214,1.0,10/40,16.05%,KARS1;TARS2;DARS2;CARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,0.7947795193275979,1.173419936165207,0.2777777777777778,0.8445816622149822,1.0,3/6,10.75%,DCC;UNC5D;UNC5C
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6349717344738589,1.1733392707476122,0.2564102564102564,0.844453181324628,1.0,3/13,8.88%,WDR12;PES1;RPL7L1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5795482683351267,-1.1732043853109546,0.2631578947368421,0.8494909216046485,1.0,1/7,5.04%,PIK3C2B
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6277832556480052,-1.1729933808237705,0.25,0.8488186180703204,1.0,5/12,13.23%,IKZF3;IL4I1;NCKAP1L;BTK;SYK
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.790954298309943,1.172726134439611,0.26153846153846155,0.8469009877458662,1.0,2/6,7.49%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.5958393606906655,1.1725356545317007,0.27380952380952384,0.8472640674692904,1.0,13/36,26.87%,TFRC;SLC11A1;TTYH1;SLC39A14;FTH1;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;SLC11A2;ATP6V1E2
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,0.5556900007705541,1.1722966934670844,0.3333333333333333,0.8478410938360551,1.0,23/72,22.68%,GALNT8;TSHZ3;GNAO1;RTN1;NRXN2;AATK;OLIG1;ABCA2;NLGN3;TTYH1;CELF2;RNF175;TMEM132D;KDM4B;GPR162;B3GAT1;DLG4;NCAM1;GABBR1;PDZD4;SORCS3;SYT11;TSPOAP1
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.5912035774892176,-1.1722555086486908,0.21739130434782608,0.8492444112906086,1.0,3/14,8.79%,YES1;FYN;SRC
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,0.7594807191945488,1.1722534637918967,0.3125,0.8475371459693039,1.0,2/8,15.61%,PAICS;PFAS
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4516734649515736,-1.171919804309292,0.2,0.8489525825052141,1.0,15/75,11.78%,CCL5;PDE12;GBP3;TRIM38;PTAFR;LGALS9;ICAM1;SIRPA;DAPK3;HLA-E;IRF5;HCK;HLA-DPA1;FCGR1A;OAS2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5701168322335542,1.1718320296027365,0.18085106382978725,0.8490739848960165,1.0,16/64,15.09%,COBL;ZDHHC15;RELN;ZNF804A;EPHA3;PTK7;PTN;NTRK3;ALK;CAMK2B;NTRK2;MAGI2;LRRC7;STMN2;WNT5A;NDRG4
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.7996808389475216,1.1718061170119647,0.2638888888888889,0.8486597508998068,1.0,3/6,7.63%,SHROOM3;MAL;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7649682559958181,1.1715358104666793,0.35185185185185186,0.8492633426282982,1.0,1/5,2.44%,DCC
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7417911476964099,-1.1714197604007677,0.25925925925925924,0.8490391287190396,1.0,3/6,16.02%,RIN2;RAP1A;EMP2
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,0.798513371418926,1.170892793382218,0.2028985507246377,0.8520612400996047,1.0,1/5,11.07%,RBX1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.7590897166013426,1.1706943499775817,0.3448275862068966,0.8524541069342997,1.0,3/6,20.68%,RBX1;SASH1;LRRK2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5678957092980514,1.170299237807496,0.26666666666666666,0.8540984000175799,1.0,14/47,19.52%,LRP4;TGFB2;MYOT;MAPT;CTNND2;NLGN3;PPFIBP1;PPFIA2;CBLN2;VMP1;APP;APBB2;PPFIA4;NLGN4X
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.5579093297429754,1.1701007024140937,0.21428571428571427,0.8545067882220674,1.0,9/99,5.22%,CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;TUBA1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5321933951806501,-1.1700964156363087,0.13333333333333333,0.8517440279203398,1.0,6/15,18.30%,MED12;MED24;MED4;MED1;PAXIP1;MED30
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.6019877438851737,1.1699226172813588,0.21839080459770116,0.8547590899272285,1.0,5/46,9.28%,FGF1;PIGU;INSR;GRB10;IRS2
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.410389556799027,-1.1697807351694265,0.16666666666666666,0.8513309010658276,1.0,11/57,12.38%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1;ADRM1;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6648487791983262,1.1697545179444269,0.2631578947368421,0.8551838251199315,1.0,2/14,8.90%,FCGR2B;BOK
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,0.6401266861900969,1.1697396828467987,0.23684210526315788,0.8541568305615338,1.0,7/21,13.71%,RELN;COL26A1;PHYHIPL;LINGO1;SHC2;NREP;STMN2
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,0.6401266861900969,1.1697396828467987,0.23684210526315788,0.8541568305615338,1.0,7/21,13.71%,RELN;COL26A1;PHYHIPL;LINGO1;SHC2;NREP;STMN2
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.6638231953948801,1.1695467582562775,0.2916666666666667,0.8545351643308096,1.0,2/14,8.60%,RAP1GAP;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6278803571458742,-1.1695246007823172,0.2894736842105263,0.8507410144513478,1.0,1/9,0.45%,CCL5
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7665142578057255,1.1689285504893834,0.3333333333333333,0.8569291386418831,1.0,3/6,20.85%,ROBO2;PKD1;FGFR2
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.6426316200737316,1.1688797114487384,0.29411764705882354,0.8565877226988722,1.0,6/23,14.11%,ACSL1;SCD5;ELOVL4;FASN;SCD;HSD17B12
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.6048583296223218,1.1686562620429004,0.27058823529411763,0.857095769727533,1.0,2/21,3.16%,SOCS3;PIGU
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6749892303895251,1.1686157662835428,0.2682926829268293,0.8567833423107237,1.0,3/17,10.81%,PRKAR2B;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.4763404431920473,-1.1682140303110047,0.2777777777777778,0.8534311518731951,1.0,3/22,3.60%,CCL5;CHUK;LGALS9
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.5529509806728163,1.1680837355243239,0.16326530612244897,0.8587344802751191,1.0,31/110,20.08%,PRKAR2B;CCDC152;EMILIN2;VCAN;PNMA1;TFRC;OSMR;CHI3L1;SRGN;ENO2;HINT1;SYCP3;RND3;SPRY1;TSC22D3;RPS27A;IFITM3;SEMA5A;RPS27;RPS11;HIF3A;TMEM50A;ALDH1A1;CEBPD;CCND3;SPINT2;UBA52;NME4;SCPEP1;RNF214;PGK1
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.6586836536171031,-1.1680108742474766,0.3333333333333333,0.8527018512716454,1.0,1/5,7.64%,APH1A
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.4616195547953402,-1.1678286244304796,0.23333333333333334,0.8518566018120017,1.0,5/27,3.15%,CCL5;CX3CR1;INPP5K;TFAP4;CTDP1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.5932145538484037,1.1677123872813953,0.1951219512195122,0.8600991311009198,1.0,3/26,9.49%,FGF1;PIGU;RPS27A
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5719808496512494,1.167485174083909,0.24096385542168675,0.8607067209715464,1.0,12/34,25.73%,HSPA5;NDRG2;CALM3;CASP5;CKB;PLP1;BASP1;ATP5PB;SYNGR3;COX6B1;SUDS3;DYNLL1
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.559877978190477,1.1669570458537317,0.24444444444444444,0.8628061683878848,1.0,19/57,22.92%,ANO4;SLC9B2;TTYH1;UNC80;TSC22D3;RYR2;RPS27A;TRPC4;NALCN;RYR3;ASPH;ASIC2;UBA52;CLIC2;UBB;TRPM7;CLCA4;TTYH3;TRPC1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7561216975760839,1.1669331463512698,0.23943661971830985,0.8623368425261908,1.0,3/8,15.68%,SCN3B;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5993549487242621,1.1668770356836808,0.3058823529411765,0.8620794346713097,1.0,3/34,3.08%,AANAT;DTL;ERCC2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5861348473859693,-1.166156611145429,0.24242424242424243,0.8558895141293845,1.0,1/8,5.87%,LEO1
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.7083966699891577,1.1661006326762406,0.25925925925925924,0.8654356069623678,1.0,4/10,14.14%,OR3A2;ADCY3;C5AR1;GNAL
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7024068405596383,1.1660706730110932,0.2602739726027397,0.865028271601434,1.0,6/12,20.25%,MYRF;B4GALT5;PLP1;TPPP;EIF2B2;CNTNAP1
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6691384215770835,1.1660424073724798,0.2894736842105263,0.8646271439278396,1.0,1/14,0.27%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6456112561208472,1.1659589865642155,0.3373493975903614,0.8644601126909356,1.0,4/19,12.53%,TGFB2;CGNL1;SPRY1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.6493821497857877,1.165811509381007,0.30120481927710846,0.8646463150407807,1.0,5/17,15.47%,ARF6;EPHA3;CD300A;PICALM;MCTP1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.7510067174000845,1.1657929516950063,0.3225806451612903,0.8641665053512408,1.0,2/7,12.66%,MAT2A;SPAST
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.699092930678939,1.165684492771113,0.3125,0.8641422433421709,1.0,2/9,5.76%,GRM8;GRM3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.7385105937687766,-1.1654120716727026,0.21621621621621623,0.8564750471195761,1.0,3/7,20.12%,OPHN1;CDC42;RAP2A
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.5365444159641276,-1.1652978739408595,0.25,0.8555495462561961,1.0,2/12,2.17%,LRIG1;POLD3
prerank,KEGG_2021_Human__Folate biosynthesis,0.6611254425269912,1.165227411093471,0.23170731707317074,0.8658116583937,1.0,3/12,17.01%,CBR1;AKR1B1;PCBD2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.7442356593669099,-1.1651975569920519,0.34210526315789475,0.8547442353947211,1.0,1/5,0.98%,CALCR
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.727174539174271,1.1651359488593749,0.2777777777777778,0.8656841697065812,1.0,7/9,25.11%,MYRF;ABCA2;B4GALT5;PLP1;CNTNAP1;PTEN;B4GALT6
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5876955325245186,1.165045068392033,0.22988505747126436,0.8655341335366745,1.0,7/37,9.76%,PTPRD;DOCK1;IL1RAPL1;DOCK5;SS18L1;CSPG5;CARMIL1
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.5632066934834744,1.1649753051150125,0.2808988764044944,0.8653389004287642,1.0,16/46,26.86%,RPS6;RPS27A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPS4X;RPS24;RPS9;RPS3A;RPS16;EIF3A;EIF3D;FAU;RPS12
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.6007675569548835,1.164963952986071,0.2903225806451613,0.8648264268738154,1.0,7/43,5.89%,SLC51A;ASPN;PLIN2;CBR1;GULP1;CD55;DGAT1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.7420513901074575,1.1649164621850143,0.2857142857142857,0.8644675638201827,1.0,3/7,18.25%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.5696289250880827,1.1648040953939487,0.20224719101123595,0.8645281555068399,1.0,10/55,15.32%,PLPP3;FZD6;NR4A2;TCF7;TCF7L1;RPS27A;CELSR2;RBX1;WNT5A;CPE
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.574804883617658,1.1648027449832878,0.21505376344086022,0.8640001549728971,1.0,3/77,1.16%,RHOBTB3;RAB7B;DENND2A
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),0.7326652062185038,1.1646349946257941,0.2714285714285714,0.8643041394527688,1.0,2/8,10.42%,EGR1;C5AR1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6940746592300856,1.1645743735257343,0.30434782608695654,0.8640708239521931,1.0,8/13,27.12%,SCN3B;SCN3A;SCN1A;SCN8A;SCN2A;ATP1A2;CACNA1C;SCN9A
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,0.5447351307001786,1.1645016591160386,0.12121212121212122,0.8638434443243964,1.0,31/185,12.71%,KCNE1;ALDH3B1;CES4A;DNAH11;COL4A5;NELL2;TTLL7;IQCH;ANKUB1;DALRD3;SYBU;SHANK2;SLC13A3;TMEM232;DPY19L2;SDF2L1;PTPRT;MAP9;NPHP1;ATAT1;CCDC39;LTBP1;C5AR1;NOVA1;POLQ;CFAP54;FGF14;GALC;ASTN2;DNAH7;KLHL32
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.6888717677744048,1.1642403582664398,0.25316455696202533,0.8644856567527671,1.0,7/11,19.33%,CHRM5;GNA11;CHRM3;LY6H;PLCB1;GNAQ;CDK5R1
prerank,KEGG_2021_Human__Taste transduction,0.6423699817805888,1.1641852851025867,0.20930232558139536,0.8641849633709426,1.0,12/27,16.96%,PDE1A;GABRA2;PDE1C;SCN3A;ADCY8;CHRM3;GABRA4;SCN2A;HTR1F;ASIC2;CACNA1A;PLCB1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.7843170563318789,1.1641827829416855,0.3013698630136986,0.863676036063874,1.0,2/5,11.08%,PER1;LMO3
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,0.6238860436039758,1.163969174777129,0.2692307692307692,0.8641086916525176,1.0,3/18,10.42%,CR1;ADGRE1;C5AR1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8101409777751025,1.163871360429134,0.27419354838709675,0.8639833453538269,1.0,2/5,8.44%,TTBK2;MAP2
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.6944722483933139,1.1637861198866173,0.22727272727272727,0.8639425663052195,1.0,5/13,18.84%,PRKCE;NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7789638701837442,1.163265445532609,0.25,0.8661177345097848,1.0,3/7,17.22%,VEGFA;GAB1;HSPB1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.7330947499950897,1.1630374641526757,0.2835820895522388,0.8666658657453342,1.0,3/8,12.93%,HTR2B;PDE2A;GUCY1B1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.7558864429746043,1.1630263603898239,0.2222222222222222,0.8661685237584287,1.0,3/5,21.81%,EPHA4;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6829200731217921,1.163014502395223,0.2857142857142857,0.8656830184310528,1.0,5/9,14.68%,MAPT;SYBU;HIF1A;SPAST;NEFL
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.7385009588089179,1.16299524021375,0.25806451612903225,0.8652317693789341,1.0,5/7,20.52%,GRIN3A;GRIA2;APP;CDK5R1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.7448779765223235,1.1629349239263524,0.25,0.8650389899671753,1.0,6/10,21.66%,INSR;IGF1R;BNIP3;CALCOCO2;TNF;FYCO1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6388808404230093,1.1628908537023859,0.25,0.8647175662258821,1.0,5/18,12.26%,NFIB;BMPR1B;EIF2AK3;SOX6;SULF2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.5819314594074223,1.1627675832194078,0.21505376344086022,0.8648501396620718,1.0,19/55,21.19%,PRKCE;NUDT16;CIT;RACGAP1;INSR;SVIL;DYNC1H1;SPAST;XRCC3;CENPV;E2F7;UBXN2B;RGCC;PKP4;GPSM2;DBF4;CDC25B;ECT2;WIZ
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.6323495998410145,1.1626675887504028,0.2891566265060241,0.8648930050425961,1.0,4/19,8.14%,TGFB2;SOX4;ROBO2;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5360683305190519,1.162580082075972,0.17346938775510204,0.8647400553536059,1.0,30/127,21.77%,KLF4;RBMS3;TGFB2;MAPT;VEGFA;NOCT;OVOL2;HIF1A;ROBO1;ID2;ITGB8;CCDC3;HINFP;SH3GL2;PINK1;SDCBP;PICALM;ESR1;SLC24A3;APP;FOXP1;OLFM1;PRKAA2;AP1AR;DLG4;NOTCH2;TNF;RBL2;FLOT2;MSR1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7089985660241723,1.162497104190428,0.2727272727272727,0.8646543699241336,1.0,1/9,0.94%,ST18
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.5959615174645018,-1.1624150530052875,0.3448275862068966,0.8618829496079149,1.0,2/9,16.86%,MMAA;MMAB
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.5959615174645018,-1.1624150530052875,0.3448275862068966,0.8618829496079149,1.0,2/9,16.86%,MMAA;MMAB
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6015737704903604,1.1621547970553314,0.2716049382716049,0.8656972427248512,1.0,17/39,25.67%,KCNJ13;SLC24A2;SLC9A7;SLC24A1;SLC9A6;SLC12A8;ATP1B3;SLC39A12;KCNJ6;SLC39A14;KCNJ3;ATP1B2;ATP1A2;SLC9A1;SLC6A1;ATP2B4;SLC39A6
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.6877192665363892,1.161960270867325,0.3625,0.866007471918005,1.0,2/10,13.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.7012387783499767,1.1617898154355704,0.25333333333333335,0.8663786991253555,1.0,3/10,12.51%,CHST7;OGA;AMDHD2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6092595494937671,-1.1617851194171034,0.2727272727272727,0.8625916400719652,1.0,3/10,12.54%,TICAM1;HLA-E;TYROBP
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.5856475110159584,1.1616875047693287,0.25,0.8663535637528526,1.0,20/51,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;COX6B1;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;COA6;UQCRC2;NDUFA1
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.5470658665273948,1.1616686553630546,0.21649484536082475,0.8658993517242791,1.0,10/83,12.76%,SOCS3;ADCY3;CREB5;GNA11;ADCY10;SHC2;IRS2;GHR;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7108562968271857,1.1615504151154399,0.3108108108108108,0.8659079547243527,1.0,2/11,9.12%,ANXA1;RIMS2
prerank,KEGG_2021_Human__Morphine addiction,0.5523088317824937,1.1613443531108452,0.25806451612903225,0.8663562655234661,1.0,21/63,18.88%,PDE10A;ADCY3;PDE1A;GNAO1;GABRB1;GABRB3;GABRA2;PDE1C;PDE2A;CACNA1B;PDE4B;ADCY8;GABRB2;GNAI1;GABRA4;CACNA1A;KCNJ6;GRK4;GABRD;KCNJ3;GABRG2
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.5836579086498496,1.1609325694182695,0.2111111111111111,0.8672568152149159,1.0,6/56,5.22%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.5836579086498496,1.1609325694182695,0.2111111111111111,0.8672568152149159,1.0,6/56,5.22%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7894547756882755,1.160909249652157,0.2676056338028169,0.8668423236968368,1.0,2/5,18.25%,SOD2;SOD1
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.6108325980563267,1.1604410625522,0.22727272727272727,0.8684661269113993,1.0,7/33,16.89%,ARAF;FN1;CAMK2B;PHB1;PEBP1;CNKSR2;IQGAP1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5085622038881141,1.1601994548135095,0.21875,0.8690780085273372,1.0,26/142,13.70%,THBS1;DDIT4;NLRP12;TLE1;PDE10A;PPP2R5B;CD22;CIT;CGNL1;PHLPP1;SHANK2;HERPUD1;CAV3;DEPTOR;LIMD1;MCL1;PDE2A;PER1;PIK3IP1;MAGI2;OTUD7B;UACA;DGKG;PINK1;BCL2L2;PEBP1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.6935843687416817,-1.1600016479821436,0.22580645161290322,0.8664111784477917,1.0,1/5,8.37%,PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8056160995725292,1.1598994040761572,0.24615384615384617,0.8699442589276989,1.0,2/5,6.56%,ALG10B;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.6634201197372835,1.1598626762569753,0.2753623188405797,0.8696122824520308,1.0,3/12,11.99%,VEGFA;INSR;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6808207438281709,1.15941841122796,0.3880597014925373,0.8712637222656882,1.0,3/9,20.68%,TXN;NR4A3;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.7867160264680634,1.159383515364908,0.2923076923076923,0.8709368857538683,1.0,1/5,0.57%,ALG10B
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6841997635322606,-1.1593598259933688,0.35135135135135137,0.8671887822006977,1.0,2/6,4.83%,PKDCC;ATP2C1
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.32570356069235606,-1.1593510594320866,0.0,0.8659272518699118,1.0,13/125,6.60%,RNASEL;CCL5;TICAM1;GBP3;BCL2L1;TXN2;IL1B;CHUK;NLRP1;IRAK4;ITPR2;MAPK13;BRCC3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5928277616538455,1.1593296418232868,0.34831460674157305,0.870671300822456,1.0,9/37,14.63%,DAPK2;EIF2AK3;HERPUD1;SEPTIN4;BOK;MCL1;PINK1;BCL2L2;PYCARD
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.6887519510016444,1.1593074806008181,0.2923076923076923,0.8702512207374394,1.0,2/8,13.23%,VEGFA;GAB1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5956203615389362,1.159286224093804,0.2619047619047619,0.8698813792147154,1.0,9/36,9.89%,MYOT;CADM1;CDH2;IGSF11;ROBO2;PTPRT;PALLD;ROBO1;CELSR2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.569218464499517,1.15909830164813,0.29545454545454547,0.870356920301923,1.0,11/53,10.87%,HTR2B;FGF1;HMGB2;NR4A1;VEGFA;LAMB1;HIF1A;PTN;SEMA5A;C5AR1;NOD2
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.5848259457026223,1.1587872400388204,0.2261904761904762,0.8713120539195329,1.0,17/48,26.87%,NAMPT;PDK4;INSR;GRB10;IRS2;IGF1R;SORBS1;GAB1;SLC39A14;ATP6V0B;ATP6V1B2;APPL1;ATP6V0E2;ATP6V1D;AP3S1;PHIP;ATP6V1E2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.597015434043831,-1.1586462839602996,0.36666666666666664,0.8666257962216934,1.0,1/7,9.87%,PJVK
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.44714380716708274,-1.1584952184909487,0.1111111111111111,0.8657749783505119,1.0,8/37,9.73%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;SUPT16H;TCEA1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.6578142301172831,1.158251720746643,0.35802469135802467,0.87343539170251,1.0,5/16,21.98%,SH2D4A;MTMR9;ZCCHC9;HSP90B1;CHP1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.5639127826116199,1.1582354993999324,0.27472527472527475,0.8730094000234022,1.0,4/47,4.93%,RHOB;MAPT;ANXA1;PTPRK
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.7498333228772827,1.1580528788973734,0.2898550724637681,0.8733882619495614,1.0,4/6,22.07%,WNT5A;FGFR2;STAT1;CTNNBIP1
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.6582903006792923,1.1579807447209085,0.2898550724637681,0.8732436101681063,1.0,5/15,18.81%,PIGU;RPS27A;CDC37;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.509025783349387,-1.1579083518703772,0.2631578947368421,0.8660854347900045,1.0,8/22,16.60%,ABI3;NEK6;CGAS;ZKSCAN3;RSL1D1;TERF2;NUAK1;HMGA1
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.7561324906594418,1.1578884298113135,0.3230769230769231,0.8731816706683743,1.0,3/5,24.09%,MEI1;PARM1;BRSK1
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.6194124229767575,1.1577771734157714,0.30120481927710846,0.8733067808127055,1.0,8/22,16.64%,FOLH1;ASPA;GAD1;ASRGL1;GLUL;GAD2;NAT8L;GFPT1
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.5207274407411613,1.1575930905582623,0.14,0.8735746363606403,1.0,45/236,18.65%,KLF4;NUDT12;RBMS3;TGFB2;NLRP12;EIF4A3;NUDT16;MAPT;RIDA;SLC11A1;ENC1;SRGN;VEGFA;NOCT;GPNMB;FCGR2B;EIF2AK3;DAPK1;OVOL2;PUS7;HIF1A;BMI1;ZNF540;ROBO1;ID2;ITGB8;CCDC3;SMYD5;HINFP;SH3GL2;PINK1;RNF139;CENPV;PICALM;ESR1;SLC24A3;SHQ1;HSPA1B;APP;FOXP1;RGCC;OLFM1;PRKAA2;SUZ12;EZH2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.6665265112993431,-1.1574916541583176,0.39473684210526316,0.8662214189134823,1.0,5/6,14.21%,INPP5K;RUBCNL;PPP1R3F;PPP1R3E;AKT1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.646111393334281,1.1570617070597156,0.24324324324324326,0.875770103209445,1.0,4/18,8.68%,B4GAT1;DPY19L2;SDF2L1;TMTC2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.667824165783401,1.1570305831055157,0.4057971014492754,0.8753939036530436,1.0,3/14,12.63%,DDIT4;CALM3;PARD3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5699492546620472,1.1569690987890724,0.2087912087912088,0.8751553071260217,1.0,9/48,13.85%,CLIP3;MAPT;FIGNL1;STMN3;FIGN;DYNC1H1;SPAST;TPPP;HOOK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.3321493840094369,-1.1569185417720735,0.0,0.8669539473592032,1.0,13/65,11.25%,NUP42;CCHCR1;PHAX;DHX38;TGFB1;NUP155;CHTOP;THOC5;SMURF1;NUP188;NUP214;DDX39A;RAE1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.7189729284257483,1.1568190697790126,0.25,0.875404967805498,1.0,2/8,5.43%,EEF1A2;PPP2R5A
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7438316178665159,1.1565755044617985,0.27631578947368424,0.8759940622511628,1.0,6/8,18.88%,GABRB3;GABRA2;GABRB2;PLXNB1;WNT5A;GABRG2
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5308308135373773,1.156570189805921,0.18556701030927836,0.8754817208645364,1.0,33/127,21.28%,HHIP;NLRP12;RGS20;MFNG;LIFR;CDKN2AIP;CD55;KCTD8;RGS2;OVOL2;FRRS1L;GLRX2;TCF7L1;TRIM5;CAV3;GSKIP;SEMA5A;TULP3;TMEM108;RGS11;ESR1;UGCG;RASGRP4;PLCB1;GRK4;APP;IGFBP7;MAPK8IP2;NCAM1;LRRK2;FGFR2;CX3CL1;MTCH1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.7147792792768963,1.1563610339123596,0.30666666666666664,0.8760536470633304,1.0,3/9,10.68%,CACNB2;CALM3;PDE4B
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.7656067530852158,1.1563274937850456,0.3013698630136986,0.875695034335713,1.0,3/7,13.96%,COBL;CLMP;PKD1
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,0.6329757520151005,1.1561951868727678,0.2727272727272727,0.8752631788348082,1.0,6/27,15.83%,KLF4;ANXA1;FOSL2;ST14;TGFBI;IL18
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,0.6329757520151005,1.1561951868727678,0.2727272727272727,0.8752631788348082,1.0,6/27,15.83%,KLF4;ANXA1;FOSL2;ST14;TGFBI;IL18
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7291566881834713,1.156045398947416,0.36764705882352944,0.8755171943648231,1.0,2/11,5.29%,LSR;CGNL1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.7333972070102637,1.1560396594455475,0.32432432432432434,0.8750015098982483,1.0,3/8,17.34%,ABCA2;BACE2;NECAB1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.58405641272412,1.1559929465176684,0.2604166666666667,0.8746773105816475,1.0,19/50,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;COX7C;CYCS;NDUFB6;UQCRFS1;UQCRC1;CYC1;COX4I1;COX6C;COX6B1;NDUFS5;NDUFV1;NDUFS7;NDUFAF1;UQCRC2;NDUFA1
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.5390435347934935,1.1558494181837273,0.2708333333333333,0.874920320903948,1.0,23/85,21.07%,CENPF;CENPE;NUP133;RCC1;XPO1;CENPP;SBDS;PLK2;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;KIF11;SEH1L;GPSM2;SUN2;KNTC1;DYNC1I1;CENPT;TACC3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5677963809090958,-1.1556158939923278,0.28,0.8694725380760204,1.0,3/15,3.78%,ATRAID;WDR91;DAB2IP
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,0.7756135139563678,1.1555537527695097,0.29850746268656714,0.8756968478336399,1.0,2/5,21.61%,KCTD1;TFAP2E
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.6540024362398463,1.155509392551936,0.2597402597402597,0.8753837006791841,1.0,3/14,4.14%,LRP2;TGFB2;KITLG
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.5744033567947466,1.155230774113013,0.25925925925925924,0.8762406388398278,1.0,6/39,16.96%,FZD6;GNAO1;TCF7;TCF7L1;WNT5A;PLCB1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7125958143624063,1.1551480326937544,0.32857142857142857,0.8760852223664874,1.0,2/9,7.57%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6046499493088027,1.1551304459721765,0.2823529411764706,0.875631115824617,1.0,2/30,2.98%,HMGB2;H2BC11
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.6210490069747934,-1.1549988161651386,0.23529411764705882,0.8698717728134807,1.0,6/12,25.35%,SVIP;DERL2;EDEM2;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7449887366285168,1.1546941875843542,0.3582089552238806,0.8772738590182343,1.0,3/5,17.86%,TNFRSF1B;RGCC;TNFRSF1A
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7650598759590854,1.1546483441326703,0.31746031746031744,0.876960705187987,1.0,4/7,18.34%,DPYD;PAICS;PRPS1;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.8111507625348596,1.1542972243545742,0.2463768115942029,0.8781396408254597,1.0,1/5,1.97%,RPL23
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6641081873821387,1.1540145088057854,0.2898550724637681,0.8789268539385925,1.0,5/11,14.10%,PTPRZ1;ID2;PTN;TNFRSF1B;SERPINE2
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6150276893807254,1.153964361652543,0.2823529411764706,0.8786891306839003,1.0,6/17,23.75%,CD22;FCGR2B;CD300A;FOXP1;PRKCB;GPS2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.643719068702955,1.1539297998597127,0.3411764705882353,0.878327147396466,1.0,5/22,13.15%,CR1;FCGR2B;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.546405527104778,1.1533818488027905,0.21052631578947367,0.8799516573718001,1.0,33/118,22.89%,CENPF;PRLR;CENPE;MAPT;ANLN;NRG1;VBP1;DMD;TRAF2;HIGD1C;RPL38;FCHO2;MID1IP1;COX7A2;CCDC39;PDE4DIP;SGIP1;NSG2;CALY;PICALM;STXBP6;SHQ1;TCP1;SMAD1;HSPD1;MAPK8IP2;HIP1R;CENPT;TCF4;SRP19;DNAAF2;RTN4;NDC1
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.7199844074623493,1.1533386672657389,0.2835820895522388,0.8796163985047099,1.0,4/9,18.84%,NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.6821578131574918,1.1533056676074398,0.29411764705882354,0.879232887811594,1.0,4/10,13.22%,KMO;FAH;ACAT1;BLMH
prerank,Reactome_2022__Lipophagy R-HSA-9613354,0.7342830900511018,1.1532784644664986,0.2714285714285714,0.8788228188207708,1.0,3/7,18.04%,PLIN2;PRKAG2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.5935157361621973,1.1529763546297245,0.2682926829268293,0.8797521539446407,1.0,9/28,29.84%,RPA2;FIGNL1;KDM1A;ZCWPW1;IL7R;H1-0;SPIDR;SMARCAD1;BLM
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5584281467223581,1.1528913893513197,0.26744186046511625,0.8796983780945575,1.0,7/41,17.58%,THBS1;VEGFA;HIF1A;ANGPT2;ATP5F1A;HSPB1;RGCC
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.7713656448220896,-1.1528476574141264,0.2857142857142857,0.8753887379386386,1.0,2/5,13.15%,EP300;SPRED2
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.5544205975910423,-1.1528444604635821,0.27586206896551724,0.874112661061177,1.0,2/13,6.48%,LRIG1;BANF1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6131632556957356,1.1526791789581734,0.32432432432432434,0.8803025534180304,1.0,4/20,13.16%,ANK3;TMTC2;FAM20A;SLC12A8
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.43166225586916107,-1.1525455163304592,0.07692307692307693,0.8738343353674162,1.0,5/52,3.43%,CCL5;PDE12;GTF2F1;CTDP1;ADARB1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.6140355811363132,1.1523118121670795,0.29411764705882354,0.8815257940319583,1.0,4/22,9.69%,HS3ST5;TRIM5;TRIM25;IFITM3
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.5897334994453229,1.152287284328576,0.24390243902439024,0.8811048101514142,1.0,3/28,9.49%,FGF1;PIGU;RPS27A
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.57536787689315,1.1520801688759483,0.23157894736842105,0.8814594761842756,1.0,16/50,20.93%,SOCS3;ACSL1;RXRB;TRAF2;IRS2;CPT1A;PRKAG2;TNFRSF1B;MAPK10;TNFRSF1A;PRKAA2;PPARA;ACSL3;TNF;ACACB;LEPR
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.612568632213852,1.1516768289549357,0.26744186046511625,0.8828681795467741,1.0,5/31,11.27%,PRKAR2B;PDE1A;PDE1C;ADCY8;CAMK2B
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.6692474051847999,1.1512102980939125,0.38028169014084506,0.8844795454506251,1.0,4/9,22.83%,VAPB;VCPIP1;BNIP1;RTN4
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.5994241217490632,1.1511888598333424,0.2345679012345679,0.8840094552215644,1.0,11/33,20.32%,NR4A2;NR4A1;RORB;RXRB;NR2F1;NR4A3;ESR1;NR2C2;ESRRG;PPARA;NR1D1
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,-0.5194003025537403,-1.1510538997429585,0.23529411764705882,0.8758342271160571,1.0,12/32,13.23%,ADGRG5;LY86;DENND1C;MPEG1;BLNK;DAPP1;ALOX5;WDFY4;HCK;BTK;CD53;SYK
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,-0.5194003025537403,-1.1510538997429585,0.23529411764705882,0.8758342271160571,1.0,12/32,13.23%,ADGRG5;LY86;DENND1C;MPEG1;BLNK;DAPP1;ALOX5;WDFY4;HCK;BTK;CD53;SYK
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6652881786338126,1.1509614736402853,0.3076923076923077,0.8845495529234189,1.0,4/18,9.58%,CHST7;NCAN;VCAN;CSPG5
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,-0.5785494040413782,-1.1508458322529656,0.35135135135135137,0.8752500890148885,1.0,1/9,3.31%,PMEPA1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.6203995474373681,1.1507804492499283,0.32926829268292684,0.8847991858223213,1.0,7/21,15.03%,CR1;EPHA4;PRELID1;GRIN2B;PYCARD;AIM2;PICALM
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),0.7362579030564181,1.1507200632058772,0.3,0.8845872117870807,1.0,1/5,0.28%,THBS1
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.5423560911664597,1.150649237936736,0.20833333333333334,0.8844451785265884,1.0,12/110,9.75%,TNC;THBS1;DDIT4;TGFB2;VIM;PRKCE;VEGFA;SOX4;BMI1;IRS2;MCL1;ST14
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5954156258008936,1.1502192827014959,0.32894736842105265,0.8858088686456539,1.0,3/31,4.63%,LRP2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6886689391172479,1.1502137055749553,0.27631578947368424,0.8853289400037081,1.0,5/9,19.52%,NLGN3;NLGN1;C5AR1;WNT5A;NLGN4X
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,0.6367698171625569,1.1502005145765983,0.3116883116883117,0.8848602748984363,1.0,7/18,22.05%,RPS27A;UBA52;UBB;DUSP16;PGK1;ENO1;RAB5A
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.6213779754590325,1.1500730182472365,0.33766233766233766,0.8850072315784161,1.0,10/25,27.69%,GNA11;PDCL;RGS11;TCP1;GNAQ;GNB5;CCT8;GNA15;CCT6B;GNA14
prerank,KEGG_2021_Human__Necroptosis,-0.39466317175670773,-1.1499153010468037,0.2,0.8767772437254534,1.0,14/96,11.56%,STAT4;TICAM1;IL1B;PLA2G4C;IL1A;RNF103-CHMP3;MLKL;BID;TNFSF10;TLR3;CHMP2B;CAPN2;NLRP3;BIRC2
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.5496912075187048,1.1499144332591655,0.2604166666666667,0.8852074704693768,1.0,12/54,21.28%,FGF1;FLRT1;PIGU;RBFOX2;RPS27A;HNRNPH1;POLR2D;FLRT2;UBA52;UBB;FGFR2;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.7690985002749323,1.1497132888606687,0.3,0.8851534222597549,1.0,1/5,5.76%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.7690985002749323,1.1497132888606687,0.3,0.8851534222597549,1.0,1/5,5.76%,GRM3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6169055013940724,1.1494667645496235,0.26666666666666666,0.8857587642776693,1.0,2/15,12.78%,NLRP12;UACA
prerank,KEGG_2021_Human__cAMP signaling pathway,0.524931483957186,1.1494585376579247,0.24242424242424243,0.8852701532761094,1.0,33/121,21.02%,HHIP;TSHR;GRIA4;PDE10A;ADCY3;CREB5;GRIN3A;GRIN2A;ADCY10;GRIA2;RAPGEF3;CALM3;RYR2;PDE4B;ADCY8;LIPE;CAMK2B;GRIA3;GNAI1;GRIN2B;MAPK10;HTR1F;ATP2A2;ATP1B3;ROCK1;GRIA1;ATP1B2;PPARA;FOS;PLD1;ATP1A2;GABBR1;SLC9A1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.5471284494972668,1.1494567180324968,0.26666666666666666,0.8847607911465996,1.0,17/52,26.86%,RPS6;RPS27A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPS4X;RPS24;RPS9;RPS3A;RPS16;EIF4A2;EIF3A;EIF3D;FAU;RPS12
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7248803728112668,1.1493058131823877,0.2625,0.8849817820242907,1.0,3/12,6.68%,SEMA3A;NSMF;SEMA6A
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.4604424424428923,-1.149226744403027,0.16666666666666666,0.8776357560971851,1.0,5/22,6.94%,CCL5;CX3CR1;C3;SIRPA;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),0.7104230116624778,1.1489366546275397,0.3333333333333333,0.8862619185649143,1.0,2/5,24.96%,RTN4;RSAD2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.5405941062241931,1.1488785076375927,0.25263157894736843,0.8860188947099611,1.0,10/62,8.75%,CDK14;AMER2;TLE1;DAAM2;CTNND2;GRB10;KANK1;PTK7;TCF7L1;GSKIP
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,0.75944577225801,1.1487134147674547,0.296875,0.8863344854444674,1.0,1/7,3.37%,NUDT4
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.7002742000847935,1.1486567944240236,0.352112676056338,0.8860810725459152,1.0,4/9,18.84%,NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.6011122294746128,1.148655557496627,0.325,0.8855783225508356,1.0,3/26,15.33%,ZDHHC15;PAQR3;TMED10
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5785808058280018,1.1485333089438363,0.3146067415730337,0.8856282093328199,1.0,10/36,20.52%,TMEM161A;SLF1;EYA2;SPIRE2;FMN2;BRCA1;ZCWPW1;ERCC6;TIMELESS;NPAS2
prerank,CellMarker_Augmented_2021__Myotube:Muscle,0.648124573992215,1.1484447080997595,0.32558139534883723,0.8855241891711575,1.0,3/18,8.38%,AMY2B;LDB3;CAV3
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6598714913495947,1.1480627724908279,0.3333333333333333,0.8868041313379166,1.0,5/12,21.02%,ATP1B3;KCNMA1;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7517948398422056,1.1480377241842752,0.24675324675324675,0.8864399001258936,1.0,3/7,21.55%,MAPT;PINK1;ATP5IF1
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.6562702514375425,1.1477846477939042,0.3246753246753247,0.8871140960682277,1.0,6/13,21.98%,ATP5ME;ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.6863302714058807,-1.1477718720430892,0.34375,0.8804057988431967,1.0,4/5,31.15%,SUPT6H;MTHFR;SUPV3L1;HDAC2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.661178135366466,1.147673443352889,0.3026315789473684,0.8871523663441693,1.0,3/13,7.57%,FBN2;VEGFA;AGTPBP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.49145314633781834,-1.1476356514093393,0.1875,0.8795724377640969,1.0,5/21,10.89%,SKAP1;ETS1;SIRPA;HLA-DPA1;ITGB2
prerank,KEGG_2021_Human__Basal transcription factors,-0.405387980005742,-1.14758428137455,0.3,0.8783824500738384,1.0,5/35,5.77%,GTF2H5;GTF2H2C;GTF2F1;GTF2H2;TAF13
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.5361092489771528,1.1473415474738031,0.2159090909090909,0.8883596468129539,1.0,18/58,23.67%,FAM234A;ERCC2;B4GAT1;ATAD3A;SCAF1;CDH2;PCBP4;ARFGAP1;PTOV1;FASN;PLOD1;DCTN1;POLRMT;WIZ;TTYH3;GANAB;USP5;GPS1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6390212855327362,1.1472007733729552,0.2894736842105263,0.8885980525839554,1.0,6/19,10.26%,SEMA3A;SEMA3B;SEMA6A;MAG;MAP2;SEMA5A
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.7046351958869198,1.1471943792070083,0.30985915492957744,0.8881017435458999,1.0,3/11,11.82%,LIPE;AGPS;NCEH1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.49279465115997007,-1.1471589492649152,0.23809523809523808,0.8783846220325349,1.0,7/20,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5338046022257038,-1.146813490743049,0.2857142857142857,0.8780853186453849,1.0,1/16,1.05%,DNMT3A
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),-0.6519486192437972,-1.1466226876670595,0.2702702702702703,0.8774293911749409,1.0,3/7,15.77%,TAL1;MAP1S;TLK2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4372452903956119,-1.1466167970603942,0.25,0.8761741273821297,1.0,13/36,16.50%,BTN3A2;IL1B;CD276;CD2;LGALS9;TLR3;HLA-DPA1;CD226;TLR7;IL18R1;IL12RB1;BTN3A1;PDE4D
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.5283316459074643,1.1465127570748241,0.23232323232323232,0.8908272316477076,1.0,33/190,14.72%,THBS1;CENPF;RHOB;TGFB2;DTL;CKS2;TBRG4;RPL23;SPATA22;CCPG1;PPP2R3B;GADD45B;BRINP1;NR4A1;WDR12;MASTL;FIGNL1;PTPRK;ALOX15B;PES1;CAMK2N1;HCFC1;BEX2;ID2;SRA1;RPS6KA2;MAGI2;BRCA1;PPP1R15A;PKD1;PRR11;UHRF2;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.620984598124829,1.1464492749748136,0.32142857142857145,0.8906468701457291,1.0,1/26,0.30%,KLF4
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.3783392234820964,-1.1464470804147893,0.08333333333333333,0.8752789103671745,1.0,16/66,15.45%,TICAM1;CHUK;NFKBIE;EML4;CD274;MAPK13;KRAS;MAP2K3;NFATC3;IKBKB;NFKBIA;PPP3CC;EGFR;AKT1;CD247;TIRAP
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.5737833098584543,1.1464029683509462,0.25,0.8904139699888667,1.0,24/56,22.34%,NCAN;TUBB4A;NELL2;GNAO1;SLC4A10;RTN1;CTNND2;KCNH8;CNR1;NLGN3;SLAIN1;FXYD7;PPP2R2B;VSTM2B;PAK5;RUNDC3A;B3GAT1;CDK5R1;PDZD4;KIF5C;SORCS3;ELAVL3;HPCAL4;KCNQ2
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.6933416139132398,1.1464005641725719,0.3037974683544304,0.889923029903811,1.0,4/13,17.56%,KLF4;HIF3A;EPAS1;FOXP1
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,0.7361300928636166,1.1463117191326635,0.2647058823529412,0.889790916046041,1.0,2/8,8.25%,ENPP2;XPO1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.7477135232115882,1.1459733709317321,0.2676056338028169,0.8908015743137088,1.0,1/7,4.32%,ALOX12
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6039140161909569,-1.1458496997772503,0.391304347826087,0.8743005553646287,1.0,2/10,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6039140161909569,-1.1458496997772503,0.391304347826087,0.8743005553646287,1.0,2/10,7.12%,SESN2;SESN3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5719909464369298,1.1457845713755463,0.25316455696202533,0.8912111462233244,1.0,1/23,0.28%,THBS1
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,0.7135083752414095,1.145683573659163,0.25,0.8911574130787168,1.0,3/12,9.75%,LSR;OVOL2;ST14
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5481885837911827,1.1454551445324515,0.26666666666666666,0.8917660572688062,1.0,7/54,11.06%,HTR2B;PPP1R9A;NUDT4;EIF2AK3;ANK2;RYR2;CHRM3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.5355605217073264,-1.145260509516201,0.21212121212121213,0.8747755372770426,1.0,4/15,9.74%,TFAP4;CTDP1;HPN;EP300
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,0.7772523382432748,1.1443871949936284,0.265625,0.8961880170053576,1.0,3/5,12.41%,SEPTIN4;GSDMD;CYCS
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.5451472585414401,1.1443780927391685,0.22105263157894736,0.8957114895234728,1.0,5/79,3.11%,NAMPT;LRP2;NUDT12;ENPP2;SLC2A3
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.5686449779274072,1.144130244170972,0.28735632183908044,0.8963846985491288,1.0,4/37,10.79%,RHOB;ANXA1;GLRX2;IMPACT
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.7042919418917093,1.1440762288454611,0.3287671232876712,0.8961498482624983,1.0,1/8,5.04%,VEGFA
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6252094852486231,1.1439845758487217,0.2911392405063291,0.8960148540195718,1.0,9/21,22.75%,KIF1B;TUBA1A;MYO10;HOOK3;KIF5A;TUBA1C;DYNC1I1;KIF5C;TUBA1B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7184538868600531,1.1438631744461463,0.3448275862068966,0.8961262212868678,1.0,1/7,0.94%,ST18
prerank,KEGG_2021_Human__Human papillomavirus infection,0.5102922862823233,1.143793612173554,0.1836734693877551,0.895944275588081,1.0,20/190,9.79%,TNC;THBS1;FZD6;PPP2R3B;CREB5;PPP2R5B;ITGA2;RELN;COL4A5;MFNG;VEGFA;LAMA2;PPP2R5A;TCF7;LAMB1;RPS6KB2;TCF7L1;FN1;RBPJ;ITGB8
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.6270928532757859,1.1436250091507785,0.3055555555555556,0.8961811353304673,1.0,3/17,10.65%,WDR12;PES1;ERI2
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.5722586651051175,1.1434461109604164,0.30337078651685395,0.896470019708169,1.0,20/51,25.81%,PRKAR2B;CACNB2;GNA11;SNAP25;RAPGEF3;ADCY8;CHRM3;GNAI1;CACNA1A;IQGAP1;PLCB1;GNAQ;ACSL3;GNB5;PRKACB;KCNB1;CACNA1C;KCNC2;GNA15;ABCC8
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7284255746707297,1.1432831852809946,0.34285714285714286,0.8962267070289369,1.0,3/7,12.76%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7284255746707297,1.1432831852809946,0.34285714285714286,0.8962267070289369,1.0,3/7,12.76%,ADCY3;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.7622369646978396,1.1432796385662036,0.36507936507936506,0.8957580917767302,1.0,3/5,17.68%,CYREN;TFIP11;ERCC6
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5871190047695387,1.1432528284849541,0.325,0.8953734912534999,1.0,7/38,10.68%,TULP2;GRM8;COL11A1;SLC4A10;PCDH15;RP2;SLC24A1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.7429097472317998,1.1428971368031806,0.3898305084745763,0.8965119954132389,1.0,4/6,18.48%,MAPT;APP;DCTN1;SPG11
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),-0.7864705099780804,-1.1428510970079757,0.3333333333333333,0.8814424544991623,1.0,3/5,19.81%,IL17RA;PLCG2;MYD88
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.6560233205590339,1.1427696620490493,0.345679012345679,0.8965287005565181,1.0,3/16,13.96%,RHOB;RYR2;PKD1
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.7216921427480902,1.142704792836621,0.2714285714285714,0.8962745349513395,1.0,2/7,10.42%,CR1;C5AR1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5762399826391602,1.1426571156748744,0.30952380952380953,0.8960258637366944,1.0,4/27,9.08%,PTPRD;IL1RAPL1;NSMF;SS18L1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6178302499408164,1.142654423854749,0.3246753246753247,0.8955329443313714,1.0,2/18,4.06%,THBS1;PTPRG
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.6682586523103138,1.1426113195052847,0.32,0.8952433772624412,1.0,8/14,28.15%,JPH1;GRIN2A;RYR2;GRIN2B;JPH4;CACNA1C;ATP2B4;CACNA2D1
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.6851585221091833,1.1425220655594333,0.3484848484848485,0.8951879979528663,1.0,2/11,14.39%,PIGU;CDC37
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.5485373917820938,1.1424292771597842,0.25842696629213485,0.8950703542083841,1.0,17/52,26.86%,RPS6;RPS27A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPS4X;RPS24;RPS9;RPS3A;RPS16;EIF4A2;EIF3A;EIF3D;FAU;RPS12
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,0.5529753194172757,1.1424197558573534,0.29473684210526313,0.8945894743093965,1.0,21/69,25.73%,MDH1;TXN;COX7A2;COX7C;PLTP;CYCS;SLIRP;EEF1B2;MPHOSPH6;ATP1B3;GSTP1;ABRACL;PSMA3;SNRPD2;MRTO4;DBI;PSMD14;AP3S1;CSTB;NDUFS5;DYNLL1
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.6620292787005455,-1.142389340286288,0.38461538461538464,0.8814775143223461,1.0,2/6,10.58%,ARL2BP;SLC29A3
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6204022849623123,1.1423109890925234,0.3170731707317073,0.8945968157282383,1.0,5/23,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5913209017152175,1.1422643214194905,0.2976190476190476,0.8943189672933501,1.0,6/33,8.95%,FBN2;GPM6B;ACVR2A;SRGN;BMPR1B;PTN
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.41964770252106676,-1.142261267906614,0.2222222222222222,0.8804707837459148,1.0,2/48,0.45%,RNASEL;CCL5
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.6151920924231329,1.1422305529579935,0.2948717948717949,0.8939481536055075,1.0,6/23,12.30%,ALDH3B1;DPYD;CARNS1;GAD1;ALDH6A1;GAD2
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,0.5321103589366329,1.1421530838414997,0.23711340206185566,0.8937590330224946,1.0,32/118,21.72%,SLC38A4;SLC16A10;SLCO1A2;SLC2A3;SLC6A15;SLC1A2;SLC4A10;SLC11A1;SLC2A9;SLC5A9;SLC13A4;SLC13A3;SLCO3A1;SLC22A15;SLC9A7;SLC24A1;SLC35A1;SLC44A5;SLC41A2;SLC17A7;SLC24A3;SLC25A4;SLC39A14;SLC16A3;SLC16A1;SLC44A1;SLC3A2;SLC24A4;SLC5A6;SLC9A1;SLC20A2;SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.4623354010486316,-1.1420847780678585,0.2608695652173913,0.8797269554845804,1.0,1/18,0.05%,TNFAIP8L3
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.573455914730334,1.1420711321525912,0.31521739130434784,0.8937047107425116,1.0,17/45,18.04%,LRP4;ENAH;DZIP1;PTPRG;CDH2;LIFR;RBFOX2;TUSC3;MAP1B;FIGN;NR2F1;KIAA1549;ADGRL2;GLRB;HSPA12A;MPDZ;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.5196076754059956,-1.1418856545835248,0.2903225806451613,0.8792078173865592,1.0,1/12,0.87%,SMPD3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.624704140260864,1.1418843885857541,0.3026315789473684,0.8940022419613248,1.0,10/25,20.23%,PFKM;ENO2;PGAM1;GPI;PKM;ENO4;ENOSF1;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5850837378718816,1.1418455314342186,0.35714285714285715,0.8936272729940485,1.0,4/24,12.87%,DTL;CLSPN;DONSON;BRCA1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.41796376851723865,-1.1416698067079007,0.23076923076923078,0.8788012812148396,1.0,9/41,11.67%,CARD14;LRP10;DENND1C;ABHD11;SSH3;LLGL2;NBEAL2;BCL3;ARHGAP27
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.7357768320858363,1.1414964943243595,0.3448275862068966,0.8946893145692069,1.0,4/5,24.45%,ADCY3;MAP1A;BRSK1;SLC6A1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6471434271336162,1.1413808024076806,0.36363636363636365,0.8946604139569247,1.0,7/13,32.66%,REEP3;RTN3;REEP2;RTN4;TMEM33;REEP1;LNPK
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.5262866157056943,1.141368124355345,0.15151515151515152,0.8942134431133182,1.0,45/125,26.87%,RPL23;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;IMPACT;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;SEH1L;RPS4X;RPL11;RPS24;RPS9;NPRL2;RPL36;SESN1;UBA52;ATP6V0B;RPS3A;RPL35;RPL4;ATF3;RPL32;ATP6V1B2;RPL27A;RPL3;ATP6V0E2;ATP6V1D;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;RPL10A;FAU;RPS12;ATP6V1E2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.6003661877632009,1.1412776512934264,0.33766233766233766,0.8941538896758054,1.0,3/28,6.92%,PLPP3;PLPPR4;MTMR7
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6607938132353082,1.1410354025340588,0.34285714285714286,0.8947234299110827,1.0,4/9,9.26%,TGFB2;NRG1;ADGRG6;RBPJ
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.5433889912077946,1.1409546301834053,0.25,0.894570901707258,1.0,8/48,16.64%,ALG10B;MGAT4C;TUSC3;MGAT1;STT3B;MCFD2;MAGT1;GFPT1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.7599025486547666,1.1409004749018326,0.3157894736842105,0.8942743403134724,1.0,2/5,9.19%,PDK4;SLC9A7
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.5782976501474649,1.1408652732175126,0.2808988764044944,0.8939163446897918,1.0,11/43,10.92%,GAS2L3;PRLR;FRAS1;ZNF804B;CREB5;NR4A2;MYO10;ATP8B1;ITGB8;LTBP1;PLD5
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6199374495992365,1.1408632611802323,0.2948717948717949,0.8929136342638918,1.0,2/15,7.60%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6199374495992365,1.1408632611802323,0.2948717948717949,0.8929136342638918,1.0,2/15,7.60%,WDR5;HCFC1
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.6122309044917502,1.1407086736709897,0.325,0.893070864954585,1.0,9/21,26.10%,RPS27A;UBA52;UBB;DUSP16;PGK1;ENO1;RAB5A;MRC1;TLR2
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.6066115844680499,1.1405399742415157,0.30864197530864196,0.8933563129010761,1.0,7/22,21.61%,VEGFA;KCTD1;ATAD2;ESR1;HSPD1;KDM5B;TFAP2E
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.7888240112018762,1.1404750228296652,0.3050847457627119,0.8926540130825605,1.0,2/5,14.36%,POLG2;RFC4
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.7888240112018762,1.1404750228296652,0.3050847457627119,0.8926540130825605,1.0,2/5,14.36%,POLG2;RFC4
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.6919368136232473,1.140417220088897,0.32857142857142857,0.8924111218705242,1.0,5/9,25.81%,VGF;CHGB;SCG5;SST;ABCC8
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6233144464937408,1.1403947342186478,0.30120481927710846,0.8920403958454319,1.0,9/25,20.39%,GRIK2;CDKN2AIP;RIMS2;SYT1;NSF;RIMS3;DLG4;TNF;CLSTN2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.6484730939251706,1.1402828088220944,0.2602739726027397,0.8920490669993748,1.0,5/17,14.63%,HMGB2;H2BC11;SLC11A1;GSDMD;PYCARD
prerank,KEGG_2021_Human__Alcoholism,0.5447907590342339,1.140178544053615,0.20430107526881722,0.891970713429066,1.0,12/81,14.52%,ARAF;PKIA;CREB5;H2BC11;GRIN3A;GNAO1;GRIN2A;CALM3;SHC2;NTRK2;GNAI1;GRIN2B
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,0.7734123011882483,1.1400804783892153,0.296875,0.8919077943334772,1.0,3/5,20.65%,ADGRA3;BCL6;UCHL1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.6685984519126531,1.1400060987664924,0.3157894736842105,0.8917784787300476,1.0,6/19,13.90%,TTBK2;HDGFL3;MID1IP1;CLASP2;STMN2;APC2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5758734669223705,1.139849284731391,0.3103448275862069,0.8920274452501572,1.0,5/37,9.71%,TUB;IL15;SLC11A1;FCGR2B;FGR
prerank,Reactome_2022__Pexophagy R-HSA-9664873,0.7187264413889437,1.139435815155963,0.34615384615384615,0.8933843806335711,1.0,4/11,18.81%,RPS27A;EPAS1;UBA52;UBB
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.7200597966627977,1.1393009700952612,0.323943661971831,0.8934688387285364,1.0,4/6,23.45%,ANXA1;AKIRIN1;ROCK1;MEGF10
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,-0.5885600370567152,-1.1391949326308364,0.22727272727272727,0.884703308745272,1.0,7/10,14.51%,YES1;FYN;SRC;HCK;FCGR1A;SYK;CD247
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.6623264319422576,-1.1390664181020593,0.3939393939393939,0.8836991208670959,1.0,3/7,11.72%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.7326196172814561,1.1390302118925346,0.3283582089552239,0.8941296657230468,1.0,1/7,2.61%,EIF4A3
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,-0.5676071625132626,-1.1390174455135644,0.3333333333333333,0.882642419127937,1.0,3/11,13.23%,SLC7A8;FYN;SYK
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6334256067550006,1.138996950348124,0.32894736842105265,0.8937598395813658,1.0,6/19,17.43%,EGR1;HIF1A;DNAJB2;PINK1;EPAS1;HSPA1B
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.5638283821060687,1.1389421503880697,0.2553191489361702,0.8935127230698932,1.0,16/72,19.11%,CLDN18;CADM1;CDH8;CDH2;CADM2;CDH9;CLDN20;CDH12;SPTAN1;MAGI2;PARD3;CDH10;IQGAP1;SPTBN1;PLEC;CD151
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5144018816354496,-1.138891170257843,0.2222222222222222,0.8817544525049155,1.0,5/15,10.06%,CCL5;TICAM1;IL1B;TGFB1;HCK
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.7244075871025906,1.138787070627745,0.2972972972972973,0.8937395244758153,1.0,1/8,7.02%,ABCA2
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,-0.5084880823020774,-1.1387799989901144,0.2,0.880795400363983,1.0,7/22,18.45%,PIK3R6;PKN1;BTK;AKT1;PIK3R5;PLCB2;CDC42
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7162996414232867,-1.1387601405691292,0.36666666666666664,0.8795818861652341,1.0,3/5,17.68%,MMAA;MCEE;PCCB
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),0.6507666657287444,1.1385888240521311,0.3108108108108108,0.8942205795869841,1.0,6/14,21.36%,RPL23;RPS20;RPL37;CHD5;UBB;HEXIM1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.666663079662683,1.1384086834020553,0.26666666666666666,0.8940828445054841,1.0,4/12,12.47%,SYT4;UNC13A;RIMS2;SYT1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.666663079662683,1.1384086834020553,0.26666666666666666,0.8940828445054841,1.0,4/12,12.47%,SYT4;UNC13A;RIMS2;SYT1
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,-0.4212910407488936,-1.1384062834287485,0.21428571428571427,0.8780991412354932,1.0,13/49,10.52%,CD300LF;ITGAM;LY86;LYL1;BIN2;P2RX1;PIK3R6;MYO1F;WDFY4;PLEK;HCK;BTK;NLRP3
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,-0.4212910407488936,-1.1384062834287485,0.21428571428571427,0.8780991412354932,1.0,13/49,10.52%,CD300LF;ITGAM;LY86;LYL1;BIN2;P2RX1;PIK3R6;MYO1F;WDFY4;PLEK;HCK;BTK;NLRP3
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,0.7435620730951001,1.138272391991663,0.3380281690140845,0.8941462143018307,1.0,5/7,25.10%,PTPRG;MAP2;NRGN;DLG4;GRM5
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.663190961702883,1.1379666375272695,0.30864197530864196,0.894905313772161,1.0,2/11,3.14%,DNAH11;MMP21
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.6397626763122506,-1.1378295174539357,0.2222222222222222,0.8787601077109819,1.0,2/8,7.62%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.67501352727034,-1.1378070778829439,0.30303030303030304,0.8776292365476747,1.0,1/5,9.02%,ENG
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.5198201343131083,1.1377826025445672,0.09,0.8953437833966158,1.0,58/291,18.25%,HTR2B;THBS1;KLF4;FGF1;RBMS3;PRR16;VIM;RPL23;EGR1;TLE1;CADM1;EIF4A3;IL15;TFRC;AGT;SLC11A1;VEGFA;SOX4;EIF2AK3;RBM3;ZNF804A;ANK3;ANK2;OVOL2;CAMK2N1;HIF1A;HCFC1;ROBO1;FN1;ID2;RIMS2;RBPJ;FGR;NTRK3;ITGB8;PDE2A;POLR1C;TENT4B;NTRK2;HINFP;EIF3E;UPF3A;BRCA1;WNT5A;SLC24A3;RPS4X;EPB41L4B;RPL11;TXK;SMAD1;ROCK1;HSPA1B;APP;RGCC;ERCC6;OLFM1;PYM1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5253237625325904,1.1377824926197735,0.24210526315789474,0.8948482970748688,1.0,12/117,10.74%,THBS1;KLF4;NLRP12;CR1;ANXA1;SLC11A1;SRGN;GPNMB;FCGR2B;FN1;TRIM25;PDCD1LG2
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.5750587680983251,1.1377412304340309,0.3068181818181818,0.8945308229991487,1.0,5/37,10.90%,ALG10B;MGAT4C;TUSC3;MGAT1;STT3B
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7381939333236647,1.137682092985304,0.36363636363636365,0.8943505251490618,1.0,1/5,13.43%,ACP3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.6917870311654494,1.1374102690459509,0.32098765432098764,0.8950972851778246,1.0,2/13,7.86%,KLF4;PAX8
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.5279884013604356,1.137368074087159,0.21428571428571427,0.8947498274969189,1.0,24/83,18.33%,GPM6A;PPP1R9A;MAPT;MANF;GPM6B;PQBP1;LAMB1;HDGFL3;STMN3;NLGN1;MAP2;MICALL2;CARMIL1;CNTNAP2;PLP1;TMEM108;SH3GL2;STMN2;RASGRF1;ROCK1;APP;ERCC6;NCDN;ATP1B2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.6949106824532634,-1.1370658277694214,0.42424242424242425,0.8786720581414518,1.0,1/5,2.23%,IL1B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5357072361863093,1.1369643362328041,0.2823529411764706,0.8962746614316172,1.0,10/43,17.45%,VIM;RPL23;FCGR2B;GRIN2A;IGF1R;NOD2;RIPK2;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.6978994070903777,1.1368738918282157,0.2875,0.8962151536121032,1.0,3/10,13.31%,MEI1;SYCP3;ZCWPW1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.6957142981634137,1.1365887046159437,0.2875,0.8972371888944379,1.0,5/11,24.57%,COX7C;CYCS;COX4I1;COX6C;COX6B1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.49826055193413027,-1.1364304979359487,0.2857142857142857,0.8793659090554772,1.0,9/22,21.35%,ZMYND11;SUPT16H;THOC5;HTATSF1;KAT7;TCEA2;THOC1;SUPT5H;WDR43
prerank,Reactome_2022__Gastrulation R-HSA-9758941,0.7762322220042022,1.1363857795237293,0.39436619718309857,0.8976924029047518,1.0,1/6,5.53%,TCF7
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.5609499534898345,1.1362702856903404,0.30434782608695654,0.8976524049663297,1.0,6/67,5.22%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.6290795456541511,1.135942697462536,0.3176470588235294,0.898767822286454,1.0,6/25,14.15%,DGKI;DGAT1;CAV3;DGKB;DGKG;GK
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.46990073181829023,-1.1358371248722516,0.2916666666666667,0.8801305955528906,1.0,10/25,22.08%,FSCN1;ABI3;CYFIP1;ARPC2;CDC42;CAPZB;ACTR3;WASF2;ACTR2;FER
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,-0.7133104176698131,-1.135681880475649,0.3939393939393939,0.8794218629881438,1.0,2/6,14.34%,LSM11;SNRPB
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,0.7838668541977429,1.1354268357203627,0.34375,0.9007846225374369,1.0,2/5,15.99%,MAFB;LDB2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7426024389543083,1.1354261486406652,0.3,0.9002944535808574,1.0,2/7,4.08%,NRG1;CDH2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.6706307109563545,1.1352204599293434,0.325,0.9007568111330945,1.0,2/14,3.59%,HTR2B;AGT
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5113454007412567,-1.1351770474213851,0.3793103448275862,0.8796764634659877,1.0,4/15,14.28%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.6485154571376307,1.1351343923573047,0.275,0.9006699323417292,1.0,5/11,20.68%,GRIN2A;GRID2;GRIN2B;MAPK8IP2;LRRK2
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5457085684931865,1.1349861564814188,0.27472527472527475,0.9008548468794646,1.0,25/65,21.88%,MAPT;INSR;EPHA3;IRS2;IGF1R;FGR;NTRK3;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;EPHA6;EPHA5;LDB2;NPRL2;SOD1;ECT2;RBL2;CDKN1B;FGFR2;SLAMF8;HNRNPU;EEF1A1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.7627360917049837,1.1349806709522625,0.3684210526315789,0.9003757722906977,1.0,1/6,3.11%,SLC2A3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.595644595057226,-1.1349571322390886,0.3448275862068966,0.8791152254988759,1.0,2/9,4.25%,ZNF703;CSF1R
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6987855249525653,1.1349363795347003,0.3230769230769231,0.9000580526612472,1.0,2/7,5.04%,LRP2;VEGFA
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.5414831764639434,1.1348125763092154,0.2696629213483146,0.9001827204317695,1.0,11/54,16.77%,PDE5A;PDE10A;PPP2R5B;PDE1A;PPP2R5A;FGR;PDE2A;KCNMB1;GUCY1B1;ATP2A2;KCNMA1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.5962736193835171,1.1348052100979984,0.32558139534883723,0.8997198622842798,1.0,9/38,15.06%,DDIT4;TGFB2;EGR1;MAPT;FCGR2B;EPHA7;GRIN2B;PICALM;WNT5A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5922629146588767,1.1347302801834878,0.3625,0.8995686066154361,1.0,10/27,30.92%,TFRC;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;ATP6V1E2;ATP6V0A1;MCOLN1
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,0.5784532501507557,1.1347241807778148,0.27058823529411763,0.8991065908257753,1.0,7/38,6.00%,SPARC;VIM;TNS1;FBXL7;CDH2;LAMA2;FHL1
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.5414592219017408,1.1345422364070237,0.2708333333333333,0.8994720911472412,1.0,15/98,14.11%,FA2H;CBR1;ACSL1;FAAH2;ALOX12;ALOX15B;ACOT13;SCD5;MID1IP1;ELOVL4;CPT1A;PRKAG2;FASN;SCD;HSD17B12
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.5190426865452856,1.1342887946061626,0.24242424242424243,0.9002780234714663,1.0,32/183,15.76%,HS3ST5;OMD;MDH1;HS3ST2;OGN;CHST7;PFKM;NCAN;VCAN;TALDO1;B4GAT1;GPC5;CEMIP;ENO2;PAPSS2;GNS;NUP133;RPS27A;CSPG5;AKR1B1;CRYL1;B4GALT5;PFKFB4;HS6ST3;FBP1;PKM;HOOK3;ALDH1A1;PHKG1;HS2ST1;NDST3;SEH1L
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.5552862367899152,1.134175119878053,0.3493975903614458,0.9003270618945163,1.0,6/26,14.87%,CR1;SPOCK1;AGT;SPOCK3;SERPINE2;TIMP3
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.7239240389616449,1.1341401059394853,0.2835820895522388,0.899965720459803,1.0,1/7,11.39%,PRKAG2
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.5415171128584142,1.1340565353313379,0.2608695652173913,0.8999348557611172,1.0,24/99,17.05%,LRP2;OR3A2;CACNB2;GPC5;PCDH15;SLC26A5;BSN;SYP;SNAP25;CHURC1-FNTB;OTOGL;SCN3A;KCNMB1;SPTAN1;SLC24A1;ADCY8;RDH11;GNAL;SCN2A;LDB2;NAPEPLD;KCNMA1;SPTBN1;GRK4
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6826363056071568,1.133924616645647,0.3333333333333333,0.8999889996056287,1.0,3/13,12.68%,CSPG5;WASF1;SLIRP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.6436686359882865,-1.133750377611499,0.3448275862068966,0.8813412681209642,1.0,4/9,15.04%,CD200R1;RIPOR2;AKT1;LRCH1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.6928962869494085,1.1336462099083133,0.39705882352941174,0.9003168057694769,1.0,3/5,22.43%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.6928962869494085,1.1336462099083133,0.39705882352941174,0.9003168057694769,1.0,3/5,22.43%,ADAM15;ATP2A2;HFE
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.5291072651738477,1.1335960487344243,0.2631578947368421,0.9000662413378783,1.0,20/75,21.82%,THBS1;PRR16;VIM;EIF4A3;SOX4;RBM3;RPS6KB2;EIF3E;UPF3A;PKM;RPS4X;RCC1L;POLR2D;RPS9;PYM1;PLD1;SAMD4A;UHMK1;POLR2G;TRMT10C
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,0.6558422620231961,1.1329199493214779,0.38028169014084506,0.9024444381862002,1.0,8/15,24.25%,ITGA2;RARRES1;ATP8B1;MROH9;GIPC2;CLCA4;MAST4;CFTR
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7527862208713272,1.1328335058355887,0.29577464788732394,0.902382416732403,1.0,5/5,24.75%,ANK3;CNTNAP2;CNTNAP1;CNTN2;EPB41L3
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.6246781038681561,1.1325485135113746,0.2857142857142857,0.9025424084192241,1.0,7/23,17.44%,MACC1;RARRES1;ITGB8;SEMA5A;SHROOM4;THY1;SPINT2
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.6246781038681561,1.1325485135113746,0.2857142857142857,0.9025424084192241,1.0,7/23,17.44%,MACC1;RARRES1;ITGB8;SEMA5A;SHROOM4;THY1;SPINT2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7531891568615,1.1324385436234448,0.2698412698412698,0.9025949015018387,1.0,1/6,9.71%,TFIP11
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.5828246811504447,1.1322722943616657,0.27586206896551724,0.9028413280321389,1.0,4/36,4.13%,FGF1;TGFB2;NRG1;SLC11A1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5941260935633739,1.1321548952907974,0.35294117647058826,0.9028389165044012,1.0,8/24,21.98%,ATP5ME;ATP5F1A;ATP5F1D;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.6353792131769844,1.1321119219351703,0.32098765432098764,0.9025334156007193,1.0,6/19,11.11%,SEMA3A;SEMA3B;SEMA6A;ROBO1;UNC5C;EPHA7
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.6269474784923961,1.1318192107522616,0.3888888888888889,0.9033406362994824,1.0,8/28,15.06%,TGFB2;IL15;IER5;CDKN2AIP;FCGR2B;ARG2;NSMCE1;WNT5A
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,0.5738130265444387,1.1317517930370409,0.27956989247311825,0.9031940214697731,1.0,20/51,28.10%,PLIN2;RPS27A;PRKAG2;DYNC1H1;TOMM20;PINK1;EPAS1;PRKAA2;UBA52;UBB;DYNC1I1;MTERF3;ATG5;MFN2;TOMM40;CFTR;DYNLL1;MAP1LC3A;HSPA8;PRKAB2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.673764126923446,1.1316942610466496,0.27906976744186046,0.9029037063178788,1.0,2/14,1.94%,FOLH1;ASPA
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,0.6024560478814752,1.1316361267431474,0.31645569620253167,0.9026781588279927,1.0,8/25,15.39%,ZBTB16;KITLG;BMI1;MCL1;CD93;ALDH1A1;CASP3;THY1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.5625883201469203,1.1316141186234252,0.2826086956521739,0.9018068226763167,1.0,16/48,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.5625883201469203,1.1316141186234252,0.2826086956521739,0.9018068226763167,1.0,16/48,28.92%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;DMAC1;ECSIT;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.5821954954433332,1.1315727682306698,0.2727272727272727,0.901503033759759,1.0,5/28,14.36%,BRIP1;DNA2;BRCA1;XRCC3;RFC4
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.569691701624361,1.1315249697244554,0.3010752688172043,0.9012836763146852,1.0,9/41,20.89%,NDUFA2;NDUFB9;NDUFA3;NDUFS8;ACAD9;NDUFB6;TIMMDC1;NDUFAF4;ECSIT
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6899480586577948,-1.131457451139228,0.35135135135135137,0.8868308256667994,1.0,3/6,11.50%,DNMT3A;KDM1B;MECP2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.6314135737372422,1.131308656463651,0.2564102564102564,0.9017469104589012,1.0,4/19,7.79%,BRINP1;RORB;EPHA3;PTK7
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5970629531925027,1.131273455300891,0.32142857142857145,0.901473296756404,1.0,3/27,6.67%,SLC16A4;SLC6A15;SLC13A3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,0.7270421753391989,1.1312408923333008,0.2894736842105263,0.9011456458942588,1.0,4/8,14.14%,GREB1L;CDH9;SERPINE2;GNAL
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.7269137722365002,-1.1310897672763633,0.4594594594594595,0.8866048233708606,1.0,1/5,1.86%,SERPINF2
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7073687397127628,1.1309968244298028,0.31746031746031744,0.9018204803725159,1.0,1/6,0.28%,THBS1
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.5811080017605805,1.130774071477576,0.3375,0.9022725604146472,1.0,6/28,18.26%,SPARC;TNS1;LTBP1;THY1;LDB2;IGFBP7
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6066378152779086,1.130601573132509,0.2823529411764706,0.9026304593486829,1.0,8/25,25.50%,SOX4;IGF1R;ADCY8;PDK3;SLC39A14;PRKAA2;KCNB1;PTPRN2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6144007299308946,1.1305706464712963,0.2911392405063291,0.902283176378355,1.0,7/20,20.00%,SHANK3;RELN;PTN;ADCY8;EPHA4;APP;CYP46A1
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.6631412802940788,1.130529801733085,0.3333333333333333,0.9020101566663442,1.0,1/10,1.35%,NDUFA2
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,0.563350118039956,1.130475531160496,0.3181818181818182,0.9018309739893977,1.0,11/37,20.42%,KLF4;VEGFA;THSD7A;CD93;FLT1;THBD;TNFRSF1B;TNFRSF1A;CD151;COLEC12;SELL
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.640918841109678,-1.130472048406725,0.38235294117647056,0.8869559129115024,1.0,3/9,7.51%,FSCN1;DDR1;TGFB1
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.6221480659899883,1.1303340898588152,0.32857142857142857,0.9018488122389797,1.0,5/14,28.34%,KCNJ6;KCNJ3;GNB5;ABCC8;GABBR2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.626783760057459,1.1302650348048549,0.35,0.9017387614166741,1.0,5/15,17.86%,ROBO2;ROBO1;TNFRSF1B;ROCK1;TNFRSF1A
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4625783708695895,-1.1301370266408914,0.19047619047619047,0.8867483485136537,1.0,8/35,16.05%,KARS1;DARS2;FARSA;YARS1;TARS1;LARS2;SARS1;WARS1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.48718316513799975,-1.1300534796524777,0.3076923076923077,0.8859125610511599,1.0,9/20,22.94%,LEO1;SUPT16H;THOC5;BRD4;KAT7;THOC1;SUPT5H;CDC73;SUPT6H
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,-0.3859667570420555,-1.1300030554081142,0.1111111111111111,0.884863766205909,1.0,20/55,14.63%,TDRD10;TAL1;GIMAP8;A2M;MPEG1;FOLR2;CSF1R;ABI3;SLCO2B1;WDFY4;CLEC9A;PCDH12;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7;CMKLR1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7034431151759933,1.1297364056290706,0.34177215189873417,0.9035311028370406,1.0,3/12,10.22%,DPYD;DPYSL5;CRMP1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7166331186497656,1.1296908809145938,0.352112676056338,0.9033220123580692,1.0,1/5,1.28%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.6856426248165917,1.1296592528699032,0.3472222222222222,0.9029511101993033,1.0,3/8,15.83%,ANXA1;NFKBIZ;IL18
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5325103202168289,-1.129595328902862,0.2857142857142857,0.8848928192258789,1.0,4/18,11.79%,NPC1;ACAA1;CH25H;OSBPL6
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4961723315941499,-1.129558645357751,0.2916666666666667,0.8837945953434889,1.0,5/14,15.26%,KARS1;NMI;TYROBP;SYK;LILRA2
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.507125370948889,-1.129462050088201,0.2727272727272727,0.8829852427806941,1.0,1/14,0.24%,SCNM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.6797245194137822,1.1294246156405905,0.37681159420289856,0.9034835930832861,1.0,2/11,12.87%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.7051790219917662,1.1293092708487686,0.31666666666666665,0.9034269160806587,1.0,4/8,20.66%,ATP1B3;KCNMA1;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.6906906898424519,1.129203822053158,0.33766233766233766,0.9034683455830523,1.0,2/12,5.04%,NRG1;VEGFA
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.5352325142632839,-1.129073593692677,0.25,0.8827669220081977,1.0,5/14,25.96%,KHSRP;AKT1;EXOSC9;EXOSC8;EXOSC2
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.5801381086016588,1.128887844583213,0.3409090909090909,0.9043916721642572,1.0,8/41,10.75%,NTN4;DCC;DOCK1;MYO10;ROBO1;UNC5D;TRPC4;UNC5C
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7203977202493483,1.1287214287021876,0.36231884057971014,0.9046578066606658,1.0,2/6,23.75%,LMO3;GPS2
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.5439122230156473,1.128630021168488,0.25263157894736843,0.9046299904362275,1.0,5/60,6.15%,DIAPH3;DOCK1;TFRC;DOCK5;VAPB
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6898796081600648,1.1285820519655716,0.3424657534246575,0.9042989104018944,1.0,3/8,13.87%,HSPA5;BOK;PPP1R15A
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.554641656839769,1.1285017393021797,0.32222222222222224,0.9041001925030748,1.0,11/44,20.36%,GADD45B;ADAM15;CARHSP1;GSKIP;INSIG1;E2F7;CASP3;PCSK6;DBF4;ENO1;HELLS
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6558963456971036,1.1284658146605435,0.3815789473684211,0.9037892943024722,1.0,1/10,0.28%,THBS1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.5092586634677945,1.128419957825681,0.2828282828282828,0.9035422195292279,1.0,48/142,25.39%,RPL23;EIF4A3;COL4A5;RPL37A;ROBO2;RPL38;ROBO1;RPS6;RPS27A;RPL23A;RPS25;RPS27;PSMB4;RBX1;RPS11;RPS20;RPL9;UPF3A;RPLP2;RPL37;RPL14;RPS4X;LDB2;RPL11;RPS24;RPS9;RPL36;UBA52;UBB;PSMC2;PSMA3;RPS3A;PSMB2;RPL35;RPL4;RPL32;PSMD5;PSMD7;RPL27A;RPL3;PSMD14;RPS16;PSMA5;RPL30;RPL36AL;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7304656976720635,1.1282361891190136,0.3157894736842105,0.9038860586550104,1.0,2/5,7.85%,KMO;AFMID
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.6503731803047809,1.1282342754464574,0.3472222222222222,0.9034147699495199,1.0,3/11,20.17%,MFNG;ATP2A2;NOTCH2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5825170351357223,1.1280940703981732,0.26666666666666666,0.9036169007488506,1.0,4/21,9.30%,SHANK3;CTNND2;INSR;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7311446682415291,1.1279617520037488,0.3472222222222222,0.9036969759795588,1.0,3/6,16.49%,TXNIP;E2F7;ORC6
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.5609355604318063,1.1278874637352447,0.27472527472527475,0.9031119985063887,1.0,10/36,18.26%,SPARC;LAMA2;FN1;PDCD1LG2;TGFBI;TIMP3;COL5A3;THY1;EPAS1;IGFBP7
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.5609355604318063,1.1278874637352447,0.27472527472527475,0.9031119985063887,1.0,10/36,18.26%,SPARC;LAMA2;FN1;PDCD1LG2;TGFBI;TIMP3;COL5A3;THY1;EPAS1;IGFBP7
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,0.6974923798165333,1.1278354692833379,0.37142857142857144,0.9028662012380322,1.0,3/6,15.39%,ALCAM;POU5F1;THY1
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,0.717083264830441,1.1278104191181755,0.2987012987012987,0.9025088092283466,1.0,3/8,18.04%,MAPT;PRKAG2;PRKAA2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7113717757763464,1.1273779660927814,0.30158730158730157,0.9038384610119747,1.0,4/7,20.17%,MFNG;FCGR2B;GPR183;NOTCH2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.3709267551659936,-1.1272531562583472,0.3333333333333333,0.8873247385150115,1.0,27/92,13.95%,GIMAP8;BIN2;SELPLG;SAMSN1;UBA7;MPEG1;LGALS9;CSF1R;ARHGDIB;ITGAX;AOAH;HLA-E;NCKAP1L;WDFY4;PLEK;HLA-DPA1;ITGB2;CYTH4;APBB1IP;LCP2;PHF11;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,0.5330255857361096,1.1271051299707695,0.2391304347826087,0.9047148974687058,1.0,17/80,16.45%,CLEC4E;CLEC12A;CR1;CD163;DPYD;CLEC2B;SRGN;F13A1;FCGR2B;FCGR2C;CD93;FGL2;MPP1;SOD2;PICALM;ITGAV;GBP2
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.704115917142007,1.1270583485858636,0.4262295081967213,0.9044202163999886,1.0,1/5,4.13%,SLC11A1
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.5532193689848326,1.1270316498298225,0.2696629213483146,0.9040481995524623,1.0,4/36,10.32%,RAB7B;ARF6;TBC1D13;TBC1D15
prerank,KEGG_2021_Human__Hippo signaling pathway,0.5416724274338378,1.126903854461952,0.25,0.9041858702912924,1.0,17/90,16.98%,FGF1;TGFB2;FZD6;BMPR1B;TCF7;TCF7L1;SAV1;ID2;LIMD1;PPP2R2B;PARD3;APC2;CTNNA2;WNT5A;CCND3;CRB1;SMAD1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6260806778261433,1.1268737296363565,0.36,0.9038192186845504,1.0,3/15,8.46%,ZBTB16;MEIS2;MAFB
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7396407530745363,1.1268584435108366,0.38961038961038963,0.9033948111671227,1.0,5/8,20.77%,MID1IP1;CPT1A;PRKAG2;PRKAA2;ACACB
prerank,KEGG_2021_Human__Wnt signaling pathway,0.527331573145142,1.1266316152327467,0.2717391304347826,0.9038667573533883,1.0,18/93,17.48%,DKK2;FZD6;TLE1;DAAM2;CTNND2;TCF7;TCF7L1;RBX1;PRICKLE1;CAMK2B;APC2;MAPK10;WNT5A;CCND3;TBL1XR1;CTBP1;PLCB1;CACYBP
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6801079370122978,1.1265492795025875,0.3424657534246575,0.9038251466825208,1.0,4/9,27.54%,DGAT1;GK;GPAT4;LPGAT1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.6812634574808426,-1.1264227477112687,0.4583333333333333,0.8885425285213195,1.0,2/7,8.88%,BCL2L1;SERPINB9
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.5506906024351803,1.1263460478712997,0.21505376344086022,0.9042092905166839,1.0,11/77,9.54%,SOCS3;PRLR;GFAP;IL15;OSMR;PIAS4;LIFR;IL7;FHL1;MCL1;GHR
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.643633742982788,1.1263388552265523,0.35714285714285715,0.903746892088963,1.0,5/21,13.15%,CR1;FCGR2B;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6794515940931584,1.1261864084818851,0.3561643835616438,0.903990529092271,1.0,3/9,21.23%,KIF5A;SPG11;KIF5C
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.7457245187905908,1.1260931690382705,0.34328358208955223,0.9039296210077403,1.0,1/6,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6455084196704903,1.1260266661367655,0.3835616438356164,0.9037625735997482,1.0,1/10,1.11%,PLIN2
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.6117750596948072,1.1260086039229344,0.2702702702702703,0.9033255082053028,1.0,6/18,14.89%,TM7SF2;IDI1;MVD;SH3D19;FDFT1;HMGCS1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6506966923018511,1.1258709616939235,0.3142857142857143,0.9033759601560604,1.0,1/13,5.92%,RBM3
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.5263791690776689,1.125584049999768,0.23958333333333334,0.9042409080026366,1.0,15/115,12.75%,CENPF;TUBA4A;DTL;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;TUBA1A;FHL1;KCNH5;PSMB4;RBX1;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.7492401215805474,1.1254671677457808,0.4,0.9042667394824038,1.0,5/5,25.11%,MYRF;B4GALT5;PLP1;CNTNAP1;B4GALT6
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.5783705527290522,1.1254543426750525,0.31868131868131866,0.903825512746139,1.0,7/34,12.76%,TSHR;ADCY3;INSR;IRS2;ADCY8;LIPE;GNAI1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.515976998812552,1.1252403477485573,0.13,0.9042605743710143,1.0,66/336,16.36%,HTR2B;THBS1;NAMPT;TUB;FGF1;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;MAPT;TBC1D8;IL15;MYRF;OSMR;NRG1;MEIS2;FRMD5;SLC11A1;KITLG;LIFR;BMPR1B;VEGFA;SPDYA;SOX4;IER5;CDKN2AIP;FCGR2B;IL7;SHANK2;MVD;INSR;AKAP6;HCFC1;PPP1R13L;FN1;RPS6;PTN;IRS2;IGF1R;RYR2;NTRK3;MFSD2A;FLT1;NTRK2;HCLS1;DYNC1H1;RIPK2;CRLF1;EPHA4;PARD3;TNFRSF1B;TPPP;FASN;NSMCE1;PYCARD;SDCBP;WNT5A;COPS9;CIDEB;RPS4X;IL11RA;EPB41L4B;ITGAV
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.5524683076962942,1.1252150897236988,0.30434782608695654,0.9039063884783644,1.0,6/67,5.22%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5136255990796909,-1.1251644643654044,0.2,0.8912320134199848,1.0,9/27,12.04%,FLNA;MYH9;ACTB;TLN1;ILK;GNAS;P2RY12;PLEK;UBASH3B
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.4276216497436449,-1.1250849608227427,0.15384615384615385,0.8902583562766629,1.0,9/51,9.73%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;LEO1;SUPT16H;TCEA1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.7208103793059208,1.1250422190351583,0.4090909090909091,0.9041534714303335,1.0,2/5,22.91%,ABCA1;ABCG1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.6074254833527157,1.1250142267995031,0.3,0.9038045175949402,1.0,2/19,11.90%,MAPT;DYNC1H1
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.5461759598310686,1.1249479520966723,0.3263157894736842,0.9036384107723291,1.0,9/64,11.33%,FGF1;PPP2R5B;PIGU;NRG1;KITLG;PPP2R5A;INSR;IRS2;NRG3
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.6299759278232361,-1.1248843255064744,0.40625,0.8896063412155835,1.0,3/8,11.72%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.7292887599165535,1.124831767532281,0.3333333333333333,0.9036740622824155,1.0,4/6,26.29%,SYT4;SYT1;KCNB1;SCAMP5
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.7059659048137926,1.1247777750068162,0.3188405797101449,0.9034554292814928,1.0,2/10,9.91%,ACSL1;MFSD2A
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.6622825430850853,1.12447585796016,0.31343283582089554,0.9043829362910805,1.0,3/13,13.96%,VEGFA;PAX8;PKD1
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7626093502061874,1.1243975637429753,0.38461538461538464,0.9043702216823792,1.0,4/7,21.29%,DGAT1;MFSD2A;ACSL3;P4HB
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.4863565281890629,-1.1241675506021196,0.2857142857142857,0.8904959071903812,1.0,4/27,5.22%,ATRAID;FLNA;DAB2IP;AZIN2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.6646429068736214,1.1239147788179955,0.37142857142857144,0.9055463936179674,1.0,4/9,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6646429068736214,1.1239147788179955,0.37142857142857144,0.9055463936179674,1.0,4/9,21.02%,ATP1B3;ATP1B2;ATP1A2;SLC9A1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.6376064565988235,1.1237126721299757,0.323943661971831,0.905891936564298,1.0,3/15,12.87%,WDR5;KDM1A;BRCA1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6961778478133728,1.1237030207916063,0.38235294117647056,0.9054576362969998,1.0,2/7,9.72%,GLYATL1;GLUL
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.49682808538558526,1.1236839486383483,0.20202020202020202,0.9050572461622194,1.0,78/240,25.39%,AANAT;KMO;FOLH1;ASPA;RPL23;NMRAL1;CKMT2;CARNS1;RIDA;FAH;SEPSECS;RPL37A;PAPSS2;RPL38;AFMID;SBDS;RPS6;ATAT1;ASRGL1;RPS27A;RPL23A;CKB;GLUL;RPS25;DARS1;RPS27;PSMB4;ALDH6A1;RPS11;RPS20;RPL9;ARG2;RPLP2;DMGDH;RPL37;RPL14;NAT8L;PEMT;RPS4X;SLC25A21;RPL11;CARNMT1;RPS24;RPS9;NPRL2;RPL36;UBA52;PSMC2;PSMA3;SLC44A1;RPS3A;SLC3A2;PSMB2;AUH;PIPOX;AHCY;RPL35;RPL4;PDHB;RPL32;PSMD5;SERINC5;PSMD7;TMLHE;RPL27A;RPL3;PSMD14;RPS16;PSMA5;RPL30;RPL36AL;GPT2;ADI1;RPL21;RPL7;ECHS1;TXNRD1;RPL12
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.6312551643676074,1.1235625912448892,0.27848101265822783,0.9051445394110924,1.0,9/21,16.10%,ERCC2;ANXA1;OVOL2;ST14;TXNIP;WNT5A;CASP3;UGCG;CLIC4
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.5690772346784931,1.1234841483193172,0.2891566265060241,0.9050312072493895,1.0,4/37,6.92%,NUDT4;ITPKC;INPP4B;MTMR7
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6045260746811738,1.1233377182524626,0.33707865168539325,0.9052472710846413,1.0,10/26,20.90%,DMD;LAMA2;FHL1;POU6F1;CAV3;SGCE;SOX6;SGCD;CHODL;UTRN
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6756721218918595,1.1232513568526512,0.3561643835616438,0.9051053854315414,1.0,1/10,2.79%,MAPT
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,0.7148533499692848,1.123122512269925,0.3698630136986301,0.9052830485231602,1.0,3/8,13.55%,RXRB;FASN;SCD
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5345245374154522,1.1230442359101733,0.2967032967032967,0.9051603505810499,1.0,6/55,12.03%,ACVR1B;CDK14;SPDYA;RCC1;PLK2;HINFP
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,-0.5775591438108146,-1.1229077288635345,0.2608695652173913,0.8926733755755811,1.0,3/11,2.85%,IL1B;MAF;IL1A
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6437909886944817,1.1228438902828966,0.3287671232876712,0.9055997231205778,1.0,4/11,20.93%,IL15;GPNMB;IL18;LEPR
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.6117509215416914,1.1226321479948331,0.30952380952380953,0.9061243150184992,1.0,9/23,26.32%,SV2B;SNAP25;SYT1;ANTXR2;SV2C;GUCY2C;PDCD6IP;TXNRD1;HSP90AB1
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,-0.5309169644291988,-1.1225500512524864,0.27586206896551724,0.8925326383712003,1.0,2/9,4.16%,CLTB;CLTA
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,0.5558823369183525,1.1225475285994992,0.2967032967032967,0.9055504730786358,1.0,12/46,18.28%,SPARC;LAMA2;IFITM3;PLTP;IFIT2;ABLIM3;COL5A3;ENKUR;CEBPD;EPAS1;IGFBP7;FTH1
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,0.5558823369183525,1.1225475285994992,0.2967032967032967,0.9055504730786358,1.0,12/46,18.28%,SPARC;LAMA2;IFITM3;PLTP;IFIT2;ABLIM3;COL5A3;ENKUR;CEBPD;EPAS1;IGFBP7;FTH1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,0.754753457379654,1.122476303730766,0.3673469387755102,0.9053566692305468,1.0,2/5,7.99%,BMI1;ALCAM
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7314944637727218,1.1224445278723243,0.390625,0.9050443189289425,1.0,1/5,8.14%,ROBO1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.7348098125480733,1.1223989416208942,0.34328358208955223,0.904789261318604,1.0,2/7,9.52%,HIF1A;MCL1
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6690196765934708,-1.1222443506912954,0.375,0.8920573498345986,1.0,2/6,12.16%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.6890746031949201,1.122067021129091,0.3939393939393939,0.9057966309304879,1.0,3/9,12.42%,VEGFA;PDE2A;SH3GL2
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.6104194778709304,1.1219903550845824,0.3170731707317073,0.9056362984177198,1.0,5/21,8.86%,EGR1;VGF;KCNH8;SH3GL3;ID2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.5012590303163983,-1.1218200320022564,0.2857142857142857,0.8921818790163156,1.0,1/14,0.45%,CCL5
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Undefined,-0.6377250412283826,-1.12175138988837,0.3448275862068966,0.8911457516472542,1.0,3/5,13.07%,GZMB;TNFSF10;PRF1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.6976046020935729,1.1216821981506895,0.3384615384615385,0.9064099250038723,1.0,3/6,22.53%,GPR183;FOXP1;PTGER4
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.560953343331334,1.1216513497038905,0.2808988764044944,0.9060741494015645,1.0,18/45,26.42%,WDR12;WDR74;MAK16;PES1;RPL23A;HEATR3;NHP2;MRPL20;RPL14;RPL11;NOP53;MRTO4;RPL24;RPL3;PAK1IP1;RPL7;TRAF7;RPL10A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5557734506329934,1.1215687060290356,0.3076923076923077,0.9059328626745111,1.0,16/55,18.25%,RAP1GAP;TDG;EPHA3;STMN3;SIPA1L1;NGEF;CHN1;TBC1D15;NTRK2;EPHA4;PLXNB1;EPHA5;FGD6;PLXNC1;FGD4;SOD1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),0.751571829662129,1.1210462618251087,0.3382352941176471,0.907382010608639,1.0,2/5,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),0.751571829662129,1.1210462618251087,0.3382352941176471,0.907382010608639,1.0,2/5,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.6349458855367928,1.120840698005995,0.36764705882352944,0.9077792422509335,1.0,4/11,22.60%,INSR;APP;DCTN1;MAP1A
prerank,KEGG_2021_Human__Insulin resistance,0.5332308017204399,1.12071857343727,0.28421052631578947,0.9078358350372133,1.0,12/80,12.30%,SOCS3;PRKCE;CREB5;AGT;RPS6KB2;INSR;IRS2;OGA;CPT1A;PRKAG2;RPS6KA2;PPP1R3B
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.7278348419626623,1.1206992961833822,0.36231884057971014,0.9074436870790837,1.0,1/6,10.87%,NOD2
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.7639323392604467,1.1206045425280518,0.2835820895522388,0.907467350584192,1.0,1/5,8.41%,DNA2
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.528768674746533,1.120031133200264,0.2872340425531915,0.9094537240887789,1.0,13/76,10.74%,SOCS3;SPARC;VIM;SLC2A3;GLIPR2;ANXA1;TSHZ3;SRGN;TUBA1A;FHL1;CELF2;AKR1B1;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),0.7891010917048464,1.1200089130839876,0.328125,0.9090990745251845,1.0,2/5,3.26%,CENPE;RIOK2
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,0.6954089815757887,1.1199996661538056,0.3493975903614458,0.9086505244416635,1.0,3/8,20.83%,SLC24A1;SLC24A3;SLC24A4
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.464318879959953,-1.1197598998581195,0.23529411764705882,0.8957833541475352,1.0,3/30,4.52%,CCL5;LY86;SCIMP
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.6895969281156542,1.1195738596384461,0.3384615384615385,0.9099737103989416,1.0,1/9,3.76%,ITPKC
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.5302758417513799,1.1195623261159195,0.3,0.9095534223633963,1.0,12/61,11.67%,HTR2B;FGF1;AGT;DIRAS2;VEGFA;RGS2;PAQR3;ROBO1;SPRY1;CAV3;NOD2;FLT1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6626199223802827,1.1194407579869983,0.3157894736842105,0.9095429879475859,1.0,2/17,6.48%,KLF4;INSR
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6181132940657786,1.119340956594512,0.325,0.9090332290608346,1.0,5/17,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6181132940657786,1.119340956594512,0.325,0.9090332290608346,1.0,5/17,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.6108754973704271,-1.1192308914541995,0.3076923076923077,0.8961478818389481,1.0,1/5,2.11%,DHODH
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.5337361819865193,1.1191933038207809,0.23655913978494625,0.9092016303888891,1.0,13/69,9.21%,PLPP3;PRLR;NTN4;TNS1;AGT;KITLG;VASN;RXRB;SEMA3B;CD55;MAFB;BOK;SHC2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.7390143181578139,1.1191721882481667,0.3620689655172414,0.9088062962328437,1.0,2/5,16.96%,RNASE10;PLCB1
prerank,KEGG_2021_Human__Oocyte meiosis,0.5377094594197164,1.119169272048008,0.22916666666666666,0.9083550394869783,1.0,13/79,11.55%,ADCY3;PPP2R5B;SMC1B;SPDYA;PPP2R5A;CALM3;IGF1R;SPDYE3;ADCY8;RBX1;SPDYE18;CAMK2B;RPS6KA2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.5474737666059026,1.1190964250084972,0.3563218390804598,0.9082467278390631,1.0,7/45,11.73%,TGFB2;ARF6;SOX4;MYRIP;APBB3;IRS2;PPID
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.6850577510345001,1.119011545508612,0.3333333333333333,0.9081854185075103,1.0,2/12,8.25%,PPP2R3B;XPO1
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.656527879808583,1.1189654334313808,0.3108108108108108,0.9079554487260448,1.0,2/13,3.38%,DCC;DOCK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6934693502621666,1.118822804334663,0.3783783783783784,0.9076507187677225,1.0,1/10,2.51%,CADM1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6934693502621666,1.118822804334663,0.3783783783783784,0.9076507187677225,1.0,1/10,2.51%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.7774123790842438,1.1188046341573585,0.4225352112676056,0.9072716276552051,1.0,1/5,3.66%,NRG1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.7351771215858098,1.118514786494704,0.35714285714285715,0.9080248031181352,1.0,4/7,22.98%,IFNLR1;PINK1;PRELID1;ISCU
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.6222711009531378,1.1184975562363857,0.35443037974683544,0.907641233070052,1.0,4/14,21.55%,ABCA2;VPS11;RDX;ATP5IF1
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,0.6872743831533282,1.1183285357181407,0.3611111111111111,0.907926210261696,1.0,1/8,4.30%,CEMIP
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.7113662464893687,1.1183213947096806,0.35526315789473684,0.907473030623783,1.0,5/9,19.80%,UCKL1;DCK;UPP2;HPRT1;UCK2
prerank,KEGG_2021_Human__Small cell lung cancer,0.5553553391490602,1.1182080118477804,0.26373626373626374,0.9075104171079647,1.0,9/55,8.46%,CKS2;GADD45B;ITGA2;COL4A5;LAMA2;RXRB;TRAF2;LAMB1;FN1
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.5541476203625393,1.1181572874358083,0.30526315789473685,0.9072585176963908,1.0,11/71,12.18%,FRAS1;CYP3A5;ZNF483;CCDC122;LRRTM4;FSIP2;CFAP54;GAN;ASTN2;ADAMTSL3;L2HGDH
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.7315097510255351,1.1181205710884732,0.3283582089552239,0.9069742341368964,1.0,3/7,10.79%,NLRP12;ERRFI1;IMPACT
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.6758578986394571,1.1180977307629758,0.3333333333333333,0.9066482947321789,1.0,4/12,12.83%,ACSL1;CLIP3;CA2;NR4A3
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6262235322799654,1.1180972467110615,0.3684210526315789,0.9061922576365422,1.0,6/18,27.75%,RUVBL2;NHP2;SHQ1;TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.6736439798378551,1.118088354202258,0.375,0.905769274430101,1.0,5/9,25.23%,DGKI;DGKB;DGKG;DGKE;DGKZ
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.5603899453053176,1.1180124089013446,0.325,0.9057422636401811,1.0,8/47,21.39%,HTR2B;MCL1;PINK1;NRBP2;MTMR9;LRRK2;LEPR;TBC1D14
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.40958991345878704,-1.117893521662935,0.3,0.8992955800873422,1.0,4/48,6.48%,RNASEL;CCL5;APOBEC3G;BANF1
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.5523084329879873,1.1177763344064722,0.35106382978723405,0.9061943421171611,1.0,2/43,3.16%,FGF1;PIGU
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.6209633652161395,1.1172721836714898,0.34146341463414637,0.9077616566832181,1.0,1/19,0.30%,DDIT4
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.68724321357382,1.1169029024132318,0.3037974683544304,0.9090764784377341,1.0,5/12,17.45%,BEGAIN;TMEM108;DLGAP1;DLGAP2;APP
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.6733600661238764,1.1167568331442643,0.2878787878787879,0.9092614718033544,1.0,3/11,5.04%,KLF4;FGF1;VEGFA
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5565714623995484,1.1166959936545167,0.30120481927710846,0.9091120778757514,1.0,4/29,16.92%,ANK3;NSF;PREPL;SPTBN1
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.36351255014528605,-1.1164773435230146,0.16666666666666666,0.9020326943058494,1.0,29/111,13.61%,NKG7;CD300LF;ITGAM;CD37;LY86;BIN2;PIK3R6;MPEG1;BLNK;GZMB;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;IRF5;WDFY4;PLEK;HCK;BTK;MCTP2;ITGB2;CYTH4;TLR7;LCP2;CD83;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7170133228741915,1.116405852879409,0.2698412698412698,0.9098535840329394,1.0,4/7,26.55%,FGR;MICB;LILRB2;BAG6
prerank,CellMarker_Augmented_2021__Basophil:Blood,0.7389157506629369,1.1162550275290481,0.35185185185185186,0.9099358902578843,1.0,2/6,16.98%,CD22;SMAD1
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.49747544808462135,-1.1161481461384974,0.19047619047619047,0.9018635446422217,1.0,4/14,8.79%,MYH9;YES1;FYN;SRC
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.696866747768193,1.1160578460284927,0.421875,0.910356440969914,1.0,4/5,29.19%,SERPINE2;LRRK2;SNX12;PRNP
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,-0.41166705423749805,-1.1160340477020083,0.3333333333333333,0.901032102635301,1.0,21/67,14.46%,TGFBR3;FLNA;ITGAM;CX3CR1;SAMD3;GNLY;BIN2;C12ORF75;GZMB;USP28;LLGL2;EFHD2;MYO1F;PLEK;CAPN2;ADGRG1;SYNE1;C1ORF21;TPST2;RGS19;PIK3R5
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6045685586624204,1.115993818031461,0.3058823529411765,0.9101882665695811,1.0,6/32,7.48%,CACNB2;SCN3B;FHL1;ANK3;ANK2;PKP2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.6874329824501084,1.115953457449275,0.4,0.9099137733141263,1.0,4/13,17.10%,ASXL3;ABCA2;BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7341426755340368,1.1159018569773735,0.3188405797101449,0.909662695222279,1.0,2/7,4.08%,NRG1;CDH2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.6575185868259442,1.1156807867377987,0.3253012048192771,0.910161164668423,1.0,3/14,8.84%,WBP11;SRSF12;WBP4
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.5131325966303093,-1.1155791474339711,0.3684210526315789,0.9009518158792206,1.0,4/21,14.51%,AP1B1;FYN;HCK;CD247
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.5387880460279838,1.115563574821481,0.28421052631578947,0.9101182473623521,1.0,30/73,29.01%,PRKAR2B;CACNB2;TALDO1;GNA11;SNAP25;RAPGEF3;ADCY8;CHRM3;PRKAG2;GNAI1;FASN;CACNA1A;IQGAP1;PLCB1;PRKAA2;GNAQ;ACSL3;ACACB;GNB5;PRKACB;KCNB1;CACNA1C;KCNC2;GNA15;ABCC8;ADCY1;GNA14;PRKAB2;ADCY2;TKT
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.5257070132750254,1.1155175840830733,0.29896907216494845,0.9098582046430802,1.0,11/77,12.53%,ACVR1B;TGFB2;ADAM15;TP53TG5;ALOX15B;CDKN2AIP;FHL1;TCHP;ING1;DNAJB2;FBP1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5257575740977066,1.1153872507040932,0.19791666666666666,0.9099032305684969,1.0,18/107,13.01%,TGFB2;TOM1L1;CENPE;EGR1;RELN;AGT;CLSPN;SLC11A1;MTCP1;VEGFA;SPDYA;INSR;SRCIN1;CALM3;GPRC5B;PRKAG2;EPHA4;PAK5
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,-0.6309160801510336,-1.1153856419821049,0.34375,0.9002977276409924,1.0,1/5,6.99%,ECI1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.6829027687095965,1.1153444113305278,0.3037974683544304,0.9096204782065442,1.0,5/8,30.64%,KDM1A;BRCA1;JARID2;RIF1;ZNF274
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.628061542302784,1.11521975789766,0.35802469135802467,0.9097117147911346,1.0,4/16,9.58%,NCAN;VCAN;GPC5;CSPG5
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.6845574403384279,1.1151293947742875,0.410958904109589,0.9096829654468169,1.0,1/8,13.26%,PINK1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6826500709360788,1.115114014936612,0.3466666666666667,0.9088378113899801,1.0,4/8,27.05%,AP3B2;AP3B1;AP3S1;AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6826500709360788,1.115114014936612,0.3466666666666667,0.9088378113899801,1.0,4/8,27.05%,AP3B2;AP3B1;AP3S1;AP3M2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5005027131852705,-1.1148515295648755,0.38095238095238093,0.9007745082034065,1.0,3/14,14.21%,EGFL7;EGFR;AKT1
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.5469724098213969,1.1148491767485993,0.32222222222222224,0.9094863859320312,1.0,16/42,25.81%,KCNH8;KCNH5;KCNMB1;KCNH7;HCN1;KCNJ6;KCNMA1;KCNB2;KCNJ3;KCNQ5;KCNQ2;GNB5;KCNK10;KCNB1;KCNC2;ABCC8
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.35762891597267404,-1.114777375224959,0.0,0.8997580656332382,1.0,21/151,13.14%,RNASEL;SCNM1;NUFIP1;ELAVL4;RP9;SNRNP35;ADARB1;SF3A1;KHSRP;MTPAP;SMU1;DDX23;AKAP8L;HNRNPUL1;IVNS1ABP;LSM6;M1AP;AURKAIP1;SON;FASTKD2;PPP1R9B
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.648576568551641,1.1147228765168067,0.35443037974683544,0.909503827968953,1.0,7/14,29.84%,ADCY10;GUCY1B1;TIMELESS;KCNC2;SPIDR;FOXO1;BLM
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.41488531869668516,-1.11464636916394,0.375,0.898917560223659,1.0,4/37,2.85%,STAT4;IL1B;MAF;IL1A
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.6253765254951991,1.1145744949123388,0.3684210526315789,0.9095856489236845,1.0,7/18,22.96%,RPS27A;PHKG1;UBA52;UBB;PGM1;GYS1;GAA
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5351043911541304,-1.1145742085317336,0.32,0.8979062425983131,1.0,1/15,0.82%,PDE12
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.5182864894339037,-1.1143882953536857,0.375,0.8973468645650386,1.0,4/28,9.74%,RING1;SMARCD1;CBFB;EP300
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.72643794701617,1.1142235045843887,0.44642857142857145,0.9107110061401787,1.0,2/6,14.65%,TG;DIO1
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.5708162642887575,1.1141508210417475,0.3181818181818182,0.9106405005750031,1.0,4/26,14.36%,BRIP1;DNA2;BRCA1;RFC4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.6403696393188287,-1.1140633230329047,0.3055555555555556,0.896996043345391,1.0,4/5,26.54%,PLCG2;RAB27A;CYBA;CD36
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.5437287686833276,1.1139029176027189,0.24210526315789474,0.9111257981981824,1.0,19/72,18.31%,RHOB;FRMD5;ADAM15;PTPRK;ALOX15B;PTPRT;KANK1;TMEFF2;ROBO1;MAGI2;EPHA4;SPOCK3;LIMCH1;DUSP10;THY1;MCTP1;CLIC4;SPINT2;GTPBP4
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,0.5147511029069493,1.1138737663229177,0.2653061224489796,0.9107934952666955,1.0,29/100,20.02%,ASPA;PLAC8;CCDC152;GLIPR2;ABHD12B;CARHSP1;ETFB;CA2;BEX2;WDHD1;TXN;PTN;COX7A2;POU5F1;IFITM3;NTRK3;NDUFA3;SUGCT;PLTP;SLIRP;PYCARD;SDCBP;PLOD1;GSTP1;ABRACL;ZC3HAV1;TMSB10;SPATA6;CPNE8
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5901057649349688,-1.1138634595135601,0.28205128205128205,0.8963531550943036,1.0,2/8,15.45%,TREM2;TIRAP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.7135721787769685,1.1136588081193473,0.4027777777777778,0.9112461128980966,1.0,3/5,26.68%,CAV3;ATP2A2;FGF13
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.5587409866615646,1.1136199981170187,0.28888888888888886,0.9109874572599919,1.0,8/36,16.18%,RXRB;KDM3A;ABCA1;KDM1A;PLTP;FASN;SCD;TBL1XR1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,0.6964046320163185,1.113582747922964,0.39436619718309857,0.9107107256964868,1.0,1/7,5.33%,RXRB
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.5557060096423747,1.1134962049473716,0.3118279569892473,0.9106266876187059,1.0,9/41,18.81%,TLE1;HIF1A;RBPJ;RPS27A;RBX1;CCNC;TBL1XR1;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.6064445032785486,1.1133686530307383,0.33766233766233766,0.9107442124075592,1.0,5/19,18.04%,INSR;HIF1A;PFKFB4;APP;PRKAA2
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.6542221220458232,1.113206707382485,0.4155844155844156,0.910930271548989,1.0,3/12,15.06%,TGFB2;GPRC5B;WNT5A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.5979451238932392,1.1130703130309003,0.3372093023255814,0.9111024215138517,1.0,10/35,18.26%,KLF4;PDK4;IFITM3;ST14;THBD;BACE2;ALDH1A1;TGFBI;EPAS1;IGFBP7
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.5058720726838061,1.1129549351510164,0.15,0.9111966721077633,1.0,111/403,21.45%,RHOB;RAP1GAP;SHANK3;SEMA3A;NTN4;RPL23;DCC;EIF4A3;CACNB2;SCN3B;NCAN;ITGA2;RELN;ENAH;PIGU;COL4A5;DOCK1;NELL2;DPYSL5;DOK6;RPL37A;CNTN1;LAMA2;ROBO2;LAMB1;ANK3;ANK2;SEMA6A;ADGRG6;RPL38;EPHA3;GRB10;NGEF;MYO10;ALCAM;MAG;ROBO1;CHL1;SCD5;RPS6;DNM3;SCN3A;IRS2;UNC5D;RPS27A;RPL23A;TRPC4;CRMP1;RPS25;SEMA5A;RPS27;SCN1A;SPTAN1;DNM1;UNC5C;PSMB4;RBX1;EPHA7;CLASP2;RPS6KA2;RPS11;KALRN;RPS20;RPL9;UPF3A;SH3GL2;EPHA4;RPLP2;NFASC;RPL37;ABLIM3;EPHA6;PLXNB1;ITSN1;EPHA5;GRIN2B;RPL14;SDCBP;SCN8A;SPTBN5;SCN2A;RPS4X;LDB2;ITGAV;RPL11;RPS24;SPTBN1;RPS9;ROCK1;RPL36;PLXNC1;FES;UBA52;UBB;PSMC2;SPTBN4;PSMA3;CDK5R1;AP2A2;NCAM1;RPS3A;CLTCL1;CNTNAP1;PSMB2;CNTN2;RPL35;RPL4;UTRN;RPL32;RDX;PSMD5
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.6441400347465633,1.1127087429012652,0.3108108108108108,0.9117980915682982,1.0,3/9,13.11%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.7179590607406329,1.1126150553385366,0.359375,0.9116680863541957,1.0,1/8,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.43178364354595034,-1.1125076932544682,0.25,0.8994813777804861,1.0,2/44,1.31%,TNFAIP8L3;NPC2
prerank,KEGG_2021_Human__AMPK signaling pathway,0.5386250704971662,1.1124260053169943,0.3125,0.9120906220580488,1.0,18/93,13.55%,PFKM;PPP2R3B;CREB5;PPP2R5B;PPP2R5A;RPS6KB2;INSR;SCD5;IRS2;IGF1R;LIPE;CPT1A;PPP2R2B;PRKAG2;PFKFB4;FBP1;FASN;SCD
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.5647142876572793,-1.1123491101417908,0.42857142857142855,0.8987509721220349,1.0,3/13,18.48%,UBA7;SENP6;DESI2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.6018699376551699,1.1123175479456742,0.34210526315789475,0.9120929308832674,1.0,10/18,23.76%,SLC24A2;PRRT1;SHANK2;PLK2;SLC24A1;PNKD;NLGN4X;LRRK2;SYT11;PTEN
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,0.7363459352685486,1.1122902615686978,0.3875,0.9117805393783981,1.0,4/6,24.95%,CDH9;IL11RA;FLRT2;GPC3
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,0.6654849054925039,1.112174564891061,0.4155844155844156,0.91179667582002,1.0,6/10,30.20%,CD22;BCL6;IL21R;CD69;FOXO1;CD86
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6875602400134658,1.1119523371639846,0.3333333333333333,0.9123777783409166,1.0,3/9,24.25%,ADCY8;C2CD2L;CFTR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.6451316155986663,1.1119093401894315,0.36486486486486486,0.9120930351570468,1.0,5/12,24.08%,MTERF1;TFAM;POLRMT;TEFM;FOXO3
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.6940940918348917,-1.1118762092468117,0.4642857142857143,0.8991554974392503,1.0,3/6,23.59%,ABL1;CHEK2;MAP2K6
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.5761792687961244,1.1117615469033446,0.35443037974683544,0.9122956154944903,1.0,13/27,24.85%,LRP4;OMG;LINGO1;MAG;PTN;HOOK3;THY1;ARHGDIA;TNF;RTN4;GDI1;PTEN;RUFY3
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.7688936299540673,1.111728781025338,0.3582089552238806,0.9120066461859034,1.0,4/5,20.52%,NLGN1;SGIP1;NR4A3;NPAS2
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,0.6288940146928185,1.111710728493303,0.35443037974683544,0.911595187340907,1.0,5/17,14.42%,CYP3A5;DGAT1;RARRES1;NBEAL1;SLC41A2
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.693581532067306,1.111535512489145,0.34285714285714286,0.9119022484858595,1.0,3/7,15.56%,VEGFA;ATAD2;ESR1
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.738816685136356,1.1114466679175807,0.3492063492063492,0.9118001568711394,1.0,1/6,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.5727084462399913,1.1113463524904348,0.3218390804597701,0.9117617335330404,1.0,6/30,8.63%,FAAH;ACSL1;FAAH2;ALOX12;ALOX15B;SCD5
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,-0.4474440259232606,-1.111299961245885,0.2777777777777778,0.8997132677743417,1.0,12/30,10.06%,SIDT1;PTAFR;DENND1C;MPEG1;BLNK;TC2N;SLC37A1;DAPP1;TNFSF10;CCDC88C;ALOX5;HCK
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5215727214462255,1.111207967625783,0.32222222222222224,0.9118050369652494,1.0,18/51,21.98%,MAPT;PPP2R5A;CAMK2N1;CAV3;GSKIP;DEPTOR;IRS2;PRKAG2;PPM1E;THY1;HSPB1;NPRL2;GSTP1;GNAQ;TAF7;CDKN1B;HNRNPU;CHP1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.7399510183205076,1.1110284073600503,0.28169014084507044,0.9121295306029643,1.0,2/6,6.40%,IDI1;MVD
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.5799650802832514,1.1106800829700998,0.32222222222222224,0.9130068236749375,1.0,5/30,16.89%,ARAF;FN1;CAMK2B;CNKSR2;IQGAP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,0.5797101368341867,1.1104262926885557,0.325,0.9136657358615586,1.0,3/26,3.23%,SPARC;ADAMTS2;TNS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.5696998520723957,1.1101648902625139,0.2413793103448276,0.9141926474308724,1.0,6/42,8.14%,THBS1;SPARC;TGFB2;NFIB;PTPRK;ROBO1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6234398839784773,1.1101545207540575,0.3291139240506329,0.9137774107280193,1.0,3/14,23.41%,SLC11A1;DMXL2;ATP6V0E2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.7761711700190802,1.1100230247340437,0.35,0.9138874633507519,1.0,1/5,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.6235891578470367,1.1099460849947276,0.35714285714285715,0.9137305745596312,1.0,5/19,9.57%,COBL;LSR;ANXA1;ARID5B;CCDC39
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.6300973075090538,1.109908784040862,0.36363636363636365,0.913429188964254,1.0,9/16,22.26%,DNAH11;ADCY10;CCDC39;CFAP54;DNAH17;DNAH7;DNHD1;DNAAF2;DNAAF5
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.7319085412695816,1.1099021856155855,0.38181818181818183,0.913010629005984,1.0,2/5,15.03%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.5470448246947851,1.1097876680461736,0.3373493975903614,0.9130350402747094,1.0,12/41,17.45%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;TMED10;HSPB1;APP
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6848384699184383,1.109766718803236,0.38961038961038963,0.9126531960194231,1.0,5/10,27.96%,VEGFA;SORBS2;FHOD3;TTN;MYH11
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5142295526552267,-1.1096071423396339,0.38461538461538464,0.9037111513549475,1.0,2/12,4.46%,DUSP3;LILRB4
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.5912653256809929,-1.1092536795065988,0.2631578947368421,0.903663039680095,1.0,4/9,9.65%,INPP5K;IL1B;APPL2;ENPP1
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,-0.4507708045018656,-1.10924418166917,0.4,0.9025050028902101,1.0,24/83,14.46%,CD300LF;ITGAM;LY86;BIN2;SAMSN1;MPEG1;HCST;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;BTK;ITGB2;CYTH4;LCP2;CD83;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5579133571447881,1.1092244732249712,0.3333333333333333,0.9145770846105119,1.0,3/36,5.87%,NUDT4;ITPKC;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.5919768796531795,1.1091218151225424,0.3670886075949367,0.9145510876720939,1.0,5/21,8.95%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,-0.5240701559338833,-1.108915021120362,0.35714285714285715,0.9013562121928327,1.0,2/10,4.16%,CLTB;CLTA
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,-0.5240701559338833,-1.108915021120362,0.35714285714285715,0.9013562121928327,1.0,2/10,4.16%,CLTB;CLTA
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.6105354494165044,1.1089102519954368,0.3670886075949367,0.9150569453428921,1.0,4/23,7.22%,ACVR1B;HMGB2;ACVR2A;HIF1A
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.5409465842667723,1.108767878127177,0.3368421052631579,0.9151703872935357,1.0,10/71,11.33%,FGF1;PPP2R5B;PIGU;NRG1;KITLG;PHLPP1;PPP2R5A;INSR;IRS2;NRG3
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5949327085104356,1.1087416878762513,0.3333333333333333,0.9147929345730123,1.0,5/32,8.46%,ACVR1B;HMGB2;ACVR2A;HIF1A;MAFB
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.7236178911311393,1.1084233868829914,0.38461538461538464,0.9157209649924082,1.0,3/6,15.39%,TFRC;ALCAM;THY1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.5039490839264991,1.1077019914072836,0.27835051546391754,0.9182494367091568,1.0,26/151,19.98%,THBS1;PRR16;VIM;EIF4A3;RIDA;ENC1;SOX4;EIF2AK3;RBM3;DAPK1;PUS7;ZNF540;IMPACT;EIF3E;UPF3A;DDX1;RBM4B;RNF139;EIF2B2;RPS4X;HSPB1;APP;PYM1;MIF4GD;PLD1;SAMD4A
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),-0.7109651197798679,-1.107691858340486,0.4838709677419355,0.9032677034138364,1.0,4/6,21.44%,NCKAP1L;AKT1;FAS;PPP2R3C
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7402744375792846,1.1076869686945117,0.3333333333333333,0.9178755252339814,1.0,3/6,11.78%,ZBTB16;BMPR1B;SOX6
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.44924168075038834,-1.1076678509127915,0.25,0.9021161704834934,1.0,5/20,10.89%,ITGA5;CD2;CD200R1;ITGAX;ITGB2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5605949684781075,1.1076392436584552,0.3372093023255814,0.9176098308153806,1.0,3/35,5.87%,NUDT4;ITPKC;INPP4B
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.6643678182157716,1.1075782351388819,0.35443037974683544,0.9174342281161435,1.0,5/14,18.81%,VPS37C;RPS27A;SGIP1;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.3892883886736287,-1.10714048107912,0.2222222222222222,0.9026643505915497,1.0,12/62,15.48%,RALB;TFAP4;GTF2F1;ACTB;NFKBIA;ILRUN;SORL1;CTSZ;DAB2;DISC1;AKT1;HABP4
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,-0.5485701647290326,-1.1070282624641494,0.34615384615384615,0.9019232594378384,1.0,2/7,9.02%,ABCG2;ENG
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.769093746383579,1.106885840440657,0.36486486486486486,0.9199658866257656,1.0,2/5,13.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.4963748567960217,1.1065887160893106,0.2857142857142857,0.920713659842607,1.0,14/119,9.12%,THBS1;SPARC;TGFB2;TUBA4A;MANF;SRGN;F13A1;VEGFA;SYT4;STEAP2;SNAP25;ENDOD1;FN1;RIMS2
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.5018632035883255,1.1065559689543878,0.15,0.9203798222171946,1.0,106/389,21.45%,RHOB;RAP1GAP;SHANK3;SEMA3A;NTN4;RPL23;DCC;EIF4A3;CACNB2;SCN3B;NCAN;ITGA2;RELN;ENAH;PIGU;COL4A5;DOCK1;NELL2;DPYSL5;DOK6;RPL37A;CNTN1;ROBO2;LAMB1;ANK3;ANK2;SEMA6A;RPL38;EPHA3;GRB10;NGEF;MYO10;ALCAM;ROBO1;CHL1;RPS6;DNM3;SCN3A;IRS2;UNC5D;RPS27A;RPL23A;TRPC4;CRMP1;RPS25;SEMA5A;RPS27;SCN1A;SPTAN1;DNM1;UNC5C;PSMB4;RBX1;EPHA7;CLASP2;RPS6KA2;RPS11;KALRN;RPS20;RPL9;UPF3A;SH3GL2;EPHA4;RPLP2;NFASC;RPL37;ABLIM3;EPHA6;PLXNB1;ITSN1;EPHA5;GRIN2B;RPL14;SDCBP;SCN8A;SPTBN5;SCN2A;RPS4X;LDB2;ITGAV;RPL11;RPS24;SPTBN1;RPS9;ROCK1;RPL36;PLXNC1;FES;UBA52;UBB;PSMC2;SPTBN4;PSMA3;CDK5R1;AP2A2;NCAM1;RPS3A;CLTCL1;CNTNAP1;PSMB2;CNTN2;RPL35;RPL4;RPL32;RDX;PSMD5
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.6755518185895439,1.106537703740312,0.375,0.9199880349088977,1.0,2/9,13.53%,GRAMD1C;INSIG1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.6920543354775553,1.1065341334349519,0.4032258064516129,0.9195473440712288,1.0,1/6,2.44%,DCC
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.6706627031166492,1.106471056097017,0.3333333333333333,0.9194519208210811,1.0,6/13,27.69%,GNA11;GNAQ;GNB5;GNA13;GNA15;GNA14
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.5910702201851368,1.1063042387549666,0.3783783783783784,0.9197415453400511,1.0,8/25,26.06%,OIP5;CENPP;CENPK;CENPI;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.7341886403187383,1.1062135353831188,0.34328358208955223,0.9196640165785849,1.0,2/5,15.06%,NR4A2;WNT5A
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.5365643120892953,1.106146168339484,0.30851063829787234,0.9194613516819892,1.0,23/58,22.83%,DCC;MAPT;PLPPR4;ANK3;MAP1B;SLITRK5;SEMA5A;PLP1;NREP;PARD3;CCK;CTNNA2;APP;KLF7;GRM7;NTNG1;SPTBN4;CDK5R1;FGFR2;PAK3;RTN4RL1;MAP1A;RTN4
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5915771233530535,1.1060785567386542,0.379746835443038,0.9192946417605015,1.0,5/22,8.95%,FBN2;GPM6B;ACVR2A;BMPR1B;PTN
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.658717580821355,1.1060598661060446,0.29411764705882354,0.9189583296850727,1.0,4/11,11.79%,MAPT;MAP2;B4GALT5;NTRK2
prerank,KEGG_2021_Human__Tyrosine metabolism,0.7408190278969614,1.1057768174051619,0.38095238095238093,0.9196716941299403,1.0,2/8,3.98%,ALDH3B1;FAH
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.8057796725680992,1.1057682948659504,0.2857142857142857,0.9192418000052797,1.0,3/5,14.58%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.657002672540798,1.1056175328509887,0.35135135135135137,0.9194680866565679,1.0,5/10,27.56%,HERPUD1;AQP11;RNFT1;BAG6;USP25
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,-0.5434786938333189,-1.1056066323792257,0.2857142857142857,0.9047211200474723,1.0,2/8,10.46%,CHUK;IKBKB
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,0.6822762525478043,1.1055465714395658,0.3076923076923077,0.9193775784634168,1.0,2/9,2.24%,VIM;GFAP
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.6624902736302113,1.1055261708542305,0.3466666666666667,0.9189930206067352,1.0,2/15,7.22%,HTR2B;HIF1A
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.546955504945548,1.1054924645564639,0.4090909090909091,0.9186934713193337,1.0,9/39,18.58%,VIM;HMGB2;MAPT;CLSPN;LMNB1;SPTAN1;CASP3;ROCK1;PLEC
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.7241277122507979,1.1053018296284942,0.4,0.9190754152558349,1.0,3/5,14.10%,ID2;EPHA4;SERPINE2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6952294899607433,1.1051873288330494,0.391304347826087,0.9191321280778818,1.0,1/10,5.06%,IHO1
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.4258789256109888,-1.1050837811168996,0.29411764705882354,0.9048581863227172,1.0,7/40,10.78%,MRC2;PSMB3;PSME3;PSMC4;PSMD12;PSME4;FCGR1A
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.5793794097636293,1.1050636153737563,0.3780487804878049,0.9191709939383947,1.0,7/34,15.82%,PLPP3;GLA;ARSA;GALC;UGT8;SPTLC2;UGCG
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6075049007141354,1.1048359822996352,0.27631578947368424,0.9196499587463774,1.0,6/20,14.89%,TM7SF2;IDI1;MVD;INSIG1;FDFT1;HMGCS1
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,-0.630162297059894,-1.1047888098118257,0.35294117647058826,0.9044040953722529,1.0,2/8,6.91%,SERPINF2;SERPINB6
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,0.6505881895921577,1.1046487379608076,0.35526315789473684,0.9201062408678782,1.0,3/10,22.53%,LMNB1;CNEP1R1;PRKCB
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.6526918991995005,-1.1044448728762648,0.38461538461538464,0.9042714811853501,1.0,3/5,19.06%,ABCC4;SLC19A1;LRRC8D
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6898372535988123,1.1040076011945381,0.3116883116883117,0.9223608951289344,1.0,1/7,2.79%,MAPT
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.5614380624282956,1.103942634381402,0.32222222222222224,0.9221717144775959,1.0,16/44,20.92%,TNC;PTPRZ1;PTPRT;CHL1;FAIM2;TAGLN3;ITGB8;NTRK2;NFASC;LY6H;KCNMA1;GSTP1;IGFBP7;NCAM1;EMC10;CLCA4
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6151251135028182,1.1039094426953378,0.3333333333333333,0.9218185399308516,1.0,6/27,13.87%,MASTL;CALM3;MAGI2;PPP4R4;CD300A;PPP1R15A
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.5014107372988339,1.103780625026045,0.32989690721649484,0.9218382530245078,1.0,13/118,11.23%,LRP4;RBMS3;DKK2;FZD6;AMER2;TLE1;LZTS2;GRB10;RUVBL2;LIMD1;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5939211518505275,1.1037419305864553,0.379746835443038,0.9215698068773823,1.0,8/22,18.62%,IL1RAPL1;ANXA1;SYT4;TNFRSF1B;STXBP6;TNFRSF1A;PNKD;GRM7
prerank,KEGG_2021_Human__Huntington disease,0.5045921949191464,1.1035693416191994,0.18181818181818182,0.9218333142124225,1.0,62/221,22.75%,NDUFA2;TUBA4A;GRIA4;CREB5;DNAH11;TUBB4A;SLC1A2;NDUFB9;TUBA1A;TRAF2;TUBB6;ACTR1B;GRIA2;DNAH14;COX7A2;NDUFA3;CACNA1B;PSMB4;NDUFS8;GRIA3;DNAH17;COX7C;CYCS;DNAH7;SOD2;KLC4;GRIN2B;MAPK10;NDUFB6;TUBB2A;CASP3;KIF5A;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;POLR2D;PLCB1;TFAM;GRIA1;SLC25A4;PIK3R4;DCTN1;SOD1;TUBA1C;GNAQ;PSMC2;PSMA3;AP2A2;DLG4;ATP5MC1;CLTCL1;CYC1;PSMB2;COX4I1;KIF5C;POLR2G;ATP5PB;PSMD7;ATP5F1E;COX6C;TUBA1B
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.5108471437905996,1.1032798564288335,0.2727272727272727,0.922535002584532,1.0,31/115,20.97%,PIANP;SVEP1;ADAMTS2;PCDH9;SH3PXD2B;ASPA;SH3TC2;LAMA2;FSIP2;CA2;ADGRB2;GHR;CRMP1;TMEM132A;SLC35A1;SYT1;SNX10;ACP3;COL5A3;SEH1L;PCSK6;SHQ1;POLL;TPGS1;FLRT2;PLXNC1;TRIM65;ADAM22;COLEC12;COL16A1;GABBR1
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.5711317386851433,-1.1031547065100014,0.35,0.907304536102283,1.0,2/9,2.17%,LRIG1;POLD3
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,0.6822371045741111,1.1031325270669974,0.3424657534246575,0.9226517147493591,1.0,1/8,4.12%,SLC4A10
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,0.5495256004246394,1.1029677063460042,0.391304347826087,0.9229320158740711,1.0,9/45,14.15%,LRP4;FAM234A;ABHD12B;NGEF;FAM124A;POU5F1;CPT1A;FBP1;GK
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.5021122106025929,1.1028397410502675,0.3333333333333333,0.9230395794529563,1.0,39/106,27.22%,ANO4;SLC9B2;TTYH1;ATP8B1;UNC80;TSC22D3;RYR2;RPS27A;TRPC4;FXYD7;CAMK2B;NALCN;RYR3;ASPH;ATP2A2;ASIC2;ATP1B3;ATP10B;ATP1B2;UBA52;CLIC2;UBB;TRPM7;ATP6V0B;ATP13A4;ATP1A2;CLCA4;ATP6V1B2;ATP10A;TTYH3;TRPC1;ATP6V0E2;ATP8A2;ATP6V1D;ATP2B4;ANO3;ATP6V1E2;ATP9A;ANO5
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5537227215049152,1.1027474978639675,0.4117647058823529,0.9230144362609956,1.0,6/31,14.58%,ARRDC3;IL15;ACOT13;RBPJ;NOVA1;ALDH1A1
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.5267569585656896,1.102585412643321,0.3191489361702128,0.9232853213828525,1.0,10/78,12.75%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;TTBK2;CEP152;TUBA1A;NPHP1;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5013126007109201,1.1024931628023809,0.2916666666666667,0.9231805988629089,1.0,18/112,12.68%,DDIT4;PLPP3;NLRP12;DMD;CAMK2N1;PAQR3;CAV3;CALM3;GSKIP;DEPTOR;NTRK3;ERRFI1;IMPACT;IBTK;PRKAG2;SH3GL2;PARD3;PPM1E
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,0.5278936305252293,1.1022351811311448,0.25806451612903225,0.9237733444927378,1.0,25/86,26.75%,DTL;RACGAP1;C5ORF34;FIGNL1;PUS7;WDHD1;PAICS;FANCI;NUDCD1;KIF11;MRPL19;HSPD1;TIMELESS;CTPS1;HSP90B1;IPO7;MTHFD1;NDC1;CAD;CSE1L;CCT8;MCM3;SYNCRIP;HSP90AB1;HSPA9
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6107899700800523,1.102154281918741,0.38961038961038963,0.9236464299464874,1.0,7/23,17.22%,NR4A1;ANXA1;VEGFA;SEMA6A;FLT1;GAB1;HSPB1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.7096388592272576,1.1020724289552355,0.36619718309859156,0.9235593227324953,1.0,2/7,5.78%,HSPA5;SEC61B
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.4988199875133296,1.1017917616066004,0.23,0.9241289946059035,1.0,89/325,22.75%,ARAF;NDUFA2;TUBA4A;DKK2;FZD6;CHRM5;GRIA4;MAPT;DNAH11;TUBB4A;NDUFB9;TUBA1A;HSPA5;TRAF2;EIF2AK3;TUBB6;VAPB;ACTR1B;GRIN2A;GRIA2;DNAH14;CALM3;RYR2;COX7A2;RPS27A;NDUFA3;CACNA1B;PSMB4;CHRM3;NDUFS8;CAMK2B;GRIA3;PPID;DNAH17;COX7C;RYR3;CYCS;DNAH7;TNFRSF1B;PINK1;APC2;KLC4;GRIN2B;NEFL;MAPK10;NDUFB6;TUBB2A;WNT5A;CASP3;KIF5A;ATP2A2;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;PLCB1;UBE2J2;GRIA1;SLC25A4;APP;PIK3R4;TNFRSF1A;DCTN1;SOD1;UBA52;SPG11;TUBA1C;UBB;GNAQ;PSMC2;PSMA3;CDK5R1;DLG4;ATP5MC1;CYC1;TNF;PSMB2;COX4I1;UCHL1;LRRK2;MFN2;KIF5C;ATP5PB;PSMD7;ATP5F1E;RAB5A;PRKCB;COX6C;TUBA1B
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.4774606868922332,-1.1017625809547842,0.25,0.9099094414464899,1.0,6/16,13.53%,BCL2L1;PKDCC;ABI3;TGFB1;DAB2;PPFIA1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.7027896185561799,1.10169819280333,0.4,0.924063765384398,1.0,4/6,23.60%,TRAF2;TNFRSF1A;TNF;TRADD
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.616821032177319,1.1015854266477227,0.35294117647058826,0.9240558393498249,1.0,2/15,4.25%,TGFB2;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.3542837466272437,-1.1015686652356713,0.3333333333333333,0.9093000696448115,1.0,4/44,7.12%,RALB;SESN2;PIP4K2B;SESN3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.679293605843306,1.1013888721285905,0.3125,0.9244660162683941,1.0,6/12,22.29%,SVIL;IGSF8;DISP1;ZBTB18;BASP1;MYL6
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.5679892812626026,1.1013391028646775,0.3258426966292135,0.92421596577251,1.0,4/27,14.36%,BRIP1;DNA2;BRCA1;RFC4
prerank,Reactome_2022__Formyl Peptide Receptors Bind Formyl Peptides And Many Other Ligands R-HSA-444473,0.7092125564230379,1.1012915186987156,0.3880597014925373,0.9240409004276179,1.0,4/5,28.74%,ANXA1;APP;FPR1;FPR3
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5699877228090864,1.101067607900813,0.34523809523809523,0.9244460999337456,1.0,12/42,20.18%,TM7SF2;IDI1;MVD;ABCA1;INSIG1;FDFT1;ABCA5;HMGCS1;SNX17;MSMO1;CYP46A1;OSBPL5
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.5194769130714515,-1.1008459035911078,0.36,0.9101346762516177,1.0,4/12,11.00%,C3;MEST;LPL;NFKBIA
prerank,KEGG_2021_Human__Parkinson disease,0.5100700281657536,1.100371077261548,0.2727272727272727,0.9269593440255061,1.0,57/180,24.06%,NDUFA2;TUBA4A;MAPT;TUBB4A;NDUFB9;TUBA1A;HSPA5;EIF2AK3;TUBB6;CALM3;TXN;COX7A2;RPS27A;NDUFA3;PSMB4;NDUFS8;CAMK2B;COX7C;RYR3;CYCS;GNAI1;PINK1;KLC4;GNAL;MAPK10;NDUFB6;TUBB2A;CASP3;KIF5A;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;UBE2J2;SLC25A4;UBA52;TUBA1C;UBB;PSMC2;PSMA3;ATP5MC1;CYC1;PSMB2;COX4I1;UCHL1;LRRK2;MFN2;KIF5C;ATP5PB;PSMD7;ATP5F1E;COX6C;TUBA1B;TRAP1;PRKACB;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5921044712779556,1.1001150347901532,0.37349397590361444,0.9276481378999956,1.0,4/27,8.38%,HTR2B;GLA;HIF1A;CAV3
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.33291770172798574,-1.1001041460632828,0.16666666666666666,0.9112184180761096,1.0,10/115,7.22%,RING1;H2BC4;TXN2;IL1A;ETS1;MAP4K4;TP53;EP400;MAP3K5;MAP2K3
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.5468825428589155,1.099718251711267,0.27848101265822783,0.9288760409875609,1.0,11/35,23.47%,WDR5;TFRC;PES1;BAIAP2L1;RCC1;FASN;PRDX4;TUBA1C;AHCY;DNAAF5;TRAP1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6472927794123499,1.0996630592441954,0.3875,0.928624598280316,1.0,6/12,19.33%,CHRM5;GNA11;CHRM3;PLCB1;GNAQ;CDK5R1
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.598899141611016,1.0995772840562237,0.35714285714285715,0.9286101410218769,1.0,5/25,16.89%,ARAF;FN1;PEBP1;CNKSR2;IQGAP1
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.6643029479649867,1.099570368916687,0.36486486486486486,0.9281837830013486,1.0,5/15,18.81%,VPS37C;RPS27A;SGIP1;UBA52;UBB
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5606065805335666,1.0994447091525852,0.3176470588235294,0.9282571496990396,1.0,11/55,15.93%,GALNTL6;GALNT8;B4GAT1;GALNT13;SDF2L1;TMTC2;GALNT18;OGA;B4GALT5;PLOD1;GCNT1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.7136096365653228,1.0993827166261025,0.38095238095238093,0.928037128049938,1.0,2/5,18.25%,E2F7;SOD1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6497827928268962,1.0993073020829223,0.4024390243902439,0.9279267113203014,1.0,4/15,19.55%,ACSL1;DGAT1;HSD17B12;ACSL3
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.6581030492522938,1.0989989104978601,0.37142857142857144,0.9287742418507643,1.0,2/11,9.28%,PIGU;IRS2
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,0.7257837231274493,1.0989696184766318,0.3287671232876712,0.9284187681113908,1.0,2/7,20.17%,ITGAE;NOTCH2
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.6086170040861925,1.0988927758918978,0.38028169014084506,0.9283389141290191,1.0,4/13,28.34%,KCNJ6;KCNJ3;GNB5;GABBR2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6618617887354638,1.0988762814730426,0.34328358208955223,0.927992721407387,1.0,5/10,29.19%,RNF139;SERPINE2;LRRK2;SNX12;PRNP
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5742670646046203,1.0988367675312178,0.32954545454545453,0.9277123390396744,1.0,9/32,20.01%,DTL;RPA2;RPS27A;TRIM25;RFC4;USP43;UBA52;UBB;RFC1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.6427633863761537,1.098693979146579,0.3670886075949367,0.9277900140671604,1.0,4/12,10.85%,ASXL3;PPP2R5A;ALK;CCDC3
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,0.5629626025383965,1.0986528337115724,0.3218390804597701,0.9274925500200943,1.0,3/45,2.02%,SOCS3;IFIT5;EGR1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.540537955822504,1.0986319639988458,0.3548387096774194,0.9271299816317569,1.0,11/61,15.56%,FGF1;PIGU;NRG1;NR4A1;KITLG;RPS6KB2;IRS2;PRR5;NRG3;NRG4;ESR1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.6229242992132645,-1.0985961343653687,0.3333333333333333,0.9142902230332451,1.0,3/7,16.02%,CCDC88C;GSN;EMP2
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.5451535862794484,-1.09847263328867,0.3225806451612903,0.9135614205290346,1.0,2/12,3.33%,TXN2;GCLC
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.36892388573461543,-1.098441855525447,0.3333333333333333,0.9124673539121418,1.0,26/83,13.65%,CD300LF;ITGAM;CD37;LYL1;GIMAP8;BIN2;P2RX1;PIK3R6;MPEG1;FAM78A;RASAL3;ITGAX;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;BTK;CYTH4;TREML1;LCP2;TYROBP;CD53;SNX20;GIMAP4
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.6450358344824285,1.098441120042777,0.36923076923076925,0.92753460348494,1.0,2/11,14.39%,PIGU;CDC37
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,0.6593500136905539,1.0983371644493627,0.44285714285714284,0.9275512452431507,1.0,3/10,18.81%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5059084071562975,1.0982703782540795,0.26804123711340205,0.9273284595264925,1.0,25/142,18.11%,ACVR1B;TGFB2;PAPPA2;SPOCK1;TFRC;AGT;ATAD3A;ADAM15;TP53TG5;CDKN2AIP;FHL1;AKAP6;TCHP;MFSD2A;ING1;NRG3;DNAJB2;FBP1;PAK5;SDCBP;BCL6;HSPA1B;APBB2;CHPT1;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.6328471913277108,1.0982443631603604,0.3968253968253968,0.9269927625701258,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.5125361373927533,1.0982290433278288,0.3191489361702128,0.9266138960163776,1.0,12/104,11.23%,LRP4;RBMS3;DKK2;FZD6;AMER2;TLE1;LZTS2;RUVBL2;LIMD1;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.6291559765827592,1.0980519905394726,0.4189189189189189,0.9270656175244024,1.0,3/14,7.27%,RFX2;SYCP3;DPY19L2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.5881811855095569,1.097975489543299,0.35802469135802467,0.9269173439922999,1.0,3/17,8.08%,SUV39H2;ANTKMT;CSKMT
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5998559965175857,1.0978755253031764,0.3333333333333333,0.9268864619292088,1.0,5/24,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,0.5993143868437167,1.0978711754863706,0.3561643835616438,0.9264606169527071,1.0,5/11,27.56%,OTUD7B;TNFRSF1A;TNF;TRADD;USP25
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.6833421473066333,1.0978218351776474,0.36619718309859156,0.926243423956743,1.0,2/10,14.24%,TUSC3;MAGT1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.5712329784167874,1.0977953604653108,0.3764705882352941,0.9259093518415606,1.0,8/25,20.23%,INSR;HIF1A;PFKFB4;PINK1;APP;PRKAA2;PPARA;ENO1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.57847810192514,1.0977044589076526,0.3707865168539326,0.9258053196988366,1.0,6/26,11.06%,SCN3B;FHL1;ANK2;CAV3;FXYD7;CHRM3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6595833426579658,-1.097532121984928,0.3870967741935484,0.9144092623159344,1.0,3/5,19.47%,LIMA1;GSN;PLEKHH2
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5231622456752429,-1.0974746021077528,0.25806451612903225,0.9134334080301661,1.0,1/15,2.40%,HPS4
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.6966429997183545,1.097440019953599,0.36619718309859156,0.9264985415824937,1.0,3/7,18.04%,MAPT;TPPP;PRKAA2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6433139940718291,1.0974335987935935,0.3875,0.9260998675499432,1.0,5/13,10.41%,TGFB2;HIF1A;FN1;ITGB8;LTBP1
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.5541042057131145,1.0971771294500805,0.2826086956521739,0.926826921979651,1.0,9/34,23.25%,BRIP1;DNA2;NEIL1;BRCA1;RFC4;MLH1;RBBP8;BARD1;RPA3
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.6549269561923843,-1.097134970147848,0.48,0.9134242007160062,1.0,2/7,15.14%,CLEC16A;CARD11
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),-0.6595839059920133,-1.0970983575773177,0.42105263157894735,0.9124022510135446,1.0,3/5,15.15%,FSCN1;LCP1;CAPG
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.709640191037537,1.0970524566830229,0.41935483870967744,0.9269259862091952,1.0,2/7,7.02%,AGT;ABCA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.5319241872198257,1.0969656965037147,0.32558139534883723,0.9268217198807852,1.0,14/50,19.88%,PRKCE;CIT;RACGAP1;MAP9;CALM3;SVIL;PLK2;SPAST;CENPV;E2F7;PIK3R4;PKP4;CDC25B;ECT2
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6870339982247491,1.096433902847088,0.4027777777777778,0.9285155683042159,1.0,4/7,21.37%,HOOK3;KIF3A;DCTN1;NIN
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.5849719003650302,1.0962603389404642,0.38372093023255816,0.9288685836655325,1.0,13/34,15.60%,P4HA3;ADAMTS2;COL11A1;COL4A5;COL26A1;COL23A1;COLGALT2;COL24A1;P4HA1;COL21A1;COL10A1;COL5A3;PLOD1
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.5084396158794148,1.096201088441179,0.29591836734693877,0.9287246869022927,1.0,16/105,6.22%,GPR18;TSHR;GRM8;FZD6;GNRHR;HTR7;CHRM5;TACR1;PLPPR4;ANXA1;ADGRE1;GPNMB;CD55;GRM3;MCHR2;LTB4R
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6547031020754903,1.0961735197678604,0.34615384615384615,0.9283737552278492,1.0,4/9,12.41%,CCDC39;CFAP54;DNAH17;DNAH7
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.7514642572436616,1.0960704078360832,0.30357142857142855,0.9283165071386557,1.0,2/5,6.39%,CLIP3;ANK3
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.5742168366087863,-1.0960577431075544,0.35714285714285715,0.9143344339997658,1.0,3/10,12.55%,LEO1;SUPT16H;BRD4
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.5758243291897635,1.0960372150192588,0.3372093023255814,0.9280350894300731,1.0,11/30,15.17%,GRM8;CHRM5;ADCY3;RGS1;AKAP12;PDE2A;ADCY8;CHRM3;GNAI1;GNAL;HTR1F
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.5928372621217493,-1.095902746337038,0.39285714285714285,0.9134629614731536,1.0,1/7,7.65%,DCP1B
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.5443759071646826,1.0958798792954316,0.3595505617977528,0.9282797517773261,1.0,16/59,20.68%,GPNMB;TRAF2;PTPRZ1;MAG;RETREG1;TYRO3;NTRK2;CRLF1;TNFRSF1B;SOD2;PINK1;NRBP2;SOD1;FBXO7;CPEB4;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.696097057777076,1.095694650457833,0.3888888888888889,0.9286534222969862,1.0,3/8,15.03%,GPM6B;CAV3;PICALM
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.5620487484700047,1.0956172623441809,0.36666666666666664,0.9285573971813084,1.0,11/36,20.01%,DTL;RPA2;RPS27A;TRIM25;BRCA1;NSMCE1;RFC4;USP43;UBA52;UBB;RFC1
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.5477042671324494,1.0955979324578526,0.34444444444444444,0.9282032286943054,1.0,11/37,19.64%,SLC6A15;SLC11A1;SLC13A4;SLC13A3;SLC22A15;SLC44A5;SLC41A2;SLC39A14;SLC16A3;SLC16A1;SLC44A1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.5177751904122553,-1.0950690491830493,0.34285714285714286,0.9145454023465022,1.0,3/7,16.52%,NR1H3;WNK3;KMT2A
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.5726550764857625,1.0949647687450226,0.3563218390804598,0.9301336869565666,1.0,8/40,15.56%,FGF1;PIGU;NRG1;KITLG;IRS2;NRG3;NRG4;ESR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5650412044260084,1.0948834320709884,0.33707865168539325,0.929989804249414,1.0,5/30,14.63%,DDIT4;HINT1;BOK;ZNF385B;PYCARD
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.46251737902982026,-1.0948575104574696,0.21428571428571427,0.9138080102762111,1.0,3/25,12.30%,PKIB;MAP3K4;NBN
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6298240187312597,1.094822193966647,0.3194444444444444,0.929798780224729,1.0,1/9,5.27%,HSPA5
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9289864403694088,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9289864403694088,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.7276378617751804,1.0947204049562342,0.34328358208955223,0.9289864403694088,1.0,2/5,18.25%,ERLIN1;SOD1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.557083900160499,1.094607337519851,0.3595505617977528,0.9289592556052333,1.0,11/33,23.76%,RPS27A;TRIM25;NOD2;OTUD7B;RIPK2;VCPIP1;ESR1;UBA52;UBB;TNIP1;PTEN
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.5136327733481046,1.0944236290239788,0.32653061224489793,0.929339436121158,1.0,20/106,18.19%,TULP2;TUB;ARF6;RPA2;SEC61B;ANK2;FSIP2;PAQR3;TULP3;DDX1;SNX10;SERP1;AUP1;PPP1R15A;CNEP1R1;GBP2;RPL11;UBE2J2;APP;CEP68
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.5993610988480199,1.094408174042608,0.36486486486486486,0.9289349628147128,1.0,5/21,5.56%,FAAH;CBR1;FAAH2;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),0.7106797399174051,1.0944061979679467,0.4166666666666667,0.9285051648370045,1.0,1/5,21.00%,SLC5A6
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5361989461296041,1.0943823343222663,0.31868131868131866,0.9281956581860099,1.0,9/67,9.77%,TGFB2;SH3PXD2B;LDB3;SOX4;PKP2;POU6F1;FN1;ID2;NTRK3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4914333272450272,-1.0941594221593045,0.34615384615384615,0.9146068247036475,1.0,6/18,17.71%,ARL2BP;BCL3;CHCHD10;SYNE1;TAF8;TAF3
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.6610878006128668,1.0941191902033423,0.410958904109589,0.928887909235669,1.0,2/11,10.81%,PRKAR2B;ADCY8
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,0.7339010188505584,1.094084987250795,0.3787878787878788,0.9285827906198693,1.0,1/5,15.39%,THY1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.5298439989379322,1.094051181075071,0.34408602150537637,0.9283036113605745,1.0,10/76,12.75%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;TTBK2;CEP152;TUBA1A;NPHP1;DYNC1H1;CKAP5
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.5720797902499989,1.093739157628104,0.33707865168539325,0.9291273315476567,1.0,4/24,14.36%,BRIP1;DNA2;BRCA1;RFC4
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.6248195154716808,1.0935753074239687,0.4057971014492754,0.9293266007299946,1.0,5/16,18.81%,PIGU;RPS27A;CDC37;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.582941992680338,1.0934400774629667,0.3655913978494624,0.9294616370776085,1.0,6/38,15.95%,GPR18;ROBO1;IRS2;GPR65;RASGRF1;RASGRP4
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.7329199028673623,1.0934338790884606,0.4507042253521127,0.9290502659488926,1.0,4/6,18.84%,NRG1;NRG3;NRG4;NRG2
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),0.7520080780372731,1.0932704290893112,0.3090909090909091,0.9292748878539702,1.0,2/5,5.56%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.5685933822297077,1.0932247019415284,0.3218390804597701,0.929026012786283,1.0,11/30,20.23%,MDH1;ENO2;PGAM1;AKR1B1;GPI;FBP1;SLC39A14;SORD;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.427543194223417,-1.0931899777628795,0.2222222222222222,0.9164911645466586,1.0,3/26,3.62%,STAT4;CALCR;NLRP1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.6511987526501386,1.0929446367279223,0.3181818181818182,0.9297149813561434,1.0,1/9,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.7187429394183864,1.0929336765952375,0.39473684210526316,0.9289194619346828,1.0,2/8,17.10%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.7187429394183864,1.0929336765952375,0.39473684210526316,0.9289194619346828,1.0,2/8,17.10%,INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.602043897077261,1.0927741469060799,0.3880597014925373,0.9290287128325503,1.0,5/15,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5207688288071634,1.0926839964038302,0.3157894736842105,0.9290144974070521,1.0,18/97,14.46%,KLF4;ARRDC3;INSR;EPHA3;BMI1;IGF1R;NTRK3;ALK;EPHA7;TYRO3;FLT1;NTRK2;EPHA4;POLG2;PINK1;EPHA6;RFC4;EPHA5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7084748074066588,1.0926236274990748,0.44594594594594594,0.9288387195470086,1.0,4/6,27.86%,UHRF2;HELLS;UHRF1;ZNF445
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.7026681667215096,1.0925994266452328,0.36666666666666664,0.9284718538252846,1.0,2/5,28.80%,TAPBPL;HLA-DMB
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.566099177753054,-1.092420686875208,0.38461538461538464,0.9176302132225981,1.0,3/7,16.14%,MAN2B2;MAN2B1;MANBA
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6403461326921192,1.0923403207482805,0.4142857142857143,0.9290144106719375,1.0,3/11,17.93%,SEMA3A;PLXNB1;PLXNC1
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,0.4902801492731506,1.0922429682478858,0.19,0.9289747517173738,1.0,103/569,16.57%,DIAPH3;FA2H;CRISPLD2;SVEP1;SH2D4A;TUBA4A;FMN1;CBR1;SYCP2L;CADM1;TMEM163;EMILIN2;MAPT;DNAH11;RELN;ENAH;ABHD12B;NAPA;NRXN1;PCDH15;GRIK2;RNF144B;PTPRK;GAD1;LAMA2;TRAF2;KCNH8;MDGA2;EYA2;INPP4B;RUNX1T1;SH3GL3;FBXL2;RGS2;GALNT13;ANK3;BAALC;ADARB2;ADGRG6;BAIAP2L1;TMEM232;PDZD2;MGAT4C;MEGF11;HERPUD1;PALLD;ACAT1;NRXN3;ATP6AP1L;SLCO3A1;POMZP3;FN1;TTC32;MICALL2;ID2;PXK;BOK;THSD7A;MAP1B;DGKB;GALNT18;GLUL;PHACTR3;CELF2;ELOVL4;AKR1B1;CKAP4;OSBPL10;SPTAN1;BCAS2;UNC5C;CNTNAP2;LMO3;MFAP3L;PRICKLE1;KALRN;TMEM108;DNAH17;CMPK1;RYR3;DNAH7;SH3GL2;ARG2;SPOCK3;INSIG1;MAP7;KDM4B;TMEM120B;UNC13C;BCAS1;NKIRAS1;ASPH;RASGRF1;FAM184B;SPTBN5;NDRG4;NRG4;MCTP1;CCDC85C;GIPC2;TBL1XR1;ARAP2;MTUS1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.670624734471345,1.0922110313911306,0.390625,0.9287144354530457,1.0,2/6,15.03%,EPHA4;PICALM
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.6682780758839068,1.0921523383768936,0.36231884057971014,0.9284967816309764,1.0,4/11,21.02%,PDK4;SLC9A7;SLC12A8;SLC9A1
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),-0.6536557942678803,-1.0919888502057407,0.40625,0.9176980394527786,1.0,3/5,20.36%,LGALS9;HAVCR2;CD81
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5708026703556034,1.0918494475915452,0.379746835443038,0.9293351364337594,1.0,8/21,27.58%,MFSD2A;SLC44A5;PEMT;CHPT1;SLC44A1;GPAT4;PCTP;LPCAT1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6028886134622928,1.0917032021282524,0.375,0.9294945993305408,1.0,6/19,22.97%,ABHD12B;MBOAT2;OSBPL10;OSBPL5;SERINC5;LPCAT4
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7196519004311981,1.0916007300699646,0.37142857142857144,0.9294844640080235,1.0,2/9,5.63%,TGFB2;CD55
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7086006651041803,1.0915491475182388,0.43478260869565216,0.9292710909606666,1.0,3/7,19.08%,BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5731384907799849,1.0911159245716366,0.4444444444444444,0.9306662115159874,1.0,3/16,16.40%,TGFB2;NOD2;RNF13
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5081513745372696,1.0908305565705578,0.26262626262626265,0.9313408753895459,1.0,41/215,17.71%,KLF4;FGF1;RBMS3;RPL23;EGR1;TLE1;TFRC;SLC11A1;VEGFA;EIF2AK3;ZNF804A;ANK3;ANK2;INSR;OVOL2;CAMK2N1;HIF1A;HCFC1;ROBO1;FN1;ID2;RIMS2;RBPJ;NTRK3;ITGB8;PDE2A;NTRK2;MAGI2;HINFP;BRCA1;NSF;WNT5A;SLC24A3;EPB41L4B;RPL11;SMAD1;ROCK1;HSPA1B;APP;RGCC;OLFM1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6045542380082981,1.090754909221218,0.4225352112676056,0.9312241957876239,1.0,6/17,14.46%,AKAP6;ADGRG6;RAPGEF3;RIMS2;PDE2A;EPHA5
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.4974742638908729,1.090711462994486,0.27,0.9309385635524308,1.0,46/217,20.53%,TOP2A;DAPK2;RHOB;TGFB2;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;NGEF;CSRNP3;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;RPS27A;FAM162A;ARHGEF4;EPHA7;PNMA2;RPS6KA2;KALRN;PPID;RBM5;IFIT2;BNIP3;C3ORF38;ITSN1;PYCARD;CASP3;SHQ1;KCNMA1;NEURL1;BCL6;OLFM1;FGD4;SOD1;UBA52;HSPD1;UBB;CDK5R1;ECT2;HIP1R;TNF;DUSP6
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,0.569852571542821,1.0906603240771202,0.3258426966292135,0.9306912155933403,1.0,9/52,10.20%,FBN2;NTN4;SH3PXD2B;TLE1;DOCK1;PAPSS2;RND3;PALLD;CKAP4
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.5508715581892654,1.0906226548619673,0.34146341463414637,0.9303934241564462,1.0,9/31,15.36%,SVEP1;ENAH;LAMB1;RND3;TCF7L1;SH3D19;UACA;TIMP3;NRG4
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.6654057619223166,1.0905611345694803,0.3582089552238806,0.9301465549428966,1.0,3/8,20.21%,GFPT1;DHDDS;PGM1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,0.5982966359210928,1.0904858263776487,0.345679012345679,0.9300095998075462,1.0,7/19,15.39%,ZBTB16;BMI1;MCL1;CD93;ALDH1A1;CASP3;THY1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.5492097432750986,1.0904108714260292,0.3404255319148936,0.9299318056554248,1.0,9/44,6.19%,P4HA3;ADAMTS2;TGFB2;COL11A1;COL4A5;COL26A1;COL23A1;COLGALT2;COL24A1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5413544609457985,1.0903028053836905,0.358695652173913,0.929913090885176,1.0,18/65,17.63%,PRLR;FKBP5;GNA11;PGAM1;RBFOX2;RND3;BOK;GALNT18;ERRFI1;SH3D19;ADGRL2;ZDHHC9;PEBP1;PLXNB1;CPE;EPB41L4B;MPDZ;SLC39A14
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.6349949969742518,1.0901306166222506,0.3875,0.9301050387783013,1.0,6/14,26.51%,KIF5A;SPG11;KIF5C;SYT11;LIMK2;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5713118487759079,1.0900940276226545,0.4166666666666667,0.9298462361058121,1.0,1/21,0.28%,THBS1
prerank,CellMarker_Augmented_2021__Macrophage:Placenta,0.7402104784994717,1.0900012450060772,0.42028985507246375,0.9298191683203302,1.0,1/5,1.70%,CD163
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.4937089646799085,1.0896503921023764,0.26,0.9307807959949623,1.0,18/172,9.84%,THBS1;RHOB;SPARC;TGFB2;TUBA4A;PRKCE;MANF;GNA11;DGKI;SRGN;F13A1;VEGFA;HSPA5;ENDOD1;FN1;RAPGEF3;DGKB;GP6
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,0.9201101083800686,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,0.9201101083800686,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,0.9201101083800686,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.6719229055042538,-1.0894814877154386,0.4358974358974359,0.9201101083800686,1.0,4/5,25.96%,EXOSC10;EXOSC9;EXOSC8;EXOSC2
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.6361043425646833,1.0894193150029505,0.4153846153846154,0.9312621510207224,1.0,4/10,16.36%,TGFB2;ITGB8;LTBP1;ITGAV
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,0.6331489681249086,1.0893860411684746,0.44,0.9310116989578096,1.0,3/14,7.99%,NFIL3;WDR5;ALCAM
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.6270841376368619,1.0892282492907235,0.3902439024390244,0.9311858102526267,1.0,2/14,10.81%,PRKAR2B;ADCY8
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5267142186253079,1.0891852702092126,0.29347826086956524,0.9309524202176436,1.0,17/59,21.28%,NLRP12;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;ROBO1;BOK;CASP5;FAM162A;CYCS;PYCARD;EGLN3;HSPD1;HIP1R;TNF;MTCH1
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,0.7016012184074725,1.088990490279019,0.4647887323943662,0.9314076301942091,1.0,4/8,24.00%,RPS27A;UBA52;UBB;TRIM56
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.5464966520537262,1.0888516711577456,0.38636363636363635,0.9315393656673728,1.0,7/47,10.93%,HTR2B;FGF1;CALM3;POU5F1;PLK2;TXNIP;SMYD5
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.782849381696079,1.0881612712346667,0.4492753623188406,0.9338726400479682,1.0,2/5,9.86%,P4HA3;P4HA1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.47860174804215977,-1.088155009481016,0.29411764705882354,0.9223305512070497,1.0,6/19,12.19%,TRIM38;LGALS9;VPS37B;CHMP2B;KPNA6;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.5443393045833089,1.087885750577896,0.40217391304347827,0.9345354763053758,1.0,4/32,5.61%,TUB;IL15;SLC11A1;FCGR2B
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.663713783463952,1.0878453641008365,0.45,0.9342298620223556,1.0,3/10,18.81%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.6788569395762747,1.087700987985473,0.43283582089552236,0.9343726311628728,1.0,2/6,20.68%,TXN;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),0.7629004289860222,1.087652001089884,0.4032258064516129,0.9341385319540698,1.0,1/5,0.62%,LRP2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6471835544191264,1.087613262794201,0.4189189189189189,0.9338628057681904,1.0,2/9,9.63%,RAPGEF3;PLK2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6121523608423757,-1.0872892615112175,0.4482758620689655,0.9238113486212468,1.0,1/5,6.84%,SLC38A1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.6319416746270339,1.0872618211156277,0.4025974025974026,0.934791792685371,1.0,4/12,8.46%,TNC;VIM;CDH2;FN1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6213082277479673,-1.0871727973868361,0.3793103448275862,0.9229584678768715,1.0,3/8,19.85%,MTHFD1L;AKT1;FPGS
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.674661926445077,1.087057482967393,0.4166666666666667,0.9352266627511598,1.0,1/7,8.41%,DNA2
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.5832960557914277,1.0866449499597217,0.42105263157894735,0.9363965252468718,1.0,9/25,26.06%,OIP5;CENPP;CENPK;CENPI;ACTR6;CENPT;ITGB3BP;NASP;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.5442894140229481,1.0865781963466865,0.3780487804878049,0.9362455660892507,1.0,11/38,17.45%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;HSPB1;APP
prerank,KEGG_2021_Human__Influenza A,-0.33301262444023616,-1.0865420278296272,0.0,0.92355604606249,1.0,22/114,11.78%,RNASEL;CCL5;TICAM1;IL1B;IL1A;CHUK;ACTB;IRAK4;ICAM1;BID;TNFSF10;TLR3;EP300;HNRNPUL1;IKBKB;NLRP3;HLA-DPA1;NFKBIA;TLR7;RAE1;KPNA6;OAS2
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.6738158133273799,1.0864255961446514,0.4,0.9365247220690593,1.0,1/8,6.69%,OVOL2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.7170830044496828,1.0863643856333347,0.4032258064516129,0.9363321155815798,1.0,4/6,27.38%,BMI1;PCGF5;PCGF6;PCGF3
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6386151298854916,1.0863164639832992,0.37662337662337664,0.9360562695138412,1.0,3/14,4.94%,COBL;LSR;ARID5B
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.6783126960977276,1.086196329293614,0.3492063492063492,0.9360933377167152,1.0,3/7,13.15%,CR1;CD55;SUSD4
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.5361728650256521,1.0861005246457753,0.3368421052631579,0.9360303654155586,1.0,23/77,21.98%,MTERF1;HCFC1;SIRT5;CRTC3;PRKAG2;CYCS;POLG2;ATP5ME;SMARCD3;ATP5F1A;TBL1XR1;ATP5F1D;TFAM;PRKAA2;CHCHD3;SIRT3;PPARA;ATP5MC1;POLRMT;NR1D1;IMMT;ATP5PB;ATP5F1E
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,0.5442209247826277,1.0857329636412014,0.32967032967032966,0.937029539878148,1.0,5/51,5.13%,RELN;DOCK1;TFRC;CLEC2B;KIF1B
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5367843669239213,-1.0855150006984111,0.3125,0.9251923627780334,1.0,3/12,5.92%,FLNA;UBTF;PHF8
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.511543206184025,1.0854970883687443,0.3402061855670103,0.9375365532916029,1.0,43/123,28.92%,NDUFA2;NDUFB9;PDK4;ETFB;SCO2;NDUFA3;NDUFS8;COX7C;L2HGDH;ACAD9;CYCS;ATP5ME;NDUFB6;PDK3;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;TIMMDC1;SCO1;SLC16A3;SLC16A1;MPC2;NDUFAF4;ATP5MC1;COX4I1;ECSIT;PDHB;PDPR;ATP5PB;ATP5F1E;COX6C;TRAP1;COX6B1;COX20;NDUFS5;SUCLG2;NDUFV1;NDUFS7;NDUFAF1;UQCRC2;HAGH;NDUFA1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.46740702535790074,-1.0849796733700994,0.34375,0.9256071359177717,1.0,7/18,21.97%,FSCN1;CYFIP1;ARPC2;CDC42;ACTR3;WASF2;ACTR2
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.586955329229403,1.084905981613392,0.3655913978494624,0.9394662627244621,1.0,8/32,15.94%,KLF4;ANKRD22;RAB20;ST14;FBP1;LTA4H;IL18;CEBPD
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6063026943268919,-1.0847419476229356,0.4444444444444444,0.9251129418368167,1.0,4/7,21.84%,APH1A;GALNT11;ADAM10;PSEN1
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,0.7325846373316385,1.0845140571002658,0.4393939393939394,0.9404999527015598,1.0,3/5,9.14%,FAH;ATAT1;ASRGL1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.5648477614622197,1.0841393299810274,0.358974358974359,0.9416782176393006,1.0,10/28,26.87%,SLC11A1;RAB20;DMXL2;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;GPR89B;ATP6V1E2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6618212901205092,1.0840435171787346,0.43243243243243246,0.9415879512360449,1.0,4/11,10.26%,SEMA3A;SEMA3B;SEMA6A;SEMA5A
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.5855812790584898,1.0839670939180235,0.3448275862068966,0.9414146919566777,1.0,5/23,11.74%,WDR12;MAK16;PES1;RPL7L1;NHP2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5144520551978001,1.0839650137714667,0.35106382978723405,0.9409883266070597,1.0,14/66,15.06%,DDIT4;EGR1;DCC;MAPT;GPNMB;TRAF2;FCGR2B;NSMF;FAIM2;GRID2;TNFRSF1B;GRIN2B;PICALM;WNT5A
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.5819194989170413,-1.0839616853370995,0.43333333333333335,0.9263364539254971,1.0,5/9,10.31%,IKZF3;MEST;MESD;HCK;BTK
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.5185778352734318,1.0839600203639583,0.3333333333333333,0.9405747972023293,1.0,19/75,21.03%,PFKM;TFRC;VEGFA;ENO2;RPS6KB2;INSR;HIF1A;RPS6;IGF1R;RBX1;CAMK2B;FLT1;ANGPT2;ENO4;EGLN3;PGK1;ENO1;CDKN1B;PDHB
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.6155880050758921,1.0839336948122373,0.3037974683544304,0.9402487520327633,1.0,4/18,14.23%,CDK14;ID2;HINFP;E2F7
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,0.5375144751408312,1.0838203234413575,0.36666666666666664,0.9402173833522085,1.0,17/64,15.39%,KLF4;CLEC12A;GFAP;ITGA2;TFRC;HSPA5;FCGR2B;CD55;BMI1;ALCAM;POU5F1;FCGR2C;FLT1;ABCA5;ALDH1A1;CASP3;THY1
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.6153342087846587,1.0837484193370601,0.3291139240506329,0.9401445995867391,1.0,2/16,10.81%,PRKAR2B;ADCY8
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.595772709812883,1.083725068246625,0.36585365853658536,0.939815048336109,1.0,4/15,9.57%,FGF1;CHI3L1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.6311930690588943,1.0837219583180309,0.4,0.9394112639658562,1.0,3/12,17.45%,VBP1;PFDN4;APP
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.6608036262865845,1.0837028925467027,0.42028985507246375,0.9390533702341818,1.0,5/9,24.08%,MTERF1;TFAM;POLRMT;TEFM;FOXO3
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,0.6760970473256893,1.083679762122574,0.4605263157894737,0.9387164838310544,1.0,3/10,14.14%,ADCY8;GNAI1;GNAL
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7045570541507282,1.083546242415987,0.4626865671641791,0.9387685911498994,1.0,4/8,19.66%,DNM3;DNM1;PICALM;SNAP91
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6906761655445404,1.0835259747728305,0.42857142857142855,0.9384032049804313,1.0,1/9,1.95%,DPYD
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.6835344044796606,1.083524333474419,0.359375,0.9379885728831161,1.0,4/6,22.60%,INSR;APP;DCTN1;MAP1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.6979438675016942,-1.083415868862608,0.3783783783783784,0.926829152349381,1.0,2/5,20.26%,IGF1;LRP6
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.6184854838048743,1.0833911273220123,0.4444444444444444,0.9380120318034735,1.0,4/17,11.53%,SLC4A10;CA2;SLC9A7;SLC9A6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.49396999436095523,-1.0832440495466398,0.34375,0.9261737443486537,1.0,2/12,11.82%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.33490875068354165,-1.0829785814861905,0.4,0.9258264850370113,1.0,21/136,8.91%,TNFAIP8L3;CCL5;TGFBR3;CALCR;RPS6KA6;SERPINF2;IL1B;FFAR4;LGALS9;DAB2IP;DUSP3;CSF1R;SCIMP;ICAM1;SIRPA;P2RY6;TGFB1;PDGFD;PHB2;ROR2;CRKL
prerank,KEGG_2021_Human__Long-term depression,0.5286130792986553,1.082876827585381,0.3829787234042553,0.9396287042414261,1.0,14/45,19.39%,ARAF;GNA11;GNAO1;GRIA2;IGF1R;GRIA3;GRID2;GNAI1;GUCY1B1;CACNA1A;PLCB1;GRIA1;GNAQ;GUCY1A2
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,-0.37484640572673067,-1.0827544833495304,0.25,0.9251578018645727,1.0,17/69,11.06%,FCGR1CP;CD300LF;ITGAM;LY86;BIN2;P2RX1;MPEG1;CSF1R;ITGAX;AOAH;MYO1F;IGSF6;PLEK;HCK;NLRP3;ITGB2;CYTH4
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.6173465695389536,1.0826078541119513,0.4177215189873418,0.940315640535499,1.0,5/14,15.42%,GAD1;SNAP25;GAD2;SYT1;CPLX1
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,0.686866378233114,1.0825572912471544,0.4155844155844156,0.9400452285286053,1.0,4/8,18.04%,MID1IP1;CPT1A;PRKAG2;PRKAA2
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.5218678182702854,1.0825314073995413,0.41304347826086957,0.9397173519339173,1.0,16/53,12.78%,THBS1;FZD6;NTN4;CACHD1;ITGA2;DOCK1;OSMR;PTPRK;LAMB1;ASAP2;ADGRG6;SVIL;OSBPL10;SH3D19;BACE2;UACA
prerank,KEGG_2021_Human__Thermogenesis,0.5052342614586823,1.0825263148740636,0.32323232323232326,0.9393032473177845,1.0,55/154,28.92%,NDUFA2;ACSL1;ADCY3;CREB5;NDUFB9;RPS6KB2;CNR1;ADCY10;KDM3A;RPS6;COX7A2;KDM1A;NDUFA3;ADCY8;LIPE;NDUFS8;CPT1A;PRKAG2;RPS6KA2;COX7C;ATP5ME;DPF3;NDUFB6;SMARCD3;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;PRKAA2;NDUFAF4;SMARCC1;ACSL3;ATP5MC1;CYC1;COX4I1;ATP5PB;ATP5F1E;SMARCD2;COX6C;PRKACB;COX6B1;COX20;PPARGC1A;NDUFS5;RPS6KA3;PRKG1;ADCY1;NDUFV1;NDUFS7;PRKAB2;NDUFAF1;COA6;UQCRC2;ADCY2;NDUFA1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7211445376559642,1.08250650247502,0.3442622950819672,0.9389924717547572,1.0,3/6,24.95%,ROBO2;FGFR2;GPC3
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.7119275506813146,1.0822968076287762,0.37681159420289856,0.939344720585408,1.0,4/8,16.59%,VEGFA;HIF1A;HIF3A;EPAS1
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.38176412505757723,-1.0818795715898688,0.2222222222222222,0.9266956430521514,1.0,9/68,7.37%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;TAF13;LEO1;SUPT16H
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6612387446036188,1.0816889223961925,0.4533333333333333,0.9411820176116504,1.0,1/11,1.97%,RPL23
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.6434784314676402,1.0816475458219708,0.38666666666666666,0.9409078320760202,1.0,4/11,22.06%,INTS12;TRNT1;INTS8;INTS6
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.6471822832699857,1.081612742649674,0.37681159420289856,0.9406626686949668,1.0,1/13,0.34%,GDPD1
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,0.7369645809262622,1.0815634451964142,0.4057971014492754,0.9404136160428432,1.0,2/5,16.77%,KCNMB1;KCNMA1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,0.6550872536151342,1.081441890942462,0.4027777777777778,0.940435862351102,1.0,3/7,15.39%,POU5F1;THBD;THY1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6581038046828745,1.0810963100691637,0.4533333333333333,0.9412955841512123,1.0,2/9,8.86%,TGFB2;ID2
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,0.5452115752228645,1.0809978656931645,0.40229885057471265,0.9412558627698949,1.0,13/42,16.26%,TSPAN13;AGT;FAH;SLC5A9;RARRES1;MFSD2A;FBP1;DRG2;STARD5;ENPP4;DAB1;GCNT1;ATP1B3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5619472344065667,1.0809263764116142,0.41025641025641024,0.9411382447097841,1.0,4/20,12.52%,THBS1;ANXA1;TYRO3;XKR4
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6385648292636724,-1.0805259892115202,0.42424242424242425,0.9298853782278099,1.0,1/6,1.12%,PGM2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.5807756220271028,1.0803563819734854,0.36363636363636365,0.942988665417718,1.0,6/27,18.85%,TGIF1;RPS27A;CCNC;UBA52;UBB;CDK9
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.58305333903333,1.0803542197115095,0.4111111111111111,0.9425835158856031,1.0,5/23,15.04%,LRGUK;MTCL1;SPAST;TPPP;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.6796300807341088,1.0801722827278475,0.38666666666666666,0.9428873706246634,1.0,2/7,9.77%,VEGFA;NTRK3
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.6620679767825334,-1.0800513160280434,0.42424242424242425,0.9301453583259405,1.0,1/5,4.25%,CSF1R
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6860008768922812,1.0798941961697568,0.38028169014084506,0.9435594470864803,1.0,4/9,20.40%,ROBO2;PAX8;PKD1;BASP1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.6245032754011519,1.0798771676987855,0.4050632911392405,0.9432118809178462,1.0,2/18,6.48%,KLF4;INSR
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7063289482882258,1.079815258201143,0.46153846153846156,0.9430691606476049,1.0,4/7,19.66%,DNM3;DNM1;PICALM;SNAP91
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.6920502174492444,1.0798005678685807,0.484375,0.9422977409496699,1.0,3/6,29.19%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6920502174492444,1.0798005678685807,0.484375,0.9422977409496699,1.0,3/6,29.19%,CHP1;ATP2B4;PRNP
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5918950185506324,1.0797394096928445,0.46511627906976744,0.942171959833999,1.0,3/20,11.87%,TOM1L1;VPS37C;RNF126
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.5285752303311944,-1.0796799886694568,0.4166666666666667,0.9300358962138829,1.0,1/13,0.82%,PDE12
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6278974886628822,1.0796532390968616,0.41333333333333333,0.9420912084546054,1.0,1/13,1.97%,RPL23
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.4523495686649463,-1.0796337176236188,0.3157894736842105,0.9290298304698037,1.0,5/26,12.21%,SESN2;SESN3;TELO2;CLEC16A;PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),0.6405052289057295,1.079008715047823,0.44,0.9441084752540364,1.0,2/10,15.74%,VBP1;PFDN4
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.457568189270865,-1.079002874783645,0.25,0.929721795720731,1.0,6/18,11.79%,TTC39B;ARV1;LAMTOR1;NR1H3;LIPG;OSBPL6
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6214799246471063,1.0789215284195488,0.3333333333333333,0.9440146945536732,1.0,2/12,5.38%,SHANK3;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.4907677415618469,1.0787182175255472,0.40816326530612246,0.9444144324094607,1.0,14/144,8.27%,THBS1;DDIT4;HHIP;NLRP12;TLE1;DCC;NR4A2;AGT;RGS2;SEMA6A;GRB10;PTPRT;KANK1;SPRY1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.5827764269612986,1.0787181892880358,0.43037974683544306,0.9439945060277756,1.0,4/21,9.71%,HMGB2;H2BC11;GSDMD;FGR
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.4106443423500805,-1.0787180080788896,0.3888888888888889,0.9294534825945071,1.0,8/25,13.23%,BLNK;STIM1;ITPR2;DAPP1;FYN;BTK;NCK1;SYK
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,-0.6401882204360614,-1.0783523994754258,0.41935483870967744,0.9293773075063826,1.0,3/5,30.03%,MBD1;TMEM135;RBL1
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,0.6808038784875539,1.0782688556760898,0.4492753623188406,0.9452821061262322,1.0,2/7,18.87%,GRIK1;GRIK4
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6279240209027395,1.07823073378894,0.373134328358209,0.9449965612488479,1.0,3/10,12.09%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.512849611328344,1.078138783139087,0.3763440860215054,0.944971796870125,1.0,5/78,5.88%,NUDT12;TBRG4;NUDT16;RIDA;GEMIN2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5035973126762394,1.077887894585199,0.30851063829787234,0.9454597391643623,1.0,14/83,12.78%,ST18;NLRP12;MAPT;BEX3;KHDC1;TRAF2;EIF2AK3;DAPK1;ROBO1;BOK;CASP5;FAM162A;CYCS;UACA
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,-0.5660477589160466,-1.0774230341362052,0.391304347826087,0.929687147330168,1.0,1/6,0.78%,CASP7
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,-0.5660477589160466,-1.0774230341362052,0.391304347826087,0.929687147330168,1.0,1/6,0.78%,CASP7
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6769299257707121,1.0770697988721722,0.46153846153846156,0.9481597622739808,1.0,5/8,29.48%,DGKB;DGKG;DGKZ;PIP5K1A;DGKQ
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.5422187742460917,1.0767239507687163,0.3409090909090909,0.9490117366288557,1.0,17/52,22.52%,ACVR1B;TGFB2;DCC;TRAF2;BOK;MCL1;SIVA1;TNFRSF1B;BCL2L2;CASP3;BAG3;ITGAV;TNFRSF1A;TNF;DEDD;APPL1;SORT1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5621327027128737,1.0766356268465775,0.3291139240506329,0.9489446012292739,1.0,5/31,7.60%,GFAP;AGT;TRAF2;VPS11;HCFC1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.36373768577615395,-1.0766351640448022,0.3,0.9310736934288721,1.0,13/46,21.23%,IDE;DAB2IP;CLTA;GZMB;RSPRY1;CAPN2;CTSZ;PISD;CASP8;RAB7A;CTSH;CTSC;CHEK2
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),0.6954270273610904,1.0764952437749598,0.46774193548387094,0.9490724876355061,1.0,3/8,19.50%,FCGR2B;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.724856447826978,1.076347717742123,0.44776119402985076,0.9492570995928705,1.0,1/5,1.06%,SLC16A10
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.6606459865794244,-1.0762971073231498,0.4,0.930853007766613,1.0,4/6,14.75%,SH2B3;ZNF385A;SRC;MED1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5057189461977261,1.0762831105886734,0.30612244897959184,0.9490763174065232,1.0,18/144,12.75%,CENPF;NEK11;TUBA4A;CENPE;PRKAR2B;HAUS6;ERCC2;ANLN;RIOK2;TUBB4A;CEP152;TUBA1A;ID2;RPS27A;KCNH5;PSMB4;DYNC1H1;CKAP5
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,0.6671341908577879,1.0759550876996793,0.38235294117647056,0.9500436346809338,1.0,4/11,23.98%,AKR1B1;CRYL1;SORD;CRPPA
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5735068423692533,1.0759259917632094,0.40476190476190477,0.9497369741324406,1.0,5/26,12.03%,BRIP1;CLSPN;DNA2;DONSON;HINFP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5416992132861405,1.0758713741075896,0.3488372093023256,0.9495400086171555,1.0,13/47,20.85%,TGFB2;CCPG1;NUDT16;MEIS2;SPDYA;HCFC1;PKD1;CCND3;APP;RGCC;CDC25B;CDKN1B;FGFR2
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.6477863150231017,1.0757996456929508,0.345679012345679,0.9493877775812083,1.0,4/14,25.14%,CACNB2;GNAI1;GNB5;CACNA1C
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.5555691942077725,1.0757980238258251,0.38095238095238093,0.9489684366900506,1.0,17/48,18.16%,CACNB2;ITGA2;CDH2;DMD;LAMA2;TCF7;PKP2;TCF7L1;RYR2;ITGB8;CACNG2;CACNA2D3;CTNNA2;ATP2A2;ITGAV;CACNG8;SGCD
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.5988871403618556,1.075784763177715,0.4230769230769231,0.9485858923977692,1.0,3/21,10.98%,LRP2;GPC5;RDH11
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.6772207194282821,1.0756659481679034,0.4090909090909091,0.9486365630984898,1.0,1/8,2.98%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6708242174503414,1.0754028107382128,0.4375,0.9492371456515315,1.0,2/5,29.72%,GSTP1;FOXO1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,-0.6059065465110192,-1.075396630604867,0.42857142857142855,0.9322189358690703,1.0,1/6,0.21%,ITGA5
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.6674159274328676,1.0751701583417357,0.463768115942029,0.9495946776771221,1.0,5/10,25.14%,PKP2;RYR2;ATP1B2;ATP1A2;CACNA1C
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.7084054141543036,1.075103011785996,0.39655172413793105,0.9494589860326392,1.0,1/6,5.49%,PDIA2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.48715556438190166,1.075077678283631,0.3684210526315789,0.9491537988733906,1.0,17/124,11.67%,THBS1;FGF1;SEMA3A;CEMIP;VEGFA;HSPA5;GPNMB;SEMA3B;LAMB1;INSR;SEMA6A;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;FLT1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,0.6782004280153477,1.0750264132389038,0.4473684210526316,0.9489134672943383,1.0,1/5,5.33%,RXRB
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5505529935349298,1.074949335679533,0.41025641025641024,0.948794394244659,1.0,7/40,16.98%,LRP2;ACVR2A;BMPR1B;RBPJ;VWC2;PCSK6;SMAD1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,0.7128416099187054,1.074758875238059,0.3939393939393939,0.9489940427511245,1.0,2/7,12.36%,KMO;RYR3
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.5332268308573707,1.074688687049849,0.41304347826086957,0.9488387568412735,1.0,4/66,6.24%,PCSK1;H2BC11;VPS37C;NUP133
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.4312487474438158,-1.0745648005621504,0.2857142857142857,0.9339142437751773,1.0,5/28,12.63%,MRPL57;MRPS11;SLC25A33;LARS2;FASTKD2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.6949980791913815,1.0745108296973354,0.4714285714285714,0.9490785061150282,1.0,2/5,25.61%,PPIB;VAPA
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.5568194483047115,1.074326701574383,0.39080459770114945,0.9494026286762858,1.0,8/37,20.52%,BRIP1;XPO1;CRTC3;SMARCD3;TBL1XR1;PPARA;NR1D1;NPAS2
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.6822891190142787,1.0742452596218317,0.45714285714285713,0.9493117845407482,1.0,7/10,26.10%,RPS27A;UBA52;UBB;PGK1;ENO1;MRC1;TLR2
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.6924195906476098,1.073893598501326,0.44285714285714284,0.9501908695989787,1.0,2/7,14.63%,CARMIL1;PYCARD
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.6040731585395452,1.073859194316903,0.37037037037037035,0.9499549491091875,1.0,7/19,16.03%,GALNTL6;GALNT8;GALNT13;GALNT18;B4GALT5;GCNT1;GALNT17
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,0.6714860323833199,1.073823683756948,0.43661971830985913,0.949282779763528,1.0,4/8,17.22%,OVOL2;PPP1R13L;MICALL2;HSPB1
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,0.6714860323833199,1.073823683756948,0.43661971830985913,0.949282779763528,1.0,4/8,17.22%,OVOL2;PPP1R13L;MICALL2;HSPB1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.5259517092868321,1.073746176897421,0.3020833333333333,0.9491921871922282,1.0,29/74,21.38%,SCN3B;NCAN;ITGA2;CNTN1;LAMB1;ANK3;ANK2;ALCAM;CHL1;DNM3;SCN3A;SCN1A;SPTAN1;DNM1;RPS6KA2;SH3GL2;NFASC;SDCBP;SCN8A;SPTBN5;SCN2A;ITGAV;SPTBN1;SPTBN4;AP2A2;NCAM1;CNTNAP1;CNTN2;RDX
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,0.6251698521761409,1.0737223843147385,0.37037037037037035,0.948900901085747,1.0,5/17,10.53%,CR1;FCGR2B;CD55;FCGR2C;CD93
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.430232885061194,-1.0734588158251537,0.25,0.9361750797794745,1.0,4/25,3.73%,GAL3ST4;IDUA;ST6GALNAC3;MAN2B2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5762409606607074,-1.0734162275844878,0.35714285714285715,0.9351907472338041,1.0,3/9,16.73%,DFFB;FBH1;REXO4
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.41379627806140296,-1.073251551367175,0.2857142857142857,0.9343508418508968,1.0,3/27,7.51%,FLNA;ZPR1;TGFB1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.677236602810132,1.0732282075325366,0.5217391304347826,0.9503357609930485,1.0,3/6,16.88%,MAP9;KIF11;UBXN2B
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.48502129882617806,1.072798445608316,0.32653061224489793,0.9515045767453898,1.0,47/190,18.65%,HTR2B;ACVR1B;PRLR;TSHR;TGFB2;ACSL1;PLAC8;CADM1;ZBTB16;IL15;GLIPR2;TFRC;AGT;SLC11A1;BMPR1B;VEGFA;GRB10;KDM3A;PAX8;NLGN1;PTN;ABCA1;IGF1R;KDM1A;GHR;FGR;B4GALT5;SOX6;DYNC1H1;SCD;TRIM16;SDCBP;WNT5A;CFL1;PEMT;IL18;NR2C2;EPAS1;TXK;PLCB1;ROCK1;MAP3K13;RGCC;OLFM1;SOD1;ESRRG;EZH2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.641048594954225,1.072608463796332,0.4444444444444444,0.9519224646943195,1.0,4/13,22.47%,CALM3;CLIC2;ATP1A2;GNB5
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.6592860725120455,1.0722248861269104,0.4090909090909091,0.9530013789483536,1.0,5/12,27.69%,GNA11;GNAQ;GNB5;GNA15;GNA14
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.48691199268496976,1.0720847510460492,0.2,0.9530496325852774,1.0,147/590,21.57%,KLF4;ACVR1B;RHOB;RAP1GAP;SHANK3;SEMA3A;NTN4;RPL23;WDR5;DCC;EIF4A3;CACNB2;SCN3B;NCAN;H2BC11;ITGA2;RELN;ENAH;PIGU;COL4A5;DOCK1;NELL2;CDH2;DPYSL5;ACVR2A;DOK6;RPL37A;CNTN1;LAMA2;TCF7;ROBO2;LAMB1;ANK3;ANK2;SEMA6A;ADGRG6;RPL38;EPHA3;KAZN;GRB10;NGEF;MYO10;PKP2;TCF7L1;ALCAM;MAG;ROBO1;CHL1;MAFB;SCD5;RPS6;ADAM23;DNM3;SCN3A;RBPJ;IRS2;UNC5D;RPS27A;RPL23A;ST14;TRPC4;CACNG2;CRMP1;RPS25;SEMA5A;RPS27;SCN1A;SPTAN1;DNM1;UNC5C;PSMB4;RBX1;EPHA7;CLASP2;RPS6KA2;RPS11;KALRN;HIF3A;RPS20;CCNC;RPL9;UPF3A;SH3GL2;EPHA4;RPLP2;NFASC;DRAP1;RPL37;CTNNA2;ABLIM3;EPHA6;PLXNB1;ITSN1;EPHA5;GRIN2B;RPL14;SDCBP;SCN8A;SPTBN5;SCN2A;SMARCD3;CEBPD;RPS4X;LDB2;CCND3;PCSK6;TBL1XR1;ITGAV;RPL11;EPAS1;RPS24;POLR2D;CACNG8;SPTBN1;RPS9;ROCK1;FOXP1;RPL36;PLXNC1;PKP4;FES;UBA52;SUZ12;EZH2;UBB;PSMC2;SPTBN4;PPARA;PSMA3;CDK5R1;AP2A2;ADAM22;NCAM1;RPS3A;CLTCL1;TNF;CNTNAP1;PSMB2;CNTN2;RPL35;RPL4;UTRN;POLR2G;RPL32;RDX;PSMD5;MED11
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.6093222923804498,1.0719942440799686,0.44155844155844154,0.9530417750057123,1.0,3/11,15.06%,VEGFA;DGKG;WNT5A
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.39598795248032786,-1.0719515305190885,0.36363636363636365,0.9371232763983458,1.0,7/40,6.41%,CCL5;GBP3;IL1B;LGALS9;DAB2IP;MAPK13;SIRPA
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.5931827438108905,1.0718860351106505,0.4246575342465753,0.9531099847776863,1.0,6/16,30.71%,CA2;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2;ATP6V0A1
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,0.7020661339634935,1.071882904851857,0.4393939393939394,0.9527099669589604,1.0,1/6,11.79%,NTRK2
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.4977482286606887,1.0718401344035804,0.3939393939393939,0.9524782851949662,1.0,7/113,3.84%,NAMPT;LRP2;NUDT12;ENPP2;TACR1;SLC2A3;GPC5
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5856863303837395,1.0717129620166006,0.3972602739726027,0.9525466514695545,1.0,8/18,26.11%,OGN;SOD2;NDRG4;CDKN1B;MFN2;PDCD4;PTEN;PRKG1
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.5668317552895067,1.0716395977203428,0.3950617283950617,0.9524351289882955,1.0,4/30,3.84%,CHST7;NCAN;VCAN;GPC5
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.6681952793490676,1.0715098383654764,0.4,0.9525314157235775,1.0,5/9,29.65%,BRCA1;LRIF1;HNRNPU;MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.6139075563537987,-1.0714518307383045,0.4444444444444444,0.9373695903337179,1.0,1/5,4.51%,APPL2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.6036593525648226,1.0714400836153077,0.4,0.9524000334113569,1.0,4/14,13.55%,ACAT1;SCD5;FASN;SCD
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.36687121100492603,-1.0713177119033876,0.3,0.9366873716042655,1.0,12/36,13.97%,ACSM5;TECR;GPX4;HACD4;ALOX5;GSTM4;LPL;MLYCD;LIPG;NDUFAB1;LTC4S;ABCD3
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6417021784867888,1.0712898930684467,0.4722222222222222,0.9525800622550454,1.0,6/14,14.45%,CDH8;CDH9;CDH20;NLGN1;CDH12;CDH10
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,0.5334559517722628,1.0711891163374436,0.3684210526315789,0.952584407530182,1.0,17/78,17.28%,SOCS3;GADD45B;NR4A2;ANXA1;MAP3K8;NDRG1;CD55;HERPUD1;BHLHE40;FOSL2;NFKBIZ;AHNAK;DUSP10;CEBPD;GBP2;EPAS1;ARRDC2
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,0.662684800280071,1.0711703124181011,0.45454545454545453,0.9522418354648561,1.0,5/7,27.69%,GNA11;PLCB1;GNAQ;GNA15;GNA14
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.533331475511742,-1.0711317448507158,0.3333333333333333,0.9348728070400765,1.0,1/9,0.87%,SMPD3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.533331475511742,-1.0711317448507158,0.3333333333333333,0.9348728070400765,1.0,1/9,0.87%,SMPD3
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,-0.6376946600839595,-1.0710755407891794,0.41935483870967744,0.9339139224046898,1.0,1/5,0.87%,SMPD3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.607730167232641,1.0710280586447634,0.42857142857142855,0.9523738689281904,1.0,9/18,22.91%,AGT;ALOX15B;ABCA1;ABCA5;IL18;ITGAV;PPARA;MSR1;ABCG1
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,0.4823753206011327,1.0709842081581629,0.26,0.952087462768993,1.0,134/630,21.07%,SOCS3;THBS1;KLF4;CLEC4E;CRISPLD2;NAMPT;SPARC;AZI2;ALDH3B1;NLRP12;NDUFA2;CLEC12A;VIM;DPYD;ACSL1;CCPG1;PLAC8;EMILIN2;NUDT16;TBC1D8;SLC2A3;VCAN;TALDO1;GLIPR2;ANXA1;SLC11A1;DOCK5;SRGN;ADGRE1;RNF144B;MRPL33;CD55;SCO2;GNS;LTB4R;PGAM1;RGS2;GRINA;RAB20;ATOX1;OLIG1;HIF1A;TRPS1;SLCO3A1;BNIP3L;MAFB;TXN;WBP4;TSC22D3;BLVRB;MID1IP1;MCL1;MXD1;TRIM25;FGR;GLUL;MEGF9;SRA1;MGAM;CKAP4;C5AR1;CD93;CACNA2D3;NOD2;FGL2;HCLS1;ETS2;NFKBIZ;SULF2;RIPK2;FBP1;TNFRSF1B;SNX10;SOD2;PKM;PRELID1;ACP3;SERP1;VMP1;AUP1;PPP1R15A;AHNAK;GK;AGFG1;PYCARD;CYRIA;SDCBP;TGFBI;PELI1;PICALM;GRPEL1;MCTP1;SLC31A2;SMARCD3;LTA4H;PHACTR1;CEBPD;RASGRP4;CCND3;PNPLA8;RNF13;GBP2;LRRC25;LITAF;IQGAP1;BCL6;TNFRSF1A;CHPT1;SLC16A3;STXBP2;RNF149;FGD4;UBA52;FBXL5;DMXL2;SCPEP1;RTN3;ACSL3;CTDSP1;KDM6B;ATP6V0B;CYP46A1;PGK1;SLC3A2;BASP1;SELL;CHCHD7;DUSP6;LRRK2;OTUD1;SLC24A4;SRSF5;IRAK3;TACC3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5130187524007376,1.070813019170416,0.41935483870967744,0.9523110418394999,1.0,13/53,16.36%,ECM2;ITGA2;ADAM15;PTPRK;OTOA;FN1;ITGB8;PPFIA2;SGCE;SORBS1;PKD1;THY1;ITGAV
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4355280381875286,-1.0705864272415373,0.18181818181818182,0.9341312879345789,1.0,2/22,0.88%,CYB5A;MAIP1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.6570126550381418,1.070576059605491,0.3972602739726027,0.9528250095551488,1.0,5/14,27.77%,TTLL7;AGTPBP1;TPGS1;GGCX;TTLL4
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.5114087040501971,1.0705184612560217,0.4175824175824176,0.952562653665468,1.0,2/48,1.30%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.5797336260870688,1.0704739870869138,0.3855421686746988,0.9523084796815648,1.0,5/21,12.83%,CLIP3;INSR;IRS2;SORBS1;NR4A3
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.5749665839043903,1.0704618814691447,0.38095238095238093,0.9519312884998613,1.0,4/23,12.03%,BRIP1;CLSPN;DONSON;HINFP
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4892255389459304,1.0703407797655236,0.29,0.951963713835645,1.0,57/294,18.46%,HTR2B;THBS1;KLF4;LRP2;ARAF;PRLR;TLE1;NAA38;NR4A2;TFRC;ATAD3A;ANXA1;BEX3;ALOX12;RNF144B;FIGNL1;VEGFA;HSPA5;PDK4;IL7;PTPRZ1;COPS5;FMN2;MAG;BNIP3L;FAIM2;RETREG1;IGF1R;RPS27A;MCL1;PLK2;TYRO3;NTRK2;HCLS1;RIPK2;CRLF1;SOD2;BNIP3;PINK1;PRELID1;BCL2L2;TMEM14A;WNT5A;CASP3;CFL1;BAG3;NUAK2;NRBP2;ARHGDIA;HSPB1;HSPA1B;GSTP1;PRKAA2;TAF9B;SOD1;UBA52;HSPD1
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.605845491641233,1.0703157926205193,0.39473684210526316,0.9516823259991194,1.0,3/19,10.98%,LRP2;GPC5;RDH11
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.7358548770106176,1.070098947936614,0.3870967741935484,0.9521118553469221,1.0,2/5,4.98%,SLC2A9;SLC5A9
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.5332428326810396,1.0700058859101882,0.4157303370786517,0.9519576397748019,1.0,12/57,10.81%,TGFB2;CACNB2;ADCY3;ITGA2;AGT;DMD;LAMA2;RYR2;ITGB8;CACNG2;CACNA2D3;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),0.7226081604550089,1.069875423258562,0.45588235294117646,0.951982063970968,1.0,1/6,5.61%,FCGR2B
prerank,CellMarker_Augmented_2021__Dendritic cell:Peripheral Blood,-0.6503734623112774,-1.0697696477814895,0.4722222222222222,0.9353018235986525,1.0,2/5,12.40%,ITGAX;CD83
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.644899294270437,1.0696011707418152,0.3770491803278688,0.9525338241492554,1.0,5/12,20.29%,CLIP3;BAG3;APP;SPG11;DYNC1I1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.5508910955720792,1.0695132062550676,0.4444444444444444,0.9524866373371583,1.0,9/36,16.92%,FA2H;CR1;ANK3;ANK2;CAV3;NSF;SERP1;UGCG;SPTBN1
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),0.7237878607568327,1.0694899480991567,0.43333333333333335,0.9521463281720799,1.0,2/5,12.87%,KDM1A;BRCA1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.5638350305801212,-1.0693499855213673,0.3333333333333333,0.9352203248608041,1.0,3/9,16.26%,CPSF1;CPSF2;CPSF4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6160525871329687,1.0693345191989156,0.4936708860759494,0.9523131869572352,1.0,6/14,20.37%,CDH2;CAV3;PKD1;PIEZO2;LHFPL5;PKD2L2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.525641960878717,1.0692426904213768,0.4024390243902439,0.9522265741056027,1.0,3/31,8.43%,THBS1;TRAF2;FAIM2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.6131795795576008,-1.0692247839159683,0.3333333333333333,0.9345775245317036,1.0,2/7,9.42%,LGALS9;NCKAP1L
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.681233783712418,1.069214744264339,0.39655172413793105,0.9519224266174342,1.0,4/9,21.77%,AGT;ALOX15B;IL18;MSR1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.5899377842045815,1.0689633618053322,0.4146341463414634,0.9525677001903484,1.0,7/22,20.15%,ERCC2;TFRC;FANCB;ZCWPW1;ERCC6;TIMELESS;KMT5C
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.513437911492653,1.0688449456292128,0.39325842696629215,0.9525601520802883,1.0,17/53,26.86%,RPS6;RPS27A;RPS25;RPS27;RPS11;RPS20;EIF3E;RPS4X;RPS24;RPS9;RPS3A;RPS16;EIF4A2;EIF3A;EIF3D;FAU;RPS12
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,-0.4859612366353143,-1.0686753134866391,0.36,0.934730757134806,1.0,4/12,13.31%,CLTB;CLTA;SRC;DAB2
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,0.6693499339342251,1.068672027340245,0.4305555555555556,0.9528015498318363,1.0,1/9,4.44%,PIAS4
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.5357731547272034,1.0683774909201167,0.3804347826086957,0.9535956997924273,1.0,9/70,12.75%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;CEP152;TUBA1A;RPS27A;DYNC1H1;CKAP5
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.648070894496138,1.0682145049031697,0.4533333333333333,0.9537772234264027,1.0,2/10,7.33%,VIM;BMI1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.5964106120803603,1.0681036111539697,0.4225352112676056,0.9538165234245797,1.0,2/15,13.44%,MAPT;CENPV
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5285385497844491,-1.0679816102461863,0.41935483870967744,0.9354904716299459,1.0,4/10,16.94%,IGF1;TGFB1;EP300;GTF2B
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6286145210683232,-1.0679570579089293,0.43243243243243246,0.9344921743118161,1.0,4/5,14.21%,INPP5K;PPP1R3F;PPP1R3E;AKT1
prerank,KEGG_2021_Human__Glioma,0.5025831276196941,1.067889940142098,0.3516483516483517,0.9543251990560575,1.0,6/54,11.27%,ARAF;GADD45B;CALM3;SHC2;IGF1R;CAMK2B
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5918443070527695,1.067803166085376,0.4,0.9542498848603921,1.0,7/25,17.45%,RBM3;PGAM1;RBM4B;PICALM;TMED10;ROCK1;APP
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5122480267516174,-1.0676673361346818,0.2857142857142857,0.9342413575032008,1.0,3/16,12.08%,BBS10;MKKS;HSPA1A
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,0.716903073286052,1.0675456023585408,0.3939393939393939,0.954702759640637,1.0,5/5,28.34%,GAD1;GAD2;GABBR1;SLC6A1;GABBR2
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.5487461478003872,-1.0675129631006652,0.38235294117647056,0.9335724975194201,1.0,1/7,1.38%,CST7
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.675413176300047,1.067479969361272,0.5454545454545454,0.9545131015011595,1.0,4/7,18.88%,GABRA2;GABRB2;GABRA4;GABRG2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5143585266130585,1.0674057692394008,0.35789473684210527,0.9544378036457613,1.0,22/99,15.83%,KCNE1;AANAT;EGR1;ADCY3;GABRB1;AKAP6;RUVBL2;RAPGEF3;GABRB3;PDE2A;IMPACT;ADCY8;GABRB2;RYR3;GNAI1;NR4A3;BRCA1;INSIG1;HCN1;CASP3;ESR1;IL18
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.564756539562229,1.067195224550664,0.41975308641975306,0.954890014388597,1.0,4/25,12.70%,TOP2A;VAPB;PPID;TMEM39A
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),-0.6990636172039277,-1.067050228084835,0.43243243243243246,0.933648578144579,1.0,2/5,8.88%,IRAK4;SERPINB9
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6947899938933207,1.067042179008249,0.410958904109589,0.955015276833329,1.0,4/6,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.4020873251822432,-1.0668707803521682,0.2857142857142857,0.9331521454048158,1.0,7/66,7.22%,RING1;H2BC4;TXN2;MAP4K4;TP53;MAP3K5;MAP2K3
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.6953017891943197,1.0667131621597525,0.4266666666666667,0.9558011374257831,1.0,3/6,29.10%,CCDC39;SRP54;PROX1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.6068496997968644,-1.0665402643113258,0.40625,0.9328113836627768,1.0,1/7,2.58%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6108473850993078,1.0664393569791226,0.4520547945205479,0.9564369428034365,1.0,5/15,10.26%,SEMA3A;VEGFA;SEMA3B;SEMA6A;SEMA5A
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,-0.6094011522706912,-1.0663870561896864,0.46875,0.9320701872189286,1.0,1/7,8.79%,NFATC3
prerank,KEGG_2021_Human__ErbB signaling pathway,0.49209157904694856,1.0662763852180512,0.32967032967032966,0.9565770987099466,1.0,15/68,22.86%,ARAF;NRG1;RPS6KB2;SHC2;CAMK2B;NRG3;PAK5;GAB1;MAPK10;NRG4;NRG2;CDKN1B;PAK3;PRKCB;JUN
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.5574600415144702,1.0662346075345837,0.4367816091954023,0.9563282905748044,1.0,10/31,18.81%,TLE1;SOX4;TCF7;TCF7L1;XPO1;RPS27A;SOX6;CTBP1;UBA52;UBB
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.4847437990756997,-1.0662106040255792,0.36,0.9316235971246123,1.0,4/18,10.32%,MYH9;CSF1R;THOC5;TREM2
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.5193514065494034,1.066010141130309,0.35555555555555557,0.956802085896539,1.0,22/74,23.47%,MAL;FKBP5;NELL2;TCF7;CD55;STMN3;IGF1R;GPR155;PIK3IP1;EIF3E;GPR183;TXK;SMAP2;SPTBN1;SPINT2;FOXP1;CEP68;SNED1;SELL;SERINC5;LRRN3;TRAP1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.4973518037998703,1.066008804165035,0.3473684210526316,0.956392495962508,1.0,33/90,24.06%,VEGFA;SUV39H2;NDRG1;HIF1A;FMN2;BNIP3L;LIMD1;RPS27A;FAM162A;PSMB4;RBX1;HIF3A;BNIP3;PINK1;CPEB2;SCN2A;HYOU1;EPAS1;EGLN3;RGCC;UBA52;UBB;PSMC2;PSMA3;NOP53;PGK1;PSMB2;P4HB;PSMD5;PSMD7;RORA;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.4966989659253107,1.065898299392139,0.30303030303030304,0.95641867343434,1.0,18/152,12.75%,ACVR1B;CDK14;TUBA4A;PRKAR2B;HAUS6;TUBB4A;FBXL7;CEP152;MASTL;SPDYA;TUBA1A;RCC1;PLK2;CLASP2;DYNC1H1;HINFP;SPAST;CKAP5
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5726674490295934,1.0658798802597813,0.425,0.9560605708266905,1.0,6/16,16.36%,DCC;BOK;MCL1;BCL2L2;CASP3;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6152462945497562,1.0658675312344366,0.3924050632911392,0.9556910164591684,1.0,5/16,14.46%,RELN;VEGFA;CRTC3;ADCY8;EPHA5
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9546586185881454,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9546586185881454,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.6742916562406479,1.0658010313864876,0.4262295081967213,0.9546586185881454,1.0,5/8,26.57%,KIF5A;HSPB1;KIF5C;MAP1A;RAB27B
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.4913415147147033,1.0657036118121737,0.41836734693877553,0.9546111290914235,1.0,22/171,11.23%,LRP4;CDK14;RBMS3;DKK2;FZD6;AMER2;TLE1;GPC5;DAAM2;SOX4;LZTS2;CTNND2;KANK1;RUVBL2;PTK7;GSKIP;LIMD1;SEMA5A;GPRC5B;PSMB4;RBX1;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.632180148339916,1.0654645821942499,0.44285714285714284,0.9550564610897594,1.0,4/9,26.37%,CFL1;PPIB;VAPA;IGF2R
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.5966609233047179,1.065380253919849,0.425,0.9549189287165127,1.0,3/21,16.76%,NUDT16;TENT4B;SND1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.6876211566360318,-1.0652649094975217,0.43902439024390244,0.9330717564042671,1.0,2/5,4.46%,LGALS9;LILRB4
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.5755632199554274,1.065110780073983,0.4444444444444444,0.9555317777773826,1.0,6/28,12.52%,P4HA3;CKMT2;CARNS1;CKB;P4HA1;ARG2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.6626372537782358,-1.0651038901341283,0.5,0.9324405042864143,1.0,1/6,2.28%,CYP19A1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.6384274582376009,1.0650743346116254,0.43478260869565216,0.9552574514458431,1.0,5/13,19.33%,SEMA3A;DPYSL5;CRMP1;FES;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.6050486430782994,1.065011135018597,0.4230769230769231,0.9550731576247824,1.0,4/18,14.98%,TFRC;IL7;IRS2;GPR183
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.4980092191214165,1.0649735596666152,0.3804347826086957,0.9548109680085997,1.0,15/68,21.46%,PPP2R5B;HSPA5;EIF2AK3;HERPUD1;ARFGAP1;SERP1;DNAJB9;HYOU1;SYVN1;GFPT1;CXXC1;DCTN1;SRPRA;ATF3;HSP90B1
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,0.4855174975996307,1.0649451026726557,0.3595505617977528,0.9544904869121802,1.0,2/47,2.61%,SKIC2;EIF4A3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5109617091437643,1.0647798750975097,0.3655913978494624,0.9547083839756271,1.0,20/67,15.17%,TSHR;GRM8;ADCY3;GNA11;GNAO1;RGS1;ADGRE1;ADGRG6;CNR1;AKAP12;ADGRB2;ABCA1;PDE2A;ADCY8;RXFP1;GPR65;ADGRL2;GNAI1;GNAL;HTR1F
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.6292123908614845,1.0647161732076573,0.4634146341463415,0.9545441253141543,1.0,1/13,4.44%,PIAS4
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6716108175787585,1.0646982279734847,0.3918918918918919,0.9537915429467627,1.0,3/7,9.58%,NCAN;VCAN;CSPG5
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,0.6716108175787585,1.0646982279734847,0.3918918918918919,0.9537915429467627,1.0,3/7,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.5247737405845266,1.064663074656628,0.3617021276595745,0.9535149947701969,1.0,14/69,19.55%,FA2H;FAAH;ACSL1;ALOX12;ALOX15B;ELOVL4;CPT1A;ACAD9;FASN;PNPLA8;HACL1;PPARA;MSMO1;ACSL3
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.6207082151803432,1.0644988783195626,0.40789473684210525,0.953697824088377,1.0,1/14,0.14%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6320889009511685,1.0643200790048435,0.46153846153846156,0.9539699542225547,1.0,3/8,21.38%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.6078438855608579,1.0641801064348375,0.4358974358974359,0.9540902316889976,1.0,4/15,16.96%,SELENOI;PNPLA8;NAPEPLD;ETNPPL
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.690837495432125,1.0641409465833505,0.40625,0.9538140258201743,1.0,2/7,4.58%,SLC2A3;SLC2A9
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.569307708793732,1.0641258621060508,0.40789473684210525,0.953452596231145,1.0,5/18,19.17%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5106602366217754,1.0640968323285465,0.3956043956043956,0.9531380664072192,1.0,22/80,22.26%,RHOB;FGF1;ENPP2;NRG1;FRMD5;TTBK2;SRCIN1;SPOCK3;SERPINE2;PLXNB1;NRG4;LDB2;ROCK1;SPINT2;PLXNC1;FES;NRG2;TMSB10;TBCCD1;CCDC125;HACE1;AMOT
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.7025415437402069,1.064050300964575,0.3968253968253968,0.9529363564328721,1.0,3/5,15.39%,ALCAM;POU5F1;THY1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,0.6376636931463096,1.064037927033693,0.39473684210526316,0.9525796366401502,1.0,3/14,15.39%,CD163;ALCAM;THY1
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,-0.6776517843020111,-1.0638369111579158,0.4666666666666667,0.9348059169810344,1.0,2/7,14.34%,LSM11;SNRPB
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.3622976799272828,-1.0637066845996326,0.0,0.9340667198933789,1.0,21/79,11.78%,GBP3;GIMAP8;TRIM38;UBA7;ELK3;LGALS9;HPGDS;CSF1R;ARHGDIB;SAMD9;ERAP2;TMEM106A;TNFSF10;ENG;HLA-E;WDFY4;APOL6;APBB1IP;LCP2;PHF11;OAS2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5725606931945831,1.0636150252334917,0.38461538461538464,0.953696810179446,1.0,8/22,23.76%,DCC;MAG;MAP2;DUSP10;PTPRS;CDKN1B;RTN4;PTEN
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5359085698682914,1.0635895854270416,0.38636363636363635,0.9533749566025853,1.0,5/32,9.26%,HTR2B;TGFB2;HIF1A;RANBP3L;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7236665550328678,1.0635764058271804,0.38095238095238093,0.9526274954469381,1.0,2/6,18.69%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7236665550328678,1.0635764058271804,0.38095238095238093,0.9526274954469381,1.0,2/6,18.69%,CALM3;CLIC2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.6952292252732166,1.063544737067609,0.410958904109589,0.9519316023036897,1.0,4/8,19.80%,UCKL1;DCK;UPP2;UCK2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.6952292252732166,1.063544737067609,0.410958904109589,0.9519316023036897,1.0,4/8,19.80%,UCKL1;DCK;UPP2;UCK2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.548244801364386,1.0635361546565663,0.39080459770114945,0.9515763600606207,1.0,9/27,20.23%,MDH1;ENO2;PGAM1;GPI;FBP1;SLC39A14;PGK1;PGM1;ENO1
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.723520070318288,1.0633695144765671,0.417910447761194,0.9518207131422951,1.0,3/5,17.56%,IRS2;BCL6;FOXP1
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,-0.32427717146405394,-1.0633620408245514,0.2,0.9336817020404063,1.0,27/91,13.95%,CX3CR1;GIMAP8;BIN2;SAMSN1;MPEG1;CSF1R;LILRB4;ABI3;P2RY13;SH2D3C;ITGAX;AOAH;MYO1F;P2RY14;NCKAP1L;WDFY4;PLEK;HCK;HLA-DPA1;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.5910724015256296,1.0630660615843428,0.3333333333333333,0.9525982017153225,1.0,7/18,20.13%,MAG;DEAF1;ATP1B3;SLC16A3;SLC16A1;ATP1B2;SLC3A2
prerank,KEGG_2021_Human__Cholinergic synapse,0.5227077595533469,1.0630373120372103,0.42105263157894735,0.9522740329874124,1.0,20/72,22.53%,CHRM5;ADCY3;CREB5;GNA11;GNAO1;CACNA1B;ADCY8;CHRM3;CAMK2B;GNAI1;CACNA1A;KCNJ6;PLCB1;KCNJ3;GNAQ;FOS;KCNQ5;KCNQ2;GNB5;PRKCB
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.621725255887288,1.0629285129166164,0.43902439024390244,0.9522281680736723,1.0,9/18,25.89%,RPA2;RPS27A;RFC4;POLE2;UBA52;UBB;RFC1;RPA3;REV3L
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),-0.6659884488242489,-1.062878659026853,0.4594594594594595,0.9339251372344138,1.0,1/6,0.76%,RAB22A
prerank,KEGG_2021_Human__Alzheimer disease,0.4920058185874496,1.0628288798739725,0.31,0.9521746219594224,1.0,64/245,22.83%,ARAF;NDUFA2;TUBA4A;DKK2;FZD6;CHRM5;MAPT;TUBB4A;NDUFB9;TUBA1A;TRAF2;EIF2AK3;TUBB6;INSR;GRIN2A;CALM3;IRS2;COX7A2;NDUFA3;PSMB4;CHRM3;NDUFS8;PPID;COX7C;RYR3;CYCS;BACE2;APC2;KLC4;GRIN2B;MAPK10;NDUFB6;TUBB2A;WNT5A;CASP3;KIF5A;ATP2A2;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;PLCB1;SLC25A4;APP;PIK3R4;TNFRSF1A;TUBA1C;GNAQ;PSMC2;PSMA3;CDK5R1;RTN3;ATP5MC1;CYC1;TNF;PSMB2;COX4I1;KIF5C;ATP5PB;PSMD7;ATP5F1E;COX6C;TUBA1B;RTN4
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.6493157280491804,1.062593355832259,0.4,0.9527037222932495,1.0,4/9,21.81%,PTN;EPHA4;PTPRS;RTN4RL1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6996264174772429,1.062581677033244,0.43661971830985913,0.9523530580334502,1.0,3/7,17.18%,BEGAIN;DLGAP1;DLGAP2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,0.5509859564613392,1.0624969572541394,0.4578313253012048,0.9518414315823678,1.0,13/33,17.60%,PREX2;PTPRD;CGNL1;INSR;SPRY1;NDRG2;THSD7A;KALRN;SORBS1;SHROOM4;LDB2;GIPC2;SORBS2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,0.5509859564613392,1.0624969572541394,0.4578313253012048,0.9518414315823678,1.0,13/33,17.60%,PREX2;PTPRD;CGNL1;INSR;SPRY1;NDRG2;THSD7A;KALRN;SORBS1;SHROOM4;LDB2;GIPC2;SORBS2
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.5969256720454895,1.0623800717398126,0.4567901234567901,0.9519037145364536,1.0,3/21,10.42%,CR1;CD55;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.5956551703647537,1.062128755889953,0.41975308641975306,0.952497270705888,1.0,4/15,20.20%,NUDT16;ESR1;SHQ1;TNF
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.7010139876968432,1.0621222078202353,0.4342105263157895,0.9521243377768067,1.0,1/8,1.95%,DPYD
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.40374408958621744,-1.062059104513592,0.25,0.9342881441372741,1.0,27/89,13.95%,LY86;GIMAP8;BIN2;SAMSN1;PIK3R6;MPEG1;LGALS9;LILRB4;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;HLA-DPA1;ITGB2;CYTH4;APBB1IP;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.40374408958621744,-1.062059104513592,0.25,0.9342881441372741,1.0,27/89,13.95%,LY86;GIMAP8;BIN2;SAMSN1;PIK3R6;MPEG1;LGALS9;LILRB4;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;HLA-DPA1;ITGB2;CYTH4;APBB1IP;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5758980975405338,1.0620373904683007,0.37349397590361444,0.952028698504143,1.0,7/32,9.37%,CADM1;CDH8;CDH2;CADM2;CDH9;CDH20;CDH12
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6617965392286514,1.061960783410937,0.44594594594594594,0.9518716140260417,1.0,2/9,9.28%,PRKCE;IRS2
prerank,KEGG_2021_Human__Fanconi anemia pathway,0.5703467659659865,1.0619165962689876,0.38372093023255816,0.9516839114535182,1.0,11/37,19.35%,BRIP1;RPA2;FANCB;FANCM;FANCI;EME2;BRCA1;FAN1;FANCL;FANCA;MLH1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.482391093102634,1.0617611532119497,0.38,0.9519189990579685,1.0,44/204,20.68%,TOP2A;DAPK2;RHOB;CLIP3;GADD45B;PNMA1;SOX4;DAPK1;NGEF;CSRNP3;SEPTIN4;BNIP3L;RPS6;BOK;RRP1B;RPS27A;FAM162A;ARHGEF4;PNMA2;RPS6KA2;KALRN;PPID;RBM5;IFIT2;BNIP3;C3ORF38;ITSN1;PYCARD;CASP3;SHQ1;KCNMA1;NEURL1;BCL6;OLFM1;FGD4;SOD1;UBA52;HSPD1;UBB;ECT2;HIP1R;TNF;DUSP6;LRRK2
prerank,KEGG_2021_Human__Prion disease,0.49365425654022926,1.0616704425314871,0.36,0.9518428086116161,1.0,53/189,22.75%,NDUFA2;TUBA4A;EGR1;CREB5;TUBB4A;NCAM2;GRIN3A;NDUFB9;TUBA1A;HSPA5;EIF2AK3;TUBB6;GRIN2A;CAV3;RYR2;COX7A2;NDUFA3;CACNA1B;PSMB4;NDUFS8;COX7C;RYR3;CYCS;KLC4;GRIN2B;MAPK10;NDUFB6;TUBB2A;CASP3;KIF5A;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;SLC25A4;HSPA1B;SOD1;TUBA1C;HSPA2;PSMC2;PSMA3;ATP5MC1;NCAM1;CYC1;TNF;PSMB2;COX4I1;KIF5C;ATP5PB;PSMD7;ATP5F1E;COX6C;TUBA1B
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5598962069330793,1.0616105161554368,0.41333333333333333,0.9516399983134036,1.0,5/23,19.39%,VEGFA;INSR;MAGI2;SDCBP;DLG4
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6364778831695453,1.0615712064195821,0.4024390243902439,0.9513874730063369,1.0,2/9,7.71%,ENPP2;KANK1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.5502034392004131,1.0615529950650282,0.40425531914893614,0.9510622809757338,1.0,10/33,20.01%,DTL;RPA2;RPS27A;TRIM25;RFC4;POLE2;USP43;UBA52;UBB;RFC1
prerank,KEGG_2021_Human__Allograft rejection,-0.4880265662851556,-1.0614860900891696,0.2727272727272727,0.9346062912866985,1.0,6/20,16.92%,GZMB;HLA-E;HLA-DPA1;PRF1;FAS;HLA-DRB5
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6319298359628023,1.0614748997274708,0.42028985507246375,0.9509098946571451,1.0,8/11,32.00%,B4GAT1;HS2ST1;NDST3;CSGALNACT2;CSGALNACT1;EXT1;B3GNT2;FUT9
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6018068158857857,1.0613723548874545,0.40789473684210525,0.9508879400485443,1.0,3/15,9.92%,AGT;CAV3;CELF2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5414234762543693,1.0613569265588405,0.3373493975903614,0.9505327174224109,1.0,7/41,13.91%,KLF4;CLIP3;NR4A2;NR4A1;MAFB;NR4A3;TMEM120B
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.5916734949811862,1.0612976153811118,0.3670886075949367,0.950373084713459,1.0,1/16,0.82%,FGF1
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.6426537943048146,-1.061285803102617,0.43902439024390244,0.9341619399358573,1.0,1/5,0.24%,ITK
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.671049974694759,1.0612588718551357,0.40540540540540543,0.9501140656629283,1.0,7/10,28.85%,ABCA2;PMP22;TPPP;CNTNAP1;EPB41L3;NCMAP;DICER1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.6334804605380031,1.0611568716597786,0.4520547945205479,0.9500580451247596,1.0,3/7,15.54%,SYT4;PPFIA2;KIF5A
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5838560084206463,1.0609944349552385,0.4084507042253521,0.9502277159431661,1.0,6/22,16.55%,LRP2;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,0.5105785583321943,1.0604881391418208,0.4367816091954023,0.951735256794972,1.0,28/68,33.92%,WDHD1;PAICS;FANCI;RRP1B;KDM1A;CKAP5;RFC4;INCENP;PFAS;HSPD1;TIMELESS;HNRNPU;MTHFD1;NDC1;CAD;TRAP1;MCM3;NASP;HSP90AB1;MCM6;NCAPD3;SET;POLA1;PPAT;DHX9;PDCD11;CHAF1A;GART
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5578991496318543,1.060349275021343,0.4268292682926829,0.9519231935155414,1.0,9/29,24.16%,PDZD2;PTPRT;NPHP1;ITGB8;DNAH7;MAP3K13;ESRRG;CX3CL1;TCTN1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6592364477859649,-1.0600894728102221,0.3939393939393939,0.9360773390865056,1.0,3/7,9.18%,CX3CR1;CD200R1;P2RY12
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.5443586642776103,1.0600887212184011,0.3870967741935484,0.9525196819911591,1.0,13/47,20.32%,MTERF1;HCFC1;SIRT5;CRTC3;CYCS;POLG2;SMARCD3;TBL1XR1;TFAM;SIRT3;PPARA;POLRMT;NR1D1
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,0.6676042694061253,1.0597438919221684,0.42028985507246375,0.9533371241832134,1.0,2/6,25.85%,AP2A2;AP2S1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.5855621162484547,1.0597282854567531,0.39759036144578314,0.9530012955088271,1.0,5/15,23.72%,DGAT1;LIPE;GK;GPD2;PRKACB
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.39090357324437164,-1.0597115472797878,0.0,0.9351883173241357,1.0,24/83,14.74%,ITK;CD37;BIN2;SELPLG;CD2;SAMSN1;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;ITGB2;CYTH4;APBB1IP;LCP2;PTPN7;TYROBP;CD53;SNX20;GIMAP4;PIK3R5;IL12RB1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.39090357324437164,-1.0597115472797878,0.0,0.9351883173241357,1.0,24/83,14.74%,ITK;CD37;BIN2;SELPLG;CD2;SAMSN1;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;ITGB2;CYTH4;APBB1IP;LCP2;PTPN7;TYROBP;CD53;SNX20;GIMAP4;PIK3R5;IL12RB1
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.5317177521672429,1.059653875001238,0.43037974683544306,0.9528450483208131,1.0,14/40,19.17%,PIGU;OTOA;MDGA2;PIGQ;CNTN5;CPM;LY6H;NEGR1;LSAMP;PIGF;THY1;CNTN3;PIGL;PIGG
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.4846433770800599,-1.0595141892873559,0.3548387096774194,0.9348060056642877,1.0,4/15,15.05%,POLD3;CTC1;SLC19A1;TERF2
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.6221533712639414,1.0594618629817991,0.4057971014492754,0.9531884798151593,1.0,6/10,28.04%,ABCA2;PLTP;ABCB4;PLEKHA3;CERT1;PLEKHA8
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6236185979942891,1.0594531803531237,0.3880597014925373,0.9528112024649644,1.0,3/12,15.83%,IL15;NOD2;IL18
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.5204359060788315,1.0594436651224053,0.3804347826086957,0.9524685303389477,1.0,4/52,6.62%,FGF1;FLRT1;NR4A1;RBFOX2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6157634792192083,1.0593813064834992,0.42857142857142855,0.952343232913325,1.0,1/10,1.11%,PLIN2
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,-0.5578953824194748,-1.0593575143884018,0.4074074074074074,0.9341519237099356,1.0,3/9,18.45%,FYN;PKN1;CDC42
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.951082627136453,1.0,2/5,19.51%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.951082627136453,1.0,2/5,19.51%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7064979901441618,1.0592951958991028,0.41379310344827586,0.951082627136453,1.0,2/5,19.51%,CRYL1;SORD
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,0.7064979901441618,1.0592951958991028,0.41379310344827586,0.951082627136453,1.0,2/5,19.51%,CRYL1;SORD
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,0.6119836287681055,1.0592451586891787,0.4473684210526316,0.9508897514193644,1.0,2/19,7.92%,CLDN18;BHLHE40
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,0.6557774225426111,1.0591894130168842,0.4426229508196721,0.9507540224528861,1.0,6/10,27.69%,GNA11;PLCB1;GNAQ;ACSL3;GNA15;GNA14
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6014387394769013,1.0590895062677952,0.4266666666666667,0.9507665104657709,1.0,6/18,19.52%,NLGN3;FCHO2;NLGN1;SYT1;AMPH;NLGN4X
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.493278376831749,1.0590539991505057,0.4166666666666667,0.9505398414274189,1.0,43/120,27.16%,RPL23;RPL37A;NUP133;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;SEH1L;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;POLR2G;RPL32;GNL3;RPL27A;NDC1;RPL3;RPS16;RPL30;RPL36AL;RPL21;POM121;RPL7;RPL12;RPL10A;FAU;RPS12;NUP58
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.541318889481051,1.0587640864097072,0.39759036144578314,0.951155718677703,1.0,5/25,18.70%,SPARC;MFSD2A;SH3D19;CFL1;NTNG1
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.5094589489886898,-1.0585216293128128,0.3076923076923077,0.9355721443769404,1.0,6/11,14.48%,KRT10;DDR1;ICAM1;ST6GAL1;IL6R;IL6ST
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.5939771851931188,1.0584850435559527,0.45,0.9519190070060791,1.0,9/25,21.28%,ANXA1;ANK2;GLRX2;RYR2;UGCG;GRK4;IGFBP7;SCG5;MTCH1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.54849749016457,1.0580469687024106,0.4177215189873418,0.9532162330460162,1.0,5/30,9.91%,COBL;TGFB2;KITLG;RBPJ;MFSD2A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.5888937793799812,1.0578617695320158,0.3974358974358974,0.9534474801326741,1.0,6/16,13.96%,FGF1;CHI3L1;VEGFA;CCDC39;ERRFI1;PKD1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7242481485218688,1.0578150080274173,0.42857142857142855,0.953193654624029,1.0,1/5,17.54%,GSTP1
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,-0.5423572851734664,-1.0577831912289153,0.4,0.9358819072245252,1.0,1/10,3.31%,PMEPA1
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,-0.5423572851734664,-1.0577831912289153,0.4,0.9358819072245252,1.0,1/10,3.31%,PMEPA1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.6490851475712639,1.057774532203642,0.40540540540540543,0.9529665448050375,1.0,2/10,5.78%,HSPA5;SEC61B
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5902115147067046,-1.0577527939823153,0.36666666666666664,0.9348677270704611,1.0,2/8,2.23%,ITGA5;IL1B
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.6331006445268671,1.0576956386090726,0.4603174603174603,0.9528115376860888,1.0,3/9,12.09%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.731588990802674,1.0576162924638262,0.4696969696969697,0.9527625950115379,1.0,2/5,25.32%,DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.67508144361513,1.0575903182802533,0.4714285714285714,0.9525094709002342,1.0,2/7,17.85%,TTLL7;TPGS1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.5951234290861884,1.057580532749883,0.4691358024691358,0.952169608053376,1.0,8/21,15.94%,ANXA1;OVOL2;HIF1A;ST14;WNT5A;UXT;ESR1;CEBPD
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,0.708542934276165,1.0575346864353592,0.4927536231884058,0.9519585034931408,1.0,4/6,20.25%,CNTN1;NFASC;SDCBP;CNTNAP1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.7001403480436079,1.0573898290083634,0.4126984126984127,0.9520648586002872,1.0,1/6,7.02%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5081282502196387,1.0573055906003281,0.38636363636363635,0.9519861190016444,1.0,14/59,20.20%,TUB;CLIP3;IL15;ANXA1;SLC11A1;FCGR2B;BOK;DYNC1H1;CALY;PYCARD;CD151;ACSL3;HIP1R;TNF
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,-0.4447875296198511,-1.0572303467268407,0.4375,0.9357083134257046,1.0,7/24,13.10%,ITGA5;ITGAM;ICAM1;ITGAX;CD226;ENTPD1;CD53
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.3334071063966877,-1.0570824330585904,0.0,0.9350125635895529,1.0,25/151,12.08%,CCL5;CASP7;TICAM1;BCL2L1;IL1B;CCL3L3;CHUK;IRAK4;OLR1;ICAM1;MAPK13;TP53;KRAS;MAP3K5;MAP2K3;ARHGEF1;BID;TNFSF10;NFATC3;SRC;IKBKB;NLRP3;NFKBIA;PPP3CC;HSPA1A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.5749109822894845,1.057047896806051,0.4578313253012048,0.9525188485439285,1.0,6/20,21.02%,AGT;RGS2;CAV3;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.5227066543246466,1.0567255994195945,0.48936170212765956,0.9533680336189412,1.0,15/55,25.73%,VIM;RETREG1;RPS27A;DYNC1H1;CALCOCO2;AUP1;UBA52;UBB;DYNC1I1;ATG5;LGALS8;ATG13;CFTR;DDRGK1;DYNLL1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.5602078652130681,1.0566120582602219,0.38095238095238093,0.9534057559906287,1.0,3/35,5.92%,KLF4;AGT;RBM3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.5508003717595368,1.0565999472879208,0.4864864864864865,0.9530589639389183,1.0,5/24,18.36%,DDIT4;DEPTOR;NPRL2;PRKAA2;SESN1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5073984046040422,-1.0564704198769261,0.45161290322580644,0.9358210086338736,1.0,1/12,1.12%,PGM2
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.584344821285332,1.0564534764992168,0.3835616438356164,0.9531872118335807,1.0,7/18,30.71%,INSR;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2;ATP6V0A1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.5363123353527853,1.0563464801971663,0.35714285714285715,0.953198597566417,1.0,5/42,5.04%,TGFB2;ECM2;FRMD5;RNASE10;VEGFA
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.6667951483809993,1.0563363435368065,0.47692307692307695,0.952852317849236,1.0,3/7,23.72%,ABCA1;BMP1;PRKACB
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.5434574499173197,1.0563118938175082,0.45054945054945056,0.9525477182450048,1.0,10/46,18.82%,PRKAR2B;PDE1A;GNA11;PDE1C;ADCY8;CAMK2B;GNAI1;GNAL;PLCB1;GNAQ
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5654981491125995,1.0562085182252312,0.44155844155844154,0.9524916415679289,1.0,2/14,10.42%,CR1;C5AR1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.6454018347367656,-1.0559455868721372,0.42857142857142855,0.9359822250322413,1.0,1/5,1.54%,PEX13
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.48750412012100053,1.0558093560100368,0.3854166666666667,0.9535711817448971,1.0,13/91,16.13%,THBS1;HSPA5;TRAF2;PDIA2;EIF2AK3;HERPUD1;RNF139;PPP1R15A;RASGRF1;DNAJB9;HYOU1;ATP2A2;SYVN1
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.5919651129359813,1.055655308797418,0.4125,0.9537590421623696,1.0,3/22,10.42%,CR1;CD55;C5AR1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,-0.3470014487594883,-1.055610753391645,0.2857142857142857,0.93477614286801,1.0,23/81,14.46%,CD300LF;ITGAM;LY86;BIN2;PIK3R6;MPEG1;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;BTK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,-0.3470014487594883,-1.055610753391645,0.2857142857142857,0.93477614286801,1.0,23/81,14.46%,CD300LF;ITGAM;LY86;BIN2;PIK3R6;MPEG1;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;BTK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),-0.5116447113340465,-1.055604001553799,0.39285714285714285,0.9337114775572265,1.0,1/8,2.54%,ACTA2
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.6618926898673569,1.0556033428722367,0.41025641025641024,0.9536198820896753,1.0,3/8,26.51%,TPPP;LIMK2;RAB11A
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.5082077530311904,-1.0556026221899757,0.34615384615384615,0.9326492346931112,1.0,4/9,10.63%,CCDC59;ZDHHC2;CSF2RA;TTF1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,0.57173084864977,1.0552501783114763,0.4318181818181818,0.9544873226639685,1.0,5/24,12.53%,MACC1;FAAH2;OVOL2;ST14;FBP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,0.5257509913327287,1.0550398087592705,0.4772727272727273,0.9548810476417958,1.0,7/38,10.46%,NFIL3;ITGA2;IL15;FCGR2B;ITGAE;ID2;FCGR2C
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.503281880069302,1.0550313826280286,0.3695652173913043,0.9545164508288577,1.0,6/75,10.05%,DIAPH3;RACGAP1;TFRC;BAIAP2L1;WASF1;SLITRK5
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.458595506904138,-1.055015773588575,0.34615384615384615,0.9333056174374824,1.0,2/12,3.59%,CCL5;FOLR2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6437334976276353,1.0548970287965629,0.43243243243243246,0.9545985139035686,1.0,4/9,25.21%,AGT;GUCY1B1;FPR1;KCNC2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.48046444130217103,1.054818473943868,0.32,0.9544817914880266,1.0,49/226,22.05%,SOCS3;TNC;DTL;ASB14;VGF;WDR5;ZBTB16;VCAN;FBXL7;CDH2;ASB16;LAMB1;GOLM1;COPS5;HIF1A;FN1;CKAP4;LTBP1;TMEM132A;STT3B;PSMB4;RBX1;DCAF6;GAN;HIF3A;ASB13;FBXO27;UBE2M;CHGB;SUMF2;KLHL2;EPAS1;APP;SUMF1;IGFBP7;FBXL13;PSMC2;FBXL5;PSMA3;FBXO7;PSMB2;SPSB3;ATG5;DDB1;P4HB;PSMD5;HSP90B1;PSMD7;RAB5A
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.4176548198767586,-1.0547798875663803,0.2631578947368421,0.9329319520600232,1.0,5/30,10.83%,NUP42;MAP4K2;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6839114195404402,1.0546595249967732,0.34782608695652173,0.9545862888539505,1.0,1/5,10.68%,PDE4B
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6855025010944937,1.0546449596572118,0.46875,0.9542448865196209,1.0,4/6,29.94%,SART3;NOP53;TNIP1;WDR48
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.5271324694918429,1.0544093709971514,0.42168674698795183,0.9546639591771506,1.0,8/39,20.81%,STEAP2;ANK3;NSF;STXBP6;PREPL;SPTBN1;OSBPL5;EXOC5
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.554166514046333,1.054230893547504,0.4444444444444444,0.9549741345009226,1.0,10/24,19.51%,LRP2;FAH;SLC13A3;GHR;CRYL1;FBP1;TGFBI;GBA3;NME4;SORD
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.4969044999007334,1.053899703534105,0.40217391304347827,0.9556769404997442,1.0,18/78,21.23%,CENPE;RACGAP1;KIF15;ACTR1B;DNM3;DNM1;SEC24C;PRICKLE1;DYNC1H1;SH3GL2;KLC4;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1;KIF5C
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.5923516954980321,1.0538904697904132,0.4482758620689655,0.9553319101226453,1.0,4/14,19.55%,ACSL1;ELOVL4;HSD17B12;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.6550223588520241,1.0538690726384126,0.5135135135135135,0.9550469803609878,1.0,3/10,19.08%,BRCA1;CTBP1;TAF7
prerank,KEGG_2021_Human__Measles,-0.31643029371479175,-1.0537875946624398,0.3333333333333333,0.9350308303806179,1.0,16/87,14.21%,BCL2L1;IL1B;CCND1;IL1A;CHUK;IRAK4;TP53;BID;IKBKB;NFKBIA;TLR7;OAS2;HSPA1A;EIF2AK4;BCL2;AKT1
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.49506811694169056,-1.0536797722978424,0.45,0.9342098713112602,1.0,4/17,10.00%,BBS10;MKKS;BBS9;SMOX
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.598480499441995,1.0535500769199369,0.4177215189873418,0.9557787945376718,1.0,8/18,22.96%,SCN3B;DMD;RYR2;SGCZ;SGCD;SOD1;ATP1A2;GAA
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4585536118303354,-1.053535738869916,0.15,0.9333610575152298,1.0,2/22,2.23%,PHLDB2;IL1B
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5445832826375304,1.0534852672389,0.43956043956043955,0.9556097201065784,1.0,10/37,19.11%,ITGA2;RARRES1;PPP1R13L;BACE2;BNIP3;TMEM14A;EPAS1;HSPB1;SLC16A3;CD151
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.5362640017482418,-1.0534077144997465,0.4,0.9326180367874508,1.0,2/10,9.26%,SRRT;PUS10
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4981433514682332,1.0533596425974385,0.4148936170212766,0.9556610971172348,1.0,20/75,20.68%,CD22;RAB3C;STXBP5L;SEPTIN4;RAB15;RIMS2;ARFGAP1;FGR;SYT1;NSF;RNF139;PICALM;CPLX1;ITGAV;SNX17;FES;RAB21;PLD1;HIP1R;LRRK2
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5277211178887229,1.053352062090577,0.4588235294117647,0.9553130430042847,1.0,15/38,27.66%,HSPA5;HERPUD1;STT3B;DNAJB2;BAG3;HSPB1;HSPA1B;HSPD1;HSPA2;HSPA14;HSP90AB1;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.6801034277797685,1.053341609252309,0.4444444444444444,0.9549727343896104,1.0,2/5,5.04%,NR4A1;VEGFA
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6991185615468813,1.0532365362903549,0.4507042253521127,0.9549534459547097,1.0,4/5,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4147081756267011,-1.0532203330841927,0.4166666666666667,0.9321286760617618,1.0,7/36,13.88%,NUP42;PHAX;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6201443825233258,1.0532045214668937,0.4358974358974359,0.9546955776026226,1.0,7/13,23.90%,MAP9;DYNC1H1;GNAI1;DCTN1;GPSM2;TACC3;BORA
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.5629590257959819,1.0530381786794945,0.3950617283950617,0.9549372753750397,1.0,3/26,6.48%,KLF4;GLA;INSR
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.6413483643581158,1.0529226355361925,0.47297297297297297,0.9545301621380995,1.0,4/8,25.49%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.6413483643581158,1.0529226355361925,0.47297297297297297,0.9545301621380995,1.0,4/8,25.49%,RYR2;PDE4B;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6774936703970679,1.052824691676581,0.3939393939393939,0.9544850385350262,1.0,4/7,17.07%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.6459061438438134,1.0527739199253159,0.40350877192982454,0.9542427655203001,1.0,5/8,29.85%,DONSON;MCMDC2;ORC3;MCM3;MCM6
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6516016319441625,1.0526876152868871,0.39655172413793105,0.9541680432639488,1.0,2/8,5.56%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6464597380708043,1.052390472278931,0.45714285714285713,0.954911225857047,1.0,4/10,16.96%,EIF2AK3;IGF1R;GHR;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.6569002945375395,1.0522934191529372,0.48333333333333334,0.9548585890191358,1.0,2/8,14.21%,TRIM5;TRIM26
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.468629805666424,1.0522751008714437,0.35353535353535354,0.9545274102382482,1.0,53/176,25.39%,RPL23;DCC;EIF4A3;ENAH;COL4A5;NELL2;RPL37A;ROBO2;RPL38;ROBO1;RPS6;RPS27A;RPL23A;RPS25;RPS27;PSMB4;RBX1;CLASP2;RPS11;RPS20;RPL9;UPF3A;RPLP2;RPL37;RPL14;RPS4X;LDB2;RPL11;RPS24;RPS9;RPL36;UBA52;UBB;PSMC2;PSMA3;RPS3A;PSMB2;RPL35;RPL4;RPL32;PSMD5;PSMD7;RPL27A;RPL3;PRKACB;PSMD14;RPS16;PSMA5;RPL30;RPL36AL;RPL21;RPL7;RPL12
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3911247094368161,-1.0522396119788624,0.25,0.9339205125776476,1.0,14/57,13.06%,PIDD1;BTG2;RPS6KA6;SESN2;TFAP4;ACER2;TP53;ZNF385A;EP300;BCL3;CNOT6L;PLK3;NBN;PLAGL1
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,0.5520280686043121,1.0521854077950379,0.42045454545454547,0.9544378419236671,1.0,4/34,4.71%,MACC1;TBC1D8;DOCK5;RNF144B
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6141411932859088,1.052137936342622,0.4461538461538462,0.9542407139781436,1.0,5/14,20.66%,SLC12A8;ATP1B3;KCNMA1;ATP1B2;ATP1A2
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6819228472219174,1.0520275425172663,0.5555555555555556,0.9542477929263667,1.0,1/5,8.27%,SPRY1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.6113351371275516,1.051968131075762,0.42168674698795183,0.9540991112112794,1.0,2/16,5.61%,THBS1;FCGR2B
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,0.6446038325012394,1.0519287995704316,0.45454545454545453,0.9538170994940642,1.0,2/6,23.87%,ARG2;H1-0
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.552728366161569,1.0517218757635851,0.4367816091954023,0.9542134136412195,1.0,8/27,18.58%,VIM;MAPT;CLSPN;LMNB1;SPTAN1;CASP3;ROCK1;PLEC
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6152214553498861,1.0510196588589682,0.4714285714285714,0.9564095300364751,1.0,8/16,21.58%,SVEP1;OVOL2;PLOD1;ATP2A2;UGCG;STS;FGFR2;FLOT2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.646728207068961,1.0509242996536596,0.46835443037974683,0.956315752338972,1.0,1/8,3.66%,NRG1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.37877613713003055,-1.0508826503823732,0.25,0.936787919983,1.0,10/45,15.60%,INPP5K;PIK3R6;PIK3C2B;MTMR14;PIP4K2B;INPP5D;OCRL;RAB4A;PIK3R5;MTMR1
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6084397425552894,-1.0507660421012126,0.3870967741935484,0.9360887051778523,1.0,1/7,7.82%,HPN
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.5557732866405122,1.0507291684392848,0.4268292682926829,0.956721680646915,1.0,6/25,13.55%,ALOX12;ACSS3;ACAT1;SCD5;FASN;SCD
prerank,KEGG_2021_Human__Sulfur metabolism,0.6654791502420143,1.0506932016384964,0.4492753623188406,0.9564650759203314,1.0,1/7,5.87%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.4801954800102214,-1.0506526134012855,0.4117647058823529,0.93534679395117,1.0,4/16,4.42%,IKZF3;SAMSN1;BANK1;IL4I1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.3439125096059364,-1.0506488310695703,0.2857142857142857,0.9342970220163201,1.0,14/67,14.21%,RANBP6;PEX13;APPL2;NUP155;RPAIN;PHB2;NUP188;NUP214;IPO13;SYK;PEX16;PTTG1IP;ABCD3;AKT1
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,0.7180869834546212,1.050627134013215,0.5087719298245614,0.9563048256765848,1.0,2/5,23.33%,OVOL2;SST
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6294761467946043,-1.050612970697574,0.4583333333333333,0.9333673863257962,1.0,3/7,16.29%,NEK6;RSL1D1;NUAK1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.48714589487103177,-1.0505876697855787,0.3333333333333333,0.9323663010609026,1.0,3/13,9.06%,SERPINF2;A2M;KLKB1
prerank,KEGG_2021_Human__Colorectal cancer,0.5089988344656516,1.050294256533316,0.43010752688172044,0.9570688266950534,1.0,11/68,15.15%,ARAF;TGFB2;DCC;GADD45B;TCF7;RPS6KB2;TCF7L1;CYCS;APC2;MAPK10;CASP3
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5061979816316584,1.0502651023049887,0.4642857142857143,0.9567717473503401,1.0,10/44,15.50%,ZBTB16;FBXL7;SYNC;LAMB1;RND3;PALLD;FN1;UACA;TIMP3;ANGPT2
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.5836190796619828,1.050260416112498,0.375,0.9564010372031712,1.0,1/18,0.82%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.6758981917527995,1.0502381408042203,0.5,0.9561340022693862,1.0,1/7,4.57%,SRGN
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.4937591549503646,-1.0500703654897998,0.4230769230769231,0.9328952023613611,1.0,1/14,2.86%,AP1B1
prerank,KEGG_2021_Human__Renal cell carcinoma,0.5182516402089732,1.0499696098549458,0.4268292682926829,0.9567049339288908,1.0,10/58,17.20%,ARAF;TGFB2;VEGFA;HIF1A;ARNT2;RBX1;PAK5;GAB1;EPAS1;EGLN3
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.6870444670048672,1.049752784215928,0.4393939393939394,0.9570835754594945,1.0,1/5,11.83%,HCLS1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.7074371321116844,1.0496515696742545,0.4925373134328358,0.9570820930132113,1.0,2/6,6.63%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5370521800917699,1.0496283968130498,0.3953488372093023,0.9568373302254015,1.0,10/41,12.65%,VGF;SOX4;PDK4;INSR;CAV3;RPS6;IGF1R;ADCY8;TENT4B;BACE2
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.5929472574225058,1.0494867107126746,0.4268292682926829,0.9569501706152207,1.0,6/16,20.17%,CNTN1;RPS27A;NEURL1;UBA52;UBB;NOTCH2
prerank,KEGG_2021_Human__Gastric acid secretion,0.5250724192611681,1.0493969363318318,0.45054945054945056,0.9569082292121159,1.0,18/49,24.25%,ADCY3;CA2;CALM3;ADCY8;CHRM3;CAMK2B;GNAI1;ATP1B3;PLCB1;ATP1B2;GNAQ;ATP1A2;SLC9A1;PRKCB;KCNK10;SST;PRKACB;CFTR
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5699090026017066,1.0492789776300184,0.37037037037037035,0.9568847297107794,1.0,4/24,16.54%,MTCL1;PARD3;LRRC7;CRB1
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.6860348483184358,-1.0492504830686387,0.4594594594594595,0.9340392071526137,1.0,2/5,9.86%,C3;LPL
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6316329803193097,-1.0492334325673662,0.52,0.9330407239356754,1.0,3/5,22.31%,ENPP1;LRMDA;MEF2C
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.707818586549796,1.0490777294833369,0.42857142857142855,0.9572439862162682,1.0,2/5,14.63%,CARMIL1;PYCARD
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.5712012804563625,-1.0490376603382423,0.3870967741935484,0.9314014154722976,1.0,3/8,17.16%,AGO1;ZFP36;RBM4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.5712012804563625,-1.0490376603382423,0.3870967741935484,0.9314014154722976,1.0,3/8,17.16%,AGO1;ZFP36;RBM4
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6506888401822476,1.0490252385653647,0.4520547945205479,0.9570474725044962,1.0,4/11,19.04%,PDK4;PRKAG2;PRKAA2;PPARA
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,0.6267917304538829,1.0488832028132584,0.410958904109589,0.9571600022869231,1.0,4/10,22.91%,ABCA2;ABCA5;PEX3;ABCG1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.5085574314093083,1.0487239430580395,0.46808510638297873,0.9574010926582067,1.0,8/75,11.07%,TOP2A;HMGB2;NUP133;COPS5;TCF7L1;RPS27A;FAM50A;RBX1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.6881512167148857,1.0486926540220658,0.5,0.9571128956485239,1.0,2/5,12.83%,DOCK5;NR4A3
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.5628438446884926,1.0485609250024839,0.4177215189873418,0.9572252639676131,1.0,5/21,11.28%,GALNTL6;GCNT7;GALNT8;GALNT18;B4GALT5
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,-0.3761777716713084,-1.0485294456148568,0.2857142857142857,0.931928448451384,1.0,24/79,14.46%,ITGAM;LY86;PTAFR;BIN2;SAMSN1;PIK3R6;MPEG1;LILRB4;ITGAX;NCKAP1L;WDFY4;PLEK;HCK;BTK;HLA-DPA1;ITGB2;CYTH4;TLR7;LCP2;TYROBP;CD53;SNX20;HAVCR2;PIK3R5
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.7011125946157277,1.0485094956201146,0.4852941176470588,0.9569887667136289,1.0,3/6,20.40%,MAGI2;IQGAP1;BASP1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.6240909551730373,1.048421456033433,0.4878048780487805,0.9568845734841442,1.0,5/14,20.77%,MID1IP1;CPT1A;PRKAG2;PRKAA2;ACACB
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.4860352222598373,1.0484130705894639,0.37,0.9565346819440038,1.0,68/275,22.94%,TNC;ARAF;EEF1A2;PAPPA2;RPL23;VGF;VCAN;CDH2;RPL37A;LAMB1;RPS6KB2;GOLM1;FBXL2;RPL38;COPS5;FN1;RPS6;RPS27A;RPL23A;CKAP4;RPS25;DARS1;LTBP1;RPS27;TMEM132A;CHRM3;RPS11;SLC35A1;RPS20;RPL9;L2HGDH;RPLP2;RPS18;MRPL43;SERP1;RPL37;UBE2M;RPL14;CHGB;CPE;LTA4H;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;APP;RPL36;IGFBP7;UBA52;ERO1A;MRPL3;RPS3A;MRPS14;RPL35;RPL4;P4HB;RPL32;DUSP12;TNIP1;HSP90B1;EEF1A1;SPCS3;RPL24;SPARCL1;RPL27A;RPL3
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.5351111807965936,1.0483496033498543,0.40860215053763443,0.9563610822950644,1.0,6/42,11.27%,PRKAR2B;PDE1A;GNA11;PDE1C;ADCY8;CAMK2B
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5823906573124509,1.0482812911165407,0.4523809523809524,0.9562755922709788,1.0,7/22,19.04%,ASXL3;PDK4;MID1IP1;PRKAG2;SORBS1;PRKAA2;PPARA
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.3909290816404589,-1.0482005935043452,0.2727272727272727,0.931695529235575,1.0,12/53,10.95%,CD300LF;ITGAM;PTAFR;P2RX1;MPEG1;LGALS9;P2RY13;AOAH;ALOX5;HCK;PTGS1;IRAG2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4701929231739682,1.048129400836669,0.33,0.9565455771311512,1.0,85/482,18.46%,TOP2A;HTR2B;THBS1;DAPK2;LRP2;RHOB;ARAF;PRLR;CLIP3;GADD45B;NAA38;PNMA1;TFRC;AGT;ATAD3A;ANXA1;RNF144B;FIGNL1;VEGFA;SOX4;HSPA5;PHLPP1;TRAF2;NDRG1;IL7;NSMF;DAPK1;COPS5;NGEF;FMN2;CSRNP3;PAX8;SEPTIN4;BEX2;BNIP3L;FAIM2;RPS6;BOK;IGF1R;RRP1B;RPS27A;MCL1;PLK2;SRA1;ALK;FAM162A;ARHGEF4;PNMA2;RPS6KA2;KALRN;PPID;RIPK2;GRID2;RBM5;IFIT2;BNIP3;PINK1;PRELID1;BCL2L2;C3ORF38;ITSN1;TMEM14A;PYCARD;WNT5A;CASP3;CFL1;BAG3;CIDEB;NUAK2;SHQ1;KCNMA1;NEURL1;EGLN3;ARHGDIA;HSPB1;BCL6;HSPA1B;GSTP1;OLFM1;PRKAA2;TAF9B;FGD4;SOD1;UBA52;HSPD1
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6568277920081446,1.0479463802088702,0.4057971014492754,0.956775058529305,1.0,1/8,15.48%,STXBP6
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5978942013798078,1.0478881831656677,0.44285714285714284,0.9565833349064897,1.0,1/14,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6297257622411211,-1.0477793829299313,0.4666666666666667,0.9318420964716588,1.0,2/7,27.40%,AKT1;NPM1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.48512239629326637,1.0475980510663665,0.3804347826086957,0.9572590888486648,1.0,26/107,21.34%,PLPP3;PTPRD;PPP2R3B;PPP2R5B;PLPPR4;PTPRG;PTPRK;PPP2R5A;PTPRZ1;MTMR7;PP2D1;PTPRT;FBP1;PPM1E;PPM1L;ACP3;DUSP10;PTPN9;PPP2R3A;PTPN5;DUSP16;CTDSP1;SSH2;DUSP6;PTPRS;DUSP12
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.5464700545175036,1.0474374287347417,0.42857142857142855,0.9574148480735162,1.0,10/22,25.30%,RIMS2;RIMS3;CPLX1;MCTP1;PREPL;PNKD;LRRK2;RAB5A;SYT11;RIMS1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.49715263399526755,1.0473408142868916,0.3793103448275862,0.9573145156131678,1.0,10/45,15.70%,HTR2B;SLC24A2;VAPB;ANK2;TMTC2;RYR2;SLC24A1;FAM20A;ATP2A2;SLC24A3
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.3735993885243306,-1.047205657344264,0.16666666666666666,0.9321776133672656,1.0,16/52,14.51%,MYH9;WIPF3;YES1;FYN;SRC;NCKAP1L;WASF3;HCK;BTK;ABL1;CRK;CYFIP1;ARPC2;NCK1;SYK;CD247
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.30719845787242794,-1.04700943914451,0.3333333333333333,0.9316543227534051,1.0,19/130,10.83%,NUP42;GTF2H5;LRIG1;ELOA;GTF2F1;CTDP1;GTF2H2;RNF103-CHMP3;ELOC;TAF13;BANF1;SUPT16H;NUP155;VTA1;VPS37B;TCEA1;CHMP2B;NUP188;NUP214
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,0.6770913767530653,1.0468989108649775,0.4666666666666667,0.9584899347700961,1.0,4/7,28.90%,ADCY8;GNAL;ADCY1;ADCY2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.3547673406798353,-1.0468933344483657,0.3333333333333333,0.9309869160982189,1.0,13/48,17.28%,BCL2L1;TXN2;CHUK;NLRP1;MAPK13;IKBKB;NLRP3;BIRC2;BCL2;NFKB2;PSTPIP1;CASP2;CASP8
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9579179693408677,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9579179693408677,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.7174120756482565,1.0467272394676272,0.547945205479452,0.9579179693408677,1.0,1/5,2.19%,CYP3A5
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),-0.6336731518725449,-1.0466607918277728,0.4146341463414634,0.9306112108557207,1.0,1/5,4.51%,APPL2
prerank,CellMarker_Augmented_2021__B cell:Thyroid,-0.397450668901789,-1.046644560591286,0.3157894736842105,0.9296275320852132,1.0,5/32,7.87%,NKG7;CD37;CEACAM21;HCST;RASAL3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.688224314979086,1.0464430144047787,0.49206349206349204,0.9586022571045113,1.0,3/5,22.38%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4722533906790013,1.04643783074056,0.4845360824742268,0.9582499833548292,1.0,12/90,15.02%,NAMPT;PDK4;INSR;GRB10;RAB15;IRS2;IGF1R;SORBS1;GAB1;PKM;INSIG1;CPEB2
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.4721162393276096,1.046431500510973,0.35051546391752575,0.9578797573755942,1.0,17/104,19.06%,ARAF;TGFB2;FZD6;GADD45B;TCF7;RPS6KB2;TCF7L1;SHC2;IGF1R;GAB1;APC2;DPF3;WNT5A;SMARCD3;GSTP1;SMARCC1;TXNRD3
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.574180145917995,1.0464306951239415,0.4794520547945205,0.9574988906728603,1.0,9/16,25.30%,SNAP25;PPFIA2;SYT1;CPLX1;PPFIA4;TSPOAP1;SYN2;PPFIA3;RIMS1
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.5444868845860066,1.0464137367973103,0.45348837209302323,0.9572021294611233,1.0,10/44,21.03%,PFKM;SCO2;PGAM1;HIF1A;NTRK3;PKM;SLC16A3;SIRT3;FGFR2;PDHB
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.664047977422241,1.0462985351563059,0.43478260869565216,0.9572006181717064,1.0,1/8,6.02%,ETFB
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6153527262010513,1.0462625752772583,0.4696969696969697,0.9569770251908308,1.0,2/10,14.72%,ITGA2;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.585251329443787,1.0461418558979814,0.4857142857142857,0.9570156363002074,1.0,5/15,23.47%,HIF1A;SOD2;PINK1;HSPB1;TRAP1
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.49880700129508837,1.0460237485981498,0.39361702127659576,0.957036027697356,1.0,11/49,18.81%,ITGA2;PIGU;ARF6;LAMA2;LAMB1;SH3GL3;RPS27A;SH3GL2;SPINT2;UBA52;UBB
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.549260493704943,1.0459526540525588,0.4567901234567901,0.9569182208309088,1.0,6/31,17.71%,DTL;TRIM25;RBX1;RNF126;NEURL1;FANCL
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.659408156746166,1.0458932504698055,0.4155844155844156,0.9567423485264861,1.0,1/8,6.56%,AKAP6
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.5898011984140057,1.045865299686868,0.4605263157894737,0.9564648779700102,1.0,2/13,9.75%,OVOL2;ST14
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.4178915821685889,-1.0457961428071407,0.45,0.9308903178545346,1.0,4/28,3.48%,GTF2H5;GTF2F1;CTDP1;GTF2H2
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,-0.5763246804695373,-1.045632752795211,0.45161290322580644,0.930385789902393,1.0,2/8,1.62%,ADPRM;ITPA
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.5127728736439356,1.045621521343099,0.43010752688172044,0.956837763968231,1.0,22/68,30.57%,NDUFA2;NDUFB9;SCO2;NDUFA3;NDUFS8;ACAD9;NDUFB6;UQCRFS1;TIMMDC1;SCO1;NDUFAF4;DMAC1;ECSIT;COX20;NDUFS5;NDUFV1;NDUFS7;TMEM126A;NDUFAF1;NDUFA1;IMMP2L;NDUFA10
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.3852866804173635,-1.0454226551108743,0.42857142857142855,0.929940161894078,1.0,6/40,6.25%,DHRS4;PEX13;IDE;EHHADH;ACOX1;ACAA1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.45749116485926666,-1.045116374164625,0.4583333333333333,0.9299428926242616,1.0,1/18,0.14%,COL18A1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),0.6473139387167844,1.0450347369432378,0.4838709677419355,0.9586008782820423,1.0,4/7,31.30%,PRELID1;ABCB4;DBI;ABCA3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5753681682028481,1.0449263742004364,0.48717948717948717,0.9585661560813473,1.0,5/20,22.43%,RPL23;EPHA4;RPL11;ALAD;HFE
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.3620205729188803,-1.044875389813297,0.4,0.9295419763591637,1.0,22/92,15.17%,PSMB3;PSME3;CHUK;BLNK;STIM1;NFKBIE;ITPR2;PSMC4;PSMD12;DAPP1;FYN;PSME4;NFATC3;BTK;IKBKB;NFKBIA;NCK1;SYK;PSMA1;BCL10;CARD11;PSMA7
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.5761641456445624,1.0447765691286346,0.45348837209302323,0.958662059881085,1.0,9/32,20.69%,CACNB2;NCAN;COL4A5;SPTAN1;SPTBN5;SPTBN1;SPTBN4;NCAM1;CNTN2
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,0.7009608620536668,1.0445656687359133,0.5072463768115942,0.9582572403179387,1.0,5/7,26.10%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7009608620536668,1.0445656687359133,0.5072463768115942,0.9582572403179387,1.0,5/7,26.10%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7009608620536668,1.0445656687359133,0.5072463768115942,0.9582572403179387,1.0,5/7,26.10%,RPS27A;UBA52;UBB;MRC1;TLR2
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5469291158968579,1.0445199884786158,0.44047619047619047,0.9580090242841078,1.0,4/34,13.64%,WDR5;YEATS2;PER1;TRIM16
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5377191327223695,1.0444995183781303,0.5280898876404494,0.9576994545746217,1.0,5/29,12.53%,TGFB2;STMN3;KANK1;SPRY1;FBP1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.5278288367977212,1.0443371569350668,0.47191011235955055,0.9579764305435932,1.0,16/51,18.16%,TGFB2;CACNB2;ITGA2;AGT;DMD;LAMA2;RYR2;ITGB8;CACNG2;CACNA2D3;PRKAG2;ATP2A2;ITGAV;CACNG8;PRKAA2;SGCD
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.5975938476622957,1.0442440342124784,0.46153846153846156,0.9578660923699068,1.0,3/18,9.38%,MAPT;MAP2;MAP1B
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.643624139775414,1.0439503542202822,0.47692307692307695,0.9584827151708603,1.0,1/8,5.06%,DAAM2
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.3695092204507713,-1.043929686517583,0.4,0.9314171303324321,1.0,11/44,13.23%,NEDD4;RAMP1;PLEKHJ1;LILRB4;GRK2;SNX25;TGFB1;SMURF1;ITGB2;ARRB2;SYK
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.4696810897641883,-1.043897977126576,0.35294117647058826,0.9305120315982989,1.0,3/21,7.51%,FLNA;ZPR1;TGFB1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,0.6305589850759921,1.04370585521664,0.425,0.9589723314995048,1.0,4/11,18.81%,RPS27A;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.6587225789836896,1.0436743401882056,0.49206349206349204,0.9587352609432377,1.0,1/8,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.5508373258262926,1.0435937683164835,0.42528735632183906,0.9586536937886407,1.0,1/33,0.30%,KLF4
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.7129223068288222,1.0435402428771736,0.42857142857142855,0.9584674837467858,1.0,1/6,4.09%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5441949479721311,1.043527880957951,0.42168674698795183,0.9581153985302061,1.0,11/22,26.10%,SYT4;RAB15;RIMS2;SYT1;RIMS3;PREPL;LRRK2;RAB5A;SYT11;RIMS1;SYT9
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.5579922025694471,1.0435020106043311,0.42168674698795183,0.9578754306597616,1.0,4/17,19.33%,PIGU;NTRK2;GRIN2B;CDK5R1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.4806637637921003,1.043410785285736,0.3838383838383838,0.9577582668071748,1.0,31/178,21.88%,DEPP1;HTR2B;DAPK2;EEF1A2;GFAP;MAPT;FBXL2;DAPK1;TRIM5;BOK;MCL1;PLK2;PRKAG2;BNIP3;PINK1;CASP3;ROCK1;HSPB1;NPRL2;MTMR9;PRKAA2;TRIM65;CDK5R1;ATP6V0B;UCHL1;LRRK2;TRIM14;LEPR;TBC1D14;ATP6V1B2;EEF1A1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.4701023465163568,-1.043307985657228,0.39285714285714285,0.9313474938453031,1.0,2/17,2.37%,FBL;SETD6
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.645666609011416,1.0431676234115015,0.43283582089552236,0.9581963515065604,1.0,3/8,7.57%,RORB;VEGFA;AGTPBP1
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.40681498571139174,-1.0428295081272538,0.2,0.9316213734621658,1.0,21/94,15.17%,ITK;GRAP2;PSMB3;EVL;PSME3;CHUK;PSMC4;PSMD12;PSME4;PKN1;INPP5D;IKBKB;HLA-DPA1;NFKBIA;LCP2;NCK1;PSMA1;BCL10;CD247;CARD11;PSMA7
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.5774698365101267,1.0428185670189238,0.45454545454545453,0.9590340797115413,1.0,4/18,12.28%,RACGAP1;SLC13A4;SLC19A2;SLC35F3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.6317219563277956,1.0425501360013416,0.5342465753424658,0.959496533389839,1.0,2/9,11.83%,NOD2;HCLS1
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.6474929841420142,1.0423316846779085,0.4266666666666667,0.9598866105097151,1.0,4/9,19.76%,ADAM23;CACNG2;CACNG8;ADAM22
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.6972876790304072,1.0422499727012278,0.4925373134328358,0.959794081785926,1.0,3/5,14.58%,GAD1;GAD2;ALDH1A1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.5779988327849408,1.0422366529007685,0.4642857142857143,0.9594857554272443,1.0,10/23,25.82%,SLC4A10;CA2;SLC9A7;SLC9A6;LRRK2;SLC9A1;SLC26A3;CHP1;CFTR;GPR89B
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.6592836330703162,1.042198926903342,0.5076923076923077,0.9592424066605846,1.0,3/9,18.43%,CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.47252730314091923,-1.0420962064346362,0.34615384615384615,0.9326115081594831,1.0,1/17,0.77%,NDE1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6173341053224228,1.0419204791136125,0.463768115942029,0.9598620525692764,1.0,4/11,27.75%,TCP1;GNL3;CCT8;DKC1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.5247003091230158,1.0417602428637418,0.4318181818181818,0.9600284182360085,1.0,6/35,18.81%,MAPT;RPS27A;TGFBI;APP;UBA52;UBB
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.5054490021496554,-1.0416661506977776,0.42424242424242425,0.9328404477345532,1.0,8/14,25.93%,FYN;PKN1;EP300;PRKCA;RPS6KA5;RELA;NRAS;NFKB1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.6271282098739532,1.0415859221597459,0.45714285714285713,0.9603491180567347,1.0,7/14,24.08%,ERC2;LMNB1;APP;CDC25B;CDK5R1;JUN;FOXO3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5729169061573354,1.0415662726227093,0.4305555555555556,0.9600232241864693,1.0,8/22,20.28%,CLIP3;TUBB4A;KANK1;MAP2;STMN2;EML2;HIP1R;SSH2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3963940340647757,-1.0415609828421817,0.4444444444444444,0.932181927319227,1.0,10/62,10.78%,PSMB3;PSME3;CHUK;ITGB5;PSMC4;PSMD12;PSME4;HLA-E;IKBKB;FCGR1A
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.5190213730172137,1.0414979879720048,0.46511627906976744,0.9598052670833601,1.0,11/42,16.29%,FGF1;TGFB2;NR4A1;VEGFA;LAMB1;C5AR1;NOD2;DEAF1;NR4A3;DUSP10;EPB41L4B
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.396355710417885,-1.0414733975109431,0.3333333333333333,0.9313390666574034,1.0,4/23,13.17%,CCL5;HLA-E;NMI;TASL
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.42094919586766555,-1.0413151633855309,0.3333333333333333,0.9306407855650468,1.0,7/22,20.48%,PEX13;PEX16;ABCD3;FIS1;ACBD5;PEX2;SLC25A17
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.625926711287371,-1.0412456217816441,0.41935483870967744,0.9297586508731494,1.0,2/5,22.85%,AP4M1;LIN7B
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,0.531238113259086,1.0411531679851243,0.4457831325301205,0.9606746387244903,1.0,9/27,18.26%,SPARC;TNS1;CD93;THBD;SHROOM4;ABLIM3;LDB2;EPAS1;IGFBP7
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.5008551834914381,-1.0411503145673626,0.44,0.9290351110838858,1.0,8/14,30.13%,MAPKAPK2;AKT1;EXOSC9;EXOSC8;EXOSC2;XRN1;YWHAB;ZFP36L1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.49402564313187114,-1.0410784489178706,0.45,0.9282277691169699,1.0,3/12,5.41%,HHEX;C3;ANXA4
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5610521190603788,1.0410611912671897,0.41975308641975306,0.9606215798465582,1.0,6/31,14.37%,PRLR;TM7SF2;FAXDC2;PRKAG2;INSIG1;FDFT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3704309988505606,-1.0410267847551853,0.35714285714285715,0.9273937487814573,1.0,6/50,3.56%,CEBPA;TFAP4;CCND1;ACTB;HHEX;LATS2
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.5895837492143203,1.0410230460766383,0.43209876543209874,0.9604000592804574,1.0,3/14,16.31%,RUVBL2;NHP2;SHQ1
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.530213826895115,1.0409846187757117,0.4367816091954023,0.9601607930492024,1.0,6/39,12.76%,TSHR;HTR7;PRKAR2B;ADCY8;RXFP1;GNAI1
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,0.6692650153287274,1.040753448001485,0.4626865671641791,0.9605844526790336,1.0,1/7,2.19%,CYP3A5
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.3677573573430082,-1.0405594173431003,0.2222222222222222,0.9278393126448046,1.0,10/49,9.74%,PSMB3;PSME3;RUNX3;PSMC4;PSMD12;CBFB;TGFB1;SRC;SMURF1;EP300
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6518155823633663,1.0404968564180566,0.4925373134328358,0.961025686189074,1.0,6/7,34.41%,GINS1;MCMDC2;MCM3;MCM6;POLA1;GINS3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.6627639280173522,1.0401811403774113,0.47761194029850745,0.9616849291698888,1.0,3/6,22.38%,SOD2;MFN2;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6441544802539696,1.0400781483934405,0.47297297297297297,0.9616351783924022,1.0,5/12,17.76%,CALM3;MAGI2;CD300A;PPP1R15A;MTMR9
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.504001110403115,1.0400543737997257,0.4791666666666667,0.9613601292141526,1.0,19/90,14.02%,GNRHR;CHRM5;PRKCE;TACR1;ANXA1;GNA11;DGKI;RGS1;GPNMB;MCHR2;LTB4R;DGKB;CHRM3;GPR65;RPS6KA2;KALRN;RIPK2;DGKG;RGS17
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.6386064825672876,1.0397856805660226,0.4,0.9617824949148439,1.0,4/11,22.05%,RPS27A;UBA52;UBB;RAB5A
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.47591493490391057,1.039753107000212,0.4,0.9615254727285748,1.0,28/160,16.04%,DDIT4;DAPK2;RHOB;MAL;DCC;PRKCE;ZBTB16;ERCC2;CIT;ADAM15;ALOX15B;DAPK1;SEMA6A;GLRX2;SEPTIN4;BOK;CASP5;TCHP;FAM162A;IFIT2;PAK5;BNIP3;PPP1R15A;PYCARD;SCN2A;CASP3;CIDEB;IFI27L2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.39342292560152453,-1.039693824049998,0.42857142857142855,0.9291490304131718,1.0,4/42,6.66%,RALB;IDE;NVL;TRIB3
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.600046973857508,1.0394336819298255,0.48,0.9622618335542761,1.0,4/15,22.47%,CHURC1-FNTB;SLC24A1;GRK4;GNB5
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.5044227127554531,1.039187045041138,0.4222222222222222,0.9627083528319806,1.0,10/46,21.28%,FGF1;PIGU;RBFOX2;RPS27A;HNRNPH1;POLR2D;UBA52;UBB;FGFR2;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.570930053955244,1.039186105141097,0.4375,0.9623406060361107,1.0,6/24,12.31%,SOCS3;IL15;VEGFA;GHR;HCLS1;CRLF1
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.563648306054047,1.0391451660336224,0.40476190476190477,0.9621194510677538,1.0,7/22,25.73%,RPS27A;DYNC1H1;UBA52;UBB;DYNC1I1;CFTR;DYNLL1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.49312082841450194,1.038998739770313,0.4166666666666667,0.9623443480934976,1.0,20/93,21.24%,ALDH3B1;MAPT;TMEM161A;PTPRK;ERMP1;DAPK1;HIF1A;CYCS;SOD2;PINK1;CPEB2;HSPA1B;GSTP1;PRKAA2;SOD1;ERO1A;STX2;FOS;LRRK2;VRK2
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.5611003882506354,1.0387189323880162,0.4533333333333333,0.9629612918571113,1.0,5/23,13.83%,CR1;GPNMB;FCGR2B;PDCD1LG2;CD300A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.557821642614046,1.0383273814488696,0.4782608695652174,0.9640731887679429,1.0,5/17,21.46%,SEC61B;HERPUD1;AUP1;SYVN1;HSP90B1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6708782687779546,1.038325455070129,0.4714285714285714,0.9637127519134185,1.0,4/9,12.47%,CALM3;RYR2;KCNMB1;SYT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5382516961840105,-1.038248744758873,0.4,0.9319859513923187,1.0,4/10,14.28%,RPUSD3;UQCC2;FASTKD2;RPUSD4
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6026939836341548,1.0381513667403357,0.4657534246575342,0.9639081884834116,1.0,3/13,12.72%,TRAF2;CD55;TNFRSF1B
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6141097615948775,1.0378626620687772,0.47058823529411764,0.9645128862326556,1.0,4/9,18.24%,DNM3;ARHGEF4;FGD6;FGD4
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.35384521872998614,-1.037715084386562,0.5,0.9321845479985571,1.0,20/86,16.24%,INPP5K;PLA2G4C;PIK3R6;CSF1R;PIK3C2B;MTMR14;INPP5E;PIP4K2B;PLA2G12A;INPP5D;PLEK;OCRL;PI4KB;VAC14;PI4KA;MTMR10;RAB4A;PIK3R5;MTMR1;PLCB2
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.4724060483462956,1.0376899964808657,0.4444444444444444,0.9647114191858243,1.0,72/261,24.06%,NDUFA2;TUBA4A;DNAH11;TUBB4A;NRG1;SLC1A2;NDUFB9;TUBA1A;HSPA5;TRAF2;EIF2AK3;TUBB6;VAPB;ACTR1B;NUP133;GRIN2A;GRIA2;DNAH14;COX7A2;NDUFA3;PSMB4;NDUFS8;NRG3;DNAH17;COX7C;CYCS;DNAH7;TNFRSF1B;PINK1;KLC4;NXF1;GRIN2B;NEFL;NDUFB6;TUBB2A;CASP3;NRG4;KIF5A;SEH1L;ATP5F1A;UQCRFS1;ATP5F1D;UQCRC1;GRIA1;PIK3R4;TNFRSF1A;DCTN1;SOD1;SPG11;TUBA1C;PSMC2;NRG2;PSMA3;ATP5MC1;CYC1;TNF;PSMB2;COX4I1;KIF5C;ATP5PB;PSMD7;ATP5F1E;RAB5A;COX6C;TUBA1B;NDC1;ATG13;CASP1;TOMM40;SRSF3;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.5389924712471054,1.0374717312481954,0.4642857142857143,0.9650165185533003,1.0,6/23,18.90%,CR1;SOX4;IL7;DUSP10;BCL6;RHOH
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.47693928270367575,1.0373899412069867,0.422680412371134,0.9648839969228713,1.0,25/107,20.55%,CENPF;CENPE;NUP133;RCC1;MAP9;XPO1;CENPP;SBDS;PLK2;RPS27;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;INCENP;KIF11;TOGARAM1;SEH1L;GPSM2;SUN2;KNTC1;DYNC1I1;CENPT
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,0.6209819387871287,1.037383373788779,0.5,0.9645240842300268,1.0,6/10,27.69%,GNA11;CHRM3;PLCB1;GNAQ;GNA15;GNA14
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.511874223771526,-1.0372211901797328,0.4,0.9326513093235266,1.0,2/10,11.82%,SETDB1;TASOR
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.5363338518948035,1.0365657224953266,0.4157303370786517,0.9667582963063369,1.0,12/36,19.55%,FAAH;ACSL1;FAAH2;ALOX12;ALOX15B;CPT1A;ACAD9;LTA4H;PNPLA8;GSTP1;HACL1;ACSL3
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5546265460089089,1.0364904189451145,0.42857142857142855,0.9666145983549395,1.0,2/19,7.60%,WDR5;HCFC1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.5398430364681308,1.0363726102182602,0.5,0.9666627366095609,1.0,11/35,18.81%,RPA2;FANCB;FANCM;FANCI;RPS27A;XRCC3;FAN1;FANCL;FANCA;UBA52;UBB
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.6966620537994856,1.0362156245028589,0.4603174603174603,0.9668634483120405,1.0,4/7,21.28%,CNTNAP2;SPTBN4;CNTN2;MTCH1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5345696243039579,1.0361857891386048,0.48863636363636365,0.9665921588293568,1.0,3/29,9.06%,DAPK2;NR4A2;DEPTOR
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.47338861454114517,1.036131673873083,0.37373737373737376,0.9663884597137257,1.0,31/226,12.29%,FGF1;ARAF;TGFB2;TOM1L1;CENPE;ENPP2;CLIP3;FAXDC2;IL15;RELN;TFRC;AGT;CHI3L1;ACVR2A;MTCP1;CEMIP;VEGFA;SPDYA;GPNMB;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;GHR;NTRK3;PRKAG2;FAM20A;NTRK2;HCLS1;RIPK2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5534603793926165,-1.036106569700794,0.45161290322580644,0.9345574327987409,1.0,1/10,0.19%,SNAP47
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.4710438776891134,-1.035991389109493,0.45714285714285713,0.9339062633827006,1.0,3/20,1.68%,COL18A1;ARAP3;CYP2S1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.5547600916829293,1.0359393389462506,0.44594594594594594,0.9667521132204097,1.0,15/27,27.05%,AP3B2;KIF1B;SPAST;NEFL;KIF5A;KIF3A;HSPB1;SOD1;RAB21;KIF5C;MAP1A;AP3B1;AP3S1;RAB27B;AP3M2
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.6191521993244482,1.0358827733830447,0.4567901234567901,0.9665804021444047,1.0,7/9,36.30%,ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5PD;VPS9D1;ATP5MC3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.6312874698126446,1.035878024539991,0.475,0.9662352545099415,1.0,3/11,19.55%,ACSL1;HSD17B12;ACSL3
prerank,KEGG_2021_Human__Circadian rhythm,0.5588931093610778,1.0358394364836618,0.5287356321839081,0.9659859767631911,1.0,9/26,22.96%,RORB;BHLHE40;PER1;RBX1;PRKAG2;PRKAA2;NR1D1;NPAS2;RORA
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),0.674861839132002,1.0358236297784702,0.5138888888888888,0.9656767201039566,1.0,1/5,2.10%,MAL
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,0.625451826489189,1.0355964606915211,0.4024390243902439,0.9660682515713624,1.0,3/11,10.17%,EIF2AK3;FN1;ALK
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.4681557740381979,1.0354344800148219,0.38,0.9662472751320983,1.0,82/400,18.65%,HTR2B;THBS1;KLF4;NAMPT;FGF1;ST18;PRLR;TSHR;TGFB2;CR1;TBRG4;RPL23;CCPG1;HMGB2;TBC1D8;IL15;TFRC;AGT;OSMR;NRG1;MEIS2;KITLG;LIFR;PTPRK;VEGFA;SPDYA;SOX4;IER5;GPNMB;ALOX15B;IL7;SHANK2;MVD;INSR;RBFOX2;CAMK2N1;FN1;ID2;RPS6;BOK;PTN;IRS2;IGF1R;NTRK3;ALK;DNAJB2;RPS6KA2;FLT1;NTRK2;HCLS1;IFNLR1;RNF126;MAGI2;CRLF1;RBM5;NR4A3;SOD2;CLMN;RNF139;E2F7;SDCBP;COPS9;THAP12;RPS4X;IL11RA;CTBP1;ITGAV;CHD5;RPS9;PRKRA;NEURL1;EGLN3;BCL6;HSPA1B;APP;RGCC;IGFBP7;FTH1;GTPBP4;FES;AQP11;EZH2
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6768176639607127,1.035394172931333,0.5070422535211268,0.9660054480877787,1.0,1/6,7.13%,MPG
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.4461223454085803,-1.0352261868995962,0.3333333333333333,0.9349896759136994,1.0,7/28,14.80%,ING3;GATAD2B;TP53;PIP4K2B;EP300;AKT1;RBBP4
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.4300655432127003,-1.035187723896833,0.4074074074074074,0.9341283016443237,1.0,6/22,12.62%,ITGAM;CSF1R;ITGAX;TLR7;CD83;ENTPD1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5542172805041462,1.034703042969464,0.4457831325301205,0.9679372399036792,1.0,4/31,4.44%,LRP2;PRLR;CYP3A5;PIAS4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.6103543323553724,1.034611544742614,0.4666666666666667,0.9678221242844113,1.0,1/13,3.87%,ANXA1
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6663433611161469,1.034506974858971,0.5507246376811594,0.9677671296859697,1.0,3/6,18.00%,ERC2;CBLN2;DCTN1
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,-0.5062785758778462,-1.0344817585425605,0.4482758620689655,0.9350966704393563,1.0,4/9,9.74%,ING3;TP53;PIP4K2B;EP300
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.5363199753291323,-1.0344392271805016,0.43478260869565216,0.9341808413688882,1.0,2/11,4.16%,CLTB;CLTA
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.43305864536452277,-1.034301216677094,0.4444444444444444,0.9335054913353188,1.0,9/45,9.65%,CYB5A;FOLR2;SLC46A1;MMAA;MTHFD2L;MTHFD1L;HLCS;CYB5R3;ENPP1
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.3686544979289412,-1.0341597922352797,0.16666666666666666,0.931977100834107,1.0,25/84,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;MPEG1;CSF1R;LILRB4;P2RY13;ITGAX;AOAH;MYO1F;NCKAP1L;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.3686544979289412,-1.0341597922352797,0.16666666666666666,0.931977100834107,1.0,25/84,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;MPEG1;CSF1R;LILRB4;P2RY13;ITGAX;AOAH;MYO1F;NCKAP1L;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.5089604659638685,1.0339790894266994,0.45348837209302323,0.9692406475188029,1.0,7/45,12.87%,NEK11;DTL;CLSPN;RPA2;EME2;DONSON;BRCA1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6305044411595453,1.0337728250044589,0.4117647058823529,0.9695697661353567,1.0,4/9,21.37%,HOOK3;KIF3A;DCTN1;NIN
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.4622800450327603,1.033453425532547,0.45454545454545453,0.9702125556326253,1.0,46/252,16.10%,THBS1;RHOB;FGF1;SEMA3A;ENPP2;ANXA1;FRMD5;CEMIP;TTBK2;ADAM15;PTPRK;VEGFA;HSPA5;GPNMB;SEMA3B;ALOX15B;LAMB1;INSR;SEMA6A;SRCIN1;PTPRT;KANK1;TMEFF2;ROBO1;IGF1R;FGR;CARMIL1;NTRK3;SEMA5A;CAMK2B;FLT1;SASH1;MAGI2;EPHA4;SOD2;LIMCH1;CTNNA2;SERPINE2;PLXNB1;SDCBP;DUSP10;THY1;MCTP1;PHACTR1;LDB2;CLIC4
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.5360479627535003,1.0332599641409563,0.4444444444444444,0.9705234178653547,1.0,20/43,21.67%,P4HA3;ADAMTS2;COL11A1;COL4A5;COL26A1;COL23A1;COLGALT2;COL24A1;P4HA1;COL21A1;COL10A1;COL5A3;PLOD1;PLEC;CD151;COL19A1;COL16A1;P4HB;BMP1;PPIB
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.46946012592272196,1.0331366213617987,0.43434343434343436,0.9705556035600282,1.0,50/276,15.17%,GPR18;RHOB;TSHR;GRM8;FZD6;GNRHR;HTR7;PRKAR2B;CHRM5;RGS20;PDE10A;PRKCE;TACR1;PDE1A;PLPPR4;ANXA1;GNA11;DGKI;RGS1;ADGRE1;GPNMB;CD55;GRM3;MCHR2;LTB4R;NGEF;PDE1C;DGKB;PDE2A;ARHGEF4;C5AR1;PDE4B;ADCY8;RXFP1;CHRM3;CAMK2B;GPR65;RPS6KA2;KALRN;RIPK2;GNAI1;RGS11;DGKG;RGS17;GNAL;PLXNB1;ITSN1;GPR183;WNT5A;HTR1F
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.4935506366925529,-1.0328078924158726,0.3181818181818182,0.9344390941451206,1.0,2/15,1.05%,H2BC4;DNMT3A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.46259222969947855,1.0326330154818528,0.42857142857142855,0.9718913377253869,1.0,31/144,22.08%,CR1;SRGN;EIF2AK3;VAPB;ANK3;SYP;VPS11;ATP8B1;CAV3;DNM1;CLASP2;SNX10;GOLGA8B;SERP1;VMP1;HOOK3;REEP3;SPTBN5;TMED10;FAM174B;UBXN2B;SPTBN1;VPS51;SYNGR1;SUN2;SURF4;LRRK2;RAB30;DYNC2H1;BNIP1;HACE1
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,0.5601616186865975,1.032543170561667,0.4523809523809524,0.9718173186537037,1.0,7/27,16.45%,TPRG1;ANXA1;BHLHE40;FOSL2;NFKBIZ;IL18;GBP2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6163609018028091,1.0324362572440084,0.4788732394366197,0.9717715201512589,1.0,3/9,12.45%,SEMA3A;CHN1;EPHA4
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5079087954089533,1.0324260846527102,0.4625,0.9714301512815937,1.0,1/30,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.48395108984205343,1.0324195259207447,0.45054945054945056,0.9710855266357272,1.0,16/52,21.26%,HTR2B;SLC24A2;VAPB;ANK2;RYR2;SLC24A1;ATP2A2;SLC24A3;ATP1B3;KCNMA1;ATP1B2;ATP13A4;ATP1A2;SLC24A4;SLC9A1;RMDN3
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6651123465638049,1.0321117677273985,0.410958904109589,0.9718171889665291,1.0,2/8,7.02%,ALG10B;ABCA2
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,0.6394320802554466,1.031739544158316,0.47761194029850745,0.9727767694564905,1.0,4/8,21.77%,FTH1;COLEC12;HSP90B1;MSR1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6640228177144649,1.0316912468965302,0.5074626865671642,0.972562032508966,1.0,3/7,30.33%,DNA2;TOP3A;LIG3
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6931740479787332,1.0316669805182228,0.4444444444444444,0.9722561384428189,1.0,1/5,8.65%,CALM3
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5146702494750559,1.031416044707334,0.4666666666666667,0.9726983273597156,1.0,5/46,11.25%,HTR2B;NYAP2;IRS2;IGF1R;TYRO3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.5335901067471962,1.0314044638456676,0.4166666666666667,0.9723715572407992,1.0,9/31,24.88%,TIMM13;TOMM20;PINK1;GRPEL1;HSPD1;FBXO7;MFN2;TOMM40;TIMM22
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5819846805434622,1.0313835596452439,0.42028985507246375,0.9720941539827732,1.0,5/14,32.52%,SEC24C;MIA3;SEC31A;SEC23B;RAB1A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5353481207807285,1.0312881032059682,0.47619047619047616,0.9720694667629646,1.0,4/28,7.71%,THBS1;SPOCK1;ADAM15;KANK1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5277701215023247,1.0312199480900175,0.4074074074074074,0.9719536513676071,1.0,12/27,29.60%,PIGU;PIGQ;PIGF;ST6GALNAC5;ST8SIA3;PIGL;PIGG;B4GALT6;PIGA;LARGE1;MPPE1;SCCPDH
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.6643947671559326,1.031056499531016,0.4722222222222222,0.9721568172673721,1.0,5/7,33.11%,PRKAG2;PRKAA2;PPARGC1A;PRKAB2;MAPK14
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.5385085728348047,-1.030979821355276,0.36363636363636365,0.9386422252707126,1.0,4/9,12.46%,ABCG2;SLC38A1;ABCC4;GGT7
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,0.6438961393129496,1.0309393015162902,0.4864864864864865,0.9721916850101932,1.0,5/9,22.76%,RPS27A;UBA52;UBB;PGM1;GYS1
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,0.604497714352402,1.0308635505417456,0.4264705882352941,0.9720934638396389,1.0,3/7,22.47%,AMDHD2;GFPT1;GNPNAT1
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,0.6020512556967595,1.0307965771972436,0.4657534246575342,0.9719743158646655,1.0,2/11,15.15%,HMGB2;CASP3
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.5354816795506024,1.0306883511471017,0.4606741573033708,0.9720337061005433,1.0,4/35,13.26%,MAPT;INF2;PDE2A;PINK1
prerank,KEGG_2021_Human__Pathways in cancer,0.46486499411116294,1.030593306534221,0.43,0.9719986149840782,1.0,54/315,17.20%,DAPK2;HHIP;FGF1;ARAF;TGFB2;CKS2;FZD6;DCC;ZBTB16;ADCY3;GADD45B;ITGA2;IL15;COL4A5;AGT;GNA11;KITLG;VEGFA;LAMA2;RXRB;TRAF2;TCF7;IL7;LAMB1;RUNX1T1;RPS6KB2;DAPK1;HIF1A;ARNT2;PAX8;TCF7L1;FN1;CALM3;IGF1R;ALK;ADCY8;RBX1;CAMK2B;CYCS;GNAI1;APC2;CTNNA2;MAPK10;WNT5A;CASP3;ESR1;RASGRP4;CCND3;CTBP1;ITGAV;EPAS1;PLCB1;ROCK1;EGLN3
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5618743413460059,1.030584684689273,0.4430379746835443,0.9716523802085825,1.0,5/19,18.22%,KCNJ13;AKAP6;CHRM3;KCNJ6;KCNJ3
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.5565422897425711,1.030579236125009,0.4782608695652174,0.9712819446842941,1.0,6/24,12.45%,RELN;AGT;SRCIN1;GPRC5B;NTRK2;EPHA4
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6038627163355611,1.030545678989963,0.4927536231884058,0.9709956386735383,1.0,1/10,2.27%,GLA
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6665881565126455,1.0297391115584456,0.5074626865671642,0.9733567150725325,1.0,2/6,20.85%,PAX8;FGFR2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.6078734681833995,1.0296815348249904,0.4264705882352941,0.9731640932528095,1.0,3/13,24.78%,SCO2;SCO1;COX20
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.6627174744635886,1.029377550578626,0.4444444444444444,0.9738789250983466,1.0,1/7,5.16%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.612991816692989,-1.0293768893144621,0.4864864864864865,0.9419990533593571,1.0,1/5,3.78%,DAB2IP
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.6061645683467396,1.0290874053458927,0.527027027027027,0.9744606569806334,1.0,3/12,19.84%,SRSF12;SART3;PRPF6
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.5230016298611632,1.0290028667707152,0.47674418604651164,0.9743829056480485,1.0,6/31,16.18%,RXRB;KDM3A;ABCA1;KDM1A;PLTP;TBL1XR1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.6464016767768471,1.028585311904494,0.515625,0.9753439406566778,1.0,2/8,16.45%,SLC11A1;GBP2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.45639919254610506,-1.0284345316123467,0.3333333333333333,0.944010385175174,1.0,4/20,7.71%,NDE1;KIF3B;KIF1C;TRAK2
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,0.4919716562741383,1.0278938772661048,0.4479166666666667,0.9774505919750023,1.0,4/73,6.24%,PCSK1;H2BC11;KCNH8;NUP133
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.6402287532430581,1.02787627606645,0.4666666666666667,0.9771349483793837,1.0,2/7,7.92%,ACSS3;ACAT1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.5571225746322161,-1.0278510495212365,0.38235294117647056,0.9446108683825596,1.0,1/6,0.95%,ZNF703
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.581046477736636,1.027421358801489,0.5060240963855421,0.9781982938961103,1.0,9/19,23.66%,RPS27A;TOMM20;PINK1;UBA52;UBB;MTERF3;ATG5;MFN2;TOMM40
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.661384336992572,1.027298570484507,0.45714285714285713,0.9782062803701799,1.0,3/7,15.33%,CLASP2;DYNC1H1;CFL1
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.5761716927092259,1.0272678329627898,0.49333333333333335,0.9779637693526622,1.0,4/17,22.47%,GRIK1;PLCB1;GRIK4;GNB5
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.48016604139400637,1.0271199899184495,0.46153846153846156,0.9780274823820819,1.0,10/70,13.41%,EIF4A3;RIDA;ENC1;RTN1;EIF2AK3;DAPK1;PUS7;ZNF540;NTRK2;RNF139
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.37375978820021877,-1.0271087435893895,0.3333333333333333,0.9456691690964274,1.0,7/35,12.26%,CCL5;IL1B;CHUK;CGAS;IKBKB;NFKBIA;POLR3A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.514335119672543,1.0270592262934843,0.4631578947368421,0.9778964681854359,1.0,10/52,10.89%,TSHR;CD163;HTR7;PRKAR2B;ADCY3;FCGR2B;PLK2;FGR;ADCY8;RXFP1
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,0.5610301660436539,1.0270348806849028,0.44155844155844154,0.9776056991231753,1.0,5/21,10.46%,CD163;ADGRE1;GPNMB;FCGR2B;FCGR2C
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.6760124079980637,1.0265415353307354,0.581081081081081,0.9789026653035862,1.0,2/8,9.86%,P4HA3;P4HA1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.6664622096052127,1.0264863505853883,0.4794520547945205,0.9787020193074264,1.0,1/6,10.87%,NOD2
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.6710427217894626,1.0261531826146706,0.5616438356164384,0.9794422052017255,1.0,3/5,18.25%,SOD2;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5516788286018943,1.0261230374120356,0.4235294117647059,0.9791755801110273,1.0,2/23,4.86%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.4997692833269216,-1.0260164123735884,0.43478260869565216,0.9477119232758331,1.0,4/13,9.02%,TGFBR3;EGFL7;TGFB1;ENG
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.5380000697209607,1.0259640319530319,0.4235294117647059,0.9793670010281681,1.0,4/21,18.81%,FGF1;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.469574012163559,-1.0259428236770434,0.4375,0.9467934080181964,1.0,3/22,7.51%,FLNA;ZPR1;TGFB1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.6256998973760179,1.0259069116854826,0.5454545454545454,0.9792323598611027,1.0,3/12,20.38%,DGAT1;GK;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6778090278438196,1.02587805287252,0.4626865671641791,0.9789453211513107,1.0,4/6,17.07%,RELN;NRXN1;CAMK2B;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.6390221564391202,1.0258402308779806,0.4657534246575342,0.9787104681691106,1.0,2/8,10.26%,CARMIL1;SEMA5A
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.5120939435787308,-1.0256587553201046,0.4782608695652174,0.946778235598284,1.0,2/11,4.08%,POLD3;DDB2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.5179561228746304,1.0256006376688065,0.4222222222222222,0.9792550296458412,1.0,5/43,8.65%,THBS1;MAPT;NDRG1;HIF1A;CALM3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.6005903802003224,1.0255867993358587,0.5074626865671642,0.9789406118281152,1.0,3/10,15.56%,NTRK3;FLT1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.4911932558683837,1.025551279875428,0.42857142857142855,0.978699105273711,1.0,12/77,11.25%,TSHR;CR1;CD163;HTR7;PRKAR2B;ADCY3;FCGR2B;PLK2;FGR;ADCY8;RXFP1;TYRO3
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.6661423086560208,1.0254921849041685,0.5,0.978478537117882,1.0,1/7,0.62%,LRP2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.5811449324155095,1.0251442014741001,0.4583333333333333,0.97927134401239,1.0,4/10,28.16%,SLC19A2;DCK;TPK1;TYMP
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.5049801304897441,1.025079491312658,0.5,0.97913023158036,1.0,20/67,22.92%,THBS1;SYT4;NLGN1;CALM3;RYR2;KCNMB1;ADCY8;RYR3;SYT1;WNT5A;CLIC4;KCNMA1;IQGAP1;PRKAA2;ECT2;CPNE8;CPNE2;SYT11;CPNE3;TRPC1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.49131899678913743,-1.0249660824472198,0.4074074074074074,0.9475250162364549,1.0,1/14,1.69%,SLC30A5
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.6266023572257295,1.0249492316126407,0.4931506849315068,0.9792000075563725,1.0,2/12,8.80%,ITGA2;ITGAE
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.5683677977134587,1.0247303361875044,0.4868421052631579,0.9795702412276451,1.0,7/16,26.10%,SYT4;RIMS2;SYT1;RIMS3;SYT11;RIMS1;SYT9
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5978706428178627,1.0245693077871882,0.4935064935064935,0.9796605159537577,1.0,3/13,25.32%,ETFB;UQCRFS1;PPARGC1A
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.6108050474814644,1.024367440178158,0.5147058823529411,0.9799957820493782,1.0,2/8,5.56%,ALOX12;ALOX15B
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.48135522176719225,1.0239657083937646,0.45454545454545453,0.980917336762265,1.0,23/101,19.39%,PDE5A;PRKCE;ADCY3;CREB5;GNA11;RGS2;INSR;CALM3;IRS2;PDE2A;KCNMB1;ADCY8;GNAI1;GUCY1B1;ATP2A2;ATP1B3;KCNMA1;PLCB1;ROCK1;SLC25A4;ATP1B2;GNAQ;GUCY1A2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.6481965613251071,1.0238621333423845,0.5074626865671642,0.980920779214979,1.0,4/6,32.96%,RGCC;PTEN;MACROH2A1;ATF5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.5804123565194915,-1.0238389367653136,0.475,0.9495710432129112,1.0,2/6,9.02%,ABCG2;ENG
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4698475051694738,1.0237427367159213,0.44329896907216493,0.9810000672887977,1.0,64/233,24.35%,BRIP1;EEF1A2;RPL23;NR4A2;CLSPN;RPA2;RPL37A;RPS6KB2;RPL38;COPS5;PAX8;DNA2;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;DONSON;B4GALT5;RPS11;RPS20;RPL9;RPLP2;BRCA1;EEF1B2;RPS18;MRPL43;RPL37;RFC4;RPL14;POLE2;MRPL55;GCNT1;MRPL27;RPS4X;ORC6;RPL11;RPS24;POLR2D;RPS9;POLL;RPL36;DBF4;TIMELESS;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RBBP8;POLR2G;RPL32;TNIP1;EEF1A1;BARD1;RPL24;RPL27A;RPL3;RPA3;ORC3;RPS16;RPL30;MCM3
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.516851898055302,1.0236484247296116,0.4444444444444444,0.9809724589031266,1.0,8/23,24.09%,IL1RAPL1;FCGR2B;ZNF804A;CTNNA2;NTNG1;FBXO7;PTEN;BRSK1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.6472563181234394,1.0232535491892183,0.4714285714285714,0.9819714975642421,1.0,3/8,13.71%,STMN3;CKAP5;STMN2
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.632792397800321,1.02323565352855,0.4246575342465753,0.9816680441541372,1.0,2/9,15.12%,SCN3A;SCN2A
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,0.6028863970814564,1.0231894977248428,0.43478260869565216,0.9814474378635524,1.0,4/12,19.11%,ADAM15;PPP1R13L;HSPB1;CD151
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.5426809511212963,1.0230147150111164,0.3902439024390244,0.9816537029081646,1.0,4/20,18.81%,FGF1;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5216980815976394,-1.022780253921195,0.34782608695652173,0.9511289246704157,1.0,4/10,12.78%,CX3CR1;LGALS9;HLA-E;ARRB2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.6925273019235847,1.0227124975859287,0.5303030303030303,0.9819316636348542,1.0,5/7,30.45%,DNM3;DNM1;OPA1;MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.6925273019235847,1.0227124975859287,0.5303030303030303,0.9819316636348542,1.0,5/7,30.45%,DNM3;DNM1;OPA1;MX2;MX1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.5819366348036015,-1.0226561221936614,0.45161290322580644,0.9504187866985548,1.0,3/10,13.42%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6561713252034211,1.02245349978415,0.4788732394366197,0.9823609398766333,1.0,2/9,9.36%,PKP2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5636747372122429,1.0224131032988828,0.45454545454545453,0.9821164351985282,1.0,5/23,16.90%,SOX4;MYRIP;IRS2;ADCY8;C2CD2L
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.6218140787853147,1.022300445179831,0.4647887323943662,0.982095371094835,1.0,6/10,30.16%,BRCA1;CTBP1;TAF7;JARID2;MACROH2A1;SET
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.47489080581450555,-1.0221925129610654,0.3870967741935484,0.9506757838674987,1.0,4/11,11.55%,WHAMM;WASF3;CYFIP1;GSN
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.5782230327657245,1.0219557701998547,0.48717948717948717,0.9827678780821871,1.0,4/20,10.17%,PTPRZ1;HIF1A;PTN;ALK
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.6189605549732606,1.0219516828758244,0.5138888888888888,0.9824068023438705,1.0,3/12,17.76%,INPP4B;MTMR7;MTMR9
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.6739668353489237,1.0217084892434618,0.5352112676056338,0.9828419592222967,1.0,3/6,17.56%,IRS2;BCL6;FOXP1
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.38595027948564703,-1.0216992587499196,0.42857142857142855,0.9513043132595744,1.0,8/58,7.37%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;ELOC;TAF13;SUPT16H
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.5974624220029657,1.021670966991579,0.4745762711864407,0.9826148798927289,1.0,4/9,33.30%,GPR183;MYO1G;CD99;SLC12A2
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.3585585523774836,-1.021577217253144,0.2727272727272727,0.9508715442505002,1.0,6/46,7.96%,CASP7;BCL2L1;GZMB;TP53;BID;PPP1R13B
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,0.6169484191417945,1.0214107874945804,0.4788732394366197,0.9831559109726473,1.0,3/9,25.44%,TCP1;CCT8;CCT6B
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.6543751522155987,1.0213397883195043,0.5074626865671642,0.9829871434732611,1.0,2/5,28.76%,CPNE3;AGK
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5976230484525951,1.0212500107917717,0.5256410256410257,0.9829178486794268,1.0,3/12,16.59%,NRG1;HINFP;EPAS1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.49522449563374055,1.0212129593314776,0.43333333333333335,0.9827184760185237,1.0,5/44,12.03%,ACVR1B;SPDYA;RCC1;PLK2;HINFP
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.4774509115473553,1.0209256540810483,0.5,0.9833408167519208,1.0,15/141,12.75%,CENPF;TUBA4A;PRKAR2B;HAUS6;PPP2R3B;TUBB4A;FBXL7;CEP152;TUBA1A;XPO1;RPS27A;PSMB4;RBX1;DYNC1H1;CKAP5
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.512371022274124,-1.0207693314494743,0.35714285714285715,0.952034863551391,1.0,2/13,2.53%,CX3CR1;SELPLG
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.518708946996757,1.020670377578268,0.45454545454545453,0.9838463480194273,1.0,11/40,20.23%,MDH1;ENO2;PGAM1;IRS2;GPI;FBP1;SLC39A14;SORD;PGK1;PGM1;ENO1
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,0.6633204841952655,1.0206492696527032,0.463768115942029,0.983554495050548,1.0,4/9,18.81%,FZD6;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.6357830177212083,-1.0205405290541631,0.5116279069767442,0.9517945563240605,1.0,2/6,4.52%,LY86;SCIMP
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.47735306932485905,1.0204687713095515,0.5204081632653061,0.9837278920691928,1.0,15/142,12.75%,CENPF;TUBA4A;PRKAR2B;HAUS6;PPP2R3B;TUBB4A;FBXL7;CEP152;TUBA1A;XPO1;RPS27A;PSMB4;RBX1;DYNC1H1;CKAP5
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.3277742659883533,-1.0204600862083697,0.2,0.9510470065981783,1.0,22/76,14.51%,MYH9;WIPF3;YES1;ITPR2;NF2;FYN;SRC;PKN1;PLD2;NCKAP1L;WASF3;HCK;BTK;ABL1;FCGR1A;CRK;CYFIP1;ARPC2;NCK1;SYK;PLD4;CD247
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.5522337979428206,1.0202501959147978,0.5125,0.9840686457028283,1.0,5/23,14.24%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.6632178420737234,1.0201944851408178,0.5277777777777778,0.983917125261907,1.0,4/7,31.19%,CSRP1;FHOD3;TTN;ACTN2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.5563644951644453,-1.0201843887819784,0.42857142857142855,0.9507671067055368,1.0,4/8,24.37%,TMEM119;BHLHE41;HDAC5;NOTCH1
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,-0.5296791124510165,-1.0201746116655677,0.375,0.9497756915786278,1.0,2/9,1.00%,ITGAM;CX3CR1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.712405582344729,1.0200847521801084,0.45714285714285713,0.9838886769147167,1.0,1/5,13.85%,HOOK3
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.5736511016211441,1.0200155439454128,0.5,0.9837509934092691,1.0,1/13,1.94%,ASPA
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),-0.6512349402725557,-1.019976190417377,0.46875,0.9494156194206251,1.0,2/6,8.64%,CD300LF;MILR1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5664360656474651,1.0199426575408364,0.45569620253164556,0.9836646072697185,1.0,1/12,0.28%,THBS1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5775961872373541,1.0197597904730893,0.5,0.98386145815487,1.0,7/20,25.49%,RYR2;PDE4B;NR4A3;APLP1;LRRK2;SLC9A1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5442523189684856,1.0196581716867565,0.524390243902439,0.9838433042020449,1.0,10/33,26.55%,RPL23;CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.7138599877693945,1.0194488822719145,0.5217391304347826,0.9841319901356592,1.0,1/6,3.25%,CARNS1
prerank,Reactome_2022__RUNX3 Regulates BCL2L11 (BIM) Transcription R-HSA-8952158,-0.645940981391339,-1.0191110505295917,0.4722222222222222,0.9508055076387073,1.0,1/5,4.95%,RUNX3
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.5546351701714748,1.0186792907943272,0.5443037974683544,0.9863084461717949,1.0,5/22,14.24%,TUSC3;MGAT1;STT3B;MCFD2;MAGT1
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.6273786440250038,1.018494832699682,0.5135135135135135,0.9865278685140969,1.0,1/9,3.38%,DOCK1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.6733671278802752,1.0184729116694886,0.5483870967741935,0.986226104268685,1.0,2/5,15.83%,ANXA1;IL18
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.49449054393179215,-1.0182846514186012,0.3548387096774194,0.9521515517598954,1.0,1/8,1.79%,SIDT1
prerank,KEGG_2021_Human__PPAR signaling pathway,0.5259232106720299,1.0182384576031906,0.5057471264367817,0.986632620734929,1.0,10/40,14.89%,PLIN2;ACSL1;RXRB;SCD5;CPT1A;SORBS1;PLTP;SCD;GK;HMGCS1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5632183649499887,1.0181853583426175,0.4788732394366197,0.9865011843671084,1.0,1/16,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6562340343857878,1.0181837341102882,0.5074626865671642,0.9861351356901632,1.0,2/6,21.19%,DBF4;WIZ
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,0.7168179825494571,1.0181574557864075,0.5303030303030303,0.9858849697932656,1.0,1/5,4.09%,ENTPD3
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.33341656127977115,-1.0181055371131762,0.3333333333333333,0.9516673982124484,1.0,27/89,13.95%,ITGAM;GIMAP8;BIN2;SAMSN1;MPEG1;LGALS9;CSF1R;ABI3;ARHGDIB;RASAL3;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;HLA-DPA1;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,KEGG_2021_Human__Steroid biosynthesis,0.5910353259402583,1.0178807731661297,0.5625,0.9863351977335029,1.0,3/12,19.17%,TM7SF2;FDFT1;MSMO1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,0.6599125890968851,1.0177997688286526,0.5,0.9861734861817683,1.0,2/5,15.39%,ALCAM;THY1
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.4056959359875496,-1.017766197683994,0.5,0.951538451886805,1.0,6/46,12.08%,RFX5;NFYC;PSME3;HLA-E;HLA-DPA1;HSPA1A
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5902894020174455,-1.0176647795889964,0.48717948717948717,0.950838192054208,1.0,1/5,6.50%,TP53
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.6650817783301815,1.0174166771443038,0.5342465753424658,0.9870478424445822,1.0,3/5,20.93%,SGIP1;NR4A3;LEPR
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.5646034537597435,-1.0173512016572621,0.42857142857142855,0.950710371089651,1.0,3/5,30.22%,CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4988302808937872,1.017345350600415,0.46808510638297873,0.9869301255429003,1.0,7/50,9.23%,FBN2;ACVR2A;BMPR1B;RORB;NOCT;RANBP3L;LIMD1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),-0.615528420790109,-1.0170446955589583,0.4857142857142857,0.9506643000025303,1.0,1/6,2.23%,IL1B
prerank,KEGG_2021_Human__One carbon pool by folate,-0.533212179092158,-1.0170142360248162,0.45454545454545453,0.9498178776704884,1.0,3/13,11.72%,MTHFD2L;MTHFD1L;TYMS
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.5592738367499637,1.0169349316480776,0.5238095238095238,0.9878476767057006,1.0,7/20,18.90%,CR1;TCF7;IL7;PRELID1;FANCA;SOD1;RHOH
prerank,KEGG_2021_Human__Phagosome,0.4700174464752019,1.0169007819493363,0.4742268041237113,0.9876245747534806,1.0,10/108,5.91%,THBS1;RAB7B;TUBA4A;ITGA2;TFRC;TUBB4A;TUBA1A;FCGR2B;SEC61B;TUBB6
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.6817799261400842,1.0167417176024138,0.5797101449275363,0.987778097089658,1.0,4/6,29.72%,TXN;GUCY1B1;KCNC2;FOXO1
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.3473435728118761,-1.0167323736431655,0.42857142857142855,0.9495559765146945,1.0,8/53,12.07%,CCL5;CHUK;MAP3K14;MAPK13;SRC;IKBKB;NFKBIA;EGFR
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5639550983662965,1.0167214639861124,0.5119047619047619,0.9874975512930202,1.0,5/16,21.87%,INSR;IRS2;SORBS1;CLTCL1;APPL1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5415769909057807,1.0163314940317343,0.4878048780487805,0.9883830347127245,1.0,2/24,6.40%,IDI1;MVD
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.7018074739579374,1.0162784672909408,0.5211267605633803,0.9882074934098287,1.0,2/5,16.76%,TENT4B;SND1
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.543811236647534,1.0161531630212315,0.449438202247191,0.9881980209351735,1.0,4/26,14.36%,BRIP1;DNA2;BRCA1;RFC4
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.6768551931652211,1.0158778902008432,0.5915492957746479,0.9888622226696303,1.0,2/5,26.61%,RNF169;UBR5
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4606263969663592,-1.0158424216249708,0.3888888888888889,0.9508515906702937,1.0,4/18,9.03%,CYB5A;CYP2S1;ST6GAL1;CYB5R3
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.6084092324282898,1.0156565935568735,0.5135135135135135,0.9892552130179642,1.0,2/12,6.90%,SLC4A10;CA2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.6894956380446616,1.0155948828444248,0.463768115942029,0.989103288327814,1.0,1/6,12.40%,ACAD9
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5490121457851975,1.0155911424940556,0.5125,0.9887519662598498,1.0,6/20,14.32%,MAPT;TFRC;BNIP3;PINK1;PRELID1;TMEM14A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5172295892004136,1.0153661955892392,0.45977011494252873,0.9891344217312689,1.0,3/26,8.95%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5130388475665723,-1.0151049427705106,0.4634146341463415,0.9519416616207534,1.0,4/10,4.38%,ABCG2;FOLR2;SLC46A1;SLC2A8
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.47067160215839,1.0149597041187022,0.4421052631578947,0.9899829004908228,1.0,25/103,22.05%,PAPPA2;GFAP;SPOCK1;CD22;TFRC;AGT;ATAD3A;TRAF2;HCFC1;ERMN;ARFGAP1;NRG3;PAK5;PINK1;PICALM;WNT5A;SNX17;ROCK1;CHPT1;HIP1R;TNF;METTL4;IRAK3;HNRNPU;RAB5A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.630918781640704,1.0149153475724086,0.463768115942029,0.9897431093518106,1.0,4/11,6.56%,CACNB2;CEMIP;ANK2;AKAP6
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6126583072189198,1.0149087449075638,0.47619047619047616,0.9893988222924233,1.0,3/9,15.39%,RORB;VEGFA;THY1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.5789942095652694,1.014696297569744,0.475,0.9897399728433163,1.0,3/13,9.50%,LRP2;VEGFA;KDM1A
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6248472286244404,1.0143325520418998,0.5569620253164557,0.9904992543192301,1.0,2/10,13.64%,VGF;TRIM16
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.6501292329397319,1.0143058308481063,0.5342465753424658,0.990212406794441,1.0,3/7,12.37%,AGTPBP1;FAIM2;GRID2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.6682115686034039,1.014070889224962,0.5194805194805194,0.9907079737953999,1.0,2/6,21.55%,PINK1;ATP5IF1
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.4379154378169525,-1.0137782300692033,0.4090909090909091,0.9543265511832764,1.0,5/17,16.26%,CPSF1;WDR33;CSTF1;CPSF2;CPSF4
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5093640731821487,1.0137387480380657,0.47191011235955055,0.9913750631060938,1.0,6/45,19.15%,KLF4;POLG2;RFC4;TCP1;RGCC;PARM1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.6453436451338254,1.013652835093085,0.5135135135135135,0.9912465571425655,1.0,1/7,2.61%,EIF4A3
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.5086984393586271,1.013636891441754,0.5161290322580645,0.9909059709840394,1.0,5/64,6.47%,KNSTRN;CENPE;TEX14;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6569676210260907,1.013392019383733,0.5285714285714286,0.9913332230226121,1.0,4/7,29.78%,GRIPAP1;RAB11A;GRIP1;ARHGAP44
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,0.686245636754134,1.0133539116719228,0.5846153846153846,0.9910668934345191,1.0,3/5,18.81%,RPS27A;UBA52;UBB
prerank,KEGG_2021_Human__Homologous recombination,0.5090316154486618,1.013314266361216,0.5057471264367817,0.9908579497539503,1.0,5/30,13.06%,BRIP1;RPA2;SYCP3;BRCA1;XRCC3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4886463819686297,1.01331141729069,0.43956043956043955,0.9904978284556251,1.0,14/73,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.6693928650366363,1.0132542001079947,0.5625,0.9903094167499206,1.0,1/5,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6542814248283417,1.0132497766667607,0.5344827586206896,0.9899665627639841,1.0,1/8,10.28%,ERRFI1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.4862330919999768,1.0131109168660493,0.494949494949495,0.9900472208020102,1.0,26/113,20.93%,SOCS3;NDUFA2;NDUFB9;TRAF2;EIF2AK3;INSR;IRS2;COX7A2;NDUFA3;NDUFS8;PRKAG2;COX7C;CYCS;MAPK10;NDUFB6;CASP3;UQCRFS1;UQCRC1;TNFRSF1A;PRKAA2;PPARA;FOS;CYC1;TNF;COX4I1;LEPR
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Undefined,-0.61179742386122,-1.0130920527153873,0.4666666666666667,0.9551003751528915,1.0,3/7,11.22%,TLR3;CLEC9A;TLR7
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.606081517979264,1.0130644585370387,0.47368421052631576,0.9898726131273856,1.0,5/13,13.52%,ANK2;AKAP6;CALM3;RYR2;VMP1
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.5707727898075727,1.0129532627828786,0.475,0.9898559006815243,1.0,8/14,25.30%,SNAP25;PPFIA2;SYT1;CPLX1;PPFIA4;TSPOAP1;PPFIA3;RIMS1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.4947995259456511,-1.0129188845030181,0.4,0.9547534950635708,1.0,3/10,13.23%,ITGAM;ITGB2;SYK
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.5807558236136424,1.012825416146272,0.4492753623188406,0.9899163775134205,1.0,4/15,28.45%,SCO2;SCO1;COX20;COA6
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.6692361113128077,1.0127686977937773,0.578125,0.9897353007884021,1.0,1/5,11.64%,ALDH6A1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.6692794607382309,1.0126056451558232,0.5362318840579711,0.9899332533180005,1.0,2/7,15.06%,ARIH2;WNT5A
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.6205363151665364,1.0123029655120277,0.49230769230769234,0.9905869117362844,1.0,2/8,20.85%,RGS2;FGFR2
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.49827854787334647,1.012107926900516,0.5,0.990744200887872,1.0,12/36,31.18%,TIMM13;TOMM20;PMPCA;GRPEL1;HSPD1;FBXO7;MFN2;TOMM40;TIMM22;AGK;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6026779420791103,1.012084873062217,0.4857142857142857,0.9904391587753176,1.0,5/10,33.92%,PAICS;PFAS;IMPDH1;PPAT;GART
prerank,KEGG_2021_Human__Focal adhesion,0.47331438519765734,1.012050255205042,0.4222222222222222,0.9901979547212333,1.0,14/124,9.79%,TNC;THBS1;ITGA2;RELN;COL4A5;DOCK1;VEGFA;LAMA2;LAMB1;CAV3;FN1;SHC2;IGF1R;ITGB8
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,0.6156685188734851,1.011903211256065,0.5526315789473685,0.9902179887352786,1.0,4/10,21.49%,PDK4;PDK3;PDHB;PDPR
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.5935901817001806,1.0118995468745016,0.4805194805194805,0.9898632867616667,1.0,4/12,18.81%,RPS27A;NEURL1;UBA52;UBB
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,0.5602597807688475,1.0118227203030092,0.5,0.9897195474683386,1.0,7/20,20.36%,CLSPN;DPYSL5;POU5F1;GINS1;PRR11;ORC6;HELLS
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.5390702028289655,1.0115942270352223,0.4943820224719101,0.9901308985122745,1.0,14/31,30.58%,SLF1;FANCB;SPIRE2;FMN2;ZCWPW1;ERCC6;TIMELESS;KMT5C;SPIDR;ARID2;PARP9;WDR48;RIF1;PRKDC
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.37930533446844306,-1.0115688414379123,0.3333333333333333,0.9570877541164462,1.0,7/31,5.44%,GRAP2;CX3CR1;GNLY;TAL1;LYL1;P2RX1;P2RY13
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.5324671879655017,1.0115189175425454,0.4883720930232558,0.9899504037217262,1.0,8/25,21.98%,ATP5ME;ATP5F1A;ATP5F1D;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5635049181890139,1.0114750157658945,0.5217391304347826,0.989726609446058,1.0,7/15,25.30%,NLGN1;RIMS2;RIMS3;PREPL;LRRK2;RAB5A;RIMS1
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.5657782642803848,1.0114400799744423,0.46835443037974683,0.9894328459491318,1.0,2/19,10.81%,PRKAR2B;ADCY8
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5796101724347025,1.011351092065573,0.46987951807228917,0.9893529550378667,1.0,5/17,18.81%,RPS27A;RNF139;SYVN1;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),0.5943638962517253,1.0113082044820834,0.47761194029850745,0.9891329598601346,1.0,2/10,12.87%,RAPGEF3;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4798107350756488,1.0110060262746665,0.5054945054945055,0.989847200976339,1.0,20/84,20.20%,CENPE;RELN;SPDYA;CAMK2N1;CAV3;GSKIP;DEPTOR;FGR;C5AR1;PRKAG2;PPM1E;THY1;IQGAP1;HSPB1;GSTP1;SOD1;GNAQ;TAF7;ECT2;TNF
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.5202875321288893,-1.0108393772292859,0.4117647058823529,0.9582600409681477,1.0,5/12,12.56%,INPP5E;OCRL;PI4KB;VAC14;PI4KA
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.42681908721666995,-1.0107910727348315,0.4375,0.9574674088644143,1.0,3/18,11.59%,SLC46A1;UCP2;HVCN1
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.36854249975304565,-1.0107382171628745,0.42857142857142855,0.9566226850134137,1.0,15/54,14.51%,MYH9;WIPF3;NF2;PKN1;NCKAP1L;WASF3;BTK;ABL1;FCGR1A;CRK;CYFIP1;ARPC2;NCK1;SYK;CD247
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.5326225026531641,1.0104234573143902,0.4268292682926829,0.9913779417997013,1.0,5/21,20.85%,FGF1;RPS27A;UBA52;UBB;FGFR2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.5193509572762988,-1.0102418607132124,0.45161290322580644,0.9570406453135993,1.0,2/11,11.72%,POLD3;TYMS
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,-0.5357561757433579,-1.0098994615280854,0.4482758620689655,0.9559328796149907,1.0,4/6,16.14%,ITGB2;PRF1;BCL2;FAS
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,-0.5357561757433579,-1.0098994615280854,0.4482758620689655,0.9559328796149907,1.0,4/6,16.14%,ITGB2;PRF1;BCL2;FAS
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.49341955567792783,1.0098246212340278,0.47191011235955055,0.9930142432830524,1.0,4/48,9.06%,THBS1;AGT;TRAF2;DEPTOR
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.46871220289405013,-1.0097720058334165,0.4090909090909091,0.9553740021367848,1.0,5/13,16.68%,CLTB;CLTA;ARRB2;DVL2;PRKCA
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,0.6217131622096389,1.0094684972448915,0.5641025641025641,0.9938262651003856,1.0,1/10,2.03%,ACSL1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.6262242922200166,1.0094681895970237,0.5128205128205128,0.9934651363703346,1.0,1/8,0.28%,THBS1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.5001570302575549,-1.0093157681750593,0.4117647058823529,0.9557781720945668,1.0,3/9,10.46%,IL1B;ZDHHC21;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.6698285229548258,1.00928642681536,0.5396825396825397,0.9936437182547312,1.0,3/5,20.85%,PTPRK;KLF9;FGFR2
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,0.6252576513756599,1.009194784768796,0.4375,0.9935558729767071,1.0,1/6,1.27%,NAPSB
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.4908473505333986,1.0091586991520987,0.43157894736842106,0.993334991063397,1.0,11/59,18.81%,TLE1;CNTN1;HIF1A;RBPJ;RPS27A;RBX1;CCNC;TBL1XR1;NEURL1;UBA52;UBB
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.41726087261024936,-1.0090994094336094,0.21428571428571427,0.955634322724586,1.0,6/28,9.99%,RAB22A;PLEKHJ1;LAPTM4B;LAMTOR1;WASHC5;CHMP2B
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,0.5301887333308505,1.0089052662707498,0.42105263157894735,0.9937429406711175,1.0,1/23,0.24%,TNC
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,0.6488025936094679,1.0088877243900123,0.5070422535211268,0.9934689495985126,1.0,4/8,22.05%,RPS27A;UBA52;UBB;RAB5A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.45496256086685816,1.0088810618621638,0.5102040816326531,0.9931353271817451,1.0,47/153,26.89%,RPL23;EIF4A3;RPL37A;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;TENT4B;RPS11;RPS20;EIF3E;RPL9;UPF3A;RPLP2;RPS18;RPL37;RPL14;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;PYM1;UBA52;SAMD4A;RPS3A;RPL35;RPL4;POLR2G;RPL32;MRTO4;RPL24;RPL27A;CNOT6;RPL3;RPS16;RPL30;PAN2;RPL21;RPL7;RPL12;RPL10A;RPS12;CNOT7
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5424545532588225,1.0088505860205534,0.52,0.9928517868971348,1.0,3/16,15.83%,IL15;NOD2;IL18
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.4979501156765487,-1.0087874148972038,0.45161290322580644,0.9554640999558468,1.0,2/10,10.32%,CST7;TREM2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.6474325707355325,1.0087691542685755,0.5,0.9928042773036241,1.0,5/8,30.47%,ADCY8;CORO2B;MACROH2A1;CRHBP;EIF4G1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.3951392412415037,-1.0087584273151309,0.391304347826087,0.954588303949614,1.0,5/22,12.58%,ST6GALNAC3;EGFL7;NPL;ST6GAL1;ST8SIA4
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.33474929829862105,-1.008682156862822,0.2727272727272727,0.9537808112192733,1.0,19/73,13.61%,CD300LF;ITGAM;LY86;PTAFR;BIN2;MPEG1;ICAM1;ITGAX;AOAH;MYO1F;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4855385989047832,1.0085017142644102,0.46153846153846156,0.993291367055561,1.0,14/75,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,Reactome_2022__Metabolism R-HSA-1430728,0.45319876013476434,1.0084917691801643,0.47,0.9929682493251686,1.0,298/1290,22.98%,FA2H;HS3ST5;SLC51A;BRIP1;GDPD1;PLPP3;NAMPT;OMD;LRP2;MDH1;AANAT;HS3ST2;NUDT12;ALDH3B1;PLIN2;OGN;CHST7;NDUFA2;SULT4A1;KMO;FOLH1;ASPA;DPYD;CBR1;RPL23;PRKAR2B;ACSL1;ENPP2;TM7SF2;CYP3A5;NMRAL1;PFKM;IDI1;GLYATL1;TACR1;CKMT2;NUDT16;CACNB2;SLCO1A2;NCAN;ERCC2;SLC2A3;CARNS1;VCAN;CD163L1;TALDO1;NUDT4;RIDA;B4GAT1;ITPKC;GPC5;NDUFB9;FAH;GNA11;ENTPD3;FAAH2;CEMIP;ALOX12;SEPSECS;PIAS4;RPL37A;RXRB;PDK4;ALOX15B;ENO2;MBOAT2;PAPSS2;INPP4B;DGAT1;ETFB;SCO2;VAPB;GNS;NUP133;NUDT13;MVD;ACSS3;RPL38;CA2;MTMR7;SLC19A2;MAT2A;PPOX;ACOT13;SNAP25;ARNT2;AFMID;PAICS;RAPGEF3;SCD5;SBDS;FLVCR1;RPS6;BLVRB;ATAT1;ABCA1;MID1IP1;ASRGL1;RPS27A;RPL23A;CSPG5;CKB;GLUL;MFSD2A;ELOVL4;AKR1B1;RPS25;DARS1;SELENOI;NDUFA3;RPS27;OSBPL10;SH3D19;ADCY8;LIPE;ARSA;CRYL1;RDH11;PSMB4;CHRM3;SEC24C;NDUFS8;SLC25A28;B4GALT5;CPT1A;AGPS;PRKAG2;PFKFB4;COQ6;HS6ST3;UCKL1;ALDH6A1;RPS11;GALC;RPS20;COX7C;CCNC;RPL9;L2HGDH;CIAO3;CMPK1;ACAD9;CYCS;ARG2;FBP1;RPLP2;GNAI1;SLC44A5;SLC10A1;PKM;PPM1L;PPA1;UGT8;SPTLC2;FASN;INSIG1;SCD;DMGDH;RPL37;STARD5;HOOK3;HSD17B12;GK;FDFT1;ATP5ME;ALDH1A1;RPL14;PHKG1;NDUFB6;HMGCS1;HS2ST1;DCK;SMARCD3;LTA4H;PDK3;PFAS;NAT8L;NDST3;PEMT;SEH1L;UGCG;ATP5F1A;RPS4X;UQCRFS1;SLC25A21;TBL1XR1;SUMF2;CACNA1A;PNPLA8;ATP5F1D;RPL11;UQCRC1;CARNMT1;RPS24;IQGAP1;PRKD3;PLCB1;ETNPPL;RPS9;TIMMDC1;PLD3;NPRL2;DDHD1;GSTP1;SUMF1;RPL36;PIK3R4;MTMR9;UPP2;CHPT1;SCO1;SLC16A3;ADH5;PRKAA2;SLC16A1;MPC2;NDUFAF4;HPRT1;ALAD;PNPLA7;UBA52;GUK1;PCNX4;GBA3;UBB;GNAQ;PSMC2;NMNAT2;PPARA;PSMA3;MSMO1;B3GAT1;NME4;TNFRSF21;SORD;ACSL3;SLC44A1;ATP5MC1;UCK2;PGM2L1;CYP46A1;RPS3A;PGK1;SLC3A2;CTPS1;OSBPL5;AK5;PGM1;ENO1;PSMB2;STS;CDS2;NR1D1;COX4I1;GPAT4;NPAS2;AUH;PIPOX;AHCY;ACACB;RPL35;RPL4;ECSIT;SLC5A6;SLC9A1;PDHB;RPL32;PSMD5;CNDP2;PDPR;SERINC5;MED11;ABCB4;MTHFD1;ATP5PB;COQ2;PSMD7;ATP5F1E;CHST12;GSTM3;RAB5A;GPD2;PLEKHA3;GNB5;CDK19;DBI;TMLHE;CPNE3;COX6C;TSPOAP1;RPL27A;GYS1;NDC1;RPL3;RORA;GAA;LPCAT4;ISCU
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5874333916607123,1.0084014412367304,0.5405405405405406,0.9929041597873061,1.0,4/11,21.23%,NLGN1;KIF5A;SPG11;KIF5C
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.590540478428311,1.008226152644225,0.4935064935064935,0.9931154006735288,1.0,3/14,23.37%,PPP2R3B;ORC6;ORC3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.480174915632917,1.0082139027466779,0.4948453608247423,0.99278275073627,1.0,20/80,23.02%,FA2H;CYP3A5;CKMT2;ALOX12;CKB;CPT1A;FASN;PNPLA8;SLC16A3;SLC16A1;HACL1;PPARA;MSMO1;SCPEP1;ACSL3;SLC5A6;PDHB;BTD;ALDH1A2;ECHDC3
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.682625464192177,1.0081837082629883,0.576271186440678,0.9925000554836331,1.0,1/5,5.16%,SOX4
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.3169303287019351,-1.0081462448914604,0.6,0.954197840579269,1.0,7/88,6.66%,RALB;GTF2F1;IDE;ACTB;BTBD1;NVL;TRIB3
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.5850237465178776,1.0076994283378427,0.5324675324675324,0.9936223102023208,1.0,2/13,10.81%,PRKAR2B;ADCY8
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.5590858070681922,1.0076637880190338,0.4642857142857143,0.993372634724334,1.0,5/20,22.96%,NR4A2;PIAS4;ESR1;PPARA;RORA
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6550933916033642,1.007629460612825,0.5245901639344263,0.9930933434053513,1.0,2/5,8.84%,DMD;TXN
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.6266017137175101,1.0075001393630714,0.5211267605633803,0.9931749882774277,1.0,4/9,16.59%,HIF1A;COPS9;RPL11;EPAS1
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,-0.4664231267963923,-1.0071250028213348,0.4,0.9555833801153599,1.0,5/17,13.33%,GCLC;HPGDS;GSTM4;GGT7;GCLM
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.5327847045733739,1.0069696574651672,0.45348837209302323,0.994530268501419,1.0,9/24,28.64%,ATP8B1;ABCA1;MFSD2A;ATP10B;ABCB4;ATP10A;ATP8A2;ATP9A;ATP11A
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.5823593047704287,1.006875676975216,0.4794520547945205,0.994479051960938,1.0,4/14,13.96%,VEGFA;ARNT2;HINFP;PKD1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.6065803020336157,1.0068171283441159,0.5571428571428572,0.9942658827329844,1.0,3/10,22.07%,FOXP1;FES;CTNNBIP1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.689484802888588,1.0066935843821205,0.5538461538461539,0.9942974164022473,1.0,1/5,2.79%,MAPT
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.5620532015456322,1.0063581556725731,0.49382716049382713,0.9950656141141944,1.0,4/18,15.43%,DNAH11;MMP21;CCDC39;ENKUR
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6291204365901414,1.0062487844750079,0.5405405405405406,0.9950076738487532,1.0,1/8,0.28%,THBS1
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,0.57120330047177,1.0062465997655718,0.5694444444444444,0.9946559730591202,1.0,3/19,4.92%,CLEC4E;CLEC12A;F13A1
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,0.6446505859898982,1.0061855551049526,0.47368421052631576,0.9945025231092042,1.0,1/6,1.62%,VIM
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6468213968545736,1.0058703449895714,0.5,0.9951969682882337,1.0,3/8,9.58%,NCAN;VCAN;CSPG5
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5839770240732465,1.0058513202039747,0.5405405405405406,0.9948917451515501,1.0,2/9,17.54%,RNF13;GSTP1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.5309980468038695,-1.005836232995358,0.4857142857142857,0.9577355139140037,1.0,1/7,8.84%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.6854884522381202,1.0058163523760721,0.5526315789473685,0.9946460767346142,1.0,2/5,21.55%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.488314641566478,1.005738605238116,0.47191011235955055,0.9945719361551459,1.0,14/64,19.88%,KNSTRN;NUDT16;RACGAP1;IHO1;RCC1;MAP9;CALM3;PLK2;DYNC1H1;KIF11;SND1;PIK3R4;DBF4;ECT2
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.6584688687544132,-1.0054680949134482,0.5666666666666667,0.9578822498774838,1.0,1/5,10.32%,TREM2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.6317825425609447,1.005339814977333,0.47297297297297297,0.9955189987169345,1.0,3/8,20.19%,ENTPD3;CMPK1;AK5
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4466789230996092,1.0053134423539802,0.49,0.9952601983278756,1.0,45/162,25.39%,RPL23;RIOK2;WDR12;WDR74;RPL37A;PES1;IMP3;RPL38;XPO1;SBDS;RPS6;RRP1B;RPL23A;GLUL;RPS25;RPS27;RRP36;HEATR3;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;PAK1IP1;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5768457807749379,1.0052314744087172,0.5064935064935064,0.9951464171070834,1.0,1/13,3.76%,ITPKC
prerank,KEGG_2021_Human__Protein digestion and absorption,0.5003013084072166,1.0050088419091432,0.4945054945054945,0.9954670615542669,1.0,17/42,20.96%,SLC16A10;COL11A1;KCNJ13;COL4A5;COL26A1;COL23A1;COL24A1;MEP1B;COL21A1;COL10A1;COL5A3;ATP1B3;ATP1B2;COL19A1;SLC3A2;ATP1A2;COL16A1
prerank,CellMarker_Augmented_2021__M2 macrophage:Undefined,0.6288387900875798,1.004913416344873,0.6060606060606061,0.995376312889216,1.0,1/6,1.70%,CD163
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.6395877742860033,1.0047525378091964,0.5238095238095238,0.9955684080125378,1.0,3/5,31.33%,GRM5;PRNP;GOPC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6762692063114404,1.0046213693575545,0.5846153846153846,0.9955237053202872,1.0,1/5,8.27%,SPRY1
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,0.6943296512949334,1.0046155826670111,0.5774647887323944,0.9951833156239703,1.0,1/5,9.28%,IRS2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.6398289353088975,1.004539714664424,0.5217391304347826,0.9950139685239963,1.0,2/8,7.69%,CHI3L1;PTPRT
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,0.49128250940615303,1.0043599179474956,0.5061728395061729,0.9951271162946714,1.0,10/29,24.87%,NFIX;LDB3;NRXN3;KCNMB1;SLC24A3;GBP2;PIPOX;BCL11A;VSNL1;DIXDC1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.5620560687529516,1.0042794385048106,0.44594594594594594,0.9950235553400294,1.0,10/20,27.66%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.49003901731208,1.0041837642653908,0.4888888888888889,0.9949791276535537,1.0,12/44,16.26%,TGFB2;AGT;ANK2;CAV3;CALM3;RYR2;CELF2;FXYD7;RYR3;ASPH;ATP2A2;ATP1B3
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.6871833839918946,1.0040394623755622,0.49295774647887325,0.994752661538224,1.0,5/5,31.31%,PDK4;PDK3;PDPR;PDP1;PDK1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.6871833839918946,1.0040394623755622,0.49295774647887325,0.994752661538224,1.0,5/5,31.31%,PDK4;PDK3;PDPR;PDP1;PDK1
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.495473658122354,1.0039910974749109,0.4431818181818182,0.9945379460683591,1.0,16/73,12.29%,GPR18;TSHR;GNRHR;HTR7;CHRM5;TACR1;PLPPR4;ANXA1;GPNMB;MCHR2;LTB4R;C5AR1;RXFP1;CHRM3;GPR65;RIPK2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5623391453556729,1.0039844196993986,0.5,0.9942152637806979,1.0,5/19,6.41%,PIGU;ARF6;PTPRK;PRRT1;ANK2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4875604190425136,1.003954388733403,0.5280898876404494,0.9939615913056409,1.0,15/68,19.68%,ASPN;LRP2;ACVR2A;BMPR1B;VASN;SPRY1;RPS27A;MAGI2;PEG10;VWC2;SMAD1;UBA52;UBB;PPARA;SMAD5
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.6410416464544743,1.0038015159242932,0.5714285714285714,0.9941500943895285,1.0,3/7,19.35%,POLQ;POLL;MLH1
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.49423483836067256,1.0037507175238543,0.5113636363636364,0.9939849936239893,1.0,9/46,10.61%,CACNB2;PCDH15;SLC26A5;BSN;SYP;SNAP25;OTOGL;KCNMB1;SPTAN1
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.46619226115545515,1.003699200890555,0.45918367346938777,0.9937872937493638,1.0,47/185,24.35%,BRIP1;CENPF;CENPE;PPP2R5B;H2BC11;CLSPN;PIAS4;PPP2R5A;NUP133;PCBP4;XPO1;DNA2;CENPP;RPS27A;RPS27;PSMB4;CLASP2;DYNC1H1;CKAP5;BRCA1;CENPK;CENPI;RFC4;INCENP;SEH1L;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;CDKN1B;RBBP8;PSMD5;PSMD7;BARD1;ITGB3BP;RPA3;ORC3;DSN1;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5633546845862423,1.0036591331321847,0.5714285714285714,0.9935504885995039,1.0,7/16,16.10%,ANXA1;ST14;TXNIP;WNT5A;CASP3;UGCG;CLIC4
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5429706263132487,1.0036395678259542,0.5308641975308642,0.9932451957568467,1.0,6/31,13.53%,TM7SF2;FAXDC2;ALOX12;ALOX15B;PRKAG2;INSIG1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3728655738936488,-1.0034914701296531,0.3076923076923077,0.9624239242985552,1.0,9/59,8.38%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.3451502533319707,-1.0034323205668048,0.42857142857142855,0.961639870473099,1.0,3/67,3.31%,RING1;NUP42;PMEPA1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.5362484030373411,1.0032458476677193,0.5411764705882353,0.9941330122279867,1.0,9/24,12.37%,ABHD12B;FAM124A;GABRB3;FLVCR1;POU5F1;TYRO3;ZNF850;L2HGDH;GRID2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.4819669598909782,1.0032053786993047,0.47368421052631576,0.9939257403324547,1.0,6/62,8.60%,RHOBTB3;RHOB;GPM6B;EPHA3;RND3;RAPGEF3
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5796487543057703,1.0030185384077943,0.5135135135135135,0.9941039885028504,1.0,3/12,17.16%,ROBO2;ROBO1;ROCK1
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.357707083001071,-1.003009545991043,0.5,0.9616765394843475,1.0,8/35,8.84%,CLTB;EFNB2;YES1;CLTA;APH1A;FYN;SRC;EPHB3
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.46930848165806716,1.0029187607469539,0.47126436781609193,0.9940535803937995,1.0,14/60,20.94%,HTR2B;SOX4;GPNMB;TRAF2;BNIP3L;IMPACT;TNFRSF1B;BNIP3;PINK1;DUS2;HSPA1B;NPAS2;LRRK2;ATG5
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,-0.36791603016430957,-1.0029005493290055,0.6,0.9610136014647128,1.0,15/41,13.71%,TAL1;LYL1;GIMAP8;GYPC;P2RX1;P2RY13;P2RY12;TM6SF1;CLEC9A;PTGS1;TREML1;TYROBP;MMRN1;PLVAP;SCARF1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4776582276650597,1.0025094249975193,0.5,0.9949528990050447,1.0,17/68,24.06%,KLF4;FBXL7;GPNMB;FHL1;PSMB4;RBX1;E2F7;RGCC;PSMC2;PSMA3;PSMB2;RBL2;PSMD5;PSMD7;PTEN;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.6781916593847752,1.0023753716174042,0.5507246376811594,0.9947080926926007,1.0,3/5,25.52%,SLC11A1;SLC39A14;SLC11A2
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.6781916593847752,1.0023753716174042,0.5507246376811594,0.9947080926926007,1.0,3/5,25.52%,SLC11A1;SLC39A14;SLC11A2
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.6834666411188323,1.0023417766073757,0.5084745762711864,0.9944260771516088,1.0,1/5,3.54%,MFNG
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.5323329650849784,1.002064262121178,0.4567901234567901,0.9949231396288093,1.0,4/22,18.81%,FGF1;RPS27A;UBA52;UBB
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,0.6257411881309418,1.0018507747061693,0.5492957746478874,0.9951983222622782,1.0,2/7,15.39%,ALCAM;THY1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6166390984004476,1.0018432854572066,0.5063291139240507,0.9948675843267089,1.0,5/14,16.54%,MTCL1;PARD3;LRRC7;CLIC4;CRB1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4543661432972851,-1.001637896447323,0.4444444444444444,0.9637406656323284,1.0,7/21,14.81%,INPP5K;IL1B;APPL2;PIP4K2B;ENPP1;NCK1;PTPRE
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.5270778112676672,1.0015397083907602,0.5131578947368421,0.9954648788037282,1.0,9/21,25.30%,SNAP25;PPFIA2;SYT1;CPLX1;PPFIA4;TSPOAP1;SYN2;PPFIA3;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5991631193185174,1.0015080846370836,0.5131578947368421,0.9952254007381865,1.0,4/9,23.47%,ASXL3;GSTP1;PPARA;TRAP1
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.4318695094524567,-1.0014248207424334,0.45454545454545453,0.9634062937675149,1.0,5/18,13.06%,BTG2;TP53;CNOT6L;PLK3;PLAGL1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4652573495134615,1.0014138434136282,0.5306122448979592,0.9951552548455088,1.0,26/101,22.12%,LRP2;SPARC;CD163;TFRC;FCGR2B;INSR;DNAJC6;NLGN3;FCHO2;DNM3;WASF1;DNM1;SGIP1;TMEM108;LRP1B;PICALM;HYOU1;GRK4;AP2A2;SNAP91;COLEC12;HIP1R;CLTCL1;HSP90B1;MSR1;CTTN
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5168124980838058,-1.0013952719833206,0.5,0.9625462293309428,1.0,6/11,23.53%,WHAMM;ARPC2;ARPC3;ACTR3;ACTR2;ARPC5L
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.4805588102980062,1.0013346422427387,0.4897959183673469,0.9949973556529966,1.0,37/134,26.22%,ATAD3A;MTERF1;HIGD1C;AGTPBP1;HCFC1;TIMM13;BNIP3L;SIRT5;DNM3;COX7A2;WASF1;DNM1;GABPB1;CYCS;TOMM20;POLG2;SLIRP;IFIT2;BNIP3;PINK1;ATP5F1D;TFAM;SLC25A4;CHCHD3;HSPD1;SIRT3;POLRMT;FBXO7;LRRK2;MFN2;TOMM40;CLUH;SIRT4;TIMM22;PPARGC1A;MTM1;OPA1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.5339829916006458,1.0012996004991608,0.45569620253164556,0.9947387932662607,1.0,4/21,5.91%,TUBA4A;TUBB4A;TUBA1A;TUBB6
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5487355073450642,1.0011586123722924,0.5443037974683544,0.9947956312003818,1.0,3/22,13.26%,ARRDC3;BMI1;PINK1
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.49897505729581093,1.0011211821790964,0.47368421052631576,0.994589299677407,1.0,12/66,15.02%,ARAF;ADCY3;SPDYA;IGF1R;SPDYE3;ADCY8;SPDYE18;RPS6KA2;GNAI1;CCNB3;MAPK10;CPEB2
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,0.455322490172615,1.0010074123767079,0.5555555555555556,0.9946039346504834,1.0,57/261,18.28%,NAMPT;ALDH3B1;PLIN2;CLEC12A;ARRDC3;CCPG1;NUDT16;TBC1D8;NR4A1;SLC11A1;CNIH4;RNF144B;TUBA1A;GNS;SIRPB2;MAFB;SVIL;PSTPIP2;TSC22D3;CKB;IFITM3;FGR;GLUL;TXNIP;C5AR1;FCGR2C;GPR155;KIAA0513;PIK3IP1;SASH1;NFKBIZ;MPP1;TNFRSF1B;IFIT2;DRAP1;SOD2;VMP1;INSIG1;CD300A;TMEM134;SDCBP;PELI1;MCTP1;SLC31A2;LTA4H;RASGRP4;ATP1B3;DENND5A;GBP2;LRRC25;ARAP2;SMAP2;PLXNC1;STXBP2;RNF149;FGD4;FTH1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6419049897873031,1.0008905860044364,0.56,0.9942372763654207,1.0,3/7,20.25%,ADGRG6;PARD3;CNTNAP1
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6419049897873031,1.0008905860044364,0.56,0.9942372763654207,1.0,3/7,20.25%,ADGRG6;PARD3;CNTNAP1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5938698238021378,1.0008377000266218,0.47619047619047616,0.9940314344676855,1.0,1/9,11.49%,CLASP2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.5519310160517179,1.0008337997063514,0.5194805194805194,0.9936927849196164,1.0,2/19,11.73%,FKBP5;PPID
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5262621715911397,-1.000793804159053,0.39285714285714285,0.9630944974194402,1.0,2/12,2.53%,CX3CR1;SELPLG
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,0.6314858085759918,1.0007640857032616,0.5652173913043478,0.9932009108700973,1.0,2/5,15.39%,ALCAM;THY1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,0.6314858085759918,1.0007640857032616,0.5652173913043478,0.9932009108700973,1.0,2/5,15.39%,ALCAM;THY1
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,0.577305388958725,1.000628403056088,0.5135135135135135,0.9932548721436071,1.0,2/13,13.58%,POLR3F;POLR3H
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.5242648277121589,1.0005691923162174,0.48863636363636365,0.9930724080796213,1.0,13/39,14.54%,FZD6;EMILIN2;ITGA2;ANLN;KIF15;OVOL2;BAIAP2L1;BMI1;BOK;ST14;FMO5;BRCA1;INCENP
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.5520165777681153,-1.0005480002894513,0.5454545454545454,0.9627617748384338,1.0,3/6,18.21%,SENP6;SENP1;SENP5
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6143447580035388,1.0005239508358559,0.5125,0.9928382802726343,1.0,2/8,7.92%,ACSS3;ACAT1
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6617089455498079,1.0004568152046271,0.5616438356164384,0.9927175740765848,1.0,4/8,26.65%,ST14;ALDH1A1;LEPR;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.48895912453402335,1.000424681049956,0.5054945054945055,0.9924740324439304,1.0,15/74,16.08%,HTR2B;FGF1;MTCP1;CEMIP;DIRAS2;VEGFA;SPDYA;ROBO1;CALM3;NOD2;FLT1;PKD1;INCENP;WNT5A;CCND3
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.5013562286742703,-1.0003688883382718,0.4,0.9622722814942495,1.0,2/9,4.36%,PDE12;UQCC2
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.4396756163791561,-1.0003676343573378,0.5384615384615384,0.9613250364511001,1.0,2/37,4.57%,RING1;ING3
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6179672535244831,1.0003347439512182,0.5223880597014925,0.9924311465768697,1.0,7/13,34.79%,NUP133;SEH1L;RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4630362661520135,1.00016488707612,0.4897959183673469,0.9926307263517961,1.0,35/148,20.20%,SHANK3;SH3PXD2B;CACNB2;SCN3B;ZDHHC15;SYNE3;NRXN1;RAB3C;NRXN2;ANK3;ANK2;PKP2;FCHO2;NLGN1;RAB15;SAV1;CAV3;PTN;CLASP2;MAGI2;LRRC7;MAP7;CPE;THY1;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;DLG4;CYP46A1;TNF
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.4941181182494411,1.0000306617615127,0.4827586206896552,0.9926782927978702,1.0,14/45,20.85%,DDIT4;EGR1;MAPT;FCGR2B;RIPK2;BNIP3;GRIN2B;PICALM;WNT5A;CIDEB;FOS;TNF;LRRK2;CDKN1B
prerank,KEGG_2021_Human__Endocytosis,-0.3100840610979548,-1.0,1.0,0.9577395409111247,1.0,38/206,13.31%,ARAP3;EHD4;RAB22A;RAB5B;CLTB;NEDD4;FOLR2;CYTH2;WIPF3;ARAP1;RNF103-CHMP3;EPS15L1;CLTA;AGAP9;STAM2;GRK2;CYTH3;SH3GL1;SPG21;ZFYVE9;VTA1;SRC;SMURF1;HLA-E;PLD2;VPS45;VPS37B;WASHC5;CHMP2B;BIN1;RABEP1;CYTH4;EGFR;HSPA1A;ARPC2;ARRB2;VPS29;DAB2
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4104497818686698,-1.0,1.0,0.9577395409111247,1.0,47/134,14.46%,MRC2;CD300LF;ITGAM;CX3CR1;LY86;SUSD3;GIMAP8;CEBPA;PTAFR;BIN2;OLFML3;MPEG1;LGALS9;HPGDS;CSF1R;LILRB4;UCP2;P2RY13;ITGB5;SLCO2B1;OTULINL;P2RY6;ITGAX;AOAH;TMEM119;MYO1F;P2RY12;WDFY4;IGSF6;PLEK;HCK;PTGS1;TREM2;ITGB2;CYFIP1;CYTH4;APBB1IP;LCP2;SKI;LTC4S;TYROBP;ENTPD1;CD53;GIMAP4;HAVCR2;IL6R;PIK3R5
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.3641510263882531,-1.0,1.0,0.9577395409111247,1.0,48/305,9.43%,RNASEL;ZNF689;ITGA5;CCL5;ZSCAN32;TICAM1;ZNF133;ZNF682;ZNF25;BCL2L1;ZNF561;ZNF570;IL1B;ZNF398;ZNF251;ZNF875;ZNF14;ZNF786;CHUK;ZNF649;ZNF317;ZNF675;IRAK4;ZNF641;C3;ZNF557;ZNF568;ZNF620;ZNF184;ZNF426;ZNF701;ZNF699;ZNF182;TP53;ZNF514;EIF4EBP1;CGAS;ZNF420;ZNF140;BID;ZNF283;TLR3;ZNF569;SRC;ZNF552;HLA-E;ZNF354B;ZNF208
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.31776200778129526,-1.0,1.0,0.9577395409111247,1.0,28/197,10.83%,NUP42;GTF2H5;LRIG1;PSMB3;ELOA;GTF2F1;AP1B1;PSME3;CTDP1;GTF2H2;RNF103-CHMP3;ELOC;APOBEC3G;TAF13;PSMC4;BANF1;PSMD12;SUPT16H;NUP155;FYN;PSME4;VTA1;VPS37B;TCEA1;CHMP2B;HCK;NUP188;NUP214
prerank,KEGG_2021_Human__Shigellosis,-0.2742176862730122,-1.0,1.0,0.9577395409111247,1.0,36/189,14.50%,ITGA5;CCL5;BCL2L1;PFN1;IL1B;CHUK;ACTB;CYTH2;C3;ITPR2;CYTH3;MAPK13;TP53;TLN1;CGAS;ILK;SRC;CRKL;WIPI1;TIFA;CAPN2;IKBKB;NLRP3;CRK;NFKBIA;CYTH4;EGFR;TLN2;ARPC2;ATG12;NAIP;TECPR1;BCL2;BCL10;AKT1;VDAC1
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,-0.3876787129926576,-1.0,1.0,0.9577395409111247,1.0,142/423,14.48%,MYH9;ITGAM;CX3CR1;GAL3ST4;BTG2;CD37;NPC2;LY86;TAL1;RHOG;MKNK1;CEBPA;PFN1;PTAFR;LPAR5;A2M;ELAVL4;BIN2;CCND1;SELPLG;GYPC;MAF;SAMSN1;AP1B1;OLFML3;SH2B3;HTRA1;MPEG1;WDR91;ABCG2;EGFL7;P3H2;FOLR2;TMIGD3;BLNK;HPGDS;ACY3;NNAT;CSF1R;LILRB4;APPL2;C12ORF75;OLR1;C3;ABI3;UCP2;ARHGDIB;ITPR2;ANXA4;P2RY13;FAM78A;RYR1;HCST;SFT2D1;GALNT1;SIRPA;RAPGEF6;DOCK4;CPVL;CREG1;CPED1;SERPINB6;ADAP2;SLCO2B1;SESN3;TLN1;GLIPR1;NPL;IGF1;RPAIN;SLC7A8;ITGAX;AOAH;MILR1;ALOX5;RAB3IL1;MAN2B1;TMEM119;MYO1F;CAP1;P2RY12;HLA-E;LCP1;TM6SF1;NCKAP1L;CH25H;INPP5D;IL17RA;IGSF6;DHRS9;FMNL3;PLEK;HCK;GPN3;PTGS1;BHLHE41;TGOLN2;TREM2;SLC29A3;B3GNT5;FCGR1A;BIN1;SOCS6;ITGB2;IRAG2;CYFIP1;NFKBIA;CYTH4;RIN2;APBB1IP;TLR7;GSN;HVCN1;NAA20;ARHGAP12;IER2;HSPA1A;FRMD4A;LTC4S;CD83;SORL1;TYROBP;ENTPD1;ARRB2;PLVAP;NAIP;CD53;SYK;DAB2;GPX1;SIPA1L2;GIMAP4;ATP8B4;SFMBT2;GPSM3;HAVCR2;RGS19;ITM2B;PLD4;SLC15A3;IL6R;IL6ST
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,-0.3951366890775876,-0.9998320035707906,0.5,0.9572068435903758,1.0,14/41,13.92%,TDRD10;GIMAP8;A2M;MPEG1;FOLR2;HPGDS;CSF1R;SLCO2B1;TNFSF10;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.36349385055294864,-0.9997962742309368,0.25,0.9563501330896034,1.0,18/63,11.59%,PPP1R16B;CX3CR1;CD37;LY86;P2RX1;EVL;MPEG1;PLEKHO1;P2RY13;SH2D3C;WDFY4;PLEK;HCK;RASGRP2;BTK;KIF21B;TLR7;HVCN1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5208783126951698,0.9997617358765685,0.4642857142857143,0.9931392905524605,1.0,11/24,31.60%,RPA2;POLE2;ORC6;DBF4;RPA3;ORC3;MCM3;MCM6;NOC3L;POLA1;GMNN
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5633369179463926,0.9993626919130657,0.4492753623188406,0.9940617185813516,1.0,4/10,34.10%,RAPGEF3;DDX3X;TERF2IP;TAOK1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.6629625331759096,0.9991490560116439,0.5882352941176471,0.9940395459561752,1.0,1/6,1.96%,CBR1
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,0.6629625331759096,0.9991490560116439,0.5882352941176471,0.9940395459561752,1.0,1/6,1.96%,CBR1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.45483057653680126,0.9990672004797632,0.49,0.9939510558035014,1.0,68/332,22.42%,BRIP1;DDIT4;DAPK2;RHOB;FGF1;ARAF;NLRP12;PRKAR2B;MAPT;PPP2R5B;RACGAP1;RPA2;VEGFA;PHLPP1;TRAF2;TRIP10;FBXL2;ARHGAP23;AKAP6;NGEF;PEX5L;CHN1;PPP1R13L;NLGN1;AKAP12;DNA2;MOB3B;NTRK3;PDE2A;ARHGEF4;PRR5;TTC5;PRKAG2;KALRN;NTRK2;GNAI1;BRCA1;PAK5;ITSN1;RFC4;PYCARD;WNT5A;ITGAV;RPL11;ARAP2;ARHGDIA;HSPB1;PRKAA2;STARD13;TAF9B;FGD4;RHOH;TAF7;CDK5R1;NOP53;ECT2;TNF;MEAF6;LRRK2;FAM13A;RBBP8;VRK2;PAK3;STARD8;SETD9;BARD1;VAV3;RHOU
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.43918632077184594,-0.9990302444704838,0.5,0.9576254543746006,1.0,7/33,12.21%,TELO2;CLEC16A;LAMTOR1;MIOS;NCKAP1L;TREM2;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.4946999959571199,-0.9990283692536271,0.48148148148148145,0.9566791841627679,1.0,3/10,7.34%,CCL5;DOCK4;IGF1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.6197406736060198,0.998933756559828,0.5584415584415584,0.9940851193005398,1.0,4/8,21.98%,IMPACT;GPR65;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.6497076607353769,0.9989147249824919,0.5151515151515151,0.9937839323239183,1.0,4/9,20.20%,AGT;NOD2;SIRT3;TNF
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.44809815051689794,0.9987626035829695,0.46464646464646464,0.9939179603188423,1.0,41/137,25.39%,RPL23;MAPT;WDR12;WDR74;RPL37A;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.5978369905739751,0.9987254625945432,0.5675675675675675,0.993684687127828,1.0,5/9,37.51%,ECHS1;ACSM3;ACADM;MECR;HADHA
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.47733972187381607,-0.9985507821933629,0.42857142857142855,0.9569015614175673,1.0,2/11,11.82%,SETDB1;TASOR
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.5468216232867653,0.9985376030812955,0.4935064935064935,0.9939506751159012,1.0,1/16,1.64%,SEMA3A
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.4753837896565041,0.9985351296806512,0.5106382978723404,0.9936145509891318,1.0,20/80,23.72%,FKBP5;ADCY3;CREB5;GNAO1;CALM3;SHC2;ADCY8;GNAI1;ESR1;KCNJ6;PLCB1;HSPA1B;KCNJ3;HSPA2;GNAQ;FOS;GABBR1;HSP90B1;JUN;PRKACB
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.5484025177343875,0.998201159916547,0.5263157894736842,0.9941989313680666,1.0,10/24,27.66%,HSPA5;SDF2L1;DNAJC7;HSPA1B;ERO1A;HSPA2;HSPA14;HSPA9;HSPA13;HSPA8
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.6260148995684767,0.9974952204209449,0.5588235294117647,0.9959247922289549,1.0,2/6,15.39%,ALCAM;THY1
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.662476672080454,0.9973643740272439,0.5254237288135594,0.9959806160848627,1.0,3/5,23.72%,ABCA1;BMP1;PRKACB
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.44942195419637154,0.9973347170259618,0.54,0.9957310387321318,1.0,138/716,21.46%,SOCS3;HS3ST5;TNC;THBS1;DAPK2;ALG10B;ACVR1B;ARAF;CDK14;NEK11;TGFB2;DTL;ASB14;VGF;WDR5;PRKCE;ZBTB16;PTPRD;PPP2R3B;PPP2R5B;PIGU;VCAN;ANXA1;FBXL7;PTPRG;CDH2;ACVR2A;AATK;BMPR1B;ASB16;F13A1;PTPRK;GAD1;PPP2R5A;PDK4;EIF2AK3;LAMB1;PRRT1;PTPRZ1;GOLM1;FBXL2;INSR;DAPK1;NIM1K;MTMR7;COPS5;HIF1A;PP2D1;PTPRT;FN1;PXK;SIRT5;PLK2;FGR;CKAP4;OGA;MGAT1;LTBP1;CLK2;TMEM132A;LIPE;STT3B;PSMB4;CHRM3;RBX1;DCAF6;CAMK2B;B4GALT5;PRKAG2;GAN;FAM20A;SLC35A1;HIF3A;ASB13;PPM1E;PAK5;FBXO27;PINK1;PPM1L;SERP1;UBE2M;DUSP10;MAPK10;CHGB;CPE;ST8SIA3;PDK3;UGCG;SUMF2;NUAK2;CTBP1;KLHL2;EPAS1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;EGLN3;MAP3K13;APP;SUMF1;PIK3R4;PTPN9;PPP2R3A;PRKAA2;IGFBP7;FBXL13;UBA52;ERO1A;PSMC2;ZC3HAV1;CDK9;FBXL5;SIRT3;CDC25B;PSMA3;PTPN5;DUSP16;CTDSP1;FBXO7;PSMB2;SSH2;DUSP6;SPSB3;PTPRS;LRRK2;ATG5;IRAK3;MACROD1;VRK2;DDB1;P4HB;DUSP12;PAK3;PSMD5;HSP90B1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.4605983664296271,-0.9972938817859045,0.4666666666666667,0.9592216314370458,1.0,2/9,5.01%,KRT10;ICAM1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6402309785867027,0.9972765823534175,0.5194805194805194,0.9955651798190097,1.0,4/9,20.15%,CYCS;UQCRFS1;UQCRC1;CYC1
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.6580879271535022,0.9972239474250671,0.5138888888888888,0.9953641042002521,1.0,1/5,2.83%,ADCY3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5559778263846294,0.9967399625774295,0.4861111111111111,0.9966594767542424,1.0,1/14,3.44%,RIDA
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.5964445738798567,0.9964417652659705,0.5194805194805194,0.9971900013079933,1.0,3/16,9.36%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5796329949737523,-0.996358374154802,0.5806451612903226,0.9607608097958787,1.0,1/7,7.64%,APH1A
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6773422199436023,0.9963531705637532,0.5694444444444444,0.997129751446398,1.0,3/5,12.42%,SLC9A6;TMEM108;SH3GL2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.36626886499571565,-0.9962793205508126,0.4,0.960021994010782,1.0,25/79,13.65%,CD300LF;ITGAM;LY86;PTAFR;BIN2;MPEG1;FOLR2;LGALS9;CSF1R;P2RY13;ITGAX;TNFSF10;AOAH;ALOX5;MYO1F;IGSF6;PLEK;HCK;ITGB2;CYTH4;LCP2;TYROBP;CD53;SYK;GIMAP4
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.4722508984089254,0.9962597268128799,0.5106382978723404,0.9971048272305111,1.0,15/85,13.36%,GFAP;TFRC;NRG1;NAPA;SLF1;VEGFA;HSPA5;TRAF2;HCFC1;SEPTIN8;ABCA1;TFIP11;IMPACT;PINK1;TPPP
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),-0.5997298302907684,-0.9962180899165637,0.5263157894736842,0.9592200650401173,1.0,1/5,3.60%,LGALS9
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.4545729066928595,0.9962136312329607,0.55,0.9969292164787825,1.0,41/238,18.81%,HTR2B;THBS1;LRP2;ARAF;PRLR;NAA38;TFRC;ATAD3A;ANXA1;RNF144B;FIGNL1;VEGFA;HSPA5;IL7;COPS5;FMN2;BNIP3L;FAIM2;IGF1R;RPS27A;MCL1;PLK2;RIPK2;BNIP3;PRELID1;BCL2L2;TMEM14A;WNT5A;CASP3;CFL1;BAG3;NUAK2;ARHGDIA;HSPB1;HSPA1B;GSTP1;PRKAA2;TAF9B;UBA52;HSPD1;UBB
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.4942026752367743,-0.995914291251234,0.4782608695652174,0.959038937419506,1.0,3/12,9.74%,TP53;ZNF385A;EP300
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.4604422135521497,0.995786243991263,0.5,0.9980070189489137,1.0,44/137,27.16%,RPL23;RPL37A;NUP133;RPL38;XPO1;RPS6;RPS27A;RPL23A;RPS25;RPS27;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;SEH1L;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;UBA52;RPS3A;RPL35;RPL4;POLR2G;RPL32;GNL3;RPL27A;NDC1;RPL3;RPS16;RPL30;RPL36AL;RPL21;POM121;RPL7;RPL12;RPL10A;FAU;RPS12;NUP58
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,-0.37845327406745166,-0.995638344045354,0.3333333333333333,0.9585617440926073,1.0,21/77,13.61%,ITGAM;CD37;LY86;BIN2;PIK3R6;MPEG1;RASAL3;ALOX5;MYO1F;NCKAP1L;WDFY4;PLEK;HCK;BTK;ITGB2;CYTH4;TLR7;HVCN1;TYROBP;CD53;SNX20
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.5325419221209182,-0.9954831699603243,0.5263157894736842,0.9581241121690711,1.0,3/9,5.98%,LGALS9;LILRB4;CD274
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5492643892852337,-0.9953239387270792,0.4,0.9575844364431629,1.0,2/11,14.74%,HLA-E;IL12RB1
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,0.6246044399205097,0.9951825283590625,0.49295774647887325,0.9995614976449885,1.0,4/9,23.72%,ABCA1;P4HB;BMP1;PRKACB
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.5001721453291056,0.9951312612038901,0.5222222222222223,0.9993691970642048,1.0,14/44,23.73%,BRIP1;DNA2;RPS27A;EME2;BRCA1;XRCC3;RFC4;POLE2;UBA52;UBB;RBBP8;BARD1;RPA3;SLX4
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),0.5315058072141216,0.99497860689438,0.5128205128205128,0.9995068355419756,1.0,7/26,16.55%,LRP2;CYP3A5;GPC5;AKR1B1;RDH11;ALDH1A1;NAPEPLD
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.6342597283483236,0.9948373138080563,0.5277777777777778,0.999535548337271,1.0,2/8,15.12%,SCN3A;SCN2A
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.4576942213165988,0.9948288451454596,0.52,0.9992218675859182,1.0,71/342,19.53%,THBS1;SPARC;FGF1;FLRT1;EGR1;VGF;GFAP;PRKCE;ITGA2;PIGU;COL4A5;DOCK1;NRG1;ARF6;KITLG;PTPRK;VEGFA;GABRB1;LAMA2;KCNH8;LAMB1;SH3GL3;PTPRZ1;INSR;RBFOX2;HIF1A;GRB10;SPRY1;GABRB3;ID2;PTN;DNM3;SHC2;IRS2;IGF1R;RPS27A;NTRK3;WASF1;ALK;DNM1;PRR5;NRG3;GABRB2;RPS6KA2;FLT1;NTRK2;SH3GL2;CDC37;GRIN2B;NELFB;NRG4;ESR1;HNRNPH1;PCSK6;ITGAV;CXXC1;POLR2D;TEC;ROCK1;HSPB1;SPINT2;PIK3R4;FLRT2;FES;UBA52;UBB;NRG2;GABRG2;CDK5R1;AP2A2;FOS
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.48835493402746283,0.9947527918396066,0.4945054945054945,0.9990427484407449,1.0,13/46,23.75%,CLIP3;H2BC11;TRAF2;SPPL2B;CCDC3;PYCARD;HSPA1B;GSTP1;TNFRSF1A;TNF;CASP1;TRADD;GPS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.5719521026009639,0.9945322684714157,0.547945205479452,0.9992794318786861,1.0,1/13,0.28%,THBS1
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.5868021787175003,0.9941974673849272,0.581081081081081,0.9999922146612883,1.0,1/11,3.16%,PIGU
prerank,KEGG_2021_Human__Amoebiasis,0.4850366410997113,0.9939897217419608,0.4606741573033708,1.0,1.0,12/47,17.22%,RAB7B;TGFB2;COL4A5;GNA11;LAMA2;LAMB1;FN1;ARG2;GNAL;CASP3;PLCB1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.6124036725725056,0.9939885478613556,0.5147058823529411,1.0,1.0,3/10,14.21%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.532010134443436,-0.9938596125288053,0.4230769230769231,0.9602454785918583,1.0,3/12,10.03%,INPP5K;TP53;PLEK
prerank,KEGG_2021_Human__Mineral absorption,0.5247873044936492,0.9937814287944516,0.4875,1.0,1.0,12/26,25.52%,STEAP2;ATOX1;ATP1B3;FTH1;ATP1B2;TRPM7;ATP1A2;SLC26A3;ATP2B2;TF;ATP2B4;SLC11A2
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6204598231330749,0.9937458744109522,0.5584415584415584,1.0,1.0,3/8,25.32%,IRS2;DDB1;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.6164903384410816,-0.9936962467395778,0.55,0.9597047842784906,1.0,3/5,9.18%,CX3CR1;CRKL;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.668605365258349,0.9936666672549996,0.5555555555555556,0.9998760259390391,1.0,2/5,20.52%,CPEB2;CPEB4
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.5612279783584541,0.9935398186258966,0.5,0.999952356354181,1.0,6/11,28.72%,MTMR7;PIK3R4;MTMR9;MTM1;MTMR4;FIG4
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6146508151792394,0.9935303781715366,0.527027027027027,0.9996236785756634,1.0,4/8,19.60%,COL11A1;SCN1A;PIEZO2;LHFPL5
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5340026374977265,-0.9935034770997688,0.46511627906976744,0.959344695301302,1.0,1/6,0.30%,EYS
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.4728373388588063,0.993500030495385,0.5816326530612245,0.9993589796448301,1.0,17/109,13.23%,PLPP3;GRM8;ADCY3;AGT;ARF6;KITLG;DGKI;GRM3;INSR;RAPGEF3;DNM3;SHC2;DGKB;DNM1;ADCY8;DGKG;GAB1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.6428067923629947,0.9934414054964272,0.5873015873015873,0.9988237630244936,1.0,1/5,4.32%,ALOX12
prerank,Reactome_2022__Synthesis Of Lipoxins (LX) R-HSA-2142700,0.6428067923629947,0.9934414054964272,0.5873015873015873,0.9988237630244936,1.0,1/5,4.32%,ALOX12
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3129296813196459,-0.993421196243655,0.3333333333333333,0.958664998003615,1.0,18/80,16.57%,RANBP6;ARL2BP;HHEX;APPL2;NUP155;RPAIN;PHB2;BCL3;NUP188;NUP214;IPO13;CHCHD10;SYK;PTTG1IP;AKT1;TAF8;XPA;RPF2
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.5616811333531899,0.993406622595628,0.5454545454545454,0.9985946438811061,1.0,1/14,0.66%,RHOB
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.6494029339452053,0.9933374836165119,0.4864864864864865,0.9984611764578096,1.0,1/7,10.87%,NOD2
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,0.633733617949689,0.993190882663955,0.5625,0.9985187206159087,1.0,3/8,14.10%,F13A1;THBD;SERPINE2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.6893435005401249,0.9931726156529056,0.6140350877192983,0.9982358708899437,1.0,2/5,22.96%,NLGN1;RORA
prerank,KEGG_2021_Human__Drug metabolism,0.5209641207045675,0.9931363742084406,0.4157303370786517,0.9980168128774148,1.0,12/39,19.80%,ALDH3B1;DPYD;CYP3A5;UCKL1;FMO5;CMPK1;GSTP1;UPP2;ADH5;HPRT1;NME4;UCK2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.46181315835641473,0.9926775255631809,0.5274725274725275,0.9990503036098923,1.0,20/85,24.39%,ARAF;RNF144B;HERPUD1;XPO1;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;CAMLG;SDCBP;RPL11;HSPA1B;NOP53;LRRK2;HFE;MAP1A;USP5;BBS7;DDRGK1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.5025409610278185,0.9921599319453818,0.48863636363636365,1.0,1.0,14/35,25.30%,SLC1A2;GAD1;SNAP25;PPFIA2;GAD2;SYT1;SLC17A7;CPLX1;PPFIA4;TSPOAP1;SYN2;PPFIA3;SLC6A1;RIMS1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.5620315464847104,-0.9920584668525334,0.48484848484848486,0.9613530123887826,1.0,3/6,12.41%,NUFIP1;PIH1D1;ZNHIT6
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.463677631513888,0.9919518716024854,0.4827586206896552,1.0,1.0,29/73,22.72%,GPM6B;GALNT8;NRXN1;NELL2;RAB3C;RTN1;ASXL3;KCNH8;LRRN1;SLAIN1;CELF2;RNF175;CADPS;KHDRBS2;PPP2R2B;PAK5;PPM1L;LY6H;DAB1;ST8SIA3;ATP1B2;B3GAT1;NCAM1;KIF5C;SORCS3;PRKCB;SYT11;TSPOAP1;PDZRN4
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.4502299458610138,0.9918648196572026,0.56,1.0,1.0,45/256,15.17%,GPR18;RHOB;TSHR;GRM8;GNRHR;HTR7;PRKAR2B;CHRM5;RGS20;PDE10A;PRKCE;TACR1;PDE1A;ANXA1;GNA11;DGKI;RGS1;GPNMB;GRM3;MCHR2;LTB4R;NGEF;PDE1C;DGKB;PDE2A;ARHGEF4;C5AR1;PDE4B;ADCY8;RXFP1;CHRM3;CAMK2B;GPR65;RPS6KA2;KALRN;RIPK2;GNAI1;RGS11;DGKG;RGS17;GNAL;PLXNB1;ITSN1;GPR183;HTR1F
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5823072921641088,0.9917715454525172,0.5324675324675324,1.0,1.0,4/12,14.09%,CACNB2;DMD;PDE4B;AHNAK
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.4167085261569651,-0.9916344635768766,0.4117647058823529,0.9615550197720613,1.0,9/32,18.36%,RBM23;JMJD6;CDK11B;METTL16;KHDRBS3;SON;SAFB;CPSF4;LARP7
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.5287894170441116,0.9915148214829556,0.5172413793103449,1.0,1.0,9/24,23.25%,DTL;RPS27A;RBX1;RFC4;POLE2;UBA52;UBB;DDB1;RPA3
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.49413113086944815,-0.9914513530642709,0.38461538461538464,0.9611434318915464,1.0,4/12,10.32%,CST7;IGF1;CD200R1;TREM2
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,-0.520712709708536,-0.9913549764824836,0.45161290322580644,0.9604135781891618,1.0,2/11,14.21%,CHUK;AKT1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.608381635085004,0.9912050343194124,0.5365853658536586,1.0,1.0,2/10,11.06%,AGT;CHRM3
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.3984615536818098,-0.9911662658815644,0.4,0.9601696508374875,1.0,4/22,4.82%,TXN2;IL1B;IL1A;C3
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.5418995986358979,0.990871175882858,0.5121951219512195,1.0,1.0,4/22,10.93%,SUV39H2;ANTKMT;CSKMT;SMYD5
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,-0.5320832518488916,-0.9907371363677402,0.4444444444444444,0.9603720222673406,1.0,2/7,12.42%,ASCC2;MGMT
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5189164160007437,0.9907133062284231,0.5569620253164557,1.0,1.0,4/27,5.56%,FAAH;FAAH2;ALOX12;ALOX15B
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.44773705259532437,-0.9907043614062694,0.38461538461538464,0.9595305079413162,1.0,2/19,3.15%,GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6182050119891453,0.99066542256148,0.5294117647058824,1.0,1.0,5/9,25.52%,HIF1A;HAMP;HFE;TF;SLC11A2
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5710961771430656,0.9904419737590712,0.4868421052631579,1.0,1.0,2/12,9.73%,NEK11;EME2
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.5355576931708164,0.9902667447621607,0.44871794871794873,1.0,1.0,4/18,9.26%,TGFB2;SOX4;PKP2;RBPJ
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.47547116247417254,-0.9901698725691694,0.44,0.9601780687120093,1.0,5/13,10.89%,ITGAM;LGALS9;SCIMP;NMI;ITGB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.39363257327378637,-0.9900035385523801,0.5714285714285714,0.9597320980786583,1.0,10/65,10.78%,PSMB3;PSME3;CHUK;ITGB5;PSMC4;PSMD12;PSME4;HLA-E;IKBKB;FCGR1A
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3455969900984218,-0.9898901584297695,0.5,0.9589951503741176,1.0,10/91,6.02%,PHLDB2;NEXMIF;EVL;ADARB1;TMIGD3;DAB2IP;DUSP3;ARHGDIB;TRIB1;NF2
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.5587437446404417,-0.9896333405338122,0.44,0.958715975674132,1.0,3/9,5.82%,IL1B;DAGLB;MTLN
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.6427915295220672,0.9896324273235244,0.5151515151515151,1.0,1.0,2/5,17.58%,AGT;RGCC
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.6333625657613006,0.9894176491984733,0.5166666666666667,1.0,1.0,3/5,26.37%,CFL1;PPIB;IGF2R
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.4771225086021256,0.9893355927377087,0.46808510638297873,1.0,1.0,3/42,10.87%,CLEC4E;RPS27A;NOD2
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.43632038137917445,-0.9892239331411586,0.5333333333333333,0.9587792720950549,1.0,1/28,0.16%,RING1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.4771829598093824,0.9886125782376638,0.5106382978723404,1.0,1.0,16/61,21.98%,PLPP3;MAPT;PAQR3;IRS2;NTRK3;IMPACT;IBTK;SH3GL2;FBP1;ROCK1;NPRL2;PPARA;LRRK2;CDKN1B;HNRNPU;CHP1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4419563642611105,0.9885992402780576,0.5757575757575758,1.0,1.0,62/304,25.61%,DIAPH3;SYNE3;ATAD3A;EIF2AK3;MTERF1;VAPB;SEMA6A;VPS11;AGTPBP1;HCFC1;ATP8B1;PALLD;SIRT5;LIMD1;CSPG5;SH3D19;GABPB1;CLASP2;PPID;CYCS;POLG2;PAK5;GOLGA8B;PINK1;VMP1;AUP1;SPTBN5;PEX3;TMED10;CFL1;THY1;FGD6;FAM174B;UBXN2B;KIF3A;TFAM;FGD4;SIRT3;VPS51;SURF4;POLRMT;CNTNAP1;CENPT;LRRK2;RAB30;KIF5C;DYNC2H1;BRWD1;BNIP1;HACE1;CHMP5;RHOU;SORT1;MAST4;PDCD6IP;CLUH;SIRT4;CHMP7;PEX10;PPARGC1A;GOLGB1;VAPA
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.5121542669950452,0.9883040865190631,0.4939759036144578,1.0,1.0,1/32,0.21%,UAP1L1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.5840110354897317,0.9882432808680114,0.5588235294117647,1.0,1.0,5/10,26.11%,SOD2;CDKN1B;PDCD4;PTEN;PRKG1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5273452299562553,0.9878134648948302,0.5443037974683544,1.0,1.0,9/23,21.83%,HTR7;TBC1D8;SGCZ;GUCY1B1;ROCK1;SGCD;SOD1;SCPEP1;STAT1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.36972238457640044,-0.9876032055081602,0.3333333333333333,0.9613449800816415,1.0,19/57,15.96%,ITGA5;TICAM1;SH2B3;UBA7;CSF1R;ICAM1;TLN1;TRPV2;COL8A2;ENG;TMEM119;PTGS1;GSN;CTSZ;DAB2;SLC15A3;CMKLR1;ARHGAP31;C1QC
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.36972238457640044,-0.9876032055081602,0.3333333333333333,0.9613449800816415,1.0,19/57,15.96%,ITGA5;TICAM1;SH2B3;UBA7;CSF1R;ICAM1;TLN1;TRPV2;COL8A2;ENG;TMEM119;PTGS1;GSN;CTSZ;DAB2;SLC15A3;CMKLR1;ARHGAP31;C1QC
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.46375963441766804,0.9875277489530785,0.5268817204301075,1.0,1.0,11/86,5.74%,HTR2B;NLRP12;CADM1;IL15;AGT;ANXA1;SLC11A1;SRGN;GPNMB;FCGR2B;MOG
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5727604352213185,0.98741838301482,0.5294117647058824,1.0,1.0,1/12,1.41%,DTL
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.5826422112853817,0.9872386769186672,0.45161290322580644,1.0,1.0,1/11,1.28%,TGFB2
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6013992200297701,0.9871279764179743,0.575,1.0,1.0,2/11,12.68%,WASF1;SLIRP
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.47255828286540347,0.9870137169539595,0.5729166666666666,1.0,1.0,25/109,22.86%,KLF4;CBR1;CYP3A5;ADCY3;CREB5;VEGFA;RXRB;RPS6KB2;CACNA1B;ADCY8;RPS6KA2;PAQR7;GNAI1;ESR1;CCND3;CACNA1A;BCL6;GSTP1;PPARA;FOS;NOTCH2;HSP90B1;GSTM3;PRKCB;JUN
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,0.5255177260199057,0.9867805712879483,0.5,1.0,1.0,3/28,9.49%,PLIN2;VPS37C;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.46988148673611724,0.9866960134976258,0.4489795918367347,1.0,1.0,7/94,2.83%,KLF4;TSHR;NLRP12;CD163;HTR7;PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.5504412026251364,0.9866165056497307,0.5375,1.0,1.0,5/18,20.08%,GRIN2A;RIPK2;ASPH;CIDEB;PGK1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5026637025096863,0.9865776774646964,0.5232558139534884,1.0,1.0,8/41,15.86%,DDIT4;BOK;MCL1;TNFRSF1B;BRCA1;BCL2L2;PYCARD;CIDEB
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.6067276661940676,0.9865674380231444,0.5512820512820513,1.0,1.0,1/10,2.03%,ACSL1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5660301420169358,0.9861181259926267,0.4935064935064935,1.0,1.0,5/13,17.50%,ADCY3;ADCY10;ADCY8;GUCY1B1;GUCY2C
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.4677933143612417,0.9860471282852608,0.4943820224719101,1.0,1.0,17/65,23.07%,MANF;HSPA5;PES1;RCC1;ALCAM;TXN;PRDX4;TUBA1C;SURF4;ENO1;AHCY;P4HB;HSP90B1;FLOT2;PPIB;GNL3;GANAB
prerank,KEGG_2021_Human__Long-term potentiation,0.4773437593188939,0.9860291116871368,0.5319148936170213,1.0,1.0,12/53,18.82%,ARAF;GRIN2A;GRIA2;RAPGEF3;CALM3;ADCY8;CAMK2B;RPS6KA2;GRIN2B;PLCB1;GRIA1;GNAQ
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.515861485973022,0.9859880418832851,0.5730337078651685,1.0,1.0,1/31,0.84%,SKIC2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.48149268846172794,0.9859469503988205,0.5684210526315789,1.0,1.0,13/70,12.45%,SOCS3;ENPP2;IL15;RELN;AGT;VEGFA;SRCIN1;GHR;GPRC5B;HCLS1;RIPK2;CRLF1;EPHA4
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5535632900586905,0.9857757610636548,0.5384615384615384,1.0,1.0,4/17,10.89%,TSHR;ADCY3;ADCY8;RXFP1
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.5564043490950445,0.9857731518413275,0.5454545454545454,1.0,1.0,1/12,1.64%,SEMA3A
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4859774159096056,-0.9857494176872289,0.44,0.9651559758671182,1.0,2/12,2.97%,NPC2;NPC1
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.4454818115805335,0.9857068765020943,0.5257731958762887,1.0,1.0,24/139,17.16%,THBS1;ARAF;TGFB2;FZD6;ITGA2;VEGFA;RPS6KB2;ANK3;ANK2;HIF1A;CAV3;FN1;RPS6;IGF1R;CAMK2B;HCLS1;GAB1;TIMP3;WNT5A;CASP3;ESR1;ITGAV;IQGAP1;ROCK1
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,0.594221616044864,0.9856065543847431,0.5151515151515151,1.0,1.0,3/8,15.39%,CDH2;ALCAM;THY1
prerank,KEGG_2021_Human__Mitophagy,0.4936074988256747,0.9854954047819656,0.5263157894736842,1.0,1.0,14/57,21.14%,RAB7B;EIF2AK3;HIF1A;BNIP3L;RPS27A;TBC1D15;BNIP3;PINK1;CALCOCO2;MAPK10;UBA52;UBB;ATG5;MFN2
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.48656671956023584,0.9854484938798272,0.5376344086021505,1.0,1.0,11/65,18.82%,PRKAR2B;PDE1A;GNA11;PDE1C;PDE4B;ADCY8;CAMK2B;GNAI1;GNAL;PLCB1;GNAQ
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.6286428183649541,0.985405991215439,0.547945205479452,1.0,1.0,4/7,26.74%,WNT5A;MAP3K13;DLG4;GRIP1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5995178293044426,-0.9852961463128602,0.47368421052631576,0.9653768443740022,1.0,1/5,0.17%,NEXMIF
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.47758751253720644,0.9852412588288739,0.5760869565217391,1.0,1.0,16/73,23.50%,PLPP3;DGKI;RPS6KB2;HIF1A;DGKB;WASF1;SLC44A5;DGKG;MAPK10;CHPT1;FOS;SLC44A1;PLD1;PRKCB;JUN;DGKE
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5518433708241454,0.9850775787032189,0.5185185185185185,1.0,1.0,4/20,9.26%,VEGFA;HSPA5;HIF1A;RBPJ
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.654618400377765,0.9847717233628032,0.5507246376811594,1.0,1.0,1/6,10.28%,ERRFI1
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.45707540920975065,0.9847393565200661,0.5257731958762887,1.0,1.0,31/123,24.06%,CENPF;CENPE;PPP2R5B;PPP2R5A;NUP133;XPO1;CENPP;RPS27A;RPS27;PSMB4;CLASP2;DYNC1H1;CKAP5;CENPK;CENPI;INCENP;SEH1L;UBA52;UBB;PSMC2;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;PSMD5;PSMD7;ITGB3BP;DSN1;PSMD14;PSMA5
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,-0.4400289670469776,-0.9845816072474235,0.4,0.9666937852047678,1.0,7/21,14.74%,ITGAM;KLRG1;GZMB;ITGAX;IL17RA;IL18R1;IL12RB1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6083418909125462,0.98456399673291,0.527027027027027,1.0,1.0,2/8,12.83%,DOCK5;NR4A3
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.5841958202054878,0.9845446061027704,0.5277777777777778,1.0,1.0,6/10,29.99%,MGAT4C;B4GALT5;ST8SIA3;B4GALT6;MGAT4B;B4GALT4
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5907114113614829,0.9845292343459304,0.5443037974683544,1.0,1.0,6/10,28.85%,ADGRG6;PARD3;SOD1;CNTNAP1;NCMAP;DICER1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.44222834752226886,0.9845198336194264,0.5463917525773195,1.0,1.0,48/175,25.39%,EEF1A2;RPL23;RPL37A;RPS6KB2;FTSJ1;RPL38;COPS5;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;RPL9;RPLP2;EEF1B2;DRG2;RPS18;PPA1;MRPL43;RPL37;RPL14;MRPL55;MRPL27;RPS4X;RPL11;RPS24;RPS9;RPL36;UBA52;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;TNIP1;EEF1A1;RPL24;RPL27A;RPL3;RPS16;RPL30;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5356038633902162,0.9844280705529017,0.5,1.0,1.0,1/17,0.62%,LRP2
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.3818534936021692,-0.9842323844333549,0.46153846153846156,0.9665979727405908,1.0,9/52,7.37%,GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;DDB2;ELOC;TP53;SUPT16H
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4931238785987115,0.984075015671859,0.4945054945054945,1.0,1.0,15/61,25.99%,MAPT;STMN3;VPS11;PDE2A;PDE4DIP;PINK1;CENPV;PLXNB1;CLIC4;SURF4;RDX;SYT11;TJP1;MTM1;TMEM33
prerank,Reactome_2022__CLEC7A/inflammasome Pathway R-HSA-5660668,-0.5444686323461069,-0.9840418457133604,0.5135135135135135,0.9661123867408883,1.0,1/6,2.23%,IL1B
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.61952612430592,0.9838268159684898,0.5522388059701493,1.0,1.0,3/7,34.46%,SPAST;CHMP4B;CORO1C
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.4272357994442025,-0.9838217019319242,0.42105263157894735,0.9658665073334469,1.0,4/16,9.62%,PSAT1;PSPH;ALDH7A1;GLYCTK
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5206323799849375,0.9837345252914758,0.5487804878048781,1.0,1.0,6/30,12.31%,SOCS3;IL15;VEGFA;GHR;HCLS1;CRLF1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5876066344300086,0.9836078494787803,0.5875,1.0,1.0,5/13,23.47%,SIRT5;BRCA1;PINK1;PPARA;TRAP1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5495680657930939,0.9835497789758614,0.5365853658536586,1.0,1.0,5/23,11.98%,SCN3B;ANK3;PKP2;PER1;NKAIN2
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.6776331903033632,0.9833572187766955,0.5737704918032787,1.0,1.0,2/5,15.06%,PKD1;WNT5A
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.5239531652983738,0.9833444000511673,0.5465116279069767,1.0,1.0,3/25,7.35%,HSPA5;EIF2AK3;HERPUD1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,0.6276948544840015,0.9831516803074584,0.6212121212121212,1.0,1.0,2/5,15.39%,ALCAM;THY1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.6143289294682102,0.9828494162130795,0.5522388059701493,1.0,1.0,3/8,14.21%,TRIM5;IFITM3;TRIM26
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4702371039641347,0.9824544063043104,0.4891304347826087,1.0,1.0,14/77,20.29%,CENPE;RACGAP1;KIF15;FCGR2B;ACTR1B;SEC24C;DYNC1H1;SH3GL2;KIF11;KIF5A;KIF3A;DCTN1;AP2A2;DYNC1I1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6413722401021895,0.9824338266055861,0.5138888888888888,1.0,1.0,2/7,21.14%,PINK1;MFN2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.5556015081244972,0.9823960344688578,0.5465116279069767,1.0,1.0,7/19,23.25%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.391062554303251,-0.9823593364741553,0.5714285714285714,0.9690110043969795,1.0,5/30,10.48%,NCOA4;NEDD4;PMEPA1;SRC;ZMIZ1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.6005070609717732,0.98219663326342,0.5512820512820513,1.0,1.0,5/12,25.32%,ANTKMT;PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.49186210757702414,0.9818128368875346,0.5,1.0,1.0,13/48,21.87%,KLF4;ANXA1;GPNMB;FHL1;ID2;PKD1;E2F7;CCND3;PLCB1;RGCC;RBL2;RDX;APPL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4778834869479477,-0.9817609510149382,0.391304347826087,0.9696157649348525,1.0,1/15,0.77%,NDE1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.6532086608962779,0.9817413309662804,0.5757575757575758,1.0,1.0,1/5,5.04%,VEGFA
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.6029203165875646,0.9817115264976133,0.4927536231884058,1.0,1.0,3/9,22.86%,MAPK10;FOS;JUN
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.526805918921621,0.981624465603207,0.5581395348837209,1.0,1.0,9/21,19.50%,MYRF;EIF2AK3;PTPRZ1;PTN;PARD3;TNFRSF1B;TPPP;NKX6-2;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.6736977713334966,0.9816205574342148,0.5384615384615384,1.0,1.0,3/7,18.33%,ANK2;ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.5760986575134278,0.9813980670232312,0.5571428571428572,1.0,1.0,4/9,37.51%,PNPLA8;PGS1;PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5379114461063813,0.9813582164635959,0.6282051282051282,1.0,1.0,7/28,16.88%,MAPT;GPM6B;TTBK2;CAV3;OTUD7B;PICALM;UBXN2B
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.45358344957349345,0.9812390449723454,0.5408163265306123,1.0,1.0,22/104,24.35%,TOP2A;PPP2R3B;RPS27A;PSMB4;POLE2;CCND3;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;PSMB2;RBL2;CDKN1B;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.45710994284799883,0.9811584171802514,0.5510204081632653,1.0,1.0,27/124,18.90%,GPR18;GRM8;PRKAR2B;RGS20;PDE1A;ANXA1;GNA11;RGS1;GRM3;MCHR2;PDE1C;C5AR1;PDE4B;ADCY8;CAMK2B;GNAI1;RGS11;RGS17;GNAL;GPR183;HTR1F;PLCB1;APP;GPSM2;GRM7;GNAQ;ACKR4
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.5853891516709755,0.9810281032841378,0.56,1.0,1.0,5/15,18.05%,PTPRZ1;SNAP25;IFNLR1;CASP3;STXBP2
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5474728063284512,0.9808874999697198,0.5211267605633803,1.0,1.0,7/16,25.30%,SNAP25;NLGN1;SLC17A7;CPLX1;RAB5A;BRSK1;RIMS1
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.5502712038496383,0.980867026299946,0.5063291139240507,1.0,1.0,1/17,1.95%,DPYD
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.5277617773409344,0.9807888213226186,0.5,1.0,1.0,3/20,10.76%,NR4A1;RPS6KB2;PRR5
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.39874070733653394,-0.9807327799781633,0.45,0.9712218712166308,1.0,5/18,14.32%,IL1B;IL1A;IGF1;TGFA;ANAPC4
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.43583437258206653,-0.9805237247393283,0.47058823529411764,0.9709345006636969,1.0,2/17,4.46%,CALCR;LILRB4
prerank,KEGG_2021_Human__Platelet activation,-0.32683508971653524,-0.9805103672462299,0.5,0.9700348158978429,1.0,24/89,14.46%,PLA2G4C;P2RX1;PIK3R6;ACTB;STIM1;ITPR2;ARHGAP35;MAPK13;TLN1;ARHGEF1;FYN;GNAS;SRC;P2RY12;PTGS1;RASGRP2;BTK;APBB1IP;LCP2;TLN2;SYK;RAP1A;AKT1;PIK3R5
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.6195446703116437,0.980497961743332,0.5512820512820513,1.0,1.0,2/8,15.06%,GPRC5B;WNT5A
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.4548088342980751,0.9803370914036305,0.5416666666666666,1.0,1.0,44/170,24.06%,CENPF;TUBA4A;CENPE;PPP2R5B;TUBB4A;TUBA1A;PPP2R5A;TUBB6;NUP133;RCC1;XPO1;CENPP;RPS27A;LMNB1;RPS27;PSMB4;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;INCENP;TUBB2A;SEH1L;UBA52;TUBA1C;UBB;PSMC2;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;VRK2;PSMD5;PSMD7;ITGB3BP;TUBA1B;NDC1;DSN1;PSMD14;VRK1;PSMA5
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.4548088342980751,0.9803370914036305,0.5416666666666666,1.0,1.0,44/170,24.06%,CENPF;TUBA4A;CENPE;PPP2R5B;TUBB4A;TUBA1A;PPP2R5A;TUBB6;NUP133;RCC1;XPO1;CENPP;RPS27A;LMNB1;RPS27;PSMB4;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;INCENP;TUBB2A;SEH1L;UBA52;TUBA1C;UBB;PSMC2;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;VRK2;PSMD5;PSMD7;ITGB3BP;TUBA1B;NDC1;DSN1;PSMD14;VRK1;PSMA5
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,0.6045244372929841,0.9799951913551824,0.5068493150684932,1.0,1.0,2/8,15.39%,LIFR;THY1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.4936742955786805,-0.9799634687840121,0.4,0.9707112735203014,1.0,1/12,0.82%,PDE12
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.34258762498232737,-0.9798915265906603,0.5,0.969938347384924,1.0,25/84,14.46%,PPP1R16B;GIMAP8;BIN2;CD2;SAMSN1;MPEG1;SH2D3C;RASAL3;AOAH;MYO1F;P2RY14;NCKAP1L;WDFY4;PLEK;HCK;RASGRP2;BTK;HLA-DPA1;LCP2;TYROBP;CD53;SNX20;GIMAP4;GIMAP7;PIK3R5
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4016721608862559,-0.9797891163082759,0.3333333333333333,0.9694786829387546,1.0,9/32,12.15%,SERPINF2;PFN1;EVL;LPAR1;NF2;SORBS3;PLEK;ABL1;PPM1F
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.4925156877253014,0.9796443816570308,0.49411764705882355,1.0,1.0,7/40,17.05%,LRP2;GPC5;CHURC1-FNTB;SLC24A1;RDH11;NAPEPLD;GRK4
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5353344117470996,-0.9795855145877483,0.5,0.9691818695896003,1.0,1/11,0.88%,MAIP1
prerank,KEGG_2021_Human__Endometrial cancer,0.4944324754183485,0.9790440774267727,0.4942528735632184,1.0,1.0,6/45,13.99%,ARAF;GADD45B;TCF7;TCF7L1;APC2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.5122514414750831,-0.9789481463908815,0.45454545454545453,0.9697694342054314,1.0,1/9,2.10%,CEBPA
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.49738856204533216,0.9788630353822708,0.5,1.0,1.0,3/36,9.50%,RHOB;FIGNL1;KDM1A
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,0.48272237989378985,0.9787356290621136,0.5632183908045977,1.0,1.0,6/60,4.92%,CLEC12A;VIM;ANXA1;CLSPN;MAP3K8;F13A1
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5369354000392859,0.9787130118122283,0.527027027027027,1.0,1.0,7/17,22.83%,RTN1;NTRK2;PICALM;ROCK1;RTN3;FLOT2;RTN4
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,0.5018633768857551,0.9786760293607232,0.5591397849462365,1.0,1.0,11/42,15.99%,SPARC;ENPP2;PREX2;TNS1;CDH2;CD93;SGIP1;FLT1;SHROOM4;ANGPT2;LDB2
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.5789383079990374,-0.9784066670277554,0.47619047619047616,0.9704180675826843,1.0,1/5,0.24%,ITK
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.5036559702403616,0.9783499842585884,0.5116279069767442,1.0,1.0,10/36,18.81%,TGFB2;XPO1;RPS27A;ITGB8;LTBP1;PPP1R15A;UBE2M;ITGAV;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5890181480558302,-0.9781228687660303,0.475,0.9702330288690373,1.0,2/6,8.70%,KRT10;MAFG
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.5526080441598109,0.9780356244407222,0.5352112676056338,1.0,1.0,2/16,4.63%,ACVR2A;BMPR1B
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.47138583951598334,0.9777085207059076,0.5280898876404494,1.0,1.0,11/74,11.15%,GRM8;CENPE;C5ORF34;IGSF11;KIF15;PTPRK;LAMB1;NUP133;ITGAE;LMO3;MFAP3L
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.40771979732395724,-0.9776635290382933,0.375,0.9706317418052786,1.0,9/34,10.10%,FMO4;CYP2S1;CYP19A1;BPHL;NQO2;CYP4V2;CYB5R3;SMOX;PTGS1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.3751637544592681,-0.9775877454307282,0.375,0.9699508074097244,1.0,5/20,18.72%,NBN;TERF2;SMG6;UPF1;ERCC4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5358038668478691,0.9773642782044296,0.5569620253164557,1.0,1.0,3/22,13.26%,ARRDC3;BMI1;PINK1
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,-0.4937261967383686,-0.9773316903730375,0.4074074074074074,0.9697915119723332,1.0,2/8,14.48%,IL6R;IL6ST
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6078430421560072,0.9771578380797412,0.5416666666666666,1.0,1.0,1/9,3.87%,ANXA1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.37503751314616846,-0.9771506736500011,0.4166666666666667,0.9692488078590304,1.0,5/45,3.76%,TCF3;LYL1;BANK1;HHEX;BLNK
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.5553359829457556,0.9771187685438668,0.5421686746987951,1.0,1.0,5/19,18.81%,RPS27A;RNF139;SYVN1;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.49918389070262326,0.9770997352763903,0.4946236559139785,1.0,1.0,13/47,19.33%,PRKCE;MAPT;ARF6;BAIAP2L1;CAV3;CARMIL1;PINK1;TPPP;PYCARD;TOGARAM1;DCTN1;FES;CDK5R1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5283294836665168,0.9769991104252911,0.5975609756097561,1.0,1.0,4/21,20.15%,CYREN;TFIP11;ERCC6;KMT5C
prerank,KEGG_2021_Human__RNA polymerase,0.529295422808024,0.9769843467708855,0.5128205128205128,1.0,1.0,5/22,21.28%,POLR3F;POLR1C;POLR3H;POLR2D;POLR2G
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.5394242210036627,0.9769233602238618,0.5432098765432098,1.0,1.0,1/17,0.66%,RHOB
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.5021207639469679,0.9768277605382261,0.5402298850574713,1.0,1.0,3/39,3.44%,NUDT12;NUDT16;RIDA
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.4098576531018801,-0.9764562838830635,0.42857142857142855,0.9702034181972514,1.0,3/22,4.64%,SMDT1;MAIP1;MICU3
prerank,KEGG_2021_Human__Cholesterol metabolism,0.507946309223593,0.9764540463391563,0.5,1.0,1.0,5/31,12.09%,LRP2;VAPB;ABCA1;NCEH1;PLTP
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.45658794658890456,-0.9764255876968277,0.46153846153846156,0.9693895504341954,1.0,2/11,7.54%,RALB;CGAS
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.602500780925243,0.9760524708784686,0.55,1.0,1.0,5/7,39.33%,MCMDC2;MCM3;MCM6;MCM5;MCM7
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5596659719773965,0.9759752954386742,0.5443037974683544,1.0,1.0,1/12,1.43%,SULT4A1
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.46973430419316237,0.975960835913682,0.5376344086021505,1.0,1.0,10/70,18.23%,EIF4A3;PPP2R3B;PPP2R5B;PPP2R5A;PPP2R2B;UPF3A;BCL2L2-PABPN1;NXF1;PPP2R3A;PYM1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.4763597227627836,0.9757397779343162,0.5263157894736842,1.0,1.0,5/60,5.77%,SOCS3;CLIP3;LIFR;TRAF2;IL7
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.4816958130214521,0.9752883525254489,0.5348837209302325,1.0,1.0,3/44,6.84%,TRMT9B;FTSJ1;PUS7
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5300388698280437,0.9752795372168136,0.5679012345679012,1.0,1.0,10/31,27.30%,MAPT;RPA2;MCL1;NSMCE1;CDK9;NPAS2;BCLAF1;ETAA1;WDR76;FEM1B
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),0.6495076049605457,0.9751679957651841,0.5652173913043478,1.0,1.0,3/5,30.54%,STARD5;SCARB1;STARD4
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),0.6495076049605457,0.9751679957651841,0.5652173913043478,1.0,1.0,3/5,30.54%,STARD5;SCARB1;STARD4
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.33495930108750194,-0.9750740337275868,0.36363636363636365,0.9717616570943036,1.0,17/66,10.50%,NKG7;GRAP2;CD300LF;NCOA4;TAL1;LYL1;BIN2;GYPC;P2RX1;UCP2;EDRF1;RBM38;EPOR;HTATSF1;MYO1F;BTK;DCAF12
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.3140451026964547,-0.9750481806098587,0.5,0.9709355233672763,1.0,16/114,8.38%,CCL5;CARD14;GBP3;INPP5K;PSMB3;PSME3;CHUK;EDA2R;DAB2IP;CDIP1;MAP3K14;PSMC4;TP53;PSMD12;ILK;PSME4
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.41374572029500156,-0.9747124886138602,0.35,0.9709117169425601,1.0,4/18,9.42%,NEXMIF;ACER2;P2RY12;NCKAP1L
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.47971761756704867,0.9745573357790079,0.5517241379310345,1.0,1.0,6/48,12.41%,KLF4;NAPSB;FCGR2B;FGR;CD93;CYCS
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.6502409470200881,0.9745327579762989,0.5714285714285714,1.0,1.0,4/6,31.55%,EZH2;DOT1L;RIF1;EZH1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3545825201995826,-0.9745208955636508,0.5,0.9705556363002872,1.0,6/28,8.95%,CCL5;IL1B;CYP19A1;TGFB1;TLR3;HLCS
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.5266683100951053,0.9744546012255466,0.5402298850574713,1.0,1.0,1/16,0.66%,RHOB
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.5611032008404089,-0.9741518356428466,0.45161290322580644,0.9697717631301489,1.0,2/5,18.82%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.5611032008404089,-0.9741518356428466,0.45161290322580644,0.9697717631301489,1.0,2/5,18.82%,NR1H3;PPARG
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.5120722047429985,0.9741312757210466,0.49382716049382713,1.0,1.0,8/28,15.06%,VEGFA;ARNT2;DEAF1;HINFP;SULF2;BRCA1;PKD1;WNT5A
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.522455208480079,0.9740494572493164,0.5977011494252874,1.0,1.0,12/34,20.01%,RPA2;TDG;MPG;DNA2;NEIL1;POLQ;RFC4;POLL;ERCC6;NEIL2;ADPRS;RFC1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.6091338885682869,0.9738266968296059,0.6290322580645161,1.0,1.0,2/6,26.92%,VCPIP1;WAPL
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.5384786106430915,-0.9738030977315748,0.5483870967741935,0.9696632181522791,1.0,2/8,6.50%,BCL2L1;TP53
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.44448079696477627,0.9736790574377826,0.5157894736842106,1.0,1.0,6/98,7.37%,SOCS3;PIGU;ITPKC;INPP4B;MTMR7;PIGQ
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.4816212728908351,0.9735777256857707,0.5294117647058824,1.0,1.0,17/47,26.87%,TFRC;STEAP2;FLVCR1;RPS27A;FTH1;ALAD;UBA52;UBB;FBXL5;ATP6V0B;ATP6V1B2;HFE;ATP6V0E2;ATP6V1D;TF;SLC11A2;ATP6V1E2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5832157358948982,0.973481450003868,0.5285714285714286,1.0,1.0,1/10,5.63%,CD55
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.33574517290612976,-0.9732787412837424,0.36363636363636365,0.9701311962912256,1.0,17/64,15.26%,CHUK;BLNK;LILRB4;NFKBIE;KRAS;DAPP1;NFATC3;INPP5D;BTK;IKBKB;NFKBIA;PPP3CC;SYK;BCL10;AKT1;CARD11;LILRA2
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.4963223917289942,0.9732261327866083,0.5777777777777777,1.0,1.0,8/54,14.36%,BRIP1;H2BC11;CLSPN;PIAS4;DNA2;RPS27A;BRCA1;RFC4
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.39953432807265754,-0.9731738765637591,0.45454545454545453,0.9694589864224029,1.0,6/42,6.63%,CCL5;PDE12;GBP3;LGALS9;SIRPA;DAPK3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.5889144170625161,0.9731681605117825,0.5540540540540541,1.0,1.0,4/9,25.54%,ABCA1;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.5932134913727587,0.9730946920691483,0.575,1.0,1.0,6/14,34.95%,PER1;SFPQ;SMARCAD1;HDAC9;HDAC4;HDAC3
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.6226026122009312,0.9730741347202078,0.5757575757575758,1.0,1.0,2/7,21.19%,DBF4;WIZ
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.6279413021827824,0.9729911633233251,0.547945205479452,1.0,1.0,4/7,18.70%,NTN4;LAMB1;FLRT2;NTNG1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.4866706383700109,0.9723927501230715,0.5217391304347826,1.0,1.0,11/33,27.37%,RPA2;FIGNL1;FANCB;KDM1A;POLQ;ERCC6;TIMELESS;MAGEF1;SPIDR;UBQLN4;ARID2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6360416069416375,0.972322179353124,0.5789473684210527,1.0,1.0,1/7,4.63%,BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.6650724255304094,0.9723213970397597,0.6129032258064516,1.0,1.0,2/5,25.45%,STPG4;TOX
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.6650724255304094,0.9723213970397597,0.6129032258064516,1.0,1.0,2/5,25.45%,STPG4;TOX
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,-0.6279497529944891,-0.9721747444867752,0.52,0.9712726035025411,1.0,1/6,4.79%,WWTR1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.46747548749180934,-0.9721692760334534,0.4782608695652174,0.9703682528475108,1.0,4/14,20.50%,GCLC;GCLM;FPGS;MGST2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.49969908813620006,0.9720743521492528,0.5875,1.0,1.0,7/40,8.95%,TNC;ENAH;FBXL7;RND3;MYO10;TCF7L1;PTN
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,0.6647454631243805,0.9719531628564327,0.5692307692307692,1.0,1.0,2/5,11.67%,APOLD1;FLT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,0.5146681182350727,0.9719243650988842,0.5342465753424658,1.0,1.0,6/14,23.28%,INSR;FLT1;THBD;FGFR2;TSPAN7;F8
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.5272420858213879,-0.9719098909878758,0.4838709677419355,0.9701374927557675,1.0,1/6,2.23%,IL1B
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5518743129230091,0.9718691845488188,0.5428571428571428,1.0,1.0,3/16,10.26%,MAPT;VEGFA;SEMA5A
prerank,CellMarker_Augmented_2021__Macrophage:Spleen,0.622386422267617,0.9718659778058119,0.6307692307692307,1.0,1.0,2/6,4.68%,CD163;ADGRE1
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.558715331292819,0.9717105543501607,0.532258064516129,1.0,1.0,3/11,14.10%,ALOX12;THBD;SERPINE2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.564109587378648,0.9716846053741448,0.5227272727272727,1.0,1.0,6/20,18.04%,PDK4;MID1IP1;PRKAG2;BRCA1;ERLIN1;PRKAA2
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.5432824937922353,-0.9715977681002355,0.53125,0.9701634698699853,1.0,2/6,11.88%,FFAR4;CTBP2
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,0.46325447361185007,0.9715708139449043,0.5520833333333334,1.0,1.0,5/95,6.24%,PCSK1;H2BC11;VPS37C;KCNH8;NUP133
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.47502678701147893,0.9714298398381298,0.5232558139534884,1.0,1.0,7/69,8.46%,TGFB2;EGR1;PRKCE;COL4A5;AGT;VEGFA;FN1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4626486738943584,0.9712637778190258,0.5957446808510638,1.0,1.0,19/76,25.32%,ALDH3B1;TMEM161A;ERMP1;CYCS;SOD2;PINK1;CPEB2;HSPA1B;GSTP1;PRKAA2;SOD1;ERO1A;STX2;LRRK2;VRK2;FOXO3;DDX3X;TXNRD1;PPARGC1A
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5317244468049354,0.9712267021782777,0.5061728395061729,1.0,1.0,4/18,9.57%,FGF1;CHI3L1;VEGFA;CCDC39
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.5081461646547969,0.9711959058322759,0.49382716049382713,1.0,1.0,6/23,26.87%,SLC11A1;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.3380804046761095,-0.9710948513881075,0.4,0.9706039887544575,1.0,22/69,16.63%,FCGR1CP;CD300LF;CX3CR1;LY86;SELPLG;CSF1R;PPM1M;GLIPR1;CAP1;HLA-E;HCK;TREML1;TYROBP;ARL6IP5;GIMAP4;ITM2B;CMKLR1;NAGK;RCBTB2;OSTF1;ANXA5;MS4A14
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5494757132254953,0.9710604924667234,0.5432098765432098,1.0,1.0,2/15,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6021420214475113,0.970942390432475,0.5522388059701493,1.0,1.0,2/7,9.30%,INSR;IGF1R
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.4945580185812612,0.9709421925158569,0.6263736263736264,1.0,1.0,5/47,11.42%,GPR18;KANK1;ROBO1;ABCA1;GPR65
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6029376569482963,0.970796606834886,0.5942028985507246,1.0,1.0,2/8,19.10%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6029376569482963,0.970796606834886,0.5942028985507246,1.0,1.0,2/8,19.10%,KANK1;AP1AR
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.4909298367295695,0.9704656554674386,0.5555555555555556,1.0,1.0,4/39,4.12%,TULP2;GRM8;COL11A1;SLC4A10
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.6103762811476694,0.9704093018059958,0.6231884057971014,1.0,1.0,1/10,3.16%,PIGU
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,-0.33848116758096297,-0.970347203805033,0.5,0.9715066258170915,1.0,16/69,10.78%,FCGR1CP;CD300LF;ITGAM;LY86;PTAFR;MPEG1;FOLR2;CSF1R;LILRB4;P2RY13;SIRPA;ITGAX;MYO1F;IGSF6;HCK;FCGR1A
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.48881546050887276,0.9701950400341656,0.5473684210526316,1.0,1.0,9/56,11.42%,GPR18;TACR1;JPH1;CD55;CAV3;RYR2;C5AR1;ADCY8;GPR65
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.5523303608647374,-0.9701315677294524,0.4827586206896552,0.9712391524933013,1.0,5/9,20.64%,IL1B;AKAP8L;FMR1;AKAP8;RPS6KA5
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.44559821016354323,0.9699394108677409,0.6,1.0,1.0,46/177,21.94%,FGF1;ARAF;PPP2R5B;NRG1;KITLG;PPP2R5A;PAQR3;CHURC1-FNTB;FN1;SHC2;IRS2;RPS27A;SPTAN1;PSMB4;RBX1;CAMK2B;NRG3;PHB1;ZDHHC9;LRRC7;PEBP1;CNKSR2;RASGRF1;GRIN2B;NEFL;DUSP10;SPTBN5;WDR83;NRG4;RASGRP4;IQGAP1;SPTBN1;UBA52;UBB;PSMC2;NRG2;SPTBN4;PSMA3;DUSP16;NCAM1;PSMB2;DUSP6;FGFR2;DUSP12;PSMD5;PSMD7
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.6413471694503133,0.9698181751137501,0.6164383561643836,1.0,1.0,4/7,29.10%,NEBL;FHOD3;TTN;PROX1
prerank,Reactome_2022__Kinesins R-HSA-983189,0.5253578788612022,0.9695232479645524,0.5411764705882353,1.0,1.0,9/26,17.12%,CENPE;RACGAP1;KIF15;KIF1B;KIF21A;KLC4;KIF11;KIF5A;KIF3A
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.40390124349990636,-0.9692484005169982,0.42105263157894735,0.9728326471604504,1.0,3/22,6.51%,PPP1R16B;ICAM1;RAPGEF6
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.39401683973706203,-0.9692462592780929,0.5333333333333333,0.9719327094664999,1.0,5/31,10.83%,NUP42;NEK6;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.459968601162124,0.9692251092677442,0.5851063829787234,1.0,1.0,19/76,23.37%,BRIP1;CLSPN;RPA2;WDHD1;DNA2;DONSON;POLG2;BRCA1;RFC4;POLE2;ORC6;POLL;DBF4;TIMELESS;RFC1;RBBP8;BARD1;RPA3;ORC3
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),-0.5712219699827805,-0.9691932793856782,0.5675675675675675,0.9712164973726113,1.0,2/7,6.41%,CX3CR1;SIRPA
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.4657120489519734,-0.9691931518163913,0.5,0.9703197139031998,1.0,6/16,26.08%,ACO2;SUCLA2;MDH2;IDH3B;IDH3G;IDH3A
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.607610678443159,0.9691172055635415,0.5921052631578947,1.0,1.0,1/10,7.02%,ABCA2
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,0.6209482781951432,0.9688594224040937,0.6081081081081081,1.0,1.0,2/7,14.89%,ACAT1;HMGCS1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.4813369300642847,0.9687447086387102,0.5955056179775281,1.0,1.0,10/60,16.96%,HTR2B;PRKCE;ADCY3;ALOX12;CALM3;ADCY8;CAMK2B;MAPK10;ASIC2;PLCB1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.547359584822936,0.9687440161148279,0.5875,1.0,1.0,6/14,21.98%,ATP5ME;ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6356137262736611,0.9683874562252209,0.5362318840579711,1.0,1.0,1/6,4.63%,BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49464503193202825,0.9683349460509865,0.5978260869565217,1.0,1.0,2/49,1.30%,KLF4;NLRP12
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.49361993956436434,0.9680279401965397,0.5747126436781609,1.0,1.0,11/41,22.37%,GPM6A;NYAP2;WASF1;CNTNAP2;SLC9A6;PLXNB1;UBB;CNTNAP1;LRRK2;CTTN;DCLK1
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,0.6370172103185363,0.9677447703529853,0.6031746031746031,1.0,1.0,2/5,15.39%,ALCAM;THY1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.5343271731093473,0.9676759448290922,0.5866666666666667,1.0,1.0,2/17,8.84%,HMGB2;TXN
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,0.4380804173915971,0.967604302171907,0.65,1.0,1.0,112/435,22.97%,DDIT4;KLF4;MDH1;VIM;NFE2L3;RPL23;CCPG1;NMRAL1;GLIPR2;TUBB4A;ENC1;DMD;ARID5B;SOX4;TUBA1A;TRIP10;ENO2;TUBB6;RBM3;CARHSP1;ETFB;IMP3;PGAM1;DAPK1;MARCKSL1;RPL38;CA2;MYO10;PTK7;AKAP12;RAB15;PAICS;TXN;RPS6;RPL7L1;PTN;TAGLN3;ABCA1;ASRGL1;MCL1;RPL23A;POU5F1;IFITM3;POLR1C;RPS25;GPRC5B;CRIP2;CNNM3;NHP2;SASH1;PLTP;RPL9;PPP1R3B;CYCS;SNX10;BNIP3;RPS18;PKM;RPL37;PPP1R15A;RPL14;PYCARD;SDCBP;PLLP;THY1;PLOD1;DHX33;UGCG;GCNT1;RPS4X;RPL11;LITAF;RPS24;POLR2D;TEC;PCBD2;PLD3;APBB2;GSTP1;SUMF1;TSPAN18;PCED1B;ABRACL;FGD4;FES;LAPTM4A;TUBA1C;NTNG1;ZC3HAV1;TMSB10;SLC66A3;SCPEP1;RPS3A;SLC3A2;CTPS1;PGM1;ENO1;RPL35;RPL4;UTRN;RPL32;SERINC5;MTHFD1;EEF1A1;CHP1;GNL3;PABIR3;MYL6;RPL24;RPL27A;RPL3;LPCAT4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.44441094413497106,0.9675793502322682,0.5578947368421052,1.0,1.0,25/109,21.34%,PTPRD;PPP2R3B;PPP2R5B;PTPRG;PTPRK;PPP2R5A;EYA2;PTPRZ1;MTMR7;PP2D1;PTPRT;PPP2R2B;PPM1E;PPM1L;PPP1R15A;DUSP10;PTPN9;PPP2R3A;PTPN5;DUSP16;CTDSP1;SSH2;DUSP6;PTPRS;DUSP12
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.44036684696980527,0.9672611526955859,0.66,1.0,1.0,114/651,17.75%,RHOB;COBL;MAP7D2;SH2D4A;ARRDC3;FMN1;CBR1;ACSL1;SYCP2L;CADM1;ZBTB16;PPP1R9A;JPH1;SMC1B;NRG1;NRXN1;NELL2;ACVR2A;BMPR1B;CCDC122;KCTD2;CSMD3;PHLPP1;INTS12;NDRG1;TCF7;CD55;EYA2;MBOAT2;RUNX1T1;SLC41A3;FHL1;RGS2;ADGRG6;BAIAP2L1;GRB10;KLHL23;HSF2;PALLD;CHN1;PAQR3;TCF7L1;TRPS1;ROBO1;BNIP3L;SRSF12;FAIM2;MAP2;FN1;NDRG2;ID2;BOK;RYR2;ZNF518A;PLK2;GLUL;TXNIP;WASF1;ELOVL4;PTOV1;BZW1;ERRFI1;LTBP1;SPTAN1;PRR5;IMPACT;NR2F1;CNTNAP2;MXI1;CTHRC1;CAMK2B;PRKAG2;MPP1;DNAH7;SH3GL2;PARD3;GNAI1;RBM4B;ZCWPW1;LY6H;LIMCH1;KLC4;NKIRAS1;SERPINE2;GNAL;EIF2B2;ASPH;ABCA5;CYRIA;DUSP10;PELI1;NDRG4;C11ORF65;SMARCD3;PEMT;TBL1XR1;SHISA9;EPB41L4B;SHQ1;DENND5A;GBP2;MTUS1;CHD5;SMAD1;C5ORF58;KIF3A;HSPB1;MPDZ;HSPA1B;AMPH;FOXP1;EPB41L5;NEIL2;ZBTB18
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,0.43793123417663826,0.9672068665462831,0.67,1.0,1.0,87/467,20.52%,FA2H;SLC51A;GDPD1;PLPP3;LRP2;ALDH3B1;PLIN2;CBR1;ACSL1;TM7SF2;IDI1;SLCO1A2;CD163L1;FAAH2;ALOX12;PIAS4;RXRB;ALOX15B;MBOAT2;INPP4B;DGAT1;VAPB;MVD;ACSS3;MTMR7;ACOT13;ARNT2;SCD5;ABCA1;MID1IP1;MFSD2A;ELOVL4;AKR1B1;SELENOI;OSBPL10;SH3D19;LIPE;ARSA;SEC24C;CPT1A;AGPS;PRKAG2;GALC;CCNC;SLC44A5;SLC10A1;PPM1L;UGT8;SPTLC2;FASN;INSIG1;SCD;STARD5;HSD17B12;GK;FDFT1;HMGCS1;SMARCD3;LTA4H;PEMT;UGCG;TBL1XR1;SUMF2;PNPLA8;PRKD3;ETNPPL;PLD3;DDHD1;SUMF1;PIK3R4;MTMR9;CHPT1;PRKAA2;PNPLA7;GBA3;PPARA;MSMO1;TNFRSF21;ACSL3;SLC44A1;CYP46A1;OSBPL5;STS;CDS2;NR1D1;GPAT4;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.547753841642211,0.9671884567917974,0.5915492957746479,1.0,1.0,5/20,22.07%,ID2;HCLS1;FES;TNF;CTNNBIP1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.6770516717325228,0.9671848289806851,0.6271186440677966,1.0,1.0,5/5,32.32%,CACNG2;CACNG8;DLG4;CACNG3;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.6770516717325228,0.9671848289806851,0.6271186440677966,1.0,1.0,5/5,32.32%,CACNG2;CACNG8;DLG4;CACNG3;GPHN
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,-0.6313695185871103,-0.9670704949222843,0.6060606060606061,0.9740625954943306,1.0,2/5,13.58%,EGFR;TGFA
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,-0.6313695185871103,-0.9670704949222843,0.6060606060606061,0.9740625954943306,1.0,2/5,13.58%,EGFR;TGFA
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4420315571235268,0.967067934940058,0.5454545454545454,1.0,1.0,17/125,13.26%,DAPK2;ACVR1B;RIOK2;AATK;EIF2AK3;INSR;DAPK1;IGF1R;FGR;ALK;CLK2;TYRO3;CAMK2B;FLT1;NTRK2;EPHA4;PINK1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6427106414962626,0.967048977190885,0.5789473684210527,1.0,1.0,3/5,31.18%,PMPCA;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.5096158573601861,0.967016544642328,0.5116279069767442,1.0,1.0,8/35,18.97%,ETFB;NDUFS8;CYCS;NR4A3;UQCRFS1;ATP5F1D;UQCRC1;SIRT3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.6265668467567238,0.9669243146607955,0.5492957746478874,1.0,1.0,3/5,32.04%,PKM;YBX3;DHX9
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.5744200458052175,0.9668427203874712,0.6153846153846154,1.0,1.0,3/12,7.96%,PRKAR2B;AKAP6;AKAP12
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5819388643581187,0.9667888476212972,0.5753424657534246,1.0,1.0,3/16,10.73%,SCN3B;CAV3;FXYD7
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),0.617584919691559,0.9662954812084128,0.6081081081081081,1.0,1.0,2/7,20.20%,MFSD2A;TNF
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5185724366987247,0.965997053913182,0.5555555555555556,1.0,1.0,4/17,15.39%,CD22;FCGR2B;CD300A;THY1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.3496411745932864,-0.9659186222924395,0.5,0.9759711912590656,1.0,15/94,8.91%,TNFAIP8L3;CCL5;CALCR;SERPINF2;FFAR4;LGALS9;CSF1R;SCIMP;ICAM1;P2RY6;TGFB1;PDGFD;PHB2;ROR2;CRKL
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5160135449913164,-0.9657451295431808,0.5348837209302325,0.9755324361924308,1.0,2/9,13.31%,TGFB1;DAB2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5571307058342864,-0.9656737576131031,0.4857142857142857,0.974913429550662,1.0,1/7,9.22%,HLA-E
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4347520952484299,-0.9652784316758837,0.5,0.9752000189903248,1.0,1/15,1.27%,BTG2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.4409049368554955,0.9652332256699266,0.6060606060606061,1.0,1.0,61/187,26.37%,LRP2;CR1;TFRC;NAPA;TRIP10;VAPB;ANK3;ANK2;SYP;DNAJC6;FCHO2;CAV3;DNM3;RPS27A;DNM1;SGCZ;SGIP1;SH3GL2;SYT1;SPAST;SNAP29;SERP1;AGFG1;ITSN1;REEP3;PICALM;WNT5A;UBXN2B;SPTBN1;AMPH;ATP10B;UBA52;UBB;AP2A2;SYNGR1;SUN2;HIP1R;CLTCL1;CNTN2;IL7R;NAPG;MFN2;MTCH1;CHP1;RAB5A;HACE1;CTTN;CHMP5;PLEKHA3;PDCD6IP;CFTR;REPS2;CHMP7;TF;RIMS1;VAPA;AP2S1;TMEM33;SYT9;OPA1;IGF2R
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.5387372140808186,0.9652053973523536,0.5466666666666666,1.0,1.0,2/18,10.68%,PRKAR2B;PDE4B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.46113380467781734,0.9651754326046559,0.5777777777777777,1.0,1.0,6/49,7.04%,RHOB;BRINP1;NR4A1;PTPRK;ALOX15B;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.4992238672026956,0.9650753106215262,0.5411764705882353,1.0,1.0,11/29,21.83%,THBS1;OGN;ID2;NR4A3;NDRG4;IL18;FOXP1;TNF;MFN2;CX3CL1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.45326460208805763,0.9648723401852162,0.5698924731182796,1.0,1.0,18/67,23.76%,KLF4;NLRP12;TYRO3;GRID2;EPHA4;CTNNA2;MACIR;TNFRSF1A;PPARA;LRFN5;NR1D1;PTPRS;IRAK3;RTN4RL1;PTGER4;RORA;GPS2;PTEN
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.4761905628112288,0.9647567574166508,0.5666666666666667,1.0,1.0,17/59,25.06%,TUBA4A;TUBB4A;TUBA1A;TUBB6;NUP133;RCC1;LMNB1;SPAST;TUBB2A;SEH1L;TUBA1C;VRK2;TUBA1B;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.4891432356386456,-0.9647316247215071,0.4444444444444444,0.9755945181138851,1.0,1/13,0.57%,TGFBR3
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.4266936701126059,-0.9646525140220772,0.5217391304347826,0.9749049325981034,1.0,5/16,20.79%,CSF2RA;INPP5D;PTPN6;CSF2RB;GAB2
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,0.4443239960697937,0.9644693786467943,0.63,1.0,1.0,84/303,26.06%,TSPAN13;TGIF1;CADM1;PPP1R9A;CDH2;C21ORF91;DMD;MASTL;TUBA1A;CD55;INSR;RAB20;KIAA1958;TCEAL2;KLHL23;MYO10;TTYH1;ARNT2;SLAIN1;KIF21A;ENDOD1;UNC80;BEX2;MID1IP1;IGF1R;MAP1B;GALNT18;CKB;GPRC5B;CACNA2D3;CRTC3;PDE4DIP;CPT1A;ASTN2;GNAI1;PPA1;TRIM16;PEBP1;PPP1R15A;LIMCH1;ALDH1A1;DISP1;PLLP;CPE;PDK3;GBP2;ARAP2;SLC25A4;SPINT2;SLC39A14;PLXNC1;PCED1B;STXBP2;ABRACL;HPRT1;SESN1;PRDX4;ANKRD6;SYNGR1;BEX1;SLC3A2;UCHL1;BRICD5;KIF5C;RDX;CNDP2;FHOD3;PABIR3;TSPAN7;SYT11;TJP1;F8;MBNL2;ARHGAP18;FOXO3;MBOAT7;RUFY3;FLYWCH2;TOX;ATP2B4;MTM1;DYNLL1;RELL1;SMARCA5
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.4644965183017519,0.9643912369151478,0.5333333333333333,1.0,1.0,7/52,17.68%,CYREN;HMGB2;PIAS4;POLQ;BRCA1;POLL;ERCC6
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5573056862672466,0.9641926178975313,0.5714285714285714,1.0,1.0,3/14,22.06%,INTS12;INTS8;INTS6
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.46974946147398755,0.9634679681443605,0.5280898876404494,1.0,1.0,11/52,19.33%,RHOB;SEMA3A;DPYSL5;SEMA6A;CRMP1;SEMA5A;PLXNB1;ROCK1;PLXNC1;FES;CDK5R1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.46779072824392426,0.9633410208759425,0.5053763440860215,1.0,1.0,14/72,18.85%,TGFB2;TGIF1;XPO1;RPS27A;ITGB8;LTBP1;CCNC;PARD3;PPP1R15A;UBE2M;ITGAV;UBA52;UBB;CDK9
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.530246353473193,0.9633184927656983,0.5454545454545454,1.0,1.0,6/16,29.99%,MGAT4C;B4GALT5;ST8SIA3;B4GALT6;MGAT4B;B4GALT4
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,0.5514158433374218,0.9631997527677836,0.6,1.0,1.0,4/21,13.21%,PRKCE;DGKI;DGKB;DGKG
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.4978747936876786,-0.9630323691574317,0.5,0.9784017715924195,1.0,6/9,20.50%,GGTA1;ALOX5;LTC4S;GGT7;ALOX5AP;MGST2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5339097167729338,0.9627994189014881,0.5466666666666666,1.0,1.0,7/21,22.05%,NLGN3;FCHO2;NLGN1;SYT1;AMPH;NLGN4X;RAB5A
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,0.5071982501065286,0.9624291078747108,0.49333333333333335,1.0,1.0,5/26,10.28%,DOCK1;ADGRG6;OVOL2;BOK;ERRFI1
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6099251150643983,-0.9623331690485816,0.53125,0.9795011626622606,1.0,2/5,26.91%,ATP6AP1;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.45785014020659776,0.9622190564298947,0.5555555555555556,1.0,1.0,14/50,24.66%,PQBP1;PCBP4;RRP1B;NOVA1;CLK2;FAM50A;TNFRSF1B;AHNAK;HNRNPH1;METTL4;HNRNPH3;MBNL2;CLK1;AKAP17A
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.5013253271140183,-0.9621972609113774,0.5,0.978965953599277,1.0,1/11,3.38%,ABCG2
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.5495715325807593,0.962148864871297,0.5405405405405406,1.0,1.0,3/11,17.45%,ATOX1;SLC31A2;APP
prerank,KEGG_2021_Human__Apelin signaling pathway,0.4668794889780847,0.9621378047979867,0.5612244897959183,1.0,1.0,18/92,18.82%,EGR1;PRKCE;ADCY3;RPS6KB2;ADCY10;CALM3;RPS6;RYR2;ADCY8;LIPE;PRKAG2;RYR3;GNAI1;PLCB1;TFAM;PIK3R4;PRKAA2;GNAQ
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.46834009947575606,-0.962124405616715,0.4782608695652174,0.9783597618226625,1.0,5/14,13.02%,GSDMB;NLRP1;GZMB;TREM2;NAIP
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,0.5945487449018795,0.9621178295195867,0.6621621621621622,1.0,1.0,1/11,2.58%,TACR1
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,-0.5968100721650974,-0.9620831821615443,0.5555555555555556,0.9776228694554538,1.0,3/5,22.31%,MECP2;PPARG;MEF2C
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),0.6299088762790761,0.9618983093073298,0.5625,1.0,1.0,1/5,8.44%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5876657505570277,0.961893207387856,0.5921052631578947,1.0,1.0,1/9,3.87%,ANXA1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.47660802686774095,0.9618313880481117,0.5287356321839081,1.0,1.0,5/31,12.87%,DTL;CLSPN;DONSON;INTS3;BRCA1
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.4378192547075388,0.9617787009162507,0.61,1.0,1.0,57/212,24.08%,FGF1;ARAF;PPP2R5B;MAPK4;NRG1;KITLG;PPP2R5A;PAQR3;CHURC1-FNTB;XPO1;FN1;SHC2;IRS2;RPS27A;SPTAN1;PSMB4;RBX1;CAMK2B;NRG3;KALRN;PHB1;ZDHHC9;LRRC7;PEBP1;CNKSR2;RASGRF1;GRIN2B;NEFL;DUSP10;SPTBN5;WDR83;NRG4;RASGRP4;CCND3;IQGAP1;SPTBN1;HSPB1;UBA52;UBB;PSMC2;NRG2;SPTBN4;PSMA3;DUSP16;NCAM1;PSMB2;DUSP6;FGFR2;DUSP12;PSMD5;PSMD7;JUN;ARHGAP9;PRKACB;PSMD14;PSMA5;FOXO3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.4921475355577106,-0.9615764710065671,0.5161290322580645,0.9780126426498161,1.0,3/8,8.43%,TAL1;SH2B3;THOC5
prerank,CellMarker_Augmented_2021__Basophil:Undefined,0.5112386747434812,0.9615369913420249,0.5308641975308642,1.0,1.0,2/18,10.42%,CD22;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.34258733310107975,-0.961470274829942,0.6,0.9773730935339519,1.0,10/49,10.29%,NEXMIF;DSCAM;ARHGDIB;ACER2;NF2;TGFB1;SIPA1;RIPOR2;PLXNA4;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4509011099830491,0.9614227515041863,0.5760869565217391,1.0,1.0,17/89,15.83%,THBS1;LRP2;FGF1;NRG1;CHI3L1;KITLG;INSR;TXN;IRS2;IGF1R;SEMA5A;HCLS1;GAB1;PINK1;NRG4;ESR1;IL18
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.4408214503152347,0.9613317876038708,0.6363636363636364,1.0,1.0,27/192,17.70%,DIAPH3;CENPF;RHOB;CENPE;PPP2R5B;H2BC11;PPP2R5A;NUP133;PDZD2;XPO1;CENPP;KDM1A;WASF1;RPS27;CLASP2;DYNC1H1;CKAP5;CENPK;KLC4;CENPI;INCENP;KIF5A;SEH1L;DHDDS;IQGAP1;ROCK1;PIK3R4
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.46235816807542685,0.9613245152786817,0.47126436781609193,1.0,1.0,19/49,28.03%,CLIP3;CD22;EPHA3;ARFGAP1;CALY;PICALM;MCTP1;SNX17;ROCK1;CD151;HIP1R;RAB5A;SYT11;GPC3;AP2S1;SCAMP5;LRPAP1;PTPN1;SNX12
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.5774849344127845,0.961233602819442,0.5967741935483871,1.0,1.0,2/10,6.96%,FOLH1;SLC19A2
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5961466083577751,0.9611840527937441,0.6307692307692307,1.0,1.0,3/11,12.29%,VIM;NOD2;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4429074305063342,0.9611799881561852,0.6326530612244898,1.0,1.0,27/161,14.72%,THBS1;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;INSR;EPHA3;HIF1A;SLCO3A1;IGF1R;NTRK3;ALK;EPHA7;TYRO3;PFKFB4;FAM20A;FLT1;NTRK2;EPHA4;PINK1;LIMCH1;EPHA6;EPHA5;SDCBP
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,0.5246651874163469,0.9611593054286989,0.5647058823529412,1.0,1.0,9/28,27.20%,TBC1D15;ANKRD37;ZNF143;CASP3;KIAA1586;PLD1;GPT2;ZNF354C;UBE2D1
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.4374619375751597,0.9611576976388808,0.5263157894736842,1.0,1.0,18/69,24.06%,TLE1;PPP2R5B;PPP2R5A;TCF7;TCF7L1;RPS27A;PSMB4;RBX1;CTBP1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5906031134129589,0.9609785370469952,0.6,1.0,1.0,3/10,17.54%,H2BC11;CCDC3;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6397530100332719,0.9607735079597975,0.5652173913043478,1.0,1.0,1/5,13.06%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6397530100332719,0.9607735079597975,0.5652173913043478,1.0,1.0,1/5,13.06%,XRCC3
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,-0.36442351465220574,-0.9607732761216636,0.5,0.9783120720508154,1.0,12/49,13.55%,ITGA5;TAL1;EGFL7;LATS2;PDE3A;ITGB5;SMOX;PTGS1;TREML1;MMRN1;DAB2;SH3RF3
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4471044235601809,0.9607374784905146,0.5319148936170213,1.0,1.0,15/65,15.82%,SLC51A;ACSL1;SLCO1A2;ABCA2;ATP8B1;SLCO3A1;ABCA1;MFSD2A;PLTP;SLC10A1;PRELID1;STARD5;ABCA5;PEX3;UGCG
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,0.5912517201916945,0.9605486379011595,0.5970149253731343,1.0,1.0,6/10,32.04%,TBC1D13;GTPBP4;KDM5B;SNU13;EIF4G1;DHX9
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.44266361329038995,0.9603545584354856,0.6082474226804123,1.0,1.0,31/144,18.65%,FBN2;TGFB2;ZBTB16;BRINP1;GLIPR2;AGT;CDH2;KITLG;ACVR2A;BMPR1B;NOCT;ALOX15B;PAX8;PPP1R13L;RANBP3L;ID2;PTN;GPRC5B;IMPACT;LMO3;SOX6;VWC2;CTNNA2;SDCBP;AKIRIN1;IL18;PLCB1;RGCC;OLFM1;FES;EZH2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5449428808651471,0.9602869473890282,0.5633802816901409,1.0,1.0,1/14,1.41%,DTL
prerank,KEGG_2021_Human__Hepatitis B,-0.3084592517848641,-0.9599748738466299,0.75,0.9794642428509706,1.0,18/114,11.00%,STAT4;TICAM1;CHUK;IRAK4;DDB2;MAPK13;TP53;KRAS;CASP10;MAP2K3;TGFB1;BID;TLR3;NFATC3;SRC;EP300;IKBKB;NFKBIA
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5918484382706841,0.9597602985413648,0.6086956521739131,1.0,1.0,5/9,34.79%,RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.47869761930304866,0.9597554320875877,0.5402298850574713,1.0,1.0,10/38,20.20%,PRKCE;CLIP3;ARF6;EPHA3;SORBS1;GNAI1;SPTBN1;PTPN9;GPSM2;TNF
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.4487514626812817,0.9597352784124167,0.6161616161616161,1.0,1.0,25/106,24.00%,NLRP12;OSMR;CHI3L1;IL1RAPL1;ANXA1;SLC11A1;LIFR;AKAP6;MCL1;IFITM3;HCLS1;IFNLR1;CALCOCO2;TIMP3;CASP3;APP;PTPN9;CDK9;PTPN5;PTPN20;IRAK3;STAT1;ALDH1A2;CASP1;TRIM56
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.34584820204437594,-0.9593439092118775,0.2857142857142857,0.9803161202378058,1.0,14/68,15.17%,PSMB3;PSME3;CHUK;NFKBIE;PSMC4;PSMD12;PSME4;NFATC3;IKBKB;NFKBIA;PSMA1;BCL10;CARD11;PSMA7
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.4728551903594503,0.9592587267278718,0.5760869565217391,1.0,1.0,6/51,7.98%,ARAF;ZBTB16;TCF7;RUNX1T1;RPS6KB2;TCF7L1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5711527287912586,0.9591751293289068,0.6025641025641025,1.0,1.0,5/15,21.01%,INSR;IGF1R;BNIP3;TNF;IRAK3
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.5702483469992607,0.9591194186301947,0.6111111111111112,1.0,1.0,5/12,18.58%,VIM;MAPT;SPTAN1;CASP3;PLEC
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.45530616180495737,0.9590500255118349,0.6063829787234043,1.0,1.0,19/63,22.42%,EPHA3;SIPA1L1;NGEF;CHN1;DNM1;EPHA7;KALRN;EPHA4;ANKS1B;EPHA6;ITSN1;EPHA5;GRIN2B;SDCBP;ROCK1;CDK5R1;AP2A2;PAK3;VAV3
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6206150056781544,-0.959028979707747,0.6296296296296297,0.980260744791222,1.0,2/5,9.63%,ACAA1;GSTM4
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,0.545705892529684,0.95880281618196,0.5641025641025641,1.0,1.0,7/10,36.64%,LIPE;GPD2;PRKACB;PPP1CC;PLIN3;PPP1CB;ABHD5
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.5082391282093959,0.9586465558024038,0.5617977528089888,1.0,1.0,10/32,16.59%,PLPP3;PREX2;PDK4;FLT1;SORBS1;SHROOM4;TIMP3;LDB2;GIPC2;EPAS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.5404923057525514,-0.9586080966327963,0.5333333333333333,0.9805031295054346,1.0,3/10,12.54%,RIC3;GPD1L;TYROBP
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.4574611197741945,0.9584732481385223,0.5979381443298969,1.0,1.0,20/79,22.83%,OMG;BEX3;LINGO1;NGEF;MAG;RPS27A;ARHGEF4;KALRN;RIPK2;ITSN1;CASP3;ARHGDIA;FGD4;UBA52;UBB;ECT2;SORCS3;VAV3;ITGB3BP;RTN4
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.6615939460087346,0.958332789657841,0.6666666666666666,1.0,1.0,3/5,15.68%,ANK2;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5751429255193182,0.9582251917342424,0.5625,1.0,1.0,5/14,21.02%,AGT;AKAP6;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.47940512582006073,0.9581678207802975,0.5542168674698795,1.0,1.0,14/49,15.83%,TGFB2;AGT;INSR;FN1;IRS2;IGF1R;FGR;NTRK3;FLT1;NTRK2;HCLS1;GAB1;PLXNB1;IL18
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,0.45063489604458107,0.9581635895683459,0.6041666666666666,1.0,1.0,12/86,11.30%,CLEC4E;CLEC12A;CR1;CD163;SLC11A1;F13A1;FCGR2B;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,0.45063489604458107,0.9581635895683459,0.6041666666666666,1.0,1.0,12/86,11.30%,CLEC4E;CLEC12A;CR1;CD163;SLC11A1;F13A1;FCGR2B;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,0.45063489604458107,0.9581635895683459,0.6041666666666666,1.0,1.0,12/86,11.30%,CLEC4E;CLEC12A;CR1;CD163;SLC11A1;F13A1;FCGR2B;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3939821642790059,-0.9580817619958252,0.45,0.981101943276105,1.0,4/24,11.60%,NT5C3B;DCP1B;LSM6;EDC3
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.4406505790254258,0.9580317481598193,0.62,1.0,1.0,46/181,21.94%,FGF1;ARAF;PPP2R5B;NRG1;KITLG;PPP2R5A;PAQR3;CHURC1-FNTB;FN1;SHC2;IRS2;RPS27A;SPTAN1;PSMB4;RBX1;CAMK2B;NRG3;PHB1;ZDHHC9;LRRC7;PEBP1;CNKSR2;RASGRF1;GRIN2B;NEFL;DUSP10;SPTBN5;WDR83;NRG4;RASGRP4;IQGAP1;SPTBN1;UBA52;UBB;PSMC2;NRG2;SPTBN4;PSMA3;DUSP16;NCAM1;PSMB2;DUSP6;FGFR2;DUSP12;PSMD5;PSMD7
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5540053150457022,0.957951816994592,0.5735294117647058,1.0,1.0,2/11,20.66%,RGS2;ATP1A2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5527784831214044,0.957915258994575,0.5897435897435898,1.0,1.0,10/17,31.73%,RPL23A;MRPL20;RPL11;NOP53;RPL24;RPL3;TRAF7;RPL6;RPLP0;MDN1
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.5750924572999947,0.9578969603861064,0.5897435897435898,1.0,1.0,4/8,34.47%,STAT1;PIK3CA;PIK3CB;SOS1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3581971387502114,-0.9578005016405348,0.2,0.980986582817764,1.0,16/62,15.58%,CARD14;PSMB3;PSME3;CHUK;MAP3K14;PSMC4;PSMD12;PSME4;COPS8;TLR3;BIRC2;PSMA1;AKT1;PSMA7;TIRAP;NFKB2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5890061705193657,0.957781636831346,0.6515151515151515,1.0,1.0,3/10,13.53%,HSPA5;PDIA2;INSIG1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.46392703546359476,0.9577100509832243,0.574468085106383,1.0,1.0,14/86,16.64%,ALG10B;B4GAT1;MGAT4C;TUSC3;GALNT18;OGA;MGAT1;STT3B;B4GALT5;SERP1;MAGT1;ST8SIA3;PLOD1;GFPT1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.33923358265254216,-0.9575549320046247,0.4166666666666667,0.980550830422655,1.0,5/47,3.60%,SKAP1;CCL5;ITGAM;KARS1;LGALS9
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.299766814212637,-0.9572696417411981,0.8333333333333334,0.9803056791810489,1.0,16/107,10.97%,RALB;GRAP2;RHOG;SETDB1;ARHGDIB;TP53;RAPGEF6;KRAS;USP28;IGF1;ARHGEF1;PLEKHG5;CRKL;GNA12;RASGRP2;CYFIP1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.4683234051420737,-0.9572612464922254,0.4230769230769231,0.9794327794238987,1.0,3/15,4.41%,G6PC3;PGM2;RPIA
prerank,KEGG_2021_Human__Coronavirus disease,0.4456162080322135,0.9572065446068576,0.59,1.0,1.0,50/156,26.86%,RPL23;RPL36A-HNRNPH2;RPL37A;F13A1;RPL38;RPS6;RPS27A;RPL23A;RPS25;RPS27;C5AR1;RPS11;RPS20;RPL9;RPLP2;RPS18;RPL37;RPL14;MAPK10;RPS4X;RPL11;RPS24;RPS9;RPL36;TNFRSF1A;UBA52;FOS;RPS3A;TNF;RPL35;RPL4;RPL32;STAT1;PRKCB;RPL24;RPL27A;STAT2;JUN;RPL3;CASP1;RPS16;RPL30;RPL36AL;RPL21;RPL7;RPL12;TLR2;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.44356352880017663,0.957158697178292,0.574468085106383,1.0,1.0,16/92,12.45%,SPARC;LRRC4C;SHANK3;MAPT;ZDHHC15;INF2;CDH2;GPNMB;NSMF;SRCIN1;SIPA1L1;CHN1;SH3D19;PPFIA2;CLASP2;EPHA4
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,-0.3992514705571647,-0.9570901745318571,0.6363636363636364,0.9790706587241284,1.0,1/33,0.13%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.4959421635363079,0.9569761968050494,0.5853658536585366,1.0,1.0,11/37,26.29%,NRG1;FCGR2B;EPHA3;PXK;MCTP1;ITGAV;HAMP;SYT11;PTEN;TLR2;SCAMP5
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,-0.6141416026960757,-0.9568351127581965,0.6,0.9786855278846125,1.0,1/5,0.46%,MEP1A
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,0.5829232359145247,0.9567414171624872,0.5822784810126582,1.0,1.0,2/8,15.39%,POU5F1;THY1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.5705735123888485,0.9562708070518506,0.5641025641025641,1.0,1.0,3/11,21.86%,ANXA1;KLF9;HNRNPU
prerank,KEGG_2021_Human__Notch signaling pathway,0.4779404616580882,0.9562664542581663,0.5795454545454546,1.0,1.0,5/39,16.30%,TLE1;MFNG;RBPJ;DTX3;CTBP1
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.43227925553231566,0.95625221722202,0.76,1.0,1.0,246/1525,17.22%,DIAPH3;SOCS3;GPR18;THBS1;RHOBTB3;CENPF;HHIP;ACVR1B;RHOB;SPARC;FGF1;ARAF;FLRT1;TSHR;TGFB2;DKK2;PDE5A;GRM8;VIM;FZD6;CENPE;GNRHR;HTR7;PRKAR2B;EGR1;TGIF1;VGF;CHRM5;OMG;GFAP;TLE1;RGS20;PREX2;FKBP5;PDE10A;PRKCE;CLIP3;TACR1;PPP2R5B;H2BC11;ITGA2;ANLN;PIGU;COL4A5;RACGAP1;DOCK1;MAPK4;DZIP1;MFNG;PDE1A;TFRC;NRG1;NR4A1;PLPPR4;GPC5;ARF6;ANXA1;GNA11;GNAO1;BEX3;KITLG;ACVR2A;DGKI;DOCK5;RGS1;BMPR1B;ADGRE1;PTPRK;VEGFA;SOX4;GABRB1;CNTN1;LAMA2;PHLPP1;RXRB;GPNMB;PPP2R5A;PDK4;TCF7;KCNH8;CD55;GRM3;TRIP10;LAMB1;SH3GL3;MCHR2;PTPRZ1;VAPB;RPS6KB2;LTB4R;NUP133;INSR;ARHGAP23;RBFOX2;BAIAP2L1;PDZD2;LINGO1;ADCY10;RND3;HIF1A;GRB10;NGEF;KDM3A;KANK1;PAQR3;AKAP12;TCF7L1;CHURC1-FNTB;MAG;XPO1;SPRY1;SAV1;FN1;CENPP;RAPGEF3;GABRB3;PDE1C;ID2;RPS6;PTN;ABCA1;DNM3;SHC2;RBPJ;IRS2;IGF1R;DGKB;RPS27A;KDM1A;CKB;NTRK3;ITGB8;WASF1;PDE2A;LMNB1;SLITRK5;SPPL2B;GFOD1;ALK;KHDRBS2;CKAP4;ARHGEF4;LTBP1;RPS27;C5AR1;SPTAN1;PDE4B;DNM1;PRR5;ADCY8;RXFP1;RDH11;PSMB4;CHRM3;RBX1;PRICKLE1;CAMK2B;CPT1A;NRG3;GABRB2;PRKAG2;GPR65;TULP3;CLASP2;RPS6KA2;FLT1;KALRN;PPID;SOX6;NTRK2;DYNC1H1;PLTP;CCNC;OTUD7B;RIPK2;SH3GL2;PARD3;PHB1;CKAP5;GNAI1;UACA;ZDHHC9;DRAP1;RGS11;DGKG;CENPK;FASN;LRRC7;SCD;PEBP1;STMN2;KDM4B;PPP1R15A;KLC4;RGS17;CENPI;GNAL;CNKSR2;PLXNB1;ITSN1;CDC37;UBE2M;RASGRF1;GRIN2B;INCENP;ALDH1A1;NEFL;DUSP10;NELFB;GPR183;PICALM;WNT5A;SPTBN5;CASP3;HTR1F;WDR83;NRG4;KIF5A;ESR1;PDK3;MTA3;ATP2A2;SEH1L;HNRNPH1;RASGRP4;CCND3;SYVN1;PCSK6;TBL1XR1;CTBP1;ITGAV;ARAP2;EPAS1;CXXC1;DHDDS;POLR2D;IQGAP1;SPTBN1;TEC;PLCB1;SMAD1;NEURL1;KIF3A;ROCK1;ARHGDIA;HSPB1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.5146153476673425,0.956244974799446,0.5641025641025641,1.0,1.0,5/23,9.80%,TFRC;SLC11A1;ATOX1;TTYH1;TRPC4
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.647883320848194,0.9561480523567509,0.5833333333333334,1.0,1.0,2/6,26.39%,CDS2;PGS1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.42593496802521186,0.9559964859896676,0.75,1.0,1.0,197/1281,19.17%,PCSK1;TOP2A;SOCS3;THBS1;KLF4;ALG10B;SPON1;RAB7B;SKIC2;ADAMTS2;TUBA4A;DTL;THSD4;EEF1A2;ASB14;PAPPA2;RPL23;VGF;GALNTL6;WDR5;GCNT7;ZBTB16;H2BC11;PIGU;VCAN;GALNT8;NR4A2;TUBB4A;B4GAT1;GNA11;FBXL7;CLSPN;CDH2;VBP1;RAB3C;PIAS4;TTLL7;ASB16;MRPL33;RPL37A;TDG;TUBA1A;OTOA;CD55;MDGA2;MYRIP;AGBL3;SEC61B;LAMB1;TUBB6;ETFB;GOLM1;NUP133;ANK3;MVD;ANK2;RAB20;RPL38;MGAT4C;COPS5;HIF1A;PIGQ;AGTPBP1;HCFC1;RAB15;TUSC3;PDCL;FN1;RPS6;THSD7A;ARFGAP1;CNTN5;RPS27A;GALNT18;RPL23A;TRIM25;CKAP4;RPS25;SEMA5A;DARS1;CPM;LTBP1;RPS27;RNF144A;SPTAN1;TMEM132A;NOD2;ARSA;PSMB4;RBX1;DCAF6;SEC24C;B4GALT5;GAN;FAM20A;MCFD2;RPS11;SLC35A1;HIF3A;DYNC1H1;RPS20;EIF3E;RPL9;ADAMTSL3;OTUD7B;RIPK2;ASB13;TOMM20;AMDHD2;THSD7B;POLG2;VCPIP1;RPLP2;BRCA1;NSF;RGS11;EEF1B2;FBXO27;PPA1;LY6H;RNF139;MRPL43;MRPL20;RPL37;NSMCE1;NEGR1;TRIM26;MAGT1;EIF2B2;UHRF2;UBE2M;LSAMP;INCENP;RPL14;TGFBI;CHGB;TUBB2A;MRPL14;PIGF;SPTBN5;ACTR5;ST6GALNAC5;CPE;ST8SIA3;THY1;KIF5A;ESR1;MRPL55;PFDN4;SEH1L;GCNT1;RPS4X;SYVN1;SUMF2;CTBP1;COMMD8;KLHL2;TCP1;RPL11;EPAS1;GFPT1;RAB2B;CXXC1;RPS24;ADAMTS19;DHDDS;TRAPPC6B;SPTBN1;RPS9;SMAD1;UBE2J2;GRIA1;APP;MRPL19;SUMF1;RPL36;TPGS1;SSR3;CNTN3;DCTN1;TAF9B;PIGL;IGFBP7;FBXL13;UBA52;SUZ12;TUBA1C;ERO1A;UBB;GNAQ;PSMC2;FBXL5;SPTBN4;PPARA;RAB21;PSMA3;PIGG
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.4866681636079352,-0.955818704671612,0.5,0.9804997322726212,1.0,3/12,9.02%,TGFBR3;TGFB1;ENG
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,-0.5118506269791849,-0.9558084035040254,0.5517241379310345,0.9796534179853039,1.0,5/8,27.22%,APH1A;PSEN1;RELA;NFKB1;TRAF6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.5340687595450492,0.9557312074157012,0.575,1.0,1.0,4/19,15.06%,TRAF2;CD55;NOD2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.4541009146954482,0.9557016598055647,0.5061728395061729,1.0,1.0,8/29,26.89%,CR1;TYRO3;SUSD4;IRAK3;SLAMF8;STAT2;FAM3A;CNOT7
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.485374997307911,0.9556605361409187,0.5568181818181818,1.0,1.0,9/50,18.85%,ARAF;FN1;CAMK2B;KIAA1549;PEBP1;CNKSR2;SND1;IQGAP1;ZC3HAV1
prerank,KEGG_2021_Human__Thyroid cancer,0.49856397108601375,0.9556022936397537,0.5714285714285714,1.0,1.0,5/27,7.98%,GADD45B;RXRB;TCF7;PAX8;TCF7L1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.48746210479434293,-0.9552116652298069,0.4583333333333333,0.9805313389848972,1.0,3/14,10.03%,CCL5;GRK2;PLEK
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.4482347843852329,0.9551227269074999,0.5777777777777777,1.0,1.0,4/62,11.27%,SOCS3;TRIM5;TRIM25;CAMK2B
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,-0.6025805772539623,-0.9551157471596669,0.575,0.9799340810129237,1.0,3/5,13.33%,GCLC;GGT7;GCLM
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.4968685737913696,-0.9550066743205933,0.5172413793103449,0.9793378943556983,1.0,4/8,12.77%,PFN1;PLEKHM1;P2RY12;DEF8
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.4972895178606045,-0.9548501273703996,0.52,0.9787310084377702,1.0,5/11,12.57%,POLD3;ADK;DGUOK;TYMS;AMPD3
prerank,CellMarker_Augmented_2021__Kupffer cell:Liver,0.6067754117047716,0.9548325268437192,0.5733333333333334,1.0,1.0,3/8,10.46%,CD163;FCGR2B;FCGR2C
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5560076132897164,0.9546859631168514,0.5714285714285714,1.0,1.0,8/20,27.07%,NUDT13;CMPK1;GUK1;NME4;CTPS1;AK5;TXNRD1;AK6
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.47902066689211625,-0.9545434235429731,0.4864864864864865,0.9787130671794358,1.0,3/13,15.66%,METTL8;METTL16;TRMT6
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.6144725544358571,0.9545294018612045,0.6470588235294118,1.0,1.0,2/6,22.68%,AKR1B1;TSPOAP1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.631991000436342,0.9544769282341996,0.5833333333333334,1.0,1.0,3/5,12.55%,SLC2A9;CARMIL1;PRPS1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.48635754977880896,0.9544022744298115,0.6052631578947368,1.0,1.0,3/27,9.72%,LRP2;SNAP25;GLUL
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4856812149648958,-0.9543678040471543,0.46875,0.9783662519776983,1.0,1/10,0.45%,CCL5
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,-0.5032044103249992,-0.9543509363314028,0.4838709677419355,0.9775506107706524,1.0,6/10,15.54%,GRK2;SMOX;CDON;ARRB2;EFCAB7;PTCH1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.472091885607449,-0.9541036003988888,0.38461538461538464,0.977439966151044,1.0,4/14,9.42%,SH2B3;ZNF385A;SRC;NCKAP1L
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5852323975171982,0.9540899269527319,0.5797101449275363,1.0,1.0,1/9,2.26%,HMGB2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.45961663673693987,0.9539400919480814,0.6046511627906976,1.0,1.0,17/70,16.59%,PLPP3;SVEP1;NTN4;TAMALIN;DOCK1;PALLD;FN1;TMTC2;SH3D19;PMP22;THBD;BACE2;UACA;ENPP4;TIMP3;STXBP6;EPAS1
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,0.6524424197844777,0.9539365121287963,0.5616438356164384,1.0,1.0,3/7,15.15%,ITGA2;OVOL2;CASP3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.44061229186596623,-0.9539297614896884,0.4230769230769231,0.9771420756055674,1.0,5/15,10.03%,CSF1R;MLF1;TP53;TGFB1;PLEK
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4752522565283917,0.9538793289427786,0.5842696629213483,1.0,1.0,12/42,14.14%,TSHR;ADCY3;ADGRE1;ADGRG6;CNR1;ADGRB2;ABCA1;ADCY8;RXFP1;GPR65;ADGRL2;GNAL
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.45047742202752,0.9536470191508429,0.6326530612244898,1.0,1.0,27/120,24.54%,BRIP1;RPL23;RPA2;PPP1R13L;DNA2;PRR5;TTC5;PRKAG2;RPS20;BRCA1;RPL37;RFC4;RPL11;CHD5;PRKAA2;TAF9B;TAF7;CDK5R1;NOP53;MEAF6;RBBP8;HEXIM1;SETD9;BARD1;RPA3;BANP;PAK1IP1
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4894118503029006,0.9536291883492625,0.5662650602409639,1.0,1.0,3/30,4.63%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4894118503029006,0.9536291883492625,0.5662650602409639,1.0,1.0,3/30,4.63%,TGFB2;ACVR2A;BMPR1B
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.4727519676369285,0.9535741106013517,0.5957446808510638,1.0,1.0,13/62,15.56%,HMGB2;TMEM161A;ANXA1;SLC11A1;NOCT;RXRB;ABCA2;PAQR7;HNRNPA0;SCD;TRIM16;PELI1;ESR1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5682760968941403,-0.9535740906232568,0.5882352941176471,0.9772660876611612,1.0,2/6,3.95%,PLA2G4C;ZFYVE1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4594494101325969,0.95355594814439,0.5348837209302325,1.0,1.0,9/45,22.15%,TMEM161A;EYA2;STPG4;BRCA1;ZCWPW1;RGCC;ERCC6;NPAS2;GNL3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.44385482718219565,0.9534158971664386,0.6391752577319587,1.0,1.0,15/125,15.17%,BRIP1;CYREN;HMGB2;PIAS4;RPA2;DNA2;EME2;POLQ;DDX1;BRCA1;XRCC3;NSMCE1;KDM4B;FAN1;ACTR5
prerank,KEGG_2021_Human__Cell cycle,0.4493716021191524,0.9532552072003204,0.574468085106383,1.0,1.0,11/77,20.85%,TGFB2;GADD45B;SMC1B;RBX1;CCNB3;CCND3;ORC6;DBF4;CDC25B;RBL2;CDKN1B
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.4359540054298445,0.9530553637361558,0.5102040816326531,1.0,1.0,23/86,25.32%,PLIN2;ACSL1;RXRB;ARNT2;ABCA1;CPT1A;CCNC;FDFT1;HMGCS1;SMARCD3;TBL1XR1;PPARA;TNFRSF21;NR1D1;NPAS2;MED11;ABCB4;CDK19;RORA;ARHGAP9;GPS2;TXNRD1;PPARGC1A
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.3410651982523805,-0.9529289593650242,0.6,0.9781383168711977,1.0,13/58,15.17%,PSMB3;PSME3;CHUK;NFKBIE;PSMC4;PSMD12;PSME4;IKBKB;NFKBIA;PSMA1;BCL10;CARD11;PSMA7
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.45725758397561206,0.9528911438236544,0.5698924731182796,1.0,1.0,9/57,12.76%,TSHR;HTR7;PRKAR2B;PDE10A;PDE1A;PDE2A;ADCY8;RXFP1;GNAI1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.5351940597448063,0.9528220470024455,0.569620253164557,1.0,1.0,4/17,15.33%,STMN3;CKAP5;STMN2;CFL1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.4717458421396183,0.9528206869766596,0.6,1.0,1.0,16/63,23.25%,BRIP1;PDZD2;DNA2;RPS27A;PRKAG2;BRCA1;RFC4;PRKAA2;TAF9B;UBA52;UBB;TAF7;CDK5R1;RBBP8;BARD1;RPA3
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.44751556790777003,-0.9527755806700937,0.48484848484848486,0.9777003928219961,1.0,3/10,12.49%,SESN2;SESN3;EIF2AK4
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,-0.32850645271686535,-0.9526410648233219,0.75,0.9770764704403148,1.0,14/69,12.02%,TICAM1;RHOG;LRP10;SH3BGRL3;RNPEPL1;AGTRAP;MAP2K3;COMMD5;SSNA1;EFHD2;LAMTOR1;BCL3;NUDT22;TEX264
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.48353967562637407,-0.9526375909966032,0.5294117647058824,0.9762087293475614,1.0,3/10,14.80%,SUPT16H;UBN1;RBBP4
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.5534433830721139,-0.9525697947143177,0.5333333333333333,0.9754823622222337,1.0,1/6,0.45%,CCL5
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4623934785741991,-0.9522581298283308,0.5185185185185185,0.9746499945441719,1.0,1/9,4.16%,CLTA
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4623934785741991,-0.9522581298283308,0.5185185185185185,0.9746499945441719,1.0,1/9,4.16%,CLTA
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6324173252841728,0.9522244434974333,0.6,1.0,1.0,2/5,32.66%,TMEM33;LNPK
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.31387651517115017,-0.9521384668755544,0.45454545454545453,0.9740431542496102,1.0,14/50,16.47%,DHX38;CPSF1;LSM11;CHTOP;THOC5;WDR33;DDX39A;SNRPB;CSTF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.47383428843832326,-0.9517962162197168,0.4444444444444444,0.973925075323263,1.0,1/9,2.85%,IL1A
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4460774476152146,0.9517195013622399,0.6170212765957447,1.0,1.0,13/73,20.81%,CLVS1;NAPA;STEAP2;DNAJC6;RP2;SH3D19;SH3GL2;SCAMP3;STXBP6;APP;FTH1;OSBPL5;EXOC5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4545350638291151,-0.9516161325330282,0.5,0.973551974927095,1.0,2/11,3.00%,ITK;DDR1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.47231137119169336,0.9515747151357931,0.5647058823529412,1.0,1.0,6/38,10.85%,ARRDC3;IL15;ACOT13;RBPJ;NOVA1;CCDC3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5617320705183617,0.9515228738835275,0.59375,1.0,1.0,1/8,3.59%,AGT
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4872988334917506,-0.9514077243427194,0.5666666666666667,0.9732954444191698,1.0,4/11,14.21%,BCL2L1;IGF1;GPX1;AKT1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.5490913574701463,0.9512905630356951,0.6103896103896104,1.0,1.0,7/14,25.61%,HSPA5;ANK2;RYR2;PPP1R15A;LRRK2;DDRGK1;VAPA
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,-0.47568470980564237,-0.9512725174451652,0.6521739130434783,0.972900395464959,1.0,3/11,10.46%,CHUK;CASP10;IKBKB
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3936140364129225,-0.951217815615296,0.46153846153846156,0.9721357801262842,1.0,4/27,11.53%,MYH9;TGFB1;APH1A;HM13
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.461347984459567,0.9511574193020773,0.6526315789473685,1.0,1.0,23/84,21.27%,ACVR1B;PRLR;TGFB2;IL15;OSMR;ACVR2A;LIFR;BMPR1B;IL7;TNFRSF11B;GHR;IFNLR1;TNFRSF1B;IL18;IL11RA;TNFRSF1A;ACKR4;GDF11;TNFRSF21;TNF;IL7R;LEPR;CX3CL1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.4208575949910831,-0.9511490432340578,0.5652173913043478,0.9714534345662071,1.0,3/22,5.69%,LRIG1;POLD3;CTC1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5796012146319734,0.9510663626423601,0.5945945945945946,1.0,1.0,1/9,3.93%,SLC1A2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,0.4777213973445316,0.9509935144778492,0.5795454545454546,1.0,1.0,10/43,9.56%,VIM;ZBTB16;ITGA2;TFRC;CDH2;BMPR1B;CD55;ALCAM;FN1;POU5F1
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5281251125995183,0.9509068891321029,0.5975609756097561,1.0,1.0,6/15,21.98%,ATP5ME;ATP5F1A;ATP5F1D;ATP5MC1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.5014182551592286,0.9507170956287782,0.5853658536585366,1.0,1.0,2/25,4.68%,SLF1;RPA2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.46249474040399163,-0.9506215262747183,0.4,0.9719157739390436,1.0,2/11,5.52%,KRT10;FARSA
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5092342989931895,0.9505549590839188,0.6341463414634146,1.0,1.0,14/29,33.08%,ARF6;SGIP1;PICALM;RAB21;SNAP91;HIP1R;HFE;TF;LRPAP1;SMAP1;HIP1;PIK3CB;SERPINE1;BICD1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.4628758847037749,0.9504765962815197,0.6263736263736264,1.0,1.0,14/63,21.92%,ARAF;FN1;CAMK2B;KIAA1549;PHB1;PEBP1;CNKSR2;DUSP10;SND1;IQGAP1;ZC3HAV1;DUSP16;DUSP6;TRIM24
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.45288341183535646,0.9504656782920919,0.5894736842105263,1.0,1.0,10/80,14.79%,ADCY3;CREB5;COL4A5;GNAO1;VEGFA;SHC2;ADCY8;RXFP1;GNAI1;MAPK10
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5948743621088466,0.9504511706881066,0.6521739130434783,1.0,1.0,5/7,38.47%,GFPT1;CSGALNACT1;EXTL2;FUT8;GMDS
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.4494252704819451,0.9500072633994007,0.6404494382022472,1.0,1.0,22/83,23.72%,CENPE;PRKAR2B;RACGAP1;DOCK1;DOCK5;KIF15;KIF1B;KIF21A;KDM1A;CARMIL1;KLC4;KIF11;KIF5A;KIF3A;CBX5;MFN2;KIF5C;RAB5A;AKAP10;KIFC2;PHF21A;PRKACB
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.30330037015073763,-0.9499692533944608,0.3333333333333333,0.972988931395325,1.0,24/89,13.95%,PPP1R16B;GIMAP8;BIN2;SAMSN1;MPEG1;FOLR2;CSF1R;LILRB4;ABI3;RASAL3;P2RY14;NCKAP1L;WDFY4;PLEK;HLA-DPA1;APBB1IP;LCP2;TYROBP;PLVAP;CD53;SNX20;GIMAP4;GIMAP7;HAVCR2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.44225037821809104,0.9497524415237815,0.64,1.0,1.0,12/144,12.84%,PCSK1;PAPPA2;FOLH1;SRGN;ERMP1;FBXL2;ST14;SPPL2B;CPM;TYSND1;BACE2;TRHDE
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.42827820212250456,-0.9497004634156366,0.52,0.9728034269770668,1.0,1/26,0.13%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5269314505698953,0.9496828634479473,0.6025641025641025,1.0,1.0,3/18,9.43%,RAP1GAP;KANK1;TCHP
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6089408550304567,0.949635760732066,0.5714285714285714,1.0,1.0,2/8,8.14%,SEMA6A;ROBO1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.6552473553829824,0.9496027210541569,0.6268656716417911,1.0,1.0,1/6,4.44%,PIAS4
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.47261519786233785,0.9495146122098584,0.5909090909090909,1.0,1.0,12/67,18.11%,TGFB2;MAPT;CDKN2AIP;SYT4;AKAP6;UNC13A;RIMS2;MFSD2A;SYT1;SDCBP;MAP3K13;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.656236301804817,0.9494472908731766,0.5625,1.0,1.0,2/5,18.58%,GNAI1;GPSM2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.656236301804817,0.9494472908731766,0.5625,1.0,1.0,2/5,18.58%,GNAI1;GPSM2
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.4241872775537715,0.9493641925294867,0.73,1.0,1.0,148/940,19.17%,TOP2A;SOCS3;THBS1;ALG10B;SPON1;RAB7B;ADAMTS2;DTL;THSD4;ASB14;VGF;GALNTL6;WDR5;GCNT7;ZBTB16;H2BC11;PIGU;VCAN;GALNT8;NR4A2;TUBB4A;B4GAT1;FBXL7;CLSPN;CDH2;RAB3C;PIAS4;TTLL7;ASB16;TDG;TUBA1A;OTOA;CD55;MDGA2;AGBL3;LAMB1;TUBB6;ETFB;GOLM1;NUP133;ANK3;MVD;ANK2;RAB20;MGAT4C;COPS5;HIF1A;PIGQ;AGTPBP1;HCFC1;RAB15;TUSC3;FN1;THSD7A;ARFGAP1;CNTN5;RPS27A;GALNT18;TRIM25;CKAP4;SEMA5A;CPM;LTBP1;RNF144A;SPTAN1;TMEM132A;NOD2;ARSA;PSMB4;RBX1;DCAF6;SEC24C;B4GALT5;GAN;FAM20A;MCFD2;SLC35A1;HIF3A;DYNC1H1;ADAMTSL3;OTUD7B;RIPK2;ASB13;TOMM20;AMDHD2;THSD7B;POLG2;VCPIP1;BRCA1;NSF;FBXO27;LY6H;RNF139;NSMCE1;NEGR1;TRIM26;MAGT1;UHRF2;UBE2M;LSAMP;INCENP;CHGB;TUBB2A;PIGF;SPTBN5;ACTR5;ST6GALNAC5;ST8SIA3;THY1;ESR1;SEH1L;GCNT1;SYVN1;SUMF2;CTBP1;COMMD8;KLHL2;EPAS1;GFPT1;RAB2B;CXXC1;ADAMTS19;DHDDS;TRAPPC6B;SPTBN1;SMAD1;UBE2J2;GRIA1;APP;SUMF1;TPGS1;CNTN3;DCTN1;TAF9B;PIGL;IGFBP7;FBXL13;UBA52;SUZ12;TUBA1C;UBB;PSMC2;FBXL5;SPTBN4;PPARA;RAB21;PSMA3;PIGG
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.45419656071763503,-0.9492695610168995,0.4166666666666667,0.9730444863258305,1.0,7/23,13.78%,GZMB;TP53;BID;PPP1R13B;PPP3CC;CHCHD10;BCL2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3358176164029659,-0.9490259917280837,0.5714285714285714,0.9729398273867275,1.0,9/69,8.79%,RALB;CCND1;ACTB;DAB2IP;CSF1R;TRIB1;TRIB3;TELO2;SRC
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.4321108305811504,0.9490242839652336,0.6326530612244898,1.0,1.0,43/148,25.39%,RPL23;RIOK2;WDR12;WDR74;MAK16;RPL37A;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;NHP2;RPL9;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;RPL24;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.6373572033959132,0.9490162476428408,0.5972222222222222,1.0,1.0,2/7,6.63%,NUDT16;ADARB2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6436727154644729,0.9488517228370611,0.6197183098591549,1.0,1.0,4/6,34.00%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6436727154644729,0.9488517228370611,0.6197183098591549,1.0,1.0,4/6,34.00%,FBP1;PPARA;GIT1;HDAC4
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.596885198675051,0.9485166325427115,0.6164383561643836,1.0,1.0,3/6,32.04%,DDX1;DDX3X;DHX9
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.4933243654895484,0.9482327920489217,0.5443037974683544,1.0,1.0,13/37,21.03%,ALDH3B1;PFKM;ENO2;PGAM1;GPI;FBP1;PKM;ENO4;ADH5;PGK1;PGM1;ENO1;PDHB
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.3796406556751434,-0.9482077892700339,0.6,0.974019829033014,1.0,6/38,10.00%,BBS10;MKKS;INPP5E;BBS9;EXOC7;SMOX
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.5332818711477766,0.9482007057419549,0.5822784810126582,1.0,1.0,5/17,22.96%,CPT1A;SMARCD3;TBL1XR1;PPARA;RORA
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.36266622159440237,-0.9478446981672202,0.375,0.974224722305769,1.0,7/35,13.01%,YKT6;CYTH2;CYTH3;RAB39A;VPS45;CYTH4;GOSR1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6019818271710322,0.94779415762252,0.6111111111111112,1.0,1.0,4/9,24.45%,SLC9A7;SLC9A6;SLC9A1;SLC6A1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.47742310859045944,0.9477467498942319,0.5978260869565217,1.0,1.0,9/52,10.89%,TSHR;CD163;HTR7;PRKAR2B;ADCY3;PLK2;FGR;ADCY8;RXFP1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),0.5671035224993067,0.9476647924697479,0.5526315789473685,1.0,1.0,4/10,21.98%,CEMIP;CEMIP2;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.4322299215993246,0.9476203869793438,0.5425531914893617,1.0,1.0,14/76,17.28%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;RNF139;AUP1;DNAJB9;SYVN1;ERLIN1;UBE2J2
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.5962141315590781,0.9475575017988475,0.6119402985074627,1.0,1.0,3/8,21.89%,ADCY10;DYNC1I1;DNAAF2
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),0.6195450837201643,0.9475410745678119,0.6206896551724138,1.0,1.0,1/6,14.98%,GPR183
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.521891074399514,0.9474180286761283,0.6,1.0,1.0,3/20,13.99%,CDH2;TCF7L1;CTNNA2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.43687929755978444,0.9472042791468388,0.6421052631578947,1.0,1.0,37/137,24.15%,PLPP3;RPL23;SOX4;ANK2;HCFC1;EPHA4;PINK1;CDC37;CAMLG;CDC37L1;BAG3;SYVN1;ATP1B3;TCP1;RPL11;PRKRA;HSPA1B;MTMR9;TAF9B;GTPBP4;ATP1B2;HSPD1;GBA3;GNAQ;RAB21;NOP53;HIP1R;C10ORF90;NAPG;WIZ;FLOT2;PPIB;CHP1;RTN4;MFSD1;PTEN;CCT8
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),0.641848422089258,0.9471737292444634,0.6164383561643836,1.0,1.0,1/6,2.19%,CYP3A5
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,-0.5198000307874215,-0.947031564323645,0.5384615384615384,0.9756116639037781,1.0,1/9,1.69%,SLC30A5
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,0.5021470237595027,0.9469560249320839,0.5487804878048781,1.0,1.0,3/21,13.86%,POLR3F;POLR3H;ZNF143
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.4580491219673417,0.9469539003433644,0.5638297872340425,1.0,1.0,20/77,18.58%,SPARC;APOLD1;GPM6A;PLAC8;TNS1;LIFR;SRGN;CD55;MFSD2A;CD93;FLT1;THBD;SHROOM4;TIMP3;LDB2;CLIC4;EPAS1;RGCC;IGFBP7;PLEC
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.5939796404788367,0.9467712247562878,0.6029411764705882,1.0,1.0,2/8,8.95%,MAFB;PTN
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.5837886891549804,0.9466107740754098,0.6111111111111112,1.0,1.0,4/8,34.47%,ANGPT2;PIK3CA;PIK3CB;SOS1
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,0.6190606531228274,0.9465881057171454,0.6349206349206349,1.0,1.0,1/6,1.35%,NDUFA2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.47887252556848514,-0.9463292191730759,0.5652173913043478,0.976789729211961,1.0,1/15,0.87%,SMPD3
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.507686571910532,0.9462500475241782,0.5529411764705883,1.0,1.0,11/30,27.42%,RND3;CKB;CKAP4;PICALM;ROCK1;PKP4;FLOT2;ANKRD26;TNFAIP1;KCTD13;ARHGAP5
prerank,Reactome_2022__RUNX3 Regulates Immune Response And Cell Migration R-HSA-8949275,-0.570308780977823,-0.946232885188329,0.5666666666666667,0.9761321960454552,1.0,2/5,7.43%,RUNX3;CBFB
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5197674691659399,0.9460769981623289,0.6410256410256411,1.0,1.0,4/24,11.02%,CYREN;FANCB;TFIP11;POLQ
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5272509384398807,-0.9460497429038639,0.53125,0.9757048024007497,1.0,1/7,1.00%,CX3CR1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.5304323044635886,0.9460302464058352,0.5522388059701493,1.0,1.0,6/16,23.45%,DMD;KDM1A;SGCZ;NEBL;RORA;MEGF10
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.5026789589785251,0.9458813705802234,0.5324675324675324,1.0,1.0,7/18,28.17%,CMPK1;DCK;GUK1;NMNAT2;AK5;ME1;PNP
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.4715591334613348,0.9458312676393671,0.6170212765957447,1.0,1.0,18/48,20.93%,RHOB;TM7SF2;RND3;GHR;GLUL;ALDH6A1;SLC10A1;BNIP3;SAMD5;SCD;OCIAD1;HMGCS1;EPB41L4B;SPTBN1;HAMP;MSMO1;GPAT4;LEPR
prerank,Reactome_2022__Hemostasis R-HSA-109582,0.4177983434212558,0.9458122126626948,0.71,1.0,1.0,62/364,18.33%,THBS1;RHOB;SPARC;TGFB2;TUBA4A;PDE5A;CENPE;PRKAR2B;PDE10A;PRKCE;MANF;PPP2R5B;ITGA2;RACGAP1;DOCK1;PDE1A;GNA11;DGKI;DOCK5;SRGN;KIF15;F13A1;VEGFA;KIF1B;HSPA5;PPP2R5A;KIF21A;ENDOD1;MAG;FN1;RAPGEF3;DGKB;KDM1A;FGR;CARMIL1;GP6;PDE2A;KCNMB1;CD99L2;DEAF1;THBD;GNAI1;GUCY1B1;DGKG;KLC4;SERPINE2;CDC37L1;TIMP3;KIF11;ANGPT2;KIF5A;ATP2A2;ATP1B3;ITGAV;KCNMA1;KIF3A;APP;SLC16A3;SLC16A1;STXBP2;SOD1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5604996914293855,0.9457545021779419,0.6438356164383562,1.0,1.0,4/9,18.00%,CKAP5;EML2;HSPA1B;DCTN1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6176779648330213,0.9457400827472182,0.6619718309859155,1.0,1.0,3/5,20.85%,ROBO2;WNT5A;FGFR2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.46309035691004125,-0.945705792978192,0.35294117647058826,0.9757586197439807,1.0,2/18,7.58%,NDE1;LLGL2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.43567095024468205,0.9452307428744111,0.631578947368421,1.0,1.0,22/114,15.83%,THBS1;LRP2;FGF1;PPP2R5B;NRG1;CHI3L1;KITLG;PHLPP1;INSR;TXN;IRS2;IGF1R;NTRK3;SEMA5A;NTRK2;HCLS1;MAGI2;GAB1;PINK1;NRG4;ESR1;IL18
prerank,KEGG_2021_Human__Pancreatic cancer,0.4572531249565338,0.9451516193182117,0.5913978494623656,1.0,1.0,5/62,6.18%,ARAF;TGFB2;GADD45B;VEGFA;RPS6KB2
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.5520988161244312,0.9450119493948734,0.5789473684210527,1.0,1.0,3/13,20.36%,HSPD1;CTPS1;HELLS
prerank,KEGG_2021_Human__Pyruvate metabolism,0.47793623454454365,0.9449236146917211,0.5357142857142857,1.0,1.0,6/31,21.03%,MDH1;ACAT1;PKM;ADH5;ACACB;PDHB
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,0.607025246981339,0.9448977086974767,0.5862068965517241,1.0,1.0,6/6,39.33%,GINS1;MCM3;MCM6;GINS3;MCM5;MCM7
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.5461662131714071,0.9444428314885283,0.573170731707317,1.0,1.0,2/15,11.46%,TACR1;COQ6
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.3850386619240873,-0.9444290007524865,0.6153846153846154,0.977881122727004,1.0,8/40,9.67%,IL4I1;EHHADH;ALDH9A1;BCKDHB;ACAA1;ALDH7A1;AACS;IVD
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.48509100114898324,0.9443786319296137,0.5393258426966292,1.0,1.0,13/40,21.27%,PTPRZ1;HIF1A;MAG;RETREG1;TYRO3;NTRK2;CRLF1;SOD2;PINK1;NRBP2;SOD1;CPEB4;CX3CL1
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,-0.43656117457639343,-0.9443669973770937,0.45714285714285713,0.9772020880323536,1.0,7/13,16.68%,SH2B3;YES1;FYN;SRC;SOCS6;CBL;PRKCA
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6007807859734555,0.9443516650547359,0.6266666666666667,1.0,1.0,1/9,9.50%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.639610472474007,0.9442947488134011,0.6774193548387096,1.0,1.0,2/5,15.46%,ALOX12;BAG3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5764013872194509,0.9442686152229328,0.6578947368421053,1.0,1.0,2/11,9.36%,VGF;RYR2
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.49484779931294254,0.9440824137793551,0.5714285714285714,1.0,1.0,8/25,25.21%,PRKAR2B;RAPGEF3;ADCY8;IQGAP1;GNB5;PRKACB;KCNB1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6625500939413133,0.9438131534546319,0.6716417910447762,1.0,1.0,3/5,29.72%,GUCY1B1;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6625500939413133,0.9438131534546319,0.6716417910447762,1.0,1.0,3/5,29.72%,GUCY1B1;KCNC2;FOXO1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,0.6006656996897609,0.9437543580252797,0.6351351351351351,1.0,1.0,6/8,22.37%,BMI1;ALCAM;POU5F1;ALDH1A1;FLOT2;DCLK1
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.43199889937432046,0.94370235653865,0.5714285714285714,1.0,1.0,23/88,25.32%,PLIN2;ACSL1;RXRB;ARNT2;ABCA1;CPT1A;CCNC;FDFT1;HMGCS1;SMARCD3;TBL1XR1;PPARA;TNFRSF21;NR1D1;NPAS2;MED11;ABCB4;CDK19;RORA;ARHGAP9;GPS2;TXNRD1;PPARGC1A
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.44152920310636656,-0.9435259715169044,0.5161290322580645,0.9786122375259867,1.0,1/15,0.88%,MAIP1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5677214354448821,0.9434883329402509,0.5921052631578947,1.0,1.0,2/13,8.33%,PCBP4;SRSF12
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5516886062224134,0.943351906258007,0.5844155844155844,1.0,1.0,1/13,9.50%,KDM1A
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5036142415895573,0.9433460185994381,0.5405405405405406,1.0,1.0,1/18,0.28%,THBS1
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.5213260050479667,0.9432888698671144,0.5675675675675675,1.0,1.0,2/17,5.43%,PPP2R5B;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.3311715584103276,-0.9432460091937521,0.4444444444444444,0.9785151447721171,1.0,9/66,8.38%,TCF3;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.5005469430599627,0.9428367427445921,0.5681818181818182,1.0,1.0,7/30,15.99%,ASPN;PREX2;CD93;FLT1;SHROOM4;ANGPT2;LDB2
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.48567414074022086,0.9428359554796972,0.5795454545454546,1.0,1.0,8/31,20.20%,CLIP3;RPS27A;SPPL2B;OTUD7B;TNFRSF1A;UBA52;UBB;TNF
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.613177369591702,0.9427192883234543,0.5972222222222222,1.0,1.0,1/6,12.23%,NFKBIZ
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.5068590818814562,-0.9426086070017019,0.5454545454545454,0.9792838655942767,1.0,1/6,8.54%,MYBL1
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,0.633880780863545,0.9424124226600691,0.6176470588235294,1.0,1.0,4/6,22.76%,RPS27A;UBA52;UBB;GYS1
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.4715821412930527,0.9423462311610181,0.6067415730337079,1.0,1.0,1/27,0.66%,RHOB
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,0.5493718433240268,0.942175806585414,0.647887323943662,1.0,1.0,3/15,7.93%,LSR;BAIAP2L1;PPP1R13L
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,0.671055729024163,0.9419971950821637,0.5846153846153846,1.0,1.0,2/5,7.98%,TCF7;TCF7L1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4479755498577875,0.94185036819113,0.6363636363636364,1.0,1.0,5/74,4.93%,ACVR1B;TGFB2;ACVR2A;BMPR1B;PTPRK
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.6250571335278656,0.9416168312241001,0.6461538461538462,1.0,1.0,2/5,7.44%,SPIRE2;FMN2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.5504845828345691,0.9416038649128231,0.55,1.0,1.0,1/14,0.30%,KLF4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5538195970937119,-0.9414182897089857,0.5121951219512195,0.9812916957046024,1.0,2/5,9.22%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.593761795225234,0.9412542469177373,0.6285714285714286,1.0,1.0,3/10,9.50%,PTPRZ1;ID2;KDM1A
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.34396764333476115,-0.9410675612082776,0.5,0.9806050444966498,1.0,8/33,10.45%,NPC2;TTC39B;NPC1;LIMA1;LAMTOR1;LPL;NR1H3;LIPG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.34396764333476115,-0.9410675612082776,0.5,0.9806050444966498,1.0,8/33,10.45%,NPC2;TTC39B;NPC1;LIMA1;LAMTOR1;LPL;NR1H3;LIPG
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.5727343267116173,0.9409887319524264,0.6142857142857143,1.0,1.0,3/9,22.96%,ABCA2;INSIG1;RORA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.44809755490613556,-0.9409635686556475,0.4782608695652174,0.9799504651326909,1.0,1/8,1.05%,STPG1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.39293244463442645,-0.9408587893364613,0.4444444444444444,0.97944444784653,1.0,3/17,3.71%,ABCG2;FOLR2;SLC46A1
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.5127945795475523,0.9407865832432456,0.5657894736842105,1.0,1.0,8/18,25.21%,KCNH8;KCNH5;KCNH7;KCNB2;KCNQ5;KCNQ2;KCNB1;KCNC2
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5831761303685918,0.9403280395486447,0.5588235294117647,1.0,1.0,2/9,16.96%,SELENOI;ETNPPL
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5059184526181597,0.9402420963325007,0.6125,1.0,1.0,7/21,30.03%,DGAT1;CAV3;GK;GPAT4;GK5;LPGAT1;SLC27A5
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.38188825278232785,-0.9401287776595678,0.5882352941176471,0.9806049758827048,1.0,7/35,12.30%,HUS1;POLD3;TPRKB;CTC1;TEP1;LTO1;NBN
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.44942116539075644,0.9395610855992007,0.5698924731182796,1.0,1.0,11/73,17.16%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;ZNF540;EIF3E;RNF139;CPEB2;ROCK1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,0.46321182467961336,0.9394334021225781,0.6382978723404256,1.0,1.0,8/70,10.33%,SOCS3;GADD45B;ITPKC;RAB20;BHLHE40;GSDMD;IFITM3;MGAT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.524361866675485,-0.9391268891205944,0.5384615384615384,0.9822276777314061,1.0,3/5,15.85%,SRC;BCL2;MLLT11
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,0.6035752636920976,0.938817990956888,0.6056338028169014,1.0,1.0,4/6,37.51%,ECHS1;ACADM;MECR;HADHA
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.48443193058454637,-0.9387595692368139,0.47619047619047616,0.9823544552271071,1.0,6/17,18.45%,RHOG;NCKAP1L;CYFIP1;GSN;CAPG;CDC42
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.5366065484667024,0.9387564649156338,0.6024096385542169,1.0,1.0,2/12,6.64%,SLC11A1;ATOX1
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,-0.30570026722240246,-0.9387342483520243,0.5714285714285714,0.9815655647676114,1.0,21/78,11.59%,CD300LF;ITGAM;CD37;LY86;BIN2;P2RX1;PIK3R6;MPEG1;SCIMP;ITGAX;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;BTK;CYTH4;TLR7;LCP2;HVCN1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.477555136127139,0.9385758474567926,0.5333333333333333,1.0,1.0,7/31,22.15%,ZBTB16;NOCT;ID2;LMO3;NAPEPLD;HNRNPU;AAMDC
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.4255950879560179,0.9382867953816955,0.75,1.0,1.0,92/462,24.35%,TOP2A;BRIP1;CENPF;TUBA4A;CENPE;PRKAR2B;HAUS6;PPP2R3B;PPP2R5B;H2BC11;SMC1B;OIP5;TUBB4A;FBXL7;CLSPN;PIAS4;CEP152;MASTL;TUBA1A;PPP2R5A;SMC4;TUBB6;NUP133;NCAPH2;RCC1;SYCP3;RUVBL2;PCBP4;XPO1;DNA2;CENPP;RPS27A;LMNB1;GINS1;RPS27;PSMB4;RBX1;CLASP2;NHP2;DYNC1H1;SPAST;CKAP5;BRCA1;CENPK;CENPI;RFC4;INCENP;TUBB2A;POLE2;SEH1L;CCND3;CNEP1R1;SHQ1;ORC6;POLR2D;DCTN1;UBA52;TUBA1C;DBF4;HSPA2;UBB;PSMC2;CDC25B;PSMA3;MLH1;SUN2;KNTC1;PSMB2;DYNC1I1;CENPT;RBL2;CDKN1B;RBBP8;VRK2;POLR2G;PSMD5;PSMD7;BARD1;PRKCB;ITGB3BP;TUBA1B;NDC1;RPA3;ORC3;DSN1;SYCE2;PSMD14;BORA;VRK1;PSMA5;NEK9;MCM3
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.44624612163493205,0.9381035960603253,0.6145833333333334,1.0,1.0,16/69,21.03%,PFKM;CREB5;PGAM1;CALM3;CAMK2B;CPT1A;PRKAG2;FBP1;PKM;PHKG1;PLCB1;PRKAA2;GNAQ;PPARA;ACACB;PDHB
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.46413749467082444,0.9379921186276647,0.6,1.0,1.0,13/42,20.68%,BRINP1;NLGN1;ID2;ALK;GPRC5B;IMPACT;NREP;VWC2;ROCK1;CDK5R1;ECT2;TCF4;LRRK2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.47454371430829406,0.9378953682774375,0.6470588235294118,1.0,1.0,11/46,12.45%,PRLR;IL15;RELN;AATK;INSR;EPHA3;IGF1R;GHR;FGR;FLT1;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.5184802712604052,0.9378819128886003,0.5569620253164557,1.0,1.0,3/17,8.64%,SLC11A1;NOCT;TENT5A
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.46004145779191763,0.9378534410575577,0.5529411764705883,1.0,1.0,4/42,8.20%,RAB7B;RAB3C;RAB20;RAB15
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.4028620565603205,-0.9378401462113136,0.625,0.983070333532033,1.0,3/14,18.28%,BRCC3;ENY2;TRRAP
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.38826365187363954,-0.9376205129292261,0.4375,0.9827221982999425,1.0,5/14,7.51%,IL1B;IL1A;HPSE;C3;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5046539866965348,0.937557663885892,0.5529411764705883,1.0,1.0,6/20,20.17%,RELN;IRS2;RASGRF1;RASGRP4;ITGAV;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.48823919886434536,0.9374304373264754,0.6022727272727273,1.0,1.0,12/31,27.56%,CAMLG;SDCBP;RPL11;ALAD;AQP11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6;USP25
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.6091449233875456,0.9372616460289563,0.5909090909090909,1.0,1.0,2/5,18.85%,KDM1A;CDK9
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.4903229098062026,0.9372148650930124,0.569620253164557,1.0,1.0,5/27,14.03%,H2BC11;OIP5;CENPP;CENPK;CENPI
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.528360129846977,0.9371544651714053,0.6585365853658537,1.0,1.0,9/22,27.54%,MID1IP1;MFSD2A;SORBS1;CNEP1R1;PPARA;CHP1;SIRT4;SCARB1;LPGAT1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,0.426009635214602,0.9370340736350378,0.71,1.0,1.0,55/302,20.23%,DDIT4;NAMPT;TSPAN13;CADM1;ADCY3;TBC1D8;TFRC;NAPA;BEX3;RGS1;C21ORF91;ARID5B;SOX4;SMC4;SCO2;GRINA;ATOX1;HERPUD1;TRPS1;CALM3;RBPJ;MCL1;AFTPH;SRA1;MGAT1;GABPB1;PLTP;GPI;TNFRSF1B;NSF;GOLGA8B;PKM;VMP1;SERPINE2;GK;DUSP10;PELI1;ZNF292;NINJ2;GCNT1;GBP2;HSPB1;HSPA1B;CACYBP;FANCL;SLC16A1;HPRT1;LAPTM4A;PSMC2;KDM5B;DUSP16;PGK1;SURF4;SLC3A2;ENO1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.515424422476083,-0.9370206881886174,0.5714285714285714,0.9827372931459541,1.0,2/6,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.515424422476083,-0.9370206881886174,0.5714285714285714,0.9827372931459541,1.0,2/6,13.33%,GCLC;GCLM
prerank,CellMarker_Augmented_2021__Stem cell:Eye,0.5995569320353125,0.9367254764331758,0.6142857142857143,1.0,1.0,2/5,15.39%,POU5F1;THY1
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.5155580716471393,0.9366284992654235,0.5205479452054794,1.0,1.0,2/21,9.28%,PIGU;IRS2
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.49708791230901417,0.9364563706132848,0.6049382716049383,1.0,1.0,8/23,22.12%,INSR;GHR;MFSD2A;PLCB1;APP;OLFM1;SOD1;CTTN
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.5321782598327685,0.9363545489583532,0.6285714285714286,1.0,1.0,6/16,19.50%,CIT;FAM162A;BNIP3;SCN2A;APP;TNFRSF21
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.543150737897675,0.9363411184890237,0.618421052631579,1.0,1.0,3/10,25.61%,FBXL2;PPIB;VAPA
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.4640333512701342,0.9362591066305835,0.5842696629213483,1.0,1.0,8/59,9.52%,SOCS3;VIM;ANXA1;F13A1;VEGFA;HIF1A;FN1;MCL1
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.42306202601126447,0.9361215681775319,0.73,1.0,1.0,109/417,24.25%,SLC38A4;SLC16A10;PRKAR2B;LSR;SLCO1A2;ANO4;SLC2A3;SLC6A15;TFRC;SLC1A2;SLC4A10;SLC11A1;SLC2A9;SLC5A9;SLC13A4;STEAP2;SLC13A3;SLC9B2;CA2;ABCA2;TTYH1;ATP8B1;UNC80;SLCO3A1;SLC22A15;TUSC3;FLVCR1;TSC22D3;ABCA1;SLC9A7;RYR2;RPS27A;TRPC4;SLC24A1;FXYD7;ADCY8;PSMB4;CAMK2B;SLC35A1;NCEH1;PLTP;NALCN;RYR3;PHB1;PMPCA;SLC44A5;MAGT1;SLC41A2;ASPH;ABCA5;SLC17A7;HDLBP;PEX3;ATP2A2;ASIC2;SLC24A3;PCSK6;ATP1B3;ERLIN1;SLC25A4;SLC39A14;ATP10B;SLC16A3;SLC16A1;FTH1;ATP1B2;ALAD;UBA52;AQP11;CLIC2;UBB;PSMC2;FBXL5;PSMA3;AP2A2;SLC44A1;TRPM7;ATP6V0B;SLC3A2;PSMB2;ATP13A4;ATP1A2;SLC24A4;CLCA4;SLC5A6;SLC9A1;P4HB;PSMD5;SLC20A2;BMP1;ABCB4;SLC26A3;ATP6V1B2;PSMD7;ATP10A;HFE;GNB5;TTYH3;ABCG1;TRPC1;SLC25A26;ATP6V0E2;PRKACB;ATP8A2;PSMD14;ATP6V1D;SLC20A1;PSMA5;CFTR
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,-0.49722894223595465,-0.9359982546633303,0.5161290322580645,0.9844272083687825,1.0,1/8,2.72%,MAF
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5076435695532648,0.9358854793778469,0.6103896103896104,1.0,1.0,5/17,19.68%,VEGFA;HIF1A;RBPJ;SMAD1;SMAD5
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.5883142520734488,0.9358647161852576,0.6119402985074627,1.0,1.0,3/9,27.75%,TCP1;CCT8;DKC1
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.43652908662540124,0.9355799899896797,0.6595744680851063,1.0,1.0,30/116,24.06%,RELN;GRIN3A;TRAF2;GRIN2A;GRIA2;RBPJ;BEAN1;PSMB4;GRIA3;FGF14;CYCS;GRIN2B;MAPK10;DAB1;ATP2A2;CACNA1A;PLCB1;GRIA1;SLC25A4;PIK3R4;GNAQ;PSMC2;PSMA3;PSMB2;PSMD7;PRKCB;RORA;ATG13;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4124343506642791,-0.9354810587819773,0.5,0.9848661690649403,1.0,6/20,14.81%,INPP5K;IL1B;PIP4K2B;ENPP1;NCK1;PTPRE
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.43725970353544014,0.9354562723427585,0.6391752577319587,1.0,1.0,30/114,17.50%,ACVR1B;COBL;SHANK3;ENPP2;ZBTB16;ZDHHC15;RELN;TFRC;NRXN1;BMPR1B;VEGFA;INSR;PPP1R13L;NLGN1;RAPGEF3;PTN;ALK;CAMK2B;B4GALT5;CLASP2;SOX6;BNIP3;PINK1;WNT5A;CFL1;NR2C2;PLCB1;NEURL1;MAP3K13;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5679484907208203,0.9350309404734679,0.5857142857142857,1.0,1.0,5/11,29.94%,FANCB;ERCC6;TIMELESS;ARID2;WDR48
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.5652458781841959,-0.9349126757980185,0.5652173913043478,0.9845632594048367,1.0,1/5,9.22%,HLA-E
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.5652458781841959,-0.9349126757980185,0.5652173913043478,0.9845632594048367,1.0,1/5,9.22%,HLA-E
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.5086580847518823,0.9348343242093763,0.5930232558139535,1.0,1.0,6/22,24.51%,RPS27A;RNF139;SYVN1;UBA52;UBB;MAN1A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.43814025821025326,-0.9347504487768081,0.5357142857142857,0.9840701355249152,1.0,2/14,14.74%,HLA-E;IL12RB1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.5151659039757547,0.9346702077306985,0.5633802816901409,1.0,1.0,2/18,12.87%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5506884866846297,-0.9345773702942407,0.6333333333333333,0.9834994152371009,1.0,4/8,15.20%,IL4I1;NPL;GNPDA1;NAGK
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.48198178847985196,-0.9344905068697114,0.6060606060606061,0.9829184721805883,1.0,2/11,5.16%,CORO1B;TRIB1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.5008726165861646,0.9344594099736219,0.5783132530120482,1.0,1.0,7/22,23.83%,MAPT;MAP2;HCLS1;TPPP;PAK3;CTTN;ARHGAP18
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.38040272577211104,-0.9343874224353865,0.5454545454545454,0.9823608914602174,1.0,1/26,0.76%,RAB22A
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.5571858642998524,0.9341695896509286,0.5921052631578947,1.0,1.0,2/10,9.30%,INSR;IGF1R
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.5100201424585084,0.9341626559023853,0.6428571428571429,1.0,1.0,7/24,25.97%,RPS27A;RNF139;SYVN1;UBA52;UBB;GANAB;PRKCSH
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6266087659133206,0.9339270455796016,0.6818181818181818,1.0,1.0,3/5,18.25%,DOCK5;KCNMA1;SOD1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.5360059214196065,0.9338387819547835,0.589041095890411,1.0,1.0,2/11,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.6029348970964664,0.9337406023961922,0.5857142857142857,1.0,1.0,1/6,7.03%,SYCP3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5838776226269393,0.9336781436588143,0.6521739130434783,1.0,1.0,3/9,11.78%,ZBTB16;BMPR1B;SOX6
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,0.46012981245745094,0.9335708047252155,0.6022727272727273,1.0,1.0,13/56,16.08%,KLF4;PLAC8;CD22;SOX4;NDRG1;BHLHE40;TXN;THBD;TSEN54;ACP3;SLC41A2;ZNF789;CCND3
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.33465096872073985,-0.9334408324349835,0.6666666666666666,0.9839054995347902,1.0,25/90,13.92%,PPP1R16B;GIMAP8;SELPLG;GYPC;SAMSN1;UBA7;NLRP1;ETS1;ABI3;ARHGDIB;IFFO1;RASAL3;TRPV2;NCKAP1L;WDFY4;FMNL3;PLEK;HLA-DPA1;CYTH4;APBB1IP;LCP2;SYNE1;CD53;GIMAP4;GIMAP7
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),0.6275823149024023,0.9333297331281134,0.6567164179104478,1.0,1.0,2/5,21.05%,ADPRS;MACROD1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5557067411710436,0.9332432988897775,0.6,1.0,1.0,2/8,20.68%,TXN;LRRK2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.5528695685831742,0.9332114052648341,0.6086956521739131,1.0,1.0,2/11,5.63%,CADM1;CD55
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.587563805103363,0.9331080115174313,0.631578947368421,1.0,1.0,1/8,3.93%,SLC1A2
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,0.49035367068988045,0.933092483269099,0.5764705882352941,1.0,1.0,5/27,3.65%,THBS1;FZD6;NTN4;ITGA2;OSMR
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.48124589888831676,0.933048200762175,0.5662650602409639,1.0,1.0,3/26,5.63%,FZD6;ADGRE1;CD55
prerank,Reactome_2022__eNOS Activation R-HSA-203615,0.605909378420699,0.932782614784192,0.6575342465753424,1.0,1.0,1/8,2.58%,TACR1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.35835262518533073,-0.932761188211562,0.5882352941176471,0.9848444463660687,1.0,6/25,17.23%,IGHMBP2;RPAIN;RECQL;HDAC10;FBH1;THAP9
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5519575586921719,-0.9327609900524351,0.5588235294117647,0.9840077051202183,1.0,1/5,6.72%,COPRS
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.48415106618085735,0.9323853647540169,0.5679012345679012,1.0,1.0,6/20,20.68%,TXN;SOD2;PINK1;HSPB1;FBXO7;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.5294929161196001,0.9323219317975232,0.5974025974025974,1.0,1.0,6/11,33.36%,TMEM39A;PINK1;LRRK2;MTM1;FEZ1;CHMP4B
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.501128413294949,0.9322413602686955,0.5853658536585366,1.0,1.0,5/25,13.36%,MAPT;HDGFL3;CLASP2;CKAP5;TPPP
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3618113874818669,-0.9322339191204392,0.4375,0.9846997075024837,1.0,5/26,10.32%,ZMYND11;ZNF675;DUSP3;SIRPA;TREM2
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.5969993124944994,0.9320928254825893,0.5972222222222222,1.0,1.0,1/6,3.87%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.47877932204226586,0.9320784456371978,0.6190476190476191,1.0,1.0,6/46,10.41%,ASPN;FBN2;VASN;SPRY1;RPS27A;LTBP1
prerank,KEGG_2021_Human__mTOR signaling pathway,0.43496884324219215,0.9320288286243305,0.6875,1.0,1.0,17/108,20.20%,DDIT4;FZD6;RPS6KB2;INSR;GRB10;RPS6;DEPTOR;IGF1R;PRR5;RPS6KA2;WNT5A;SEH1L;NPRL2;TNFRSF1A;PRKAA2;SLC3A2;TNF
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4721170838462154,-0.9319704198311806,0.5925925925925926,0.9844437305745322,1.0,1/8,0.73%,HUS1
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,-0.4768709660716322,-0.931903115740807,0.6,0.9838097862847699,1.0,3/11,4.24%,IDUA;HPSE;SDC3
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6004920764794761,0.9318362585815122,0.6,1.0,1.0,2/7,14.52%,FCGR2B;GRIN2B
prerank,CellMarker_Augmented_2021__Macrophage:Lung,0.5458555936394054,0.9315214102725056,0.5394736842105263,1.0,1.0,2/11,3.57%,CD163;TFRC
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.6355817615357637,0.9314905016799943,0.6290322580645161,1.0,1.0,2/5,21.66%,CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.5447684625478768,-0.9314836691060827,0.5,0.9839553172419861,1.0,2/5,10.32%,P2RY12;TREM2
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,0.45166421738842166,0.9314225114691391,0.6555555555555556,1.0,1.0,6/73,7.95%,KLF4;ALDH3B1;ANXA1;GPNMB;CD55;FOSL2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.545081590962156,0.9313410648315501,0.5903614457831325,1.0,1.0,3/14,17.50%,BNIP3;PINK1;DDHD1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.6206049745340199,0.9313391132380715,0.6851851851851852,1.0,1.0,4/6,29.85%,MCMDC2;ORC3;MCM3;MCM6
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.47319515493692604,0.931256677294819,0.5512820512820513,1.0,1.0,4/29,5.61%,THBS1;GULP1;DOCK1;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.613500148834855,0.9311791443122474,0.6307692307692307,1.0,1.0,4/6,36.85%,GPS2;UBR5;PLAA;PARP10
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.6037727136823096,0.9310258282727517,0.6323529411764706,1.0,1.0,2/6,13.26%,PRR5;PINK1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.5515900637324145,0.9309898804373878,0.625,1.0,1.0,2/11,14.98%,FCGR2B;GPR183
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),-0.5058543240802806,-0.9309878056730614,0.52,0.9843117036602848,1.0,1/7,2.23%,IL1B
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.39384740404971597,-0.9309418152234641,0.6666666666666666,0.9827155660608178,1.0,2/30,3.78%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.39384740404971597,-0.9309418152234641,0.6666666666666666,0.9827155660608178,1.0,2/30,3.78%,RING1;DAB2IP
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.6294208574911504,0.9306568142740903,0.6285714285714286,1.0,1.0,4/5,31.83%,SLC39A12;SLC39A14;SLC39A6;SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.49948291644173926,0.9305667738427053,0.6049382716049383,1.0,1.0,2/16,10.74%,CR1;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.5251029275803987,0.9305261689109721,0.6282051282051282,1.0,1.0,5/15,13.36%,MYRF;RIMS2;PARD3;TNFRSF1B;TPPP
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.5414012827836802,0.9303962507260886,0.6756756756756757,1.0,1.0,6/14,36.10%,CHURC1-FNTB;GRK4;GNB5;PDE6B;FNTA;CAMKMT
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5868058825154798,0.9302935145993464,0.6756756756756757,1.0,1.0,2/10,9.57%,ADCY10;CCDC39
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.5322934146604881,0.930234260156472,0.5465116279069767,1.0,1.0,6/16,30.09%,RPS27A;UBA52;UBB;UBE2D1;ANAPC5;ANAPC7
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.4554703252197907,0.9299686325419744,0.5681818181818182,1.0,1.0,10/39,18.84%,PRKCE;PIGU;NRG1;RPS27A;NRG3;CDC37;NRG4;UBA52;UBB;NRG2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4772200804816022,0.9298571473220636,0.5662650602409639,1.0,1.0,12/34,20.27%,GLA;ABCA2;ARSA;GALC;UGT8;ST6GALNAC5;ST8SIA3;UGCG;SUMF2;SUMF1;GBA3;STS
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.3702518473495472,-0.9298282268862373,0.5333333333333333,0.9844574074362912,1.0,6/30,10.84%,GRAP2;SH2B3;YES1;FYN;SRC;SOCS6
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4619942314134866,0.9298219483158351,0.5632183908045977,1.0,1.0,3/48,3.87%,KLF4;CHI3L1;ANXA1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.5702703244201703,0.9297691878756015,0.6142857142857143,1.0,1.0,2/8,12.62%,OTUD7B;VCPIP1
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.4580038289569715,-0.9294488962503863,0.6206896551724138,0.9847235833807817,1.0,2/13,2.17%,LRIG1;POLD3
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.6338446743231998,0.9291379997558032,0.7058823529411765,1.0,1.0,2/5,18.94%,SRSF12;PRPF39
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.5249799355212316,-0.9290772523780245,0.5714285714285714,0.9840054322319768,1.0,1/14,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.5249799355212316,-0.9290772523780245,0.5714285714285714,0.9840054322319768,1.0,1/14,0.03%,PHLDB2
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.5390053745709055,0.9289290841680272,0.68,1.0,1.0,6/14,19.80%,SCO2;UCKL1;DCK;UPP2;HPRT1;UCK2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.44149012881147814,0.9288902844895744,0.5217391304347826,1.0,1.0,14/54,21.26%,HTR2B;SLC11A1;SLC24A2;VAPB;ANK2;RYR2;SLC24A1;ATP2A2;SLC24A3;SLC39A12;SLC39A14;ATP13A4;SLC24A4;RMDN3
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.49210318487441096,-0.9288366023449643,0.5151515151515151,0.9837963729134319,1.0,1/6,0.27%,FGL1
prerank,Reactome_2022__Keratinization R-HSA-6805567,0.5826222129372541,0.9287292946919427,0.6212121212121212,1.0,1.0,5/9,17.97%,KAZN;PKP2;ST14;PCSK6;PKP4
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.4549818275012465,0.92859694004095,0.5729166666666666,1.0,1.0,16/60,22.12%,PRKCE;MAPT;ARF6;BAIAP2L1;CAV3;CARMIL1;SEMA5A;STMN2;PYCARD;TOGARAM1;APP;DCTN1;FES;CDK5R1;CX3CL1;CTTN
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5511372268618173,-0.9285116363138803,0.5757575757575758,0.9829823478268047,1.0,3/5,18.82%,TGFB1;EP300;PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5511372268618173,-0.9285116363138803,0.5757575757575758,0.9829823478268047,1.0,3/5,18.82%,TGFB1;EP300;PPARG
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.5491828112158195,0.9284852417641574,0.6231884057971014,1.0,1.0,5/12,21.67%,GHR;MFSD2A;APP;SOD1;PPIB
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.4578709916280071,0.9284799029477352,0.5609756097560976,1.0,1.0,12/40,22.12%,FAM234A;GNA11;ADAM15;TRIP10;BOK;HDLBP;PLOD1;HSPB1;CD151;P4HB;BMP1;CTTN
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,-0.32074937775999934,-0.9284604681611127,0.42857142857142855,0.9823339767062603,1.0,18/62,15.60%,CD37;RHOG;RPIA;NFKBIE;MTMR14;GMIP;PPCDC;SIPA1;MAN2B1;BTK;DDX39A;C19ORF38;GPSM3;DEF6;RGS19;EDEM2;FERMT3;RPS6KA1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.4395764876753002,-0.9283580184296998,0.45454545454545453,0.9816977007160591,1.0,1/15,0.19%,SNAP47
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.479850696938794,0.9282609981314254,0.6395348837209303,1.0,1.0,17/44,26.81%,SYT4;NLGN1;ADCY8;RYR3;SYT1;WNT5A;CLIC4;IQGAP1;PRKAA2;ECT2;CPNE8;CPNE2;SYT11;CPNE3;SYT9;SLC25A24;ADCY1
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.5265583306586756,0.9281077087175813,0.6081081081081081,1.0,1.0,6/16,27.53%,B4GAT1;B3GAT1;POMGNT1;CRPPA;B3GAT2;LARGE1
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.48853887394718665,0.9280581844432451,0.6046511627906976,1.0,1.0,5/31,12.93%,PDE5A;ANXA1;CAV3;SORBS1;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.4610245837535593,0.9279191678157418,0.6,1.0,1.0,4/36,10.68%,CR1;ANXA1;TRAF2;PDE4B
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.33902453340752986,-0.927889341751289,0.6428571428571429,0.9823273699534294,1.0,1/45,0.03%,PHLDB2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.46018279457040234,0.9277487465873784,0.5842696629213483,1.0,1.0,13/52,20.93%,SOX4;PDK4;INSR;HIF1A;CAV3;RPS6;IGF1R;ADCY8;BACE2;KLF7;PRKAA2;NR1D1;LEPR
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.42481611776283945,0.9277236990034019,0.6666666666666666,1.0,1.0,8/117,7.27%,DIAPH3;PREX2;ANLN;RACGAP1;TFRC;VAPB;ARHGAP23;NGEF
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.5168120900941655,0.9276294542953292,0.6375,1.0,1.0,8/21,28.64%,ATP8B1;ABCA1;ATP10B;ABCB4;ATP10A;ATP8A2;ATP9A;ATP11A
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.6059394743752353,0.9276252076384294,0.6417910447761194,1.0,1.0,2/6,12.51%,CHI3L1;AMDHD2
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.49793847308283645,0.9276138323351829,0.5714285714285714,1.0,1.0,10/25,30.51%,PRKAR2B;ADCY8;AQP11;GNB5;PRKACB;RAB11A;ADCY1;AQP4;ADCY2;PRKAR1A
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.503854509469368,0.9275778690362827,0.6091954022988506,1.0,1.0,5/24,12.09%,INSR;GRB10;IRS2;PRKAG2;SORBS1
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.4464204336210686,0.9274375150203247,0.6559139784946236,1.0,1.0,8/50,16.84%,ALG10B;MVD;SLC35A1;AMDHD2;ST6GALNAC5;ST8SIA3;GFPT1;DHDDS
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.5877675734106623,0.9273959639481658,0.6176470588235294,1.0,1.0,4/7,36.21%,NREP;RTN4RL1;GAP43;DHFR
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.552453449229289,0.9272603107407769,0.5833333333333334,1.0,1.0,3/11,22.47%,CALM3;CLIC2;GNB5
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,-0.3600088372538804,-0.927213172749648,0.5555555555555556,0.9831867700485033,1.0,3/16,6.40%,LATS2;WWTR1;MOB1A
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.44580173438765597,0.9271685471792045,0.6767676767676768,1.0,1.0,27/107,28.10%,PLIN2;GFAP;VPS37C;RPS27A;PRKAG2;DYNC1H1;TOMM20;PINK1;EPAS1;PIK3R4;PRKAA2;UBA52;UBB;DYNC1I1;MTERF3;ATG5;MFN2;EEF1A1;ATG13;TOMM40;CFTR;CHMP7;DYNLL1;HSP90AB1;MAP1LC3A;HSPA8;PRKAB2
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.4493386384037965,0.9271613721296729,0.5862068965517241,1.0,1.0,4/56,10.17%,ARAF;GADD45B;RXRB;ALK
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6328065376968149,0.9270296931710386,0.6507936507936508,1.0,1.0,4/6,31.12%,GK;COQ2;GK5;GOT1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.555783286796654,0.9268297672655249,0.5866666666666667,1.0,1.0,2/11,15.06%,IL7;WNT5A
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,0.532328083198832,0.9268026855613692,0.5882352941176471,1.0,1.0,4/14,18.81%,RPS27A;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.4537430394071907,0.9265833051268781,0.6739130434782609,1.0,1.0,18/90,21.27%,RAP1GAP;HMGB2;MTCL1;RGS1;RAPGEF3;CALM3;PINK1;PLXNB1;RASGRF1;PICALM;THY1;MTMR9;PKP4;EZH2;GBA3;ECT2;TBC1D2;CX3CL1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.43515037161916037,-0.9264869774949736,0.5714285714285714,0.9844619942519691,1.0,2/11,13.35%,ALG1;ALG2
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.37585621467711994,-0.9261613010553187,0.631578947368421,0.9844294928988929,1.0,7/23,11.00%,TICAM1;CHUK;IRAK4;TLR3;BTK;IKBKB;NFKBIA
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.5182630047244445,0.9261257076832029,0.6533333333333333,1.0,1.0,8/20,15.14%,COL11A1;COL4A5;COL26A1;COL23A1;COL24A1;COL21A1;COL10A1;COL5A3
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5240219878989456,0.926124810072371,0.6708860759493671,1.0,1.0,2/17,3.00%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5240219878989456,0.926124810072371,0.6708860759493671,1.0,1.0,2/17,3.00%,CLIP3;ZDHHC15
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.46344517463627205,0.9260084023757054,0.6222222222222222,1.0,1.0,13/42,25.92%,ENPP2;MBOAT2;MFSD2A;SLC44A5;PEMT;PNPLA8;CHPT1;SLC44A1;GPAT4;DBI;LPCAT4;MBOAT7;PCTP
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,-0.5152172592743609,-0.925999430043886,0.52,0.9840243300782987,1.0,2/9,3.38%,ITGA5;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5406457033754151,-0.9259272106656647,0.6071428571428571,0.9833350628965014,1.0,1/5,2.23%,IL1B
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),0.5782691501393094,0.9256851898788159,0.6133333333333333,1.0,1.0,3/8,18.81%,RPS27A;UBA52;UBB
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.5218045474068566,0.9256647603178987,0.5769230769230769,1.0,1.0,4/16,18.81%,NDUFA2;RPS27A;UBA52;UBB
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.4412719329725878,0.9254690309065438,0.6063829787234043,1.0,1.0,3/53,3.08%,SAP30;H2BC11;ERCC2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5044014535559966,0.9252325239823455,0.6190476190476191,1.0,1.0,5/25,18.81%,RPS27A;NOD2;RIPK2;UBA52;UBB
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.6086824899510874,0.9251511763544386,0.6527777777777778,1.0,1.0,4/8,28.16%,UPP2;NME4;MACROD1;TYMP
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.4255944098152129,0.9247944219433746,0.6494845360824743,1.0,1.0,21/109,17.63%,GRM8;CD163;ITGA2;TNS1;CHI3L1;F13A1;LTB4R;CA2;HIF1A;MAFB;ABCA1;TNFRSF11B;CD93;THBD;SNX10;TGFBI;ESR1;CEBPD;ITGAV;KCNMA1;SLC39A14
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.5269190585618058,0.9242208143731201,0.5897435897435898,1.0,1.0,4/13,18.81%,RPS27A;PARD3;UBA52;UBB
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.4413180741790223,0.9240594633560322,0.6276595744680851,1.0,1.0,3/51,3.08%,SAP30;H2BC11;ERCC2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.4751898263089407,-0.9240388626707817,0.5517241379310345,0.9867275642063814,1.0,1/9,1.12%,PGM2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.4751898263089407,-0.9240388626707817,0.5517241379310345,0.9867275642063814,1.0,1/9,1.12%,PGM2
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.3644930371143656,-0.9238899534477717,0.6666666666666666,0.9854037026694628,1.0,8/37,11.67%,GSDMB;LGALS9;MAPK13;CASP10;TNFSF10;APOL6;MCTP2;ARHGAP27
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.3644930371143656,-0.9238899534477717,0.6666666666666666,0.9854037026694628,1.0,8/37,11.67%,GSDMB;LGALS9;MAPK13;CASP10;TNFSF10;APOL6;MCTP2;ARHGAP27
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.42085725861648293,0.9238133921948622,0.6666666666666666,1.0,1.0,13/151,11.06%,DIAPH3;FGF1;ARAF;CHRM5;ITGA2;ENAH;DOCK1;FN1;ITGAE;ITGB8;WASF1;ARHGEF4;CHRM3
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.47678106561917966,0.9235120515156675,0.5925925925925926,1.0,1.0,5/27,18.85%,DNA2;FANCM;EME2;ZGRF1;CDK9
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4514721576395656,0.9234890455569111,0.6144578313253012,1.0,1.0,12/31,22.96%,NLRP12;TLE1;PER1;OTUD7B;PYCARD;ESR1;GSTP1;RHOH;NR1D1;TNIP1;STAT1;RORA
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.44480837051399397,-0.9234469090867996,0.4594594594594595,0.9857305588692006,1.0,4/11,24.27%,TRAPPC10;STX5;LMAN1;SNX1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6049302045723207,0.9233561265023728,0.6470588235294118,1.0,1.0,2/5,20.17%,RBPJ;NOTCH2
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,0.49725816550955093,0.9233353207658007,0.6265060240963856,1.0,1.0,6/18,20.36%,ABHD12B;FLVCR1;POU5F1;ZNF850;ORC6;HELLS
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,0.49725816550955093,0.9233353207658007,0.6265060240963856,1.0,1.0,6/18,20.36%,ABHD12B;FLVCR1;POU5F1;ZNF850;ORC6;HELLS
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,-0.3929317604442233,-0.923275277972722,0.6666666666666666,0.9845314285313943,1.0,3/24,1.74%,GRAP2;TAL1;LYL1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,-0.3929317604442233,-0.923275277972722,0.6666666666666666,0.9845314285313943,1.0,3/24,1.74%,GRAP2;TAL1;LYL1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.48161522405268575,-0.9232728130256699,0.6153846153846154,0.9837157438350137,1.0,2/11,8.55%,ZDHHC5;TLR3
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.5703886544272054,0.9231808976986725,0.6962025316455697,1.0,1.0,1/11,0.28%,THBS1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4275369531867108,-0.9231656660424062,0.6190476190476191,0.9833036543828064,1.0,7/12,25.40%,LTO1;MMS19;CISD3;CIAO2B;NFU1;ISCA1;YAE1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.5154603059276083,0.9230140898994176,0.6097560975609756,1.0,1.0,7/21,22.53%,SH3PXD2B;RANBP3L;SBDS;SULF2;FGFR2;PPIB;PTGER4
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5776432877177661,0.9224798825911333,0.6428571428571429,1.0,1.0,3/9,16.96%,RANBP3L;AKIRIN1;PLCB1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.537794899665624,0.9224044926221692,0.6666666666666666,1.0,1.0,2/12,9.12%,ANXA1;RIMS2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.43002744847409635,-0.9223732046480532,0.5172413793103449,0.9844890324019964,1.0,2/12,6.52%,CYP19A1;SRD5A1
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.349670113729838,-0.9222548277521898,0.6153846153846154,0.9840010104312163,1.0,6/42,10.83%,NUP42;SNUPN;PHAX;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.5612953330971242,-0.9221880567472983,0.5128205128205128,0.9833836598599724,1.0,1/5,9.17%,CAP1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.4179539872434123,-0.9221625709834484,0.55,0.9826373008085632,1.0,1/20,0.13%,STAT4
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.563339351254589,0.9221545306073912,0.6619718309859155,1.0,1.0,1/8,1.62%,VIM
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.4232198705795449,0.921912441847437,0.7,1.0,1.0,12/144,11.69%,DIAPH3;PREX2;RACGAP1;DOCK1;TFRC;DOCK5;ARHGAP23;BAIAP2L1;NGEF;WASF1;ARHGEF4;KALRN
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.6165730547304047,0.9217100758652966,0.6617647058823529,1.0,1.0,4/5,37.13%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.6165730547304047,0.9217100758652966,0.6617647058823529,1.0,1.0,4/5,37.13%,DLG4;CRHBP;SLC12A2;DLG2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.4522062977692891,-0.9215698467288735,0.5862068965517241,0.9832888125267026,1.0,5/12,15.53%,ELAVL4;ELAVL1;MAPKAPK2;TIRAP;ZFP36
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6169713216196956,0.9215574387291422,0.6470588235294118,1.0,1.0,4/5,35.19%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6169713216196956,0.9215574387291422,0.6470588235294118,1.0,1.0,4/5,35.19%,HNRNPU;UHRF1;DHX9;SETMAR
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,0.49665015302870535,0.9205650649404933,0.627906976744186,1.0,1.0,7/26,18.05%,MACC1;ITGA2;DOCK5;ST14;IL18;SPINT2;STXBP2
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,0.49665015302870535,0.9205650649404933,0.627906976744186,1.0,1.0,7/26,18.05%,MACC1;ITGA2;DOCK5;ST14;IL18;SPINT2;STXBP2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.44464118678744197,0.9205510180538073,0.6391752577319587,1.0,1.0,11/76,15.44%,BRIP1;H2BC11;CLSPN;PIAS4;DNA2;RPS27A;EME2;BRCA1;XRCC3;RFC4;POLE2
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6293525465868774,0.9205460917970494,0.6,1.0,1.0,4/5,30.47%,EIF3E;CDK9;EIF3D;EIF4G1
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6338526984272616,0.9204555228777805,0.6833333333333333,1.0,1.0,1/5,13.22%,BLMH
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.3124248219124039,-0.9203182594297383,0.8,0.9854212826369283,1.0,19/93,14.21%,MATK;RPS6KA6;SH2B3;IRAK4;ARHGDIB;NFKBIE;MAPK13;TP53;KRAS;MAP3K5;CRKL;IKBKB;ABL1;CRK;NFKBIA;MAPKAPK2;BCL2;RAP1A;AKT1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.5379956312989864,-0.920256939999068,0.5882352941176471,0.9839409233952245,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.5379956312989864,-0.920256939999068,0.5882352941176471,0.9839409233952245,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.47685792190026377,-0.9200546083682497,0.5517241379310345,0.9835964429118432,1.0,5/11,26.07%,EXOSC10;EXOSC9;EXOSC8;EXOSC2;XRN1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4695277146484926,0.9200011134504815,0.6145833333333334,1.0,1.0,6/42,12.50%,RBFOX2;SRSF12;CELF2;KHDRBS2;NOVA1;RBM5
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5485185026967663,0.9196122590516183,0.6197183098591549,1.0,1.0,4/10,23.76%,SHANK3;CTNNA2;VPS51;PTEN
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4593321837997555,0.9195834354062171,0.6818181818181818,1.0,1.0,12/49,16.93%,PLPP3;ITGA2;DOCK1;ADAM15;FN1;PTN;FGR;ITGB8;THY1;ITGAV;TXK;TEC
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4487978434076543,0.919546510150488,0.6413043478260869,1.0,1.0,16/72,22.63%,RAP1GAP;TBC1D8;TBC1D13;SIPA1L1;NGEF;NTRK3;TBC1D15;GPR65;APC2;RASGRF1;ECT2;TBC1D2;CCDC125;TBC1D14;ARHGAP42;GARNL3
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.4758122658108528,0.9193734212608422,0.5925925925925926,1.0,1.0,3/27,6.84%,TRMT9B;FTSJ1;PUS7
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.4748763470926109,-0.919188207178845,0.5357142857142857,0.9849992482895956,1.0,3/8,16.20%,FFAR4;REST;MIDN
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,0.5040358692819821,0.9191864186613194,0.5571428571428572,1.0,1.0,3/11,22.96%,PHKG1;PGM1;GAA
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.47027235964317393,-0.919045941678039,0.47619047619047616,0.9846113712869672,1.0,2/15,1.98%,TTC39B;ARV1
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,0.4593637635015286,0.9190398644316847,0.6179775280898876,1.0,1.0,10/59,11.30%,CLEC4E;CLEC12A;CR1;SIRPB2;CASP5;MXD1;FGR;C5AR1;FCGR2C;FGL2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.5568273713461257,0.918973376879247,0.6323529411764706,1.0,1.0,3/10,17.23%,CR1;DUSP10;BCL6
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,-0.3233643393373687,-0.9189415973084066,0.5,0.9832459580743335,1.0,15/70,15.00%,ITGA5;CD300LF;IL1B;UBA7;ICAM1;SIRPA;ENG;PTGS1;BCL3;C1RL;TYROBP;CTSZ;DAB2;SLC15A3;KCNE3
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,-0.3233643393373687,-0.9189415973084066,0.5,0.9832459580743335,1.0,15/70,15.00%,ITGA5;CD300LF;IL1B;UBA7;ICAM1;SIRPA;ENG;PTGS1;BCL3;C1RL;TYROBP;CTSZ;DAB2;SLC15A3;KCNE3
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.4382933901090557,0.9189117547312395,0.6451612903225806,1.0,1.0,13/86,26.67%,NEK11;EYA2;RUVBL2;INCENP;MTA3;TBL1XR1;MORF4L2;EZH2;UHRF1;SUDS3;ATXN7L3;TAF6L;PRMT1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4202967644488013,0.9188972251708803,0.5957446808510638,1.0,1.0,13/64,17.28%,HSPA5;SEC61B;HERPUD1;TRIM25;RNF175;STT3B;DNAJB2;FBXO27;AUP1;DNAJB9;SYVN1;ERLIN1;UBE2J2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.35296281562584003,-0.918860359113041,0.5789473684210527,0.9826562764107474,1.0,6/38,10.83%,NUP42;CPSF1;NUP155;NUP188;WDR33;NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.370707186586266,-0.9187998761593204,0.625,0.9811901107036723,1.0,6/32,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.370707186586266,-0.9187998761593204,0.625,0.9811901107036723,1.0,6/32,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.5630600174220839,0.9185443004224557,0.6285714285714286,1.0,1.0,1/8,1.62%,VIM
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.500304550583501,0.918479995036686,0.6785714285714286,1.0,1.0,11/27,23.60%,RPS27A;FASN;CDC37;SDCBP;PELI1;UBA52;UBB;FLOT2;GNL3;PDCD6IP;TRADD
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5221232448119119,0.918274799900837,0.64,1.0,1.0,2/18,8.33%,PCBP4;SRSF12
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.4173887374327806,0.9181256462264061,0.72,1.0,1.0,47/306,18.04%,HTR2B;DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;ACVR2A;DGKI;AATK;BMPR1B;PDK4;EIF2AK3;PRRT1;INSR;DAPK1;NIM1K;PXK;LIMD1;DGKB;PLK2;FGR;ALK;CLK2;LIPE;EPHA7;CAMK2B;PRKAG2;FAM20A;PAK5;DGKG;PINK1;GK;MAPK10;PDK3;NUAK2;CTBP1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;MAP3K13;APP;PIK3R4;PRKAA2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5215963626926396,0.9179413140267088,0.6428571428571429,1.0,1.0,4/20,13.15%,CR1;CD55;C5AR1;SUSD4
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5136940215601353,0.9178423846039642,0.6125,1.0,1.0,7/16,30.02%,AKAP6;TNF;SLC9A1;CHP1;ATP2B4;PRNP;CAMTA1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5583388917327055,-0.9177621728919909,0.5757575757575758,0.9827691147875147,1.0,3/7,23.84%,UPF1;SHFL;GSPT1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.527318050402332,0.9177040374395056,0.5952380952380952,1.0,1.0,3/17,6.67%,SLCO1A2;SLC13A4;SLC13A3
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.49747996488542967,-0.9176812290944732,0.6071428571428571,0.9821067629217517,1.0,2/10,7.64%,IDE;APH1A
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.5932472686608303,0.9176627770998921,0.625,1.0,1.0,3/6,20.66%,SNAP25;GLUL;ATP1A2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4490115101223844,0.9176445240415321,0.6458333333333334,1.0,1.0,15/64,21.85%,TGFB2;ARF6;KANK1;SPRY1;IRS2;ARFGAP1;FBP1;RASGRF1;RASGRP4;ARHGDIA;STARD13;NOTCH2;MFN2;RDX;STARD8
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5782483601209368,0.9175729472239699,0.6891891891891891,1.0,1.0,3/9,15.59%,PDK4;SCD;PDK3
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.48001167936747324,-0.9174789607033892,0.56,0.9818308035914747,1.0,5/11,26.62%,CDK11B;SAFB;SUPT6H;SAFB2;SRPK1
prerank,KEGG_2021_Human__Cellular senescence,-0.29130924335237435,-0.9174358063589012,1.0,0.9811596001513374,1.0,22/109,15.01%,HUS1;CCND1;IL1A;ETS1;ITPR2;MAPK13;TP53;KRAS;EIF4EBP1;MAP2K3;TGFB1;NFATC3;HLA-E;CAPN2;PPP3CC;NBN;TRPV4;MAPKAPK2;AKT1;VDAC1;RBBP4;CACNA1D
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.4336062390797423,-0.9172770187922721,0.4666666666666667,0.9808421177034009,1.0,5/16,13.10%,ITGAM;CD2;CD96;ITGB2;CD53
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.4379158090277717,0.9172284291195457,0.6382978723404256,1.0,1.0,3/61,2.91%,ARAF;TGFB2;GADD45B
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,0.5658718871445105,0.9171770370655075,0.6056338028169014,1.0,1.0,2/7,25.85%,AP2A2;AP2S1
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.4732604182735058,-0.916937678232272,0.5416666666666666,0.9810162949178968,1.0,3/13,11.60%,DCP1B;LSM6;EDC3
prerank,KEGG_2021_Human__Hepatitis C,0.4339038829270405,0.9169286432470906,0.6868686868686869,1.0,1.0,9/104,12.41%,SOCS3;CLDN18;ARAF;TRAF2;EIF2AK3;CLDN20;PPP2R2B;EIF3E;CYCS
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5447443676586846,0.9167942416517887,0.6,1.0,1.0,2/9,23.87%,ATAD2;H1-0
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.5487707214403388,0.9167692925315614,0.6716417910447762,1.0,1.0,3/12,13.11%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3352952182837692,-0.9167004521237246,0.625,0.9808488017029007,1.0,16/52,15.36%,BTN3A2;IL1B;CD276;CD2;LGALS9;LILRB4;CD274;SIRPA;TLR3;HLA-DPA1;CD226;TLR7;IL18R1;HAVCR2;IL12RB1;BTN3A1
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.3945149210798736,-0.9166523348829061,0.47368421052631576,0.9801592551776435,1.0,4/18,11.90%,LRIG1;POLD3;POLE3;SLC19A1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.43542412947485315,-0.9165886615393819,0.6190476190476191,0.9794388739794542,1.0,5/14,13.53%,BCL2L1;ABI3;TGFB1;DAB2;PPFIA1
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,0.6457975445641119,0.916580984450558,0.6290322580645161,1.0,1.0,3/5,34.21%,TXNRD1;HSP90AB1;EEF2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.49636321122567395,0.9165702079469356,0.6623376623376623,1.0,1.0,3/25,2.26%,TOP2A;CENPF;HMGB2
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.4681762099497573,0.9164840178776679,0.6153846153846154,1.0,1.0,4/50,8.41%,BRIP1;H2BC11;PIAS4;DNA2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.5947619039844747,0.9164600416422347,0.6774193548387096,1.0,1.0,1/6,5.98%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.41444128054879564,0.9164127133988231,0.6836734693877551,1.0,1.0,25/156,13.64%,FGF1;TGFB2;SHANK3;RELN;NRXN1;CDKN2AIP;IL7;HIF1A;GRB10;NLGN3;KANK1;NLGN1;ROBO1;PDCL;RIMS2;RBPJ;NTRK3;NOD2;LMO3;TMEM108;SASH1;SORBS1;SULF2;LANCL2;TRIM16
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4703197560151322,0.9163309451238421,0.625,1.0,1.0,8/30,20.20%,TUSC3;MFSD2A;C5AR1;GPR155;SHROOM4;MAGT1;APP;TNF
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.3181962385333897,-0.9163151511029346,0.5,0.9793369207888789,1.0,14/68,14.74%,IL1B;CHUK;NFKBIE;MAPK13;TGFB1;NFATC3;IKBKB;HLA-DPA1;NFKBIA;PPP3CC;IL6R;IL6ST;CD247;IL12RB1
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.4823809155881819,0.9162271042204022,0.6741573033707865,1.0,1.0,12/44,17.50%,TNS1;VCAN;SLC5A9;RARRES1;DAPK1;ABCA1;MGAM;ETS2;ALDH1A1;TGFBI;GIPC2;GUCY2C
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.5181195297769676,0.9159968654125591,0.6024096385542169,1.0,1.0,4/15,18.81%,NDUFA2;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.58986073596129,0.915958084496429,0.6724137931034483,1.0,1.0,2/6,7.99%,ROBO2;ALCAM
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.45567519082461216,0.9159200116551642,0.6046511627906976,1.0,1.0,2/40,2.98%,HMGB2;H2BC11
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.564513760199239,-0.9159131899231346,0.5675675675675675,0.9794903440068766,1.0,2/6,16.05%,PUM3;WARS1
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.4306898400694756,-0.9158048699365933,0.5882352941176471,0.9788891297064299,1.0,6/17,14.64%,MAP4K2;EP300;MAML1;PDHX;AKT1;MAMLD1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.45589369683086955,0.9157503759847972,0.6588235294117647,1.0,1.0,14/41,24.61%,DAPK1;GRIN2A;RIPK2;CYCS;UACA;ASPH;GRIN2B;PYCARD;AIM2;CIDEB;TNF;GRAMD4;CASP1;DDX3X
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.4255153432774936,0.9156926451003384,0.7551020408163265,1.0,1.0,34/144,24.06%,DAPK2;NDUFA2;VIM;HMGB2;DCC;MAPT;CLSPN;DAPK1;SEPTIN4;GSDMD;RPS27A;LMNB1;SPTAN1;PSMB4;CYCS;UACA;FASN;CASP3;ROCK1;UBA52;PLEC;UBB;PSMC2;PSMA3;PSMB2;PSMD5;APPL1;PSMD7;GSDME;TJP1;TRADD;PSMD14;H1-0;PSMA5
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,-0.5003391274767102,-0.9156398269958224,0.5,0.9784056701832231,1.0,1/7,9.60%,AGO1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.3037294453432773,-0.9154758915649454,0.8333333333333334,0.9779335997289218,1.0,26/86,15.53%,GBP3;GIMAP8;SELPLG;UBA7;LGALS9;CSF1R;ABI3;ARHGDIB;RASAL3;TRPV2;ENG;HLA-E;WDFY4;PLEK;HLA-DPA1;ITGB2;APBB1IP;LCP2;PHF11;OAS2;TYROBP;GIMAP4;GIMAP7;DOCK10;FERMT3;ZFP36
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.4724370816477571,0.9153705695465403,0.6707317073170732,1.0,1.0,1/34,1.31%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.44429001705005755,0.9147783614101309,0.6774193548387096,1.0,1.0,10/65,13.87%,PLPP3;MAPT;DMD;PAQR3;NTRK3;IMPACT;IBTK;SH3GL2;TPPP;PPP1R15A
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.43340624852357146,0.9143845422360574,0.5777777777777777,1.0,1.0,11/54,22.47%,RHOB;NGEF;ARHGEF4;KALRN;PLXNB1;ITSN1;ROCK1;FGD4;ECT2;VAV3;GNB5
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.5360918494344035,0.9141295764480807,0.6376811594202898,1.0,1.0,3/10,23.66%,TOMM20;GRPEL1;TOMM40
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.4444814888503293,0.914092916090434,0.6195652173913043,1.0,1.0,12/65,16.59%,RAP1GAP;COBL;DOCK1;GNA11;ST14;PLXNB1;HDLBP;CPE;EPB41L4B;ITGAV;MTUS1;EPAS1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,0.507095055324056,0.9140090551667819,0.6410256410256411,1.0,1.0,3/18,22.53%,PDZD2;PIK3R4;PRKCB
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5611698683438505,0.9138162868612734,0.5882352941176471,1.0,1.0,3/7,21.27%,FN1;COL16A1;CX3CL1
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,-0.5066361751559412,-0.9137366139370448,0.6428571428571429,0.9813734971909516,1.0,5/7,25.93%,NFKB2;MYD88;RELA;IRF7;NFKB1
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,0.5254636278552712,0.9137214452934509,0.6376811594202898,1.0,1.0,6/15,30.39%,PPOX;BLVRB;ALAD;UROS;HMOX1;ALAS1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5300332397532864,0.9135886249680735,0.6049382716049383,1.0,1.0,2/13,8.38%,PRKCE;CAV3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.6296269499651898,0.9135309599363628,0.7230769230769231,1.0,1.0,1/6,2.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.6050189347224162,0.9133727523095898,0.6349206349206349,1.0,1.0,4/8,19.04%,IRS2;MFSD2A;TYSND1;PPARA
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.4460389286081248,-0.9132758525274561,0.6206896551724138,0.9816093867747371,1.0,1/10,1.84%,BCL2L1
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,0.49435592371070736,0.9132598035599834,0.6103896103896104,1.0,1.0,2/20,8.27%,RHOB;SPRY1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.5647972654270447,0.9131370917999576,0.64,1.0,1.0,4/9,25.54%,PLTP;ABCA5;ABCG1;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5582552234463386,0.9130773663068816,0.6923076923076923,1.0,1.0,5/9,25.80%,TCHP;ODF2L;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.521686957866086,0.913075899744871,0.6329113924050633,1.0,1.0,4/16,12.76%,PRKAR2B;PEX5L;PDE2A;GNAI1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5073031372046538,0.9130572875282703,0.6162790697674418,1.0,1.0,5/20,21.02%,GPM6B;EPHA3;LIMCH1;ROCK1;SLC9A1
prerank,CellMarker_Augmented_2021__Myeloid Conventional Dendritic cell:Bone Marrow,-0.4597697767804703,-0.9128454306647449,0.5238095238095238,0.9819189729408293,1.0,6/9,10.73%,ITGAM;CD2;SIRPA;ITGAX;CLEC9A;CD226
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.579752873936044,0.9127556131506157,0.7,1.0,1.0,2/9,10.68%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.579752873936044,0.9127556131506157,0.7,1.0,1.0,2/9,10.68%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5139974687955357,0.9126619522106638,0.6883116883116883,1.0,1.0,7/16,33.92%,PAICS;PFAS;HPRT1;IMPDH1;NT5C2;PPAT;GART
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.6190825378632707,0.9125532214532214,0.6338028169014085,1.0,1.0,1/5,12.65%,BACE2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.4059716955095735,0.9125196756724261,0.7171717171717171,1.0,1.0,47/170,25.39%,RPL23;WDR12;WDR74;RPL37A;INTS12;PES1;IMP3;RPL38;SBDS;RPS6;RRP1B;RPL23A;RPS25;RPS27;RRP36;RPL9;INTS3;RPLP2;RPL37;RPL14;MPHOSPH6;RPL11;RPS24;RPS9;SMAD1;PRKRA;NOB1;RPL36;INTS8;UBA52;NOP53;RPL35;RPL4;RPL32;MRTO4;MPHOSPH10;INTS6;RPL24;RPL27A;RPL3;RPS16;INTS10;RPL30;WDR3;RPL21;RPL7;RPL12
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5795515022037698,0.9122783767296858,0.6619718309859155,1.0,1.0,2/7,22.07%,FES;CTNNBIP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,0.6116262755670689,0.9122758930514887,0.7014925373134329,1.0,1.0,2/5,15.39%,POU5F1;THY1
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.5641405207454976,0.9122222716885213,0.6144578313253012,1.0,1.0,7/11,25.32%,PDK4;TYSND1;PRKAG2;NR4A3;PPARA;SIRT4;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.42662571115683884,0.9118761974273986,0.711340206185567,1.0,1.0,20/141,13.92%,ALG10B;FGF1;CLIP3;FAXDC2;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;NSMF;INSR;SLCO3A1;RAPGEF3;CALM3;TXN;NTRK3;FAM20A;NTRK2;PINK1;LIMCH1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.4116594084643598,0.9118399059065333,0.75,1.0,1.0,60/316,21.94%,FGF1;ARAF;DKK2;FZD6;PPP2R5B;PIGU;NRG1;NR4A1;KITLG;PPP2R5A;EIF2AK3;RPS6KB2;KANK1;FN1;PPFIBP1;RPS6;RBPJ;IRS2;RPS27A;ALK;PRR5;PSMB4;RBX1;CAMK2B;NRG3;CCNC;KIAA1549;PHB1;PEBP1;CNKSR2;CDC37;DUSP10;NRG4;ESR1;SYVN1;TBL1XR1;CTBP1;SND1;POLR2D;IQGAP1;SPTBN1;NEURL1;DCTN1;UBA52;UBB;PSMC2;NRG2;ZC3HAV1;PSMA3;DUSP16;PSMB2;DUSP6;BCL11A;CDKN1B;FGFR2;POLR2G;PSMD5;STAT1;TRIM24;PSMD7
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.48515574950016055,0.9118068514462442,0.6025641025641025,1.0,1.0,8/24,24.50%,SHANK3;KANK1;CAV3;IQCJ-SCHIP1;HIP1R;SSH2;TJP1;TWF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.40656405768892173,-0.911780720471032,0.6521739130434783,0.9835603683728248,1.0,4/12,18.72%,NBN;TERF2;SMG6;ERCC4
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,0.5442792549762286,0.9116585191414647,0.675,1.0,1.0,4/11,19.36%,DNM3;DNM1;SH3GL2;AP2A2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.48745365947259905,0.9116492907691915,0.6,1.0,1.0,12/33,24.09%,HSPA5;EIF2AK3;NIM1K;IMPACT;PRKAG2;NUAK2;PIK3R4;PRKAA2;SESN1;CPEB4;FOXO3;BRSK1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.4373805963129417,0.9116221654040387,0.7244897959183674,1.0,1.0,2/101,1.16%,RHOBTB3;DENND2A
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.49159520164711407,-0.9116217609394376,0.6410256410256411,0.9830543537586732,1.0,3/7,28.04%,MTIF3;GFM2;MRRF
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.6249712900574557,0.911401974753694,0.7246376811594203,1.0,1.0,4/6,28.69%,HS2ST1;NDST3;CSGALNACT1;EXT1
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.45998380358488006,0.9113211620570713,0.6588235294117647,1.0,1.0,14/32,27.36%,ADCY3;CREB5;DYNC2LI1;DYNC1H1;NSF;ARHGDIA;DCTN1;DYNC1I1;DYNC2H1;RAB5A;PRKACB;DYNLL1;RAB11A;AQP4
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4475006957347589,-0.9111085990906864,0.5,0.9834253730148533,1.0,6/14,12.77%,PFN1;EVL;ABI3;PLEKHM1;P2RY12;DEF8
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.4904378339701578,0.9106792493071951,0.6585365853658537,1.0,1.0,7/31,27.42%,TFRC;CKAP4;PKP4;ANKRD26;TNFAIP1;KCTD13;ARHGAP5
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.34020188939027207,-0.9106729000708824,0.45454545454545453,0.9837114091187594,1.0,10/49,7.46%,CYSLTR1;KIR3DX1;TRIM38;TMEM154;MLKL;APOBEC3G;TMEM106A;HELB;GLIPR1;SLFN12L
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.47126409531009306,0.9105270453208076,0.6,1.0,1.0,7/26,18.26%,SPARC;FBXL7;LAMA2;FLT1;SHROOM4;LDB2;IGFBP7
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.5811376014574396,0.9103486670104199,0.6451612903225806,1.0,1.0,5/7,31.61%,VMP1;PRKCB;MIA3;LRP1;ZDHHC17
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.38793621214491647,-0.90997861956412,0.5,0.9845345223406275,1.0,4/23,7.86%,ZDHHC3;DAB2IP;DELE1;BID
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4103163196372708,0.9098967560877742,0.6292134831460674,1.0,1.0,17/66,21.98%,HTR2B;DCC;SOX4;BNIP3L;IMPACT;RIPK2;TNFRSF1B;BNIP3;CIDEB;DUS2;HSPA1B;UBB;NPAS2;LRRK2;CDKN1B;ATG5;CHP1
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.48840298687668243,0.9098491049983645,0.6976744186046512,1.0,1.0,7/23,23.93%,CNTN1;RPS27A;NEURL1;UBA52;UBB;DNER;DTX2
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.48781403431259035,0.9098430509314052,0.5842696629213483,1.0,1.0,1/19,0.66%,RHOB
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.5633542272561706,0.9098134679070103,0.6527777777777778,1.0,1.0,1/7,1.62%,VIM
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.35149535478115385,-0.909559577406978,0.5263157894736842,0.984429545688237,1.0,2/30,9.48%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.49818295995357176,-0.9094578389659578,0.6296296296296297,0.9838617237072614,1.0,4/7,23.72%,RNF8;RNF168;MSH6;MSH2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.41674780718379606,0.9091793397996566,0.6236559139784946,1.0,1.0,7/53,10.32%,TBC1D8;ARF6;TBC1D13;MYO10;ATP8B1;DYNC2LI1;TBC1D15
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.48026489221453683,0.9090988248314361,0.6527777777777778,1.0,1.0,6/24,21.82%,GEMIN2;DBR1;BCAS2;WDR83;PRPF6;MPHOSPH10
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.4142680906979296,0.908617808703692,0.78,1.0,1.0,73/370,24.35%,TOP2A;CENPF;TUBA4A;CENPE;PRKAR2B;HAUS6;PPP2R3B;PPP2R5B;H2BC11;TUBB4A;FBXL7;CEP152;MASTL;TUBA1A;PPP2R5A;SMC4;TUBB6;NUP133;NCAPH2;RCC1;XPO1;DNA2;CENPP;RPS27A;LMNB1;GINS1;RPS27;PSMB4;RBX1;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;RFC4;INCENP;TUBB2A;POLE2;SEH1L;CCND3;CNEP1R1;ORC6;DCTN1;UBA52;TUBA1C;DBF4;UBB;PSMC2;CDC25B;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;RBL2;CDKN1B;VRK2;PSMD5;PSMD7;PRKCB;ITGB3BP;TUBA1B;NDC1;RPA3;ORC3;DSN1;PSMD14;BORA;VRK1;PSMA5;NEK9;MCM3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5388255244070996,0.90852266583363,0.6301369863013698,1.0,1.0,4/9,20.90%,FRMD5;SPOCK3;SPINT2;CCDC125
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.5902518264764711,0.9084404602614596,0.6901408450704225,1.0,1.0,1/6,4.91%,SESTD1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.34363678617873983,-0.9083402374941062,0.5714285714285714,0.9856185398440713,1.0,5/44,9.86%,RALB;ZFYVE1;CLEC16A;WIPI1;LPL
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,0.5795909008533744,0.9083349774691353,0.6376811594202898,1.0,1.0,2/6,7.13%,TDG;MPG
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.3508822184314735,-0.9082935005287502,0.631578947368421,0.9848615636080168,1.0,6/39,10.83%,NUP42;CPSF1;NUP155;NUP188;WDR33;NUP214
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.5897551916370489,0.9082650463843972,0.6666666666666666,1.0,1.0,1/6,8.38%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6182363902100189,0.9082623695665145,0.7101449275362319,1.0,1.0,1/5,2.27%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6182363902100189,0.9082623695665145,0.7101449275362319,1.0,1.0,1/5,2.27%,GLA
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,0.5900209856293724,0.908071709916002,0.7,1.0,1.0,5/9,24.53%,ARSA;SUMF2;SUMF1;STS;ARSK
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.5584767011319636,-0.907651582128274,0.625,0.9855859874174742,1.0,1/6,1.00%,CX3CR1
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.4558846202649139,0.9074047795157828,0.6506024096385542,1.0,1.0,15/41,25.77%,CACNB2;PCDH15;BSN;SYP;SNAP25;KCNMB1;SPTAN1;KCNMA1;SPTBN1;LHFPL5;RDX;TWF1;EPB41L3;ATP2B4;CABP1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4351760389364223,0.9073865063538271,0.6067415730337079,1.0,1.0,8/69,7.83%,EIF4A3;RIDA;ENC1;EIF2AK3;DAPK1;PUS7;CAMK2N1;ZNF540
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.45530142973332116,0.9072338950635462,0.6428571428571429,1.0,1.0,6/36,14.74%,MACC1;NTN4;VASN;GAN;GK;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.572866491749037,0.9071955926738169,0.7333333333333333,1.0,1.0,4/8,25.32%,PINK1;PPARA;ENO1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.572866491749037,0.9071955926738169,0.7333333333333333,1.0,1.0,4/8,25.32%,PINK1;PPARA;ENO1;PPARGC1A
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.5110321699477813,-0.9068340729281421,0.6129032258064516,0.9867393200376218,1.0,2/13,10.49%,TXN2;GOT2
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.4416861107051996,0.9068230582277421,0.711340206185567,1.0,1.0,11/79,15.44%,BRIP1;H2BC11;CLSPN;PIAS4;DNA2;RPS27A;EME2;BRCA1;XRCC3;RFC4;POLE2
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5765701246526109,-0.9067889951577823,0.5945945945945946,0.9860251858937851,1.0,2/5,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),0.49023310697939343,0.906484444784026,0.6455696202531646,1.0,1.0,7/24,32.89%,SIRT5;ZC3HAV1;SIRT3;SIRT4;PARP9;TIPARP;PARP11
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.5505983098544922,0.9064630109085177,0.5694444444444444,1.0,1.0,3/7,21.42%,DNA2;POLG2;TEFM
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.4193794757373099,0.9064405422152156,0.797979797979798,1.0,1.0,24/231,11.33%,FGF1;PRKAR2B;EGR1;PREX2;PRKCE;PPP2R5B;PIGU;PDE1A;NRG1;NR4A1;KITLG;PHLPP1;PPP2R5A;RPS6KB2;INSR;PDE1C;IRS2;RPS27A;KDM1A;PRR5;ADCY8;PSMB4;CAMK2B;NRG3
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,-0.43284192613361583,-0.9064341356041891,0.47619047619047616,0.9862233144028881,1.0,2/12,8.55%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.497299907758094,-0.9063742139843912,0.525,0.9854793364575745,1.0,2/5,4.42%,THAP4;IL4I1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.41304790184068435,-0.9063287734914216,0.45161290322580644,0.984809735258838,1.0,1/14,1.69%,SLC30A5
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.46630380781600383,0.9063129490583515,0.6105263157894737,1.0,1.0,10/50,15.94%,KLF4;CLDN18;ALOX15B;ST14;THBD;CRLF1;FBP1;SCD;ALDH1A1;CEBPD
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.46387676429868263,0.9061637987363187,0.6808510638297872,1.0,1.0,4/50,10.87%,TGFB2;MFNG;RBPJ;NOD2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.5252546836930813,0.9060546653825948,0.5797101449275363,1.0,1.0,4/11,17.54%,ALOX12;ALOX15B;LTA4H;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.39620313830455806,-0.9059402928608319,0.5909090909090909,0.9847994040224644,1.0,5/20,12.54%,TICAM1;SIRPA;NCKAP1L;HLA-DPA1;TYROBP
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4508789890308048,0.9056812703102317,0.6875,1.0,1.0,11/54,22.15%,PIAS4;SEPTIN4;FANCI;PRICKLE1;RIPK2;BRCA1;PINK1;UBB;LRRK2;TNIP1;GNL3
prerank,KEGG_2021_Human__Tight junction,0.42932250144723844,0.9056391203267358,0.6526315789473685,1.0,1.0,27/109,24.36%,CLDN18;TUBA4A;PRKCE;TUBA1A;CGNL1;CLDN20;MICALL2;PPP2R2B;PRKAG2;HCLS1;PARD3;MAPK10;EPB41L4B;ROCK1;MPDZ;PRKAA2;TUBA1C;RDX;CTTN;AMOT;MYL6;TUBA1B;TJP1;JUN;PRKACB;CFTR;JAM3
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.587582422786753,0.9054119459336119,0.6567164179104478,1.0,1.0,2/8,16.96%,SELENOI;ETNPPL
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.47069324597857737,0.9052830754359908,0.6704545454545454,1.0,1.0,7/38,17.56%,HMGB2;SLC11A1;NOCT;FCGR2B;HNRNPA0;PELI1;FOXP1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5823914300952386,0.9051817629543943,0.6538461538461539,1.0,1.0,2/7,8.50%,NIPSNAP1;RETREG1
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.3826564775849909,-0.9051191799350119,0.7272727272727273,0.9859896186622529,1.0,7/17,17.71%,ARL2BP;TAPT1;BCL3;CHCHD10;AKT1;TAF8;TAF3
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.4169254095999888,-0.905039119764013,0.4827586206896552,0.9854672430369971,1.0,6/23,16.05%,KARS1;FARSA;YARS1;TARS1;SARS1;WARS1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.4962453426574931,0.9050006450398257,0.6585365853658537,1.0,1.0,6/18,28.48%,NDUFS8;ATP5F1D;UQCRC1;SIRT3;NDUFS7;UQCRC2
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.4051392367134261,0.9047431572766838,0.88,1.0,1.0,95/493,23.07%,RHOBTB3;LRP2;SPARC;RAB7B;DENND2A;CD163;CENPE;TACR1;CLVS1;NAA38;RACGAP1;TFRC;ARF6;KIF15;TBC1D13;KIF1B;VPS37C;CD55;TRIP10;SH3GL3;GNS;ANK3;ANK2;COPS5;DNAJC6;FCHO2;KIF21A;DNM3;ARFGAP1;RPS27A;TBC1D15;SPTAN1;SH3D19;DNM1;SEC24C;PRKAG2;SGIP1;MCFD2;DYNC1H1;SH3GL2;SYT1;NSF;SNAP29;GOLGA8B;KLC4;AGFG1;ITSN1;KIF11;PICALM;WNT5A;SPTBN5;HYOU1;KIF5A;DENND5A;TRAPPC6B;SPTBN1;ASPSCR1;KIF3A;GRIA1;APP;AMPH;DCTN1;PRKAA2;FTH1;UBA52;DENND5B;UBB;SPTBN4;RAB21;VPS51;AP2A2;SNAP91;COLEC12;HIP1R;CLTCL1;SURF4;DYNC1I1;TBC1D2;RAB30;IL7R;EXOC5;NAPG;KIF5C;TBC1D14;HSP90B1;MSR1;BNIP1;RAB5A;CTTN;CHMP5;SORT1;TJP1;GDI1;CNIH1;KIFC2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.402064674393761,0.9046942923660877,0.7171717171717171,1.0,1.0,36/201,21.27%,SH3PXD2B;TLE1;NAPA;FBXL7;DMD;TRAF2;TCF7;TCF7L1;FN1;BOK;GSDMD;WASF1;DARS1;ADCY8;RBX1;SEC24C;PDE4DIP;MCFD2;PPID;PARD3;NSF;AIM2;PICALM;TMED10;TRAPPC6B;GRIA1;TNFRSF1A;FANCA;DLG4;KNTC1;TNF;LRRK2;COL16A1;SLC9A1;NAPG;CX3CL1
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.4784343575352508,-0.9046289745650195,0.5769230769230769,0.9856336024405654,1.0,1/7,1.80%,LRIG1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.47909564464188786,0.9045510270042001,0.6428571428571429,1.0,1.0,7/26,21.87%,FCGR2B;CD55;TRIM5;FGR;FOXP1;CX3CL1;APPL1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.5582227044764394,0.9044137301517192,0.5806451612903226,1.0,1.0,1/6,17.68%,ERCC6
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.4722643793345303,0.9043952959539884,0.6888888888888889,1.0,1.0,6/34,12.93%,ADCY3;PAPSS2;ADCY10;ACAT1;ADCY8;GUCY1B1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.5478762013685694,0.9042680097760242,0.6461538461538462,1.0,1.0,3/9,9.26%,TGFB2;SPRY1;RBPJ
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.40006308261761997,-0.9042092835634215,0.6,0.9859350871483009,1.0,5/15,20.44%,TMEM119;BHLHE41;MAML1;FBXO22;HDAC5
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.4689890639314476,0.9041742836118232,0.627906976744186,1.0,1.0,5/26,16.67%,ADCY3;ADAM15;ADCY8;GNAI1;KLF9
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.6042738754891763,0.9036847954254221,0.6206896551724138,1.0,1.0,1/5,12.22%,OTUD7B
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.3878636723913037,-0.9035985154872667,0.6666666666666666,0.9867772215708005,1.0,2/20,4.87%,NFYC;KHSRP
prerank,KEGG_2021_Human__DNA replication,0.46987079568224155,0.9034116382128194,0.6153846153846154,1.0,1.0,8/23,24.35%,RNASEH2C;RPA2;DNA2;RFC4;POLE2;RFC1;RPA3;MCM3
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.6280841441826159,0.903362021066648,0.6619718309859155,1.0,1.0,1/5,6.90%,CA2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.44062559706265336,-0.903166321928554,0.5384615384615384,0.9869109544490164,1.0,4/10,10.32%,IL1B;IGF1;CD200R1;TREM2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.47884566666031964,0.9030803533702543,0.64,1.0,1.0,7/21,26.87%,RAB20;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.4108483208241815,-0.9030142051325967,0.5238095238095238,0.9864418654405583,1.0,3/15,14.21%,CHUK;EGFR;AKT1
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,0.5986940143781828,0.9028660600727711,0.6231884057971014,1.0,1.0,3/5,37.51%,ECHS1;ACADM;HADHA
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.30094190324311687,-0.902776058265951,0.6923076923076923,0.98617076883916,1.0,6/53,4.08%,MEI4;PDE12;GTF2H5;POLD3;GTF2H2;DDB2
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.4444833411954077,0.9027037732167652,0.6410256410256411,1.0,1.0,6/27,17.45%,FCGR2B;GRIN2A;IGF1R;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.5974333050264479,0.9026383496937895,0.6323529411764706,1.0,1.0,3/5,38.94%,FGFR2;FGFR1;FGFR3
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,0.4702327651056556,0.9025863638963783,0.6708860759493671,1.0,1.0,2/29,2.62%,ACVR1B;TMEM163
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.3897936939036519,-0.9024244718883537,0.75,0.9862113030758036,1.0,8/39,19.39%,GTF2F1;SNRNP35;DDX23;POLR2C;SNRPB;SF3B5;ZCRB1;SNRNP40
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4724194324664343,0.9023423327675081,0.6511627906976745,1.0,1.0,9/27,17.56%,EGR1;ALOX15B;IL7;HIF1A;PYCARD;WNT5A;IL18;APP;FOXP1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.44792935701239833,0.9022974137005932,0.6629213483146067,1.0,1.0,5/39,5.36%,CR1;IL15;TFRC;ANXA1;GPNMB
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4955194820976788,0.9019335809110628,0.6666666666666666,1.0,1.0,2/22,4.25%,TGFB2;ACVR2A
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.2955157909313705,-0.9019028024340188,1.0,0.9866871130491387,1.0,19/81,15.17%,PSMB3;CCND1;PSME3;WWTR1;RUNX3;PSMC4;TP53;PSMD12;CBFB;TGFB1;SRC;SMURF1;EP300;MAML1;PSMA1;MAMLD1;ZFHX3;SMURF2;PSMA7
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.5911617964355322,0.9018419744520596,0.6805555555555556,1.0,1.0,2/7,28.85%,PRKRA;DICER1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.494196559267145,-0.9015166922410442,0.6363636363636364,0.9869343172798587,1.0,1/6,0.73%,HUS1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.5659328943733872,0.9015113243631331,0.6714285714285714,1.0,1.0,1/5,10.55%,CLK2
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.5183865455011492,0.9014744665585729,0.6506024096385542,1.0,1.0,4/14,18.81%,NDUFA2;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.5193443020478024,-0.9014297733600677,0.6666666666666666,0.9863118246924664,1.0,3/8,18.09%,ALOX5;MOCS1;MOCS2
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.497230623740035,0.9013663917827675,0.7142857142857143,1.0,1.0,6/23,24.02%,IRS2;FBP1;SORD;PGM1;GAA;GALM
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.46927717603034236,0.9013620110556925,0.6341463414634146,1.0,1.0,6/28,21.00%,SLC38A4;SLC13A3;SLC25A21;SLC16A1;SLC38A10;SLC5A6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.5369972134103425,-0.9011701254802096,0.5882352941176471,0.9861246237680947,1.0,1/5,2.66%,FSCN1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.5579994197852212,0.9011105601240658,0.6811594202898551,1.0,1.0,3/10,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.6216450920311081,0.9007303647950705,0.6571428571428571,1.0,1.0,1/5,13.58%,POLR3H
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.42134440624907876,0.9006490896817245,0.6868686868686869,1.0,1.0,12/117,18.81%,SOCS3;UBE2QL1;PIAS4;RPS27A;RBX1;BRCA1;UBE2M;SYVN1;UBE2J2;FANCL;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4139132234465597,0.9005094719212029,0.81,1.0,1.0,55/305,20.96%,KLF4;CENPF;NFIL3;HMGB2;TLE1;ZBTB16;NRG1;TSHZ3;PIAS4;RORB;PTPRK;ARID5B;ZNF93;SUV39H2;RUNX1T1;SFMBT1;RBFOX2;ATP8B1;ZNF540;YEATS2;BHLHE40;KCTD1;ID2;LIMD1;RBPJ;KDM1A;PER1;PRICKLE1;DEAF1;HINFP;BRCA1;LANCL2;RLIM;YAF2;DPF3;HIC2;WNT5A;MTA3;CTBP1;PLCB1;BCL6;FOXP1;ZBTB18;EZH2;TAF7;NKX6-2;CDK5R1;TIMELESS;TNF;ENO1;NR1D1;BASP1;CDKN1B;MTERF3;CBX5
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.41855200481654486,0.9003601119650412,0.7291666666666666,1.0,1.0,14/125,11.78%,DKK2;FZD6;TLE1;PPP2R5B;H2BC11;SOX4;PPP2R5A;TCF7;TCF7L1;XPO1;RPS27A;PSMB4;RBX1;SOX6
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.41002359123160265,0.899878450199676,0.82,1.0,1.0,64/369,20.96%,KLF4;CENPF;NFIL3;HMGB2;TLE1;EIF4A3;ZBTB16;RIDA;NRG1;TSHZ3;ENC1;PIAS4;RORB;PTPRK;ARID5B;ZNF93;SUV39H2;EIF2AK3;RUNX1T1;DAPK1;SFMBT1;RBFOX2;PUS7;ATP8B1;ZNF540;YEATS2;BHLHE40;KCTD1;ID2;LIMD1;RBPJ;KDM1A;PER1;PRICKLE1;DEAF1;HINFP;BRCA1;LANCL2;RNF139;RLIM;YAF2;DPF3;HIC2;WNT5A;MTA3;CTBP1;PLCB1;BCL6;FOXP1;ZBTB18;GTPBP4;EZH2;TAF7;NKX6-2;CDK5R1;TIMELESS;SAMD4A;TNF;ENO1;NR1D1;BASP1;CDKN1B;MTERF3;CBX5
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.532441701863289,0.8997814628833084,0.6266666666666667,1.0,1.0,2/11,5.04%,ANXA1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4199843964834551,0.8995324651034754,0.6808510638297872,1.0,1.0,28/96,23.76%,ZBTB16;MEIS2;RORB;VASN;NOCT;RUNX1T1;OVOL2;PKP2;SPRY1;RANBP3L;ID2;ABCA1;LIMD1;SRA1;ABCA5;NELFB;WNT5A;ITGAV;SUZ12;PPARA;TNF;HNRNPU;ANKRD26;PDCD4;ABCG1;RORA;GPS2;PTEN
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.46656791024992045,0.8994843888328546,0.6470588235294118,1.0,1.0,5/35,9.76%,DOCK1;DOCK5;KANK1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5125147015967042,0.8994701457379306,0.6265060240963856,1.0,1.0,5/17,20.20%,MASTL;PPP4R4;PPP1R15A;ROCK1;TNF
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5356600240902887,0.8994467642369317,0.6615384615384615,1.0,1.0,2/12,20.66%,RGS2;ATP1A2
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.30671500968461696,-0.899431726236285,0.6666666666666666,0.9894301398486468,1.0,5/41,9.99%,ST6GALNAC3;RNF103-CHMP3;GALNT1;ST6GAL1;CHMP2B
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),0.5604156457615077,0.8993880866221534,0.6461538461538462,1.0,1.0,2/9,15.28%,PDCL;TXNDC15
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.46093928199721357,0.8993395139521452,0.6144578313253012,1.0,1.0,9/25,18.82%,HTR2B;NTRK3;C5AR1;FLT1;NTRK2;ESR1;RASGRP4;TXK;GNAQ
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.37112109249136377,-0.8992960493308639,0.45,0.9890342920072315,1.0,3/24,5.45%,GTF2H5;GTF2H2;UBTF
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,0.5475838977749672,0.8992839610081267,0.6086956521739131,1.0,1.0,3/7,21.16%,ALDH1A1;THY1;IMMT
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5303708016560154,0.8992592461291159,0.6962025316455697,1.0,1.0,5/13,24.04%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.5866151665363308,0.8989939132286805,0.6857142857142857,1.0,1.0,2/5,37.51%,ECHS1;HADHA
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),0.6235915700663517,0.8988346614099291,0.7014925373134329,1.0,1.0,3/5,37.06%,RIOK3;C1QBP;DHX58
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.4203632663855145,0.8987846197202671,0.7157894736842105,1.0,1.0,31/124,22.47%,RAP1GAP;RGS1;EPHA3;STMN3;SIPA1L1;NGEF;CHN1;RAPGEF3;RRP1B;TBC1D15;NTRK2;EPHA4;PLXNB1;EPHA5;RASGRF1;CPEB2;PICALM;THY1;FGD6;PLXNC1;PKP4;FGD4;SOD1;EZH2;ECT2;TBC1D2;LRRK2;CX3CL1;RDX;VAV3;GNB5
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.4207659985689139,0.8987517616201273,0.7708333333333334,1.0,1.0,26/108,24.06%,HHIP;PRKAR2B;DZIP1;GPC5;ADCY10;RPS27A;ADCY8;PSMB4;RBX1;TULP3;SYVN1;KIF3A;UBA52;UBB;PSMC2;PSMA3;PSMB2;IQCE;IFT122;P4HB;PSMD5;DYNC2H1;PSMD7;PRKACB;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5019561537377155,-0.898747343709211,0.5769230769230769,0.9895056417694343,1.0,1/10,0.57%,TGFBR3
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5982921012276394,0.8985968440108216,0.6229508196721312,1.0,1.0,1/5,4.88%,RORB
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5982921012276394,0.8985968440108216,0.6229508196721312,1.0,1.0,1/5,4.88%,RORB
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.5514853211862685,0.8984494091953559,0.6447368421052632,1.0,1.0,1/11,0.28%,THBS1
prerank,CellMarker_Augmented_2021__B cell:Synovium,-0.33748494161231657,-0.8983905699954944,0.6666666666666666,0.9880540482558553,1.0,4/43,2.32%,IKZF3;CD37;LY86;BIN2
prerank,CellMarker_Augmented_2021__B cell:Brain,-0.33748494161231657,-0.8983905699954944,0.6666666666666666,0.9880540482558553,1.0,4/43,2.32%,IKZF3;CD37;LY86;BIN2
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,-0.33748494161231657,-0.8983905699954944,0.6666666666666666,0.9880540482558553,1.0,4/43,2.32%,IKZF3;CD37;LY86;BIN2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5668119297240138,0.8981705248013357,0.6486486486486487,1.0,1.0,2/6,22.53%,FOXP1;PRKCB
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5232065352318592,0.8981692650284123,0.6835443037974683,1.0,1.0,5/14,24.04%,INTS12;INTS3;INTS8;INTS6;INTS10
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.42810486323691804,0.8981579564414175,0.6931818181818182,1.0,1.0,14/63,23.39%,TBC1D8;TBC1D13;VPS11;DYNC2LI1;PLK2;TBC1D15;NPRL2;TBC1D2;C10ORF90;ATG5;RDX;TBC1D14;RAB5A;PDCD6IP
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5597752523438845,0.8980546051034025,0.6753246753246753,1.0,1.0,4/9,36.10%,GRK4;PDE6B;FNTA;CAMKMT
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3797250390583189,-0.8979027861340484,0.6086956521739131,0.9882573035701168,1.0,3/28,9.22%,IDE;ERAP2;HLA-E
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.45522871046357805,0.8977249766221725,0.6593406593406593,1.0,1.0,16/55,23.07%,CENPE;RACGAP1;KIF15;KIF1B;KIF21A;ARFGAP1;NSF;KLC4;KIF11;KIF5A;KIF3A;SURF4;NAPG;KIF5C;BNIP1;KIFC2
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6060704751030905,0.8977144998100783,0.7142857142857143,1.0,1.0,2/5,21.82%,TRNT1;TRMT10C
prerank,KEGG_2021_Human__Proteasome,-0.3614535480407726,-0.8977048966455615,0.5294117647058824,0.9877922997705767,1.0,10/39,18.47%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;ADRM1;PSMA1;PSMA7;PSMD3;PSMB5
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5587044706670459,0.897698703245171,0.6575342465753424,1.0,1.0,2/6,30.09%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5587044706670459,0.897698703245171,0.6575342465753424,1.0,1.0,2/6,30.09%,TACC3;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.4808159070074957,0.8976542565692096,0.6125,1.0,1.0,11/28,21.98%,SH2D4A;MAP2;RRP1B;NEIL1;CPEB2;SLC39A14;LRRK2;ZCCHC9;RDX;ATP5IF1;CHP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4115623673238179,-0.8976073232772472,0.6111111111111112,0.9872150753117362,1.0,1/15,0.45%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.4332416208630588,0.8975495046995267,0.7362637362637363,1.0,1.0,19/67,21.98%,SH3BP5;SRCIN1;CAMK2N1;PTPRT;CAV3;GSKIP;DEPTOR;PRKAG2;PPM1E;PYCARD;DUSP10;THY1;HSPB1;GSTP1;GNAQ;TAF7;SH3BP5L;CDKN1B;CHP1
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.4468318870375762,0.8973372593427547,0.6666666666666666,1.0,1.0,13/62,19.51%,NUDT12;RIDA;B4GAT1;ACAT1;FAM162A;PEBP1;TMEM14A;CISD1;MRPL19;ADH5;MPC2;PRDX4;SORD
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.531094595769862,0.8972612190907939,0.6052631578947368,1.0,1.0,2/12,11.90%,LIMD1;DYNC1H1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.45825003782468804,0.8971573242568962,0.6436781609195402,1.0,1.0,8/32,26.04%,HSPA5;SEC61B;TOMM20;GRPEL1;HSPD1;TOMM40;PEX10;SRP54
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5710595307023795,0.8970603267026787,0.6447368421052632,1.0,1.0,1/7,1.28%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.6003923465457662,0.8966290251955479,0.7014925373134329,1.0,1.0,3/6,34.64%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.6003923465457662,0.8966290251955479,0.7014925373134329,1.0,1.0,3/6,34.64%,CHP1;CABP1;MDFIC
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3908156595424243,-0.8964615566668076,0.5652173913043478,0.9889780235496769,1.0,2/22,3.15%,GTF2F1;CTDP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.4826219697821891,0.8964561492014984,0.6575342465753424,1.0,1.0,1/13,11.67%,FLT1
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.47599198913971996,0.8963253241498538,0.6829268292682927,1.0,1.0,3/33,4.03%,SPARC;ADAMTS2;FBXL7
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.5584409926166016,-0.8960640021965767,0.625,0.9890876553425656,1.0,2/6,9.02%,NFATC3;ENG
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.5488225242265068,0.8959024819213908,0.6447368421052632,1.0,1.0,4/11,20.77%,MVD;ACAT1;HMGCS1;ACACB
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.4999797771860442,0.8958534343274916,0.6818181818181818,1.0,1.0,4/16,18.81%,MAP3K8;RPS27A;UBA52;UBB
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,0.43902071745306004,0.8958125830709559,0.735632183908046,1.0,1.0,4/58,5.61%,CLEC4E;CLEC12A;CR1;FCGR2B
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.48074640209351155,0.8957845444211702,0.6626506024096386,1.0,1.0,6/22,26.32%,HSPA1B;UBB;TNFRSF21;EEF1A1;RPA3;HSP90AB1
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.4854826596500183,0.8957537311199719,0.5975609756097561,1.0,1.0,9/24,30.51%,PRKAR2B;ADCY8;GNB5;PRKACB;RAB11A;ADCY1;AQP4;ADCY2;PRKAR1A
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.590058437991427,0.8957500676083046,0.6065573770491803,1.0,1.0,1/5,3.24%,SLC6A15
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5458370610905037,0.8955126215425432,0.6119402985074627,1.0,1.0,3/7,26.65%,CLCA4;CFTR;DUOX1
prerank,Reactome_2022__Disease R-HSA-1643685,0.40355450769346696,0.8954980522694309,0.92,1.0,1.0,237/1160,23.76%,PCSK1;BRIP1;THBS1;OMD;SPON1;FGF1;ADAMTS2;ARAF;SAP30;TSHR;OGN;NLRP12;NDUFA2;DKK2;THSD4;FZD6;CD163;HTR7;RPL23;PRKAR2B;NCAN;PPP2R5B;H2BC11;ERCC2;PIGU;VCAN;TALDO1;DOCK1;B4GAT1;NRG1;NR4A1;GPC5;KITLG;SLC2A9;RPL37A;VEGFA;VPS37C;PPP2R5A;KCNH8;EIF2AK3;SV2B;PAPSS2;GEMIN2;SH3GL3;RPS6KB2;GNS;NUP133;RPL38;RCC1;MGAT4C;MYO10;VPS11;SNAP25;KANK1;CHURC1-FNTB;ERC2;XPO1;TUSC3;DNA2;FN1;PPFIBP1;RPS6;GSDMD;ABCA1;SLC9A7;THSD7A;RBPJ;IRS2;RPS27A;KDM1A;RPL23A;CSPG5;TRIM25;PLK2;NEIL1;FGR;TXNIP;WASF1;LMNB1;ALK;RPS25;SEMA5A;RPS27;SLC24A1;FXYD7;PRR5;ADCY8;NOD2;RXFP1;PSMB4;RBX1;SEC24C;CAMK2B;NRG3;SGIP1;RPS11;SLC35A1;DYNC1H1;RPS20;CCNC;KIAA1549;RPL9;ADAMTSL3;RIPK2;SH3GL2;SYT1;THSD7B;RPLP2;PHB1;GNAI1;ZDHHC9;BRCA1;ANTXR2;PEBP1;RPL37;CNKSR2;MAGT1;RFC4;CDC37;RPL14;PYCARD;DUSP10;GTF2H3;NELFB;WNT5A;NRG4;ESR1;MTA3;SEH1L;IL18;CEBPD;RPS4X;CCND3;SYVN1;TBL1XR1;ATP1B3;CTBP1;RPL11;NAPEPLD;GFPT1;RPS24;SND1;ADAMTS19;DHDDS;POLR2D;SV2C;IQGAP1;SPTBN1;RPS9;NEURL1;ERLIN1;ROCK1;SLC25A4;APP;GUCY2C;RPL36;PIK3R4;DCTN1;SLC16A1;TAF9B;ATP1B2;HPRT1;UBA52;SUZ12;EZH2;UBB;PSMC2;NRG2;ZC3HAV1;CDK9;CDC25B;TAF7;PSMA3;CDK5R1;MLH1;AP2A2;DUSP16;ALG11;RPS3A;PGK1;SLC3A2;NOTCH2;PGM1;ENO1;PSMB2;DYNC1I1;DUSP6;ATP1A2;AHCY;BCL11A;RPL35;SLC24A4;CDKN1B;FGFR2;RPL4;RBBP8;POLR2G;RPL32;SNRPD2;PSMD5;SLC20A2;ABCB4;POMGNT1;SLC26A3;STAT1;TRIM24;PSMD7;RAB5A;CHMP5;GNL3;BARD1;VAV3;GNB5;PTGER4;RPL27A;GYS1;GSDME;TJP1;STAT2;JUN;NDC1;RPL3;GAA;ISCU;GANAB;MRC1;PHF21A;RPA3;F8;ARID4B;CASP1;PDCD6IP;TLR5;TRADD;PRKACB;GPS2;PTEN
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.40947107863665627,-0.8953713211265897,0.6176470588235294,0.9899039488876058,1.0,1/16,0.45%,CCL5
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.4172087467655098,-0.8950422126217702,0.65,0.990074103907796,1.0,2/23,1.05%,H2BC4;DNMT3A
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.5337725607977191,0.8948380491339213,0.6455696202531646,1.0,1.0,2/9,6.73%,GAS2L3;BAIAP2L1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.5265057556104802,0.8948037185038636,0.6538461538461539,1.0,1.0,3/19,9.36%,SCN3B;DMD;RYR2
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.42812402933437477,0.8947212536152589,0.6559139784946236,1.0,1.0,12/58,16.91%,LRP2;GRIN3A;SLC11A1;TUSC3;RYR2;TRPC4;CACNA1B;SLC24A1;RYR3;MAGT1;CACNA1A;CACNG8
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.40100254570935406,0.8946100153121792,0.8,1.0,1.0,43/272,22.91%,CENPF;LRP2;ARRDC3;TBC1D8;TFRC;NAPA;ARF6;RAB3C;TVP23A;TBC1D13;ANK3;RAB20;RAB15;ABCA1;TXNIP;TBC1D15;NSF;LRP1B;VMP1;SCAMP3;TMED10;PREPL;SNX17;SPTBN1;KIF3A;ARRDC2;STXBP2;SCG5;RAB21;STX2;ATP6V0B;TBC1D2;STX19;NAPG;TBC1D14;HSP90B1;ATP6V1B2;RAB5A;CTTN;HFE;PRKCB;NDC1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.4937662262501304,0.8945467984849979,0.7261904761904762,1.0,1.0,3/25,4.63%,FBN2;ACVR2A;BMPR1B
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,0.4171343107815896,0.8945452603746242,0.7157894736842105,1.0,1.0,13/84,16.38%,SPARC;TNS1;VCAN;CHI3L1;TSHZ3;SIRPB2;MAFB;ABCA1;THBD;TGFBI;CEBPD;GPR162;ZBTB47
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.36684504881129437,-0.89440967483276,0.8333333333333334,0.990745165746235,1.0,8/44,10.00%,PSMB3;PSME3;AZIN2;PSMC4;PSMD12;SLC38A1;PSME4;SMOX
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.4475351641582721,0.894402464273087,0.6555555555555556,1.0,1.0,3/41,9.61%,AZI2;TRAF2;TRIM25
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4318152984926356,0.8942971015694297,0.6777777777777778,1.0,1.0,16/74,14.20%,TGFB2;PPP2R5B;AGT;FBXL2;INSR;FN1;IRS2;IGF1R;FGR;NTRK3;FLT1;NTRK2;HCLS1;PIK3IP1;GAB1;PLXNB1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.2938056235324513,-0.8941413136983385,0.5,0.9905158198255813,1.0,8/105,6.69%,TNFAIP8L3;PSMB3;NFYC;PSME3;RUBCNL;SC5D;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.32970621555064145,-0.8940681599080159,0.8,0.9898783469698553,1.0,11/57,10.46%,CHUK;LGALS9;MAP4K2;TRIB1;SH2D3C;MAPK13;MAP3K5;MAP2K3;MAP3K10;CRKL;IKBKB
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.5844046511427807,0.8940287835493724,0.6231884057971014,1.0,1.0,3/6,31.92%,TMED10;TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.3248659180568791,-0.8938019697959384,0.6363636363636364,0.9897826849947955,1.0,15/53,16.47%,RPRD1B;DHX38;CPSF1;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;CSTF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.48168111870640906,-0.8932584599668022,0.5909090909090909,0.9901460020535768,1.0,1/6,0.42%,CYB5A
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.50056022241512,-0.8931388303900255,0.5,0.9895714296834139,1.0,1/8,1.43%,GTF2H5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4981129858192549,0.8931384408988124,0.6282051282051282,1.0,1.0,7/17,24.25%,ADCY8;EPHA5;C2CD2L;KLF7;NR1D1;PIM3;CFTR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4457018009277747,0.8928711053998161,0.7272727272727273,1.0,1.0,11/45,20.68%,TMEM161A;HERPUD1;MCL1;SOD2;PINK1;BCL2L2;HYOU1;SYVN1;HSPB1;ENO1;LRRK2
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.4679676819301752,0.8927945694876583,0.7282608695652174,1.0,1.0,6/40,11.55%,EGR1;VGF;KCNH8;SH3GL3;ID2;RPS6KA2
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.49641298042051024,0.8927643844549794,0.7317073170731707,1.0,1.0,10/25,23.60%,RPS27A;FASN;CDC37;SDCBP;PELI1;UBA52;UBB;FLOT2;PDCD6IP;TRADD
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5177008495505784,0.8923051953837937,0.6285714285714286,1.0,1.0,3/9,18.75%,DNAJB2;HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.4925285304226031,0.8922944956018625,0.6363636363636364,1.0,1.0,3/17,15.09%,MMP21;CCDC39;NDRG4
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.4336104947821227,0.8922748328286446,0.6744186046511628,1.0,1.0,9/48,21.39%,HTR2B;MCL1;MFSD2A;TIMP3;ROCK1;MTMR9;NELL1;LEPR;TBC1D14
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.42922297892449224,0.8921899889614232,0.6777777777777778,1.0,1.0,18/53,23.60%,NLRP12;IL15;AGT;OSMR;PDE2A;GPRC5B;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A;TNF;CX3CL1;TNIP1;PDCD4;PTGER4;TRADD
prerank,KEGG_2021_Human__Purine metabolism,0.4249610306141265,0.891753834105785,0.6842105263157895,1.0,1.0,26/91,20.21%,PDE5A;PDE10A;NUDT16;ADCY3;PDE1A;ENTPD3;PAPSS2;ADCY10;PAICS;PDE1C;PDE2A;PDE4B;ADCY8;PRPS1;GUCY1B1;PKM;ENPP4;DCK;PFAS;GUCY2C;HPRT1;GUK1;NME4;GUCY1A2;AK5;PGM1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.4451857839375205,-0.8915441862472544,0.6923076923076923,0.9926728815505358,1.0,5/16,8.12%,GAL3ST4;HPSE;B4GALT7;IGF1;XYLT1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.4848812677405213,0.8914085608677625,0.6216216216216216,1.0,1.0,4/28,14.49%,CAMK2N1;RNF139;SERPINE2;ASPH
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.46033185946177074,0.8912276686077466,0.6626506024096386,1.0,1.0,5/29,10.90%,B4GALNT4;MGAT4C;TUSC3;MGAT1;STT3B
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.4248098908100612,0.8910199599728245,0.7142857142857143,1.0,1.0,30/117,22.12%,LRP2;TACR1;TFRC;ARF6;TRIP10;SH3GL3;COPS5;DNAJC6;FCHO2;DNM3;ARFGAP1;RPS27A;DNM1;SGIP1;SH3GL2;SYT1;AGFG1;ITSN1;PICALM;WNT5A;AMPH;UBA52;UBB;AP2A2;SNAP91;HIP1R;CLTCL1;IL7R;RAB5A;CTTN
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.4604018709527808,0.8909841025464844,0.651685393258427,1.0,1.0,8/47,20.85%,KLF4;PCBP4;TXNIP;PINK1;BCL6;SIRT3;RBL2;CDKN1B
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.47297337286673347,-0.8909300222562354,0.6521739130434783,0.9935722601972136,1.0,6/13,10.97%,INPP5K;CORO1B;CSF1R;LIMA1;PLEK;CYFIP1
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.4846971243311766,0.8907907356498127,0.6375,1.0,1.0,9/20,31.60%,POLE2;ORC6;DBF4;RPA3;ORC3;MCM3;MCM6;POLA1;GMNN
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.4473696032344223,0.8907049684481988,0.6741573033707865,1.0,1.0,6/55,12.87%,RHOB;ANXA1;FIGNL1;CLK2;INTS3;BRCA1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4587849324162544,0.8905175829753538,0.6470588235294118,1.0,1.0,11/32,26.32%,MAP2;KDM1A;DYNC1H1;PINK1;EPHA5;STXBP2;FES;NR1D1;LRRK2;BRSK1;HSP90AB1
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,0.5369422450156731,0.8905144061436148,0.7,1.0,1.0,3/16,15.83%,ANKRD22;ST14;IL18
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,0.5369422450156731,0.8905144061436148,0.7,1.0,1.0,3/16,15.83%,ANKRD22;ST14;IL18
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.3743254344574066,-0.8904471048324455,0.5714285714285714,0.9938908606642982,1.0,3/19,4.64%,SMDT1;MAIP1;MICU3
prerank,Reactome_2022__Interleukin-1 Processing R-HSA-448706,-0.4729725177667552,-0.8904387960086629,0.5483870967741935,0.9931526606520101,1.0,2/8,2.85%,IL1B;IL1A
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,-0.4695245532555069,-0.8903537594280642,0.6774193548387096,0.9925576869732964,1.0,5/9,14.14%,TLN1;SRC;CRK;APBB1IP;RAP1A
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,0.44940862240375995,0.8899347474035585,0.6777777777777778,1.0,1.0,10/42,15.99%,CD163;TNS1;F13A1;PDK4;RAPGEF3;CD93;FLT1;SHROOM4;SLC24A3;LDB2
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.49079846961658147,-0.8898602212827473,0.5625,0.9928357683506425,1.0,1/7,0.28%,IKZF3
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5794926388690548,0.8898573983653838,0.726027397260274,1.0,1.0,2/7,21.83%,DDB1;STAT1
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.3311860099364203,-0.8898527827076754,0.6666666666666666,0.992110224542528,1.0,27/90,13.95%,CD300LF;ITGAM;LY86;GIMAP8;BIN2;MPEG1;FOLR2;LGALS9;CSF1R;LILRB4;ITGAX;AOAH;MYO1F;NCKAP1L;WDFY4;IGSF6;PLEK;HCK;HLA-DPA1;ITGB2;CYTH4;LCP2;TYROBP;CD53;GIMAP4;GIMAP7;HAVCR2
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.3552795235390618,-0.8898414078552043,0.75,0.991395925018049,1.0,17/53,13.92%,TDRD10;GIMAP8;A2M;MPEG1;FOLR2;HPGDS;CSF1R;SLCO2B1;CLEC9A;HLA-DPA1;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.5067860916385654,-0.8897832708537631,0.5925925925925926,0.9907434321874069,1.0,1/9,9.22%,HLA-E
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.41427263490084143,0.8897595642744064,0.7368421052631579,1.0,1.0,19/136,14.74%,HTR2B;PLPP3;PFKM;PTPRD;NUDT4;PLPPR4;ITPKC;ALOX15B;INPP4B;LIMD1;ALK;EPHA7;PFKFB4;GPI;FBP1;PPA1;ACP3;GK;DUSP10
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.5268012549741361,0.8897000008379948,0.64,1.0,1.0,1/14,1.11%,PRLR
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.560502336855378,0.8894334248590108,0.7121212121212122,1.0,1.0,4/7,34.80%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.560502336855378,0.8894334248590108,0.7121212121212122,1.0,1.0,4/7,34.80%,SLC12A8;SLC12A5;SLC12A2;SLC12A9
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.35714484705517086,-0.8893906486329386,0.5454545454545454,0.990850185780981,1.0,1/39,0.13%,STAT4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4859111037655277,0.8892257373626554,0.6216216216216216,1.0,1.0,4/21,17.56%,VPS11;PER1;BRCA1;FOXP1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.45243766094303745,0.8892147777299743,0.6666666666666666,1.0,1.0,18/37,31.73%,SBDS;RPL23A;RPS27;MRPL20;RPL11;NOP53;MTERF3;RPL24;RPL3;DDX3X;TRAF7;DHX37;RPL6;RPLP0;C1QBP;DHX29;MRPS7;MDN1
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.40718843755542355,0.8891496900379406,0.7604166666666666,1.0,1.0,47/149,26.86%,RPL23;RIOK2;WDR12;RPL37A;PES1;RPL38;RPS6;RRP1B;RPS27A;RPL23A;RPS25;RPS27;RRP36;RPS11;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;UBA52;RPS3A;RPL35;RPL4;RPL32;MPHOSPH10;GNL3;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL36AL;RPL21;RPL7;RPL12;DHX37;RBM28;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.4377775096118187,0.888968046596431,0.6704545454545454,1.0,1.0,6/43,9.76%,ECM2;DOCK1;DOCK5;FN1;CSPG5;CARMIL1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.5506307156917843,0.8888292727808431,0.6417910447761194,1.0,1.0,5/9,33.92%,PRPS1;HPRT1;MTHFD1;PPAT;GART
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.4630829428751309,-0.8887414333828311,0.5652173913043478,0.9916033104371426,1.0,3/9,7.34%,IL1B;IL1A;IGF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4061240079801932,-0.8885947372568088,0.6190476190476191,0.9913963141602679,1.0,3/16,2.85%,BCL2L1;IL1B;IL1A
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.49357917507595594,0.8884476553669007,0.675,1.0,1.0,4/17,26.22%,VPS11;CHCHD3;MFN2;OPA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.43123407121192586,0.8884421133955788,0.6842105263157895,1.0,1.0,12/66,17.45%,TGFB2;SEMA3A;GADD45B;VEGFA;TRAF2;FCGR2B;NOD2;SASH1;PYCARD;SDCBP;PLCB1;APP
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.5497768787917542,0.8884121040196457,0.6582278481012658,1.0,1.0,3/11,22.96%,PDK4;PDK3;RORA
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.547349583994657,0.8882964237655226,0.6521739130434783,1.0,1.0,4/10,24.47%,NOD2;ECSIT;SLAMF8;SIRT4
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,0.5358868639016713,0.8881722920238613,0.6986301369863014,1.0,1.0,2/9,21.83%,CRLF1;STAT1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.4608362822309297,0.8881364208223058,0.6744186046511628,1.0,1.0,7/36,16.37%,ENPP2;CYP3A5;RIDA;AMDHD2;TRHDE;LTA4H;PNPLA8
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.46945239879431394,-0.8881192563838437,0.5185185185185185,0.9921075161046583,1.0,2/8,7.85%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.6055226989479625,0.8880093457389754,0.7121212121212122,1.0,1.0,1/5,4.06%,PTPRG
prerank,CellMarker_Augmented_2021__B cell:Undefined,0.47273986383339867,0.8879553779127214,0.6896551724137931,1.0,1.0,4/39,5.61%,CR1;CD163;CD22;FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5709059206276907,0.8879544858801198,0.7101449275362319,1.0,1.0,3/7,17.45%,PTN;EPHA4;APP
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.40361860031845814,0.8876254992963968,0.7575757575757576,1.0,1.0,6/143,4.53%,SOCS3;THBS1;CR1;WDR5;H2BC11;LIFR
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.4065259809594991,0.887487304093928,0.7653061224489796,1.0,1.0,20/136,12.76%,THBS1;FGF1;RAP1GAP;ADCY3;ENAH;GNAO1;KITLG;VEGFA;INSR;GRIN2A;CNR1;SIPA1L1;RAPGEF3;CALM3;IGF1R;ADCY8;FLT1;MAGI2;PARD3;GNAI1
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.335737611369765,-0.8874271595143597,0.7,0.9929284938180095,1.0,7/69,6.70%,TNFAIP8L3;INPP5K;PIK3R6;PIK3C2B;MTMR14;INPP5E;PIP4K2B
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3956394772055142,-0.8874065702381483,0.42857142857142855,0.9922073300904147,1.0,1/18,0.77%,NDE1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.4333433773776891,-0.8874056791745905,0.5882352941176471,0.9914470179600773,1.0,2/14,11.33%,RRP7A;MRPS11
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4213435330484463,0.887300570816387,0.7872340425531915,1.0,1.0,21/140,12.83%,RAB7B;CLEC12A;KMO;CD163;PLAC8;CADM1;CD22;VCAN;ANXA1;SLC11A1;ADGRE1;FCGR2B;ITGAE;FGR;FCGR2C;PDCD1LG2;FGL2;GPR65;HCLS1;TNFRSF1B;NR4A3
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.34479665586254304,-0.887061486200834,0.65,0.9915224935247817,1.0,5/33,10.83%,NUP42;BANF1;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.6344688470052062,0.887045753614107,0.7391304347826086,1.0,1.0,1/5,2.72%,CACNB2
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.5729505176608167,-0.8868582038966581,0.6764705882352942,0.9913064613231293,1.0,2/5,9.18%,HPS4;P2RY12
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.4043742443023024,-0.8867772055787996,0.5,0.9907393479864246,1.0,3/13,8.49%,TTC39B;ARV1;LAMTOR1
prerank,KEGG_2021_Human__GnRH signaling pathway,0.42318891882745946,0.8864865208555606,0.7263157894736842,1.0,1.0,15/68,23.72%,GNRHR;EGR1;ADCY3;GNA11;CALM3;ADCY8;CAMK2B;MAPK10;PLCB1;GNAQ;PLD1;MAP3K3;PRKCB;JUN;PRKACB
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.4965478458189101,0.8861094500276784,0.68,1.0,1.0,3/20,5.56%,CBR1;ALOX12;ALOX15B
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.313950727574808,-0.8860383215512132,0.75,0.9917783262830665,1.0,7/52,8.38%,PSMB3;PSME3;CHUK;MAP3K14;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.3777231190629604,-0.8859093579414324,0.5,0.9913620935460506,1.0,5/15,7.51%,IL1B;IL1A;HPSE;C3;TGFB1
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.49263217156379496,0.8855960700754698,0.6625,1.0,1.0,3/22,6.47%,H2BC11;SMC4;NCAPH2
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.5490449942551897,-0.8853677046755063,0.6666666666666666,0.9919482309778641,1.0,3/5,38.66%,RACK1;LTN1;ZNF598
prerank,Reactome_2022__RSK Activation R-HSA-444257,-0.5252068578653891,-0.8853429027550609,0.5454545454545454,0.9912722506082687,1.0,1/7,1.33%,RPS6KA6
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,0.4729373621742534,0.8852815802886306,0.65,1.0,1.0,7/24,18.81%,PTPRK;SH3GL3;SPRY1;RPS27A;SH3GL2;UBA52;UBB
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4107193133217886,0.8852539908086662,0.7575757575757576,1.0,1.0,25/180,13.92%,PLPP3;FGF1;CLIP3;FAXDC2;PPP2R5B;TFRC;ACVR2A;VEGFA;GPNMB;PPP2R5A;EIF2AK3;INSR;PAQR3;SLCO3A1;FN1;FGR;NTRK3;IMPACT;IBTK;EPHA7;FAM20A;NTRK2;SH3GL2;PINK1;LIMCH1
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.4903215991244301,0.8851976333020519,0.7294117647058823,1.0,1.0,8/24,31.27%,RPS27A;UBA52;UBB;USP5;UBE2D2;UBE2D1;UBE2L3;UBE2R2
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.4263693609505111,0.8849147820372784,0.7340425531914894,1.0,1.0,12/77,11.70%,CD163;FAXDC2;CHI3L1;RTN1;F13A1;MAFB;NDRG2;GLUL;FCGR2C;CD93;FGL2;KIAA0513
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.41660779450146207,0.8849141142172453,0.6770833333333334,1.0,1.0,14/65,24.06%,BRIP1;TALDO1;RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5719700522848865,0.8848716186258794,0.6666666666666666,1.0,1.0,1/6,7.35%,HERPUD1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.5305491655243662,0.8848379152366735,0.6231884057971014,1.0,1.0,5/9,28.17%,CMPK1;NMNAT2;AK5;ME1;PNP
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.4539498584827847,-0.8847421711819827,0.56,0.9910927308344318,1.0,2/8,7.54%,ABI3;CGAS
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.4539498584827847,-0.8847421711819827,0.56,0.9910927308344318,1.0,2/8,7.54%,ABI3;CGAS
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.49823813669487194,0.8847133011483623,0.65,1.0,1.0,4/21,13.26%,RPS6KB2;RPS6;PRR5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.4950622293423064,0.8845880300168992,0.684931506849315,1.0,1.0,5/15,22.83%,RTN1;NTRK2;ROCK1;RTN3;RTN4
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.32818723825169543,-0.8845501552610334,0.5,0.9906786020967573,1.0,18/61,16.47%,RPRD1B;DHX38;LEO1;CPSF1;LSM11;MTPAP;CHTOP;THOC5;WDR33;DDX39A;RPRD1A;CSTF1;GRSF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.43830524845842567,0.8844327935583824,0.6043956043956044,1.0,1.0,4/41,7.06%,SULT4A1;GLYATL1;PAPSS2;MAT2A
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.3555606867379464,-0.8844255771841742,0.5,0.9901852683981456,1.0,19/86,15.58%,PSMB3;IL1B;PSME3;CHUK;ITPR2;MAP3K14;PSMC4;PSMD12;PSME4;NFATC3;SRC;IKBKB;NFKBIA;SYK;PSMA1;BCL10;CARD11;PSMA7;NFKB2
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.534757073644829,0.8841205729085744,0.6944444444444444,1.0,1.0,5/12,34.64%,CHP1;BARD1;CABP1;NUP153;MDFIC
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.40926113356512295,0.8841020951932256,0.696969696969697,1.0,1.0,32/153,27.16%,NLRP12;GEMIN2;NUP133;VPS11;RPS6;RPS27A;TRIM25;RPS25;RPS27;NOD2;SEC24C;RPS11;RPS20;RIPK2;SEH1L;RPS4X;RPS24;RPS9;PIK3R4;RPS3A;SNRPD2;STAT1;TJP1;STAT2;NDC1;RPS16;POM121;TLR2;HSP90AB1;FAU;RPS12;NUP58
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.5719768315737912,0.8840794078202997,0.6027397260273972,1.0,1.0,1/5,3.87%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.463470355623423,0.8837698817929831,0.6235294117647059,1.0,1.0,4/25,9.76%,DOCK1;DOCK5;CSPG5;CARMIL1
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.40049680979374896,0.8836391255418157,0.87,1.0,1.0,87/503,22.75%,DIAPH3;RHOBTB3;CENPF;RHOB;PDE5A;VIM;CENPE;HTR7;PREX2;PPP2R5B;H2BC11;ANLN;RACGAP1;DOCK1;TFRC;DOCK5;PPP2R5A;TRIP10;VAPB;NUP133;ARHGAP23;BAIAP2L1;PDZD2;RND3;NGEF;AKAP12;XPO1;CENPP;KDM1A;CKB;WASF1;LMNB1;SLITRK5;GFOD1;CKAP4;ARHGEF4;RPS27;SPTAN1;CLASP2;KALRN;DYNC1H1;CKAP5;UACA;CENPK;STMN2;KLC4;CENPI;PLXNB1;ITSN1;CDC37;INCENP;PICALM;KIF5A;SEH1L;ARAP2;DHDDS;IQGAP1;SPTBN1;ROCK1;ARHGDIA;PIK3R4;PKP4;STARD13;FGD4;RHOH;ECT2;CPNE8;KNTC1;DYNC1I1;BASP1;CENPT;CDKN1B;FAM13A;MFN2;VRK2;FLOT2;STARD8;CDC42BPA;CTTN;MYL6;ANKRD26;VAV3;RHOU;ARHGAP42;PRKCB;ITGB3BP;TUBA1B
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.5408431643706672,0.8835913594045872,0.6266666666666667,1.0,1.0,1/9,1.46%,TRMT9B
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,-0.46032319478355144,-0.883590350106624,0.71875,0.9916172248144225,1.0,3/9,19.70%,CTC1;TERF2;PRIM1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5613246965607017,0.8834845184290362,0.6857142857142857,1.0,1.0,4/8,24.61%,NOD2;SASH1;GPS2;DDX3X
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.44678475040689647,-0.8834293576447163,0.5714285714285714,0.9912933180999353,1.0,1/12,0.78%,CASP7
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.41219107668133226,0.8834172490344567,0.77,1.0,1.0,44/219,21.98%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;TTBK2;CEP152;TUBA1A;MTERF1;HCFC1;DYNC2LI1;NPHP1;ATAT1;SIRT5;CRTC3;IFT74;PRKAG2;DYNC1H1;CYCS;POLG2;CKAP5;PKD1;ATP5ME;SMARCD3;ATP5F1A;TBL1XR1;TCP1;ATP5F1D;CC2D2A;KIF3A;TFAM;DCTN1;PRKAA2;CHCHD3;SIRT3;PPARA;ATP5MC1;POLRMT;NR1D1;EXOC5;IFT122;IMMT;DYNC2H1;ATP5PB;ATP5F1E
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.5464052580133724,0.8832906449039438,0.6527777777777778,1.0,1.0,4/10,22.97%,MBOAT2;OSBPL10;OSBPL5;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4993272808157352,-0.8832840342914712,0.5416666666666666,0.9908802931740007,1.0,2/9,0.45%,SKAP1;CCL5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.44179042454640177,0.8829498219570594,0.6625,1.0,1.0,7/25,20.62%,PTPRZ1;PTPRT;DUSP10;PTPN9;DUSP16;DUSP6;PTPRS
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4962814699777455,-0.8828003453741775,0.5555555555555556,0.9911842257666057,1.0,2/7,8.99%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.5855301144073359,0.8824484219342233,0.7027027027027027,1.0,1.0,2/5,17.34%,ABCA2;NECAB1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.3925325953861199,0.8824088296836865,0.94,1.0,1.0,98/645,17.71%,KLF4;NFIL3;ACVR1B;FGF1;SAP30;RBMS3;TGFB2;RPL23;EGR1;TLE1;MAPT;TFRC;PQBP1;SLC11A1;RORB;VEGFA;SOX4;TDG;NOCT;TCF7;EIF2AK3;MOG;APBB3;ZNF804A;ANK3;ANK2;HINT1;INSR;OVOL2;CAMK2N1;HIF1A;BMI1;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;PCBP4;BHLHE40;TCF7L1;ROBO1;TRIM5;FN1;MAFB;ID2;RIMS2;LIMD1;RBPJ;RRP1B;POU5F1;NTRK3;ITGB8;PDE2A;CELSR2;PER1;NOVA1;CLK2;FAM50A;CCDC3;ZNF536;TULP3;SOX6;NTRK2;HCLS1;HINFP;CIAO3;NFKBIZ;SH3GL2;BRCA1;DRAP1;PINK1;RLIM;YAF2;ZNF143;AHNAK;TRIM26;PICALM;WNT5A;ACTR5;MLF2;ESR1;SLC24A3;HNRNPH1;NR2C2;EPB41L4B;RPL11;TXK;CXXC1;SMAD1;ROCK1;BCL6;SART3;HSPA1B;APP;APBB2;FOXP1;RGCC;OLFM1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.5589300185338119,0.8823470912599146,0.6619718309859155,1.0,1.0,4/9,29.84%,DNA2;XRCC3;SLX4;BLM
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.5887790599894702,0.8823083025627255,0.7142857142857143,1.0,1.0,3/8,19.08%,TMEFF2;GSTP1;TAF7
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.5156669994053346,0.882169868164972,0.6538461538461539,1.0,1.0,6/14,25.89%,RPS27A;RFC4;UBA52;UBB;RPA3;REV3L
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.4074333723778265,-0.8817591160636787,0.6,0.9928496864790014,1.0,2/23,1.05%,H2BC4;DNMT3A
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.46201800098306983,0.8816031835336839,0.6666666666666666,1.0,1.0,7/24,20.17%,CNTN1;RBPJ;RPS27A;NEURL1;UBA52;UBB;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.4421947310036121,0.8811947928151942,0.7391304347826086,1.0,1.0,3/30,9.63%,TOM1L1;BRINP1;PLK2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.42677412492427175,-0.8810969473980946,0.631578947368421,0.993698039567622,1.0,5/14,6.66%,INPP5K;IL1B;FFAR4;C3;TRIB3
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4874294069165741,0.8808769956516196,0.7,1.0,1.0,6/26,20.05%,ANLN;RPS27A;RGCC;UBA52;UBB;KNTC1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,0.4342351466955756,0.8807693056386559,0.7021276595744681,1.0,1.0,11/68,11.30%,CLEC4E;CLEC12A;CR1;CD163;SLC11A1;F13A1;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5157727785733672,0.8806818741244038,0.6923076923076923,1.0,1.0,3/11,20.62%,NTRK3;NELFB;PTPRS
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.32242655556030947,-0.8806713447878628,0.8333333333333334,0.9938601822737628,1.0,4/37,5.77%,GTF2H5;GTF2F1;GTF2H2;TAF13
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.44320579306270674,0.8806515626388896,0.6470588235294118,1.0,1.0,8/43,20.58%,WDR5;HCFC1;RUVBL2;PER1;TRIM16;CHD5;MORF4L2;MEAF6
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.5889839274839105,0.8806179015084993,0.7466666666666667,1.0,1.0,1/5,26.54%,SAE1
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.43993652919153214,0.8805794164616386,0.627906976744186,1.0,1.0,5/34,12.87%,H2BC11;SMC1B;SYCP3;LMNB1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.49890706481137337,0.8804448421936562,0.686046511627907,1.0,1.0,3/18,6.39%,MTCL1;CEMIP;ANK3
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.5366237917466181,0.8804084132837916,0.7,1.0,1.0,6/12,33.03%,DONSON;TIMELESS;BLM;LIG3;GMNN;ZRANB3
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5010189827514743,0.8804036709980645,0.676056338028169,1.0,1.0,6/17,30.80%,RYR2;SRPRA;SPCS3;MAN1A1;SRP54;SRP14
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4471625221773329,-0.8803451630899345,0.72,0.9937840241916717,1.0,5/13,12.43%,LILRB4;APPL2;SIRPA;TREM2;CHID1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.42503775538207184,-0.8802924985387217,0.5555555555555556,0.9931529366104729,1.0,2/14,6.50%,IL1B;TP53
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5331393228475685,0.8801859465226116,0.6285714285714286,1.0,1.0,5/10,38.56%,PRKAA2;KCNB1;EIF4G1;ULK1;MTOR
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.44095674455749173,0.8800814097224492,0.6777777777777778,1.0,1.0,6/48,11.07%,EIF2AK3;FN1;PPFIBP1;RPS6;ALK;RBX1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.5326644041495356,-0.8799721052778742,0.6129032258064516,0.9930873307984317,1.0,1/6,6.50%,TP53
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.47470240511340933,0.879626007730533,0.6296296296296297,1.0,1.0,1/14,9.61%,TRIM25
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.4755152170452261,-0.8795452099595071,0.6486486486486487,0.9931999621229988,1.0,1/5,8.61%,SVIP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.3861970820809533,-0.8793452514408586,0.6521739130434783,0.992768522350523,1.0,8/19,19.17%,LGALS9;SCIMP;TLR3;IRF5;SYK;TIRAP;IL16;PLCG2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.3467217188367176,-0.8792795120149872,0.5,0.9922586784346886,1.0,1/34,0.13%,STAT4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.46912411423958555,0.8792358800195299,0.6590909090909091,1.0,1.0,11/26,23.90%,MAP9;DYNC1H1;GNAI1;HSPA1B;DCTN1;GPSM2;TACC3;HNRNPU;CHMP5;PDCD6IP;BORA
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5198106959867348,-0.8792319568809717,0.5294117647058824,0.9916508587333246,1.0,1/6,0.30%,EYS
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,-0.5115374219330472,-0.8792058991501303,0.6129032258064516,0.9909452840784043,1.0,2/5,19.62%,DVL2;CSNK2A2
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5021222208273278,0.8789967151295882,0.6363636363636364,1.0,1.0,3/11,21.38%,VPS11;RAB21;RDX
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.37419137221011073,-0.8787436964087375,0.5333333333333333,0.9904042887780813,1.0,3/27,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.37419137221011073,-0.8787436964087375,0.5333333333333333,0.9904042887780813,1.0,3/27,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,0.5614336193188384,0.8783056319865661,0.6351351351351351,1.0,1.0,2/6,9.63%,CD163;PLK2
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,0.5360548405033393,0.8782587040994583,0.6507936507936508,1.0,1.0,1/5,15.39%,HYOU1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.46432195807785553,0.8778016451567705,0.6493506493506493,1.0,1.0,5/17,20.68%,EIF2AK3;HERPUD1;BOK;SYVN1;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.3559535458794949,-0.8777477436130121,0.7222222222222222,0.9919655022741352,1.0,2/28,9.48%,PKIB;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40294143951802885,0.877714846267043,0.8383838383838383,1.0,1.0,40/179,21.58%,PLPP3;RAB7B;RELN;TFRC;AGT;ARID5B;VEGFA;TRAF2;COPS5;SLCO3A1;TRIM5;RPS27A;KDM1A;TRIM25;ALK;CRTC3;ADCY8;NOD2;HCLS1;RIPK2;TRIM26;EPHA5;PYCARD;AIM2;WNT5A;ESR1;DHX33;IL18;MAP3K13;HSPA1B;APP;RGCC;UBA52;UBB;BEX1;TNF;TRIM14;IRAK3;CX3CL1;FLOT2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.48332149196772134,0.8775096648784421,0.6875,1.0,1.0,7/28,14.98%,CD22;TFRC;FCGR2B;IL7;IRS2;CD300A;GPR183
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,-0.437967011528145,-0.8774216446714783,0.59375,0.9918913909477763,1.0,2/6,9.02%,BSG;ENG
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.5138503702477158,0.8770665170136506,0.6875,1.0,1.0,2/14,8.33%,PCBP4;SRSF12
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.40137104926721645,0.8767715386680219,0.8541666666666666,1.0,1.0,49/156,26.86%,RPL23;RIOK2;WDR12;RPL37A;PES1;RPL38;RPS6;RRP1B;RPS27A;RPL23A;RPS25;RPS27;RRP36;RPS11;NHP2;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;DIMT1;UBA52;RPS3A;RPL35;RPL4;RPL32;MPHOSPH10;GNL3;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL36AL;RPL21;RPL7;RPL12;DHX37;RBM28;RPL10A;FAU;RPS12
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.45181751337065906,-0.8766878563259021,0.6,0.9928397003111991,1.0,4/14,11.90%,LRIG1;POLD3;POLE3;SLC19A1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.44014179581103335,0.8766454209196799,0.6818181818181818,1.0,1.0,8/45,19.53%,MAPT;PTPRK;HIF1A;GLRX2;SOD2;GSTP1;SOD1;FOS
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.4255073115211687,0.8765308256265354,0.6774193548387096,1.0,1.0,17/44,23.57%,CBR1;VEGFA;PAX8;MFSD2A;ERRFI1;CPT1A;PKD1;NDRG4;PPP2R3A;TIMELESS;PGK1;FGFR2;IFT122;STAT1;MTHFD1;ALDH1A2;HNRNPH3
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.5047601017724876,0.8763856134481303,0.6891891891891891,1.0,1.0,7/17,24.08%,ERC2;LMNB1;APP;CDC25B;CDK5R1;JUN;FOXO3
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.5602230213389837,0.8763059304067506,0.6911764705882353,1.0,1.0,3/8,29.84%,TIMELESS;SPIDR;BLM
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.4045078841498441,0.8761149951057288,0.7083333333333334,1.0,1.0,17/91,22.53%,SLC16A10;PFKM;RXRB;HIF1A;DIO1;ESR1;ATP2A2;ATP1B3;ITGAV;PLCB1;ATP1B2;NOTCH2;ATP1A2;SLC9A1;STAT1;RCAN2;PRKCB
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.4638973491755736,0.8760981398894001,0.627906976744186,1.0,1.0,8/20,22.49%,RXRB;PDK4;RDH11;CPT1A;ALDH1A1;PDK3;PDHB;ALDH1A2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,0.44905795966371964,0.8760776569455468,0.7065217391304348,1.0,1.0,9/29,23.12%,SPARC;TNS1;SORBS1;SHROOM4;LDB2;IGFBP7;CX3CL1;SPARCL1;MRC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.4226646765238441,-0.8760186745394003,0.5,0.9936196077755018,1.0,2/16,4.46%,LATS2;LILRB4
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.5373981244091218,0.8759281276179718,0.6349206349206349,1.0,1.0,1/7,8.86%,ID2
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.38281235910306466,-0.8758708423826224,0.7222222222222222,0.9932696005427429,1.0,5/27,10.55%,PPP1R16B;LGALS9;C3;PRR5L;HLA-DPA1
prerank,Reactome_2022__M Phase R-HSA-68886,0.4017007906627937,0.8758195014387,0.83,1.0,1.0,55/280,24.19%,CENPF;TUBA4A;CENPE;PRKAR2B;HAUS6;PPP2R5B;H2BC11;TUBB4A;CEP152;MASTL;TUBA1A;PPP2R5A;SMC4;TUBB6;NUP133;NCAPH2;RCC1;XPO1;CENPP;RPS27A;LMNB1;RPS27;PSMB4;CLASP2;DYNC1H1;SPAST;CKAP5;CENPK;CENPI;INCENP;TUBB2A;SEH1L;CNEP1R1;DCTN1;UBA52;TUBA1C;UBB;PSMC2;PSMA3;KNTC1;PSMB2;DYNC1I1;CENPT;VRK2;PSMD5;PSMD7;PRKCB;ITGB3BP;TUBA1B;NDC1;DSN1;PSMD14;VRK1;PSMA5;NEK9
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.47818821531044053,0.8756424804102733,0.6025641025641025,1.0,1.0,3/24,6.86%,TOM1L1;INSR;RCC1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.4440110753374108,0.8754334257644572,0.7701149425287356,1.0,1.0,11/49,20.69%,FGF1;ANXA1;SOX4;ID2;NREP;TOMM20;CPE;SLC16A1;HSPD1;KDM6B;AHCY
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.4440110753374108,0.8754334257644572,0.7701149425287356,1.0,1.0,11/49,20.69%,FGF1;ANXA1;SOX4;ID2;NREP;TOMM20;CPE;SLC16A1;HSPD1;KDM6B;AHCY
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.31617320733038196,-0.8754164937538595,0.7142857142857143,0.9934889730063731,1.0,7/51,8.38%,PSMB3;PSME3;CHUK;MAP3K14;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.394365098172478,0.875210015147112,0.89,1.0,1.0,60/332,18.63%,HTR2B;KLF4;ACVR1B;RHOB;ST18;TGFB2;CR1;BRINP1;NR4A1;ADAM15;TP53TG5;PTPRK;SOX4;GPNMB;ALOX15B;CDKN2AIP;FCGR2B;EIF2AK3;FHL1;CAMK2N1;BNIP3L;TCHP;TXNIP;SEMA5A;IMPACT;SMYD5;ING1;DNAJB2;RPS6KA2;IFNLR1;MAGI2;RBM5;FBP1;TNFRSF1B;SOD2;BNIP3;CLMN;RNF139;PLXNB1;E2F7;TGFBI;THAP12;DUS2;CTBP1;ORC6;CHD5;PRKRA;NEURL1;ARHGDIA;BCL6;HSPA1B;APP;APBB2;RGCC;PLXNC1;IGFBP7;FTH1;GTPBP4;SUZ12;AQP11
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,-0.31491242206640946,-0.8751806133491028,0.8,0.9932571923619262,1.0,12/157,3.54%,BRD3;SNAP47;ITGA5;CASP7;PFN1;PSMB3;A2M;CBX1;GYPC;H4C3;SH3BGRL3;ELK3
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.5238166446975745,-0.8747428917677876,0.6206896551724138,0.9936623186511843,1.0,2/5,27.06%,PRCP;PLCB3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.48841770955888575,0.8747019788606659,0.6436781609195402,1.0,1.0,4/22,15.59%,PDK4;IRS2;FBP1;PDK3
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.4469816759374871,0.8746228650466861,0.7446808510638298,1.0,1.0,8/45,14.37%,PRLR;ACSL1;MVD;SCD5;ELOVL4;AGPS;SCD;FDFT1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5493711811126668,0.8745623572746746,0.7297297297297297,1.0,1.0,1/10,2.79%,MAPT
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.4959700296321214,0.8744901481037088,0.675,1.0,1.0,3/14,9.68%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.45920127495491614,0.8744299556621705,0.6951219512195121,1.0,1.0,9/27,21.27%,MAPT;SLC11A1;C5AR1;CD93;CRTC3;APP;FOXP1;TNF;CX3CL1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.5562617007555919,-0.8741438554425294,0.7333333333333333,0.9944093495130746,1.0,1/6,0.87%,SMPD3
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,-0.36485654244073606,-0.8741288260181266,0.6666666666666666,0.993698246680061,1.0,4/29,7.02%,DNMT3A;CCND1;COPRS;SMARCD1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.36606492147000036,-0.8740936000409611,0.6956521739130435,0.9930370589861538,1.0,11/25,22.80%,CCDC88C;EP300;GSN;PYHIN1;FBXL3;PEX2;CTSH;CUL3;BTRC;PRKN;CDC73
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47799093058628145,0.8740922637798708,0.6712328767123288,1.0,1.0,6/10,46.81%,ADAM17;FGFR1;FGF2;AKT3;SIRT6;PLCG1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.43112951523130166,0.8738567433109143,0.7037037037037037,1.0,1.0,9/52,17.58%,TGFB2;ARF6;APBB3;CADPS;CLASP2;PPID;TMED10;RAB2B;RGCC
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.32440971396685325,-0.87368770255726,0.7692307692307693,0.9932946822303114,1.0,2/42,2.62%,EHD4;DENND1C
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5088798708696117,0.8736008689653311,0.6712328767123288,1.0,1.0,6/16,34.79%,GSDMD;RTN4;NDC1;AHCTF1;NUP153;NUP205
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.47577967892840095,0.873262263143493,0.75,1.0,1.0,3/23,7.98%,TLE1;TCF7;TCF7L1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.39972901852938975,0.8731592484054378,0.7473684210526316,1.0,1.0,14/114,12.08%,TGFB2;CLEC12A;CD163;EGR1;TNS1;CDH2;KITLG;F13A1;BAALC;BMI1;TXNIP;CD93;FGL2;THBD
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.5568341365554317,0.8730221207424544,0.7195121951219512,1.0,1.0,2/9,8.25%,KIF1B;ERC2
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.5284975403797282,0.8729671768233881,0.7183098591549296,1.0,1.0,1/9,3.70%,ATAD3A
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.46050061857672214,0.8727888642951769,0.6875,1.0,1.0,5/22,19.17%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3882002175896049,-0.8726263482339335,0.8260869565217391,0.9951032651524999,1.0,7/19,20.91%,CTC1;TP53;SRC;TERF2;EXOSC10;ERCC4;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.3407316620308298,-0.8725112507362479,0.625,0.9946959972799239,1.0,5/40,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.3229747107595929,-0.872494424705272,0.7,0.9932796922354404,1.0,5/55,5.45%,H2BC4;GTF2H5;GTF2H2;GATAD2B;UBTF
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.3229747107595929,-0.872494424705272,0.7,0.9932796922354404,1.0,5/55,5.45%,H2BC4;GTF2H5;GTF2H2;GATAD2B;UBTF
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.40355222780476746,-0.8722821512699265,0.5652173913043478,0.9930595114691224,1.0,5/16,12.50%,IL1B;APPL2;IGF1;REST;SORL1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.3994767216497139,0.8722762702976815,0.8,1.0,1.0,43/170,24.06%,DAPK2;NDUFA2;VIM;HMGB2;DCC;MAPT;CLSPN;DAPK1;SEPTIN4;GSDMD;CASP5;RPS27A;LMNB1;SPTAN1;PSMB4;CYCS;UACA;FASN;CDC37;SDCBP;PELI1;CASP3;IL18;ROCK1;UBA52;PLEC;UBB;PSMC2;PSMA3;PSMB2;PSMD5;FLOT2;APPL1;PSMD7;GNL3;GSDME;TJP1;CASP1;PDCD6IP;TRADD;PSMD14;H1-0;PSMA5
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.544675398032873,0.8721388150965119,0.71875,1.0,1.0,1/8,1.28%,TGFB2
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.5042987391762818,0.8720988452787023,0.7439024390243902,1.0,1.0,9/22,23.66%,RPS27A;TOMM20;PINK1;UBA52;UBB;MTERF3;ATG5;MFN2;TOMM40
prerank,KEGG_2021_Human__Prostate cancer,0.41754669792929455,0.8720174420258107,0.7582417582417582,1.0,1.0,5/66,9.30%,ARAF;CREB5;TCF7;TCF7L1;IGF1R
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.4187770998278083,0.8718565189851056,0.7551020408163265,1.0,1.0,18/104,19.61%,BRIP1;H2BC11;CLSPN;PIAS4;EYA2;DNA2;RPS27A;EME2;BRCA1;XRCC3;KDM4B;RFC4;POLE2;POLL;LRIF1;UBA52;UBB;TIMELESS
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.5444746058998169,0.8717908688962753,0.6666666666666666,1.0,1.0,2/7,26.20%,APPL1;CTNS
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.5044575766784929,-0.8717900158893547,0.5757575757575758,0.9935881552604989,1.0,2/5,10.73%,HAVCR1;CD226
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.3122289413536999,-0.8715419901160502,0.8666666666666667,0.9935137756202067,1.0,3/26,4.24%,HAVCR1;RNF103-CHMP3;SDC3
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.608240056634789,0.8715301656950329,0.7076923076923077,1.0,1.0,1/5,8.46%,MAFB
prerank,KEGG_2021_Human__FoxO signaling pathway,0.4297381576962051,0.8713991474617978,0.7032967032967034,1.0,1.0,17/92,20.85%,ARAF;TGFB2;GADD45B;INSR;IRS2;IGF1R;PLK2;PRKAG2;SOD2;BNIP3;CCNB3;MAPK10;BCL6;PRKAA2;RBL2;IL7R;CDKN1B
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.5139751959086165,0.8709957250975628,0.6923076923076923,1.0,1.0,6/14,25.89%,RPS27A;RFC4;UBA52;UBB;RPA3;REV3L
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4928799489244256,0.8709420218086305,0.6388888888888888,1.0,1.0,6/14,22.60%,TMEM108;DYNC1H1;NEFL;KIF5A;SOD1;MAP1A
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.45350711947134725,0.8708840054195602,0.6705882352941176,1.0,1.0,3/31,7.92%,LRP2;HMGB2;BHLHE40
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.4381121224152938,0.8707896819755878,0.6419753086419753,1.0,1.0,11/31,22.92%,RYR2;FXYD7;CAMK2B;RYR3;ASPH;ATP2A2;ATP1B3;ATP1B2;CLIC2;ATP1A2;TRPC1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.402750078866928,0.8705781537574024,0.7191011235955056,1.0,1.0,8/57,17.39%,NAPA;VAPB;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.3992913784737175,-0.8705212363433904,0.5806451612903226,0.9948663455388911,1.0,3/17,11.53%,MYH9;APH1A;HM13
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.45798881418883314,0.8703203173140699,0.7058823529411765,1.0,1.0,2/39,2.98%,RHOB;H2BC11
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.40043037340887916,0.8700061094335743,0.84375,1.0,1.0,50/161,26.86%,RPL23;RIOK2;WDR12;RPL37A;PES1;RPL38;RPS6;RRP1B;RPS27A;RPL23A;RPS25;RPS27;RRP36;RPS11;NHP2;RPS20;RPL9;RPLP2;RPL37;RPL14;RPS4X;MPHOSPH6;RPL11;RPS24;RPS9;NOB1;RPL36;DIMT1;UBA52;RPS3A;RPL35;RPL4;RPL32;MPHOSPH10;TRMT10C;GNL3;RPL27A;RPL3;RPS16;RPL30;WDR3;RPL36AL;RPL21;RPL7;RPL12;DHX37;RBM28;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.5654031084091868,0.8699645892507921,0.7121212121212122,1.0,1.0,2/6,13.71%,SEMA5A;STMN2
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.35631952067102907,-0.8698582664134784,0.6153846153846154,0.9954797766041846,1.0,6/41,12.38%,NUP42;GTF2F1;NUP155;NUP188;NUP214;POLR2C
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.5674547067598437,0.8698400835789729,0.6805555555555556,1.0,1.0,2/6,8.14%,HIF1A;ROBO1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.44696143502381797,0.8696043174730426,0.7065217391304348,1.0,1.0,16/44,25.85%,LSR;ABCA1;RPS27A;NCEH1;PLTP;HDLBP;PCSK6;UBA52;UBB;AP2A2;P4HB;BMP1;ABCG1;PRKACB;SCARB1;AP2S1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.46045142243855885,0.8695765501531466,0.6790123456790124,1.0,1.0,3/20,12.62%,MINDY1;OTUD7B;VCPIP1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,0.43644165022365455,0.869500354442215,0.6818181818181818,1.0,1.0,14/38,17.72%,VCAN;TSHZ3;SLC5A9;DAAM2;LRRN1;ACSS3;RNF175;MGAM;SULF2;TMEM132D;LDB2;GPR162;OLFM1;TSPAN18
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,0.43644165022365455,0.869500354442215,0.6818181818181818,1.0,1.0,14/38,17.72%,VCAN;TSHZ3;SLC5A9;DAAM2;LRRN1;ACSS3;RNF175;MGAM;SULF2;TMEM132D;LDB2;GPR162;OLFM1;TSPAN18
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.4669154243444021,-0.8694788133509017,0.6071428571428571,0.9956464672399384,1.0,1/8,0.91%,ITGAM
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.36917912799718394,-0.8693770589574384,0.6,0.9951446527052529,1.0,2/19,2.75%,IL1B;TADA2B
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.4868664257019172,0.8692953866630754,0.6933333333333334,1.0,1.0,4/13,20.96%,VEGFA;THY1;ROCK1;COL16A1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3022583392678909,-0.8691761237231662,0.6875,0.9948855222792886,1.0,11/48,13.06%,PIDD1;BTG2;CCND1;TP53;ZNF385A;RFWD3;EP300;CNOT6L;PLK3;SDE2;PLAGL1
prerank,CellMarker_Augmented_2021__Platelet:Plasma,0.47680331799777564,0.869063532127432,0.65,1.0,1.0,5/20,16.25%,NLRP12;ALOX12;GP6;RASGRP4;NRGN
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,0.47680331799777564,0.869063532127432,0.65,1.0,1.0,5/20,16.25%,NLRP12;ALOX12;GP6;RASGRP4;NRGN
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.3590472456924062,-0.8689153085820948,0.6470588235294118,0.9947138093755477,1.0,3/30,5.69%,HUS1;POLD3;CTC1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.42123700878472126,0.8688616412905629,0.7525773195876289,1.0,1.0,9/63,12.76%,TSHR;CD163;HTR7;PRKAR2B;PLK2;FGR;ADCY8;RXFP1;GNAI1
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.4644779124945414,0.8686663810977714,0.65,1.0,1.0,7/26,29.95%,NUP133;RCC1;SEH1L;NDC1;POM121;NUP58;AHCTF1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.5029690714359095,0.868542004257312,0.75,1.0,1.0,3/11,8.14%,NR4A1;VEGFA;ROBO1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4112736990764498,0.868175778887796,0.7096774193548387,1.0,1.0,19/62,24.06%,VEGFA;HIF1A;LIMD1;RBPJ;RPS27A;PSMB4;RBX1;HIF3A;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.5749824005733537,0.8677744923716307,0.7121212121212122,1.0,1.0,2/7,11.49%,ROBO1;CLASP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.39547999372657805,0.8676505611829951,0.7368421052631579,1.0,1.0,22/137,18.98%,NAPA;CNIH4;CD55;VAPB;ANK3;ANK2;ARFGAP1;SPTAN1;SEC24C;MCFD2;DYNC1H1;SPAST;NSF;SPTBN5;TMED10;HYOU1;TRAPPC6B;SPTBN1;NRBP2;GRIA1;DCTN1;SPTBN4
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.4490842484984412,0.8676143961058536,0.6853932584269663,1.0,1.0,7/41,5.77%,CR1;ITGA2;CD22;TFRC;KITLG;CD55;IL7
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.4271919609278412,0.8675894942455484,0.7294117647058823,1.0,1.0,6/50,8.46%,PLPP3;NTN4;SH3PXD2B;DOCK1;PAPSS2;FN1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.3198466863481867,-0.8675585409226841,0.6666666666666666,0.9973061210691351,1.0,2/38,1.45%,PPP1R16B;SESN2
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.5207765817152554,0.867141883099354,0.6714285714285714,1.0,1.0,5/14,27.69%,GNA11;GNAQ;GNB5;GNA15;GNA14
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.42428149861471987,0.8668298247486346,0.7191011235955056,1.0,1.0,3/36,18.23%,RPL23;SNAP29;PYM1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.4209052235415073,0.8665188440319455,0.6976744186046512,1.0,1.0,13/56,21.27%,THBS1;NR4A2;HERPUD1;MCL1;PINK1;PRELID1;BCL2L2;TMEM14A;ITGAV;GSTP1;MAPK8IP2;TNF;CX3CL1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5073189355289679,-0.866503364139344,0.6666666666666666,0.9988710386900755,1.0,3/6,30.18%,MAPRE1;DIAPH1;KIF20B
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.49071757557554513,0.866352980005426,0.6835443037974683,1.0,1.0,7/20,27.69%,GNA11;GNAI1;GNAQ;GNB5;GNA13;GNA15;GNA14
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.42041981908217513,0.8661773217368218,0.75,1.0,1.0,15/83,21.98%,SOX4;SEPTIN4;FANCI;PRICKLE1;DNAJB2;SASH1;RIPK2;BRCA1;PINK1;CAMLG;HSPA1B;GTPBP4;UBB;LRRK2;CHP1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.5918733627637884,0.866171210975583,0.7142857142857143,1.0,1.0,3/5,17.45%,ROBO2;ROBO1;APP
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.44211931780621083,0.865947173146959,0.6923076923076923,1.0,1.0,6/39,14.23%,BRIP1;CLSPN;NDRG1;DONSON;HINFP;E2F7
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4407387392007513,0.8658307376914132,0.6547619047619048,1.0,1.0,6/34,20.52%,TMEM161A;EYA2;BRCA1;ERCC6;CDK9;NPAS2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.57221338811172,0.8656403025196605,0.7323943661971831,1.0,1.0,1/7,12.65%,BACE2
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.48210559141486864,0.8654375277140762,0.7469879518072289,1.0,1.0,3/23,17.00%,MAPT;TENT4B;PRKRA
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.31560753175035844,-0.8654035016059107,0.6666666666666666,1.0,1.0,7/46,8.38%,PSMB3;PSME3;ELOC;APOBEC3G;PSMC4;PSMD12;PSME4
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,0.47938287203004326,0.8652814258594658,0.6666666666666666,1.0,1.0,1/13,9.61%,TRIM25
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,-0.47901318589769665,-0.8651409957534351,0.7058823529411765,1.0,1.0,2/8,11.90%,POLD3;SLC19A1
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.39297296655530073,0.8651340575119286,0.826530612244898,1.0,1.0,32/177,21.45%,SOCS3;DTL;ASB14;WDR5;ZBTB16;FBXL7;ASB16;COPS5;HIF1A;RPS27A;PSMB4;RBX1;DCAF6;GAN;HIF3A;ASB13;FBXO27;UBE2M;COMMD8;KLHL2;EPAS1;FBXL13;UBA52;UBB;PSMC2;FBXL5;PSMA3;FBXO7;PSMB2;SPSB3;DDB1;PSMD5
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.495498250931802,0.8651310215921313,0.7051282051282052,1.0,1.0,5/17,29.48%,CLK2;FBP1;DDB1;PPARGC1A;DGKQ
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.4017544249328272,0.8650976912850203,0.6853932584269663,1.0,1.0,2/73,1.16%,RAB7B;DENND2A
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.4225348011559425,-0.8650405302495674,0.6521739130434783,1.0,1.0,1/10,0.45%,CCL5
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.5871227961569747,0.8650293825972717,0.7083333333333334,1.0,1.0,3/5,21.98%,IMPACT;SLC9A1;CHP1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,0.6093654669554768,0.8646382419864773,0.8135593220338984,1.0,1.0,1/5,4.57%,SRGN
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.47919659907600853,-0.8642543472182512,0.631578947368421,1.0,1.0,1/7,5.75%,TMEM106A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.37781075033109585,-0.8641806088307429,0.6666666666666666,1.0,1.0,3/16,14.21%,CHUK;EGFR;AKT1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5025985239717268,0.8639348822751389,0.6891891891891891,1.0,1.0,5/15,21.58%,RANBP3L;SRA1;AKIRIN1;PLCB1;FLOT2
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.5739228374254783,-0.8636986527402786,0.6585365853658537,1.0,1.0,1/6,1.88%,PUS1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.39717964573842646,-0.8636014209423873,0.6190476190476191,1.0,1.0,1/14,2.93%,FLII
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.39556192775206644,0.8634196352336188,0.8383838383838383,1.0,1.0,36/207,18.89%,THBS1;ACSL1;GNA11;VBP1;CGNL1;EIF2AK3;GOLM1;ANK2;KLHL23;PCBP4;SAV1;SVIL;PDE1C;SLC9A7;CSPG5;ST14;MEGF9;CELF2;AKR1B1;GPRC5B;DARS1;CAMK2B;PRKAG2;SLC35F3;PDK3;AKIRIN1;CCDC85C;FAM174B;KCNMA1;UBXN2B;NEURL1;APP;FOXP1;PPP2R3A;SNTB1;ANKRD6
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.40344894640279766,0.8633085136122255,0.8,1.0,1.0,42/227,19.61%,BRIP1;DTL;H2BC11;ERCC2;CLSPN;PIAS4;TDG;EYA2;FANCB;COPS5;MPG;DNA2;FANCM;FANCI;RPS27A;TRIM25;NEIL1;EME2;RBX1;POLG2;BRCA1;XRCC3;KDM4B;FAN1;RFC4;GTF2H3;ACTR5;POLE2;POLR2D;POLL;ERCC6;NEIL2;FANCL;ADPRS;USP43;FANCA;LRIF1;UVSSA;UBA52;UBB;MLH1;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.3552878985161857,-0.8632715404133892,0.6296296296296297,1.0,1.0,5/26,12.15%,SKAP1;MAP4K4;ABL1;RIN2;PPM1F
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.3685041367897181,-0.8631753503992761,0.6470588235294118,0.9998827492642819,1.0,5/22,16.61%,SRC;CRKL;CRK;NCK1;RAPGEF1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4216529560631763,-0.8631474090796704,0.7083333333333334,0.9984816048376027,1.0,3/13,2.85%,BCL2L1;IL1B;IL1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4216529560631763,-0.8631474090796704,0.7083333333333334,0.9984816048376027,1.0,3/13,2.85%,BCL2L1;IL1B;IL1A
prerank,KEGG_2021_Human__TNF signaling pathway,0.41627475949189796,0.8630335118502508,0.7446808510638298,1.0,1.0,5/79,5.44%,SOCS3;CREB5;IL15;MAP3K8;TRAF2
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.5930001192826583,0.8629661639242424,0.75,1.0,1.0,1/6,3.93%,SLC1A2
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.4023873487700168,-0.8628916590407929,0.5217391304347826,0.9983185950288712,1.0,7/12,21.91%,CD274;HLA-DPA1;CD247;HLA-DRB5;PTPN6;CSK;CD4
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.3602152511298039,-0.8627427922557719,0.7058823529411765,0.9979549576208582,1.0,4/22,6.41%,ZMYND11;ZNF675;DUSP3;SIRPA
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4140013129290655,0.8626950492646773,0.7701149425287356,1.0,1.0,16/64,24.39%,RNF144B;CAV3;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;RNF139;HSPA1B;NOP53;LRRK2;MAGEF1;USP5;PTEN;BBS7;DDRGK1
prerank,KEGG_2021_Human__Ras signaling pathway,0.3861001089904048,0.8626697752588403,0.7628865979381443,1.0,1.0,20/137,15.95%,FGF1;HTR7;ARF6;KITLG;VEGFA;INSR;GRIN2A;CALM3;SHC2;IGF1R;FLT1;NTRK2;ETS2;PAK5;GAB1;RASGRF1;GRIN2B;MAPK10;ANGPT2;RASGRP4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5620115258669834,0.8626639328568046,0.7101449275362319,1.0,1.0,1/9,10.26%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.5437928633044192,0.8624278236508276,0.676056338028169,1.0,1.0,1/6,20.26%,METTL4
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,0.46185926636567504,0.8623561918821449,0.7261904761904762,1.0,1.0,6/28,11.84%,LSR;OVOL2;BAIAP2L1;PPP1R13L;ST14;IFNLR1
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,0.46185926636567504,0.8623561918821449,0.7261904761904762,1.0,1.0,6/28,11.84%,LSR;OVOL2;BAIAP2L1;PPP1R13L;ST14;IFNLR1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4207884334940999,0.8623071944163051,0.7052631578947368,1.0,1.0,16/78,22.36%,KLF4;DTL;AGT;ABCA2;PLK2;NSF;APC2;WNT5A;IL18;HECW2;APP;TNF;CDKN1B;DDB1;HACE1;BARD1
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.42644885095266993,0.8622922343139344,0.7708333333333334,1.0,1.0,15/44,28.45%,TIMM13;TOMM20;PMPCA;GRPEL1;ATP5F1A;SLC25A4;CHCHD3;HSPD1;ATP5MC1;CHCHD7;COQ2;TOMM40;TIMM22;HSPA9;COA6
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5668381103989196,0.8622791827355114,0.6901408450704225,1.0,1.0,3/6,21.12%,RYR2;NDRG4;IFT122
prerank,Reactome_2022__Gamma-carboxylation Of Protein Precursors R-HSA-159740,-0.5286813498680584,-0.8622111495574099,0.6875,0.9976877218890949,1.0,3/5,16.35%,PROS1;TTF2;FAM110A
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",-0.5286813498680584,-0.8622111495574099,0.6875,0.9976877218890949,1.0,3/5,16.35%,PROS1;TTF2;FAM110A
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,0.49765875147185,0.8618611971969672,0.6756756756756757,1.0,1.0,1/13,1.35%,NDUFA2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.4926654977278936,0.8618377751782025,0.6986301369863014,1.0,1.0,3/17,6.20%,CHI3L1;GPC5;GNS
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.30344415579971357,-0.8616966835227818,0.7777777777777778,0.9978788963883225,1.0,22/73,17.19%,GIMAP8;CD2;MAF;MPEG1;FOLR2;HPGDS;CSF1R;P2RY13;TNFSF10;AOAH;IGSF6;HCK;HLA-DPA1;TYROBP;GIMAP4;GIMAP7;HAVCR2;CMKLR1;C1QC;MS4A14;GPR34;RNASE6
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.5427021887836552,0.8616939932887964,0.7222222222222222,1.0,1.0,1/7,11.83%,HCLS1
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.391375433129884,0.8616930477554081,0.91,1.0,1.0,36/462,10.88%,FA2H;GPR18;TSPAN13;LRRC4C;TSHR;CDK14;CR1;PCDH9;GALNTL6;GPM6A;TLE1;PLAC8;CD22;NR4A1;SESTD1;PTPRK;ARID5B;FAM177B;FCGR2B;CD55;IL7;ANK2;MARCKSL1;CNR1;CA2;AKAP12;SAV1;CCSER1;MOB3B;NBEAL1;PXK;PTOV1;KHDRBS2;CKAP4;OSBPL10;ARSA
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3944571674763964,-0.8616245372770078,0.6,0.9973545019199436,1.0,2/26,1.84%,MAIP1;BCL2L1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.46403643665713185,0.861594364242575,0.75,1.0,1.0,8/26,20.01%,RPA2;TDG;MPG;NEIL1;RFC4;POLL;ADPRS;RFC1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5152737227529611,0.8615035234429791,0.6716417910447762,1.0,1.0,4/11,26.10%,SYT4;SYT1;SYT11;SYT9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.5173047753830652,0.8610143684585402,0.7162162162162162,1.0,1.0,4/12,22.09%,RPL23;SMARCD3;SMARCC1;SMARCD2
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.47164407996328,0.8608010982232718,0.7073170731707317,1.0,1.0,10/23,27.66%,HSPA5;BAG3;HSPA1B;HSPD1;HSPA2;HSPA14;HSPA9;HSPA13;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4989920986283131,0.8607404318875254,0.7101449275362319,1.0,1.0,3/10,35.76%,STAT2;CNOT7;NLRC5
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.40275171612047406,-0.8602322141064208,0.7916666666666666,0.9996613665384612,1.0,6/17,13.23%,CCL5;OLR1;ICAM1;SEMA4D;ITGB2;SYK
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5475052891650506,0.8601732962637887,0.6571428571428571,1.0,1.0,4/8,23.89%,ARF6;EPB41L4B;PTEN;IQSEC1
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.500783824896391,-0.8601488183014273,0.6666666666666666,0.9990697763347496,1.0,4/10,13.27%,IDUA;HPSE;ARSB;HPSE2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.46857491185169575,0.859995305235801,0.6582278481012658,1.0,1.0,6/18,23.89%,ARF6;VEGFA;THY1;ROCK1;COL16A1;IQSEC1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,0.44705287440111263,0.8598681907086978,0.6962025316455697,1.0,1.0,6/26,16.49%,ABHD12B;FLVCR1;POU5F1;ZNF850;SHISA9;ORC6
prerank,PanglaoDB_Augmented_2021__Platelets,0.3889342794017987,0.8596679030694052,0.7628865979381443,1.0,1.0,20/143,12.72%,THBS1;SPARC;CLEC12A;PRKAR2B;ITGA2;SLC2A3;ALOX12;SRGN;F13A1;VEGFA;FHL1;SIRPB2;CA2;PALLD;FGR;CD93;NOD2;FGL2;HCLS1;TNFRSF1B
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.5321693474606088,0.8596477768305393,0.75,1.0,1.0,2/9,9.58%,NELL2;CSPG5
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.5383986794488462,0.8596425504048568,0.7121212121212122,1.0,1.0,2/8,15.71%,BMPR1B;AIDA
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.41350875481827903,-0.8595073314043108,0.625,0.9995448897436261,1.0,10/15,26.54%,ABCB7;ALOX5;SLC25A33;PLCG2;SPHK2;SLC30A10;PIKFYVE;RAB27A;CYBA;CD36
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.41883985080032166,0.8594847696857271,0.7802197802197802,1.0,1.0,21/67,25.89%,RPA2;FANCB;FANCM;POLQ;BRCA1;XRCC3;MCMDC2;NSMCE1;FAN1;POLL;SWI5;RBBP8;RNF138;SFPQ;RPA3;SLX4;PSMD14;RAD54B;MCM3;SPIDR;REV3L
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5274463112829729,0.8593230396338297,0.6615384615384615,1.0,1.0,1/7,7.76%,RUVBL2
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.4014509687551046,0.8591977911966798,0.75,1.0,1.0,21/88,27.40%,CCPG1;BROX;PPP2R5A;FCHO2;AFTPH;STT3B;VMP1;PICALM;IQGAP1;PCMTD1;SPG11;UHMK1;RBL2;PDCD6IP;HBP1;ZNF33A;DDX3X;KLF3;PTBP3;UBR2;CMTR2
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.3437678751905141,-0.8591940512184874,0.6153846153846154,0.9995153066394513,1.0,14/39,14.63%,TDRD10;GIMAP8;A2M;FOLR2;CSF1R;ICAM1;SLCO2B1;ENG;PCDH12;MMRN1;PLVAP;GIMAP4;SCARF1;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.47123450673467676,0.8590959443128527,0.7763157894736842,1.0,1.0,1/19,1.30%,NLRP12
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5028901057759192,0.8590168263289691,0.7391304347826086,1.0,1.0,3/10,18.75%,DNAJB2;HSPA1B;HSPA2
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,-0.5567899524688197,-0.8587087756163994,0.7083333333333334,0.9991334101764615,1.0,2/5,18.09%,MOCS1;MOCS2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.5567899524688197,-0.8587087756163994,0.7083333333333334,0.9991334101764615,1.0,2/5,18.09%,MOCS1;MOCS2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.4058917237616039,-0.8585693088750104,0.6666666666666666,0.9986487174714678,1.0,4/9,12.05%,TTC39B;NR1H3;TREM2;PPARD
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.46651899880379505,0.8585391328791736,0.7441860465116279,1.0,1.0,8/22,20.42%,ITGA2;CD22;FCGR2B;FCGR2C;TNFRSF1B;B3GAT1;NCAM1;SELL
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.5540707009452963,0.858372039918782,0.7101449275362319,1.0,1.0,1/5,2.19%,CYP3A5
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,-0.5743779683428023,-0.8582676480129984,0.7352941176470589,0.9988189915644913,1.0,3/5,25.34%,EGFR;PRKCA;NRAS
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.4475481190424677,0.8581735682014592,0.7375,1.0,1.0,11/36,24.29%,PDK4;ABCA2;PINK1;FASN;PDK3;PPARA;ACACB;CNDP1;ABCG1;BTN2A2;MBOAT7
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.4359224051919635,0.8580622961884314,0.7294117647058823,1.0,1.0,9/57,8.46%,THBS1;NTN4;ITGA2;OSMR;SYNC;LAMB1;PAPSS2;RND3;FN1
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),-0.4734538800809085,-0.8580148004064039,0.6111111111111112,0.9986289590326857,1.0,1/5,3.60%,LGALS9
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.32711930688628266,-0.8578051636424656,0.6153846153846154,0.9983823897853156,1.0,5/35,4.08%,GTF2H5;POLD3;GTF2H2C;GTF2H2;DDB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.43608845021074155,0.8577233406210929,0.7108433734939759,1.0,1.0,9/37,20.20%,PRKCE;CLIP3;ARF6;EPHA3;SORBS1;SPTBN1;PTPN9;ACSL3;TNF
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.40044488259435046,-0.8576694013349503,0.68,0.9979469431412038,1.0,1/14,1.69%,SLC30A5
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.485078020989529,0.8572705387197366,0.7951807228915663,1.0,1.0,4/21,6.04%,DPYD;NUDT16;ENTPD3;SCO2
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.44137750304919415,0.8570952090725965,0.7647058823529411,1.0,1.0,7/39,9.37%,CDH8;CDH2;CDH9;CTNND2;PKP2;CDH20;CDH12
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.41251870402569785,0.8570521949092172,0.6630434782608695,1.0,1.0,10/62,22.48%,KLF4;CCNC;SMARCD3;CEBPD;CCND3;TBL1XR1;PPARA;TNF;MED11;CDK19
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5642684058361904,0.8570063550235455,0.7432432432432432,1.0,1.0,2/6,18.81%,UXT;UBB
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.34579741951232434,-0.8568967653126115,0.631578947368421,0.9988547082652781,1.0,7/29,12.15%,SERPINF2;EVL;LPAR1;NF2;SORBS3;ABL1;PPM1F
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.4916577988832827,0.8568248893819728,0.6753246753246753,1.0,1.0,5/11,20.85%,PTPRK;EPB41L4B;KLF9;NOTCH2;FGFR2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.37477265445965635,-0.8564468249428747,0.6071428571428571,0.9991753899920273,1.0,5/13,12.05%,TTC39B;LPL;NR1H3;TREM2;PPARD
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.44657059713114233,-0.856430013252028,0.6666666666666666,0.9984948404615042,1.0,2/9,3.04%,ZNF703;SH2B3
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3581773772493106,-0.8563797766645221,0.631578947368421,0.9978435720687949,1.0,3/34,3.04%,TGFBR3;TAL1;SH2B3
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.4390951103510908,0.8562912990354781,0.7241379310344828,1.0,1.0,15/34,29.16%,ATP8B1;FXYD7;CAMK2B;ATP2A2;ATP1B3;ATP10B;ATP1B2;ATP13A4;ATP1A2;ATP10A;ATP8A2;ATP2B4;ATP9A;ATP11A;CUTC
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5246006881949381,0.8562584881417414,0.6716417910447762,1.0,1.0,5/7,33.13%,SMAD1;SMAD5;NOTCH2;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5438102807468038,-0.8559857128044728,0.6363636363636364,0.9978814588517236,1.0,1/6,4.51%,APPL2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.48609002094453374,-0.8559656120847466,0.7096774193548387,0.9972315648624542,1.0,3/7,20.19%,NKD1;DAB2;WNT5B
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.46570588652235034,0.8559228059019571,0.7023809523809523,1.0,1.0,3/24,10.68%,TGFB2;ANXA1;PDE4B
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.2774895407985546,-0.8558557773206202,0.7777777777777778,0.9966955724983333,1.0,19/82,13.68%,CARD14;PSMB3;PSME3;CHUK;EDA2R;CDIP1;MAP3K14;PSMC4;TP53;PSMD12;ILK;PSME4;EDA;IKBKB;NFKBIA;BIRC2;PLVAP;EIF5A;PSMA1
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.47655087734956075,0.8558032983370683,0.7323943661971831,1.0,1.0,5/19,19.17%,PIGU;PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.46958776080177766,-0.8557687320176591,0.7619047619047619,0.996282644397887,1.0,3/9,18.81%,EP300;KAT7;KAT5
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.5218542985278769,0.8557134603352141,0.7246376811594203,1.0,1.0,3/9,25.86%,PTN;MTUS1;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.503583898411563,0.8557104603895335,0.6578947368421053,1.0,1.0,4/10,13.36%,MYRF;PARD3;TNFRSF1B;TPPP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,0.4991999460433445,0.8555951220848624,0.6933333333333334,1.0,1.0,2/10,15.39%,CASP3;THY1
prerank,CellMarker_Augmented_2021__M1 macrophage:Undefined,0.5359512928879335,0.8554686660193214,0.7532467532467533,1.0,1.0,2/10,10.46%,FCGR2B;FCGR2C
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,-0.48582095465201147,-0.8552571703894458,0.6428571428571429,0.9967445705882434,1.0,2/8,7.96%,TP53;PPP1R13B
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.48727439821625773,0.8552507543572404,0.68,1.0,1.0,5/15,18.81%,SH3GL3;RPS27A;SH3GL2;UBA52;UBB
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.5430219088148275,0.8552432943410745,0.7792207792207793,1.0,1.0,1/9,1.46%,TRMT9B
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.39726372860396764,0.8552200698689142,0.8210526315789474,1.0,1.0,34/138,25.18%,BRIP1;TALDO1;SCO2;ATOX1;BLVRB;RPS27A;TXNIP;PSMB4;RBX1;COX7C;CYCS;SMARCD3;TBL1XR1;GSTP1;SCO1;SOD1;SESN1;UBA52;ERO1A;UBB;PSMC2;PPARA;PSMA3;PSMB2;COX4I1;P4HB;PSMD5;PSMD7;COX6C;PSMD14;PSMA5;COX6B1;COX20;TXNRD1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.3903200259553986,-0.855103899503117,0.75,0.996322804225889,1.0,1/16,1.69%,SLC30A5
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.27827167286245563,-0.8548389737477846,1.0,0.9961644835275558,1.0,17/119,10.83%,NUP42;GTF2H5;ELOA;GTF2F1;CTDP1;GTF2H2;RNF103-CHMP3;ELOC;TAF13;SUPT16H;NUP155;VTA1;VPS37B;TCEA1;CHMP2B;NUP188;NUP214
prerank,KEGG_2021_Human__Leishmaniasis,0.42061877781952245,0.8547205380745687,0.7419354838709677,1.0,1.0,4/57,6.61%,TGFB2;CR1;EEF1A2;MARCKSL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.5547510378657426,0.8545220926125806,0.703125,1.0,1.0,2/6,18.33%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.5355997808364911,0.8544922312343788,0.78125,1.0,1.0,4/10,22.52%,NRG1;PLD3;KDM6B;SORT1
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.44597843933326276,0.8543112348777266,0.7209302325581395,1.0,1.0,7/33,20.85%,PPP2R3B;RPS27A;CCND3;UBA52;UBB;RBL2;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5334340467593114,0.8540047800413462,0.6875,1.0,1.0,1/9,9.23%,LIMD1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4892582431333849,0.8539913181361075,0.7205882352941176,1.0,1.0,4/11,30.93%,RYR2;GRM5;PRNP;ADGRL1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4301577421019227,-0.8539654573165971,0.55,0.9975166550513885,1.0,2/12,9.65%,TGFB1;ENPP1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5138808926713175,-0.853950555021875,0.7741935483870968,0.9968702686008241,1.0,2/6,18.45%,NR1H3;CDC42
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5247688484060322,0.8539244307844659,0.7246376811594203,1.0,1.0,5/10,25.52%,SLC11A1;TRPC4;SLC39A14;TRPC1;SLC11A2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.574938366527204,0.8538521796246997,0.734375,1.0,1.0,2/5,18.34%,PFAS;HPRT1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3462521533378933,-0.8538477056051629,0.75,0.9963934129930239,1.0,3/24,9.60%,SRRT;PUS10;AGO1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.3326485401671062,-0.8535342276511344,0.631578947368421,0.9965537495397505,1.0,2/24,1.86%,CCL5;SERPINF2
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,-0.33779099757983905,-0.8535092123466593,0.6363636363636364,0.9959000762776506,1.0,14/56,10.55%,CD300LF;LY86;PTAFR;PIK3R6;MPEG1;FOLR2;CSF1R;P2RY13;ADAP2;ITGAX;WDFY4;IGSF6;HCK;HLA-DPA1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.46938431798942176,0.8532297203371978,0.6829268292682927,1.0,1.0,7/20,25.64%,ENO2;ENO4;NPRL2;ENO1;TBC1D14;RAB5A;MTM1
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.3838888372944178,0.8531074219205327,0.92,1.0,1.0,89/476,23.07%,RHOBTB3;LRP2;RAB7B;DENND2A;CENPE;TACR1;CLVS1;NAA38;RACGAP1;TFRC;ARF6;KIF15;TBC1D13;KIF1B;VPS37C;CD55;TRIP10;SH3GL3;GNS;ANK3;ANK2;COPS5;DNAJC6;FCHO2;KIF21A;DNM3;ARFGAP1;RPS27A;TBC1D15;SPTAN1;SH3D19;DNM1;SEC24C;PRKAG2;SGIP1;MCFD2;DYNC1H1;SH3GL2;SYT1;NSF;SNAP29;GOLGA8B;KLC4;AGFG1;ITSN1;KIF11;PICALM;WNT5A;SPTBN5;KIF5A;DENND5A;TRAPPC6B;SPTBN1;ASPSCR1;KIF3A;GRIA1;APP;AMPH;DCTN1;PRKAA2;FTH1;UBA52;DENND5B;UBB;SPTBN4;RAB21;VPS51;AP2A2;SNAP91;HIP1R;CLTCL1;SURF4;DYNC1I1;TBC1D2;RAB30;IL7R;EXOC5;NAPG;KIF5C;TBC1D14;BNIP1;RAB5A;CTTN;CHMP5;SORT1;TJP1;GDI1;CNIH1;KIFC2
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.38898131486142185,0.8530460637353511,0.8247422680412371,1.0,1.0,33/170,22.17%,DDIT4;NFE2L3;RPL23;CCPG1;GLIPR2;ENC1;DMD;HSPA5;HINT1;EMC7;RAB15;TAGLN3;MCL1;POU5F1;PPP1R3B;PEG10;PEBP1;THY1;PLOD1;DHX33;RPS4X;RPL11;SUMF1;PCED1B;TUBA1C;SLC66A3;SLC3A2;STARD8;MTHFD1;EEF1A1;TRIM24;CHP1;PABIR3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3882259875162199,0.8530160635379807,0.94,1.0,1.0,88/426,24.08%,KLF4;NFIL3;SAP30;RPL23;TGIF1;NFIX;ZBTB16;NR4A2;NFIB;MEIS2;ARID5B;VEGFA;SUV39H2;BMI1;HCFC1;POU6F1;YEATS2;BHLHE40;TRPS1;KCTD1;ID2;RBPJ;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;PER1;IMPACT;NR2F1;MXI1;ZNF536;DEAF1;PPID;ETS2;OTUD7B;FBP1;ZNF550;NR4A3;DRAP1;E2F7;SDCBP;ZNF248;UXT;BAG3;ESR1;MTA3;NR2C2;LDB2;TBL1XR1;CTBP1;HAMP;BCL6;KLF7;FOXP1;ZBTB18;TAF9B;ZNF778;UBA52;EZH2;UBB;PPARA;TAF7;ZNF684;NOP53;TNF;ENO1;NR1D1;BCL11A;FGFR2;CBX5;ATF3;HEXIM1;STAT1;HNRNPU;CGGBP1;MYT1L;SFPQ;JUN;PHF21A;MNT;UHRF1;GPS2;H1-0;NACC2;ZNF141;ZNF169;FOXO3
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.3309787675747932,-0.8529668733031576,0.5714285714285714,0.9966400591273349,1.0,1/36,0.13%,STAT4
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.5565855683711696,0.8528135559485208,0.7571428571428571,1.0,1.0,4/7,32.71%,PRKAG2;PRKAA2;PRKAB2;STK11
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.44291313579312985,0.8528006932535319,0.7407407407407407,1.0,1.0,10/35,20.27%,GLA;ABCA2;ARSA;GALC;UGT8;UGCG;SUMF2;SUMF1;GBA3;STS
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.415392854074007,-0.8526134400021217,0.6538461538461539,0.9966410895743666,1.0,7/14,28.78%,MAPKAPK2;ZFP36;EXOSC9;EXOSC8;EXOSC2;XRN1;YWHAB
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.4748078780098065,0.852350575517602,0.7380952380952381,1.0,1.0,6/21,14.68%,CAMK2B;RPS6KA2;LRRC7;RASGRF1;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.5092476069325722,0.8521502763513614,0.7183098591549296,1.0,1.0,2/13,3.26%,NUDT16;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.38430245986710176,0.8521337682679643,0.7473684210526316,1.0,1.0,16/87,17.86%,THBS1;NLRP12;IL15;AGT;POLR3F;PTN;PDE2A;GPRC5B;SASH1;THBD;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.5769694351460974,0.8520873423384091,0.7121212121212122,1.0,1.0,3/5,30.41%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.5769694351460974,0.8520873423384091,0.7121212121212122,1.0,1.0,3/5,30.41%,SYCE2;BAG6;RAD21
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.4850637143234289,0.851955035148932,0.7272727272727273,1.0,1.0,3/18,9.28%,SOX4;MYRIP;IRS2
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.5496728218406604,0.8518935317687779,0.6911764705882353,1.0,1.0,2/7,18.33%,ATP1B3;ATP1B2
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,0.5758926250467024,0.8518532976386766,0.6885245901639344,1.0,1.0,1/6,8.14%,ROBO1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.540070326944774,0.851804098270677,0.6764705882352942,1.0,1.0,2/7,9.36%,ANK2;RYR2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.5772966703772748,0.8516088595613528,0.7101449275362319,1.0,1.0,1/5,8.95%,PTN
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.39912837648391286,-0.8513581163402602,0.72,0.9972686534264362,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.39912837648391286,-0.8513581163402602,0.72,0.9972686534264362,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.39912837648391286,-0.8513581163402602,0.72,0.9972686534264362,1.0,3/10,13.67%,PANK1;PPCDC;PPCS
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.4715709374051557,0.8513156006073204,0.6626506024096386,1.0,1.0,4/16,31.20%,STAT1;TRIM24;CPSF6;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.4820559277126768,0.8512852214775934,0.675,1.0,1.0,2/20,5.63%,TRAF2;CD55
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3819144182790822,-0.8511408643102158,0.65,0.9969339309277963,1.0,5/25,12.55%,ZMYND11;LEO1;SUPT16H;RNF8;BRD4
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.4348946201405908,0.8510171534309764,0.7446808510638298,1.0,1.0,9/39,18.81%,DTL;RPS27A;TRIM25;RBX1;RFC4;POLE2;USP43;UBA52;UBB
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.5169511831682662,0.8510131498357036,0.6986301369863014,1.0,1.0,6/13,25.89%,RPS27A;RFC4;UBA52;UBB;RPA3;REV3L
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.4933261215098191,0.8508400884621174,0.7435897435897436,1.0,1.0,7/19,23.25%,RPA2;RPS27A;RFC4;UBA52;UBB;RFC1;RPA3
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.3651089442378464,-0.8507605664345053,0.7058823529411765,0.996953364261066,1.0,6/36,8.65%,CCL5;IL1B;UQCC2;ITPR2;PASK;ALOX5
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.38613170237934735,0.8505457882117675,0.7872340425531915,1.0,1.0,4/99,5.09%,RAB7B;DENND2A;ARF6;TBC1D13
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.4188114865377499,-0.8504934385262443,0.6363636363636364,0.9967681521776529,1.0,3/12,18.04%,MYO1F;MYO1D;MYO7A
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.48301069478089687,0.85039208890236,0.7368421052631579,1.0,1.0,2/16,8.08%,SUV39H2;CSKMT
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.35922961004585907,-0.8502275665052432,0.8,0.9966761445576179,1.0,6/33,8.01%,TAL1;LYL1;RHOG;HHEX;FAM78A;EPOR
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.46775402573077307,0.8500980339842737,0.7101449275362319,1.0,1.0,1/20,2.27%,GLA
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,0.523644719199909,0.8499700932874407,0.6582278481012658,1.0,1.0,4/11,20.78%,FCGR2B;FCGR2C;SELL;IL7R
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.43613036379646375,0.8499603094876125,0.7411764705882353,1.0,1.0,13/49,20.32%,TLE1;ZBTB16;SLC4A10;GPR65;GALC;PDK3;CEBPD;ODF2L;SESN1;HACL1;TBC1D31;TNF;NR1D1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.4475844635991195,0.849945126040455,0.6951219512195121,1.0,1.0,10/31,23.17%,VPS11;MICALL2;ARIH2;PINK1;ABLIM3;UBE2J2;LRRK2;ATP5IF1;RHOU;ATG13
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.5843349934646033,0.8498717893886276,0.7230769230769231,1.0,1.0,1/5,12.87%,BRCA1
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.3936738340322982,0.8498656303917569,0.8080808080808081,1.0,1.0,24/143,21.78%,RHOBTB3;CENPE;NAA38;RACGAP1;KIF15;KIF1B;KIF21A;ARFGAP1;DYNC1H1;NSF;SNAP29;GOLGA8B;KLC4;KIF11;KIF5A;KIF3A;DCTN1;VPS51;SURF4;DYNC1I1;RAB30;NAPG;KIF5C;BNIP1
prerank,CellMarker_Augmented_2021__Macrophage:Serum,-0.5209914919228595,-0.849820121811845,0.6,0.9968071708650555,1.0,3/5,8.22%,ITGAM;CSF1R;ITGAX
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.38478480979220675,0.8497776293081761,0.92,1.0,1.0,84/489,22.75%,DIAPH3;CENPF;RHOB;PDE5A;VIM;CENPE;PREX2;PPP2R5B;H2BC11;ANLN;RACGAP1;DOCK1;TFRC;DOCK5;PPP2R5A;TRIP10;VAPB;NUP133;ARHGAP23;BAIAP2L1;PDZD2;RND3;NGEF;AKAP12;XPO1;CENPP;KDM1A;CKB;WASF1;LMNB1;SLITRK5;GFOD1;CKAP4;ARHGEF4;RPS27;SPTAN1;CLASP2;KALRN;DYNC1H1;CKAP5;UACA;CENPK;STMN2;KLC4;CENPI;PLXNB1;ITSN1;CDC37;INCENP;PICALM;KIF5A;SEH1L;ARAP2;DHDDS;IQGAP1;SPTBN1;ROCK1;ARHGDIA;PIK3R4;PKP4;STARD13;FGD4;RHOH;ECT2;CPNE8;KNTC1;DYNC1I1;BASP1;CENPT;CDKN1B;FAM13A;VRK2;FLOT2;STARD8;CDC42BPA;CTTN;MYL6;ANKRD26;VAV3;RHOU;ARHGAP42;PRKCB;ITGB3BP;TUBA1B
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5756911555329446,0.8493421286813703,0.7571428571428571,1.0,1.0,3/5,22.26%,CCDC39;DNAH7;DNAAF5
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5759605467101035,0.8492899510191897,0.7301587301587301,1.0,1.0,3/6,31.26%,BRCA1;BARD1;RNF6
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.47743113811359666,-0.8492851734059739,0.6129032258064516,0.9973278179316781,1.0,1/7,3.00%,DDR1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.4559953605578583,0.8492157727035755,0.6756756756756757,1.0,1.0,5/20,25.05%,TOMM20;GRPEL1;HSPD1;TOMM40;PEX10
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.28182597172387697,-0.8491575607884936,1.0,0.996855353869908,1.0,16/66,15.86%,LRP10;DENND1C;ARAP1;TC2N;MAPK13;MAP2K3;NBEAL2;HLA-E;BCL3;ARHGAP27;PSD4;DEF6;ZFP36;NFKB2;RPS6KA1;OSTF1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.38462005917649905,-0.8489868407886344,0.6666666666666666,0.9965225765773704,1.0,7/22,19.44%,LSM11;MTPAP;SNRPB;EXOSC10;CPSF2;UPF1;TUT7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.39515714609947905,0.8489155745228855,0.8041237113402062,1.0,1.0,25/119,21.28%,ERCC2;NR4A2;NR4A1;RORB;RXRB;RBPJ;POLR1C;NR2F1;NR4A3;POLR3H;GTF2H3;ESR1;NR2C2;TBL1XR1;POLR2D;TFAM;TAF9B;ESRRG;CDK9;PPARA;TAF7;POLRMT;NOTCH2;NR1D1;POLR2G
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.4753011564772832,0.84885333680812,0.6666666666666666,1.0,1.0,5/15,23.82%,PPOX;FLVCR1;ALAD;ATP5IF1;UROS
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4159886866745971,0.848820278481514,0.7717391304347826,1.0,1.0,12/49,23.75%,ZBTB16;NOCT;RUNX1T1;ID2;LMO3;WNT5A;TNF;NR1D1;AAMDC;ANKRD26;RORA;GPS2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5172003088993768,0.8487371515338046,0.7922077922077922,1.0,1.0,4/13,21.02%,AGT;NR4A3;ROCK1;SLC9A1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.44561682862266905,-0.8487166535423049,0.6857142857142857,0.9962458373977644,1.0,4/10,13.33%,DSCAM;ROBO3;BSG;DSCAML1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.3571545081274873,-0.8487015414988285,0.5238095238095238,0.9955622712660657,1.0,3/17,6.40%,LATS2;WWTR1;MOB1A
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.5216360662845092,0.8485945867228719,0.7258064516129032,1.0,1.0,2/7,14.10%,ALOX12;SERPINE2
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.4848963773225439,0.8483331359989699,0.6756756756756757,1.0,1.0,3/14,14.10%,F13A1;THBD;SERPINE2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4451399341537672,0.8483232896724059,0.7386363636363636,1.0,1.0,4/40,7.92%,SULT4A1;HINT1;ACOT13;ACAT1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.33639015861350774,-0.8482142291718342,0.8571428571428571,0.9959247387156949,1.0,4/31,5.06%,DAB2IP;EPS15L1;DUSP3;STAM2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.502985606873274,0.8480340471067956,0.726027397260274,1.0,1.0,6/16,28.00%,TCP1;TNF;CHP1;CCT8;DKC1;CORO2B
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,0.5769693613477468,0.8479377302702626,0.696969696969697,1.0,1.0,2/5,18.02%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.5769693613477468,0.8479377302702626,0.696969696969697,1.0,1.0,2/5,18.02%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.5769693613477468,0.8479377302702626,0.696969696969697,1.0,1.0,2/5,18.02%,ALDH1A1;ADH5
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,-0.4269818882159575,-0.84791285238734,0.5555555555555556,0.995685972124713,1.0,2/10,11.08%,AGO1;CNOT6L
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.5722611533097899,0.8478616018500021,0.7761194029850746,1.0,1.0,1/5,9.61%,TRIM25
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.4779480533936391,0.8478163384816432,0.7662337662337663,1.0,1.0,4/17,16.92%,SPTAN1;MAGI2;IQGAP1;SPTBN1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.44543784227919836,-0.8478075317201255,0.6785714285714286,0.9951889499654757,1.0,2/7,12.16%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.2683514398266174,-0.8477774490844262,1.0,0.9946003371960717,1.0,13/80,14.72%,NUP42;LOXL3;NNAT;NUP155;EP300;NUP188;NUP214;RAE1;NDUFAB1;SENP6;VCPKMT;SENP1;HDAC10
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.389988221575954,0.847607872960218,0.7666666666666667,1.0,1.0,10/76,10.81%,HTR2B;SLC24A2;VAPB;ANK2;HERPUD1;CAV3;RYR2;TRPC4;SLC24A1;ADCY8
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,-0.3792195590122951,-0.8475872537078714,0.5882352941176471,0.9942707793260912,1.0,2/15,3.38%,ITGA5;ABCG2
prerank,KEGG_2021_Human__Longevity regulating pathway,0.4227373813423684,0.847363433646364,0.7717391304347826,1.0,1.0,24/79,28.10%,ADCY3;CREB5;RPS6KB2;INSR;IRS2;IGF1R;ADCY8;PRKAG2;SOD2;HSPA1B;PRKAA2;SOD1;SESN1;HSPA2;ATG5;APPL1;ATG13;PRKACB;FOXO3;PPARGC1A;EIF4EBP2;ADCY1;HSPA8;PRKAB2
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.3911465966697739,-0.8473053356055243,0.6153846153846154,0.994291890613702,1.0,3/13,8.55%,ZNF675;LILRB4;TLR3
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.3782073222930276,0.8472623379003172,0.92,1.0,1.0,131/557,25.39%,BRIP1;RPL23;FKBP5;PPP2R5B;H2BC11;TALDO1;RPL37A;VEGFA;HSPA5;EIF2AK3;SCO2;NUP133;ATOX1;RPL38;HIF1A;GRB10;HERPUD1;XPO1;DNAJC7;RPS6;BLVRB;LIMD1;ARFGAP1;RPS27A;RPL23A;TXNIP;LMNB1;RPS25;RPS27;CRTC3;IMPACT;PSMB4;RBX1;CAMK2B;RPS6KA2;RPS11;HIF3A;DYNC1H1;ETS2;RPS20;COX7C;RPL9;CYCS;RPLP2;SERP1;RPL37;PPP1R15A;RPL14;DNAJB9;MAPK10;HYOU1;BAG3;SMARCD3;SEH1L;RPS4X;SYVN1;TBL1XR1;RPL11;EPAS1;GFPT1;CXXC1;RPS24;HSPA12A;RPS9;EGLN3;NPRL2;HSPA1B;GSTP1;RPL36;SCO1;DCTN1;SOD1;IGFBP7;SESN1;UBA52;SUZ12;EZH2;ERO1A;HSPA2;UBB;PSMC2;PPARA;PSMA3;TNFRSF21;FOS;SRPRA;KDM6B;ATP6V0B;RPS3A;PSMB2;DYNC1I1;NR1D1;COX4I1;CSRP1;NPAS2;HSPA14;RPL35;CDKN1B;RPL4;ATF3;P4HB;RPL32;PSMD5;HSP90B1;ATP6V1B2;EEF1A1;PSMD7;COX6C;RPL27A;JUN;NDC1;RPL3;RORA;RPA3;ATP6V0E2;UBE2D2;PSMD14;H1-0;ATP6V1D;RPS16;PSMA5;RPL30;COX6B1;RPL36AL;COX20;RPL21;POM121;RPL7;TXNRD1;PPARGC1A;RPL12
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.4640241762630261,0.8472054899481278,0.75,1.0,1.0,5/17,22.32%,RPS27A;TTC5;UBA52;UBB;SETD9
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.5442725745031349,0.8470386408489741,0.6935483870967742,1.0,1.0,3/5,23.77%,ID2;FGFR2;BBS7
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.4406324349631707,0.8470162203256479,0.7160493827160493,1.0,1.0,1/21,3.04%,IL15
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.41944636638673055,0.8469778781183614,0.7578947368421053,1.0,1.0,8/46,18.81%,RBPJ;RPS27A;RBX1;CCNC;TBL1XR1;NEURL1;UBA52;UBB
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.38431765303972576,0.8468679671683765,0.91,1.0,1.0,64/351,24.92%,DIAPH3;RHOB;PDE5A;VIM;PREX2;ANLN;RACGAP1;DOCK1;TFRC;DOCK5;TRIP10;VAPB;ARHGAP23;BAIAP2L1;RND3;NGEF;AKAP12;CKB;WASF1;LMNB1;SLITRK5;GFOD1;CKAP4;ARHGEF4;SPTAN1;KALRN;UACA;STMN2;PLXNB1;ITSN1;CDC37;PICALM;ARAP2;DHDDS;IQGAP1;SPTBN1;ROCK1;ARHGDIA;PKP4;STARD13;FGD4;RHOH;ECT2;CPNE8;BASP1;FAM13A;VRK2;FLOT2;STARD8;CDC42BPA;ANKRD26;VAV3;RHOU;ARHGAP42;TUBA1B;DNMBP;ARHGAP9;GPS1;ARHGAP18;CFTR;DDRGK1;TWF1;GNA13;ARMCX3
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.48567848432330507,0.8467534735578175,0.7560975609756098,1.0,1.0,5/17,23.25%,RPS27A;RFC4;UBA52;UBB;RPA3
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.3774819341374265,0.8464032734462825,0.92,1.0,1.0,130/553,25.39%,BRIP1;RPL23;FKBP5;PPP2R5B;H2BC11;TALDO1;RPL37A;VEGFA;HSPA5;EIF2AK3;SCO2;NUP133;ATOX1;RPL38;HIF1A;GRB10;HERPUD1;XPO1;DNAJC7;RPS6;BLVRB;LIMD1;ARFGAP1;RPS27A;RPL23A;TXNIP;LMNB1;RPS25;RPS27;CRTC3;IMPACT;PSMB4;RBX1;CAMK2B;RPS6KA2;RPS11;HIF3A;DYNC1H1;ETS2;RPS20;COX7C;RPL9;CYCS;RPLP2;SERP1;RPL37;PPP1R15A;RPL14;DNAJB9;MAPK10;HYOU1;BAG3;SMARCD3;SEH1L;RPS4X;SYVN1;TBL1XR1;RPL11;EPAS1;GFPT1;CXXC1;RPS24;HSPA12A;RPS9;EGLN3;NPRL2;HSPA1B;GSTP1;RPL36;SCO1;DCTN1;SOD1;IGFBP7;SESN1;UBA52;SUZ12;EZH2;ERO1A;HSPA2;UBB;PSMC2;PPARA;PSMA3;TNFRSF21;FOS;SRPRA;KDM6B;ATP6V0B;RPS3A;PSMB2;DYNC1I1;NR1D1;COX4I1;NPAS2;HSPA14;RPL35;CDKN1B;RPL4;ATF3;P4HB;RPL32;PSMD5;HSP90B1;ATP6V1B2;EEF1A1;PSMD7;COX6C;RPL27A;JUN;NDC1;RPL3;RORA;RPA3;ATP6V0E2;UBE2D2;PSMD14;H1-0;ATP6V1D;RPS16;PSMA5;RPL30;COX6B1;RPL36AL;COX20;RPL21;POM121;RPL7;TXNRD1;PPARGC1A;RPL12
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.5729489337928138,0.8463582711737828,0.8135593220338984,1.0,1.0,2/5,33.24%,ASAH1;SLC6A6
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.46999980407617,0.846317897648473,0.6575342465753424,1.0,1.0,5/14,22.54%,SOD2;HSPB1;SOD1;P4HB;SFPQ
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,-0.42672416665658913,-0.846301075372399,0.6666666666666666,0.9959062159449057,1.0,1/7,7.71%,TRAK2
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.42842714079602245,0.8462243877295644,0.7,1.0,1.0,7/41,21.83%,TGIF1;RPS27A;CCNC;UBA52;UBB;CDK9;STAT1
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.4487520246522629,0.8461113343805988,0.7176470588235294,1.0,1.0,6/29,16.89%,ARAF;FN1;PEBP1;CNKSR2;WDR83;IQGAP1
prerank,Reactome_2022__Translation R-HSA-72766,0.37594715122955286,0.845897921864957,0.87,1.0,1.0,59/235,26.86%,EEF1A2;RPL23;MRPL33;RPL37A;SEC61B;RPL38;RPS6;RPS27A;RPL23A;RPS25;DARS1;RPS27;RPS11;RPS20;EIF3E;RPL9;RPLP2;EEF1B2;PPA1;MRPL43;MRPL20;RPL37;EIF2B2;RPL14;MRPL14;MRPL55;RPS4X;RPL11;RPS24;RPS9;MRPL19;RPL36;SSR3;UBA52;SRPRA;MRPL3;RPS3A;MRPS14;RPL35;RPL4;RPL32;SRP19;EEF1A1;SPCS3;RPL27A;RPL3;RPS16;EIF4A2;RPL30;EIF3A;RPL36AL;RPL21;RPL7;RPL12;EIF3D;SRP54;RPL10A;FAU;RPS12
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4382372385220698,0.8458186680890365,0.7051282051282052,1.0,1.0,9/28,30.92%,RAB20;ATP6V0B;SLAMF8;ATP6V1B2;ATP6V0E2;ATP6V1D;ATP6V1E2;ATP6V0A1;MCOLN1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.5070298170740056,0.8456706200168614,0.7777777777777778,1.0,1.0,1/8,9.61%,TRIM25
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.41234555278956464,0.8455556729981859,0.8144329896907216,1.0,1.0,20/83,20.78%,LRP2;TACR1;TFRC;SH3GL3;COPS5;FCHO2;RPS27A;SGIP1;SH3GL2;SYT1;AGFG1;ITSN1;PICALM;WNT5A;UBA52;UBB;AP2A2;SNAP91;CLTCL1;IL7R
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.549673410387073,0.8452761277073801,0.6333333333333333,1.0,1.0,2/6,24.61%,DHX33;DDX3X
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.38474214922138017,-0.8452687926235695,0.7142857142857143,0.9974262482605184,1.0,3/25,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3025827484769983,-0.845094275773889,0.8,0.9971324210021979,1.0,8/56,8.65%,CCL5;IL1B;STXBP4;NNAT;UQCC2;ITPR2;AACS;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.4098928552829702,0.8449609253838642,0.7684210526315789,1.0,1.0,7/71,6.80%,PRKCE;CLIP3;ARF6;MTCL1;CEMIP;ANK3;EPHA3
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",-0.4398365881218731,-0.8449525275647561,0.6111111111111112,0.9967654836448202,1.0,2/11,8.55%,TICAM1;TLR3
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.3367484432400167,-0.8447603674602449,0.5714285714285714,0.9965551830672407,1.0,5/41,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.3335602181325077,-0.8445195158825398,0.7,0.996345176410804,1.0,4/40,5.45%,GTF2H5;GTF2H2;GATAD2B;UBTF
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.48745426782062307,-0.8442109149670217,0.6666666666666666,0.9964105904674057,1.0,1/6,7.42%,PLEKHM2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3845889025452634,0.844143330979422,0.87,1.0,1.0,38/214,18.46%,HTR2B;RAB7B;EGR1;CADM1;IL15;AGT;CHI3L1;PQBP1;ANXA1;SLC11A1;POLR3F;TRAF2;ALOX15B;EIF2AK3;IL7;HIF1A;FGR;POLR1C;PDE4B;NOD2;SULF2;RIPK2;BRCA1;POLR3H;PYCARD;WNT5A;TMED10;DHX33;IL18;TXK;SPTBN1;PLCB1;HSPA1B;APP;FOXP1;RGCC;SOD1;HSPD1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.32585265150147574,-0.8440715125350077,0.8,0.9960360165655103,1.0,7/43,15.93%,PKIB;CTC1;SRC;MAP3K4;TERF2;SMG6;EXOSC10
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5375719896848667,0.8439504456008879,0.76,1.0,1.0,3/8,21.02%,AKAP6;TNF;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5375719896848667,0.8439504456008879,0.76,1.0,1.0,3/8,21.02%,AKAP6;TNF;SLC9A1
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.2865256236737137,-0.8436950684461014,0.8,0.9960557643671878,1.0,13/83,10.78%,MRC2;PSMB3;PSME3;CHUK;SEC61A2;ITGB5;PSMC4;PSMD12;PSME4;HLA-E;BTK;IKBKB;FCGR1A
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4352177992567956,0.8435058114706024,0.6941176470588235,1.0,1.0,14/27,26.47%,AGT;ANK2;RYR2;FXYD7;RYR3;ASPH;ATP2A2;ATP1B3;ATP1B2;ATP1A2;TRPC1;ATP2B2;ATP2B4;TMEM65
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.3418380295517406,-0.8432551484227447,0.7777777777777778,0.9962768229466258,1.0,8/36,13.97%,EHHADH;ACOX1;MTLN;ACAA1;ECI1;IVD;PPARD;ABCD3
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.4783297692530479,0.8430590310108315,0.6842105263157895,1.0,1.0,3/16,11.93%,GADD45B;VEGFA;SASH1
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,0.4626797773632123,0.8430459320604158,0.6666666666666666,1.0,1.0,8/27,12.09%,RELN;AGT;SLC1A2;PHYHIPL;NDRG2;RANBP3L;MPPED1;SORBS1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.3148018796581049,-0.8424191996179736,1.0,0.9973846743282405,1.0,9/68,8.38%,H2BC4;TAL1;PSMB3;PSME3;LMO1;PSMC4;PSMD12;CBFB;PSME4
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.32750964124386106,-0.8423220087393156,0.75,0.9962258074004301,1.0,7/47,12.38%,NUP42;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.32750964124386106,-0.8423220087393156,0.75,0.9962258074004301,1.0,7/47,12.38%,NUP42;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.4612903855123271,0.842283619742857,0.7469879518072289,1.0,1.0,7/25,19.66%,DNAJC6;FCHO2;SGIP1;ITSN1;PICALM;AP2A2;SNAP91
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.5215758662375504,0.8422585578608072,0.7464788732394366,1.0,1.0,3/11,9.68%,TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.4136289503453363,0.8422283628589381,0.7252747252747253,1.0,1.0,8/49,15.73%,TMEM161A;PTPRK;RUVBL2;KDM1A;IMPACT;PPID;ACTR5;COPS9
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.43852472183279523,-0.8422256835575753,0.7272727272727273,0.9957434080971275,1.0,1/12,1.38%,CST7
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,0.46109147834898706,0.8421709214340165,0.7023809523809523,1.0,1.0,6/19,20.23%,MDH1;ENO2;FBP1;PCNX4;PGK1;ENO1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3221752931455603,-0.842121021973917,0.8,0.9952434388647203,1.0,12/77,8.55%,RNASEL;FLNA;PDE12;BCL2L1;ZMYND11;NLRP1;MLKL;APOBEC3G;MAP3K14;CGAS;NCBP3;TLR3
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.4742314377985687,0.8421207301397515,0.6835443037974683,1.0,1.0,8/17,29.84%,DNA2;BRCA1;RBBP8;RNF138;BARD1;SLX4;SMARCAD1;BLM
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.4914555418972404,-0.8416060504776604,0.6666666666666666,0.9954459134590845,1.0,2/8,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.3823855228418219,-0.8415237673871653,0.5714285714285714,0.9949104147121617,1.0,3/13,12.46%,IDE;ERAP2;GGT7
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.34189791223270216,-0.8415168926521702,0.65,0.9942300421089366,1.0,4/32,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.4583163380263522,0.8414480928465207,0.6987951807228916,1.0,1.0,2/19,10.71%,DNM3;DNM1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.4325042451834179,0.8413656035462425,0.735632183908046,1.0,1.0,6/35,18.63%,VGF;SLC4A10;IRS2;TENT4B;PNPLA8;AQP11
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.5360897542865316,0.8413248057516413,0.7540983606557377,1.0,1.0,1/5,7.76%,RUVBL2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4171082830748646,0.8412833676277175,0.7222222222222222,1.0,1.0,8/59,20.58%,WDR5;RUVBL2;YEATS2;PER1;TRIM16;CHD5;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.5741163418284185,0.8412021011894546,0.78125,1.0,1.0,4/6,27.30%,RPA2;ETAA1;WDR76;FEM1B
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.44388530907108886,-0.841035881814627,0.7,0.9945510289611501,1.0,2/11,3.95%,PLA2G4C;ZFYVE1
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.4037983610977771,0.8407863908259477,0.7575757575757576,1.0,1.0,23/94,28.10%,PLIN2;RPS27A;PRKAG2;DYNC1H1;TOMM20;PINK1;EPAS1;PIK3R4;PRKAA2;UBA52;UBB;DYNC1I1;MTERF3;ATG5;MFN2;ATG13;TOMM40;CFTR;CHMP7;DYNLL1;MAP1LC3A;HSPA8;PRKAB2
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.39506798577264735,0.8407042982299276,0.8282828282828283,1.0,1.0,27/118,23.60%,OMG;CLIP3;BEX3;LINGO1;NGEF;MAG;RPS27A;SPPL2B;ARHGEF4;KALRN;OTUD7B;RIPK2;FASN;ITSN1;CASP3;ARHGDIA;TNFRSF1A;FGD4;UBA52;UBB;ECT2;TNF;SORCS3;VAV3;ITGB3BP;RTN4;TRADD
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,0.5519876314122665,0.8406086460579125,0.7777777777777778,1.0,1.0,1/6,6.57%,ACSS3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.4232348828450675,-0.8404447043764672,0.68,0.9949624556118978,1.0,2/9,11.00%,NFKBIE;NFKBIA
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.48722757770205893,0.840049155922906,0.7402597402597403,1.0,1.0,5/14,19.39%,MFSD2A;WNT5A;MAP3K13;NTNG1;DLG4
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.4185646648224416,0.8398103736148949,0.6805555555555556,1.0,1.0,7/35,15.03%,SPOCK1;AGT;SPOCK3;PRELID1;SERPINE2;TIMP3;PICALM
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.43038412694168615,-0.8398103550462211,0.6,0.9955912841332574,1.0,3/7,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.3975270035236252,0.8397091696135592,0.7209302325581395,1.0,1.0,5/46,13.04%,TRMT9B;FTSJ1;TRNT1;DDX1;TSEN54
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.5031734696102227,-0.8396998400375502,0.6136363636363636,0.9951029145254868,1.0,1/5,0.45%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5222474840827417,0.8396056115998994,0.7222222222222222,1.0,1.0,1/9,5.27%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.42951555865974733,0.839251607170329,0.797752808988764,1.0,1.0,8/48,18.11%,TGFB2;CDKN2AIP;INSR;AKAP6;MFSD2A;SDCBP;PLCB1;TAF9B
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.37030311651415543,0.8390923417014996,0.82,1.0,1.0,54/346,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.456633014380177,0.8390186301159515,0.7011494252873564,1.0,1.0,4/22,9.68%,H2BC11;TDG;MPG;NEIL1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.47814351140373407,0.8388782775635,0.7307692307692307,1.0,1.0,2/18,4.08%,NRG1;CDH2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4816365584292014,0.8384953762521813,0.6923076923076923,1.0,1.0,5/16,25.32%,CYCS;NR4A3;GFPT1;LEPR;PPARGC1A
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,0.49597759502121863,0.838207635920061,0.7424242424242424,1.0,1.0,2/11,15.39%,TFRC;THY1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.46942158107647286,0.8381868188543206,0.6428571428571429,1.0,1.0,1/17,5.92%,RBM3
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.4527097272776875,0.8378199707656221,0.7283950617283951,1.0,1.0,3/22,10.74%,CR1;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.5049689430472175,0.8378141515165681,0.7037037037037037,1.0,1.0,2/9,20.16%,HSPD1;CTPS1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.3934750793186566,0.8374568176241706,0.7395833333333334,1.0,1.0,20/93,31.73%,TTBK2;ZNF518A;CLASP2;HOOK3;ZNF292;BRWD1;ANKRD26;CEP350;BCLAF1;GOLGB1;CCP110;REV3L;UBR5;PHIP;DZIP3;NHLRC2;HERC1;RIF1;PDS5B;MDN1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4151602298985295,0.8372146738980506,0.7261904761904762,1.0,1.0,8/47,22.66%,GDPD1;PIGQ;PIGF;PLCB1;PIGL;PIGG;SERINC5;CPNE3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.34877843567230843,-0.8371951659803211,0.7692307692307693,0.9991227994921245,1.0,7/39,8.73%,PEX13;EHHADH;ACOX1;MTLN;ACAA1;ECI1;CYP4V2
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.4786307973349677,0.8371548830197746,0.7012987012987013,1.0,1.0,2/15,13.49%,ENPP2;FASN
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3770425630155749,0.8369777976441956,0.89,1.0,1.0,61/366,19.02%,DAPK2;ACVR1B;CDK14;NEK11;TGFB2;PRKCE;RELN;CIT;RIOK2;CLSPN;ACVR2A;TTBK2;AATK;BMPR1B;MASTL;PDK4;EIF2AK3;PRRT1;RPS6KB2;INSR;DAPK1;NIM1K;EPHA3;PXK;IGF1R;PLK2;FGR;ALK;CLK2;LIPE;TYRO3;CAMK2B;PRKAG2;RPS6KA2;FAM20A;FLT1;NTRK2;EPHA4;PAK5;PINK1;PKD1;INCENP;MAPK10;GTF2H3;PDK3;NUAK2;CTBP1;TXK;TEC;GRK4;NRBP2;GMFB;ROCK1;MAP3K13;APP;PIK3R4;PRKAA2;FES;PRDX4;CDK9;CDC25B
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,0.44127118917362895,0.8369713793925668,0.7228915662650602,1.0,1.0,2/22,13.58%,POLR3F;POLR3H
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.5007257649786233,0.8369034446854203,0.6829268292682927,1.0,1.0,5/9,37.27%,WAPL;PARP9;GMNN;MED25;HMBOX1
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.43352706713421785,0.8366072806052683,0.7586206896551724,1.0,1.0,8/33,27.41%,RPS27A;RNF139;SYVN1;UBA52;UBB;GANAB;PRKCSH;MLEC
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",0.5487139887960419,0.8365887695600431,0.7534246575342466,1.0,1.0,1/7,3.84%,GPC5
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,0.530836385864498,0.8365719908103023,0.6875,1.0,1.0,1/6,9.28%,IRS2
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.4875085209544076,-0.8365335364667749,0.5853658536585366,0.9998471514098957,1.0,1/5,16.06%,SETD3
prerank,KEGG_2021_Human__Osteoclast differentiation,0.398859766271616,0.8365144004989281,0.83,1.0,1.0,7/100,10.46%,SOCS3;TGFB2;TRAF2;FCGR2B;FOSL2;TNFRSF11B;FCGR2C
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5262447874940948,0.8365007103014023,0.6486486486486487,1.0,1.0,4/8,30.59%,MFSD2A;CNEP1R1;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5725621572334982,0.8364866770087253,0.7435897435897436,1.0,1.0,1/5,5.64%,EIF2AK3
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.38665359240834524,-0.8364439265091415,0.8333333333333334,0.9993206288700647,1.0,4/14,14.64%,ACTA2;EP300;MAML1;MAMLD1
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.3978691708817315,0.8364099061622369,0.7956989247311828,1.0,1.0,16/66,24.06%,HHIP;DZIP1;RPS27A;PSMB4;RBX1;KIF3A;UBA52;UBB;PSMC2;PSMA3;PSMB2;IQCE;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.5491758357755736,0.8362898357115921,0.8064516129032258,1.0,1.0,3/8,34.86%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.5491758357755736,0.8362898357115921,0.8064516129032258,1.0,1.0,3/8,34.86%,ST6GALNAC5;FUT9;FUT8
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.5474809347907995,0.8359616694792396,0.7671232876712328,1.0,1.0,1/8,12.53%,FBP1
prerank,CellMarker_Augmented_2021__Myeloid cell:Tonsil,0.5435573819107221,0.8359564833894264,0.6818181818181818,1.0,1.0,2/7,10.46%,CR1;FCGR2C
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.3938618232472047,0.835751195923613,0.8526315789473684,1.0,1.0,15/134,14.21%,CLEC4E;CR1;H2BC11;ATAD3A;SLC11A1;ADAM15;TRIM5;TRIM25;IFITM3;FGR;NOD2;IFNLR1;RIPK2;CALCOCO2;TRIM26
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.46978806049680805,0.8354778623836976,0.7183098591549296,1.0,1.0,1/12,1.62%,VIM
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.4567634457553811,0.8353208819752632,0.6707317073170732,1.0,1.0,5/18,15.15%,SEPTIN4;GSDMD;CYCS;UACA;CASP3
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5069670664319197,0.8352507566537722,0.72,1.0,1.0,3/7,18.00%,CKAP5;HSPA1B;DCTN1
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,-0.4778344352663771,-0.8352283203060614,0.5806451612903226,1.0,1.0,1/6,2.67%,CD2
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.5241828762618799,0.8351168506839767,0.7,1.0,1.0,1/9,13.05%,BNIP3
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,0.49339528120785303,0.8351118326634245,0.6805555555555556,1.0,1.0,4/9,23.82%,PPOX;FLVCR1;ALAD;UROS
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.36291438111487945,-0.8350356310924749,0.7083333333333334,1.0,1.0,6/21,16.16%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.36291438111487945,-0.8350356310924749,0.7083333333333334,1.0,1.0,6/21,16.16%,LEO1;CPSF1;MTPAP;WDR33;GRSF1;CPSF2
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),0.5434519479024592,0.8349037377999897,0.7142857142857143,1.0,1.0,1/6,3.87%,ANXA1
prerank,KEGG_2021_Human__Peroxisome,0.41332506445114353,0.8346611373697523,0.7934782608695652,1.0,1.0,10/51,20.57%,NUDT12;ACSL1;PEX5L;AGPS;SOD2;PEX3;SOD1;HACL1;ACSL3;PIPOX
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.43182061885431827,0.8345736058194713,0.7078651685393258,1.0,1.0,5/29,21.83%,TGIF1;RPS27A;UBA52;UBB;STAT1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.2951170427920089,-0.8345048370674386,0.875,1.0,1.0,13/58,14.34%,RANBP6;SNUPN;APPL2;NUP155;RPAIN;PHB2;NUP188;NUP214;IPO13;SYK;PTTG1IP;AKT1;SNRPB
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.4001066038831886,0.8344936670669849,0.7159090909090909,1.0,1.0,13/52,17.56%,NLRP12;EGR1;GSDMD;NOD2;RIPK2;TRIM16;PYCARD;AIM2;WNT5A;HSPB1;APP;GSTP1;FOXP1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,0.4407130531640132,0.8340237256542399,0.6987951807228916,1.0,1.0,2/23,13.58%,POLR3F;POLR3H
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,0.44190968586417545,0.8340052698132066,0.8068181818181818,1.0,1.0,9/40,17.61%,ZNF814;SYCP3;MGAT4C;FLVCR1;YWHAQP5;POU5F1;ZNF850;ORC6;ZNF665
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4454058893923017,-0.8339954541241432,0.6842105263157895,1.0,1.0,5/10,12.81%,CCND1;TP53;RFWD3;PLK3;SDE2
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.4837362628107068,-0.8338226359633923,0.8076923076923077,0.9999276326813711,1.0,2/7,11.69%,UQCC2;SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.4837362628107068,-0.8338226359633923,0.8076923076923077,0.9999276326813711,1.0,2/7,11.69%,UQCC2;SLC25A33
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.42818886566002173,0.8337850209370824,0.7375,1.0,1.0,9/32,28.31%,PDZD2;RPS27A;TRIM25;UBA52;UBB;ATG5;UBE2D2;UBE2D1;TAX1BP1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5239279784157317,-0.8337699694084403,0.625,0.9993408923508932,1.0,1/5,22.47%,PRKN
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.5189115250722038,-0.83360497828289,0.6538461538461539,0.999006989876414,1.0,3/8,8.43%,MYH9;CSF1R;THOC5
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.5283943771536902,0.833575090125915,0.7681159420289855,1.0,1.0,3/7,8.95%,IHO1;FMN2;PTN
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.3894098507421031,-0.8335507898108382,0.7058823529411765,0.9984036938109695,1.0,3/23,3.48%,GTF2H5;GTF2F1;GTF2H2
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.27406053527445734,-0.833328364086555,1.0,0.9981877452932668,1.0,15/115,10.83%,NUP42;PSMB3;AP1B1;PSME3;ELOC;APOBEC3G;PSMC4;BANF1;PSMD12;NUP155;FYN;PSME4;HCK;NUP188;NUP214
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.44413648227446123,0.8330839150562562,0.704225352112676,1.0,1.0,2/14,14.10%,ALOX12;SERPINE2
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.4873114990445038,0.8330565127620414,0.7469879518072289,1.0,1.0,1/15,11.29%,PDE4DIP
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4213619348588967,0.8330237486633407,0.7283950617283951,1.0,1.0,4/31,7.94%,GPM6A;ARF6;MYO10;NLGN1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.33540618767750635,-0.8327772711107969,0.9285714285714286,0.9985380040514381,1.0,6/32,7.96%,PIDD1;TP53;CASP10;ZNF420;BID;PPP1R13B
prerank,KEGG_2021_Human__MAPK signaling pathway,0.37996198383291135,0.8326539973064245,0.89,1.0,1.0,41/203,20.89%,FGF1;ARAF;TGFB2;CACNB2;MAPT;GADD45B;NR4A1;KITLG;MAP3K8;VEGFA;TRAF2;INSR;IGF1R;CACNG2;CACNA1B;CACNA2D3;RPS6KA2;FLT1;NTRK2;RASGRF1;DUSP10;MAPK10;CASP3;ANGPT2;RASGRP4;CACNA1A;CACNG8;HSPB1;MAP3K13;HSPA1B;TNFRSF1A;HSPA2;CDC25B;PTPN5;MAPK8IP2;FOS;DUSP16;TNF;DUSP6;FGFR2;ECSIT
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.5149312919585047,0.8325953978155161,0.7166666666666667,1.0,1.0,2/10,16.30%,VEGFA;CTBP1
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.49645594824842987,0.8324348368088488,0.75,1.0,1.0,3/11,18.81%,RPS27A;UBA52;UBB
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,0.5247415752670039,0.8321530060405417,0.7391304347826086,1.0,1.0,1/8,7.42%,VPS11
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,0.568833136017477,0.8319981567045536,0.7727272727272727,1.0,1.0,3/5,28.64%,ARNT2;HSP90AB1;MIA3
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,-0.4215963516835147,-0.8316332978999866,0.72,1.0,1.0,1/8,7.71%,TRAK2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5266419903932813,0.8316127482542481,0.7272727272727273,1.0,1.0,5/9,22.91%,ABCA1;ABCA5;ITGAV;PPARA;ABCG1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.40523483392195214,0.8315589226793904,0.7582417582417582,1.0,1.0,14/66,25.18%,DDIT4;SCO2;PRKAG2;COX7C;CYCS;SCO1;PRKAA2;SESN1;COX4I1;COX6C;PTEN;COX6B1;COX20;TXNRD1
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.4876461581305246,0.8314196573213269,0.7777777777777778,1.0,1.0,4/14,18.18%,CR1;DUSP10;BCL6;FANCA
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.3974868311275461,-0.8312936208704702,0.7368421052631579,1.0,1.0,3/12,13.67%,PANK1;PPCDC;PPCS
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.35814600399425,-0.8311449539347215,0.7777777777777778,1.0,1.0,3/30,5.72%,NPC2;NPC1;LIMA1
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.4189063406385305,0.8311011299398797,0.7126436781609196,1.0,1.0,4/36,7.98%,TLE1;H2BC11;TCF7;TCF7L1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,0.5405953418465121,0.8308206439471846,0.7230769230769231,1.0,1.0,2/5,15.39%,ALCAM;THY1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.36531827905199776,-0.8307540690281884,0.7222222222222222,1.0,1.0,6/22,9.99%,IL1B;IL1A;RNF103-CHMP3;GZMB;TP53;CHMP2B
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3922491209367102,0.8301943040862823,0.8144329896907216,1.0,1.0,19/82,22.13%,ST18;EGR1;MAP3K8;RPS27A;NOD2;PSMB4;RBX1;RIPK2;PELI1;PLCB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;IRAK3;PSMD5;PSMD7;MAP3K3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.3668008902105616,0.829936874597714,0.88,1.0,1.0,54/349,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3483503611723528,-0.829791714846188,0.8571428571428571,1.0,1.0,6/27,18.20%,TGFB1;LCP1;PRR5L;PLK3;RAB29;CEP290
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.5479091991173414,0.829650731929739,0.7846153846153846,1.0,1.0,2/6,20.00%,SNX17;CYP46A1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.3788551576689634,-0.8295560636584416,0.7272727272727273,1.0,1.0,3/18,12.16%,PFN1;ARHGAP35;CXCL12
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.47094845774859934,0.8294344684262425,0.7195121951219512,1.0,1.0,2/17,7.13%,H2BC11;MPG
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.476864843184807,0.8293087790230391,0.75,1.0,1.0,6/17,30.09%,RPS27A;UBA52;UBB;UBE2D1;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.39183044153391683,0.8288869413344464,0.8762886597938144,1.0,1.0,21/113,15.59%,VIM;HMGB2;ADCY3;BRINP1;ADAM15;RORB;PDK4;EPHA3;RUVBL2;PTK7;PDE4B;PDCD1LG2;ADCY8;NOD2;TNFRSF1B;GNAI1;INSIG1;PYCARD;WNT5A;ESR1;PDK3
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.5113456598761583,-0.8288470095271363,0.6666666666666666,1.0,1.0,2/5,10.32%,IL1B;TREM2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.40198487729386867,0.8281358814789201,0.8085106382978723,1.0,1.0,14/77,15.86%,TRAF2;HINT1;GSKIP;BOK;MCL1;ZNF385B;TNFRSF1B;BRCA1;BNIP3;BCL2L2;PPP1R15A;PYCARD;SCN2A;CIDEB
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.44989709396718913,-0.8278323388356081,0.7037037037037037,1.0,1.0,1/9,14.03%,EIF2S2
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5915390882987173,0.8276698992528346,0.7777777777777778,1.0,1.0,3/6,21.66%,MAPT;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.37368859169792074,0.827431952673315,0.91,1.0,1.0,59/347,17.45%,HTR2B;THBS1;LRP2;FGF1;TGFB2;NLRP12;IFIT5;RPL23;RELN;TFRC;AGT;NRG1;CHI3L1;KITLG;VEGFA;TRAF2;INSR;NLGN1;SEPTIN4;TRIM5;FN1;TXN;BOK;IRS2;IGF1R;TRIM25;PLK2;FGR;NTRK3;SEMA5A;GPRC5B;NOD2;FLT1;NTRK2;HCLS1;SASH1;RPS20;RIPK2;DDX1;GAB1;PINK1;RPL37;RUNDC3A;PLXNB1;PELI1;IQCJ-SCHIP1;WNT5A;NRG4;ESR1;SEH1L;DHX33;IL18;ITGAV;RNF13;LITAF;CHD5;IQGAP1;ROCK1;APP
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.43891424527944156,0.8272957159531028,0.75,1.0,1.0,12/30,25.49%,PCDH15;SLC26A5;OTOGL;KCNMB1;SPTAN1;KCNMA1;SPTBN1;LHFPL5;RDX;TWF1;EPB41L3;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.41031123807053005,0.8272956001566414,0.7362637362637363,1.0,1.0,10/48,18.89%,SEMA3A;GADD45B;TRAF2;FCGR2B;NOD2;PYCARD;SDCBP;PLCB1;APP;ANKRD6
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.34431526030867377,-0.8269628335857895,0.8571428571428571,1.0,1.0,7/30,14.81%,INPP5K;IL1B;PIP4K2B;ENPP1;SORL1;NCK1;PTPRE
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.4787144161657965,0.8269174193167369,0.6533333333333333,1.0,1.0,5/11,26.32%,B4GALT5;SPTBN4;PTEN;B4GALT6;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.5672018845713651,0.8269005897621851,0.7692307692307693,1.0,1.0,4/6,32.90%,SMYD5;PRDM15;MLLT3;NCOA3
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.5372247223076939,0.8268900976746165,0.6825396825396826,1.0,1.0,1/8,7.42%,VPS11
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.43067230645998444,0.8268703136778854,0.7468354430379747,1.0,1.0,10/29,22.86%,THBS1;ID2;NR4A3;IL18;FOXP1;TNF;MFN2;CX3CL1;STAT1;JUN
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.39091016999197403,0.8264273478882681,0.8210526315789474,1.0,1.0,21/97,21.28%,ERCC2;NR4A2;NR4A1;RORB;RXRB;RBPJ;NR2F1;NR4A3;GTF2H3;ESR1;NR2C2;TBL1XR1;POLR2D;TAF9B;ESRRG;CDK9;PPARA;TAF7;NOTCH2;NR1D1;POLR2G
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.43894067403000525,-0.8263815322205372,0.5714285714285714,1.0,1.0,2/8,7.93%,TECR;HACD4
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.43894067403000525,-0.8263815322205372,0.5714285714285714,1.0,1.0,2/8,7.93%,TECR;HACD4
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4430837353087585,0.82632222870316,0.8072289156626506,1.0,1.0,5/34,14.98%,TFRC;IL7;IRS2;NOD2;GPR183
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.44784110629721013,0.8262713322862026,0.7721518987341772,1.0,1.0,1/24,5.20%,ZNF93
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.29491019015878084,-0.8262400359085826,0.7142857142857143,1.0,1.0,15/86,13.78%,H2BC4;GTF2F1;CCND1;PMEPA1;TLE3;CBFB;AGO1;EP300;USF1;H2BC26;CXCL12;MBD4;POLR2C;TGFA;BCL2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.5263406568423573,0.8261608733537782,0.746268656716418,1.0,1.0,1/8,12.94%,NSF
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.3096857010503733,-0.8260473057914768,0.7777777777777778,1.0,1.0,5/46,6.69%,PSMB3;CCND1;PSME3;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.48293591702650596,0.825894891134305,0.75,1.0,1.0,3/19,11.11%,TGFB2;MCL1;EPHA7
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.3643223205697355,0.8258488588034245,0.87,1.0,1.0,54/350,20.42%,CRISPLD2;ALDH3B1;CLEC12A;CR1;GLA;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;PGAM1;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;GPI;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;STXBP2;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;PLD1;SURF4;PGM1;SELL
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.5632490953866963,0.8256978429553942,0.7457627118644068,1.0,1.0,1/5,13.33%,ANTXR2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.424701437663734,0.8255536403654037,0.8023255813953488,1.0,1.0,4/37,9.50%,TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.49890078831522955,0.8254788623775805,0.7941176470588235,1.0,1.0,3/11,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.49890078831522955,0.8254788623775805,0.7941176470588235,1.0,1.0,3/11,27.75%,TCP1;CCT8;DKC1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.4272267021447598,0.8254328415898543,0.7317073170731707,1.0,1.0,4/30,11.99%,VEGFA;INSR;SGIP1;MAGI2
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.39619027678654994,-0.8251975302842218,0.7894736842105263,1.0,1.0,3/20,3.62%,BCL2L1;TXN2;NLRP1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.5398011206365522,0.8250688936732726,0.7681159420289855,1.0,1.0,3/6,28.76%,TIMM13;TIMM22;AGK
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.4702812183971116,-0.8248558159724353,0.6410256410256411,1.0,1.0,3/6,11.41%,AZIN2;ASL;ALDH18A1
prerank,KEGG_2021_Human__Galactose metabolism,0.4526509463723193,0.8248539543511021,0.7638888888888888,1.0,1.0,4/18,10.06%,GLA;PFKM;MGAM;AKR1B1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.46414238772066324,0.8246991177309396,0.7105263157894737,1.0,1.0,7/17,27.58%,MFSD2A;SLC44A5;PEMT;CHPT1;SLC44A1;PCTP;LPCAT1
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,0.3736558032603064,0.8246233319960696,0.98,1.0,1.0,97/662,19.09%,BRIP1;GDPD1;MACC1;WDR17;ADAMTS2;FRAS1;MKRN2OS;NEK11;NLRP12;ZNF793;FMN1;LDB3;ZDHHC15;TBC1D8;DNAH11;SLC2A3;ZNF483;PIGU;FAAH2;KIF1B;SUV39H2;NYAP2;TCF7;MOG;ENO2;MBOAT2;MCHR2;SIRPB2;CLMP;ACSS3;SRCIN1;PPOX;KDM3A;VPS11;YEATS2;SUGP2;GABRB3;FLVCR1;RPL7L1;LIMD1;POU5F1;NEIL1;PDE2A;SEMA5A;ARHGEF4;CPM;C5AR1;ZNF34;SPTAN1;SH3D19;METTL2A;GPR155;HEATR3;ELMOD1;L2HGDH;PPP1R3B;DNAH7;ZNF606;COL21A1;SHROOM4;SNAP29;ZNF549;CLMN;ZCWPW1;TMEM120B;PKD1;PRR11;PLXNB1;ITSN1;ABCA5;PHKG1;MAPK10;GTF2H3;FAM184B;EFCAB5;ANGPT2;ICA1L;TSHZ2;SHISA9;NAPEPLD;CACNG8;ODF2L;ZNF665;PCMTD1;MTMR9;ADPRS;CNTN3;USP43;RNF149;KCNJ3;UVSSA;FBXL13;PNPLA7;DENND5B;ACKR4;IPP;TRIM65
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.37475729661422674,-0.8245541397076456,0.6470588235294118,1.0,1.0,3/32,9.13%,RALB;PIP4K2B;UBQLN2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.39070083247753606,-0.8245162988041254,0.7419354838709677,1.0,1.0,2/10,6.50%,PSMC4;TP53
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.5573305451499779,0.8244882731032075,0.7868852459016393,1.0,1.0,1/5,8.19%,SLCO3A1
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.38652212592499263,0.8241132106364808,0.7708333333333334,1.0,1.0,16/91,20.20%,PRKCE;PPP2R3B;PPP2R5B;PPP2R5A;TRAF2;PPP2R2B;GNAI1;SPTLC2;MAPK10;PLCB1;ROCK1;PPP2R3A;TNFRSF1A;GNAQ;PLD1;TNF
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4027835818683391,0.8240134030277597,0.7888888888888889,1.0,1.0,9/73,17.43%,MAPT;RPA2;IER5;NUP133;DNAJC7;CAMK2B;BAG3;SEH1L;HSPA1B
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.38484073471297503,0.8240012841970782,0.84375,1.0,1.0,15/122,13.42%,DAPK2;AGT;PHLPP1;TRAF2;NDRG1;DAPK1;PAX8;SEPTIN4;BEX2;BNIP3L;SRA1;ALK;BNIP3;PINK1;PRELID1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.408292019862731,0.8239732083797913,0.7666666666666667,1.0,1.0,16/36,26.51%,DNM3;DNM1;ESR1;ATP1B3;PLCB1;ATP1B2;GNAQ;AP2A2;CLTCL1;ATP1A2;PRKCB;PRKACB;ATP2B2;ATP2B4;AP2S1;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4511049790493117,0.8239404108480249,0.7307692307692307,1.0,1.0,2/16,9.26%,AGT;RBPJ
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.39891005929254847,0.8239179950567129,0.8369565217391305,1.0,1.0,14/83,20.25%,MTCL1;ARHGAP23;PCBP4;ADGRB2;SPTAN1;DYNC1H1;TNPO2;PKD1;ATP2A2;CCDC85C;SPTBN1;DCTN1;PLEC;CNTNAP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4429725455420086,0.8238893205165954,0.7307692307692307,1.0,1.0,6/23,28.37%,RUVBL2;ATAT1;MORF4L2;TAF6L;BAG6;MSL3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.39469348723536357,-0.8238037125649708,0.6666666666666666,1.0,1.0,2/12,9.63%,HPGDS;GSTM4
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.39469348723536357,-0.8238037125649708,0.6666666666666666,1.0,1.0,2/12,9.63%,HPGDS;GSTM4
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.3831961669680837,0.8237879143126718,0.75,1.0,1.0,11/84,17.10%,ACVR1B;VPS37C;GNS;GOLM1;GRINA;TRIM25;B4GALT5;ZSWIM4;PICALM;ATP2A2;ERLIN1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.3831961669680837,0.8237879143126718,0.75,1.0,1.0,11/84,17.10%,ACVR1B;VPS37C;GNS;GOLM1;GRINA;TRIM25;B4GALT5;ZSWIM4;PICALM;ATP2A2;ERLIN1
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.3831961669680837,0.8237879143126718,0.75,1.0,1.0,11/84,17.10%,ACVR1B;VPS37C;GNS;GOLM1;GRINA;TRIM25;B4GALT5;ZSWIM4;PICALM;ATP2A2;ERLIN1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.4029474106988354,0.8237428084919133,0.7065217391304348,1.0,1.0,2/44,5.16%,NFIL3;SOX4
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.4498112337968,0.8235999906813941,0.6883116883116883,1.0,1.0,3/23,8.64%,SLC11A1;NOCT;TENT5A
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.36893469405492757,0.8234530976309645,0.8775510204081632,1.0,1.0,40/216,23.28%,ALG10B;CD55;ANK3;MVD;ANK2;MGAT4C;TUSC3;ARFGAP1;RPS27A;SPTAN1;SEC24C;B4GALT5;MCFD2;SLC35A1;DYNC1H1;AMDHD2;NSF;RNF139;MAGT1;SPTBN5;ST6GALNAC5;ST8SIA3;SYVN1;GFPT1;DHDDS;TRAPPC6B;SPTBN1;GRIA1;DCTN1;UBA52;UBB;SPTBN4;ALG11;DYNC1I1;NAPG;GNPNAT1;CNIH1;ST6GAL2;GANAB;F8
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.36067862497972647,-0.8232205949142326,0.85,1.0,1.0,6/24,13.95%,LGALS9;CD274;SIRPA;IGF1;ILRUN;HAVCR2
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,-0.5301094677912268,-0.8232190469700618,0.65625,1.0,1.0,1/7,1.88%,PUS1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,0.3979482615728485,0.8230144801914558,0.782608695652174,1.0,1.0,9/50,15.99%,CD163;ENPP2;TNS1;F13A1;CD93;FGL2;FLT1;THY1;LDB2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4005254920404965,0.8230021227230588,0.8469387755102041,1.0,1.0,10/86,15.56%,KLF4;NLRP12;FZD6;BHLHE40;ID2;KDM1A;PKD1;PYCARD;AIM2;ESR1
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,-0.482017459102139,-0.8229705830317404,0.6666666666666666,1.0,1.0,1/5,0.42%,CYB5A
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.38026238833339016,0.8229106349758928,0.89,1.0,1.0,36/198,21.25%,TOP2A;HMGB2;RPA2;TDG;MPG;GLRX2;ENDOV;WDHD1;DNA2;RPS27A;NEIL1;POLQ;HINFP;INTS3;BRCA1;XRCC3;FAN1;RFC4;UHRF2;GTF2H3;POLE2;ORC6;POLL;FANCL;ADPRS;FANCA;UBA52;DBF4;UBB;TIMELESS;NOP53;RFC1;KMT5C;HELLS;RBBP8;DDB1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.45434446212144447,0.8228897359159243,0.7692307692307693,1.0,1.0,6/18,22.53%,SHANK3;ROCK1;SLC9A1;CX3CL1;RDX;PTGER4
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.44984565951708566,0.8228711957690379,0.7297297297297297,1.0,1.0,2/18,7.94%,GPM6A;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.5542903011527764,0.8228519860147115,0.7692307692307693,1.0,1.0,2/5,10.26%,VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.5781821549627852,0.8225383091754922,0.8,1.0,1.0,2/5,12.11%,GLUL;NMD3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.4314449623136919,0.8224852304081627,0.7272727272727273,1.0,1.0,6/29,14.74%,GADD45B;VEGFA;PHLPP1;PER1;SASH1;DUSP10
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.38974405695213565,0.8224169496261516,0.8350515463917526,1.0,1.0,25/102,24.35%,BRIP1;H2BC11;CLSPN;PIAS4;DNA2;RPS27A;PSMB4;BRCA1;RFC4;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;PSMB2;RBBP8;PSMD5;PSMD7;BARD1;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.4665488560466022,0.8218302020372565,0.6956521739130435,1.0,1.0,4/15,10.41%,FBN2;TGFB2;ITGB8;LTBP1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.47113714595718736,0.8215251511085448,0.7285714285714285,1.0,1.0,4/16,21.25%,TRIM5;TRIM25;TRIM26;DDB1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,0.4278574774055821,0.8214963232394145,0.7529411764705882,1.0,1.0,3/29,13.86%,POLR3F;POLR3H;ZNF143
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.3799200548758351,-0.8213639185726955,0.7894736842105263,1.0,1.0,4/18,6.66%,NEDD4;FFAR4;ACTB;TRIB3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.34053761155457934,-0.8212499982813585,0.6363636363636364,1.0,1.0,6/29,7.51%,SESN2;LATS2;LILRB4;WWTR1;NVL;TGFB1
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.25238007145157565,-0.821035292842846,0.8,1.0,1.0,19/93,14.14%,GBP3;TMEM267;ELK3;ETS1;MLKL;SAMD9;MOB1A;GLIPR1;CBFB;NMI;RECQL;BIRC2;PHF11;DNAJB14;REST;NBN;BNIP2;TRAM1;BCL10
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",-0.4841022397973437,-0.8208227951618429,0.625,1.0,1.0,1/5,5.98%,CD274
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),0.5267571346645031,0.8208129264811528,0.7727272727272727,1.0,1.0,1/7,9.71%,FGR
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.47734018038839027,-0.8206113307276957,0.6153846153846154,1.0,1.0,1/5,7.83%,NUP155
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5032029047868343,0.8205268705902768,0.7272727272727273,1.0,1.0,1/8,13.06%,XRCC3
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.43517920845572894,0.8203634198916513,0.8095238095238095,1.0,1.0,6/37,12.62%,MAPT;GPC5;ABCA2;MAP2;KDM1A;VCPIP1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.4120101888127742,0.8197194244299408,0.8131868131868132,1.0,1.0,6/42,10.87%,TGFB2;PHLPP1;COPS5;IGF1R;PER1;NOD2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2871726404793923,-0.8196871267518295,1.0,1.0,1.0,19/126,8.42%,LURAP1;FLNA;TICAM1;TRIM38;CHUK;EDA2R;LGALS9;IRAK4;LPAR1;TMEM9B;ATP2C1;TMED4;NEK6;TMEM106A;MAP3K14;ZDHHC13;CASP10;TNFSF10;PLEKHG5
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.5037861871465688,0.819675107443399,0.7974683544303798,1.0,1.0,1/12,1.95%,DPYD
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.434890587096099,0.8196012140096106,0.7777777777777778,1.0,1.0,9/36,20.18%,TM7SF2;FAXDC2;ABCA1;PRKAG2;INSIG1;ABCA5;MSMO1;CYP46A1;OSBPL5
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.468586936232131,0.8195925694807588,0.7142857142857143,1.0,1.0,2/15,5.63%,TRAF2;CD55
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5155082686662604,0.8195615888174288,0.7424242424242424,1.0,1.0,3/10,22.49%,SOX4;PKD1;ALDH1A2
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,0.4532523273800616,0.8192697355443165,0.7469879518072289,1.0,1.0,7/19,21.49%,PDK4;PDK3;SLC16A3;SLC16A1;MPC2;PDHB;PDPR
prerank,KEGG_2021_Human__Renin secretion,0.42403608968811196,0.8186747508537683,0.8505747126436781,1.0,1.0,14/39,25.14%,PDE1A;AGT;CALM3;PDE1C;GNAI1;GUCY1B1;KCNMA1;PLCB1;GNAQ;GUCY1A2;CLCA4;PTGER4;PRKACB;CACNA1C
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3985523543755127,0.8185641006631994,0.8,1.0,1.0,9/58,12.29%,ENPP2;IL15;RELN;AGT;VEGFA;GHR;EPHA7;HCLS1;RIPK2
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.5259133612554098,0.8185428899530095,0.7205882352941176,1.0,1.0,4/8,33.03%,DONSON;TIMELESS;BLM;ZRANB3
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,-0.49523651342061453,-0.8185305030992143,0.71875,1.0,1.0,2/6,6.48%,APOBEC3G;BANF1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.5177466418495055,0.8184068171666411,0.78125,1.0,1.0,1/9,6.86%,RCC1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.32960738409802637,-0.8183957143385656,0.8571428571428571,1.0,1.0,4/29,5.06%,DAB2IP;EPS15L1;DUSP3;STAM2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.4869932314727352,-0.8182887028106719,0.6875,1.0,1.0,1/7,1.45%,SESN2
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,0.374899651197626,0.8182285072144105,0.85,1.0,1.0,36/258,16.31%,UAP1L1;NAMPT;PLIN2;CR1;CD163;GLA;EIF4A3;CD163L1;NR4A2;CHI3L1;CLEC2B;SRGN;RNF144B;F13A1;EYA2;MAFB;ABCA1;IRS2;C5AR1;PDE4B;FGL2;GPR65;HCLS1;THBD;RIPK2;TNFRSF1B;SNX10;NR4A3;SOD2;CD300A;CYRIA;PELI1;LILRB5;NINJ2;ATP1B3;CNEP1R1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.38206792059412786,0.8180935961411429,0.8350515463917526,1.0,1.0,5/135,6.24%,TOP2A;NR4A2;PIAS4;TDG;NUP133
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.32182125316784577,-0.818050302715016,0.7058823529411765,1.0,1.0,4/37,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.49754581891793054,-0.8179673927453706,0.6578947368421053,1.0,1.0,2/7,9.65%,ITPA;ENPP1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.36113077511383956,0.8178973718327653,0.91,1.0,1.0,48/256,21.46%,DAPK2;TSPAN13;PLAC8;EIF4A3;GPM6B;ADGRE1;SEC61B;TUBB6;COL24A1;ABCA2;HERPUD1;KANK1;PTK7;PPFIBP1;SBDS;ITGAE;TXN;SIVA1;MFSD2A;ARHGEF4;PDCD1LG2;SULF2;GAB1;TMEM19;ASPH;TGFBI;GPR183;DCK;UGCG;SND1;EGLN3;APP;PCMTD1;TATDN3;DENND5B;PPARA;MIF4GD;TNFRSF21;PAPLN;CYP46A1;SLC3A2;SELL;TCF4;PTPRS;AHCY;BCL11A;P4HB;HSP90B1
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5371728127305377,-0.8177457157645001,0.8055555555555556,1.0,1.0,2/6,8.12%,B4GALT7;XYLT1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.33407272322900117,-0.8176712551578564,0.7727272727272727,1.0,1.0,4/26,8.28%,BCL2L1;FAIM;ICAM1;TNFSF10
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4609680065974426,0.8176669616376963,0.6463414634146342,1.0,1.0,5/18,15.06%,IL1RAPL1;CAMK2B;EPHA4;CTNNA2;WNT5A
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.552435919733072,-0.8174691147381332,0.775,1.0,1.0,1/5,4.42%,IL4I1
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.5710808175044801,0.8173798366344052,0.8181818181818182,1.0,1.0,3/5,42.89%,PARVB;ACTN1;LIMS1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.38029222173170096,0.8173244040619873,0.9090909090909091,1.0,1.0,45/209,22.53%,HTR2B;FGF1;ARAF;SHANK3;NRG1;KITLG;MAP3K8;PAQR3;SHC2;IRS2;RPS27A;SPTAN1;PSMB4;RBX1;CAMK2B;ZDHHC9;LRRC7;PEBP1;RASGRF1;GRIN2B;NEFL;SPTBN5;WDR83;NRG4;IL18;RASGRP4;ITGAV;SPTBN1;UBA52;UBB;PSMC2;NRG2;SPTBN4;PSMA3;DLG4;NCAM1;TNF;PSMB2;DUSP6;LRRK2;FGFR2;PSMD5;PSMD7;MAP3K3;PTGER4
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.5504323478351775,0.8170078848838623,0.7777777777777778,1.0,1.0,1/6,6.24%,NUP133
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.4403389223085528,0.8169124529635323,0.6708860759493671,1.0,1.0,5/17,23.82%,PPOX;FLVCR1;ALAD;ATP5IF1;UROS
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.5397975328216612,0.8168692709053281,0.7777777777777778,1.0,1.0,1/6,7.58%,FCHO2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,-0.5159501671625657,-0.8167555007814017,0.7307692307692307,1.0,1.0,4/5,27.12%,JAG2;ADAM10;NOTCH1;JAG1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5473014895161499,0.8165258200259987,0.7945205479452054,1.0,1.0,4/6,42.91%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5473014895161499,0.8165258200259987,0.7945205479452054,1.0,1.0,4/6,42.91%,STAT1;JAK3;STAT5B;STAT5A
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,0.5473014895161499,0.8165258200259987,0.7945205479452054,1.0,1.0,4/6,42.91%,STAT1;JAK3;STAT5B;STAT5A
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.5489355000393964,0.8163177566449569,0.8208955223880597,1.0,1.0,2/5,28.64%,LRRK2;MIA3
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.2899032619026869,-0.8161602700381019,0.8333333333333334,1.0,1.0,8/84,10.94%,SCNM1;RP9;SNRNP35;KHSRP;SMU1;DDX23;IVNS1ABP;LSM6
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,-0.325839352869704,-0.8160521672366594,0.875,1.0,1.0,11/46,13.92%,TDRD10;GIMAP8;A2M;FOLR2;HLA-DPA1;PCDH12;LCP2;MMRN1;PLVAP;GIMAP4;GIMAP7
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.4440179406509492,0.815862890077662,0.7530864197530864,1.0,1.0,8/25,23.17%,VPS11;MICALL2;ARIH2;PINK1;ABLIM3;UBE2J2;RHOU;ATG13
prerank,KEGG_2021_Human__GnRH secretion,0.40791078227397726,0.8152628001067432,0.797752808988764,1.0,1.0,11/40,25.14%,GNA11;TRPC4;HCN1;KCNJ6;PLCB1;KCNJ3;GNAQ;GABBR1;PRKCB;TRPC1;CACNA1C
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.40493708574300485,0.8152204695655646,0.7471264367816092,1.0,1.0,12/55,27.37%,HMGB2;H2BC11;SMARCD3;ACTR6;SART3;SMARCC1;SMARCD2;H1-0;NASP;NAP1L2;SMARCA5;ARID2
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.5483304382828943,0.8150055235636142,0.7962962962962963,1.0,1.0,2/6,19.75%,UNC80;TRPM7
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.5163878758022282,0.8147700486129558,0.7464788732394366,1.0,1.0,1/7,14.63%,PYCARD
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.44965823889562717,0.8147043019764958,0.7865168539325843,1.0,1.0,7/26,19.36%,LSR;RPS27A;NCEH1;HDLBP;UBA52;UBB;AP2A2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.4026004202109752,0.8146468565736483,0.7692307692307693,1.0,1.0,11/57,19.04%,NUP133;PGAM1;INSR;HIF1A;PRKAG2;PFKFB4;FBP1;SEH1L;APP;PRKAA2;PPARA
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.45797719859160557,0.8146451728149463,0.7402597402597403,1.0,1.0,9/23,29.61%,SLC11A1;PICALM;SLC39A14;FBXL5;HFE;NEO1;TF;CUTC;HMOX1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4892064600887017,0.814467808436973,0.7808219178082192,1.0,1.0,2/12,10.93%,ZNF93;SMYD5
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.47766420131964704,0.8138107559243349,0.72,1.0,1.0,1/9,5.27%,HSPA5
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.3960047706524639,-0.8137232162681408,0.6666666666666666,1.0,1.0,6/8,23.66%,ALOX5;LTC4S;FADS1;ALOX5AP;MGST2;MGST3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.33855018149357263,-0.8136871516205029,0.8,1.0,1.0,4/23,8.12%,GAL3ST4;B4GALT7;IGF1;XYLT1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.3767772836855736,0.813549456051687,0.9,1.0,1.0,41/218,20.15%,BRIP1;ERCC2;PIAS4;RPA2;TDG;FANCB;MPG;ENDOV;WDHD1;DNA2;FANCM;FANCI;RPS27A;NEIL1;EME2;POLQ;HINFP;INTS3;DDX1;VCPIP1;BRCA1;XRCC3;NSMCE1;KDM4B;FAN1;RFC4;GTF2H3;ACTR5;POLE2;POLL;ERCC6;NEIL2;FANCL;ADPRS;FANCA;UBA52;UBB;MLH1;TIMELESS;NOP53;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3900858597831302,0.8135339466524366,0.7469879518072289,1.0,1.0,1/52,0.28%,THBS1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.48700785924508594,0.8134926739212958,0.7654320987654321,1.0,1.0,1/11,3.93%,SLC1A2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.4060105156099726,0.813436577095565,0.8297872340425532,1.0,1.0,9/80,10.33%,KLF4;ANKRD22;NFIB;RAB20;MARCKSL1;BHLHE40;FOSL2;ST14;MGAT1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.4991334764092342,0.8132595163582862,0.7733333333333333,1.0,1.0,5/11,22.83%,EPHA3;SEMA5A;EPHA4;CDK5R1;RTN4
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,-0.3770070888600515,-0.8131607560402202,0.6470588235294118,1.0,1.0,4/10,14.21%,TP53;PPP1R13B;ZNF385A;AKT1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29744913956071956,-0.813051472086315,0.7142857142857143,1.0,1.0,18/81,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.49004727859244235,0.812975854132003,0.7564102564102564,1.0,1.0,2/12,6.56%,NRG1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.48658343199173626,-0.8129267631193646,0.6923076923076923,1.0,1.0,1/6,16.72%,VEZF1
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.47951404274764353,-0.8126246221744396,0.6333333333333333,1.0,1.0,1/6,3.71%,SLC46A1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.34310401754679976,-0.8124238913721203,0.625,1.0,1.0,9/51,11.78%,TRIM38;PTAFR;ICAM1;HLA-E;IRF5;HCK;HLA-DPA1;FCGR1A;OAS2
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.3809876505595359,0.8122775659700923,0.8571428571428571,1.0,1.0,24/92,26.29%,TTBK2;MTMR7;BSN;SUGP2;CRAMP1;TRIM9;SPTAN1;CD99L2;CLASP2;DYNC1H1;NSF;NR2C2;ZBTB18;AP2A2;DLG4;CDS2;LENG8;TMEM170B;IQSEC1;RGL1;RUFY3;TF;PTPRA;SCAMP5
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.3312560788755108,-0.8122774550182037,0.9,1.0,1.0,6/43,8.38%,PSMB3;CCND1;PSME3;PSMC4;PSMD12;PSME4
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.3011500400546949,-0.8122507347393139,0.75,1.0,1.0,6/28,11.57%,WDR35;DYNLT2;KIF3B;TTC21B;IFT43;KIF3C
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.4669726216009647,0.8122421577343675,0.7066666666666667,1.0,1.0,5/12,22.92%,CEMIP;AKAP6;THY1;CX3CL1;TRPC1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3680175596010772,0.8121531316539036,0.9387755102040817,1.0,1.0,37/310,15.98%,NFIL3;ACVR1B;SAP30;TOM1L1;PQBP1;RORB;SOX4;TCF7;RBM3;APBB3;HINT1;INSR;HIF1A;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;BHLHE40;TCF7L1;MAFB;LIMD1;POU5F1;CELSR2;ZNF536;TULP3;SOX6;HCLS1;HINFP;RBM4B;DRAP1;YAF2;ZNF143;ACTR5;MLF2;ESR1;NR2C2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.44076936112446496,0.8120201330556065,0.813953488372093,1.0,1.0,3/28,4.09%,NUDT16;RNASEH2C;ENTPD3
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.2779380423970939,-0.8120102902777361,0.875,1.0,1.0,18/69,13.92%,TAL1;GIMAP8;MPEG1;FOLR2;CSF1R;ABI3;NCKAP1L;WDFY4;PLEK;HLA-DPA1;PCDH12;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.2779380423970939,-0.8120102902777361,0.875,1.0,1.0,18/69,13.92%,TAL1;GIMAP8;MPEG1;FOLR2;CSF1R;ABI3;NCKAP1L;WDFY4;PLEK;HLA-DPA1;PCDH12;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.2779380423970939,-0.8120102902777361,0.875,1.0,1.0,18/69,13.92%,TAL1;GIMAP8;MPEG1;FOLR2;CSF1R;ABI3;NCKAP1L;WDFY4;PLEK;HLA-DPA1;PCDH12;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.2779380423970939,-0.8120102902777361,0.875,1.0,1.0,18/69,13.92%,TAL1;GIMAP8;MPEG1;FOLR2;CSF1R;ABI3;NCKAP1L;WDFY4;PLEK;HLA-DPA1;PCDH12;LCP2;TYROBP;MMRN1;PLVAP;GIMAP4;SCARF1;GIMAP7
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.372541502402043,0.8119504385667636,0.94,1.0,1.0,59/332,18.14%,SOCS3;KLF4;PCDH17;VIM;SHANK3;CCPG1;TLE1;FKBP5;CREB5;INF2;RACGAP1;NFIB;MEIS2;FBXL7;ADAM15;PDK4;LAMB1;TUBB6;SLC41A3;ASAP2;SEMA6A;GRB10;CSRNP3;YEATS2;AKAP12;SPRY1;FN1;NARF;GALNT18;PDE4B;CRIP2;PRR5;NR2F1;RPS6KA2;SASH1;ETS2;GAB1;LIMCH1;FAM171A1;CDC37;TIMP3;PELI1;THY1;PIEZO2;POC5;LDB2;EDIL3;SMAP2;SPTBN1;SMAD1;EGLN3;HSPB1;MPDZ;APP;TSPAN18;TNFRSF1A;FLRT2;SCO1;DIMT1
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,0.41513964687784355,0.8118348995798634,0.8222222222222222,1.0,1.0,7/37,15.50%,SPARC;TNS1;PDE2A;CD93;FLT1;SHROOM4;ANGPT2
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,-0.3063361202592719,-0.8116876352343914,0.8571428571428571,1.0,1.0,15/83,15.23%,ZMYND11;PDIK1L;TMEM267;CHUK;PRELID3B;CBFB;MANEA;LYSMD3;ARMC1;DNAJB14;ATP11B;ABCD3;TRAM1;SLC10A7;HCFC2
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.4180090332513129,0.811582434479573,0.7241379310344828,1.0,1.0,4/29,18.81%,RPS27A;PRR5;UBA52;UBB
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.4638716694503663,-0.8115306042673395,0.71875,1.0,1.0,3/10,20.12%,OPHN1;CDC42;RAP2A
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.47744474625068345,-0.8112563862821731,0.6923076923076923,1.0,1.0,2/7,10.10%,DAGLB;PTGS1
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,0.36147640311690554,0.8111299200325722,0.898989898989899,1.0,1.0,45/191,25.45%,NR4A2;TFRC;NAPA;RGS1;SRGN;ARID5B;SCO2;RGS2;TRPS1;CALM3;ITGAE;ID2;RBPJ;MCL1;GFOD1;SPTAN1;TNFRSF1B;DRAP1;PKM;VMP1;CALCOCO2;PELI1;CASP3;GCNT1;IFI27L2;TBL1XR1;GBP2;SNX17;RHOH;FIBP;MTHFD1;CHST12;GPD2;TTYH3;ABCG1;ARHGAP9;GALM;PSMA5;MS4A6A;IL21R;NASP;RHBDD2;SLA;SEL1L3;TOX
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5037828102577141,0.8109376646557557,0.75,1.0,1.0,2/12,5.44%,CHI3L1;TRAF2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.48248467464946904,0.8108665632447114,0.7272727272727273,1.0,1.0,5/11,20.20%,SH3D19;TNFRSF1B;TIMP3;ROCK1;TNF
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3880090980600316,0.8108112483034342,0.8369565217391305,1.0,1.0,24/90,26.45%,ZDHHC15;VPS37C;AKAP6;TIMM13;NLGN1;TOMM20;PARD3;ZDHHC9;CDC37;SDCBP;RPL11;NACA;AQP11;HACL1;SRPRA;FBXO7;MFN2;SPCS3;TOMM40;MAN1A1;TIMM22;SRP54;ZDHHC7;ZDHHC18
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.3753994318162783,0.810799725856994,0.865979381443299,1.0,1.0,20/151,18.75%,HSPA5;TRAF2;EIF2AK3;SEC61B;HERPUD1;TUSC3;CKAP4;STT3B;RBX1;SEC24C;DNAJB2;PPP1R15A;MAPK10;HYOU1;SYVN1;UBE2J2;HSPA1B;SSR3;ERO1A;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.40203517462854294,0.8106876963913489,0.7692307692307693,1.0,1.0,9/36,25.12%,CLIP3;NLGN1;SGIP1;CALY;CD151;RAB21;HFE;GPC3;TF
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.4695950132071848,0.8106679294921162,0.7258064516129032,1.0,1.0,4/7,35.43%,SLAMF8;DUSP1;C5;PADI2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.3985752317649625,0.8106260483397352,0.782051282051282,1.0,1.0,6/50,17.45%,THBS1;NOD2;PYCARD;WNT5A;HSPB1;APP
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.3684445428562054,0.8105134757752283,0.98,1.0,1.0,103/564,22.15%,KLF4;NAMPT;MACC1;FGF1;ST18;TGFB2;EGR1;HMGB2;PLAC8;PFKM;NFIX;NR4A2;NFIB;NR4A1;MEIS2;SLC11A1;ACVR2A;BMPR1B;ASXL3;RORB;VEGFA;SOX4;IER5;RXRB;COPS5;HIF1A;HSF2;HCFC1;CSRNP3;ARNT2;RUVBL2;PAX8;FOSL2;SS18L1;ATAD2;RBPJ;RRP1B;RPS27A;KDM1A;POU5F1;PTOV1;PER1;CRTC3;NR2F1;NOD2;GABPB1;DCAF6;HCLS1;HINFP;CCNC;CSRNP2;RIPK2;NR4A3;BRCA1;DRAP1;ZNF143;PKD1;E2F7;DPF3;WNT5A;SMARCD3;ESR1;AKIRIN1;IL18;NR2C2;LDB2;TBL1XR1;EPAS1;LITAF;TXK;SMAD1;APP;KLF7;RGCC;ZBTB18;TNFRSF1A;UBA52;UBB;CDK9;PPARA;TAF7;FOS;PRDM15;SMAD5;PRPF6;KDM6B;PCGF5;BEX1;TNF;NR1D1;NPAS2;TCF4;FGFR2;SLC9A1;ATF3;CX3CL1;TNIP1;MTF1;STAT1;HNRNPU;PLAG1;SMARCD2;GNL3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.46119472356006935,0.8103468988630367,0.7466666666666667,1.0,1.0,2/14,12.09%,EEF1A2;SORBS1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.4656088502883773,0.8102514388296862,0.7014925373134329,1.0,1.0,3/13,16.93%,THBD;TXK;TEC
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.5452229766946619,0.8102349651031836,0.828125,1.0,1.0,1/5,12.55%,PRPS1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.36803124166141565,0.8101523093477834,0.98,1.0,1.0,101/599,21.09%,KLF4;CENPF;NFIL3;SAP30;RPL23;TGIF1;HMGB2;TLE1;NFIX;ZBTB16;NR4A2;NRG1;MEIS2;TSHZ3;PIAS4;RORB;PTPRK;ARID5B;VEGFA;ZNF93;SUV39H2;RUNX1T1;SFMBT1;RBFOX2;BMI1;HCFC1;ATP8B1;POU6F1;ZNF540;YEATS2;BHLHE40;TRPS1;KCTD1;ID2;LIMD1;RBPJ;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;PER1;IMPACT;NR2F1;MXI1;PRICKLE1;ZNF536;DEAF1;PPID;ETS2;HINFP;OTUD7B;FBP1;ZNF550;NR4A3;BRCA1;DRAP1;LANCL2;RLIM;YAF2;E2F7;SDCBP;DPF3;ZNF248;HIC2;WNT5A;UXT;ESR1;MTA3;NR2C2;LDB2;TBL1XR1;CTBP1;PLCB1;HAMP;BCL6;KLF7;FOXP1;ZBTB18;TAF9B;ZNF778;UBA52;EZH2;UBB;PPARA;TAF7;NKX6-2;CDK5R1;ZNF684;TIMELESS;NOP53;TNF;ENO1;NR1D1;BASP1;BCL11A;CDKN1B;FGFR2;MTERF3;CBX5;ATF3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.40679984891723386,-0.8101501813257952,0.7307692307692307,1.0,1.0,3/11,12.07%,TP53;TGFB1;EGFR
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,-0.46393423136636247,-0.810125308509913,0.7352941176470589,1.0,1.0,1/9,1.76%,RHOG
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,0.4067486965701457,0.8099457138891698,0.7816091954022989,1.0,1.0,5/40,12.08%,CD163;VEGFA;FCGR2B;FCGR2C;THBD
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.40298735568394506,-0.8099446778157486,0.7307692307692307,1.0,1.0,1/11,0.55%,MEI4
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.41878191407914456,0.8098880276422838,0.8,1.0,1.0,8/34,17.45%,EGR1;ALOX15B;IL7;HIF1A;PYCARD;WNT5A;IL18;APP
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.45364185435693616,0.8098156038364074,0.7432432432432432,1.0,1.0,2/15,13.85%,SNX10;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.3086549985806449,-0.8097656333528105,0.8,1.0,1.0,5/28,10.62%,AZIN2;APH1A;CHTOP;SSBP1;ABL1
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.43006874444970766,0.8097125310467632,0.7631578947368421,1.0,1.0,3/25,17.70%,HSPA5;SEC24C;PIK3R4
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.37397889670863715,0.8096706396282773,0.8888888888888888,1.0,1.0,18/198,11.33%,FGF1;EGR1;PREX2;PPP2R5B;PIGU;NRG1;NR4A1;KITLG;PHLPP1;PPP2R5A;RPS6KB2;INSR;IRS2;RPS27A;KDM1A;PRR5;PSMB4;NRG3
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.39060424303918545,0.809467514664797,0.8469387755102041,1.0,1.0,22/95,20.62%,EGR1;VGF;PIGU;KCNH8;SH3GL3;ID2;DNM3;SHC2;IRS2;NTRK3;DNM1;RPS6KA2;NTRK2;SH3GL2;GRIN2B;NELFB;PCSK6;CDK5R1;AP2A2;FOS;DUSP6;PTPRS
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.519717005670911,0.8094400485051672,0.7375,1.0,1.0,1/6,3.65%,OSMR
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5329156016139076,0.8094314779492134,0.8115942028985508,1.0,1.0,3/8,13.77%,KDM3A;KDM1A;KDM4B
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.3175422016434202,-0.8091051229762715,0.8235294117647058,1.0,1.0,5/36,10.83%,NUP42;BANF1;NUP155;NUP188;NUP214
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.41091326792396715,0.8088376010720348,0.7974683544303798,1.0,1.0,9/33,27.66%,FKBP5;DYNC1H1;HSPA1B;DCTN1;HSPA2;DYNC1I1;DYNLL1;HSP90AB1;HSPA8
prerank,KEGG_2021_Human__Arginine biosynthesis,0.4858993140073634,0.8088291411701608,0.717948717948718,1.0,1.0,2/8,12.52%,GLUL;ARG2
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,-0.41568454371741015,-0.8088141733967155,0.6551724137931034,1.0,1.0,1/6,2.72%,MAF
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,0.5208485628816575,0.8086621652163634,0.75,1.0,1.0,2/6,37.51%,PLA2G4A;HADHA
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.2529953117079209,-0.8085559290488827,1.0,1.0,1.0,26/131,14.48%,TICAM1;CCND1;PIK3R6;CHUK;C3;ICAM1;ITPR2;MAPK13;TP53;KRAS;BID;CD200R1;TLR3;NFATC3;SRC;HLA-E;EP300;HCK;IKBKB;NFKBIA;PPP3CC;SYK;MAPKAPK2;AKT1;PIK3R5;IL6ST
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4372490097500223,0.8085301640561285,0.7808219178082192,1.0,1.0,10/18,29.19%,CAMK2N1;EPHA4;SERPINE2;TIMP3;ROCK1;LRRK2;CSTB;BAG6;SNX12;PRNP
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.37697572759542325,0.8084337582866096,0.8350515463917526,1.0,1.0,15/100,13.83%,CLEC4E;CLEC12A;CD163;SLC11A1;ADGRE1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2;PLTP;TNFRSF1B;STARD5;CD300A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.47475485460544276,0.8084122382708847,0.6956521739130435,1.0,1.0,4/8,27.13%,TMEM39A;TNF;IRAK3;UBQLN4
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.5366012337790155,0.8083863584646254,0.75,1.0,1.0,5/6,45.77%,PRNP;HSF1;DAXX;SNCA;MT2A
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.5026497765639166,0.8083800250540919,0.71875,1.0,1.0,2/8,20.32%,THBD;NR1D1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.5020517514497553,0.8083327996939443,0.68,1.0,1.0,1/10,1.96%,CBR1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.5436506408403299,0.8082876462274673,0.7727272727272727,1.0,1.0,4/6,33.67%,TFIP11;DCLRE1C;RIF1;TERF2IP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,0.49959811008455846,0.8081681028453483,0.7794117647058824,1.0,1.0,6/9,27.24%,POU5F1;THY1;NCAM1;DCLK1;GPC3;CTNNB1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.4546402912093337,0.8080890432688913,0.775,1.0,1.0,2/14,15.55%,ALOX12;LTA4H
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.5202605031204295,-0.8080401342767839,0.7027027027027027,1.0,1.0,3/6,14.21%,CCND1;EGFR;AKT1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.36804002077962444,-0.807970677258396,0.6571428571428571,1.0,1.0,1/9,1.36%,BTN3A2
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.5110872520993311,0.8079370649654201,0.7605633802816901,1.0,1.0,3/7,29.84%,XRCC3;SLX4;BLM
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.3797906651641276,0.8078772164535584,0.813953488372093,1.0,1.0,7/50,17.39%,NAPA;SEC24C;MCFD2;NSF;TMED10;TRAPPC6B;GRIA1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.5018421870525813,0.8078664738193838,0.7647058823529411,1.0,1.0,1/7,12.23%,NFKBIZ
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,0.35706243979151064,0.8074940057957601,0.92,1.0,1.0,51/341,20.42%,CRISPLD2;ALDH3B1;NDUFA2;CLEC12A;CR1;PLAC8;SLC2A3;CHI3L1;SLC11A1;CD55;DGAT1;GNS;ACTR1B;SNAP25;GSDMD;FGR;MGAM;CKAP4;C5AR1;CD93;SPTAN1;ARSA;FGL2;DYNC1H1;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;CD300A;HOOK3;MAGT1;ENPP4;PYCARD;SDCBP;LTA4H;ITGAV;IQGAP1;ROCK1;HSPA1B;GSTP1;FTH1;ALAD;PRDX4;PSMC2;AP2A2;SYNGR1;SURF4;PGM1;SELL
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.2808081037053482,-0.8074732571810866,0.8333333333333334,1.0,1.0,22/67,19.28%,KLRC4-KLRK1;GZMB;ICAM1;HCST;KRAS;BID;FYN;TNFSF10;HLA-E;ITGB2;LCP2;PPP3CC;TYROBP;PRF1;SYK;CD247;FAS;PRKCA;ITGAL;SH3BP2;PLCG2;PTPN6
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.5130455025590507,0.8073806081533805,0.8194444444444444,1.0,1.0,1/11,3.57%,TFRC
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.4800934692334059,0.8070201145897618,0.7866666666666666,1.0,1.0,4/11,18.81%,SEPSECS;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5002943268358784,0.8068463284453569,0.8088235294117647,1.0,1.0,1/8,20.52%,CPEB4
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.3871964760088976,0.8067869121679649,0.8260869565217391,1.0,1.0,19/60,24.06%,VEGFA;HIF1A;LIMD1;RPS27A;PSMB4;RBX1;HIF3A;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;UBE2D2;PSMD14;PSMA5
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.3903466460942439,0.8067836758091235,0.8526315789473684,1.0,1.0,14/76,19.39%,ARAF;PRKCE;ADCY3;AGT;GNA11;CALM3;KCNMB1;ADCY8;GUCY1B1;KCNMA1;PLCB1;ROCK1;GNAQ;GUCY1A2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.5140091775700069,-0.8067771109926258,0.6904761904761905,1.0,1.0,2/5,8.99%,PHF8;KDM7A
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3854963877914351,0.8066627971646405,0.8350515463917526,1.0,1.0,7/77,7.17%,RHOBTB3;RHOB;MAPT;GPM6B;EPHA3;STMN3;RND3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.5191668993689843,0.806602135659514,0.7121212121212122,1.0,1.0,1/5,12.87%,BRCA1
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,-0.43189457578631674,-0.8065354837752208,0.7142857142857143,1.0,1.0,2/6,10.29%,ARHGAP35;SEMA4D
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.3781328661259996,0.8064230683070472,0.8585858585858586,1.0,1.0,23/106,19.53%,CACNB2;ADCY3;GNAO1;RGS2;CALM3;RYR2;CACNG2;CACNA2D3;ADCY8;CAMK2B;PRKAG2;RYR3;GNAI1;GUCY1B1;KCNJ6;CACNG8;PLCB1;ROCK1;PRKAA2;KCNJ3;GNAQ;GUCY1A2;FOS
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.530664465449248,0.8064062098000886,0.7391304347826086,1.0,1.0,3/7,23.89%,ARF6;EPB41L4B;IQSEC1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5023544548198509,0.8059760225222217,0.7971014492753623,1.0,1.0,3/9,15.06%,DEAF1;SULF2;WNT5A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.38298083590217114,0.8059362625260296,0.8172043010752689,1.0,1.0,21/70,24.06%,VEGFA;HIF1A;LIMD1;RPS27A;IMPACT;PSMB4;RBX1;HIF3A;BAG3;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;ATF3;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.4192154016391165,0.8058391053047294,0.8354430379746836,1.0,1.0,6/38,12.42%,PIGU;PTPRK;SH3GL3;SPRY1;RPS27A;SH3GL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5316511762337894,-0.8057353113397571,0.8076923076923077,1.0,1.0,2/5,7.51%,EFNB2;TGFB1
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3220634945964795,-0.8057309581199971,0.9166666666666666,1.0,1.0,6/34,13.88%,NUP42;NUP155;NUP188;NUP214;RAE1;XPOT
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.37985785963156776,0.8057258091388227,0.8315789473684211,1.0,1.0,32/103,32.04%,GEMIN2;RPL38;RPL23A;CELF2;RPS27;DDX1;RBM5;MRPL20;SHQ1;RPL11;POLR2D;SART3;PRPF6;NOP53;SRSF5;SNRPD2;RPL24;RPL3;EIF3A;TRAF7;SRSF9;CPSF6;HSP90AB1;DICER1;RPL6;RPLP0;PRKDC;DHX29;MRPS7;PRPF19;MDN1;DHX9
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.2691823969367478,-0.8056891705496445,1.0,1.0,1.0,12/117,10.05%,RING1;NEDD4;PSMB3;PSME3;GATAD2B;PSMC4;TP53;PSMD12;PSME4;LAMTOR1;AGO1;OTUD3
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,0.4076478801370357,0.8053432841911243,0.7840909090909091,1.0,1.0,14/42,28.96%,TFRC;DNAJC6;SH3D19;SH3GL2;PICALM;FTH1;HIP1R;SORT1;AP3B1;AP3S1;GOLGB1;IGF2R;HSPA8;TPD52L1
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.2996527460995878,-0.8053317190512786,0.875,1.0,1.0,13/68,15.17%,PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;RASGRP2;IKBKB;NFKBIA;PSMA1;BCL10;CARD11;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4513260582639552,0.8051919978481628,0.8235294117647058,1.0,1.0,5/27,17.10%,GLA;ABCA2;CLK2;BRCA1;ERLIN1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.428300682775042,0.80512356861751,0.7647058823529411,1.0,1.0,7/34,18.28%,AGT;BMI1;FN1;CD300A;WNT5A;GSTP1;FTH1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.43864618742473815,-0.8050616030815207,0.696969696969697,1.0,1.0,1/10,2.51%,CCND1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.37233733710296396,0.8050099173294634,0.8686868686868687,1.0,1.0,32/113,23.75%,KLF4;NLRP12;IL15;AGT;ANXA1;CASP5;PDE2A;GPRC5B;NOD2;TYRO3;NFKBIZ;TNFRSF1B;WNT5A;IL18;NAPEPLD;BCL6;APP;FOXP1;MACIR;TNFRSF1A;PPARA;LRFN5;TNF;NR1D1;CX3CL1;TNIP1;PDCD4;PTGER4;RORA;CASP1;TRADD;GPS2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.38884802484095543,0.8048288404137591,0.7912087912087912,1.0,1.0,19/69,20.83%,CACNB2;GRIN3A;SLC24A2;ANK2;RYR2;TRPC4;CACNA1B;SLC24A1;NALCN;RYR3;PKD1;ATP2A2;SLC24A3;CACNA1A;ITGAV;CACNG8;TRPM7;SLC3A2;SLC24A4
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5046973671703978,0.8045418888259502,0.7605633802816901,1.0,1.0,2/8,14.48%,RBX1;UBE2M
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.34232721814593015,-0.8045232881242154,0.8214285714285714,1.0,1.0,4/21,8.31%,PSME3;STXBP4;APPL2;PHB2
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.2916774686420457,-0.804359677764155,0.9,1.0,1.0,6/49,8.38%,PSMB3;PSME3;PSMC4;TP53;PSMD12;PSME4
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.45540772965806825,0.804351681578994,0.6835443037974683,1.0,1.0,3/14,14.11%,CD163L1;AKR1B1;HSD17B12
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.5066267631711266,0.8043053518055253,0.7692307692307693,1.0,1.0,3/8,22.68%,AKR1B1;CYP46A1;TSPOAP1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2893760454554652,-0.8039652676716389,0.8,1.0,1.0,19/85,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;ENY2;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.5439257108138502,0.8038064270378334,0.7758620689655172,1.0,1.0,1/6,6.35%,GALNT13
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.5094458775213644,0.8034130381840667,0.7666666666666667,1.0,1.0,1/5,5.78%,SEC61B
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.4947548832584717,-0.8033714751318013,0.75,1.0,1.0,2/5,9.94%,ELAVL4;METTL16
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.3917956757989317,0.8033160774709781,0.75,1.0,1.0,12/39,26.87%,ADCY3;SEC61B;ERO1A;ATP6V0B;ATP6V1B2;TJP1;ATP6V0E2;PRKACB;ATP6V1D;CFTR;KDELR1;ATP6V1E2
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.48683528643478585,0.8031942976553291,0.6721311475409836,1.0,1.0,2/7,15.03%,EPHA4;PICALM
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,0.4869658437661888,0.8030413871584291,0.7466666666666667,1.0,1.0,1/9,2.44%,DCC
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.37705303902344395,0.8029066793153612,0.8979591836734694,1.0,1.0,18/142,18.00%,TUBA4A;PRKAR2B;HAUS6;TUBB4A;TTBK2;CEP152;TUBA1A;DYNC2LI1;NPHP1;ATAT1;IFT74;DYNC1H1;CKAP5;PKD1;TCP1;CC2D2A;KIF3A;DCTN1
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.3150922337251419,-0.8028797042735745,0.7272727272727273,1.0,1.0,8/54,12.38%,NUP42;H2BC4;NUP155;AGO1;NUP188;NUP214;H2BC26;POLR2C
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4395103622724196,0.8028474016884775,0.7901234567901234,1.0,1.0,4/24,12.86%,CLIP3;ZDHHC15;GLUL;ZDHHC9
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.4662200075856347,0.8027910750665732,0.7297297297297297,1.0,1.0,2/16,9.95%,ACSL1;ELOVL4
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.4938436780353307,0.8026347433642587,0.7428571428571429,1.0,1.0,5/9,22.90%,DUSP10;AIDA;GSTP1;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.4524363854079256,0.8023862290593168,0.7866666666666666,1.0,1.0,3/14,8.46%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.44377189052487026,0.8023343237813649,0.7341772151898734,1.0,1.0,7/22,22.12%,PTPRK;FN1;SORBS1;THY1;PLEC;CD151;CTTN
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.360327821046195,-0.8023090455321028,0.8666666666666667,1.0,1.0,5/24,10.83%,NUP42;CCHCR1;TGFB1;SMURF1;NUP214
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,0.5211496992534825,0.8022278961647692,0.8028169014084507,1.0,1.0,3/7,14.58%,BMI1;POU5F1;ALDH1A1
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.30228990457420063,-0.8022104601396165,0.8888888888888888,1.0,1.0,6/44,8.38%,PSMB3;PSME3;PSMC4;TP53;PSMD12;PSME4
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,0.5017249477497845,0.8022002920966625,0.8095238095238095,1.0,1.0,4/12,22.70%,RPS27A;UBA52;UBB;ITGB3BP
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3959682932018753,0.8020800120731861,0.8105263157894737,1.0,1.0,8/73,12.50%,RBM3;RBFOX2;PCBP4;SRSF12;CELF2;KHDRBS2;NOVA1;RBM5
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,-0.39708776562671205,-0.80202926065239,0.6923076923076923,1.0,1.0,4/10,22.37%,TLR3;TLR7;CNPY3;UNC93B1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.3760818437025495,0.8019839969613459,0.8969072164948454,1.0,1.0,5/140,6.24%,TOP2A;NR4A2;PIAS4;TDG;NUP133
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5429904665275583,0.8015073167447943,0.8405797101449275,1.0,1.0,1/5,12.62%,VCPIP1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.48443423552412423,0.8014054936804514,0.7681159420289855,1.0,1.0,1/8,10.65%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.48443423552412423,0.8014054936804514,0.7681159420289855,1.0,1.0,1/8,10.65%,ERI2
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.44644345629906257,0.8013878464645726,0.7972972972972973,1.0,1.0,3/15,8.96%,PPOX;FLVCR1;BLVRB
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.3662966105099503,0.8013178441179922,0.8484848484848485,1.0,1.0,4/119,3.57%,DIAPH3;PREX2;RACGAP1;TFRC
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.3284878879945533,-0.8012908794555621,0.8260869565217391,1.0,1.0,2/13,9.74%,NFYC;EP300
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.34573703390647875,-0.801182873180874,0.8421052631578947,1.0,1.0,2/16,7.64%,PSME3;APH1A
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.4140997249192872,-0.8011163570246048,0.6666666666666666,1.0,1.0,2/10,8.88%,NCOA4;SERPINB9
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.5121820784142969,0.8010895160299186,0.8113207547169812,1.0,1.0,3/6,27.75%,NHP2;METTL4;DKC1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.3776208455768946,0.801037202037659,0.7555555555555555,1.0,1.0,20/55,29.61%,EIF2AK3;SEC61B;VAPB;VCPIP1;SERP1;REEP3;UBE2J2;APP;RTN3;REEP2;LRRK2;BNIP1;RTN4;VAPA;TMEM33;MIA3;PRNP;SEC31A;REEP1;HMOX1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3054686563337891,-0.8010076352941344,0.9,1.0,1.0,13/51,16.58%,GTF2H5;GTF2H2;UBTF;CPSF1;LSM11;WDR33;TTF1;SNRPB;CSTF1;CPSF2;CPSF4;TTF2;POLR1F
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.45582295851275045,0.8009583360120318,0.7142857142857143,1.0,1.0,3/12,22.42%,HPRT1;GUK1;VAV3
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3983676223534774,0.8009119251405553,0.7956989247311828,1.0,1.0,10/43,20.85%,CBR1;ANXA1;VEGFA;OVOL2;CPT1A;E2F7;KDM6B;PGK1;BASP1;FGFR2
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,0.3830845060445085,0.8006330284907877,0.7659574468085106,1.0,1.0,10/70,16.48%,NLRP12;CLEC12A;CR1;SLC11A1;FGR;C5AR1;GPR65;CD300A;RASGRP4;LRRC25
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,0.49398015634400716,0.800582322110757,0.8055555555555556,1.0,1.0,1/8,11.27%,CAMK2B
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3802076604217805,0.8004428219899677,0.851063829787234,1.0,1.0,25/98,24.35%,HMGB2;H2BC11;ERCC2;RPA2;RPS27A;PSMB4;RBX1;CENPV;GTF2H3;ORC6;SART3;UBA52;UBB;PSMC2;PSMA3;PSMB2;TCF4;DDB1;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.39752914888303476,0.8004090554042275,0.8072289156626506,1.0,1.0,9/53,22.91%,TGFB2;ARF6;APBB3;PPID;TMED10;ACSL3;TNF;CHP1;ABCG1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.3411344522604589,-0.8003900198820113,0.7083333333333334,1.0,1.0,3/11,11.12%,WDR35;TTC21B;IFT43
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.2906860541830622,-0.800295747309902,0.8571428571428571,1.0,1.0,19/85,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;ZFP36;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.3785733731720578,0.8001916904517091,0.7684210526315789,1.0,1.0,18/62,22.53%,NLRP12;IL15;AGT;POLR3F;PDE2A;GPRC5B;NFKBIZ;WNT5A;IL18;NAPEPLD;APP;TNFRSF1A;TNF;NPAS2;CX3CL1;TNIP1;PDCD4;PTGER4
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.28944322539588874,-0.800186206227156,1.0,1.0,1.0,5/46,14.23%,MYH9;KIF3B;EXOC7;AKT1;RAB4A
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.28649614919320476,-0.7998173395983844,1.0,1.0,1.0,6/46,8.38%,PSMB3;PSME3;PSMC4;TP53;PSMD12;PSME4
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.3624114089357546,0.7997898215103623,0.9494949494949495,1.0,1.0,29/207,18.00%,TUBA4A;PRKAR2B;HAUS6;DZIP1;TUBB4A;LRGUK;TTBK2;CEP152;RFX2;TUBA1A;DYNC2LI1;NPHP1;ATAT1;CCDC39;RP2;IFT74;CFAP54;DYNC1H1;CKAP5;SNX10;SNAP29;PKD1;ABLIM3;TOGARAM1;TXNDC15;CC2D2A;KIF3A;MACIR;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.38160003806925746,-0.799788040780286,0.7241379310344828,1.0,1.0,4/16,11.22%,CHUK;TLR3;IRF5;TLR7
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4422389011547314,0.7996762340770427,0.8235294117647058,1.0,1.0,1/31,1.81%,CENPE
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.40810258461895704,0.7995480472710461,0.7692307692307693,1.0,1.0,11/47,18.58%,PRKCE;ARF6;BAIAP2L1;CARMIL1;NTRK3;SEMA5A;HCLS1;DYNC1H1;PYCARD;FES;GPSM2
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,-0.45078509623982366,-0.7994860349831421,0.6764705882352942,1.0,1.0,2/5,22.90%,PI4KA;MTMR2
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.3706086575653301,0.7989705921550745,0.8526315789473684,1.0,1.0,6/99,5.61%,GPR18;NAPSB;CR1;CD22;LINC00926;FCGR2B
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.28566916521248187,-0.7989365851916288,1.0,1.0,1.0,7/53,8.38%,PSMB3;PSME3;DAB2IP;PSMC4;PSMD12;RASAL3;PSME4
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.5177626312277867,-0.7988434127077133,0.7428571428571429,1.0,1.0,1/5,6.50%,TP53
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.47386535826468024,0.7987913094364761,0.8148148148148148,1.0,1.0,2/18,6.47%,SMC4;NCAPH2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.4261785234161088,0.7986975950299361,0.7560975609756098,1.0,1.0,1/26,0.80%,SLC38A4
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.4556932701965552,-0.7986094692761323,0.6428571428571429,1.0,1.0,4/9,15.20%,NPL;GNPDA1;ST6GAL1;NAGK
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.521560294020406,0.798605591962705,0.828125,1.0,1.0,1/7,1.95%,DPYD
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.31221875112887354,-0.7985471187656247,0.8235294117647058,1.0,1.0,8/29,12.43%,TICAM1;LILRB4;APPL2;SIRPA;ALOX5;IL17RA;TREM2;CHID1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.4837710791585241,0.798447726454498,0.8088235294117647,1.0,1.0,1/11,8.14%,ROBO1
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.45876500163674444,-0.7982577992329054,0.6428571428571429,1.0,1.0,3/6,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.45876500163674444,-0.7982577992329054,0.6428571428571429,1.0,1.0,3/6,15.72%,ABHD17A;ABHD10;LYPLA1
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.3819915741264681,0.7982157414022006,0.8571428571428571,1.0,1.0,27/80,28.76%,MBOAT2;DGAT1;MFSD2A;SELENOI;OSBPL10;SLC44A5;PEMT;PNPLA8;ETNPPL;PLD3;DDHD1;CHPT1;SLC44A1;OSBPL5;CDS2;GPAT4;GPD2;CPNE3;LPCAT4;MBOAT7;PCTP;PRKCSH;PGS1;LPGAT1;LPCAT1;OSBPL8;AGK
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,0.49300190874058536,0.7980859375904328,0.8142857142857143,1.0,1.0,1/10,11.27%,CAMK2B
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.3837363234271359,0.7977698869130382,0.8787878787878788,1.0,1.0,21/119,23.25%,BRIP1;PDZD2;PPP1R13L;DNA2;RPS27A;PRR5;TTC5;PRKAG2;BRCA1;RFC4;PRKAA2;TAF9B;UBA52;UBB;TAF7;CDK5R1;MEAF6;RBBP8;SETD9;BARD1;RPA3
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.4313308767583164,0.7976339903329421,0.7142857142857143,1.0,1.0,7/25,16.31%,PPP2R5A;NSMF;CALM3;MAGI2;CD300A;PPP1R15A;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5173269410647421,0.7975634065336533,0.75,1.0,1.0,2/5,29.94%,TNIP1;WDR48
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,-0.3199437454001446,-0.7975573511232346,0.8461538461538461,1.0,1.0,6/17,11.55%,MSANTD2;FCGBP;ZBTB24;MYO1F;SRP72;GSN
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.38178611824713965,-0.7975384533723833,0.7142857142857143,1.0,1.0,4/17,7.34%,LGALS9;LILRB4;CD274;IGF1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.48316860720115773,0.7974750481289443,0.75,1.0,1.0,2/11,12.34%,PLK2;INTS3
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.44165110188435014,0.7973977533497074,0.8311688311688312,1.0,1.0,6/21,19.88%,ARID5B;KDM3A;KDM1A;KDM4B;KDM5B;KDM6B
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3703764099985946,-0.7972528265365231,0.6538461538461539,1.0,1.0,3/16,8.55%,ZNF675;LILRB4;TLR3
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.4661063600086294,0.7972193300114104,0.7763157894736842,1.0,1.0,3/11,15.35%,ABCA2;ST6GALNAC5;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.48453834313482763,0.7970034267626636,0.7105263157894737,1.0,1.0,2/10,17.10%,BRCA1;ERLIN1
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.31842175125310773,-0.7968590101883586,0.7857142857142857,1.0,1.0,5/40,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.4954961526416994,0.7967926389327744,0.7945205479452054,1.0,1.0,4/11,22.29%,SVIL;IGSF8;ZBTB18;MYL6
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.33296741702817034,-0.796790137510156,0.85,1.0,1.0,4/26,11.60%,NT5C3B;DCP1B;LSM6;EDC3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4083287542334901,0.7967542469750842,0.7974683544303798,1.0,1.0,5/30,19.61%,FANCM;EME2;DONSON;CDK9;TIMELESS
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.44348974665888885,-0.7966688180089001,0.7435897435897436,1.0,1.0,3/7,14.39%,RPUSD3;RPUSD4;GAR1
prerank,KEGG_2021_Human__Chagas disease,-0.295326237378945,-0.796580027237444,0.6666666666666666,1.0,1.0,10/75,8.58%,CCL5;TICAM1;IL1B;CCL3L3;CHUK;IRAK4;C3;MAPK13;TGFB1;GNAS
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4109691818671012,-0.7965494358707803,0.6538461538461539,1.0,1.0,5/11,19.64%,STXBP4;PHB2;KLHL18;PLCG2;CUL3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.4809666558856638,0.7965427557328759,0.7702702702702703,1.0,1.0,1/11,6.33%,PGAM1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.42096629897267124,0.7964772760959627,0.7752808988764045,1.0,1.0,5/31,9.76%,PRKCE;ARF6;BAIAP2L1;SPIRE2;CARMIL1
prerank,Reactome_2022__Purine Salvage R-HSA-74217,-0.4369854562205599,-0.7964084996434879,0.6785714285714286,0.9996477005679975,1.0,3/7,12.57%,ADK;DGUOK;AMPD3
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.5069501339711979,0.7961381064498237,0.8,1.0,1.0,1/8,2.53%,PRKCE
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.3959461404519145,-0.7960832432478127,0.6818181818181818,0.9996215799827362,1.0,1/9,6.51%,RAPGEF6
prerank,KEGG_2021_Human__Salmonella infection,0.3617852244480106,0.7960135953740508,0.92,1.0,1.0,47/199,23.68%,RHOB;RAB7B;TUBA4A;TUBB4A;ARF6;TUBA1A;TRAF2;TCF7;TUBB6;ACTR1B;VPS11;TCF7L1;DYNC2LI1;TXN;GSDMD;CASP5;DYNC1H1;RIPK2;CYCS;KLC4;AHNAK;PYCARD;MAPK10;TUBB2A;CASP3;KIF5A;IL18;TNFRSF1A;DCTN1;TUBA1C;RHOH;FOS;TNF;DYNC1I1;EXOC5;KIF5C;PAK3;HSP90B1;DYNC2H1;FYCO1;RAB5A;TUBA1B;JUN;CASP1;TLR5;TRADD;CSE1L
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.33515753392467423,-0.7959597979358612,0.7916666666666666,0.9991686155988654,1.0,7/21,19.26%,TRIB1;NMI;ILRUN;TRAFD1;LILRA2;SIGIRR;NLRC3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.3959769627375085,0.7956831653104857,0.8241758241758241,1.0,1.0,4/49,6.80%,THBS1;GPM6B;ADAM15;EPHA3
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.4065809788527779,0.7956621472463196,0.7738095238095238,1.0,1.0,7/24,27.83%,PQBP1;IFNLR1;AIM2;STAT1;TRAF3IP2;MICB;PARP9
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.44332596978407646,0.7956510799838113,0.8,1.0,1.0,4/22,15.93%,GALNT8;GALNT13;B4GALT5;GCNT1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5231943384731936,0.795429270862014,0.7866666666666666,1.0,1.0,2/7,14.99%,SLC1A2;DISP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5231943384731936,0.795429270862014,0.7866666666666666,1.0,1.0,2/7,14.99%,SLC1A2;DISP1
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,0.4978370119538206,0.7953488173576202,0.7162162162162162,1.0,1.0,2/8,22.86%,WNT5A;JUN
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.3856234754209758,0.7952816190062051,0.8172043010752689,1.0,1.0,9/92,10.46%,PIANP;TGFB2;IL15;CD22;CLEC2B;FCGR2B;FGR;SPPL2B;FCGR2C
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.47164116508509707,0.7952570081755246,0.72,1.0,1.0,6/15,21.72%,CYP3A5;SLC5A9;FMO5;GIPC2;GBA3;SLC26A3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,0.5369013674015638,0.795254527206049,0.835820895522388,1.0,1.0,2/5,16.36%,THY1;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5068801739306741,0.7952472911662939,0.7808219178082192,1.0,1.0,1/8,2.53%,PRKCE
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.5454793035969361,0.7952201923543789,0.7719298245614035,1.0,1.0,2/5,38.48%,NIPBL;XRCC6
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,0.517056807592581,0.7948032123054728,0.8289473684210527,1.0,1.0,1/7,6.57%,ACSS3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.4481831650708462,-0.7947903406081007,0.6666666666666666,1.0,1.0,3/7,18.63%,SERPINB9;RNF213;RAB7A
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.434544357716451,0.7947205128146484,0.7662337662337663,1.0,1.0,2/17,7.66%,CYP3A5;ARNT2
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5495273928660667,0.7945636905164764,0.8253968253968254,1.0,1.0,1/5,8.90%,BOK
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.49955622217274687,0.7943431966923276,0.7910447761194029,1.0,1.0,1/8,5.64%,EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.38988073500832315,-0.7943055924330875,0.7142857142857143,1.0,1.0,4/15,11.73%,DAB2IP;B4GALT7;TP53;SKI
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,0.5235785840279801,0.7942600917874302,0.7868852459016393,1.0,1.0,3/5,20.53%,DUSP10;DUSP16;DUSP6
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.3908961188137491,0.7942166363334819,0.8666666666666667,1.0,1.0,18/86,21.78%,CENPE;RACGAP1;KIF15;KIF1B;KIF21A;ARFGAP1;DYNC1H1;NSF;KLC4;KIF11;KIF5A;KIF3A;DCTN1;SURF4;DYNC1I1;NAPG;KIF5C;BNIP1
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,-0.37440206473235216,-0.7941168168033219,0.7777777777777778,1.0,1.0,2/8,18.21%,SENP1;SENP5
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.47439729110808804,0.7940428111996463,0.7681159420289855,1.0,1.0,3/12,14.73%,PRLR;GHR;OCIAD1
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.3792712215262335,0.7934283566977988,0.8686868686868687,1.0,1.0,17/91,21.01%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT;IRAK3
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.3195384502840562,-0.7933584007280767,0.6923076923076923,1.0,1.0,7/44,10.32%,MYH9;CEBPA;LGALS9;CSF1R;THOC5;EP300;TREM2
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.4400997942291519,0.793100502160513,0.7236842105263158,1.0,1.0,8/16,33.36%,SPAST;UBXN2B;DCTN1;CHMP7;NSFL1C;NEMP1;TARDBP;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.39421492834806854,0.7930411077621958,0.7792207792207793,1.0,1.0,5/25,14.87%,SPOCK1;AGT;SPOCK3;SERPINE2;TIMP3
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),0.5235448261135702,0.7930005769569484,0.7397260273972602,1.0,1.0,2/5,37.51%,PLA2G4A;HADHA
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.48449500315343236,-0.7928642590301518,0.7105263157894737,1.0,1.0,2/6,19.93%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.48449500315343236,-0.7928642590301518,0.7105263157894737,1.0,1.0,2/6,19.93%,GTF3C2;GTF3C3
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.4057614987075283,-0.7926833512450585,0.6333333333333333,1.0,1.0,1/10,1.54%,PEX13
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.39528978583106095,0.7924628235751765,0.7777777777777778,1.0,1.0,6/32,9.79%,THBS1;ITGA2;COL23A1;FN1;ITGAE;ITGB8
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.4580985221585944,-0.7923186948843045,0.6829268292682927,1.0,1.0,1/5,12.50%,SORL1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.42271975815460394,-0.7921430669187791,0.7575757575757576,1.0,1.0,1/10,1.50%,INPP5K
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,-0.39944819388777286,-0.7919706344553741,0.7241379310344828,1.0,1.0,4/10,14.14%,TLN1;SRC;APBB1IP;RAP1A
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.39891645059665765,-0.7919262116830633,0.7857142857142857,0.999427078077905,1.0,4/14,7.96%,TP53;ZNF420;BID;PPP1R13B
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,-0.4727157340523715,-0.791899074358351,0.7096774193548387,0.9988364624316148,1.0,1/6,2.67%,CD2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.41584518522570585,0.7917248097485805,0.7738095238095238,1.0,1.0,6/26,14.63%,NDRG1;HINT1;BOK;ZNF385B;E2F7;PYCARD
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.3661136297328731,0.791480241805111,0.9042553191489362,1.0,1.0,22/120,21.94%,VIM;TBRG4;RIDA;SLC11A1;NOCT;CARHSP1;PCBP4;XPO1;TENT5A;RPS27A;PSMB4;ROCK1;HSPB1;UBA52;UBB;PSMC2;PSMA3;SAMD4A;PSMB2;PSMD5;HNRNPU;PSMD7
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.39585178582696806,0.791462434139604,0.845360824742268,1.0,1.0,11/57,20.53%,MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;MAPK10;UBA52;UBB;FOS;DUSP6
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.48442279208295114,0.79142602151068,0.7272727272727273,1.0,1.0,1/8,15.09%,NDRG4
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.39182397321795115,0.7914129149149979,0.8409090909090909,1.0,1.0,7/44,18.83%,ARAF;XPO1;PINK1;PKD1;ALAD;UBB;PSMC2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.386957415384827,-0.7913595064313433,0.8947368421052632,0.9991680441860818,1.0,2/11,6.66%,APPL2;TRIB3
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.4569449735389535,0.7913262104240613,0.825,1.0,1.0,8/17,35.73%,TUSC3;MAGT1;LRRC8B;CTNS;NIPA2;LRRC8A;ADD2;MMGT1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2881676706938615,-0.7913103702502419,0.875,0.9986115228279904,1.0,8/39,12.58%,GAL3ST4;ST6GALNAC3;GANC;HPSE;B4GALT7;MAN2B1;NGLY1;ST8SIA4
prerank,KEGG_2021_Human__Riboflavin metabolism,0.546894717978947,0.7912683813968734,0.7868852459016393,1.0,1.0,1/5,8.96%,BLVRB
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.43782658757477977,-0.7911776919350949,0.6923076923076923,0.9981966490476215,1.0,2/7,6.50%,PSMC4;TP53
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.39332362408561383,0.7910605376842139,0.797752808988764,1.0,1.0,3/30,9.50%,HMGB2;TXN;KDM1A
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4648456512394878,0.7909824758706484,0.75,1.0,1.0,4/9,34.02%,TRIM16;EZH2;KLF2;DHRS3
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.5143250041990232,0.7909163795043089,0.7910447761194029,1.0,1.0,1/5,9.30%,IGF1R
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.49290801930490835,0.7908550564205601,0.7777777777777778,1.0,1.0,1/7,4.13%,SLC11A1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4339040865672839,0.7908208063843355,0.7840909090909091,1.0,1.0,9/25,23.25%,ERCC2;RPA2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1;RPA3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.5372774715407906,0.7904341865559872,0.7611940298507462,1.0,1.0,2/5,11.06%,DOCK5;CHRM3
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.452635961306493,-0.790305140002991,0.6428571428571429,0.9989920030232888,1.0,3/8,9.84%,DHRS4;RDH10;DHRS9
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.26943247659473357,-0.7898766472767869,1.0,0.9991404811653353,1.0,10/68,11.56%,PSMB3;PSME3;CHUK;EDA2R;MAP3K14;PSMC4;PSMD12;PSME4;EDA;BIRC2
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.3824708008091807,-0.789867673888228,0.625,0.9985109030423578,1.0,2/15,5.45%,H2BC4;UBTF
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.4514207331033204,0.789759435932953,0.7142857142857143,1.0,1.0,2/12,13.49%,ABCA2;SPTLC2
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.2619558048837164,-0.7896300339119987,1.0,0.9982625374988148,1.0,15/89,14.68%,TRIM38;MLKL;SAMD9;ITPR2;MOB1A;USP12;NMI;RECQL;NBN;ATP11B;NCK1;BNIP2;TRAM1;AP4E1;SRFBP1
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,-0.532292579171995,-0.7893276123144837,0.8333333333333334,0.9980558085017662,1.0,1/5,9.74%,EP300
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,0.490534867288913,0.7892287681508554,0.7714285714285715,1.0,1.0,3/10,7.93%,LSR;OVOL2;PPP1R13L
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.5234087897835706,0.7891917903943253,0.8208955223880597,1.0,1.0,3/6,28.45%,NDUFB6;NDUFV1;COA6
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4616641460390073,0.7891331232908344,0.7808219178082192,1.0,1.0,3/13,23.92%,PAICS;PFAS;IMPDH1
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.42369328166352394,-0.7890767280035311,0.7941176470588235,0.9977667436401947,1.0,4/8,19.40%,ALOX5;LTC4S;MAPKAPK2;ALOX5AP
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5328926199394324,0.7885613145935318,0.7611940298507462,1.0,1.0,2/5,19.08%,CTBP1;TAF7
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.3615176345179541,0.7882276496024447,0.8645833333333334,1.0,1.0,37/167,24.27%,FKBP5;H2BC11;RXRB;PDK4;KCNH8;KDM3A;KANK1;XPO1;ABCA1;IGF1R;KDM1A;RDH11;CPT1A;PPID;PLTP;GNAI1;FASN;SCD;KDM4B;ALDH1A1;ESR1;PDK3;TBL1XR1;POLR2D;CDK9;FOS;UHMK1;CDKN1B;PDHB;POLR2G;GNB5;ALDH1A2;JUN;ABCG1;GPS2;FOXO3;GREB1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.5122525131582495,0.7881430268128649,0.7777777777777778,1.0,1.0,1/6,5.61%,FCGR2B
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.3267188949892427,-0.7880790597644264,0.8666666666666667,0.9989555795127611,1.0,7/41,12.66%,H2BC4;CCND1;TP53;AGO1;EP300;H2BC26;MAML1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.41883212177576595,0.7879181160452478,0.7692307692307693,1.0,1.0,4/17,27.62%,IFITM3;AIM2;STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3947419671166021,0.7879137174320152,0.788235294117647,1.0,1.0,9/41,20.22%,BOK;FAM162A;BNIP3;PINK1;PYCARD;CIDEB;DDHD1;HIP1R;FBXO7
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.3710211459607811,-0.7878994477580856,0.7058823529411765,0.998616817332823,1.0,3/18,9.94%,PUS1;METTL8;METTL16
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3682907924229123,0.7877715162577938,0.8229166666666666,1.0,1.0,24/96,24.95%,DKK2;GPC5;DAAM2;SOX4;KANK1;PTK7;GSKIP;SEMA5A;GPRC5B;PSMB4;TBL1XR1;PSMC2;PSMA3;PRDM15;PSMB2;LRRK2;FGFR2;PSMD5;PSMD7;PSMD14;PSMA5;RNF220;DDX3X;GPC3
prerank,CellMarker_Augmented_2021__M2 macrophage:Peripheral Blood,0.5069351537339489,0.7877349878685197,0.7875,1.0,1.0,1/8,1.70%,CD163
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.3730679677477423,-0.7877260590387388,0.6666666666666666,0.9982784804663563,1.0,1/10,2.17%,POLD3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.37951145041496415,-0.7877213997672234,0.6666666666666666,0.9976522078939181,1.0,2/13,11.68%,ACTB;ARHGAP12
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.44390997138192645,0.787642891015722,0.7625,1.0,1.0,5/15,28.72%,INPP4B;PIK3R4;MTM1;MTMR4;FIG4
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.38969494728673965,0.7875085591228723,0.8636363636363636,1.0,1.0,7/53,17.22%,DOCK1;VEGFA;SHC2;FLT1;ITGAV;ROCK1;HSPB1
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.4352887430495132,0.787213728751802,0.75,1.0,1.0,5/18,21.07%,RPS27A;NEURL1;UBA52;UBB;TACC3
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.5020971526572204,0.787159880223967,0.7301587301587301,1.0,1.0,1/8,4.13%,SLC11A1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3765348856017789,-0.7870787198979676,0.7142857142857143,0.9981712046337629,1.0,6/22,9.02%,TGFBR3;SERPINF2;EGFL7;EFNB2;TGFB1;ENG
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,0.3712463382972666,0.7869692134522195,0.7894736842105263,1.0,1.0,15/85,16.48%,CLEC12A;CR1;CD163;F13A1;FCGR2B;SIRPB2;FGR;FCGR2C;CD93;FGL2;HCLS1;TNFRSF1B;CD300A;LILRB5;LRRC25
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.296408455119275,-0.786657006293233,0.8333333333333334,0.998195838661204,1.0,18/83,16.47%,NUP42;HHEX;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;RAE1;SLU7;SMG6;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.4205963717548612,0.7864859202943077,0.7435897435897436,1.0,1.0,10/24,21.08%,SNAP25;UNC13A;RIMS2;SYT1;SNAP29;UNC13C;RIMS3;CPLX1;STX2;STX19
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.4081571136944976,-0.7863621880905733,0.7391304347826086,0.9979984104024603,1.0,2/10,5.60%,CASP7;RYR1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),0.46293439335853737,0.786358102434244,0.8481012658227848,1.0,1.0,3/11,15.04%,LRGUK;CCDC39;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.42248128375907723,0.786303556796306,0.8311688311688312,1.0,1.0,9/27,33.78%,ANXA1;CALCOCO2;SURF4;FYCO1;PPARGC1A;PFDN2;C2CD5;LNPK;HTRA2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.3394360775987475,-0.7862974091910709,0.9411764705882353,0.9975135908217305,1.0,4/28,10.71%,NDE1;TRAK2;MYO1F;MYO1D
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,0.46363241218419854,0.7862764956986782,0.8108108108108109,1.0,1.0,3/13,21.09%,GRB10;PPP1R15A;ATF3
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.5432849715682129,0.7860732726064437,0.8181818181818182,1.0,1.0,1/5,11.37%,AGPS
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.5432849715682129,0.7860732726064437,0.8181818181818182,1.0,1.0,1/5,11.37%,AGPS
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.5097316544969837,0.785978383406033,0.7428571428571429,1.0,1.0,2/7,21.89%,ADCY10;DNAAF2
prerank,CellMarker_Augmented_2021__Effector Memory T cell:Undefined,-0.4990710114315321,-0.7858514864681787,0.7575757575757576,0.9975714423005564,1.0,1/5,3.32%,KLRG1
prerank,KEGG_2021_Human__Base excision repair,0.4163127256251901,0.7856564056046536,0.8117647058823529,1.0,1.0,6/21,17.69%,TDG;MPG;NEIL1;POLE2;POLL;NEIL2
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.3861389470502286,0.785401684669663,0.8850574712643678,1.0,1.0,6/71,9.50%,DTL;ERCC2;TMEM161A;PTPRK;RUVBL2;KDM1A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.4026012915716717,0.7852457441891172,0.8205128205128205,1.0,1.0,8/27,23.45%,PTPRG;RNASE10;CELSR2;EPHA7;SPINT2;GTPBP4;FLOT2;MEGF10
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.48449309550012426,0.7848009323023767,0.8235294117647058,1.0,1.0,2/9,13.49%,ABCA2;SPTLC2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.48449309550012426,0.7848009323023767,0.8235294117647058,1.0,1.0,2/9,13.49%,ABCA2;SPTLC2
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.3691368129345385,0.7847275372809471,0.8333333333333334,1.0,1.0,11/83,16.48%,CLEC4E;CLEC12A;CR1;SLC11A1;SIRPB2;FGR;C5AR1;ARG2;CD300A;RASGRP4;LRRC25
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.48231388295880673,0.7844777038603366,0.7721518987341772,1.0,1.0,1/11,3.93%,SLC1A2
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.24563361589111157,-0.7844328865502292,1.0,0.9994021424799457,1.0,23/139,15.17%,H2BC4;PSMB3;TADA2B;PSME3;IDE;DDB2;STAM2;PSMC4;TP53;PSMD12;USP28;USP12;PSME4;NFKBIA;BIRC2;ADRM1;H2BC26;UFD1;ARRB2;PSMA1;VDAC1;SMURF2;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.47829420719733456,0.7840942990612568,0.6875,1.0,1.0,1/8,12.09%,SORBS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.46704524552567284,0.7838212115328969,0.7236842105263158,1.0,1.0,3/9,20.03%,BOK;TMEM14A;HIP1R
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.36624926358919424,0.7836907508676636,0.875,1.0,1.0,13/63,24.39%,RNF144B;HERPUD1;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;HSPA1B;NOP53;LRRK2;USP5;BBS7;DDRGK1
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,-0.45481361087235633,-0.7835707368959258,0.782608695652174,1.0,1.0,3/9,9.45%,CX3CR1;CSF1R;CSF2RA
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.3727456898782036,-0.7834295878283664,0.8235294117647058,1.0,1.0,2/18,1.00%,ITGAM;CX3CR1
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.3467006302348637,-0.783239991152345,0.7857142857142857,0.9997191963524398,1.0,2/19,2.17%,LRIG1;POLD3
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.4293430932731519,0.7831528823774178,0.7209302325581395,1.0,1.0,3/15,13.49%,ABCA2;ARG2;SPTLC2
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,-0.42897179978204053,-0.7831508889227281,0.6111111111111112,0.9992105550053499,1.0,1/6,9.60%,ASCC2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.4799141178407273,0.7830832105025802,0.746268656716418,1.0,1.0,3/9,29.80%,SORBS1;ECHDC3;ZBTB7B
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4233897488510647,0.783082324119992,0.759493670886076,1.0,1.0,4/23,14.17%,CARMIL1;WASF1;ARHGEF4;ABLIM3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.4427464632785405,0.7830086730381581,0.7974683544303798,1.0,1.0,3/14,9.52%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3398508170586624,-0.78276796555748,0.7894736842105263,0.9993407744974289,1.0,7/29,19.54%,NEDD4;PRR5L;PLK3;SORL1;RAB29;CEP290;STX18
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),-0.48901370809503325,-0.7826777363873769,0.6842105263157895,0.998873888720602,1.0,2/5,21.30%,AGO1;MOV10
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.41313113743994007,0.7824756884024086,0.810126582278481,1.0,1.0,9/28,24.23%,CLVS1;ABCA1;ACP3;HOOK3;ATP10B;LRRK2;GAA;TMEM106B;CLVS2
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.4269389101738471,0.7824612614676436,0.7721518987341772,1.0,1.0,8/23,18.84%,NRG1;RPS27A;NRG3;CDC37;NRG4;UBA52;UBB;NRG2
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.44515011711648866,0.7822640056482126,0.8048780487804879,1.0,1.0,4/13,22.82%,NPHP1;ROCK1;TNF;TJP1
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.4151922234664211,0.7822626007597038,0.7701149425287356,1.0,1.0,4/27,10.46%,ITGA2;VEGFA;FCGR2B;FCGR2C
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.34565288116846027,-0.7820934707269089,0.8461538461538461,0.9994372830011106,1.0,3/29,5.22%,FLNA;IL1B;AZIN2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.4165912822440009,-0.7819977346410956,0.8461538461538461,0.9989545836462569,1.0,2/11,7.51%,FSCN1;TGFB1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.4045067549327257,-0.781844522009785,0.65,0.998635725412523,1.0,1/7,2.11%,DHODH
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.4306154270155382,0.781717726334423,0.7466666666666667,1.0,1.0,5/19,17.72%,LUZP2;GHR;SEMA5A;RYR3;TSPAN18
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.4319004553512879,0.7812869366312298,0.7625,1.0,1.0,4/20,10.81%,ADCY3;INSR;IGF1R;ADCY8
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.43868444313147015,0.7810739635198417,0.7714285714285715,1.0,1.0,6/15,26.29%,SYT4;SYT1;SYT11;KCNB1;SYT9;SCAMP5
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.43267710555784905,0.7810284100670469,0.8115942028985508,1.0,1.0,2/17,16.69%,TTBK2;CC2D2A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.42394834778967855,0.7810227306726862,0.8636363636363636,1.0,1.0,12/30,23.25%,ERCC2;RPA2;RPS27A;RBX1;FAN1;RFC4;GTF2H3;UBA52;UBB;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3502488336116039,0.7810226548414467,0.9494949494949495,1.0,1.0,34/281,15.98%,NFIL3;ACVR1B;SAP30;PQBP1;RORB;SOX4;TCF7;APBB3;HINT1;INSR;HIF1A;GLRX2;HCFC1;FOXN2;ARNT2;ZKSCAN5;BHLHE40;TCF7L1;MAFB;LIMD1;POU5F1;CELSR2;ZNF536;TULP3;SOX6;HCLS1;HINFP;DRAP1;YAF2;ZNF143;ACTR5;MLF2;ESR1;NR2C2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.4940166182606741,-0.7809652431527289,0.7586206896551724,0.9996305381018344,1.0,1/5,15.49%,FIS1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.41592606299735985,0.7809253155765092,0.8589743589743589,1.0,1.0,7/25,30.08%,LIMD1;PRKRA;CNOT6;CNOT7;AGO4;DICER1;CNOT8
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.45155431019382997,0.7808506185265809,0.7631578947368421,1.0,1.0,3/13,8.95%,IHO1;FMN2;PTN
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4582854789936637,0.7808008866357664,0.7333333333333333,1.0,1.0,2/14,17.45%,ERRFI1;APP
prerank,Reactome_2022__HDL Remodeling R-HSA-8964058,0.5067757970330419,0.7806748481747035,0.75,1.0,1.0,2/5,22.91%,PLTP;ABCG1
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.35182838946236183,0.7806451079890697,0.97,1.0,1.0,76/299,24.31%,SOCS3;VIM;IL15;TALDO1;OSMR;IL1RAPL1;ANXA1;LIFR;MAP3K8;F13A1;VEGFA;KCNH8;IL7;PTPRZ1;HIF1A;SNAP25;FN1;GSDMD;IRS2;RPS27A;MCL1;LMNB1;NOD2;PSMB4;RBX1;RPS6KA2;IFNLR1;RIPK2;CRLF1;TNFRSF1B;NKIRAS1;MAPK10;PELI1;CASP3;IL18;CEBPD;IL11RA;TCP1;TEC;BCL6;APP;PTPN9;TNFRSF1A;STXBP2;SOD1;UBA52;UBB;PSMC2;PSMA3;PTPN5;FOS;TNF;PSMB2;DUSP6;IL7R;PTPN20;IRAK3;P4HB;PSMD5;HSP90B1;BRWD1;STAT1;PSMD7;MAP3K3;PDCD4;RHOU;STAT6;STAT2;JUN;RORA;FPR1;CASP1;PSMD14;PSMA5;FOXO3;IL21R
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.3578230597512071,0.7804456990804582,0.8571428571428571,1.0,1.0,5/89,5.77%,GPR18;NAPSB;CD22;FCGR2B;IL7
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.3430998229839416,-0.7803413801254659,0.8,1.0,1.0,10/25,23.28%,DUSP3;LILRB4;CD226;BCL10;CARD11;RAB29;CD81;PRKD2;RELA;LAPTM5
prerank,KEGG_2021_Human__Adherens junction,0.3753611365854312,0.7801078136136258,0.8297872340425532,1.0,1.0,9/58,16.89%,TCF7;INSR;TCF7L1;IGF1R;WASF1;SORBS1;PARD3;CTNNA2;IQGAP1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.2630954491640743,-0.7793349381692992,1.0,1.0,1.0,16/113,12.19%,ATRAID;ZNF711;TRIM38;PRDM10;RNF187;IGF2BP3;KHSRP;SIRPA;PCBP3;IGF1;HMG20A;LAMTOR1;TREM2;ADNP2;REST;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3577466794249745,0.7793344896676009,0.9183673469387755,1.0,1.0,17/146,11.79%,HTR2B;FGF1;TGFB2;GLIPR2;CHI3L1;DIRAS2;VEGFA;GPNMB;INSR;ROBO1;TRIM5;IGF1R;NTRK3;C5AR1;NOD2;FLT1;NTRK2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4736951966901228,0.7792215260297859,0.8493150684931506,1.0,1.0,5/18,15.86%,FAM162A;BNIP3;PINK1;PYCARD;CIDEB
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.438169693191777,-0.7792160387018204,0.6285714285714286,1.0,1.0,3/7,12.44%,ABCG2;SLCO2B1;HMOX2
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.422429284708369,0.7790770396325891,0.8292682926829268,1.0,1.0,7/26,27.66%,CAMK2B;HSPA1B;HSPA2;UBB;TNFRSF21;HSP90AB1;HSPA8
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),0.5153300823480355,0.7788937924565791,0.7402597402597403,1.0,1.0,1/5,17.56%,FOXP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.36991808588570335,-0.7786382028306073,0.7307692307692307,1.0,1.0,3/10,9.89%,CD300LF;MILR1;NR1H3
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.5054323874817785,0.7786156216128469,0.8181818181818182,1.0,1.0,2/6,24.69%,PLK2;PRCC
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,0.5269436154419315,0.778449705031857,0.8472222222222222,1.0,1.0,5/8,27.24%,RPS27A;UBA52;UBB;FZR1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.4152449661893549,0.7784265772163843,0.8271604938271605,1.0,1.0,3/26,6.39%,PLPP3;RNASE10;ANK3
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.4029173439115259,-0.7783486968190342,0.7575757575757576,1.0,1.0,3/9,22.71%,GNAS;VIPR1;GNB4
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,0.35486102787750284,0.7783341252792091,0.96,1.0,1.0,62/406,17.55%,SCRG1;SPON1;CREG2;PCDH9;FMN1;CADM2;RGS1;TTBK2;ADGRE1;CDH9;ARID5B;SOX4;IER5;CRELD2;TCF7;MDGA2;SYT4;COL24A1;SLC13A4;MVD;ARPP21;GRIK1;HERPUD1;ARNT2;PALLD;PPP1R13L;MAFB;ID2;TSC22D3;IGF1R;SIVA1;NEIL1;MGAM;SLITRK5;GFOD1;KCNMB1;PER1;RPS27;C5AR1;DNM1;CHRM3;RPS6KA2;SGIP1;ZNF606;TNFRSF1B;NEGR1;NKIRAS1;CSMD1;HMGCS1;PLLP;DTX3;MRPL55;CCDC85C;NUAK2;TBX19;CCDC92;C2CD2L;BCL6;HECW2;KLF7;GSTP1;AMPH
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.3693794719279805,0.7782504131610561,0.8791208791208791,1.0,1.0,8/59,17.63%,INSR;RAB15;IRS2;SORBS1;PKM;INSIG1;CPEB2;SLC39A14
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.24260891841801305,-0.7781922059659424,1.0,1.0,1.0,31/189,14.14%,EHD4;KIF27;FLNA;INPP5K;FSCN1;WDR35;WHAMM;MKKS;MAP4K4;KIF3B;RAPGEF6;INPP5E;BBS9;EXOC7;P2RY12;TMEM67;TCTN3;OCRL;ABCC4;CYFIP1;SRGAP2;IFT43;GSN;OPHN1;CCDC66;NUDCD3;PPP1R9B;STK26;GALNT11;DISC1;RAP1A
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,-0.49984398754678194,-0.7780701127408536,0.7083333333333334,1.0,1.0,3/6,16.35%,TPST2;TTF2;FAM110A
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.41012155517267496,-0.7780234423527863,0.8518518518518519,0.9999638150259874,1.0,3/12,13.42%,ACOX1;PXDNL;GPX1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.4853725402676379,0.7780119198354867,0.7727272727272727,1.0,1.0,4/7,32.90%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.4853725402676379,0.7780119198354867,0.7727272727272727,1.0,1.0,4/7,32.90%,TRIM16;MACROH2A2;MACROH2A1;NCOA3
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,0.35770488881555373,0.7779380602515914,1.0,1.0,1.0,45/286,18.46%,HHIP;COL11A1;PRKAR2B;TLE1;WDR5;VEGFA;PPP2R5A;TRIP10;LAMB1;PAPSS2;ETFB;GOLM1;ACSS3;PKP2;TIMM13;ALCAM;MAFB;SCD5;TXN;DEPTOR;SS18L1;SIRT5;GHR;PRICKLE1;GPR155;PPID;RNF126;PLTP;SULF2;UPF3A;BNIP3;SUSD4;RPS18;ASPH;RPL14;TGFBI;GRPEL1;SLC31A2;TTC33;CXXC1;HSPA12A;APBB2;MPC2;INTS8;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4640390497363289,0.777913370939687,0.8,1.0,1.0,2/10,9.56%,NFIB;POU5F1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.44393276234025475,0.7778896481962555,0.7432432432432432,1.0,1.0,7/11,40.43%,AIM2;STAT1;IRF1;HTRA2;UBE2G2;UBE2K;PNPT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.47744474391566805,0.7777657025727246,0.803030303030303,1.0,1.0,5/8,26.94%,B3GAT1;CSGALNACT2;CSGALNACT1;B3GAT2;DSE
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.3255748136518266,-0.7777650044731561,0.8461538461538461,0.9997274193206931,1.0,7/26,12.46%,ACSM5;ABCG2;SLC38A1;SLCO2B1;BSG;ABCC4;GGT7
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.3800507661835498,0.7776453647039067,0.8494623655913979,1.0,1.0,18/83,25.86%,TRAF2;NUP133;WASF1;DARS1;PPID;PARD3;PICALM;SEH1L;FANCA;DLG4;KNTC1;NAPG;HFE;NDC1;REPS2;RIMS1;PPARGC1A;PTK2B
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.38589700685510075,0.7776246552526695,0.7692307692307693,1.0,1.0,13/47,24.50%,PRKCE;ARF6;BAIAP2L1;KANK1;CARMIL1;HCLS1;PYCARD;HIP1R;SSH2;PAK3;CTTN;ARHGAP18;TWF1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.4049570399596386,0.7776076746626527,0.8023255813953488,1.0,1.0,2/26,4.57%,SH3PXD2B;ADAM15
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.4650787564720027,0.7775845353637337,0.7777777777777778,1.0,1.0,1/12,2.26%,HMGB2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.28896084024084984,-0.7773510340527044,0.9411764705882353,1.0,1.0,8/40,13.06%,PIDD1;BTG2;TP53;ZNF385A;EP300;CNOT6L;PLK3;PLAGL1
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,0.48585597347421994,0.7773143017126736,0.85,1.0,1.0,3/11,18.81%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4657276541664681,0.7773136381794584,0.8421052631578947,1.0,1.0,3/13,14.62%,HSPA5;PPP1R15A;DNAJB9
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.3494915443633463,0.7772216976417976,0.93,1.0,1.0,72/291,26.42%,EEF1A2;RPL23;EIF4A3;NR4A2;RPL37A;RBM3;RPS6KB2;NUP133;ADARB2;RPL38;COPS5;PAX8;RPS6;RPS27A;RPL23A;TFIP11;CELF2;RPS25;DARS1;RPS27;NOVA1;RPS11;RPS20;RPL9;RBM5;RPLP2;RPS18;MRPL43;RPL37;AGFG1;NXF1;RPL14;ANGPT2;MRPL55;SEH1L;HNRNPH1;MRPL27;RPS4X;RPL11;RPS24;POLR2D;RPS9;RPL36;HSPD1;MRPL3;RPS3A;MRPS14;RPL35;RPL4;SRSF5;POLR2G;RPL32;TNIP1;MPHOSPH10;HNRNPU;EEF1A1;RPL24;RPL27A;NDC1;RPL3;HNRNPH3;SRSF3;RPS16;RPL30;RPL21;POM121;RPL7;RPL12;SYNCRIP;SRSF9;EIF4EBP2;RPL10A
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.44780437765749215,-0.7770660676275585,0.7878787878787878,0.9998550238048414,1.0,3/6,10.89%,ITGAM;IRF5;ITGB2
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.37649602126623966,0.7770186862444487,0.8315789473684211,1.0,1.0,15/59,25.28%,BEX3;NGEF;RPS27A;ARHGEF4;KALRN;ITSN1;CASP3;FGD4;UBA52;UBB;ECT2;VAV3;ITGB3BP;GNA13;MAGED1
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.2662443952914149,-0.7770026472672282,1.0,0.9993438466800308,1.0,8/59,8.92%,PSMB3;PSME3;PSMC4;PSMD12;CBFB;HIVEP3;PSME4;SMURF1
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,-0.407668121726583,-0.7769428686447698,0.9032258064516129,0.9988818493727194,1.0,2/9,4.41%,PGM2;RPIA
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.41833897430845446,-0.7764789135937826,0.696969696969697,0.9990511811040692,1.0,3/9,16.89%,CHTOP;PIH1D1;ZNF335
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.28754632811230424,-0.7764549785013806,1.0,0.9985010339071244,1.0,5/47,7.51%,FLNA;SESN2;ZPR1;WWTR1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.48354755139844163,0.7764154349034734,0.7428571428571429,1.0,1.0,3/8,20.20%,POU5F1;ESR1;TNF
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.3455719341831417,-0.7763957677153135,0.8125,0.9979354099561062,1.0,8/20,14.21%,TLN1;SRC;RASGRP2;CRK;APBB1IP;SYK;RAP1A;AKT1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.378868236299805,0.7760176563309158,0.8295454545454546,1.0,1.0,10/44,20.94%,ZDHHC15;PIGU;PIGQ;GLUL;ZDHHC9;PIGF;UGCG;PIGL;PIGG;ATG5
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.38655596605594217,0.7758884162002175,0.7717391304347826,1.0,1.0,7/33,21.83%,RBPJ;RPS27A;NEURL1;UBA52;UBB;TACC3;STAT1
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.3843068414738601,0.7756810553560882,0.8,1.0,1.0,12/46,21.28%,ERCC2;COPS5;RPS27A;RBX1;GTF2H3;POLR2D;ERCC6;UVSSA;UBA52;UBB;DDB1;POLR2G
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.463315528056979,-0.7756544723141893,0.8285714285714286,0.9985973883303556,1.0,2/7,19.93%,GTF3C2;GTF3C3
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.37347627386399485,0.7755930575508527,0.8351648351648352,1.0,1.0,18/54,24.06%,HIF1A;LIMD1;RPS27A;PSMB4;RBX1;HIF3A;EPAS1;EGLN3;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;UBE2D2;PSMD14;PSMA5
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.25587682758986074,-0.7755448032656496,1.0,0.9982018028356702,1.0,8/49,12.25%,ZDHHC3;ST6GALNAC3;ZDHHC5;GALNT1;ZDHHC2;ST6GAL1;DDOST;DAD1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.4450427980681733,0.7754447500656718,0.8115942028985508,1.0,1.0,2/10,24.50%,CARMIL1;TWF1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.4476442116043851,-0.7753637335290866,0.6923076923076923,0.9979276307202778,1.0,1/8,1.82%,FBL
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.4422858555047664,-0.7753424554657226,0.6956521739130435,0.9973556896838193,1.0,2/6,9.22%,LGALS9;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.3562848266684986,-0.7751814577484079,0.8947368421052632,0.9970984764610694,1.0,1/17,6.50%,TP53
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.40387604537664523,-0.7751037373340195,0.625,0.9966162616912634,1.0,2/11,7.85%,TPRKB;TEP1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.48970684076777793,0.7748990215101503,0.765625,1.0,1.0,4/7,46.18%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.48970684076777793,0.7748990215101503,0.765625,1.0,1.0,4/7,46.18%,EIF4G1;EIF4E2;EIF4ENIF1;DDX6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.43866664660925214,-0.7748798782303351,0.75,0.9963356899931076,1.0,1/7,9.74%,EP300
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.47802684256609873,-0.7747745663856553,0.7241379310344828,0.9959107925144999,1.0,3/8,12.41%,NUFIP1;PIH1D1;ZNHIT6
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.37965262894127355,0.7746555221551088,0.8227848101265823,1.0,1.0,7/30,17.45%,FCGR2B;GRIN2A;IGF1R;CACNA1B;EPHA4;CACNA1A;APP
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.478732698401122,0.7746195146749937,0.7837837837837838,1.0,1.0,3/10,22.86%,IMPACT;BAG3;JUN
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.37502227183640463,0.7740687949797451,0.8817204301075269,1.0,1.0,12/104,17.43%,MAPT;MANF;RPA2;NUP133;DNAJC7;MCL1;ADCY8;CAMK2B;PINK1;BAG3;SEH1L;HSPA1B
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.3737591800228092,0.7737720511316873,0.7222222222222222,1.0,1.0,5/46,14.00%,FAAH;LRRN1;PTOV1;BTBD2;KLC4
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.4159688622186281,0.7737603532175926,0.8552631578947368,1.0,1.0,4/19,15.06%,NOD2;GPI;DNAJB9;WNT5A
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.4378055981011951,0.7736300292216841,0.8108108108108109,1.0,1.0,6/23,17.21%,SEMA3A;SEMA3B;SEMA6A;SEMA5A;PLXNB1;ARHGDIA
prerank,CellMarker_Augmented_2021__Neuron:Undefined,0.4254276544917517,0.7736113264439767,0.8701298701298701,1.0,1.0,9/22,22.36%,CDH2;SYP;ALCAM;MAP2;THY1;DLG4;FOS;NCAM1;TSPAN7
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.41815847975984677,0.7734165410576521,0.8,1.0,1.0,8/24,24.23%,CLVS1;ABCA1;ACP3;HOOK3;LRRK2;GAA;TMEM106B;CLVS2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.49649804747561893,0.7732328956339021,0.8507462686567164,1.0,1.0,1/9,7.13%,MPG
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.49649804747561893,0.7732328956339021,0.8507462686567164,1.0,1.0,1/9,7.13%,MPG
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.39149158894649494,0.7730857122874487,0.8409090909090909,1.0,1.0,5/38,15.95%,ZBTB16;FLVCR1;HCLS1;CASP3;RASGRP4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4784332978431566,0.7729603211554125,0.796875,1.0,1.0,2/8,10.44%,PCBP4;NOVA1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4067993137754556,0.7726005390408952,0.7710843373493976,1.0,1.0,2/26,12.94%,NAPA;NSF
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.5030442767369261,-0.7724697384116175,0.7241379310344828,0.9993659973012522,1.0,2/5,19.66%,IVD;MCCC1
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.3213876995346865,-0.7723308446551513,0.8333333333333334,0.9989558216956067,1.0,4/49,8.49%,RING1;GATAD2B;TP53;LAMTOR1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.46845124565789403,0.7722972434783623,0.8026315789473685,1.0,1.0,4/10,17.78%,TDG;NEIL1;NEIL2;UPP2
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.4047842526994234,0.7722673720584927,0.875,1.0,1.0,9/42,20.16%,DPYD;ENTPD3;UCKL1;CMPK1;DCK;UPP2;NME4;UCK2;CTPS1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,0.39143743976890016,0.7718155840366623,0.8314606741573034,1.0,1.0,7/43,12.85%,CD163;PREX2;F13A1;CD93;FLT1;SORBS1;SHROOM4
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.4255477065601352,0.7715891596565618,0.8378378378378378,1.0,1.0,8/27,27.46%,ANTKMT;MAP2;DYNC1H1;RNF139;LRRK2;GRIPAP1;ATP9A;PTPN1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.4478967371109123,0.7715667544736757,0.8493150684931506,1.0,1.0,6/13,21.27%,VEGFA;PTN;KDM1A;SMARCD3;LRRK2;CX3CL1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,0.42889534929336537,0.7714270245713919,0.7792207792207793,1.0,1.0,8/16,19.96%,TFRC;ALCAM;POU5F1;CASP3;THY1;ITGAV;TNFRSF1A;NCAM1
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.3872612689800277,-0.7706200557651953,0.8333333333333334,1.0,1.0,4/13,14.64%,RUNX3;EP300;MAML1;MAMLD1
prerank,KEGG_2021_Human__Protein export,0.41902197170868133,0.7706017862328914,0.8227848101265823,1.0,1.0,2/23,5.78%,HSPA5;SEC61B
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.44354944215895975,0.7701799977018317,0.7432432432432432,1.0,1.0,1/11,5.27%,HSPA5
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.4084240399195319,-0.7695681201528245,0.8275862068965517,1.0,1.0,2/12,11.22%,IRAK4;TLR7
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),0.47831155547558196,0.7694721395648229,0.782608695652174,1.0,1.0,3/9,18.25%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.4047072384117063,0.7694267153191301,0.8260869565217391,1.0,1.0,5/43,7.02%,PLPP3;ENPP2;PLPPR4;ALOX15B;ABCA2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.41969274136496404,0.7692432290557364,0.8024691358024691,1.0,1.0,7/25,22.60%,GPM6B;ABCA2;CAV3;PICALM;TNF;HFE;MAP1A
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.4500331472147371,0.7691098601723333,0.7792207792207793,1.0,1.0,3/9,13.31%,IHO1;FMN2;ZCWPW1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.41273931152313614,-0.768700610466185,0.8,1.0,1.0,2/8,7.26%,BUD23;RIOK1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),0.4016936523818583,0.7683036742169101,0.7752808988764045,1.0,1.0,2/27,7.86%,NR4A2;PAX8
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.3507333740492509,0.7682242911303867,0.9494949494949495,1.0,1.0,47/240,24.92%,SH3PXD2B;ZDHHC15;TBC1D8;PIGU;NAPA;ARF6;DMD;PTPRK;TBC1D13;PRRT1;ANK2;RAB20;SEPTIN4;SEPTIN8;NPHP1;TBC1D15;CNTNAP2;GRID2;NSF;ITSN1;WNT5A;CPE;TMED10;SNX17;STXBP2;CEP68;SCG5;RAB21;STX2;CNTNAP1;TBC1D2;LRRK2;CNTN2;STX19;NAPG;MFN2;TBC1D14;RAB5A;CTTN;AMOT;ATG13;SEPTIN11;JAM3;AP3B1;VPS26B;EPB41L3;ARMCX3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.3134807421827077,-0.7680260238734682,0.9166666666666666,1.0,1.0,9/37,13.23%,NEDD4;RAMP1;GTF2H2;LILRB4;GRK2;SCYL2;ITGB2;ARRB2;SYK
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.422492474479921,0.767684742801163,0.7972972972972973,1.0,1.0,6/19,18.82%,HTR2B;C5AR1;NTRK2;RASGRP4;TXK;GNAQ
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.5237110415460287,0.7676726832054965,0.8955223880597015,1.0,1.0,3/5,41.13%,PRMT1;PADI2;NDUFAF5
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.4549788929339938,0.7673559025185931,0.782608695652174,1.0,1.0,1/9,10.65%,ERI2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.38291842935454135,0.767130727925472,0.8555555555555555,1.0,1.0,8/51,18.63%,ZDHHC15;SYNE3;VPS37C;PARD3;ZDHHC9;SDCBP;NACA;AQP11
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.5142928282891487,-0.7671195615532299,0.75,1.0,1.0,2/5,15.95%,SRC;CBL
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.467879520459094,0.76685323707041,0.7857142857142857,1.0,1.0,3/8,24.65%,PAX8;FGFR2;TTC39C
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.37204921655222917,-0.7668055186201983,0.8333333333333334,1.0,1.0,2/15,1.98%,NPC2;ARV1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.49105495176517633,0.7665013288197184,0.8311688311688312,1.0,1.0,2/9,23.04%,RTN4;MFSD1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.4058025458322566,0.7664971166810803,0.7926829268292683,1.0,1.0,4/25,6.84%,GULP1;DOCK1;FCGR2B;SPIRE2
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.36551492631586674,0.7662976642292312,0.9010989010989011,1.0,1.0,27/82,27.66%,LRRC20;B4GAT1;SCAF1;GRINA;ACAP3;PCBP4;ARFGAP1;PTOV1;SMYD5;IGSF8;TNPO2;PKD1;RCC1L;NCDN;DCTN1;POLRMT;WIZ;POMGNT1;USP5;GPS1;CLUH;PEX10;PTGES2;BAG6;UBQLN4;NDUFV1;SNTA1
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.4680713879312902,0.7662372863531949,0.7605633802816901,1.0,1.0,1/9,4.68%,RPA2
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.3482650894582907,0.7660873082534281,0.8695652173913043,1.0,1.0,16/65,28.80%,PQBP1;POLR3F;POLR1C;RIPK2;POLR3H;DHX33;HSPD1;STAT1;STAT6;TRIM56;DDX3X;TLR2;CTNNB1;POLR3E;IRF1;RIOK3
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,0.3640729691020959,0.7660056879415262,0.8888888888888888,1.0,1.0,10/84,13.00%,KMO;CD163;DPYD;CHI3L1;GPNMB;FCGR2B;CPM;CD93;FGL2;SOD2
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,0.3640729691020959,0.7660056879415262,0.8888888888888888,1.0,1.0,10/84,13.00%,KMO;CD163;DPYD;CHI3L1;GPNMB;FCGR2B;CPM;CD93;FGL2;SOD2
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.44488133400652186,0.7659830989489246,0.7922077922077922,1.0,1.0,2/18,12.29%,NOD2;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.45927375341320376,0.765959290407675,0.8481012658227848,1.0,1.0,3/10,21.36%,IFITM3;TRIM14;HEXIM1
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.41814530413064194,0.7656363711471537,0.7804878048780488,1.0,1.0,7/25,22.53%,AMY2B;MGAM;ATP1B3;PLCB1;ATP1B2;ATP1A2;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.48832146277835564,-0.7655933892258626,0.7931034482758621,1.0,1.0,3/5,19.32%,MKKS;NENF;BBS2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.35457129031895995,0.7655920555125673,0.8958333333333334,1.0,1.0,23/109,22.42%,RHOB;RELN;RACGAP1;CGNL1;TRIP10;ARHGAP23;NGEF;CHN1;ARHGEF4;KALRN;ITSN1;RASGRF1;ITGAV;ARAP2;ARHGDIA;STARD13;FGD4;RHOH;ECT2;FAM13A;STARD8;VAV3;RHOU
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.39266610403578334,0.7655542524757459,0.8620689655172413,1.0,1.0,9/40,18.81%,ERCC2;ANXA1;RPS27A;RBX1;DDX1;MCMDC2;GTF2H3;UBA52;UBB
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.47532371856511885,-0.7655358331597725,0.7407407407407407,1.0,1.0,2/7,13.42%,PXDNL;GPX1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4472066318369131,0.7654933176331407,0.8375,1.0,1.0,3/11,9.52%,TLE1;PDK4;MCL1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.36294899459747576,0.7653276258907358,0.8617021276595744,1.0,1.0,7/56,8.38%,PKIA;PRKAR2B;AGT;RGS2;PAQR3;SPRY1;CAV3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3465958135167616,0.7652017310461909,0.9696969696969697,1.0,1.0,31/285,17.59%,CENPF;CENPE;SH3PXD2B;HAUS6;MAPT;ANLN;DZIP1;TTBK2;RFX2;TMEM41B;VPS37C;RCC1;ATAT1;LIMD1;RP2;IFT74;CFAP54;DYNC1H1;SNX10;SNAP29;GOLGA8B;VMP1;AUP1;PKD1;ABLIM3;TXNDC15;ATP2A2;CC2D2A;UBXN2B;KIF3A;MACIR
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.41043699106629833,0.7648519946829149,0.8518518518518519,1.0,1.0,1/32,0.66%,RHOB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.31195299313591174,-0.7648294376604203,0.8823529411764706,1.0,1.0,10/35,15.45%,IL1B;CD2;LGALS9;TLR3;TLR7;HSPA1A;SYK;BCL10;LILRA2;TIRAP
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.38141402665110635,0.7647730791363607,0.8762886597938144,1.0,1.0,11/58,20.53%,MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;MAPK10;UBA52;UBB;FOS;DUSP6
prerank,KEGG_2021_Human__RNA degradation,0.361355494542871,0.7647581650209168,0.8181818181818182,1.0,1.0,15/63,28.05%,PFKM;NUDT16;ENO2;TENT4B;ENO4;MPHOSPH6;HSPD1;ENO1;CNOT6;PAN2;LSM5;HSPA9;CNOT7;LSM3;TENT4A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.4400249574634557,0.7647259254542184,0.7926829268292683,1.0,1.0,2/12,8.38%,ANK2;CAV3
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.3769334184558778,0.7645556753489731,0.8777777777777778,1.0,1.0,18/66,24.29%,PLPP3;DGKI;MBOAT2;DGKB;SELENOI;DGKG;PEMT;ETNPPL;PLD3;CHPT1;PNPLA7;PLD1;CDS2;GPAT4;GPD2;LPCAT4;DGKE;MBOAT7
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,0.4844297506658753,0.7644088559884633,0.8055555555555556,1.0,1.0,3/8,20.27%,CYP3A5;HSD17B12;STS
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.3785123681787528,0.7643392007184424,0.8571428571428571,1.0,1.0,13/70,20.23%,MDH1;PFKM;ENO2;NUP133;PFKFB4;FBP1;PKM;HOOK3;SEH1L;PCNX4;PGM2L1;PGK1;ENO1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.47995901748743386,0.7641105145479004,0.8382352941176471,1.0,1.0,1/7,8.38%,CAV3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.37195081611902425,0.7640339495583023,0.8709677419354839,1.0,1.0,8/68,14.72%,THBS1;ASPN;VASN;SPRY1;RPS27A;NREP;PEG10;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.382843565501148,0.763935786905873,0.8352941176470589,1.0,1.0,13/34,22.90%,AGT;RGS2;PAQR3;SPRY1;CAV3;CD300A;DUSP10;AIDA;GSTP1;UCHL1;IRAK3;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.3724443829720168,0.7639106757230367,0.8444444444444444,1.0,1.0,4/32,11.25%,PLPP3;MEGF11;FN1;TYRO3
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3600779371198832,0.7638963502909806,0.8947368421052632,1.0,1.0,27/99,20.85%,KLF4;BMPR1B;ALOX15B;MBOAT2;EPHA3;PPP1R13L;NLGN1;TRPS1;MAFB;ID2;ALK;SMYD5;CLASP2;NREP;APC2;OCIAD1;CEBPD;ST7;ROCK1;BCL6;FES;SUZ12;CDK9;CDK5R1;TNF;NR1D1;FGFR2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.40023850656487225,-0.7638441105051118,0.7391304347826086,1.0,1.0,3/11,20.41%,BUB3;CTCF;ZW10
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.4109974416703592,0.763671250841262,0.8170731707317073,1.0,1.0,6/19,27.66%,HSPA1B;HSPA2;UBB;TNFRSF21;HSP90AB1;HSPA8
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.3403999629900416,0.7635481796409824,0.8762886597938144,1.0,1.0,32/128,28.64%,CD55;ANK3;ANK2;MGAT4C;ARFGAP1;SPTAN1;SEC24C;B4GALT5;MCFD2;DYNC1H1;NSF;SPTBN5;ST8SIA3;TRAPPC6B;SPTBN1;GRIA1;DCTN1;SPTBN4;DYNC1I1;NAPG;CNIH1;F8;MAN1A1;B4GALT6;GOLGB1;DYNLL1;KDELR1;PTGES2;MGAT4B;TMED2;BET1L;MIA3
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.42942540046715527,0.7632458410497741,0.8333333333333334,1.0,1.0,3/21,14.47%,NUDT16;NHP2;ZC3H12B
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.34176996088138134,0.7629278898933254,0.8947368421052632,1.0,1.0,17/98,25.40%,ATP8B1;CLASP2;VCPIP1;GOLGA8B;VMP1;SPTBN5;TMED10;FAM174B;UBXN2B;VPS51;SURF4;LRRK2;RAB30;DYNC2H1;HACE1;VRK1;GOLGB1
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.37169581192263007,0.7629087874485299,0.8522727272727273,1.0,1.0,18/60,21.35%,AGT;RGS2;SEMA6A;CAMK2N1;PAQR3;SPRY1;CAV3;LMO3;PEBP1;CD300A;DUSP10;TIMP3;GSTP1;PRDM15;DUSP6;UCHL1;IRAK3;TNIP1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4628078724363026,0.762770929468308,0.8533333333333334,1.0,1.0,3/11,19.04%,CLK2;FBP1;PPARA
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,-0.27719635379027174,-0.7627525529241467,1.0,1.0,1.0,15/53,15.00%,TDRD10;GIMAP8;FOLR2;LGALS9;CSF1R;SLCO2B1;ENG;PCDH12;MMRN1;PLVAP;DAB2;GIMAP4;SCARF1;CMKLR1;KCNE3
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.47420707973504067,0.76274675106032,0.8333333333333334,1.0,1.0,4/12,25.32%,ETFB;UQCRFS1;GPD2;PPARGC1A
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.31075316760218413,-0.762676897901924,0.9411764705882353,1.0,1.0,4/33,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3719392787702075,0.7624285268885238,0.8095238095238095,1.0,1.0,7/48,15.93%,ALG10B;BMPR1B;MGAT1;B4GALT5;SERP1;ST8SIA3;GCNT1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.4609865747777042,0.7624038561838424,0.7704918032786885,1.0,1.0,5/7,33.13%,RBPJ;MYLK;PROX1;LRP1;BMPR1A
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4322427870289019,0.7623291950902927,0.8148148148148148,1.0,1.0,5/22,12.72%,HMGB2;PTPRZ1;BHLHE40;PTN;TNFRSF1B
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,-0.3915687554154993,-0.7621783846260848,0.7619047619047619,1.0,1.0,4/11,19.33%,RNF103-CHMP3;CHMP2B;BECN1;CHMP2A
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.346723413091999,0.7620965638600181,0.9292929292929293,1.0,1.0,16/190,11.78%,DKK2;FZD6;TLE1;PPP2R5B;H2BC11;GNAO1;SOX4;PPP2R5A;TCF7;TCF7L1;XPO1;RPS27A;PSMB4;RBX1;PRICKLE1;SOX6
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4569674448437561,-0.7620438462716742,0.7575757575757576,1.0,1.0,2/5,25.48%,VPS4B;APEH
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.41836893236073985,-0.7619733089164863,0.7419354838709677,1.0,1.0,1/10,5.87%,LEO1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3543436429157838,0.7618419369726109,0.8958333333333334,1.0,1.0,25/135,22.63%,RAP1GAP;TBC1D8;RGS1;TBC1D13;SIPA1L1;NGEF;RAPGEF3;NTRK3;TBC1D15;GPR65;APC2;PLXNB1;RASGRF1;PICALM;THY1;PKP4;EZH2;ECT2;TBC1D2;CCDC125;CX3CL1;TBC1D14;GNB5;ARHGAP42;GARNL3
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.2470109087002269,-0.7618274242664261,0.8888888888888888,1.0,1.0,5/65,6.69%,PSMB3;CCND1;PSME3;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.5130458827819486,0.76168429765287,0.8450704225352113,1.0,1.0,1/6,10.42%,C5AR1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.39282045500255003,-0.7615490531788189,0.8,1.0,1.0,1/12,1.12%,PGM2
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.5045602418424183,0.7615180582304374,0.7575757575757576,1.0,1.0,2/6,15.06%,PTN;WNT5A
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.4599554746104705,0.7614505754007419,0.8,1.0,1.0,3/9,5.86%,ITGA2;LAMA2;LAMB1
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,0.3706651307110098,0.7614478094520644,0.8780487804878049,1.0,1.0,3/39,6.43%,NAPSB;CLEC12A;SIRPB2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.45349423021529034,0.7613469551427026,0.8055555555555556,1.0,1.0,4/9,30.20%,NOD2;IL18;RSAD2;CD86
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.45380735050083165,-0.7611065740260385,0.7096774193548387,1.0,1.0,3/6,12.44%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.45380735050083165,-0.7611065740260385,0.7096774193548387,1.0,1.0,3/6,12.44%,ABCG2;SLCO2B1;HMOX2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.4568623173305091,0.7610838883173559,0.76,1.0,1.0,2/8,21.46%,RYR3;HSP90B1
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.273607299308529,-0.7609912760880947,1.0,1.0,1.0,14/96,11.19%,PSMB3;IL1B;IL1A;PSME3;CHUK;IRAK4;PSMC4;TP53;PSMD12;PSME4;TIFA;IKBKB;NFKBIA;ALPK1
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.3952506932860449,0.7609570014568495,0.8409090909090909,1.0,1.0,5/40,16.18%,SAP30;H2BC11;KDM1A;MTA3;TBL1XR1
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,0.37127871560976183,0.7609555371977618,0.8636363636363636,1.0,1.0,9/62,16.32%,NDUFA2;GLA;NGDN;TRNAU1AP;ITGAE;RBX1;NDUFB6;UXT;COMMD8
prerank,KEGG_2021_Human__p53 signaling pathway,0.3633694006663223,0.7609309910868726,0.8791208791208791,1.0,1.0,2/50,2.91%,THBS1;GADD45B
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.4516595531031618,0.7609034239073931,0.8148148148148148,1.0,1.0,4/14,7.48%,TOM1L1;ADGRG6;BAIAP2L1;PKP2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.4356933534425155,0.7607408106985226,0.765625,1.0,1.0,4/8,31.67%,PLCB1;SLAMF8;MIA3;DUSP1
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.2944868633165592,-0.7607360737783627,1.0,1.0,1.0,6/44,10.83%,NUP42;NEK6;BANF1;NUP155;NUP188;NUP214
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.3608382913877649,0.7604839355277625,0.8229166666666666,1.0,1.0,15/56,20.12%,EGR1;NDRG2;ABCA1;CADPS;CPM;PMP22;NFKBIZ;DDX1;BACE2;VWC2;TIMP3;STXBP6;LAPTM4A;RHOH;BEX1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.3549195824612146,0.7604304387810396,0.8602150537634409,1.0,1.0,18/76,26.32%,SAP30;VEGFA;CHURC1-FNTB;KDM1A;FXYD7;RBX1;MTA3;ATP1B3;ROCK1;ATP1B2;AP2A2;ATP1A2;STAT2;PHF21A;ARID4B;SUDS3;AP2S1;HSP90AB1
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,0.3777510788762279,0.7603867314788754,0.9120879120879121,1.0,1.0,11/72,13.83%,CLEC12A;CR1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2;HCLS1;TNFRSF1B;CD300A
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,0.3604427250980582,0.7603468256691285,0.8279569892473119,1.0,1.0,24/75,32.35%,CKS2;VBP1;SAAL1;NHP2;CACYBP;HPRT1;PSMB2;SNRPD2;TRMT10C;RPA3;PSMA5;CCT8;PAK1IP1;MZT1;AK6;DKC1;MRPL47;COA6;MRPL45;PFDN2;C1QBP;GMNN;DCUN1D5;PSMA4
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.3434488482716866,0.7601713432115561,0.9591836734693877,1.0,1.0,36/242,22.08%,SOCS3;ASB14;ZBTB16;FBXL7;RNF144B;ASB16;LNX1;RPS27A;ARIH2;TRIM9;PSMB4;RBX1;GAN;RNF126;ASB13;FBXO27;BLMH;RLIM;UBE2M;KLHL2;UBE2J2;HECW2;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;FBXO7;PSMB2;RNF138;PSMD5;PSMD7;HACE1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.5064845417972255,0.7600189035679898,0.8245614035087719,1.0,1.0,1/5,3.86%,ARF6
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.40127089873747573,0.7600083975403815,0.7763157894736842,1.0,1.0,8/21,11.97%,CREB5;SLC2A3;NR4A2;FCGR2B;PER1;CACNA2D3;NOD2;ETS2
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),-0.48299274422946664,-0.7598502300756115,0.7428571428571429,1.0,1.0,1/5,3.60%,LGALS9
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.4039832912649475,0.7597569375966549,0.8441558441558441,1.0,1.0,6/24,19.50%,FCGR2B;PDCD1LG2;NOD2;PYCARD;HSPD1;TNFRSF21
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.31300189825001506,-0.7596486476885235,0.875,1.0,1.0,4/32,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,0.5061051433621663,0.759634448277666,0.8490566037735849,1.0,1.0,1/6,9.28%,IRS2
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5024575295010435,0.7592508753096315,0.8529411764705882,1.0,1.0,1/6,9.03%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.477028461476492,0.7592277825375268,0.8108108108108109,1.0,1.0,1/11,3.57%,TFRC
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.3796092624274953,-0.7591608239539926,0.8387096774193549,1.0,1.0,3/10,14.72%,SMOX;SMS;HDAC10
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.3712861084741676,0.7589878406022241,0.8865979381443299,1.0,1.0,12/82,12.42%,EGR1;VGF;KCNH8;SH3GL3;ID2;DNM3;SHC2;IRS2;DNM1;RPS6KA2;NTRK2;SH3GL2
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.3183318764121513,-0.7588047589536329,1.0,1.0,1.0,1/26,0.21%,ITGA5
prerank,CellMarker_Augmented_2021__Memory B cell:Undefined,0.5105305694318893,0.7585224907233079,0.765625,1.0,1.0,1/5,9.26%,RBPJ
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.4527588384885841,0.7583528712120475,0.8333333333333334,1.0,1.0,4/12,31.90%,LRRK2;IMPDH1;OPA1;GTPBP1
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,0.3879618888840904,0.7582586192085031,0.7738095238095238,1.0,1.0,3/37,6.43%,NLRP12;CLEC12A;SIRPB2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.47409475868461476,0.7581759620383253,0.8153846153846154,1.0,1.0,2/9,21.86%,KDM1A;HNRNPU
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.4814901215008143,0.7581530549995035,0.8028169014084507,1.0,1.0,5/8,31.83%,SLC25A28;SLC39A14;SLC11A2;SLC25A37;SLC39A8
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.26621448400054787,-0.7581325759609241,1.0,1.0,1.0,13/57,16.47%,SIDT1;DHX38;NUP155;CHTOP;THOC5;NUP188;NUP214;DDX39A;RAE1;SLU7;ZFP36;THOC7;POLDIP3
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.36358301492149364,-0.7580569589339544,0.9259259259259259,1.0,1.0,2/17,9.36%,MAP4K2;PLXNA4
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.37663614091491643,0.7578746344187639,0.8369565217391305,1.0,1.0,9/42,21.00%,SLC1A2;SLC13A4;SLC13A3;SLC35A1;SFXN3;SLC25A21;SLC25A4;SLC3A2;SLC5A6
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.3908774780616613,0.7576263840302018,0.8045977011494253,1.0,1.0,4/30,18.81%,RPS27A;PRR5;UBA52;UBB
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.2814440609213273,-0.7575129615124108,0.9,1.0,1.0,15/68,16.47%,NUP42;DHX38;CPSF1;NUP155;CHTOP;THOC5;NUP188;WDR33;NUP214;DDX39A;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.45336537405718114,0.7574692596298112,0.8055555555555556,1.0,1.0,2/10,8.41%,CLSPN;DNA2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3874240106856894,0.7573985633869259,0.8941176470588236,1.0,1.0,9/39,20.85%,RELN;INSR;EPHA3;FGR;FLT1;EPHA4;TEC;FES;FGFR2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.4062242152033393,0.757324010443978,0.8148148148148148,1.0,1.0,1/21,2.35%,WDR5
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.32899769186572625,-0.757207364838107,0.75,1.0,1.0,3/20,4.41%,G6PC3;IDUA;RPIA
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.39161096618107516,0.7572038354424387,0.85,1.0,1.0,5/32,11.75%,SLCO1A2;SLC4A10;CA2;SLCO3A1;SLC35A1
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.264134643570101,-0.7571479528693058,1.0,1.0,1.0,19/93,15.53%,GBP3;TRIM38;SELPLG;UBA7;ARHGDIB;APOBEC3G;TMEM106A;GLIPR1;HLA-E;NFKBIA;PHF11;OAS2;PLK3;ARPC2;PTPRE;NAGK;NECAP2;BTN3A1;ZFP36
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,-0.40203329122350984,-0.7569686484762729,0.75,1.0,1.0,1/10,0.62%,G6PC3
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.498594506482264,0.7568505248091641,0.8484848484848485,1.0,1.0,2/5,17.86%,TNFRSF1B;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.4324086366772627,0.7567844305866736,0.8026315789473685,1.0,1.0,3/16,8.90%,GPM6B;CAV3;PXK
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.4709160254993857,-0.7566432054926798,0.7878787878787878,1.0,1.0,2/6,11.73%,COL5A1;SKI
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.37697651327604814,-0.7562867809897313,0.64,1.0,1.0,1/13,1.16%,NCOA4
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,0.37680097840110993,0.7561910075511951,0.8645833333333334,1.0,1.0,17/63,20.19%,DPYD;NUDT16;ENTPD3;SCO2;NUDT13;PAICS;UCKL1;CMPK1;DCK;PFAS;UPP2;HPRT1;GUK1;NME4;UCK2;CTPS1;AK5
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.3783853062029178,0.7560465068009945,0.8214285714285714,1.0,1.0,12/44,26.67%,KCNH8;XPO1;IGF1R;GNAI1;ESR1;FOS;UHMK1;CDKN1B;GNB5;FOXO3;ZDHHC7;PRMT1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.46122084049683265,0.7559935349551933,0.918918918918919,1.0,1.0,8/13,34.16%,PNPLA8;CDS2;LPCAT4;PGS1;LPGAT1;LPCAT1;ABCA3;PLA2G4A
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.34338174560323104,0.7559821793166395,1.0,1.0,1.0,129/704,23.39%,PCSK1;SAP30;TSHR;NLRP12;CD163;HTR7;RPL23;PRKAR2B;H2BC11;ERCC2;DOCK1;GPC5;RPL37A;VEGFA;VPS37C;KCNH8;SV2B;GEMIN2;SH3GL3;NUP133;RPL38;RCC1;MGAT4C;MYO10;VPS11;SNAP25;CHURC1-FNTB;XPO1;TUSC3;RPS6;GSDMD;RPS27A;KDM1A;RPL23A;TRIM25;PLK2;FGR;TXNIP;WASF1;RPS25;RPS27;FXYD7;ADCY8;NOD2;RXFP1;PSMB4;RBX1;SEC24C;SGIP1;RPS11;DYNC1H1;RPS20;RPL9;RIPK2;SH3GL2;SYT1;RPLP2;GNAI1;ZDHHC9;ANTXR2;RPL37;MAGT1;RPL14;PYCARD;GTF2H3;NELFB;WNT5A;MTA3;SEH1L;IL18;CEBPD;RPS4X;TBL1XR1;ATP1B3;RPL11;RPS24;POLR2D;SV2C;RPS9;ROCK1;SLC25A4;GUCY2C;RPL36;PIK3R4;TAF9B;ATP1B2;UBA52;SUZ12;EZH2;UBB;PSMC2;CDK9;TAF7;PSMA3;AP2A2;DUSP16;RPS3A;PGK1;ENO1;PSMB2;DYNC1I1;ATP1A2;RPL35;RPL4;POLR2G;RPL32;SNRPD2;PSMD5;STAT1;PSMD7;RAB5A;CHMP5;GNL3;VAV3;GNB5;PTGER4;RPL27A;TJP1;STAT2;JUN;NDC1;RPL3;ISCU;GANAB;MRC1;PHF21A;ARID4B;CASP1;PDCD6IP
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.42032737533724307,0.7558673173810468,0.8157894736842105,1.0,1.0,3/17,8.46%,COL11A1;LAMB1;FN1
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,0.3652501699745267,0.7557091759784087,0.8144329896907216,1.0,1.0,17/58,26.52%,CLVS1;TFRC;GNS;DNAJC6;SH3D19;SH3GL2;PICALM;APP;FTH1;HIP1R;SORT1;CLVS2;AP3B1;AP3S1;GOLGB1;IGF2R;PTGES2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.38229779339809244,0.7556728528334513,0.7831325301204819,1.0,1.0,2/41,3.87%,DTL;ANXA1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.4607736022218408,0.7554720041794277,0.835820895522388,1.0,1.0,2/10,22.47%,PLCB1;GNB5
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.4482882364180646,0.7554316274965006,0.7777777777777778,1.0,1.0,1/9,3.52%,TMEM161A
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.40129967583082854,0.7553984017597904,0.7926829268292683,1.0,1.0,5/20,22.53%,INSR;ATP1B3;ATP1B2;ATP1A2;PRKCB
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.44544306856122906,-0.7551823129093459,0.7586206896551724,1.0,1.0,2/8,9.22%,CD274;HLA-E
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.4242550035722154,0.7549669738198403,0.7654320987654321,1.0,1.0,5/17,14.69%,TFRC;PDE4B;FBP1;PPM1E;AIM2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.41595108450743756,0.7547820211465457,0.8311688311688312,1.0,1.0,4/20,20.15%,TFRC;GPI;DNAJB9;KMT5C
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3652932762446858,0.7546580431217886,0.8522727272727273,1.0,1.0,8/50,15.04%,KNSTRN;SMC4;MAP9;CLASP2;SPAST;CENPK;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.49717705700813,0.7546094848095202,0.8135593220338984,1.0,1.0,2/6,9.87%,VEGFA;PDE2A
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.34063000513522973,-0.7545224137652209,0.8,1.0,1.0,9/21,16.32%,TLN1;SRC;RASGRP2;CRK;APBB1IP;SYK;RAP1A;AKT1;TTF2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.40417628801895666,0.7544510496106199,0.7951807228915663,1.0,1.0,2/23,5.04%,KLF4;VEGFA
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.34989986757143565,0.754157921592424,0.8804347826086957,1.0,1.0,19/72,24.08%,MAPK4;XPO1;RPS27A;PSMB4;KALRN;CCND3;HSPB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;JUN;PRKACB;PSMD14;PSMA5;FOXO3
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.2619597559184651,-0.7541470195211706,1.0,1.0,1.0,5/63,6.69%,PSMB3;CCND1;PSME3;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.4557214401263052,-0.7540646476682688,0.7666666666666667,1.0,1.0,1/7,5.54%,ITGB5
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.43920307457220387,0.7540394374778684,0.8,1.0,1.0,5/11,32.04%,PKM;CPEB2;CPEB4;YBX3;DHX9
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,0.4882145901374885,0.7540182301804197,0.8194444444444444,1.0,1.0,3/9,27.24%,IQGAP1;FZR1;CTNNB1
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.48621252188760067,0.7539886969527987,0.8153846153846154,1.0,1.0,1/7,14.39%,CDC37
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.3498890376622524,-0.7535601059114088,0.8421052631578947,1.0,1.0,2/27,1.81%,H2BC4;MSH4
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.3583068945271415,0.7532144005152055,0.8444444444444444,1.0,1.0,11/70,16.85%,H2BC11;OIP5;RUVBL2;DNA2;CENPP;NHP2;CENPK;CENPI;RFC4;SHQ1;POLR2D
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.48633244065720954,0.7531935055326978,0.7846153846153846,1.0,1.0,3/6,17.69%,TDG;NEIL1;NEIL2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,0.3638577693701649,0.7531839704412707,0.8723404255319149,1.0,1.0,11/77,11.42%,CLEC12A;CR1;CD163;SLC11A1;F13A1;FCGR2B;FGR;FCGR2C;CD93;FGL2;GPR65
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.4545011275213544,0.7529224937208243,0.8289473684210527,1.0,1.0,1/10,3.42%,MYRF
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.5100687485032787,0.7528719138936106,0.8507462686567164,1.0,1.0,2/7,18.43%,STXBP2;FES
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.3588064784535832,0.752799728691703,0.8645833333333334,1.0,1.0,21/88,23.73%,BRIP1;ERCC2;RPA2;COPS5;RPS27A;RBX1;FAN1;RFC4;GTF2H3;POLR2D;POLL;ERCC6;UVSSA;UBA52;UBB;RFC1;DDB1;POLR2G;RPA3;GPS1;SLX4
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.3667599334812086,0.7526475843868424,0.8522727272727273,1.0,1.0,19/65,28.40%,CD55;ANK3;ANK2;ARFGAP1;SPTAN1;DYNC1H1;NSF;SPTBN5;SPTBN1;DCTN1;SPTBN4;DYNC1I1;NAPG;GOLGB1;DYNLL1;KDELR1;PTGES2;TMED2;BET1L
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.39764786241855277,0.7524748858364888,0.8539325842696629,1.0,1.0,5/29,22.31%,TFRC;STMN2;PKP4;FLOT2;ANKRD26
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.3931190526223116,0.752340971436819,0.8777777777777778,1.0,1.0,17/46,27.32%,CIT;FRMD5;SORBS1;FAM171A1;PHACTR1;EPB41L4B;ROCK1;EPB41L5;CSRP1;FHOD3;CDC42BPA;TJP1;EPB41L3;TNFAIP1;KCTD13;TTN;FRMD3
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.4760923425458995,-0.7522084900073224,0.717948717948718,1.0,1.0,4/6,26.07%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.361254386100042,0.7518261445182935,0.8636363636363636,1.0,1.0,11/49,23.52%,H2BC11;SMC1B;SYCP3;LMNB1;BRCA1;HSPA2;MLH1;SUN2;RBBP8;RPA3;SYCE2
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4503842649242015,0.7517433284996718,0.8607594936708861,1.0,1.0,6/11,31.16%,EMC7;CAMLG;EMC10;BAG6;EMC8;EMC3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.5079676633684933,0.7517370450703014,0.7910447761194029,1.0,1.0,1/5,6.68%,SEMA6A
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.3625228216001355,0.7517066289310194,0.8602150537634409,1.0,1.0,12/45,21.62%,COL26A1;ADAM15;COL23A1;LAMB1;ERC2;SPOCK3;CASP3;CXXC1;COL19A1;SCUBE3;COL16A1;BMP1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.36599948173566993,0.7516912698608339,0.8588235294117647,1.0,1.0,12/50,25.80%,TBC1D8;TBC1D13;DYNC2LI1;TCHP;TBC1D15;ODF2L;TBC1D2;ATG5;TBC1D14;CDK10;LIMK2;CCP110
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.43416351661693436,0.751488341502664,0.8472222222222222,1.0,1.0,4/14,25.86%,KANK1;ROCK1;RUFY3;PTK2B
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,-0.4526342451874367,-0.7514134556794186,0.8108108108108109,1.0,1.0,5/5,54.76%,RXRA;NCOA1;CYP7B1;NCOA2;CYP27A1
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5106278547599716,-0.7509475362657863,0.8333333333333334,1.0,1.0,1/5,4.55%,ATPAF2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.4299263128933777,0.7508981595452803,0.8148148148148148,1.0,1.0,4/15,14.52%,MAT2A;TMEM120B;PKD1;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.46906911632123693,0.7506185374935603,0.8309859154929577,1.0,1.0,1/7,8.38%,CAV3
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.2698304525399117,-0.7506011727908464,1.0,1.0,1.0,9/57,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.3631173875180478,0.7503668919852008,0.9010989010989011,1.0,1.0,5/57,6.80%,PRKCE;CLIP3;ARF6;PPP2R5A;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.3983883285266439,0.7503651758869575,0.8181818181818182,1.0,1.0,3/22,10.68%,ANXA1;TRAF2;PDE4B
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4546290568624458,0.7498550989949818,0.75,1.0,1.0,3/13,20.61%,PLK2;BRCA1;C10ORF90
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.3346078220846603,0.7498192251108959,0.96,1.0,1.0,36/299,19.16%,SOCS3;NDUFA2;ASB14;ZBTB16;FBXL7;RNF144B;ASB16;LNX1;HSPA5;SEC61B;RPS27A;ARIH2;TRIM9;PSMB4;RBX1;SEC24C;GAN;RNF126;ASB13;FBXO27;BLMH;RLIM;UBE2M;ITGAV;KLHL2;UBE2J2;HECW2;PIK3R4;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.4357931807596698,0.749655332908726,0.8421052631578947,1.0,1.0,6/14,25.11%,B4GALT5;APP;CX3CL1;MTCH1;ADGRB3;B4GALT6
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.3470702052588152,0.7496410024281895,0.90625,1.0,1.0,20/82,24.06%,PRKAR2B;ADCY10;RPS27A;ADCY8;PSMB4;RBX1;TULP3;KIF3A;UBA52;UBB;PSMC2;PSMA3;PSMB2;IFT122;PSMD5;DYNC2H1;PSMD7;PRKACB;PSMD14;PSMA5
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.2921972203908733,-0.7496296969799229,1.0,1.0,1.0,6/44,8.38%,PSMB3;PSME3;PSMC4;PSMD12;MED12;PSME4
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.3530543612339299,0.7495691369380509,0.898989898989899,1.0,1.0,34/146,23.60%,CLDN18;TUBA4A;TUBB4A;ARF6;TUBA1A;TRAF2;TUBB6;BAIAP2L1;MYO10;CLDN20;WASF1;SEC24C;HCLS1;CYCS;PYCARD;MAPK10;TUBB2A;CASP3;TMED10;IL18;ROCK1;TNFRSF1A;TUBA1C;FOS;TNF;PAK3;CTTN;MYO1G;TUBA1B;TJP1;JUN;CASP1;TLR5;TRADD
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.508205867457498,0.7495414304179138,0.8157894736842105,1.0,1.0,3/7,26.32%,ABCA2;LILRB2;HSP90AB1
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.39271928402136713,0.7488627177147985,0.8709677419354839,1.0,1.0,8/43,18.81%,H2BC11;PIAS4;EYA2;RPS27A;BRCA1;KDM4B;UBA52;UBB
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.3919323535846426,0.7488139170647898,0.8674698795180723,1.0,1.0,8/36,24.63%,TMEM161A;EYA2;BRCA1;NSMCE1;ERCC6;NPAS2;NACC2;BCLAF1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.32272315287053366,-0.747940477092102,0.8857142857142857,1.0,1.0,4/13,17.60%,SCYL2;UBQLN2;DAB2;DGKD
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4391085259646148,0.7478534092052534,0.881578947368421,1.0,1.0,4/12,18.43%,BAIAP2L1;NTRK3;HCLS1;FES
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.34631870895881856,0.7477575776634182,0.9278350515463918,1.0,1.0,13/145,12.73%,SOCS3;IFIT5;EGR1;EIF4A3;NUP133;PDZD2;TRIM5;RPS27A;TRIM25;IFITM3;CAMK2B;SGIP1;IFIT2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.43109079752920465,0.7475686447359252,0.8214285714285714,1.0,1.0,2/14,6.67%,SLC1A2;SLC13A3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.3897295537981841,-0.7474828859682376,0.8709677419354839,1.0,1.0,2/10,4.41%,PGM2;RPIA
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.4237544790239982,0.7474344170127294,0.7424242424242424,1.0,1.0,3/10,18.70%,ERMN;MFSD2A;NTNG1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.4120288780679548,0.7472514877332155,0.7837837837837838,1.0,1.0,5/22,21.83%,ANLN;KANK1;ROCK1;STARD13;STAT1
prerank,CellMarker_Augmented_2021__Monocyte:Lung,0.35679550810737387,0.7470801773736919,0.8645833333333334,1.0,1.0,10/75,11.30%,CLEC12A;CD163;F13A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.35746386588520973,0.7470781447074901,0.8888888888888888,1.0,1.0,9/56,17.54%,THBS1;TRAF2;EYA2;FAIM2;MCL1;BRCA1;ITGAV;HSPA1B;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.32051822341299696,-0.7468946802835461,0.9629629629629629,1.0,1.0,6/21,19.65%,TP53;TGFB1;EGFR;ZFP36;DDX5;FMR1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.4558445082988183,-0.7465335019642771,0.7555555555555555,1.0,1.0,3/5,14.21%,ALOX5;IL18R1;AKT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.4558445082988183,-0.7465335019642771,0.7555555555555555,1.0,1.0,3/5,14.21%,ALOX5;IL18R1;AKT1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.49308005610065175,0.7462909394135738,0.8611111111111112,1.0,1.0,1/6,17.16%,ROCK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.41181965372696094,0.7462430778760819,0.9101123595505618,1.0,1.0,11/28,23.25%,ERCC2;RPA2;RPS27A;RBX1;RFC4;GTF2H3;UBA52;UBB;RFC1;DDB1;RPA3
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.3865274590057545,0.7459973328316866,0.8372093023255814,1.0,1.0,2/27,4.57%,SH3PXD2B;ADAM15
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.3495423210666486,0.7456628241281047,0.8865979381443299,1.0,1.0,13/82,21.94%,BRIP1;TALDO1;RPS27A;PSMB4;RBX1;SESN1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.40578123725255555,0.7456060044762812,0.8243243243243243,1.0,1.0,1/19,3.76%,ITPKC
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,0.39308012902083544,0.7455349331813943,0.8817204301075269,1.0,1.0,8/42,18.81%,H2BC11;PIAS4;EYA2;RPS27A;BRCA1;KDM4B;UBA52;UBB
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.47784749368508267,0.7455222580646758,0.8169014084507042,1.0,1.0,2/6,20.77%,FASN;ACACB
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.3554550747375464,0.7454185714183944,0.8295454545454546,1.0,1.0,13/71,19.68%,TGFB2;PTPRK;OVOL2;RPS27A;PDE2A;SOX6;PARD3;WNT5A;SMAD1;UBA52;UBB;FOS;SMAD5
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.4270032930845225,-0.7451710585627801,0.8157894736842105,1.0,1.0,6/6,57.33%,CD4;NECTIN2;GAS6;PPIA;CXCR4;CTSL
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.4270032930845225,-0.7451710585627801,0.8157894736842105,1.0,1.0,6/6,57.33%,CD4;NECTIN2;GAS6;PPIA;CXCR4;CTSL
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.36870288092536124,0.744853927322494,0.8631578947368421,1.0,1.0,5/65,9.71%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.4711137694086377,-0.7443147929486361,0.7777777777777778,1.0,1.0,4/5,25.89%,TRPV4;CAB39;SLC12A6;STK39
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.35061848540397605,0.7442313551643377,0.9381443298969072,1.0,1.0,22/98,21.38%,INSR;DAPK1;HIF1A;VPS11;TRIM5;IRS2;PLK2;SH3D19;PFKFB4;TNFRSF1B;BNIP3;ROCK1;NPRL2;APP;PRKAA2;ZC3HAV1;PPARA;TRIM65;TNF;LRRK2;TRIM14;RDX
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.3980000486646742,0.7442100261392064,0.8518518518518519,1.0,1.0,5/31,12.08%,CR1;F13A1;CD55;C5AR1;THBD
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.28316613748645963,-0.7436381373273445,1.0,1.0,1.0,16/47,15.45%,IL1B;IL1A;LGALS9;SCIMP;TMEM106A;MAPK13;TLR3;IL17RA;LPL;TLR7;TYROBP;SYK;BCL10;IL6R;LILRA2;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.43453508318922873,0.7435833350730146,0.8552631578947368,1.0,1.0,2/18,9.50%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.3793914028037577,-0.7434776999587093,0.8095238095238095,1.0,1.0,1/13,0.93%,TICAM1
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.2877165644868353,-0.743463435484862,1.0,1.0,1.0,9/73,12.38%,NUP42;H2BC4;NUP155;MYBL1;AGO1;NUP188;NUP214;H2BC26;POLR2C
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.3310248565261886,-0.7433836879423664,0.8461538461538461,1.0,1.0,1/16,0.42%,CYB5A
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.44866693898838284,0.7432259840439538,0.75,1.0,1.0,4/7,16.96%,B4GALT5;CFL1;NR2C2;PLCB1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.358550763820655,0.7431924068732497,0.845360824742268,1.0,1.0,18/74,19.42%,SEMA3A;GADD45B;PHLPP1;TRAF2;FCGR2B;COPS5;IGF1R;PER1;NOD2;PINK1;PYCARD;SDCBP;DUSP10;AIDA;PLCB1;APP;ANKRD6;MAPK8IP2
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.3310648980120208,-0.7431632250974844,0.8421052631578947,1.0,1.0,6/23,12.29%,PLA2G12A;GPD1L;PLD2;AGPAT4;MIGA1;AGPAT1
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.4089243094530756,0.7424286657113878,0.8795180722891566,1.0,1.0,7/20,25.18%,ATOX1;CYCS;GSTP1;SOD1;ERO1A;P4HB;TXNRD1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.36925658525593213,0.7423884250578807,0.8723404255319149,1.0,1.0,5/64,9.71%,PRKCE;DOCK1;FCGR2B;MYO10;FGR
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.4322648289098996,0.7423273424374885,0.8225806451612904,1.0,1.0,3/9,26.90%,SLC44A1;SLC25A26;SEC14L1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.35375296531012357,-0.7421862563682176,0.6923076923076923,1.0,1.0,2/14,6.41%,CD300LF;SIRPA
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.3780011034718305,0.7421722716733277,0.7727272727272727,1.0,1.0,11/29,25.80%,CAV3;TCHP;TMEM39A;BRCA1;PINK1;ODF2L;LRRK2;CDK10;LIMK2;MTM1;CCP110
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.4062911799907504,0.742120694522988,0.8513513513513513,1.0,1.0,5/17,30.08%,LIMD1;CNOT6;CNOT7;AGO4;CNOT8
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.43243567904434527,-0.7420836135848666,0.7333333333333333,1.0,1.0,3/9,21.37%,ZKSCAN3;TERF2;SLC30A10
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,0.508996324390245,0.7420035422189708,0.828125,1.0,1.0,3/5,36.04%,KCNIP4;KCNIP2;KCND3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.43737577022648394,0.7419198590988426,0.855072463768116,1.0,1.0,3/11,26.55%,HERPUD1;RNFT1;BAG6
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.4436554818694384,0.7410366231178882,0.8441558441558441,1.0,1.0,5/12,29.56%,SLC25A4;OPA1;TOP3A;TYMP;SLC25A36
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,0.4919467813077309,0.741013735090754,0.8169014084507042,1.0,1.0,1/5,23.27%,KCNK10
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.26318757699020695,-0.7408695337385377,1.0,1.0,1.0,31/138,18.58%,H2BC4;GTF2H2C;CCND1;H4C3;GTF2H2;C3;TP53;KRAS;H2BC7;HPN;SRC;HLA-E;EP300;NFKBIA;GSN;VAC14;HDAC11;SYK;MAPKAPK2;POLB;IL6ST;HDAC10;NFKB2;ATF6B;GTF2E2;RANBP1;GTF2B;CASP8;HDAC7;CDC42;H2BC21
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.40262079127589323,0.7407513445199537,0.8157894736842105,1.0,1.0,1/17,1.30%,NLRP12
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.3365679685442068,-0.7407342707813598,0.7619047619047619,1.0,1.0,2/15,8.79%,MKNK1;SRC
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.35735576604393804,-0.7406511622832809,0.9166666666666666,1.0,1.0,3/21,3.26%,G6PC3;PGM2;GANC
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.3699047341339814,0.7406010889029794,0.8494623655913979,1.0,1.0,17/61,23.67%,ERCC2;RPA2;COPS5;RPS27A;RBX1;RFC4;GTF2H3;POLR2D;ERCC6;UVSSA;UBA52;UBB;RFC1;DDB1;POLR2G;RPA3;GPS1
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.36967805289908695,0.7405765649153466,0.8666666666666667,1.0,1.0,1/22,2.61%,EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.38174881923937454,0.7404202466174057,0.7804878048780488,1.0,1.0,9/23,33.36%,TMEM39A;PINK1;NRBP2;LRRK2;MTM1;UBQLN4;PIK3CA;FEZ1;CHMP4B
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.33713612860287895,0.7402282310873813,1.0,1.0,1.0,114/739,20.58%,KLF4;NAMPT;NFIL3;MACC1;FGF1;ST18;EGR1;HMGB2;PLAC8;PFKM;NFIX;ZBTB16;CREB5;MYRF;NR4A2;AGT;NFIB;NR4A1;MEIS2;SLC11A1;ACVR2A;BMPR1B;ASXL3;RORB;VEGFA;SOX4;IER5;RXRB;EIF2AK3;COPS5;HIF1A;KDM3A;HSF2;HCFC1;CSRNP3;ARNT2;RUVBL2;PAX8;FOSL2;MAFB;ID2;SS18L1;ATAD2;RBPJ;RRP1B;RPS27A;KDM1A;POU5F1;PTOV1;PER1;CRTC3;NR2F1;NOD2;ING1;GABPB1;DCAF6;DEAF1;HCLS1;ETS2;HINFP;CCNC;CSRNP2;RIPK2;NR4A3;BRCA1;DRAP1;TRIM16;YAF2;ZNF143;PKD1;E2F7;DPF3;PICALM;WNT5A;SMARCD3;ESR1;AKIRIN1;DHX33;IL18;NR2C2;LDB2;TBL1XR1;EPAS1;LITAF;TXK;CXXC1;PLCB1;SMAD1;PCBD2;TFAM;APP;KLF7;RGCC;ERCC6;ZBTB18;TNFRSF1A;UBA52;ESRRG;SMARCC1;UBB;CDK9;PPARA;TAF7;FOS;PRDM15;SMAD5;PRPF6;KDM6B;PCGF5;BEX1;TNF;NR1D1;NPAS2;TCF4
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.42138914374502606,-0.7401138313785754,0.8387096774193549,1.0,1.0,2/6,8.88%,MILR1;SERPINB9
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.4510323578854366,-0.7398666443980881,0.6944444444444444,1.0,1.0,1/5,7.51%,TGFB1
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,0.3635912968663124,0.7397726444228822,0.8478260869565217,1.0,1.0,13/51,17.38%,ENPP2;PREX2;DAAM2;RUNX1T1;CD93;SGIP1;FLT1;HIF3A;SORBS1;SHROOM4;ANGPT2;LDB2;HECW2
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.3910078048293715,-0.7395149542749853,0.75,1.0,1.0,2/8,9.42%,RHOG;NCKAP1L
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,0.3566915290478351,0.7394923019572112,0.875,1.0,1.0,10/71,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.4976324518428929,0.7392866203971403,0.7605633802816901,1.0,1.0,1/5,3.65%,OSMR
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,0.49490526182186556,0.7390805919997067,0.8115942028985508,1.0,1.0,2/6,7.98%,TCF7;TCF7L1
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.4058377184307119,0.7387088226053189,0.8051948051948052,1.0,1.0,5/20,12.55%,PFKM;TALDO1;GPI;FBP1;PRPS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.39395417643333475,0.7384806462220138,0.8,1.0,1.0,2/17,15.68%,HERPUD1;ATP2A2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.25062695301335086,-0.7384786896268947,1.0,1.0,1.0,18/97,16.04%,ZFYVE1;STAM2;RUBCNL;MTMR14;PIP4K2B;PLEKHM1;VTA1;SRC;VPS37B;WIPI1;CHMP2B;ILRUN;ATG12;TECPR1;VDAC1;HDAC10;VTI1B;BECN1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.36167645722372016,0.7384638851523123,0.8314606741573034,1.0,1.0,9/52,22.86%,WDR5;H2BC11;MAFB;POLR2D;SUZ12;EZH2;POLR2G;CNOT6;JUN
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),0.501864926201152,0.738222347623028,0.8461538461538461,1.0,1.0,4/5,48.22%,VAMP7;VAMP3;SNX4;VAMP8
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.36677602033843487,0.7377992380062346,0.8791208791208791,1.0,1.0,17/56,25.89%,RPA2;POLQ;BRCA1;XRCC3;NSMCE1;FAN1;POLL;SWI5;RBBP8;RNF138;SFPQ;RPA3;SLX4;PSMD14;RAD54B;SPIDR;REV3L
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3603186263425168,0.7377468005682575,0.9368421052631579,1.0,1.0,16/75,22.36%,DTL;EEF1A2;GFAP;FMN2;PLK2;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;IRAK3;DDB1;EEF1A1;HACE1;BARD1
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.4124181570483035,0.7375263715284716,0.8536585365853658,1.0,1.0,6/19,27.69%,GNA11;GNAQ;GNB5;GNA13;GNA15;GNA14
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.383061671102223,0.7373407807575061,0.8888888888888888,1.0,1.0,7/39,21.98%,SOX4;CAMLG;COPS9;RPL11;HSPA1B;GTPBP4;CHP1
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.4085215985408185,0.7373268438456505,0.8493150684931506,1.0,1.0,6/17,24.08%,KCNH8;XPO1;FOS;UHMK1;CDKN1B;FOXO3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.3455484912830914,0.7372359787642341,0.9042553191489362,1.0,1.0,22/101,21.58%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;CLASP2;MAP7;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3450969657208064,0.7369237302073993,0.8913043478260869,1.0,1.0,21/98,27.78%,HMGB2;SUV39H2;HCFC1;RUVBL2;TCF7L1;FAM50A;KDM4B;SMARCD3;ESR1;SMARCC1;EZH2;KDM5B;KDM6B;BRWD1;SMARCD2;SATB2;SMARCA5;JARID2;TAF6L;SETDB2;KDM6A
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.2804512084552277,-0.7366799262354878,0.9,1.0,1.0,1/26,2.51%,CCND1
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.3149077530037626,-0.736539153742097,0.9545454545454546,1.0,1.0,3/23,8.84%,ST6GALNAC3;GALNT1;ST6GAL1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.39511535232371353,0.7362813182537133,0.8571428571428571,1.0,1.0,2/22,6.41%,CACNB2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.4295901273906546,-0.7362540626036722,0.84375,1.0,1.0,2/7,15.01%,STIM1;CACNA1D
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.38258118193633683,0.7357413487355962,0.7625,1.0,1.0,11/25,33.13%,NR4A3;SOD2;CDKN1B;MFN2;PDCD4;JUN;PTEN;PRKG1;MEF2D;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.39293446187038195,0.7356322084261215,0.8414634146341463,1.0,1.0,2/27,3.45%,TGFB2;GLIPR2
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.3605922434340784,0.7354640850663978,0.8586956521739131,1.0,1.0,5/80,7.90%,WDR5;H2BC11;HCFC1;RUVBL2;YEATS2
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.4892855480546039,-0.7352704196169375,0.8181818181818182,1.0,1.0,1/5,5.10%,MLKL
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.35085217863570617,0.7351593243101371,0.8876404494382022,1.0,1.0,12/56,22.43%,TTBK2;ADAM15;MAP2;KDM1A;TFIP11;DNAJB2;IFIT2;ATP2A2;ROCK1;LRRK2;CTNNBIP1;HFE
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.398855678478521,0.7351250121206749,0.9176470588235294,1.0,1.0,7/30,21.55%,SH3D19;TNFRSF1B;PINK1;ASPH;TNF;TNIP1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.3516617557085149,-0.7351104087352084,0.8888888888888888,1.0,1.0,5/13,16.02%,PPP1R3F;BAG5;SMG6;FEM1A;EMP2
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.4447648861017992,0.7351080702433781,0.863013698630137,1.0,1.0,3/11,20.66%,CAV3;HAMP;ATP1A2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.340052886850579,0.7349622195948851,0.875,1.0,1.0,22/103,21.58%,CACNB2;SCN3B;RAB3C;ANK3;ANK2;PKP2;FCHO2;RAB15;CAV3;CLASP2;MAP7;ATP1B3;KCNIP4;SPTBN1;ROCK1;DPP6;KCNB2;TNFRSF1A;SPTBN4;TNF;RDX;FLOT2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.4706146286549041,0.7349300251711619,0.7910447761194029,1.0,1.0,3/6,18.25%,SGCZ;SGCD;SOD1
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.4011709379606136,0.7348894830884928,0.825,1.0,1.0,1/19,2.98%,H2BC11
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3725985196492167,0.7347484247920187,0.9080459770114943,1.0,1.0,11/51,17.63%,RGS20;KCTD8;RGS2;SYP;TULP3;RGS11;RASGRP4;PLCB1;GRK4;ROCK1;SLC39A14
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.4290726798310807,-0.7347386010544592,0.7647058823529411,1.0,1.0,2/5,15.67%,PLK3;STX5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.44295456677636896,0.7346913159181934,0.8243243243243243,1.0,1.0,4/12,20.20%,NOD2;TNFRSF1B;WNT5A;TNF
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.37558600795026775,0.7346028441256819,0.875,1.0,1.0,15/61,22.36%,DTL;VPS11;PLK2;SH3D19;TNFRSF1B;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;DDB1;RDX;HACE1;BARD1
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.37573986556447864,0.7345954229055391,0.8505747126436781,1.0,1.0,8/37,21.49%,PDK4;L2HGDH;PDK3;SLC16A3;SLC16A1;MPC2;PDHB;PDPR
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.33398726660100597,-0.7345234674597649,0.85,1.0,1.0,2/21,6.50%,IL1B;TP53
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.41275921688015604,-0.7339646443341951,0.7096774193548387,1.0,1.0,4/8,12.62%,ITPA;ENPP1;ENTPD4;ENTPD1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4498388438934152,0.7338087464551815,0.8260869565217391,1.0,1.0,6/8,42.20%,SNAPC3;ICE2;SNAPC4;ELL;SNAPC1;ICE1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.48156268098574767,0.7337182088630759,0.8888888888888888,1.0,1.0,3/7,13.96%,RELN;SOX4;PKD1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.47366066093952486,0.7336527203790162,0.7945205479452054,1.0,1.0,4/8,34.00%,SIRT3;SIRT4;HDAC9;HDAC4
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3873806709679009,0.733558368014114,0.8518518518518519,1.0,1.0,2/24,10.58%,NGDN;RRP36
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.39333899917802356,-0.7329633713329999,0.7741935483870968,1.0,1.0,1/7,4.31%,PHAX
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.5003459195799091,0.7329402596026023,0.8571428571428571,1.0,1.0,2/7,12.87%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.3994588346431338,-0.7328256930488415,0.8214285714285714,1.0,1.0,2/7,8.54%,APOBEC3G;MYBL1
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.270950288538099,-0.7327729183223606,0.9285714285714286,1.0,1.0,3/39,9.23%,SESN2;LAMTOR1;MIOS
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3766787370639507,0.7326376987594021,0.8928571428571429,1.0,1.0,8/36,24.91%,NUP133;REEP3;SEH1L;SUN2;CHMP5;NDC1;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3745659041901037,0.732537804171373,0.8148148148148148,1.0,1.0,7/20,25.86%,EPHA4;PINK1;PKD1;UBB;ATP5IF1;PSMD14;PTK2B
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.3979950973901082,0.732262707132626,0.8260869565217391,1.0,1.0,1/14,5.36%,GPNMB
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.43606817399918746,0.7319814079338802,0.8552631578947368,1.0,1.0,4/15,17.58%,SPDYA;PKD1;CCND3;RGCC
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.3327397539185013,0.7316664455473095,0.9797979797979798,1.0,1.0,62/290,27.18%,SAP30;NLRP12;GPC5;VEGFA;GEMIN2;NUP133;MGAT4C;VPS11;CHURC1-FNTB;TUSC3;RPS6;RPS27A;KDM1A;TRIM25;RPS25;RPS27;FXYD7;NOD2;RBX1;SEC24C;RPS11;RPS20;RIPK2;ZDHHC9;MAGT1;MTA3;SEH1L;RPS4X;ATP1B3;RPS24;RPS9;ROCK1;PIK3R4;ATP1B2;UBA52;UBB;AP2A2;RPS3A;ATP1A2;SNRPD2;STAT1;TJP1;STAT2;NDC1;ISCU;GANAB;PHF21A;ARID4B;RPS16;CHMP7;GPC3;POM121;SUDS3;AP2S1;PRKCSH;TLR2;HSP90AB1;FAU;PRMT1;RPS12;NUP58;MGAT4B
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.25842438376165977,-0.7316210930250083,1.0,1.0,1.0,17/61,20.22%,GTF2F1;RPRD1B;PHAX;SRRT;TAF13;INTS9;RPAP2;POLR2C;RPRD1A;TAF8;GTF2E2;INTS4;GTF2B;POU2F2;TBP;INTS7;SNAPC5
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.40406854805612225,0.7316190083632718,0.85,1.0,1.0,6/18,23.39%,CDC37;SDCBP;PELI1;SLC25A4;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.4362894614016995,0.731273433507884,0.8289473684210527,1.0,1.0,4/13,18.43%,FGR;CD300A;STXBP2;FES
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),-0.4550225314982884,-0.7311370694574915,0.7428571428571429,1.0,1.0,2/6,12.49%,PHB2;EIF2AK4
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.44824592339596847,-0.7310113806570545,0.8275862068965517,1.0,1.0,3/7,22.13%,IVD;MCCC1;BCAT2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.4184283254488835,0.7308591219021385,0.7466666666666667,1.0,1.0,8/15,33.92%,PRPS1;HPRT1;NMNAT2;MTHFD1;ME1;PNP;PPAT;GART
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,0.3504284136789436,0.7307441922560879,0.9081632653061225,1.0,1.0,11/83,12.72%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;CD93;FGL2;TNFRSF1B
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.42520422788257656,-0.7306558288306317,0.8620689655172413,1.0,1.0,1/8,2.69%,ZDHHC3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.43280786951752453,-0.7305670251528175,0.7428571428571429,1.0,1.0,1/5,13.75%,POLB
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.47100479368321135,0.7305055329121695,0.875,1.0,1.0,4/8,33.99%,NPRL2;ATG5;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.47100479368321135,0.7305055329121695,0.875,1.0,1.0,4/8,33.99%,NPRL2;ATG5;MAP1LC3A;MAP1LC3B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.4552420507692845,0.7304478855030783,0.8382352941176471,1.0,1.0,3/7,22.38%,SOD2;MFN2;PDCD4
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.4046113966242001,0.7304447645031397,0.8170731707317073,1.0,1.0,1/20,2.53%,PRKCE
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4213963800320757,0.7303990109060994,0.7777777777777778,1.0,1.0,6/12,36.26%,TMEM50A;CHMP5;CHMP7;CHMP4B;STAM;SNF8
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.35234467177702883,0.7303122603323846,0.8620689655172413,1.0,1.0,12/50,24.06%,FBXL7;FHL1;PSMB4;RBX1;INTS3;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.3236926869010529,0.730257625963176,0.98,1.0,1.0,70/390,24.06%,DTL;MKRN3;H2BC11;FBXL7;UBE2QL1;ENC1;RNF144B;TRAF2;FBXL2;HIF1A;VPS11;TRIM5;RPS27A;TRIM25;ARIH2;RNF144A;PSMB4;RBX1;GAN;HIF3A;RNF126;SASH1;VCPIP1;BRCA1;FBXO27;BLMH;PINK1;RNF139;RLIM;TRIM26;UHRF2;PELI1;DTX3;KLHL8;SYVN1;KLHL2;RNF13;EPAS1;NEURL1;UBE2J2;HECW2;FANCL;UVSSA;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;FBXO7;PSMB2;C10ORF90;TRIM14;RNF138;DDB1;PSMD5;TRIM24;PSMD7;HACE1;BARD1;MAGEF1;USP5;UHRF1;UBE2D2;RNFT1;PSMD14;DTX2;PSMA5
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.3508141099895077,0.7301517265790495,0.9285714285714286,1.0,1.0,17/92,20.89%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;PIK3R4;UBA52;UBB;FOS;DUSP6;ECSIT
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.447777357041948,0.7301134222266126,0.8082191780821918,1.0,1.0,2/7,17.54%,MID1IP1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.4597113182187098,0.7300154839401204,0.8840579710144928,1.0,1.0,1/11,3.57%,TFRC
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.4656593986892472,0.7298974033854713,0.7936507936507936,1.0,1.0,1/6,5.54%,ROBO2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.4604833333260855,0.729864489064885,0.8493150684931506,1.0,1.0,1/8,8.94%,ADGRB2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.4604833333260855,0.729864489064885,0.8493150684931506,1.0,1.0,1/8,8.94%,ADGRB2
prerank,KEGG_2021_Human__Retinol metabolism,0.4225088369100369,0.7296638812377144,0.7972972972972973,1.0,1.0,5/12,18.02%,CYP3A5;DGAT1;RDH11;ALDH1A1;ADH5
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.34346164677392604,0.7296108229901164,0.9052631578947369,1.0,1.0,18/65,23.64%,CLEC4E;NLRP12;SLC11A1;OLIG1;CELF2;RNF175;CD300A;PHACTR1;RASGRP4;LRRC25;PLXNC1;B3GAT1;NCAM1;SLC24A4;PRKCB;SYT11;FPR1;ARHGAP9
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.4615798828692781,0.7295729038111017,0.8235294117647058,1.0,1.0,2/8,11.92%,PPP2R5A;PIK3IP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4161679254289343,0.7293141565407354,0.8181818181818182,1.0,1.0,4/18,14.88%,ERCC2;RPA2;RBX1;GTF2H3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4161679254289343,0.7293141565407354,0.8181818181818182,1.0,1.0,4/18,14.88%,ERCC2;RPA2;RBX1;GTF2H3
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.3028869124483553,-0.7292312894933035,0.875,1.0,1.0,2/32,4.87%,PDE12;KHSRP
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.3418530046023568,0.7288922528548123,0.9894736842105263,1.0,1.0,14/110,12.83%,CDK14;ZBTB16;GADD45B;RXRB;RUNX1T1;BMI1;ARNT2;PAX8;ID2;IGF1R;GRIA3;FLT1;NFKBIZ;NR4A3
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.3307132618401226,0.7288880857564185,0.98989898989899,1.0,1.0,90/368,24.31%,SOCS3;ST18;PRLR;VIM;IFIT5;EGR1;IL15;TALDO1;OSMR;ANXA1;LIFR;MAP3K8;F13A1;VEGFA;TRAF2;IL7;PTPRZ1;HIF1A;GRB10;TRIM5;FN1;IRS2;TNFRSF11B;RPS27A;MCL1;GHR;TRIM25;IFITM3;LMNB1;NOD2;PSMB4;RBX1;CAMK2B;IFNLR1;RIPK2;CRLF1;TNFRSF1B;IFIT2;SOD2;TRIM26;PYCARD;AIM2;PELI1;CASP3;CFL1;UGCG;IL18;CEBPD;IL11RA;TCP1;GBP2;TEC;PLCB1;BCL6;TNFRSF1A;SOD1;UBA52;UBB;PSMC2;PSMA3;FOS;NCAM1;TNF;PSMB2;IL7R;CDKN1B;LEPR;IRAK3;CX3CL1;P4HB;PSMD5;HSP90B1;BRWD1;STAT1;APPL1;PSMD7;MAP3K3;PDCD4;RHOU;STAT6;STAT2;RORA;FPR1;CASP1;TRADD;PSMD14;PSMA5;FOXO3;TRAF3IP2;IL21R
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,-0.4061972306653158,-0.7288848738231821,0.7142857142857143,1.0,1.0,5/5,59.41%,MAP2K2;MAPK3;BRAF;MAP2K1;MAPK1
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.399023871124998,0.7288361421525743,0.8488372093023255,1.0,1.0,3/21,9.68%,H2BC11;TDG;NEIL1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.4035580603271267,0.7288118428468556,0.8783783783783784,1.0,1.0,7/15,30.41%,RUVBL2;ESR1;CHMP7;MACROH2A2;WAPL;MACROH2A1;RAD21
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.35502774623300365,0.7286183992235907,0.8791208791208791,1.0,1.0,5/36,16.76%,RNASEH2C;OGA;STT3B;FBXO27;SND1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,0.46346250892988294,0.7283936516518321,0.8904109589041096,1.0,1.0,2/7,19.96%,THY1;NCAM1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3068765867017882,-0.728377152352029,0.8333333333333334,1.0,1.0,7/23,16.39%,DAB2IP;TRIB3;MAP3K5;QRICH1;ATP2A3;BCL2;DNAJC10
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4448870103581983,0.7281518394986113,0.8636363636363636,1.0,1.0,1/11,2.98%,H2BC11
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.3924681246305835,-0.7280587042558752,0.7948717948717948,1.0,1.0,6/6,60.78%,DENND4C;DENND1A;DENND4A;DENND3;DENND4B;MADD
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.33931218597894247,0.7277220028448101,0.9042553191489362,1.0,1.0,25/109,24.95%,DKK2;GPC5;DAAM2;SOX4;KANK1;PTK7;GSKIP;SEMA5A;GPRC5B;PSMB4;SULF2;TBL1XR1;PSMC2;PSMA3;PRDM15;PSMB2;LRRK2;FGFR2;PSMD5;PSMD7;PSMD14;PSMA5;RNF220;DDX3X;GPC3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.38460415993532404,-0.7276440734850061,0.7692307692307693,1.0,1.0,4/10,15.49%,BCL2L1;BID;BCL2;FIS1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.3548751824744698,-0.7275440363022406,0.8620689655172413,1.0,1.0,3/11,18.20%,TREM2;SCFD1;CEP290
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.3516968689089347,-0.7275133656642235,0.8888888888888888,1.0,1.0,2/18,2.17%,LRIG1;POLD3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.444229406692212,0.7274912097571544,0.8676470588235294,1.0,1.0,1/11,9.26%,RBPJ
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.5072584680644382,0.7274353521725471,0.8771929824561403,1.0,1.0,2/5,14.62%,HSPA5;DNAJB9
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.35109543302815427,0.727414799970044,0.8791208791208791,1.0,1.0,9/58,14.53%,ZDHHC15;NUP133;RYR2;PRICKLE1;HEATR3;FAM53C;PINK1;TNPO2;RANBP17
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.2635391670787125,-0.7272036849357751,1.0,1.0,1.0,11/75,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;LARS2;FASTKD2;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.35601083487949897,0.7268932568942912,0.8804347826086957,1.0,1.0,7/55,15.04%,HAUS6;RCC1;MAP9;CLASP2;GOLGA8B;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.36000695463188426,0.7268929453140164,0.8409090909090909,1.0,1.0,9/46,15.66%,ANXA1;SIPA1L1;PTK7;MICALL2;THSD7A;GPR65;THSD7B;GAB1;PHACTR1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.3521431304632261,0.7267594428659884,0.9318181818181818,1.0,1.0,9/54,17.08%,HMGB2;H2BC11;SLC11A1;GSDMD;FGR;NOD2;PYCARD;GBP2;HAMP
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.4186146921818373,0.7266968056527142,0.8225806451612904,1.0,1.0,4/11,29.50%,ROCK1;TNF;LRPAP1;LRP1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.4265257957314464,-0.725715942268106,0.7222222222222222,1.0,1.0,2/6,8.31%,SLC30A5;PHB2
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.40656665482601917,0.7256704471132298,0.8518518518518519,1.0,1.0,5/22,18.46%,BOK;IFIT2;SOD2;BNIP3;HSPD1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.3345951895644952,-0.7256652566222086,0.8421052631578947,1.0,1.0,4/19,12.04%,ZNF675;LILRB4;TLR3;UBASH3B
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.3851287238467437,-0.7254561512133276,0.7567567567567568,1.0,1.0,1/8,8.58%,GNAS
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.4509908130576735,-0.7253764328966272,0.8787878787878788,1.0,1.0,1/5,14.21%,AKT1
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.4304263262435912,0.7253463746943325,0.8382352941176471,1.0,1.0,3/11,29.42%,PLCB1;GNB5;GRIK3
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.4122816021945589,-0.7253117943974988,0.8,1.0,1.0,3/7,13.01%,ICAM1;RIPOR2;PLVAP
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,-0.36729357850328537,-0.7253009667852276,0.875,1.0,1.0,2/11,8.73%,CYP19A1;CYP4V2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3755699376821006,0.7252212449947733,0.8620689655172413,1.0,1.0,9/39,29.62%,PER1;MTA3;TBL1XR1;MORF4L2;SFPQ;SUDS3;MSL3;SMARCAD1;HDAC9
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.4697593432188024,0.724822743837434,0.8142857142857143,1.0,1.0,3/6,33.42%,PMP22;MYLK;EMP3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3693592463790255,0.7246725321197952,0.8333333333333334,1.0,1.0,5/29,15.04%,RACGAP1;MAP9;CLASP2;KIF11;TOGARAM1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.2533793252135721,-0.7245044832109973,1.0,1.0,1.0,6/62,6.35%,GTF2F1;RPRD1B;PHAX;SRRT;TAF13;INTS9
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.3345376299891493,0.7244143225087298,0.99,1.0,1.0,57/277,24.83%,BRIP1;DDIT4;ERCC2;NDRG1;SCO2;PDZD2;PCBP4;PPP1R13L;BNIP3L;DNA2;FANCI;RPS27A;PLK2;PRR5;TTC5;PRKAG2;COX7C;CYCS;BRCA1;PRELID1;FASN;E2F7;RFC4;GTF2H3;NELFB;POLR2D;BCL6;RGCC;SCO1;PRKAA2;TAF9B;SESN1;UBA52;UBB;CDK9;TAF7;CDK5R1;MLH1;FOS;COX4I1;MEAF6;RBL2;CDKN1B;RBBP8;POLR2G;SETD9;BARD1;COX6C;CNOT6;JUN;RPA3;CASP1;PTEN;BANP;COX6B1;COX20;CDK12
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.37992626923237177,0.7243270356964558,0.8505747126436781,1.0,1.0,8/27,17.93%,TDG;MPG;NEIL1;POLG2;RFC4;POLE2;NEIL2;ADPRS
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.39271828341655685,-0.7241229071762245,0.88,1.0,1.0,3/8,22.47%,PHB2;BECN1;PRKN
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.4268843498993005,0.7240586754922452,0.8311688311688312,1.0,1.0,1/14,2.51%,CADM1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.4445518628805807,0.723864142867623,0.8648648648648649,1.0,1.0,1/7,1.74%,AMER2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3894923175108179,0.7237219234023905,0.8414634146341463,1.0,1.0,8/27,22.30%,CAMK2N1;CCNB3;CDC37;CCND3;GTPBP4;CDK5R1;CDKN1B;CNPPD1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.3749601378023202,0.7236222411002661,0.9069767441860465,1.0,1.0,8/43,15.83%,IL15;TFRC;ANXA1;IL7;IRS2;PDCD1LG2;GPR183;IL18
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.4140161286623811,0.7236203045763591,0.891566265060241,1.0,1.0,1/18,2.26%,HMGB2
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Undefined,0.4923959377729811,0.7232169422675826,0.7941176470588235,1.0,1.0,1/5,17.23%,BCL6
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.44980081484697204,0.7232078940803419,0.8484848484848485,1.0,1.0,2/9,30.03%,HSD17B4;SLC27A5
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,0.3735770891171507,0.7231691448924384,0.8192771084337349,1.0,1.0,2/29,7.06%,MDH1;MAT2A
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.4753202972795433,0.7230776431006913,0.9054054054054054,1.0,1.0,3/8,26.41%,STXBP2;FES;DNASE1
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.41442142753753825,0.7230176469653844,0.8214285714285714,1.0,1.0,3/14,24.01%,LMNB1;VRK2;VRK1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3197494710071358,-0.7229363392994337,0.8888888888888888,1.0,1.0,7/46,8.14%,KRT10;APPL2;ALDH9A1;FARSA;RYR1;KCNC3;SSBP1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.44601793834476045,0.7227861402950018,0.863013698630137,1.0,1.0,5/12,30.15%,CDK9;METTL4;HNRNPU;TLK1;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.41790163968524696,0.7226834535520278,0.8767123287671232,1.0,1.0,6/11,34.26%,RAPGEF3;PRKAA2;DDX3X;TERF2IP;TAOK1;DIP2B
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3576309328834151,0.722487898016975,0.9157894736842105,1.0,1.0,6/66,12.83%,PRKCE;DOCK1;FCGR2B;MYO10;FGR;NR4A3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.37181466437634036,0.7223696131123083,0.9047619047619048,1.0,1.0,7/33,23.75%,H2BC11;ROBO1;CCDC3;GSTP1;IRAK3;STAT2;GPS2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.429446582978387,0.7222594452577416,0.8518518518518519,1.0,1.0,2/10,14.44%,NUP133;NXF1
prerank,KEGG_2021_Human__Toxoplasmosis,0.3461726078948334,0.7222440358813315,0.9565217391304348,1.0,1.0,12/78,20.20%,TGFB2;GNAO1;LAMA2;LAMB1;CYCS;GNAI1;MAPK10;CASP3;HSPA1B;TNFRSF1A;HSPA2;TNF
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.39961171003627277,0.7222210282336954,0.8734177215189873,1.0,1.0,4/23,20.98%,SRSF12;CELF2;PRPF39;SRSF5
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.3309967482414921,0.7221736373627452,0.9897959183673469,1.0,1.0,65/277,23.36%,SOCS3;PRLR;NLRP12;VIM;EGR1;OSMR;CHI3L1;IL1RAPL1;ANXA1;LIFR;F13A1;VEGFA;TCF7;IL7;PTPRZ1;DAPK1;AKAP6;HIF1A;GRB10;PTPRT;FN1;RPS27A;MCL1;GHR;PDE2A;HCLS1;IFNLR1;CRLF1;TNFRSF1B;BRCA1;PYCARD;AIM2;WNT5A;CASP3;IL18;CEBPD;IL11RA;GBP2;TEC;BCL6;PTPN9;TNFRSF1A;UBA52;UBB;CDK9;PTPN5;TNFRSF21;FOS;TNF;NR1D1;PTPN20;CDKN1B;LEPR;IRAK3;CX3CL1;HSP90B1;STAT1;HNRNPU;RHOU;STAT6;GSDME;STAT2;RORA;FPR1;CASP1
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,0.3421228164580999,0.7220913166233328,0.9473684210526315,1.0,1.0,11/83,16.48%,CLEC12A;CR1;SLC11A1;FCGR2B;FGR;FCGR2C;FGL2;GPR65;CD300A;RASGRP4;LRRC25
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.38295443256675377,0.7220452048542856,0.8505747126436781,1.0,1.0,6/24,20.58%,BRINP1;GPRC5B;IMPACT;VWC2;ECT2;TCF4
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.27265226928847264,-0.7218009617917125,1.0,1.0,1.0,12/45,16.47%,DHX38;CPSF1;CHTOP;THOC5;WDR33;DDX39A;CSTF1;SLU7;CPSF2;CPSF4;THOC7;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.4436672385767889,0.7216478430442171,0.7945205479452054,1.0,1.0,1/7,6.39%,ANK3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.37533141788534563,0.7215908115303389,0.9240506329113924,1.0,1.0,5/33,15.01%,TRAF2;TRIM5;ARIH2;RNF126;PELI1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.3988160763347029,0.7212799935021564,0.8611111111111112,1.0,1.0,5/20,19.88%,KDM3A;KDM1A;KDM4B;KDM5B;KDM6B
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,0.34987661257851593,0.7211805226354224,0.851063829787234,1.0,1.0,14/66,25.06%,EIF4A3;NUP133;PDZD2;RPS27A;TRIM25;SGIP1;SEH1L;UBA52;UBB;STAT1;GNL3;NDC1;EIF4A2;POM121
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.3559749921841759,0.7209441232477883,0.9195402298850575,1.0,1.0,1/38,0.72%,MDH1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.3767058257871102,0.720802097520495,0.896551724137931,1.0,1.0,8/35,28.25%,RBM3;PER1;RBM4B;APP;FOXO3;GRM5;PARP9;MAPKAPK5
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.42594623040064283,0.7207966919958785,0.7647058823529411,1.0,1.0,4/9,30.88%,SDCBP;DLG4;LRPAP1;ATXN2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.30020099577127934,-0.7207928918605161,0.8666666666666667,1.0,1.0,3/18,8.28%,MEP1A;LGR4;TNFSF10
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.29491334636865607,-0.7207194692041776,0.8823529411764706,1.0,1.0,6/29,17.28%,CHUK;MAPK13;IKBKB;BIRC2;CASP2;CASP8
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.4109945712224157,0.7207148271724227,0.8333333333333334,1.0,1.0,1/16,3.24%,SLC6A15
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3258900654499201,0.7205939405986288,0.98989898989899,1.0,1.0,59/300,25.82%,MKRN3;H2BC11;FBXL7;ENC1;PIAS4;NUP133;FBXL2;HIF1A;VPS11;TRIM5;RPS27A;ARIH2;RNF144A;RBX1;GAN;HIF3A;VCPIP1;BRCA1;PINK1;RNF139;RLIM;TRIM26;UHRF2;UBE2M;DTX3;KLHL8;SEH1L;SYVN1;KLHL2;EPAS1;KIAA1586;UBE2J2;HECW2;UVSSA;UBA52;UBB;FBXL5;FBXO7;C10ORF90;TRIM14;BCL11A;RNF138;DDB1;TRIM24;HACE1;BARD1;MAGEF1;NDC1;USP5;UHRF1;UBE2D2;DTX2;DDRGK1;RNF220;PEX10;POM121;TRIM52;TRAF7;TNFAIP1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.38369074098643347,0.7205151974654532,0.8795180722891566,1.0,1.0,9/27,26.55%,CAMLG;SDCBP;RPL11;NOP53;HFE;MAP1A;DDRGK1;HSP90AB1;BAG6
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.41223063351389844,0.720443010827471,0.8292682926829268,1.0,1.0,2/13,16.84%,MVD;DHDDS
prerank,KEGG_2021_Human__African trypanosomiasis,-0.33903721526715497,-0.7199895980484682,0.8076923076923077,1.0,1.0,2/14,5.01%,IL1B;ICAM1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.4336379128364282,-0.719801059472252,0.71875,1.0,1.0,3/6,15.20%,NPL;GNPDA1;NAGK
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.3638763992714331,0.7197563162567001,0.8571428571428571,1.0,1.0,7/38,12.29%,TACR1;ANXA1;GPNMB;MCHR2;C5AR1;RXFP1;RIPK2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.43630400019514193,0.7196948436053895,0.8955223880597015,1.0,1.0,5/11,41.90%,PARP9;TIPARP;PARP11;PARP10;PARP12
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.31884163886110767,-0.7190090581129205,0.9,1.0,1.0,9/17,25.20%,CD226;BCL10;CARD11;RAB29;CD81;PRKD2;SLC39A10;RELA;IKBKG
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3783610372388538,0.7189605434441426,0.9012345679012346,1.0,1.0,5/29,21.40%,GEMIN2;SRSF12;SART3;PRPF6;SNRPD2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.4013337759864553,0.7188191820043288,0.8428571428571429,1.0,1.0,4/15,20.53%,PPM1E;DUSP10;DUSP16;DUSP6
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.37826468829295445,0.7186013590442202,0.8488372093023255,1.0,1.0,3/30,10.81%,PRKAR2B;FGR;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.45848616781284646,0.7184671796337647,0.8481012658227848,1.0,1.0,4/7,37.27%,PARP9;GMNN;MED25;HMBOX1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.30487988060738713,-0.7183252779058749,0.8888888888888888,1.0,1.0,4/14,12.50%,IL1B;APPL2;REST;SORL1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3778406238664881,0.717983572441838,0.8414634146341463,1.0,1.0,2/23,5.25%,WDR5;SUV39H2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.2636445245869302,-0.7177505232706413,1.0,1.0,1.0,9/56,12.73%,NUP42;TGFB1;NUP155;AGO1;NUP188;NUP214;RAE1;POLR2C;ELAVL1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.3692034800236506,-0.7176517873879681,0.8076923076923077,1.0,1.0,10/10,63.12%,OPTN;TRIP11;GCC2;MYO18A;VTI1A;VAMP4;GOLGA2;STX6;GOLPH3;TMED5
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.4085351256112637,0.7175319480983713,0.7792207792207793,1.0,1.0,2/16,10.76%,MAP3K8;PRR5
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3286439548272484,0.7173829268255517,0.9489795918367347,1.0,1.0,21/133,24.09%,PRKCE;CLSPN;TTBK2;MASTL;EIF2AK3;RPS6KB2;PLK2;RPS6KA2;PINK1;PKD1;PDK3;ROCK1;MAP3K13;CDK5R1;UHMK1;LRRK2;VRK2;PRKCB;MAST4;VRK1;BRSK1
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.4293246933936674,0.7171924135274366,0.8604651162790697,1.0,1.0,2/13,11.82%,LSR;NCEH1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.3982896610443658,0.716921180921979,0.8875,1.0,1.0,8/26,24.91%,VPS37C;RPS27A;SGIP1;UBA52;UBB;CHMP5;PDCD6IP;CHMP7
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.34606661761504476,0.7168802145152485,0.9285714285714286,1.0,1.0,16/87,20.89%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.3587553057255433,0.7168746397816821,0.8941176470588236,1.0,1.0,13/56,25.06%,PFKM;ENO2;NUP133;PFKFB4;PKM;HOOK3;SEH1L;PGM2L1;PGK1;ENO1;NDC1;PRKACB;POM121
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.5021270725613192,0.7166892532440522,0.8676470588235294,1.0,1.0,2/5,27.46%,PPP1R15A;PTPN1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.3166455032036543,-0.7166736304563054,0.96,1.0,1.0,1/22,0.32%,MATK
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,0.5003276725169238,0.7166554488638308,0.9117647058823529,1.0,1.0,1/5,11.37%,AGPS
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.4747741236387998,0.7159515626261344,0.8783783783783784,1.0,1.0,2/6,14.74%,PTPRT;DUSP10
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4276475375178952,0.71587520362892,0.8333333333333334,1.0,1.0,1/10,13.53%,INSIG1
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.3354858289333746,0.7158651803547427,0.9157894736842105,1.0,1.0,4/88,5.17%,SAP30;H2BC11;ERCC2;TDG
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",-0.4198167953063394,-0.7157824659550969,0.6842105263157895,1.0,1.0,1/7,0.78%,CASP7
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.3446467964147917,0.715706321971676,0.9183673469387755,1.0,1.0,16/88,20.89%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.3446467964147917,0.715706321971676,0.9183673469387755,1.0,1.0,16/88,20.89%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.3708265358066566,0.715589158908435,0.8536585365853658,1.0,1.0,4/27,12.35%,SLC11A1;NOCT;TENT5A;HNRNPA0
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.32908785121668016,0.7155119464320444,0.9587628865979382,1.0,1.0,22/138,24.09%,PRKCE;CLSPN;TTBK2;MASTL;EIF2AK3;RPS6KB2;GALNT13;PLK2;RPS6KA2;PINK1;PKD1;PDK3;ROCK1;MAP3K13;CDK5R1;UHMK1;LRRK2;VRK2;PRKCB;MAST4;VRK1;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3333114716904785,0.7155021673198768,0.9791666666666666,1.0,1.0,26/117,21.58%,RAB7B;TFRC;AGT;TRAF2;SLCO3A1;TRIM5;RPS27A;TRIM25;ALK;NOD2;RIPK2;PYCARD;AIM2;WNT5A;DHX33;IL18;MAP3K13;HSPA1B;APP;UBA52;UBB;TNF;TRIM14;IRAK3;CX3CL1;FLOT2
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.38038451818064334,-0.7154956515373602,0.8064516129032258,1.0,1.0,4/9,21.06%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.38038451818064334,-0.7154956515373602,0.8064516129032258,1.0,1.0,4/9,21.06%,VTA1;CHMP2B;CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.42605597628553177,-0.7154277963678238,0.9032258064516129,1.0,1.0,1/9,2.37%,SETD6
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,0.45688596343112226,0.7151463666638856,0.8873239436619719,1.0,1.0,3/6,25.27%,COQ6;COQ2;GGCX
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.34415833594272366,-0.7150330250937511,0.7692307692307693,1.0,1.0,3/20,7.15%,TAL1;DUSP3;EIF4EBP1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.32934545766158135,0.7148043778349324,0.9347826086956522,1.0,1.0,6/71,15.82%,PQBP1;POLR3F;TRIM25;POLR1C;POLR3H;DHX33
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.400985072013234,0.7147420102383956,0.8461538461538461,1.0,1.0,1/20,2.51%,CADM1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.32749409483586484,0.7146466835010034,0.97,1.0,1.0,37/203,18.63%,KLF4;ST18;OGN;TGFB2;BMPR1B;PTPRK;SOX4;GPNMB;ALOX15B;CAMK2N1;DNAJB2;RPS6KA2;IFNLR1;MAGI2;RBM5;SOD2;CLMN;RNF139;CD300A;PLXNB1;E2F7;DUSP10;WNT5A;NDRG4;THAP12;CTBP1;CHD5;PRKRA;NEURL1;HSPA1B;APP;GSTP1;RGCC;IGFBP7;FTH1;GTPBP4;AQP11
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.36754260649229564,0.7142259264250435,0.9,1.0,1.0,3/25,15.77%,ENPP2;CARMIL1;AKIRIN1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.25342041787752484,-0.7141394397081563,0.9090909090909091,1.0,1.0,8/60,10.96%,NUP42;DHX38;NUP155;CHTOP;THOC5;NUP188;NUP214;DDX39A
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.4887652255609911,0.7141295751525489,0.8769230769230769,1.0,1.0,4/6,40.80%,MTHFD1;GOT1;PLOD2;MTR
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.4489626242386071,-0.7140384767769349,0.8275862068965517,1.0,1.0,2/5,13.13%,SRC;NCK1
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.409643690344892,0.7140288259114235,0.8518518518518519,1.0,1.0,1/15,2.98%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3827541748687049,0.7138111704961245,0.868421052631579,1.0,1.0,3/14,8.27%,VASN;OVOL2;SPRY1
prerank,CellMarker_Augmented_2021__Monocyte:Liver,0.3558530211874689,0.7138033474931526,0.90625,1.0,1.0,10/69,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;CASP5;FGR;C5AR1;FCGR2C;FGL2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.4683200944135551,0.7135970481550532,0.8571428571428571,1.0,1.0,2/6,30.45%,TRIM56;MX1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.35052323634014426,0.7135475809099417,0.9318181818181818,1.0,1.0,13/46,24.06%,FBXL7;RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,-0.3867644616203788,-0.7133434917712895,0.8292682926829268,1.0,1.0,1/8,2.17%,POLD3
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.32701481285486356,0.7130171738240629,0.98,1.0,1.0,46/222,27.18%,NLRP12;GPC5;GEMIN2;NUP133;MGAT4C;VPS11;TUSC3;RPS6;RPS27A;TRIM25;RPS25;RPS27;NOD2;SEC24C;RPS11;RPS20;RIPK2;ZDHHC9;MAGT1;SEH1L;RPS4X;RPS24;RPS9;PIK3R4;UBA52;UBB;RPS3A;SNRPD2;STAT1;TJP1;STAT2;NDC1;ISCU;GANAB;RPS16;CHMP7;GPC3;POM121;PRKCSH;TLR2;HSP90AB1;FAU;PRMT1;RPS12;NUP58;MGAT4B
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.2599340844209352,-0.713003378393757,1.0,1.0,1.0,5/45,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.43742177496798135,0.7129777897842806,0.8873239436619719,1.0,1.0,5/13,24.36%,VEGFA;PTN;THY1;TNF;JAM3
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,-0.3972212258302407,-0.7128859633956053,0.9130434782608695,1.0,1.0,4/10,16.35%,KLKB1;TPST2;TTF2;FAM110A
prerank,Reactome_2022__Immune System R-HSA-168256,0.31697166115069675,0.7128046832161316,1.0,1.0,1.0,240/1274,24.15%,SOCS3;CLEC4E;CRISPLD2;PIANP;RAP1GAP;ALDH3B1;PRLR;NDUFA2;CLEC12A;CR1;VIM;IFIT5;ASB14;CENPE;EGR1;PLAC8;PRKCE;EIF4A3;ZBTB16;PPP2R5B;IL15;CD22;SLC2A3;ENAH;TALDO1;RACGAP1;DOCK1;OSMR;CHI3L1;IL1RAPL1;ANXA1;FBXL7;SLC11A1;SEPSECS;LIFR;MAP3K8;KIF15;RNF144B;ASB16;LNX1;F13A1;VEGFA;HSPA5;POLR3F;PPP2R5A;KCNH8;FCGR2B;CD55;IL7;SEC61B;DGAT1;PTPRZ1;GNS;ACTR1B;NUP133;ATOX1;PDZD2;HIF1A;GRB10;MYO10;SNAP25;TRIM5;FN1;RAPGEF3;GSDMD;DNM3;IRS2;TNFRSF11B;RPS27A;MCL1;GHR;TRIM25;ARIH2;IFITM3;FGR;TXNIP;WASF1;LMNB1;MGAM;CKAP4;C5AR1;TRIM9;CD93;SPTAN1;DNM1;PDCD1LG2;PRR5;NOD2;ARSA;PSMB4;RBX1;SEC24C;PRICKLE1;CAMK2B;FGL2;RPS6KA2;GAN;SGIP1;IFNLR1;RNF126;DYNC1H1;RIPK2;CRLF1;SH3GL2;ASB13;TNFRSF1B;IFIT2;NFASC;SNAP29;FBXO27;BLMH;PKM;ACP3;LRRC7;RLIM;POLR3H;CD300A;HOOK3;KLC4;NKIRAS1;TRIM26;MAGT1;ENPP4;UBE2M;PYCARD;AIM2;SDCBP;MAPK10;KIF11;PELI1;CASP3;LILRB5;KIF5A;LTA4H;SEH1L;IL18;CEBPD;RASGRP4;IL11RA;ITGAV;KLHL2;TCP1;GBP2;TXK;IQGAP1;TEC;KIF3A;ROCK1;BCL6;UBE2J2;PLD3;HECW2;HSPA1B;APP;GSTP1;PIK3R4;PTPN9;TNFRSF1A;DCTN1;STXBP2;SOD1;FTH1;FBXL13;ALAD;UBA52;PRDX4;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;PTPN5;AP2A2;FOS;SYNGR1;COLEC12;NCAM1;ATP6V0B;SURF4;TNF;PGM1;FBXO7;PSMB2;DYNC1I1;SELL;DUSP6;CPNE2;TRIM14;IL7R;PTPN20;CDKN1B;ECSIT;ATG5;IRAK3;RNF138;KIF5C;P4HB;PSMD5;HSP90B1;BRWD1;ATP6V1B2;STAT1;EEF1A1;PSMD7;HACE1;MAP3K3;GNL3;PDCD4;VAV3;RHOU;PRKCB;STAT6;CPNE3;GSDME;STAT2;JUN;NDC1;TRPC1;RORA;GAA;MRC1;FPR1;CASP1;ATP6V0E2;DSN1;TLR5;UBE2D2;ARHGAP9;BTN2A2;PRKACB;PTEN;PSMD14;ATP6V1D;TRIM56;ILF2;PSMA5;FOXO3;CCT8;EIF4A2
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.4287621187876735,0.7127463446359591,0.875,1.0,1.0,1/15,5.04%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.48645798525930384,0.712740947998017,0.9,1.0,1.0,1/6,3.86%,ARF6
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.48645798525930384,0.712740947998017,0.9,1.0,1.0,1/6,3.86%,ARF6
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,0.3177016790316869,0.7126221724533351,0.93,1.0,1.0,16/126,15.72%,FBN2;SMC1B;MEIS2;GNS;ATOX1;GLRX2;SDF2L1;PTOV1;PPID;MPP1;SPOCK3;CALCOCO2;SERPINE2;FDFT1;CPE;PEMT
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3225785110305089,-0.712486725507607,1.0,1.0,1.0,3/14,18.72%,TERF2;SMG6;ERCC4
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.4432510059386126,0.7124357078748086,0.8266666666666667,1.0,1.0,1/9,5.63%,CD55
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.3426071114141591,-0.7123960564470383,0.9333333333333333,1.0,1.0,2/19,1.98%,TTC39B;ARV1
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,0.33526197381940986,0.712385880798996,0.9111111111111111,1.0,1.0,4/59,5.61%,NAPSB;CLEC12A;CR1;FCGR2B
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.2666770585657527,-0.7122294264409054,1.0,1.0,1.0,5/42,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.37833288439579815,-0.7119155518932826,0.8461538461538461,1.0,1.0,2/13,8.30%,PGM2;AOAH
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.29229092425360265,-0.7117397369551383,1.0,1.0,1.0,17/75,17.01%,PSMB3;PSME3;CHUK;PSMC4;PSMD12;PSME4;INPP5D;IKBKB;HLA-DPA1;NFKBIA;PSMA1;BCL10;CD247;CARD11;PSMA7;HLA-DRB5;PSMD3
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.36270155777026836,-0.7114376949589751,0.8,1.0,1.0,2/9,4.36%,IDE;UQCC2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.4695135262776621,0.7111664594290728,0.8253968253968254,1.0,1.0,2/6,29.10%,KDM6B;PROX1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.42383751584350726,-0.7108373646961359,0.8333333333333334,1.0,1.0,2/6,8.59%,FYN;ABCB7
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.4039058331470948,0.710797418275719,0.8243243243243243,1.0,1.0,3/12,17.51%,ERRFI1;ROCK1;KLF7
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.40113649999300716,-0.7106562609813095,0.8095238095238095,1.0,1.0,3/6,14.21%,CYB5R3;DDAH2;AKT1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.40113649999300716,-0.7106562609813095,0.8095238095238095,1.0,1.0,3/6,14.21%,CYB5R3;DDAH2;AKT1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.4481393552645606,0.7106525968836316,0.8125,1.0,1.0,2/7,19.67%,KDM1A;KDM5B
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.33401282400791593,0.7104064532068411,0.9574468085106383,1.0,1.0,18/90,22.89%,THBS1;NUP133;PGAM1;HIF1A;FN1;PRKAG2;SDCBP;SEH1L;LDB2;ROCK1;HSPB1;APP;NOP53;CDKN1B;SLAMF8;BARD1;STAT2;NDC1
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.27417158154564036,-0.7102115236540191,1.0,1.0,1.0,13/51,21.28%,H2BC4;GATAD2B;EP300;TTF1;H2BC26;RBBP4;POLR1F;H2BC21;TBP;CBX3;CHD4;H2AC6;DDX56
prerank,PanglaoDB_Augmented_2021__Monocytes,0.3375844686273296,0.7101916714415057,0.9587628865979382,1.0,1.0,20/127,16.48%,CLEC12A;CD163;VCAN;RGS1;ADGRE1;FCGR2B;RGS2;SIRPB2;FN1;IFITM3;FGR;C5AR1;FCGR2C;FGL2;NFKBIZ;TNFRSF1B;CD300A;PYCARD;LTA4H;LRRC25
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.24308707039791957,-0.7101384866547904,1.0,1.0,1.0,24/144,15.81%,EHD4;KIF27;FLNA;RTTN;WDR35;MKKS;KIF3B;INPP5E;BBS9;EXOC7;TMEM67;TCTN3;OCRL;ABCC4;IFT43;GSN;CCDC66;NUDCD3;GALNT11;DISC1;MARK4;RAB3IP;CDC14B;CFAP70
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.2782541057747166,-0.7099174192842344,0.9230769230769231,1.0,1.0,4/38,9.94%,BTG2;KHSRP;PRR5L;METTL16
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.34136027104603794,0.7097548053208774,0.9354838709677419,1.0,1.0,14/65,24.66%,PQBP1;RRP1B;KHDRBS2;CLK2;FAM50A;AHNAK;HNRNPH1;METTL4;HNRNPH3;MBNL2;SRSF3;CLK1;C9ORF78;AKAP17A
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.4241419020399213,0.7096947968639851,0.8904109589041096,1.0,1.0,2/10,26.55%,AUP1;BAG6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.32042768371709807,-0.7096343180660314,0.8235294117647058,1.0,1.0,5/18,22.80%,LEO1;RNF8;RNF20;UBE2A;CDC73
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4573109328747843,0.7095793827713807,0.8260869565217391,1.0,1.0,1/7,5.04%,VEGFA
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.3221163868489832,0.7095303820819768,0.9368421052631579,1.0,1.0,26/108,28.64%,CD55;ANK3;ANK2;ARFGAP1;SPTAN1;SEC24C;MCFD2;DYNC1H1;NSF;SPTBN5;TRAPPC6B;SPTBN1;GRIA1;DCTN1;SPTBN4;DYNC1I1;NAPG;CNIH1;F8;GOLGB1;DYNLL1;KDELR1;PTGES2;TMED2;BET1L;MIA3
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,0.3782301881256139,0.7094730482305692,0.8518518518518519,1.0,1.0,5/26,16.25%,NLRP12;ALOX12;GP6;RASGRP4;NRGN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,0.388409582137293,0.7094638073631248,0.8181818181818182,1.0,1.0,7/15,19.96%,TFRC;ALCAM;CASP3;THY1;ITGAV;TNFRSF1A;NCAM1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.3285028544850352,-0.7093508467284079,0.92,1.0,1.0,1/19,1.76%,RHOG
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3714545631161082,0.7092413433358634,0.8658536585365854,1.0,1.0,6/23,25.81%,SFXN3;ASIC2;TRPM7;SLC3A2;ATP1A2;ABCC8
prerank,KEGG_2021_Human__Ferroptosis,0.35290243137508504,0.7091298848197153,0.9080459770114943,1.0,1.0,2/35,3.57%,ACSL1;TFRC
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.4474402323891017,0.7087342255908939,0.8507462686567164,1.0,1.0,4/8,24.47%,KLF7;PIM3;KCNB1;SIRT4
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.44105481121565604,0.7086799971812435,0.8450704225352113,1.0,1.0,4/9,27.94%,OSBPL10;OSBPL5;LPCAT4;OSBPL8
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.3627890113304412,0.7086249685947807,0.8390804597701149,1.0,1.0,9/40,29.74%,TMEM41B;VMP1;ATP2A2;UBXN2B;ATG5;ATG13;MAP1LC3A;NSFL1C;ATG2B
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,-0.4567482352123362,-0.7081170621947995,0.75,1.0,1.0,1/5,7.43%,CBFB
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.45740414945482927,0.7081167662069103,0.868421052631579,1.0,1.0,2/8,18.11%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.45740414945482927,0.7081167662069103,0.868421052631579,1.0,1.0,2/8,18.11%,KDM1A;TAF9B
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,-0.40960391237266114,-0.7080450168446862,0.8064516129032258,1.0,1.0,1/7,1.72%,IDUA
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.27418439960443025,-0.7079880532169729,1.0,1.0,1.0,18/115,12.50%,FLNA;ITGAM;IL1B;HPS4;ZPR1;BAP1;GZMB;TP53;TGFB1;BID;PPP1R13B;FYN;ZDHHC2;PRR5L;ITGB2;PPP3CC;PLK3;SORL1
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.31449603848541624,0.7079692612901328,1.0,1.0,1.0,70/530,20.42%,SOCS3;PIANP;RAP1GAP;NDUFA2;ASB14;CENPE;ZBTB16;PPP2R5B;CD22;ENAH;RACGAP1;FBXL7;MAP3K8;KIF15;RNF144B;ASB16;LNX1;HSPA5;PPP2R5A;FCGR2B;SEC61B;ACTR1B;RAPGEF3;DNM3;RPS27A;ARIH2;TRIM9;DNM1;PDCD1LG2;PRR5;PSMB4;RBX1;SEC24C;PRICKLE1;GAN;RNF126;DYNC1H1;RIPK2;SH3GL2;ASB13;FBXO27;BLMH;RLIM;CD300A;KLC4;UBE2M;KIF11;LILRB5;KIF5A;ITGAV;KLHL2;KIF3A;UBE2J2;HECW2;PIK3R4;DCTN1;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;AP2A2;COLEC12;FBXO7;PSMB2;DYNC1I1;SELL
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.27297919164602324,-0.7079387458540063,0.8666666666666667,1.0,1.0,9/28,16.04%,BCL2L1;TP53;BID;NCK1;EIF5A;BCL2;FIS1;FBH1;BECN1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.26539624852405963,-0.7079277625014271,1.0,1.0,1.0,7/53,8.46%,PSMB3;PSME3;PSMC4;TP53;PSMD12;PSME4;ZNF385A
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.26539624852405963,-0.7079277625014271,1.0,1.0,1.0,7/53,8.46%,PSMB3;PSME3;PSMC4;TP53;PSMD12;PSME4;ZNF385A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.3426923188093958,0.707495022187619,0.9473684210526315,1.0,1.0,11/81,11.30%,CLEC12A;CD163;SLC11A1;ADGRE1;FCGR2B;SIRPB2;CASP5;FGR;C5AR1;FCGR2C;FGL2
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.44332845900442497,0.7074752937114008,0.8524590163934426,1.0,1.0,1/6,8.86%,ID2
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3353922663647658,-0.7074163263584063,0.9230769230769231,1.0,1.0,4/14,15.93%,CTC1;SRC;TERF2;EXOSC10
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.37204325159843404,-0.7072648557804053,0.8333333333333334,1.0,1.0,4/14,20.12%,CYTH3;OPHN1;CDC42;RAP2A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.2874137840571951,-0.7072524516141581,0.9545454545454546,1.0,1.0,1/24,2.51%,CCND1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.36062474407761835,0.7072000002339767,0.8651685393258427,1.0,1.0,4/40,8.90%,AGT;TRAF2;SEPTIN4;BOK
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3696050359578406,0.7070004059189691,0.875,1.0,1.0,9/31,21.35%,SEMA6A;CAMK2N1;SPRY1;LMO3;DUSP10;TIMP3;GSTP1;DUSP6;TNIP1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.33616498700733677,-0.7069497725441238,0.8620689655172413,1.0,1.0,4/12,22.94%,AKAP8L;NSUN2;NRDE2;SUPT6H
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.4036050936953339,0.7069337780141844,0.8857142857142857,1.0,1.0,5/15,26.10%,SYT4;SYT1;SYT11;KCNB1;SYT9
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.34122352389575555,-0.7067293564901503,0.8421052631578947,1.0,1.0,4/15,10.97%,CORO1B;ARFIP1;WASF3;CYFIP1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3041562914216386,-0.7066027149933909,1.0,1.0,1.0,6/31,9.74%,ZDHHC3;ZDHHC5;ZDHHC21;ZDHHC13;ZDHHC2;EP300
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.4410503181709313,0.7065164420526863,0.8933333333333333,1.0,1.0,4/8,31.16%,EMC7;EMC10;EMC8;EMC3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.3709539842294676,0.7064943259405578,0.875,1.0,1.0,12/28,34.29%,ITPKC;GK;GK5;LPCAT1;TPK1;PIP5K1A;TKT;GNPAT;GPHN;IP6K1;AGPAT3;AGPAT5
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.25527776955248616,-0.7064561927053313,1.0,1.0,1.0,9/54,16.27%,YKT6;FOLR2;TRAPPC10;TRAPPC4;TRAPPC2;CTSZ;TGFA;STX5;TFG
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.4447681135092437,0.7064014274147169,0.8873239436619719,1.0,1.0,2/8,31.76%,WDPCP;ECE1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.44987691356921866,0.7062915884428573,0.8840579710144928,1.0,1.0,2/7,24.61%,NOD2;DDX3X
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.3334511506726942,0.7061193858335008,0.9052631578947369,1.0,1.0,12/75,21.88%,EEF1A2;MRPL33;EEF1B2;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14;EEF1A1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.3569210249408854,0.7060905606457355,0.9036144578313253,1.0,1.0,13/41,25.52%,TFRC;SLC11A1;FLVCR1;PICALM;HAMP;SOD1;FTH1;FBXL5;HFE;ISCU;NEO1;TF;SLC11A2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.415281339954527,0.706077334103283,0.8382352941176471,1.0,1.0,3/11,23.92%,PAICS;PFAS;IMPDH1
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.29462384396505914,-0.7060744803649159,0.8947368421052632,1.0,1.0,6/28,13.07%,IL1B;IL1A;GZMB;HLA-E;HLA-DPA1;PRF1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",0.3901841933131921,0.7059861865380194,0.8125,1.0,1.0,5/19,21.00%,SLCO1A2;SLCO3A1;SLC35A1;SLC25A4;SLC5A6
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.2521028353225925,-0.7059431255669345,1.0,1.0,1.0,6/63,6.35%,GTF2F1;RPRD1B;PHAX;SRRT;TAF13;INTS9
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.3337548270255589,0.70573155379833,0.9591836734693877,1.0,1.0,12/100,12.35%,THBS1;TACR1;CHI3L1;ANXA1;SLC11A1;FCGR2B;LTB4R;PXK;C5AR1;ADCY8;RIPK2;HNRNPA0
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.36204812721304835,0.7056639458734026,0.8354430379746836,1.0,1.0,3/24,11.13%,DALRD3;FTSJ1;METTL2A
prerank,Reactome_2022__S Phase R-HSA-69242,-0.22931439841201337,-0.7055955700791614,1.0,1.0,1.0,8/116,6.69%,LRIG1;PSMB3;POLD3;CCND1;PSME3;PMEPA1;PSMC4;PSMD12
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.456790564940173,0.7054036946503796,0.8082191780821918,1.0,1.0,5/9,30.04%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3241906715046315,0.705202681889694,1.0,1.0,1.0,37/316,17.17%,KLF4;NFIL3;EGR1;HMGB2;ZBTB16;CREB5;MYRF;AGT;NFIB;RORB;SOX4;RXRB;HIF1A;KDM3A;HCFC1;ARNT2;PAX8;MAFB;ID2;SS18L1;ATAD2;ING1;DEAF1;ETS2;HINFP;BRCA1;TRIM16;YAF2;PICALM;WNT5A;SMARCD3;ESR1;TBL1XR1;CXXC1;PLCB1;PCBD2;TFAM
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.324750385506644,0.705018394582975,0.98,1.0,1.0,38/274,21.25%,TOP2A;DTL;SLF1;MASTL;SPDYA;CDKN2AIP;FMN2;ENDOV;WDHD1;BOK;MCL1;POLQ;HINFP;INTS3;VCPIP1;TNFRSF1B;BRCA1;XRCC3;BCL2L2;PPP1R15A;FAN1;RFC4;GTF2H3;POLE2;CIDEB;BCL6;FOXP1;FANCL;ADPRS;FANCA;TIMELESS;NOP53;KMT5C;GNL1;CBX5;MACROD1;RBBP8;DDB1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.40165161428079804,0.7049957761208476,0.8717948717948718,1.0,1.0,1/22,0.99%,ADAMTS2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.32773331067754474,-0.7048189393153088,0.7931034482758621,1.0,1.0,2/13,5.98%,LGALS9;CD274
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.4434357129176603,0.7047712754893872,0.8253968253968254,1.0,1.0,1/6,18.04%,PRKAA2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.3166045057884281,0.7045213072255576,0.9183673469387755,1.0,1.0,26/162,23.84%,DTL;FBXL7;RNF144B;HERPUD1;RPS27A;TRIM25;ARIH2;RNF144A;RBX1;RNF126;PINK1;RLIM;KLHL8;SYVN1;RNF13;RNF149;UBA52;UBB;PSMC2;FBXO7;DDB1;HACE1;FEM1C;UHRF1;UBE2D2;PSMD14
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,0.43936611109108165,0.70448498157309,0.7941176470588235,1.0,1.0,3/7,20.85%,PCBP4;E2F7;CDKN1B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4021720117004178,0.7043301006303179,0.8928571428571429,1.0,1.0,7/19,21.25%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.4362570526430055,0.7039896221072157,0.92,1.0,1.0,3/7,21.98%,IMPACT;SLC9A1;CHP1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.48814206994848586,0.7039522628556973,0.8636363636363636,1.0,1.0,1/5,11.99%,MAGI2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.4858324869960764,0.7038840940605977,0.859375,1.0,1.0,4/5,31.05%,HPRT1;PRTFDC1;PNP;NT5C2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.3937379860344037,0.7038555831758301,0.8873239436619719,1.0,1.0,5/18,21.88%,PAICS;PRPS1;DCK;HPRT1;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3938686190404585,0.7037655358516662,0.8795180722891566,1.0,1.0,1/18,3.59%,AGT
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.31434651069651054,-0.7037484727447649,1.0,1.0,1.0,3/16,10.46%,CHUK;TP53;IKBKB
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.2609986372734591,-0.7037312945344356,1.0,1.0,1.0,9/63,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3740174644627086,0.703723490582622,0.8902439024390244,1.0,1.0,9/27,27.66%,HSPA5;BAG3;HSPA1B;HSPA2;HSPA14;HSPA9;HSPA13;PTPN1;HSPA8
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.3326740543931318,0.7036954201084484,0.9278350515463918,1.0,1.0,6/79,9.47%,ITPKC;DGKI;INPP4B;MTMR7;CALM3;DGKB
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3684826777525203,0.7035547147944351,0.891566265060241,1.0,1.0,8/26,26.10%,RPS27A;UBA52;HSPD1;UBB;IRAK3;TNIP1;TLR5;TLR2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.48097707096651887,0.7032225883078513,0.8666666666666667,1.0,1.0,2/6,12.36%,RYR2;RYR3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.42691190779592264,0.703013492435603,0.8732394366197183,1.0,1.0,3/9,29.71%,CDK9;BARD1;CTR9
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.28096089213754843,-0.7027927211282863,1.0,1.0,1.0,17/103,14.72%,H2BC4;ITGAM;SELPLG;H4C3;ACTB;C3;MAPK13;H2BC7;SRC;FCGR1A;ITGB2;TLR7;HDAC11;SYK;AKT1;VDAC1;HDAC10
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,0.40957681252371747,0.7027496210368307,0.8666666666666667,1.0,1.0,4/14,22.91%,PLTP;PCSK6;P4HB;ABCG1
prerank,CellMarker_Augmented_2021__Basal cell:Lung,0.3690476261044499,0.7026790000393014,0.8987341772151899,1.0,1.0,7/25,17.22%,GPNMB;TUBB6;PPP1R13L;THBD;IFI27L2;ATP1B3;HSPB1
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,0.34543918289626113,0.7025414091508679,0.9021739130434783,1.0,1.0,9/58,12.85%,CD163;AMY2B;PREX2;F13A1;CELF2;CD93;FGL2;FLT1;SHROOM4
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.33903386805942715,0.7024178586447616,0.9,1.0,1.0,17/58,25.67%,TFRC;SLC11A1;ATOX1;FLVCR1;SLC31A2;SLC39A12;HAMP;APP;SLC39A14;SOD1;FTH1;FBXL5;HFE;ISCU;TF;SLC11A2;SLC39A6
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.4597904161461466,0.7022314883174103,0.855072463768116,1.0,1.0,4/7,25.32%,IRS2;NR4A3;PPARA;PPARGC1A
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,0.3152968149101421,0.7018935971242372,1.0,1.0,1.0,95/465,22.96%,SOCS3;PRLR;VIM;IFIT5;EGR1;EIF4A3;IL15;TALDO1;OSMR;IL1RAPL1;ANXA1;SEPSECS;LIFR;MAP3K8;F13A1;VEGFA;KCNH8;IL7;PTPRZ1;NUP133;PDZD2;HIF1A;GRB10;SNAP25;TRIM5;FN1;GSDMD;IRS2;TNFRSF11B;RPS27A;MCL1;GHR;TRIM25;IFITM3;LMNB1;NOD2;PSMB4;RBX1;CAMK2B;RPS6KA2;SGIP1;IFNLR1;RIPK2;CRLF1;TNFRSF1B;IFIT2;NKIRAS1;TRIM26;UBE2M;MAPK10;PELI1;CASP3;SEH1L;IL18;CEBPD;IL11RA;TCP1;GBP2;TEC;BCL6;APP;PTPN9;TNFRSF1A;STXBP2;SOD1;UBA52;UBB;PSMC2;PSMA3;PTPN5;FOS;NCAM1;TNF;PSMB2;DUSP6;TRIM14;IL7R;PTPN20;CDKN1B;IRAK3;P4HB;PSMD5;HSP90B1;BRWD1;STAT1;PSMD7;MAP3K3;GNL3;PDCD4;RHOU;STAT6;STAT2;JUN;NDC1;RORA
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,0.3493229729591414,0.7017277344708829,0.925531914893617,1.0,1.0,10/51,24.93%,CD163;F13A1;CD93;ALDH1A1;VAV3;SPARCL1;MRC1;MS4A6A;CFTR;SLA
prerank,KEGG_2021_Human__Legionellosis,0.3700451926105059,0.7011328310775768,0.9325842696629213,1.0,1.0,15/44,23.91%,CR1;EEF1A2;CYCS;BNIP3;PYCARD;CASP3;IL18;HSPA1B;HSPD1;HSPA2;TNF;EEF1A1;CASP1;TLR5;CLK1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4214846284777909,0.7006803252899988,0.8795180722891566,1.0,1.0,6/14,20.03%,FCHO2;SGIP1;NSG2;CALY;PICALM;HIP1R
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.46249712045016256,0.7005955922720167,0.9016393442622951,1.0,1.0,4/7,39.02%,ATG13;ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.46249712045016256,0.7005955922720167,0.9016393442622951,1.0,1.0,4/7,39.02%,ATG13;ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.43949786633629057,0.7005134199548628,0.8382352941176471,1.0,1.0,4/9,23.47%,IFNLR1;PRELID1;NOP53;TRAP1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.3965436465803023,-0.7003617503644038,0.8620689655172413,1.0,1.0,3/8,12.57%,ADK;DGUOK;AMPD3
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.3161644854428928,0.7001310128562742,1.0,1.0,1.0,112/803,19.67%,SOCS3;BRIP1;THBS1;DDIT4;KLF4;ZNF382;ZNF793;CR1;MOBP;TGIF1;WDR5;FKBP5;ZNF804B;H2BC11;ERCC2;SLC2A3;ZNF483;NR4A2;NR4A1;ZNF41;LIFR;RORB;GAD1;VEGFA;RXRB;NDRG1;TCF7;SCO2;GRIN2A;PDZD2;ZKSCAN5;ZNF235;ZNF540;GRIA2;PCBP4;PPP1R13L;TCF7L1;KCTD1;BNIP3L;DNA2;ATAD2;FANCI;RBPJ;RPS27A;PLK2;TXNIP;ZNF34;PRR5;NR2F1;TTC5;PSMB4;RBX1;CAMK2B;PRKAG2;COX7C;CCNC;GAD2;CYCS;ZNF606;ZNF550;NR4A3;BRCA1;ZNF549;PINK1;PRELID1;FASN;YAF2;E2F7;RFC4;GRIN2B;ZNF248;GTF2H3;NELFB;UXT;SMARCD3;ESR1;NR2C2;LDB2;CCND3;TBL1XR1;ZNF717;CXXC1;POLR2D;SMAD1;BCL6;RGCC;ZNF665;SCO1;PRKAA2;TAF9B;SESN1;ZNF778;UBA52;HSPD1;ESRRG;SUZ12;SMARCC1;EZH2;UBB;PSMC2;CDK9;SIRT3;PPARA;TAF7;PSMA3;ZNF197;CDK5R1;MLH1;ZNF684;FOS;ZNF213;KDM5B
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.38574373460955397,0.7000955987523076,0.8292682926829268,1.0,1.0,1/21,1.28%,TGFB2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.4403370684882418,0.6996573511693259,0.8571428571428571,1.0,1.0,1/9,5.61%,FCGR2B
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.4909088031601746,0.6996522687427666,0.8833333333333333,1.0,1.0,2/5,37.24%,DDRGK1;UBA5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.3802646504226626,0.6993791866140897,0.8705882352941177,1.0,1.0,1/22,1.26%,KNSTRN
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.3855466390373307,0.6992769065693074,0.8666666666666667,1.0,1.0,7/23,21.25%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,0.39200489464179605,0.6991888991956177,0.8513513513513513,1.0,1.0,7/14,19.96%,TFRC;ALCAM;CASP3;THY1;ITGAV;TNFRSF1A;NCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,0.39200489464179605,0.6991888991956177,0.8513513513513513,1.0,1.0,7/14,19.96%,TFRC;ALCAM;CASP3;THY1;ITGAV;TNFRSF1A;NCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,0.39200489464179605,0.6991888991956177,0.8513513513513513,1.0,1.0,7/14,19.96%,TFRC;ALCAM;CASP3;THY1;ITGAV;TNFRSF1A;NCAM1
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.33602531498245564,0.6991032207370288,0.9021739130434783,1.0,1.0,21/85,27.66%,HSPA5;NUP133;DNAJC7;CAMK2B;BAG3;SEH1L;HSPA12A;HSPA1B;HSPA2;UBB;TNFRSF21;HSPA14;EEF1A1;NDC1;RPA3;POM121;HSP90AB1;HSPA9;HSPA13;NUP58;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.3228900435605543,-0.6989640130480063,0.7619047619047619,1.0,1.0,5/16,12.05%,TTC39B;NR1H3;TREM2;NFKBIA;PPARD
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.3514850709400842,0.6989544866239845,0.9204545454545454,1.0,1.0,4/27,10.26%,HMGB2;NR4A1;VEGFA;SEMA5A
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.405957792502173,0.6989492490732782,0.8076923076923077,1.0,1.0,3/12,21.86%,NELFB;HEXIM1;HNRNPU
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,0.4660054564360313,0.6987661142556522,0.8840579710144928,1.0,1.0,2/5,19.96%,THY1;NCAM1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.387227790347224,0.698726905297451,0.8860759493670886,1.0,1.0,2/17,9.50%,H2BC11;KDM1A
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.3681491370967334,0.6986992045243482,0.8571428571428571,1.0,1.0,4/16,12.30%,INSR;IRS2;SORBS1;PPP1R3B
prerank,CellMarker_Augmented_2021__Platelet:Undefined,-0.32563205130949124,-0.6986748858126786,0.8260869565217391,1.0,1.0,3/13,10.73%,TGFB1;BSG;CD226
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,0.43387484644600427,0.6983583995848314,0.8918918918918919,1.0,1.0,1/7,6.69%,OVOL2
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4042947701298326,0.6983514240346232,0.8170731707317073,1.0,1.0,3/15,17.00%,TENT4B;SND1;PRKRA
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.3087627617012566,-0.6981709904794591,0.9473684210526315,1.0,1.0,6/20,13.42%,GCLC;HPGDS;GSTM4;GGT7;GCLM;GPX1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.313937587272696,0.6981623628343466,1.0,1.0,1.0,43/254,24.20%,DTL;MKRN3;FBXL7;UBE2QL1;RNF144B;TRAF2;TRIM5;RPS27A;ARIH2;RNF144A;PSMB4;RBX1;RNF126;SASH1;BRCA1;FBXO27;BLMH;RLIM;PELI1;SYVN1;UBE2J2;HECW2;FBXL13;UBA52;UBB;PSMC2;FBXL5;LONRF1;ZNRF1;PSMA3;FBXO7;PSMB2;C10ORF90;TRIM14;PSMD5;PSMD7;HACE1;BARD1;UBE2D2;PSMD14;TRIM56;PSMA5;TRAF3IP2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.42010114099593976,0.6978718322260983,0.8955223880597015,1.0,1.0,1/13,8.50%,RETREG1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.32897567606917927,-0.6976277000149472,0.8571428571428571,1.0,1.0,5/20,12.46%,ZNF703;CYP19A1;TGFB1;EGFR;GGT7
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.46508645237869395,0.6976079072468305,0.8787878787878788,1.0,1.0,3/7,41.99%,ZCCHC3;DHX58;USP15
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.33818723382820326,0.6975812650232784,0.9897959183673469,1.0,1.0,13/134,10.89%,TSHR;CD163;HTR7;PRKAR2B;DOCK1;MYO10;GSDMD;PLK2;FGR;TXNIP;WASF1;ADCY8;RXFP1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.3426771119372243,-0.697548399425638,0.8518518518518519,1.0,1.0,2/11,9.52%,SHLD1;KMT5B
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,-0.4494679085361722,-0.6974562254327722,0.8275862068965517,1.0,1.0,2/5,14.92%,DNAJC24;DPH5
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.3685269523957889,-0.6971752941762299,0.8717948717948718,1.0,1.0,2/7,18.09%,AKT1;STK10
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.4599773329796974,0.6971668373050166,0.8448275862068966,1.0,1.0,3/6,30.41%,WAPL;CTNNB1;RAD21
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.3595616500655338,0.6969645104758982,0.8470588235294118,1.0,1.0,1/25,5.92%,RBM3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.4052265821337926,0.6968548734203449,0.8,1.0,1.0,1/9,17.56%,FOXP1
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,0.46876912076820804,0.6966417674187692,0.8208955223880597,1.0,1.0,3/5,31.83%,SLC39A14;SLC39A6;SLC39A8
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.425319215318876,0.6964946700817637,0.8873239436619719,1.0,1.0,2/7,23.75%,TBL1XR1;GPS2
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.3989866111627538,0.6964721008678397,0.9342105263157895,1.0,1.0,5/19,18.81%,SH3GL3;RPS27A;SH3GL2;UBA52;UBB
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.3666520537105711,0.6962447582971454,0.875,1.0,1.0,7/20,22.96%,PRKAG2;PHKG1;PGM2L1;PGM1;NR1D1;GYS1;GAA
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.36376487325745566,-0.6962393372900434,0.9,1.0,1.0,2/12,9.32%,KHSRP;PRR5L
prerank,KEGG_2021_Human__Mismatch repair,0.39844117202734175,0.6961472560326039,0.8705882352941177,1.0,1.0,5/16,23.25%,RPA2;RFC4;MLH1;RFC1;RPA3
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,0.34489710337640245,0.6960699500074574,0.9247311827956989,1.0,1.0,9/66,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,0.34489710337640245,0.6960699500074574,0.9247311827956989,1.0,1.0,9/66,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,0.34489710337640245,0.6960699500074574,0.9247311827956989,1.0,1.0,9/66,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,0.34489710337640245,0.6960699500074574,0.9247311827956989,1.0,1.0,9/66,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.36572126899847496,0.6951039300728592,0.9247311827956989,1.0,1.0,9/58,18.74%,ARAF;FBXL2;CHRM3;SLC35A1;SERP1;UBE2M;CPE;UBA52;ERO1A
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3255652755563543,0.695084942942079,0.9387755102040817,1.0,1.0,14/84,17.56%,VIM;HMGB2;SLC11A1;NOCT;PDE4B;PDCD1LG2;NOD2;HNRNPA0;TNFRSF1B;PYCARD;PELI1;WNT5A;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.39571072365217297,-0.6950465950666409,0.8125,1.0,1.0,1/7,0.95%,ZNF703
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.46001625484310227,0.6949842526357093,0.7878787878787878,1.0,1.0,5/7,30.04%,NAPEPLD;HNRNPU;PIM1;ZBTB7B;RREB1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.393483932519145,0.6946914292071891,0.9,1.0,1.0,3/12,18.60%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.2994076587198944,-0.6946868108835644,0.8888888888888888,1.0,1.0,7/26,10.62%,BAIAP2L2;CSF1R;ABI3;ARHGDIB;DAPK3;HCK;ABL1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.4617866691626127,0.6945434081041645,0.8125,1.0,1.0,1/5,12.83%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.4617866691626127,0.6945434081041645,0.8125,1.0,1.0,1/5,12.83%,NR4A3
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.34464726827327086,0.6945211754668844,0.9080459770114943,1.0,1.0,3/57,5.61%,PIANP;CD22;FCGR2B
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,0.34025317429863783,0.6944819699919659,0.9263157894736842,1.0,1.0,7/84,9.26%,ITGA2;RGS1;SRGN;RGS2;CHN1;TRPS1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.4381541167576611,0.6940601666862604,0.8783783783783784,1.0,1.0,2/8,13.83%,FCGR2B;CD300A
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.37038034441903067,-0.6935360743936414,0.7777777777777778,1.0,1.0,1/7,2.23%,IL1B
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.40434693830715773,-0.6934843528582408,0.76,1.0,1.0,2/7,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.40434693830715773,-0.6934843528582408,0.76,1.0,1.0,2/7,13.33%,GCLC;GCLM
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.4269528903047037,-0.6931737534450181,0.7714285714285715,1.0,1.0,4/7,26.07%,EXOSC10;EXOSC9;EXOSC8;XRN1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.3212852364350051,0.6931119457385467,0.9896907216494846,1.0,1.0,20/152,12.83%,RAB7B;CLEC12A;CD163;SLC11A1;RGS1;ADGRE1;F13A1;GPNMB;FCGR2B;RAB20;RBPJ;FGR;CPM;C5AR1;FCGR2C;FGL2;NCEH1;PLTP;TNFRSF1B;NR4A3
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.41445924603711204,0.6930285570548793,0.8970588235294118,1.0,1.0,3/9,31.12%,L2HGDH;GPT2;GOT1
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.3569432237468706,0.6929911191615478,0.9101123595505618,1.0,1.0,8/39,20.20%,CLIP3;RPS27A;SPPL2B;OTUD7B;TNFRSF1A;UBA52;UBB;TNF
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.4051490425528788,-0.6929606112413955,0.8055555555555556,1.0,1.0,1/5,7.51%,TGFB1
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3414381640916022,-0.6927968095928351,0.8333333333333334,1.0,1.0,6/16,19.24%,FLII;GSN;CAPG;CAPZB;CAPZA1;VILL
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3414381640916022,-0.6927968095928351,0.8333333333333334,1.0,1.0,6/16,19.24%,FLII;GSN;CAPG;CAPZB;CAPZA1;VILL
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,-0.3405554368073451,-0.6924257962296683,0.8333333333333334,1.0,1.0,3/12,12.74%,ITGAX;YARS1;SYNE1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.3865963705277057,0.6924221660385803,0.8831168831168831,1.0,1.0,1/11,9.26%,RBPJ
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.3744138045999483,-0.6923759054425517,0.9230769230769231,1.0,1.0,3/8,18.50%,IL6R;APOL2;SIGIRR
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.27952956809848106,-0.6921843362849365,1.0,1.0,1.0,4/22,12.08%,BCL2L1;ALOX5;NR1H3;HSPA1A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.4498712583392427,0.6917057065975074,0.8873239436619719,1.0,1.0,2/9,4.09%,NUDT16;ENTPD3
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.38142962597846225,0.691476305173594,0.8888888888888888,1.0,1.0,6/19,30.98%,POLR2D;PRKRA;POLR2G;AGO4;DICER1;POLR2A
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,0.4409914151973636,0.6914748344926706,0.8421052631578947,1.0,1.0,1/7,9.56%,POU5F1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.32106379112233424,0.6914437530380398,0.96875,1.0,1.0,26/99,24.35%,RPA2;WDHD1;DNA2;RPS27A;GINS1;PSMB4;POLG2;MCMDC2;RFC4;POLE2;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;RFC1;PSMB2;TEFM;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.34712261369488373,0.6913886208777393,0.9090909090909091,1.0,1.0,10/44,18.90%,IL15;TFRC;ANXA1;IL7;PDCD1LG2;NOD2;PYCARD;THY1;HSPD1;RHOH
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.36849801065745363,0.6913122556276373,0.8846153846153846,1.0,1.0,3/17,17.16%,ERRFI1;TRIM16;ROCK1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.32797654286843797,-0.6912294840404996,0.92,1.0,1.0,5/19,13.95%,CHUK;TLR3;IRF5;TLR7;HAVCR2
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.2721786940565135,-0.6912121861741025,0.9285714285714286,1.0,1.0,11/33,20.91%,H2BC4;TP53;EP400;H2BC26;UBN1;TERF2;HMGA1;H2BC21;KAT5;H2AC6;CDKN1A
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,0.3686692693138704,0.6911743232081683,0.8928571428571429,1.0,1.0,4/19,21.28%,RBFOX2;HNRNPH1;POLR2D;POLR2G
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.3300115424226135,0.6910597179312326,0.9247311827956989,1.0,1.0,12/64,22.58%,PLPP3;ABCA2;ACOT13;CPM;NIT1;CPE;NAPEPLD;GPAT4;SLC5A6;MTHFD1;BTD;DBI
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.3376786792773848,0.6908610843134254,0.8764044943820225,1.0,1.0,5/48,10.76%,PPP2R5B;MAP3K8;PPP2R5A;PDCD1LG2;PRR5
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4389671097668728,0.6906035341857593,0.9047619047619048,1.0,1.0,3/11,14.62%,HSPA5;COPS5;DNAJB9
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.45313369309917784,0.6902578530965654,0.8840579710144928,1.0,1.0,1/6,6.68%,SEMA6A
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.36429253280609675,-0.690216921153497,0.9,1.0,1.0,4/9,14.64%,GZMB;EP300;MAML1;MAMLD1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.4462753987725754,0.6898922289422087,0.8873239436619719,1.0,1.0,2/7,15.39%,POU5F1;THY1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.3928163492458191,-0.6896538101830685,0.875,1.0,1.0,1/11,0.95%,ZNF703
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,0.3228735258229401,0.6894196374419133,0.9680851063829787,1.0,1.0,8/84,12.23%,DPYD;ANXA1;CLEC2B;SRGN;FOSL2;GSDMD;PDCD1LG2;NFKBIZ
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.3276967896249296,0.6893974350027298,0.9468085106382979,1.0,1.0,14/69,16.18%,TM7SF2;IDI1;MVD;ID2;MID1IP1;IRS2;CCDC3;PRKAG2;FASN;SCD;FDFT1;HMGCS1;SMARCD3;TBL1XR1
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.3751602266168206,0.6892907060657743,0.9135802469135802,1.0,1.0,4/16,21.34%,DUSP10;DUSP16;DUSP6;DUSP12
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,0.35868660399564534,0.6891719441286783,0.9310344827586207,1.0,1.0,8/35,18.26%,PREX2;TNS1;CD93;FLT1;SHROOM4;ANGPT2;LDB2;IGFBP7
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.34858170289229484,0.6890823140731513,0.9101123595505618,1.0,1.0,13/38,26.75%,TIMM13;ATP5ME;ATP5F1A;ATP5F1D;CHCHD3;ATP5MC1;IMMT;ATP5PB;ATP5F1E;TIMM22;GHITM;OPA1;HSPA9
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.33534021787991686,-0.6890166602033483,0.8484848484848485,1.0,1.0,4/14,18.04%,MYO1F;MYO1D;SYNE2;MYO7A
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.35207893210641067,0.6889597197799587,0.8941176470588236,1.0,1.0,2/37,3.08%,H2BC11;ERCC2
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.3509594403270285,-0.6888933597199656,0.88,1.0,1.0,5/11,13.23%,ITGAM;TGFB1;ITGB2;TYROBP;SYK
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.3367641590545489,0.6888264322630375,0.9690721649484536,1.0,1.0,14/92,20.53%,NDUFA2;MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;APP;UBA52;UBB;FOS;DUSP6
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.38940353757948254,0.688822918165732,0.9240506329113924,1.0,1.0,7/20,24.35%,CLSPN;RFC4;ORC6;DBF4;RPA3;ORC3;MCM3
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.44743325638400133,0.6886691206227818,0.9365079365079365,1.0,1.0,3/6,34.73%,PCSK6;ZDHHC17;XIAP
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.3835281092471855,0.6881984218947479,0.8313253012048193,1.0,1.0,4/19,14.11%,SCD5;ELOVL4;SCD;HSD17B12
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,0.4031448809842971,0.688079634317123,0.875,1.0,1.0,3/11,15.39%,ALCAM;POU5F1;THY1
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.3455186454411953,0.6880712880508374,0.9130434782608695,1.0,1.0,13/52,21.28%,ERCC2;RPS27A;RBX1;RFC4;GTF2H3;POLE2;POLR2D;ERCC6;UVSSA;UBA52;UBB;DDB1;POLR2G
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.41254468139825584,0.6879492006215833,0.9041095890410958,1.0,1.0,2/14,11.27%,ANK2;CAMK2B
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,0.3338286382104419,0.6879423609398938,0.9550561797752809,1.0,1.0,12/59,21.06%,CD163;TNS1;F13A1;CD93;FGL2;THBD;ALDH1A1;LILRB5;IGFBP7;FES;IRAK3;SLAMF8
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.3701031089654444,-0.687896483888478,0.8333333333333334,1.0,1.0,3/10,22.71%,PKN1;CDC42;GNB4
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.2445870352246702,-0.6878913038620896,1.0,1.0,1.0,12/67,15.17%,PSMB3;ACTA2;PSME3;PSMC4;PSMD12;APH1A;EP300;MAML1;PSMA1;AKT1;MAMLD1;PSMA7
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.36112972524905057,0.6877979797283527,0.8452380952380952,1.0,1.0,7/30,22.49%,ACOT13;RYR3;SOD2;HCN1;HPRT1;ACACB;ALDH1A2
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),0.31857307848621674,0.6877867467662497,0.9213483146067416,1.0,1.0,2/69,1.30%,RAB7B;NLRP12
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.28142526505321347,-0.6877047606461023,0.9375,1.0,1.0,7/31,14.21%,GRAP2;SH2B3;FYN;HCK;SOCS6;SYK;AKT1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.4162776307706736,-0.6874026852399681,0.8611111111111112,1.0,1.0,2/5,15.54%,ENG;PTCH1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.3279257626256866,-0.6872266253375405,0.8461538461538461,1.0,1.0,3/9,15.70%,PRF1;SYK;DVL2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.3466188409556832,0.6871841104763666,0.9012345679012346,1.0,1.0,12/39,25.52%,TFRC;SLC11A1;FLVCR1;HAMP;SLC39A14;SOD1;FTH1;FBXL5;HFE;ISCU;TF;SLC11A2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.4173386562402831,0.6871196001050716,0.8732394366197183,1.0,1.0,2/9,21.86%,NELFB;HNRNPU
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.35357946098273335,0.6868553269826584,0.8947368421052632,1.0,1.0,6/29,22.75%,TFRC;UACA;ROCK1;ARHGDIA;RHOH;TUBA1B
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),-0.41912741965320044,-0.6868408565211697,0.7560975609756098,1.0,1.0,2/5,22.17%,IL12RB1;SMAD7
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.393364964670498,0.6866703859156793,0.9382716049382716,1.0,1.0,3/13,18.60%,DDX1;TSEN54;ZBTB8OS
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.42202468383508673,0.686604560183866,0.8873239436619719,1.0,1.0,1/7,9.87%,PDE2A
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.43196375981220836,0.6865949700672245,0.8591549295774648,1.0,1.0,2/8,22.12%,OLFM1;CTTN
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.2509160754409881,-0.6861872588161764,1.0,1.0,1.0,9/61,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;TUFM;MRPS11;AURKAIP1;MRPS10;MRPL1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.41161041705858215,0.6860760042761967,0.8961038961038961,1.0,1.0,4/16,17.58%,SPDYA;PKD1;CCND3;RGCC
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.34848930375808373,0.6860129132125776,0.8604651162790697,1.0,1.0,6/28,17.71%,TGFB2;HIF1A;RBPJ;WNT5A;ROCK1;OLFM1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.3819324808097309,0.6859404973189662,0.8484848484848485,1.0,1.0,2/9,26.06%,H1-0;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2906755724378516,-0.6857482521977845,0.9583333333333334,1.0,1.0,5/19,17.46%,TLR3;NR1H3;TASL;TIRAP;NINJ1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.2941744959718603,-0.6856517305722044,0.9259259259259259,1.0,1.0,5/18,11.56%,APPL2;LGR4;TLR3;TREM2;BIRC2
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.43206772117734615,0.685636493282906,0.8873239436619719,1.0,1.0,4/9,22.83%,SEMA5A;EPHA4;CDK5R1;RTN4
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.4256536798206948,0.6856150536576019,0.8676470588235294,1.0,1.0,1/8,7.35%,HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.40628051580607627,0.6853633539217645,0.9240506329113924,1.0,1.0,1/15,1.38%,SH2D4A
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.3401424245562344,-0.6853585608665068,0.8928571428571429,1.0,1.0,2/9,9.66%,MDM1;TMEM67
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.39629597956180307,0.6853522037815437,0.9066666666666666,1.0,1.0,4/14,25.86%,KANK1;ROCK1;RUFY3;PTK2B
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.3475717626757563,0.6852430931165309,0.896551724137931,1.0,1.0,7/36,17.27%,RIOK2;RPS6;RPS25;RPS27;RRP36;RPS24;NOB1
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.25782746647135846,-0.685193512974164,1.0,1.0,1.0,5/46,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.34884546764305885,-0.685122212590172,0.8,1.0,1.0,3/15,12.21%,TELO2;CLEC16A;PIH1D1
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.39054950823617096,0.6850817032146225,0.9487179487179487,1.0,1.0,8/21,27.07%,NUDT13;CMPK1;GUK1;NME4;CTPS1;AK5;TXNRD1;AK6
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.3690370332617569,0.6846842290601914,0.8625,1.0,1.0,8/25,22.90%,TRAF2;SASH1;DUSP10;AIDA;GSTP1;TNF;PDCD4;MAPK8IP1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.32040531117180504,-0.6845897800161643,0.9090909090909091,1.0,1.0,6/17,22.55%,CBFB;RAP1A;RAPGEF1;PRKACA;MEF2C;RUNX1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.39760875099921494,-0.6843070132155609,0.8620689655172413,1.0,1.0,1/5,13.66%,BNIP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.3336242871209335,0.6842048040204836,0.9473684210526315,1.0,1.0,10/70,12.72%,CD163;F13A1;FCGR2B;SIRPB2;FGR;FCGR2C;CD93;FGL2;HCLS1;TNFRSF1B
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.37594779930616584,-0.683681971969732,0.7647058823529411,1.0,1.0,1/7,2.11%,DHODH
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.2682387419601723,-0.6836793031689892,1.0,1.0,1.0,1/38,0.68%,FLNA
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.28596449175138733,-0.6836058383708126,0.9583333333333334,1.0,1.0,5/24,11.00%,TTC39B;LAMTOR1;NR1H3;TREM2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.3222540947036205,0.6835788650386687,0.9680851063829787,1.0,1.0,21/97,21.44%,PHLPP1;INSR;TRIM5;CAV3;FN1;IGF1R;NTRK3;EPHA7;FLT1;NTRK2;PAK5;PEBP1;DHX33;IQGAP1;ROCK1;GSTP1;PRDM15;FGFR2;VRK2;CX3CL1;PAK3
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.41622874555100686,0.6835779616689356,0.9384615384615385,1.0,1.0,1/8,1.84%,AMY2B
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.3426051764588657,0.6835757048236554,0.9767441860465116,1.0,1.0,7/37,16.84%,MVD;SLC35A1;AMDHD2;ST6GALNAC5;ST8SIA3;GFPT1;DHDDS
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,0.34369525290558267,0.6835134816317743,0.956989247311828,1.0,1.0,19/49,24.91%,GSDMD;CASP5;RPS27A;CYCS;FASN;CDC37;SDCBP;PELI1;CASP3;IL18;UBA52;UBB;FLOT2;GNL3;GSDME;CASP1;PDCD6IP;TRADD;CHMP7
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.4174617917757325,-0.6833834541435904,0.8571428571428571,1.0,1.0,6/6,58.28%,MBD2;SIRT2;SIRT1;RRP8;H3-3A;BAZ2A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.36131620916404705,-0.6832505536723404,0.9259259259259259,1.0,1.0,2/12,7.34%,TGFBR3;IGF1
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,0.32820665730423143,0.6832155922718158,0.9368421052631579,1.0,1.0,9/76,11.30%,CLEC12A;CD163;SLC11A1;FCGR2B;SIRPB2;FGR;C5AR1;FCGR2C;FGL2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,0.36642135047157554,0.683157308901463,0.9024390243902439,1.0,1.0,8/33,23.67%,COPS5;RPS27A;RBX1;ACTR5;UBA52;UBB;DDB1;GPS1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.36568807281622906,0.683109086808696,0.9166666666666666,1.0,1.0,4/26,10.74%,CR1;GPNMB;FCGR2B;PDCD1LG2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.3991308251697909,0.6826745580817687,0.8947368421052632,1.0,1.0,5/12,22.26%,CCDC39;DNAH17;DNAH7;DNAAF2;DNAAF5
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,0.4200548895884835,0.6823148973053014,0.8947368421052632,1.0,1.0,1/9,7.22%,HIF1A
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.4137379077781511,0.6822340214561619,0.8571428571428571,1.0,1.0,2/11,22.47%,GNAI1;GNB5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3570281462659877,0.6821116063859625,0.8941176470588236,1.0,1.0,7/28,21.55%,MAPT;PINK1;PRELID1;SOD1;UBB;LRRK2;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.39869117241173024,0.6819587327569494,0.9,1.0,1.0,4/13,19.50%,FCGR2B;ID2;CD300A;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.30594346491987584,-0.68192257968821,0.9,1.0,1.0,5/23,13.95%,LGALS9;SIRPA;IGF1;ILRUN;HAVCR2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.40572539521655165,0.6819032758234602,0.8493150684931506,1.0,1.0,1/11,8.25%,XPO1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.4461796564867716,0.6814418016958864,0.8666666666666667,1.0,1.0,3/5,31.54%,HIP1R;LRP1;HIP1
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.4387597882574257,0.6814374034694174,0.8513513513513513,1.0,1.0,1/6,3.72%,PLPPR4
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.399822540084781,0.6809291896825499,0.9333333333333333,1.0,1.0,2/14,9.89%,BHLHE40;CELSR2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.4381121659508471,-0.6808947711429143,0.9032258064516129,1.0,1.0,2/5,11.95%,DHODH;ENTPD4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.41384239406459106,-0.6808134765913461,0.8157894736842105,1.0,1.0,1/5,1.88%,PUS1
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.3203161718116783,0.6807130751945744,0.9484536082474226,1.0,1.0,6/92,12.29%,NLRP12;NUP133;TRIM25;NOD2;SEC24C;RIPK2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.3086529116321568,-0.6800869648137347,0.9523809523809523,1.0,1.0,5/19,18.63%,WDR91;EMP2;BECN1;STX8;RAB7A
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.41821524187621373,0.6798561023464577,0.8493150684931506,1.0,1.0,2/10,21.38%,KLF9;RDX
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.3512714021830313,0.6797615184843531,0.9545454545454546,1.0,1.0,5/31,13.85%,SRGN;VPS11;DNM1;SNX10;HOOK3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.42761777556839353,0.6797233644796737,0.8181818181818182,1.0,1.0,1/9,8.75%,GSKIP
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.3282940164724557,0.6796917383305745,0.9390243902439024,1.0,1.0,4/49,11.13%,TRMT9B;FTSJ1;PUS7;METTL2A
prerank,PanglaoDB_Augmented_2021__Basophils,0.3213714273607848,0.6796196209183546,0.9387755102040817,1.0,1.0,17/109,16.93%,NFIL3;CLEC12A;INF2;F13A1;FCGR2B;SIRPB2;FGR;FCGR2C;CD93;FGL2;TULP3;CD300A;GPR183;ST6GALNAC5;PDK3;LRRC25;TEC
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.34470896149613234,0.6795843057376372,0.8823529411764706,1.0,1.0,15/43,27.34%,TOM1L1;BMI1;BRCA1;YAF2;E2F7;UXT;SUZ12;EZH2;CBX5;RBBP8;NME6;CCP110;MAX;WAPL;PCGF6
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.30664126772913414,0.6795807546593915,1.0,1.0,1.0,181/1014,24.14%,SOCS3;BRIP1;THBS1;DDIT4;KLF4;ZNF382;SAP30;ZNF793;CR1;MOBP;TGIF1;WDR5;FKBP5;NFIX;ZNF804B;EIF4A3;H2BC11;ERCC2;SLC2A3;ZNF483;NR4A2;NFIB;NR4A1;ZNF41;LIFR;RORB;GAD1;VEGFA;TDG;POLR3F;RXRB;INTS12;NDRG1;TCF7;MTERF1;SCO2;NUP133;GRIN2A;PDZD2;ZKSCAN5;ZNF235;ZNF540;GRIA2;PCBP4;PPP1R13L;TCF7L1;KCTD1;BNIP3L;DNA2;ATAD2;FANCI;RBPJ;RPS27A;PLK2;TXNIP;ZNF34;PRR5;NR2F1;TTC5;PSMB4;RBX1;CAMK2B;PRKAG2;COX7C;CCNC;GAD2;INTS3;CYCS;ZNF606;ZNF550;NR4A3;BRCA1;ZNF549;PINK1;PRELID1;FASN;POLR3H;YAF2;ZNF143;E2F7;RFC4;GRIN2B;ZNF248;GTF2H3;NELFB;UXT;SMARCD3;ESR1;MTA3;SEH1L;NR2C2;LDB2;CCND3;TBL1XR1;ZNF717;CXXC1;POLR2D;SMAD1;PRKRA;TFAM;BCL6;RGCC;ZNF665;ERCC6;SCO1;PRKAA2;TAF9B;INTS8;SESN1;ZNF778;UBA52;HSPD1;ESRRG;SUZ12;SMARCC1;EZH2;ELL2;UBB;PSMC2;CDK9;SIRT3;PPARA;TAF7;PSMA3;ZNF197;CDK5R1;MLH1;ZNF684;FOS;ZNF213;KDM5B;COLEC12;PCGF5;POLRMT;NOTCH2;PSMB2;NR1D1;COX4I1;MEAF6;RBL2;ZNF565;CDKN1B;CBX5;SRSF5;RBBP8;POLR2G;PSMD5;TFAP2E;STAT1;PSMD7;EAF1;INTS6;SMARCD2;SETD9;BARD1;PRKCB;COX6C;CNOT6;TJP1;ZNF706;JUN;NDC1;RORA;ZNF429;RPA3;SST;ARID4B;CASP1;UHRF1;ZNF519;ZNF718;SRSF3;GPS2;PTEN;ZNF577;PSMD14;ZNF169;INTS10;PSMA5;FOXO3;ZFP2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3086971011498422,0.6795748006101744,0.98,1.0,1.0,39/238,22.06%,NFE2L3;NFIX;ERCC2;NR4A2;NR4A1;RORB;NOCT;RXRB;INTS12;RBPJ;C5AR1;NR2F1;DEAF1;INTS3;NR4A3;DRAP1;ZNF143;GTF2H3;NELFB;ESR1;CEBPD;NR2C2;KLF13;TBL1XR1;POLR2D;ERCC6;TAF9B;INTS8;ESRRG;ELL2;CDK9;PPARA;TAF7;NOTCH2;NR1D1;POLR2G;TRIM24;EAF1;INTS6
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.32326168764615854,0.6795701394616257,0.9578947368421052,1.0,1.0,10/82,13.05%,DDIT4;IFIT5;ATAD3A;PQBP1;TRIM5;BNIP3L;IFITM3;IFNLR1;IFIT2;BNIP3
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.2835699740377269,-0.6795434501246215,1.0,1.0,1.0,4/32,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.2639467174133611,-0.6794566750463962,1.0,1.0,1.0,5/44,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2568413547538402,-0.6789941675864117,0.896551724137931,1.0,1.0,3/19,9.99%,LAPTM4B;VTA1;CHMP2B
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.26906819857649195,-0.6789138077467409,1.0,1.0,1.0,5/42,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.37974418103567426,0.6788667022099336,0.9166666666666666,1.0,1.0,2/19,9.49%,NDUFA2;RPS27A
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.37625667568582,-0.6787139730651139,0.896551724137931,1.0,1.0,2/10,7.51%,TGFBR3;TGFB1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.31942811233768637,0.6776345988113232,0.9574468085106383,1.0,1.0,18/90,27.76%,TBRG4;TFRC;XPO1;STT3B;INCENP;TIMELESS;IMMT;DDB1;NDC1;GANAB;CCT8;MCM3;EIF3A;SLC11A2;EIF3D;DHX37;UBE2O;PPRC1
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.3291281269850965,0.6774751444252758,0.945054945054945,1.0,1.0,18/70,27.66%,HSPA5;NUP133;DNAJC7;BAG3;SEH1L;HSPA12A;HSPA1B;HSPA2;UBB;TNFRSF21;HSPA14;NDC1;RPA3;POM121;HSPA9;HSPA13;NUP58;HSPA8
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),0.3483429621733893,0.6770604052573861,0.9024390243902439,1.0,1.0,3/33,10.58%,RIOK2;NGDN;RRP36
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.382845725634535,0.6770094448694216,0.9111111111111111,1.0,1.0,1/16,3.93%,SLC1A2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.3582515213147731,0.6766559238678164,0.92,1.0,1.0,2/18,13.84%,RNF126;AUP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,0.3548532621322663,0.6766484474116419,0.8974358974358975,1.0,1.0,9/26,20.13%,ITGA2;TFRC;CD55;ALCAM;THY1;ITGAV;TNFRSF1A;NCAM1;SLC3A2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.43461916219360547,0.6765332231383561,0.9305555555555556,1.0,1.0,3/8,20.20%,ALK;TYSND1;TNF
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.25139272171018123,-0.6762022250609285,1.0,1.0,1.0,21/58,23.79%,MRPL57;MRPS9;MRPL50;MRPL35;MRPS11;AURKAIP1;MRPS10;MRPL1;MRPS30;CHCHD1;GADD45GIP1;MRPS35;MRPL16;MRPL37;MTIF3;MRPL4;MRPS23;MRPS33;MTFMT;MRPL18;MRPS5
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.30757458708375884,0.6760076401372901,1.0,1.0,1.0,153/745,25.91%,RUNDC3B;ZPBP;SAP30;IFIT5;SPATA22;CFAP36;CCDC152;SMC1B;DZIP1;TEX14;MEI1;ACVR2A;PHYHIPL;CCDC122;CSMD3;SPDYA;IHO1;KHDC1;PHLPP1;CD55;MBOAT2;FSIP2;ADGRG6;SYCP3;HSF2;FCHO2;DNAH14;KIF21A;SUGP2;CENPP;GSKIP;ID2;FANCI;AFTPH;MXD1;PLK2;ARIH2;RP2;WASF1;TBC1D15;IMPACT;NR2F1;SHOC1;MXI1;AGPS;GABRB2;SLC9A6;TMEM108;HINFP;ADGRL2;DNAH7;ZNF606;CKAP5;RBM4B;DRG2;MCMDC2;ZCWPW1;PPP4R4;MAP7;CCNB3;CCDC18;NKIRAS1;CNKSR2;RANBP17;ABCA5;DNAJB9;MAPK10;NDUFB6;C11ORF65;EFCAB5;PEX3;DCK;KLHL8;ITGAV;WDR47;CCDC92;TRAPPC6B;C5ORF58;KIAA1586;NECAB1;SLC25A4;SPINT2;FANCL;ZBTB18;LRRIQ3;UVSSA;HPRT1;SESN1;TMEM175;EZH2;HSPA2;DENND5B;SLC35G2;FBXL5;PRPF39;DMXL2;SPAG6;SNAP91;KDM5B;PHTF1;TBCCD1;CLTCL1;NOTCH2;RBL2;HSPA14;ZCCHC9;GPR137C;IFT122;MFN2;RBBP8;RNF138;BRWD1;INTS6;PLEKHA3;SETD9;PDCD4;ALDH1A2;CEP350;SORT1;GARNL3;ITGB3BP;RTN4;TCEANC2;PHF21A;ARID4B;PAPOLG;DGKE;SYCE2;ARHGAP9;PRKACB;BBS7;RNFT1;VRK1;TCTN1;NEK9;RIC8A;WDR3;SMIM14;FAM107B;IFT81;CDK12;FLYWCH2;ACER3;STK17B;LIMK2;CCT6B;MTDH;VAPA;PAXBP1;SLC39A6;RPS6KA3;GPR89B;DNAH12
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.3263586483573023,0.6759183894639571,0.9361702127659575,1.0,1.0,21/61,26.31%,TACR1;CD55;CAV3;RYR2;TRPC4;C5AR1;ADCY8;WNT5A;ESR1;CACNA1A;ACKR4;DLG4;TMEM178A;ATP1A2;PTGER4;TRPC1;FPR1;ATP2B2;CACNA1C;ATP2B4;C5AR2
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.4291301019062922,0.675862568081029,0.8823529411764706,1.0,1.0,2/8,17.23%,NDRG1;BCL6
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.38035207361850304,0.6758450028853051,0.8888888888888888,1.0,1.0,5/16,23.39%,CDC37;SDCBP;PELI1;FLOT2;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3387437668126003,-0.6757711578548318,0.8214285714285714,1.0,1.0,3/9,16.48%,SVIP;DERL2;OS9
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.3463667927209048,0.6757598084410708,0.9186046511627907,1.0,1.0,10/42,29.74%,TMEM41B;VMP1;ATP2A2;UBXN2B;ATG5;MFN2;ATG13;MAP1LC3A;NSFL1C;ATG2B
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.38073960787775574,0.6757060668197,0.9295774647887324,1.0,1.0,2/13,9.72%,GAD1;GLUL
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.3537574215253998,-0.6756944453616563,0.8888888888888888,1.0,1.0,5/10,13.23%,ITGAM;TGFB1;ITGB2;TYROBP;SYK
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.3216948025542723,0.675121550895249,0.9550561797752809,1.0,1.0,11/55,23.52%,H2BC11;SMC1B;SYCP3;LMNB1;BRCA1;HSPA2;MLH1;SUN2;RBBP8;RPA3;SYCE2
prerank,KEGG_2021_Human__Tuberculosis,0.3190956451435796,0.6750676818814673,0.9795918367346939,1.0,1.0,13/123,15.83%,CLEC4E;TGFB2;CR1;FCGR2B;CALM3;FCGR2C;NOD2;CAMK2B;RIPK2;CYCS;MAPK10;CASP3;IL18
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4112760628222585,0.6746884639697185,0.9,1.0,1.0,2/8,15.47%,PINK1;MCTP1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.3701716427965573,0.6745280105381012,0.8888888888888888,1.0,1.0,3/17,21.38%,VPS11;RAB21;RDX
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,0.4268429774153284,0.6741784019642348,0.9117647058823529,1.0,1.0,3/6,37.72%,RNMT;SOS1;RANBP10
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.3171988511572901,-0.6740712461874513,0.8857142857142857,1.0,1.0,11/11,68.32%,PARP2;PARP8;TNKS;PARP16;PARP6;PARP1;PARP12;TNKS2;PARP10;PARP11;TIPARP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2657545149496082,-0.6739770773614217,0.9230769230769231,1.0,1.0,6/42,7.96%,HPS4;BAP1;GZMB;TP53;BID;PPP1R13B
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.4322587971816651,0.6738340160519873,0.8636363636363636,1.0,1.0,1/6,18.77%,HACL1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.4322587971816651,0.6738340160519873,0.8636363636363636,1.0,1.0,1/6,18.77%,HACL1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.30406562140412446,0.673795423698135,1.0,1.0,1.0,206/1260,21.86%,BRIP1;KLF4;NAMPT;NFIL3;ZNF382;MACC1;FGF1;ST18;SAP30;ZNF793;NFE2L3;RPL23;EGR1;TGIF1;HMGB2;PLAC8;PFKM;NFIX;ZBTB16;CREB5;ZNF483;NR4A2;NFIB;NR4A1;MEIS2;TSHZ3;ZNF41;SLC11A1;ACVR2A;PIAS4;BMPR1B;RFX2;ASXL3;RORB;ARID5B;VEGFA;SOX4;ZNF93;IER5;SUV39H2;RXRB;TCF7;ZNF654;ZNF814;HDGFL3;OVOL2;OLIG1;ABCA2;COPS5;HIF1A;BMI1;KDM3A;HSF2;HCFC1;CSRNP3;ARNT2;ZKSCAN5;RUVBL2;POU6F1;ZNF235;ZNF540;PAX8;YEATS2;BHLHE40;PPP1R13L;FOSL2;TCF7L1;TRPS1;KCTD1;MAFB;ID2;SS18L1;ATAD2;RBPJ;RRP1B;ZNF518A;RPS27A;KDM1A;POU5F1;MXD1;PDE2A;SRA1;PTOV1;PER1;ZNF34;CRTC3;IMPACT;NR2F1;NOD2;MXI1;GABPB1;DCAF6;ZNF536;DEAF1;ZNF850;PPID;HIF3A;SOX6;HCLS1;ETS2;HINFP;CCNC;CSRNP2;OTUD7B;RIPK2;FBP1;ZNF606;ZNF550;NR4A3;BRCA1;DRAP1;ZNF549;SOD2;ZNF143;PKD1;E2F7;HIVEP2;SDCBP;DPF3;ZNF248;GTF2H3;HIC2;WNT5A;ZNF292;UXT;SMARCD3;ESR1;MTA3;AKIRIN1;IL18;ZNF789;CEBPD;NR2C2;LDB2;TSHZ2;ZNF260;KLF13;TBL1XR1;CTBP1;TBX19;ZBTB47;ZNF717;EPAS1;LITAF;TXK;KLF9;CHD5;SMAD1;HAMP;BCL6;APP;KLF7;FOXP1;RGCC;ZNF665;ZBTB18;TNFRSF1A;TAF9B;ZNF778;UBA52;HSPD1;ESRRG;SMARCC1;EZH2;UBB;CDK9;PPARA;TAF7;ZNF197;NKX6-2;ZNF684;FOS;PRDM15;ZNF213;KDM5B;SMAD5;PRPF6;NOP53;CTDSP1;KDM6B;PCGF5;BEX1;TNF;ENO1;NR1D1;POU6F2;NPAS2;TCF4;ZNF565;BCL11A;FGFR2;CBX5;SLC9A1;ATF3;RBBP8;WIZ;CX3CL1;TNIP1;HEXIM1;SP140L;BRWD1;TFAP2E;ZNF142;MTF1;STAT1;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.41231681475809756,0.6736022893124725,0.9242424242424242,1.0,1.0,2/14,19.04%,SEMA5A;PPARA
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3887370527426159,0.6735710885921908,0.9012345679012346,1.0,1.0,1/16,9.50%,KDM1A
prerank,KEGG_2021_Human__Fatty acid degradation,0.34529999773342046,0.6732944915896979,0.9302325581395349,1.0,1.0,3/29,11.31%,ACSL1;ACAT1;CPT1A
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.30908860804041477,0.6732111860575638,0.9583333333333334,1.0,1.0,22/105,24.06%,FZD6;GNAO1;TCF7;TCF7L1;RPS27A;PSMB4;PRICKLE1;WNT5A;PLCB1;UBA52;UBB;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;GNB5;PRKCB;RORA;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.3252592330140425,0.6731326651414662,0.9583333333333334,1.0,1.0,9/60,15.06%,VIM;HMGB2;FCGR2B;PDE4B;PDCD1LG2;NOD2;TNFRSF1B;PYCARD;WNT5A
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.38956433637284704,-0.6729457802363751,0.8125,1.0,1.0,5/5,61.07%,ADRB2;ADRA1A;AKAP13;RAPGEF2;ADCY9
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.35083312316487614,0.6729013358231454,0.8823529411764706,1.0,1.0,5/35,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.3938652348910645,-0.6728771668346041,0.8823529411764706,1.0,1.0,5/9,14.80%,TP53;CDAN1;SUPT16H;M1AP;RBBP4
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.3180663222583117,0.6727525607615731,0.9565217391304348,1.0,1.0,19/73,22.68%,GALNT8;TSHZ3;NELL2;OLIG1;STMN3;NLGN3;CELF2;RNF175;FXYD7;PPP2R2B;KDM4B;ZBTB18;B3GAT1;NCAM1;GABBR1;PDZD4;PRKCB;SYT11;TSPOAP1
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,0.44878119452783044,0.6727178534723416,0.9295774647887324,1.0,1.0,1/5,19.35%,MLH1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.40926485615775465,0.6726519146684283,0.92,1.0,1.0,2/14,9.50%,TMEM161A;KDM1A
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.34714402137202305,0.6724307870407199,0.896551724137931,1.0,1.0,7/43,15.76%,NUP133;PGAM1;HIF1A;COX7A2;PRKAG2;PINK1;SEH1L
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.3754641119296949,0.6721903642874774,0.9358974358974359,1.0,1.0,5/13,26.64%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.3754641119296949,0.6721903642874774,0.9358974358974359,1.0,1.0,5/13,26.64%,SORBS1;FAM171A1;PHACTR1;TNFAIP1;KCTD13
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.3062116229295047,-0.6721409911657638,0.8620689655172413,1.0,1.0,5/11,16.35%,KLKB1;PROS1;PRCP;TTF2;FAM110A
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.42314601986751343,0.6720231656479301,0.921875,1.0,1.0,3/8,34.82%,NDRG4;LRP1;HGS
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.40596144319563254,0.6719679731430463,0.8666666666666667,1.0,1.0,1/11,8.94%,ADGRB2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3287469192909727,0.6718654580960113,0.9047619047619048,1.0,1.0,11/47,24.06%,FBXL7;FHL1;PSMB4;RBX1;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.3651682855574121,0.6718447439525116,0.9259259259259259,1.0,1.0,5/23,23.39%,PLK2;XRCC3;C10ORF90;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.26481412484184996,-0.6718086373436402,1.0,1.0,1.0,5/34,13.95%,UBA7;SIRPA;ILRUN;UFD1;HAVCR2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.40212854089940187,0.6716906621793127,0.8243243243243243,1.0,1.0,2/9,20.22%,SLC25A4;FBXO7
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.3220891186266287,0.6715686406501001,0.956989247311828,1.0,1.0,9/81,17.22%,DOCK1;VEGFA;SHC2;WASF1;PRR5;FLT1;ITGAV;ROCK1;HSPB1
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.3271871924890407,0.6713853065398266,0.9787234042553191,1.0,1.0,11/61,13.99%,DOCK1;SEPTIN8;CAV3;FN1;DNM3;SHC2;WASF1;DNM1;HCLS1;GAB1;CTNNA2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.4240339346772101,0.6711841406816433,0.8307692307692308,1.0,1.0,2/6,20.22%,PINK1;FBXO7
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.4431869962530317,0.6711180242749388,0.8636363636363636,1.0,1.0,2/5,15.83%,SLC11A1;IL18
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.26130344273923617,-0.671029583847079,1.0,1.0,1.0,5/27,12.23%,YES1;FYN;SRC;PKN1;ARPC2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.31650852335845825,0.6708609081465555,0.9651162790697675,1.0,1.0,14/69,24.39%,RNF144B;ARIH2;RNF144A;RBX1;PRICKLE1;DNAJB2;HSPA1B;PSMC2;NOP53;LRRK2;USP5;BBS7;RNFT1;DDRGK1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.2700815847017977,-0.6706653324146927,1.0,1.0,1.0,7/34,13.06%,BTG2;TP53;ZNF385A;EP300;CNOT6L;PLK3;PLAGL1
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.3074734545581106,0.670634463071768,0.9795918367346939,1.0,1.0,5/153,3.04%,TGFB2;EGR1;ADCY3;CREB5;IL15
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.3632527989906694,0.67039852335938,0.9047619047619048,1.0,1.0,5/19,27.83%,PQBP1;AIM2;STAT1;TRAF3IP2;PARP9
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.44680553689046293,0.6699695555710868,0.9032258064516129,1.0,1.0,3/6,30.84%,SRM;AMD1;SAT2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.3207433169306495,0.66995509426555,0.9361702127659575,1.0,1.0,7/60,11.67%,TGFB2;ZBTB16;KITLG;BMI1;SBDS;ARIH2;FLT1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.28065281896111705,-0.6698038581113097,0.9545454545454546,1.0,1.0,3/21,10.15%,ACSM5;ACSF2;MLYCD
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.42923611992480926,0.6697950013207504,0.8620689655172413,1.0,1.0,2/5,32.04%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.42923611992480926,0.6697950013207504,0.8620689655172413,1.0,1.0,2/5,32.04%,CPSF6;DHX9
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.36046286187948373,-0.6692659895947123,0.8666666666666667,1.0,1.0,3/8,14.16%,NBN;WDR18;KAT7
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4494336908056641,0.6691946262163453,0.890625,1.0,1.0,2/6,20.20%,ESR1;TNF
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.3027431353986737,0.6690641296582852,1.0,1.0,1.0,164/904,24.14%,SOCS3;BRIP1;THBS1;DDIT4;KLF4;ZNF382;ZNF793;CR1;MOBP;TGIF1;WDR5;FKBP5;ZNF804B;EIF4A3;H2BC11;ERCC2;SLC2A3;ZNF483;NR4A2;NR4A1;ZNF41;LIFR;RORB;GAD1;VEGFA;RXRB;INTS12;NDRG1;TCF7;SCO2;GRIN2A;PDZD2;ZKSCAN5;ZNF235;ZNF540;GRIA2;PCBP4;PPP1R13L;TCF7L1;KCTD1;BNIP3L;DNA2;ATAD2;FANCI;RBPJ;RPS27A;PLK2;TXNIP;ZNF34;PRR5;NR2F1;TTC5;PSMB4;RBX1;CAMK2B;PRKAG2;COX7C;CCNC;GAD2;INTS3;CYCS;ZNF606;ZNF550;NR4A3;BRCA1;ZNF549;PINK1;PRELID1;FASN;YAF2;ZNF143;E2F7;RFC4;GRIN2B;ZNF248;GTF2H3;NELFB;UXT;SMARCD3;ESR1;NR2C2;LDB2;CCND3;TBL1XR1;ZNF717;CXXC1;POLR2D;SMAD1;BCL6;RGCC;ZNF665;SCO1;PRKAA2;TAF9B;INTS8;SESN1;ZNF778;UBA52;HSPD1;ESRRG;SUZ12;SMARCC1;EZH2;ELL2;UBB;PSMC2;CDK9;SIRT3;PPARA;TAF7;PSMA3;ZNF197;CDK5R1;MLH1;ZNF684;FOS;ZNF213;KDM5B;COLEC12;PCGF5;NOTCH2;PSMB2;NR1D1;COX4I1;MEAF6;RBL2;ZNF565;CDKN1B;CBX5;SRSF5;RBBP8;POLR2G;PSMD5;TFAP2E;STAT1;PSMD7;EAF1;INTS6;SMARCD2;SETD9;BARD1;PRKCB;COX6C;CNOT6;TJP1;ZNF706;JUN;RORA;ZNF429;RPA3;SST;CASP1;ZNF519;ZNF718;SRSF3;GPS2;PTEN;ZNF577;PSMD14;ZNF169;INTS10;PSMA5;FOXO3;ZFP2
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.27211007968753,-0.6688430355915308,0.9166666666666666,1.0,1.0,11/41,19.66%,PLA2G4C;MAPK13;KRAS;SRC;PPP3CC;MAPKAPK2;AKT1;PRKCA;CDC42;PLCG2;SPHK2
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,-0.421225937183384,-0.6686439173168978,0.7931034482758621,1.0,1.0,5/5,57.90%,GAB2;PTPN11;GRB2;STAT5A;STAT5B
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.2580126928334108,-0.6684758910273061,1.0,1.0,1.0,8/50,12.26%,TICAM1;CHUK;CGAS;TLR3;EP300;IKBKB;NFKBIA;POLR3A
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.3223196539556628,0.6684498760339209,0.9680851063829787,1.0,1.0,11/72,17.56%,ANXA1;FCGR2B;CD55;TRIM5;CASP5;FGR;NOD2;WNT5A;GRK4;BCL6;FOXP1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.4332977060400387,0.668209876524097,0.8823529411764706,1.0,1.0,1/6,23.42%,ADGRB3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3112984157566672,0.6678436631650067,0.9787234042553191,1.0,1.0,26/121,24.06%,NEK11;CKS2;ERCC2;BRINP1;MEIS2;RCC1;SRA1;PSMB4;SDCBP;IQGAP1;APP;PSMC2;CDK9;CDC25B;PSMA3;PSMB2;CDKN1B;DDB1;PSMD5;HNRNPU;PSMD7;PIM3;PSMD14;BORA;CDK10;PSMA5
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.3041485100660049,0.6675644358733602,0.9693877551020408,1.0,1.0,25/143,23.60%,GNA11;GNAO1;TRAF2;RPS6KB2;TRIM5;CALM3;RBX1;CYCS;TNFRSF1B;GNAI1;PAK5;CCNB3;MAPK10;CASP3;CFL1;TNFRSF1A;GNAQ;FOS;TNF;DDB1;PAK3;GNB5;PRKCB;JUN;TRADD
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.37751338038782456,0.6673559402314296,0.8571428571428571,1.0,1.0,3/13,21.86%,NELFB;HEXIM1;HNRNPU
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.2505200896014966,-0.6673192978493178,1.0,1.0,1.0,6/47,9.81%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;DERL2
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.38592889906359495,0.6672525681308645,0.8840579710144928,1.0,1.0,4/12,19.17%,PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.39193684267784434,0.667038784056105,0.8571428571428571,1.0,1.0,3/10,15.35%,B4GALT5;ST6GALNAC5;ST8SIA3
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,-0.36051464809517053,-0.6670269054076984,0.8620689655172413,1.0,1.0,2/9,9.74%,TXN2;EP300
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.365747601285908,0.6663711041418836,0.9012345679012346,1.0,1.0,6/17,36.38%,CDK9;CPSF6;CTR9;HSF1;NCBP1;ZC3H3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.4076016760429566,-0.6663088449707124,0.8333333333333334,1.0,1.0,1/5,15.17%,MARK4
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,0.33855222271434715,0.6661860735821526,0.9425287356321839,1.0,1.0,7/46,12.85%,CD163;TNS1;F13A1;CD93;FGL2;FLT1;SHROOM4
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,-0.3748085332960642,-0.665719083817513,0.875,1.0,1.0,4/11,28.78%,AKT1;YWHAE;YWHAG;YWHAB
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.3235742829660114,0.6656515946546281,0.896551724137931,1.0,1.0,12/47,24.06%,PDK4;SIRT5;PSMB4;PRKAG2;PSMC2;PPARA;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.34333134983438096,0.6653762217113516,0.9333333333333333,1.0,1.0,9/42,17.93%,H2BC11;TDG;MPG;NEIL1;POLG2;RFC4;POLE2;NEIL2;ADPRS
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.3655308972389335,0.6653409265045069,0.9518072289156626,1.0,1.0,2/20,9.72%,GLYATL1;GLUL
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,0.3281411672194812,0.6651770998012997,0.925531914893617,1.0,1.0,10/88,13.83%,CR1;CD163;FCGR2B;FGR;CD93;FGL2;GPR65;HCLS1;TNFRSF1B;CD300A
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.30034632622135876,0.665125877979286,1.0,1.0,1.0,157/1271,17.75%,BRIP1;KLF4;CENPF;NFIL3;ACVR1B;ZNF382;ST18;SAP30;CDK14;ZNF793;NFE2L3;EGR1;TGIF1;HMGB2;TLE1;NFIX;ZBTB16;CREB5;ZNF483;MYRF;NR4A2;AGT;NFIB;NRG1;NR4A1;PQBP1;MEIS2;TSHZ3;ZNF41;PIAS4;RFX2;RORB;PTPRK;ARID5B;VEGFA;SOX4;ZNF93;SUV39H2;POLR3F;RXRB;TCF7;ZNF654;RUNX1T1;APBB3;ZNF814;HDGFL3;HINT1;INSR;SFMBT1;RBFOX2;OVOL2;OLIG1;ABCA2;HIF1A;KDM3A;GLRX2;HSF2;HCFC1;FOXN2;CSRNP3;ATP8B1;ARNT2;ZKSCAN5;RUVBL2;POU6F1;ZNF235;ZNF540;PAX8;YEATS2;BHLHE40;PPP1R13L;FOSL2;TCF7L1;TRPS1;KCTD1;MAFB;ID2;SS18L1;ATAD2;LIMD1;RBPJ;ZNF518A;KDM1A;POU5F1;MXD1;CELSR2;SRA1;PER1;ZNF34;NR2F1;MXI1;ING1;PRICKLE1;ZNF536;DEAF1;TULP3;ZNF850;HIF3A;SOX6;HCLS1;ETS2;HINFP;CCNC;CSRNP2;ZNF606;ZNF550;NR4A3;BRCA1;DRAP1;ZNF549;SOD2;LANCL2;RLIM;TRIM16;YAF2;ZNF143;E2F7;HIVEP2;DPF3;ZNF248;PICALM;HIC2;WNT5A;ACTR5;ZNF292;MLF2;UXT;SMARCD3;ESR1;MTA3;ZNF789;CEBPD;NR2C2;TSHZ2;ZNF260;KLF13;TBL1XR1;CTBP1;TBX19;ZBTB47;ZNF717;EPAS1;LITAF;CXXC1;KLF9;CHD5;PLCB1;SMAD1;PCBD2;TFAM;BCL6;KLF7;APBB2;FOXP1;ZNF665;ERCC6;ZBTB18
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.3375887555555738,-0.6650943424520703,0.84375,1.0,1.0,5/10,17.04%,COPS7B;COPS8;COPS7A;COPS2;COPS6
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.3469747677404844,0.664765577720185,0.9285714285714286,1.0,1.0,6/36,21.40%,CELF2;DDX1;RBM5;PRPF6;SRSF5;SNRPD2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.31682828214082265,0.6643782920823883,0.9791666666666666,1.0,1.0,24/102,22.13%,ST18;EGR1;MAP3K8;HIF1A;RPS27A;NOD2;PSMB4;RBX1;RIPK2;PYCARD;PELI1;GBP2;PLCB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;NR1D1;IRAK3;CX3CL1;PSMD5;PSMD7;MAP3K3
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,0.3172444459763411,0.6642813083837996,0.9479166666666666,1.0,1.0,8/75,12.72%,CD163;F13A1;FCGR2B;FGR;CD93;FGL2;HCLS1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.32194235465613974,0.6640501148410213,0.9777777777777777,1.0,1.0,19/82,21.29%,FRMD5;VEGFA;CELSR2;SEMA5A;EPHA7;EPHA4;PLXNB1;TGFBI;IL18;EPB41L4B;ITGAV;ROCK1;ARHGDIA;PLXNC1;PKP4;FES;ADAM22;TNF;P4HB
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.3319728693492654,0.6640314813074276,0.9659090909090909,1.0,1.0,6/41,18.81%,H2BC11;RPS27A;TGFBI;APP;UBA52;UBB
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.383823032759203,-0.6638056895141817,0.8461538461538461,1.0,1.0,5/5,61.64%,RPP30;RPP38;POP1;POP5;SSB
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.38773533919332254,0.6637347063921303,0.8918918918918919,1.0,1.0,4/11,27.13%,TMEM39A;CALCOCO2;FYCO1;UBQLN4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.3859437043330479,-0.6631606097910511,0.7666666666666667,1.0,1.0,1/7,7.11%,DIP2A
prerank,KEGG_2021_Human__Non-homologous end-joining,-0.3574904521710864,-0.6631588708145616,0.8709677419354839,1.0,1.0,1/9,5.19%,POLM
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4094203792883058,0.6630813068011985,0.881578947368421,1.0,1.0,4/12,12.65%,MANF;OVOL2;OTOGL;BACE2
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.35547089467121457,0.6630153909924593,0.9213483146067416,1.0,1.0,4/25,22.91%,ABCA1;ABCA5;OSBPL5;ABCG1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.3022677915254622,0.6629415613654184,0.9560439560439561,1.0,1.0,9/76,17.56%,THBS1;NOD2;ARG2;PYCARD;WNT5A;HSPB1;APP;GSTP1;FOXP1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.37303496405439274,0.6627157303926722,0.9333333333333333,1.0,1.0,7/18,29.90%,RYR2;CCDC39;NDRG4;BBS7;SETDB2;MEGF8;MICAL2
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,0.41300216956987945,0.662443353443925,0.8823529411764706,1.0,1.0,2/8,15.55%,ALOX12;LTA4H
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3228159200103378,0.6623749514707048,0.9333333333333333,1.0,1.0,7/58,14.53%,RPL23;NUP133;PRICKLE1;HEATR3;FAM53C;TNPO2;RANBP17
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.29860864717434304,0.6623647352145324,0.9795918367346939,1.0,1.0,28/150,24.06%,TLE1;H2BC11;MFNG;CNTN1;HIF1A;RBPJ;RPS27A;PSMB4;RBX1;CCNC;ATP2A2;TBL1XR1;NEURL1;UBA52;UBB;PSMC2;PSMA3;NOTCH2;PSMB2;TACC3;PSMD5;STAT1;PSMD7;DNER;JUN;PSMD14;DTX2;PSMA5
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.24565745257389943,-0.6619498771720823,1.0,1.0,1.0,7/28,19.54%,YKT6;GOSR1;VTI1B;STX5;STX8;BET1;STX18
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.42892424292061626,0.6619378439567057,0.8387096774193549,1.0,1.0,4/6,26.39%,PLD3;CDS2;PRKCSH;PGS1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.3469381245392456,0.6615006721678489,0.9302325581395349,1.0,1.0,5/36,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.34793561128149497,0.6613356501627078,0.9302325581395349,1.0,1.0,9/44,26.32%,TRIM5;MAP2;KDM1A;TRIM25;PICALM;TRIM14;BORA;ZDHHC7;HSP90AB1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.36673399357761327,-0.6610467631317023,0.9166666666666666,1.0,1.0,1/8,2.69%,ZDHHC3
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,0.43440988873263353,0.6610361287067752,0.8888888888888888,1.0,1.0,2/6,15.55%,ALOX12;LTA4H
prerank,KEGG_2021_Human__Thiamine metabolism,-0.37889539360267427,-0.6610221882290209,0.8888888888888888,1.0,1.0,1/6,7.33%,NTPCR
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.33556280090372376,0.6607440943562207,0.9222222222222223,1.0,1.0,14/55,25.52%,SLC2A9;NUP133;SLC9A7;SLC24A1;SLC35A1;SEH1L;SLC16A1;SLC3A2;SLC24A4;SLC20A2;SLC26A3;NDC1;POM121;SLC11A2
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,0.3757758234071481,0.6607300625014596,0.9142857142857143,1.0,1.0,4/13,19.17%,PIGQ;PIGF;PIGL;PIGG
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.4169406776206717,0.6606534924594988,0.9230769230769231,1.0,1.0,1/7,4.35%,SEPSECS
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3598981521425198,0.6606452836100972,0.9195402298850575,1.0,1.0,5/26,17.43%,IL7;HIF1A;WNT5A;TXK;HSPA1B
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,0.42435301755969584,0.6605580094525019,0.9142857142857143,1.0,1.0,1/6,2.41%,GLYATL1
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,0.43839666006572525,0.6605455005259898,0.8307692307692308,1.0,1.0,2/5,18.04%,SLC16A3;SLC16A1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3643875966311604,0.660240608219097,0.9125,1.0,1.0,2/14,19.70%,REEP3;SUN2
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,0.34030142871523,0.6600611809890803,0.9024390243902439,1.0,1.0,3/33,8.25%,NUP133;RCC1;XPO1
prerank,KEGG_2021_Human__Butanoate metabolism,0.37563669646511283,0.6600238739600878,0.948051948051948,1.0,1.0,5/20,14.89%,GAD1;ACAT1;L2HGDH;GAD2;HMGCS1
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),-0.397606687057371,-0.6599544639400633,0.8,1.0,1.0,2/6,18.53%,SERPINB9;RNF213
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.34649347641682404,0.6599411973635898,0.9425287356321839,1.0,1.0,4/28,12.42%,CLVS1;GNS;DNAJC6;SH3GL2
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,-0.3151448602077878,-0.6599112713689079,0.88,1.0,1.0,10/10,68.52%,BLZF1;MAPK3;RAB2A;USO1;GORASP2;GOLGA2;RAB1B;MAPK1;RAB1A;GORASP1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.42241057766857953,0.6597560636861802,0.9848484848484849,1.0,1.0,3/7,27.93%,PELI1;SLC25A4;YBX3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.42241057766857953,0.6597560636861802,0.9848484848484849,1.0,1.0,3/7,27.93%,PELI1;SLC25A4;YBX3
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.3115697057854301,0.6596622756407876,0.968421052631579,1.0,1.0,30/112,25.81%,SLC2A9;NUP133;ABCA1;SLC9A7;RPS27A;SLC24A1;PSMB4;SLC35A1;SEH1L;ERLIN1;SLC16A1;UBA52;UBB;PSMC2;PSMA3;SLC3A2;PSMB2;SLC24A4;PSMD5;SLC20A2;ABCB4;SLC26A3;PSMD7;NDC1;PSMD14;PSMA5;CFTR;POM121;SLC11A2;ABCC8
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.39296671027959107,0.6595107701043036,0.8714285714285714,1.0,1.0,3/10,37.39%,RAD21;PDS5B;NIPBL
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,0.3333239066095356,0.6594584110764774,0.9666666666666667,1.0,1.0,7/48,12.85%,CD163;PREX2;F13A1;CD93;FGL2;FLT1;SHROOM4
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),-0.352689002973571,-0.6594325970320826,0.8518518518518519,1.0,1.0,4/8,29.12%,FAS;ATP6AP1;ATP6V1G1;ATG7
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.4100730249190849,0.6593417526921093,0.8985507246376812,1.0,1.0,3/10,19.50%,FCGR2B;PDCD1LG2;TNFRSF21
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.24688554240916444,-0.6592753337396847,1.0,1.0,1.0,6/48,9.81%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;DERL2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.4322746315997579,0.6590165789567443,0.8625,1.0,1.0,1/6,7.25%,GRB10
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.31709143501043213,0.6588556602209337,0.9368421052631579,1.0,1.0,19/77,23.88%,SLC1A2;ACOT13;GSDMD;ADCY8;POLQ;RYR3;SPAST;SOD2;HCN1;PYCARD;DISP1;HPRT1;ALAD;AQP11;ECT2;ACACB;ALDH1A2;PDCD6IP;NACC2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.4211097851255455,0.6588377386677763,0.8923076923076924,1.0,1.0,2/5,29.71%,CDK9;CTR9
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.3725514158873015,0.6584943370358172,0.9375,1.0,1.0,4/20,12.81%,BHLHE40;ID2;PER1;RBM4B
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,0.4161505095178947,0.6584496982684818,0.9041095890410958,1.0,1.0,5/6,46.68%,FUT8;CHGA;FUCA1;MAN2A2;MAN2A1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.39831657460509745,0.6583524120745559,0.8918918918918919,1.0,1.0,2/11,21.55%,PXK;ATP5IF1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.29708025304535013,0.6580011459197646,0.9797979797979798,1.0,1.0,11/111,12.50%,TBRG4;RNASEH2C;WDR74;RBM3;RBFOX2;ADARB2;TFIP11;CELF2;NOVA1;HNRNPA0;RBM5
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,0.4178884064958381,0.6578311258233831,0.9315068493150684,1.0,1.0,3/6,36.56%,SLC9A1;GUSB;CD44
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,-0.38267595327639264,-0.6576354699792946,0.825,1.0,1.0,1/6,9.74%,EP300
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,0.31887651992258775,0.6570753535346003,0.9693877551020408,1.0,1.0,9/69,11.30%,CLEC12A;CD163;SLC11A1;SIRPB2;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,0.31887651992258775,0.6570753535346003,0.9693877551020408,1.0,1.0,9/69,11.30%,CLEC12A;CD163;SLC11A1;SIRPB2;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.3208224764114115,0.6570089810455505,0.9680851063829787,1.0,1.0,4/60,5.04%,TFRC;NRG1;SLF1;VEGFA
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,0.34598722776365665,0.6569974177028907,0.9213483146067416,1.0,1.0,8/37,23.25%,ERCC2;RPS27A;RBX1;GTF2H3;UBA52;UBB;DDB1;RPA3
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.3757493256833336,0.6568409847913169,0.9178082191780822,1.0,1.0,4/16,34.47%,SPTBN1;GOLGB1;PIK3CA;SOS1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.249012917527068,-0.6568185409268058,1.0,1.0,1.0,8/106,3.99%,NKG7;CD37;LY86;BIN2;CD2;BANK1;BLNK;CEACAM21
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.28729315393603005,-0.6567217877088415,1.0,1.0,1.0,5/33,12.08%,NUP42;NUP155;NUP188;NUP214;HSPA1A
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.35978535943092266,0.6567109994907785,0.7875,1.0,1.0,5/17,24.06%,ENC1;PSMB4;PSMA3;PSMB2;PSMA5
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.3187253761430594,0.6565685884226456,0.979381443298969,1.0,1.0,17/84,23.49%,MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT;JUN;TLR5
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.37021100489232317,0.6564107035036114,0.9117647058823529,1.0,1.0,3/15,17.93%,SEMA6A;SEMA5A;PLXNC1
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.3783006529819214,0.6563760765165896,0.925,1.0,1.0,3/14,21.88%,ETFB;EEF1AKMT1;EEF1A1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.36591512099817214,0.6563011874660225,0.8888888888888888,1.0,1.0,7/22,23.67%,COPS5;RPS27A;RBX1;UBA52;UBB;DDB1;GPS1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.37964756277737,-0.6562264915253337,0.8787878787878788,1.0,1.0,1/8,2.28%,CYP19A1
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.27890587619058194,-0.6559985954459776,1.0,1.0,1.0,4/32,10.83%,NUP42;NUP155;NUP188;NUP214
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.34147890788794194,0.6557736014676013,0.95,1.0,1.0,3/26,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2876613389076254,0.6555621894507548,0.9696969696969697,1.0,1.0,54/258,27.34%,FBXL7;KCTD2;HSPA5;SEC61B;FBXL2;HERPUD1;RPS27A;TRIM25;RNF175;TRIM9;STT3B;PSMB4;RBX1;DNAJB2;RNF126;FBXO27;AUP1;DNAJB9;PELI1;SYVN1;TBL1XR1;UBXN2B;ERLIN1;UBE2J2;HECW2;FBXL13;UBA52;UBB;PSMC2;FBXL5;ZNRF1;PSMA3;PSMB2;SPSB3;UCHL1;DDB1;PSMD5;HSP90B1;PSMD7;HACE1;FEM1C;FAM8A1;PSMD14;PSMA5;MAN1A1;RHBDD2;TNFAIP1;BAG6;KCTD13;FZR1;UBE2D1;CTNNB1;FEM1B;UBR2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.34640764748409525,0.6555518316360154,0.9156626506024096,1.0,1.0,3/25,15.68%,SNAP29;VMP1;ATP2A2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.3197321277531525,-0.6553917377770258,0.9130434782608695,1.0,1.0,4/16,12.54%,CSF1R;SRC;TREM2;TYROBP
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,0.3293664636776704,0.655309560948346,0.9325842696629213,1.0,1.0,9/49,15.99%,CD163;TNS1;F13A1;CD93;FGL2;FLT1;SHROOM4;LILRB5;LDB2
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.32098656197603875,0.655077466486853,0.967032967032967,1.0,1.0,6/77,7.66%,SULT4A1;CYP3A5;GLYATL1;PAPSS2;MAT2A;ARNT2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.2706906754586187,-0.6550082932436196,0.9333333333333333,1.0,1.0,20/20,72.99%,ANAPC4;UBE2E2;UBE2A;UBE2E3;CDC26;PRKN;UBE2D4;ANAPC11;CDC16;UBE2H;ANAPC1;CDC27;CDC23;RNF4;UBE2D3;UBE2B;UBE2L3;ANAPC7;ANAPC5;FZR1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.34625583686582395,0.6549183449142324,0.9382716049382716,1.0,1.0,9/30,26.57%,RAB15;CADPS;CLASP2;SDCBP;RAB2B;RAB5A;PDCD6IP;CFTR;RAB27B
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.3203588075054853,0.6548921186559924,0.9425287356321839,1.0,1.0,3/48,5.64%,MAPT;TFRC;EIF2AK3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.4030821718443641,0.6546151856784517,0.8974358974358975,1.0,1.0,1/8,15.56%,ESR1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.40751615972276717,0.6545598669189232,0.8783783783783784,1.0,1.0,3/9,29.48%,RYR3;HSP90B1;DGKQ
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,0.3804162558160829,0.6542480496652173,0.9090909090909091,1.0,1.0,5/14,29.30%,ITGAE;SELL;IL7R;IL21R;CCR3
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.31702390507588984,0.6542390163277196,0.9555555555555556,1.0,1.0,9/57,18.31%,RIOK2;IMP3;XPO1;SBDS;NHP2;NMD3;NXF1;NOB1;GTPBP4
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.2857076102751195,-0.6540652759833616,0.8461538461538461,1.0,1.0,4/27,12.12%,H2BC4;GATAD2B;TTF1;H2BC26
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.41613211956264357,0.6538930559584375,0.9027777777777778,1.0,1.0,2/8,20.68%,RNF139;LRRK2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.290294225436234,0.6538062432632729,0.9795918367346939,1.0,1.0,41/288,24.06%,TOM1L1;DTL;FBXL7;RNF144B;KCTD2;VPS37C;HERPUD1;TRIM25;ARIH2;TRIM9;RNF144A;PSMB4;RBX1;RNF126;OTUD7B;PINK1;RLIM;PELI1;KLHL8;SYVN1;TBL1XR1;RNF13;UBXN2B;HECW2;RNF149;PSMC2;ZNRF1;PSMA3;FBXO7;PSMB2;SPSB3;UCHL1;DDB1;PSMD5;PSMD7;HACE1;FEM1C;UHRF1;UBE2D2;PSMD14;PSMA5
prerank,CellMarker_Augmented_2021__Granulocyte:Undefined,0.4461582617920935,0.6537834086390966,0.8985507246376812,1.0,1.0,2/6,10.46%,FCGR2B;FCGR2C
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.43828917665947364,0.6535042458518263,0.890625,1.0,1.0,1/5,9.56%,POU5F1
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,0.43542851994090437,0.6534209628785095,0.8873239436619719,1.0,1.0,2/6,14.52%,NTRK2;GRIN2B
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.2975891834465778,-0.6531279147148294,0.8709677419354839,1.0,1.0,5/11,19.10%,ZDHHC21;DAPK3;CHRM2;SETD3;ADRB2
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.253614533196601,-0.6530929053207518,1.0,1.0,1.0,8/58,13.60%,MRPL57;MRPS9;MRPL50;MRPL35;MRPS11;AURKAIP1;MRPS10;MRPL1
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.3382785989482245,0.6528896849369354,0.9512195121951219,1.0,1.0,3/35,8.25%,NUP133;RCC1;XPO1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.36041670930293446,0.6528844969258525,0.9178082191780822,1.0,1.0,2/21,5.04%,NR4A1;VEGFA
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.32115251847143417,0.6526893473852435,0.9444444444444444,1.0,1.0,14/51,24.06%,GPC5;RPS27A;PSMB4;SYVN1;UBA52;UBB;PSMC2;PSMA3;PSMB2;P4HB;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.39958319110272456,0.6525726604850738,0.8823529411764706,1.0,1.0,4/8,32.52%,PTEN;FZR1;GORASP1;RAB1A
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.3547736907505241,0.6522254572180028,0.9176470588235294,1.0,1.0,3/23,6.19%,COL11A1;COL4A5;COL24A1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.44079166752945426,0.6521866586957921,0.8688524590163934,1.0,1.0,4/6,30.59%,ITGAV;PPARA;LRP1;NR1H2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.4290926796291683,0.6519616949648235,0.8939393939393939,1.0,1.0,4/9,39.67%,ZC3HAV1;PARP9;PARP10;TNKS2
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.38694970375447224,-0.6519331281636835,0.8863636363636364,1.0,1.0,1/7,3.56%,LATS2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.3716706331678065,-0.65187953840883,0.7931034482758621,1.0,1.0,2/6,23.62%,FIS1;MCU
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.4333591528316976,0.6517827668757772,0.92,1.0,1.0,1/5,21.58%,FLOT2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.3996416581224491,0.6516724676507507,0.9078947368421053,1.0,1.0,5/11,23.19%,UCKL1;DCK;UPP2;UCK2;CAD
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.40811596993365395,0.651616150564454,0.90625,1.0,1.0,1/10,10.26%,SEMA5A
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.36455025330643076,0.6515951465675056,0.926829268292683,1.0,1.0,4/21,12.81%,BHLHE40;ID2;PER1;RBM4B
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.4299690505235643,0.6514967856074674,0.8412698412698413,1.0,1.0,1/7,5.63%,CD55
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.36409311810527245,-0.651311676004495,0.8333333333333334,1.0,1.0,2/5,20.36%,NLRP3;CD81
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.36409311810527245,-0.651311676004495,0.8333333333333334,1.0,1.0,2/5,20.36%,NLRP3;CD81
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),0.3933295202066107,0.6512627052677235,0.863013698630137,1.0,1.0,2/6,16.93%,TXK;TEC
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.37582616963589205,0.6511957703428226,0.9135802469135802,1.0,1.0,4/13,22.22%,CD55;IL18;GNL1;MYO1G
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.3134242813650667,-0.6508441218113288,0.9666666666666667,1.0,1.0,1/14,2.32%,BIN2
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.3084958094473219,0.6499744285029072,0.9775280898876404,1.0,1.0,9/77,16.23%,TRMT9B;NUP133;FTSJ1;PUS7;TRNT1;DDX1;TSEN54;SEH1L;DUS2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.3740479541286713,0.6497265557104744,0.9710144927536232,1.0,1.0,2/12,21.83%,RBPJ;STAT1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,0.36934116178192045,0.649383783885847,0.8947368421052632,1.0,1.0,3/12,15.39%,ALCAM;POU5F1;THY1
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,-0.4303437935430994,-0.6491182300999369,0.9032258064516129,1.0,1.0,1/5,4.79%,WWTR1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.33091095544385357,0.6489695172494411,0.9418604651162791,1.0,1.0,2/41,2.02%,IFIT5;EGR1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.33091095544385357,0.6489695172494411,0.9418604651162791,1.0,1.0,2/41,2.02%,IFIT5;EGR1
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,-0.36329579402115936,-0.6487054602642636,0.8846153846153846,1.0,1.0,2/9,8.79%,NEDD4;SRC
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3170438529173773,0.6486920363796205,0.9782608695652174,1.0,1.0,12/86,15.82%,ERCC2;TFRC;NRG1;SLF1;RPA2;VEGFA;ABCA1;RBX1;TPPP;GTF2H3;ESR1;DHX33
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.3684504499969228,0.6484063594113794,0.8947368421052632,1.0,1.0,1/15,5.04%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.3593897569886313,0.648366361086665,0.8795180722891566,1.0,1.0,3/18,13.87%,MASTL;PPP4R4;PPP1R15A
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2924083303697594,0.6483385684699982,0.98,1.0,1.0,39/168,24.20%,HTR2B;NLRP12;IFIT5;TLE1;TFRC;TRAF2;TRIM5;TRIM25;PLK2;GPRC5B;PER1;NOD2;OTUD7B;RIPK2;DDX1;PINK1;PYCARD;PELI1;WNT5A;ESR1;LITAF;HSPB1;GSTP1;TNFRSF1A;RHOH;ECT2;TNF;NR1D1;TRIM14;CX3CL1;TNIP1;STAT1;MAP3K3;PRKCB;RORA;CASP1;TRADD;SLC20A1;TRAF3IP2
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.35840064046587145,0.6481976073210848,0.9102564102564102,1.0,1.0,6/23,23.45%,CDH2;ID2;CTNNA2;CDK9;FGFR2;MEGF10
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.37225416282291524,0.6477594992944767,0.8904109589041096,1.0,1.0,3/11,14.36%,GINS1;MCMDC2;RFC4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.4388713834467493,0.6475098924831184,0.8589743589743589,1.0,1.0,1/6,9.13%,MID1IP1
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,0.28769991595739436,0.6474985588999386,1.0,1.0,1.0,97/536,25.08%,SKIC2;TRMT9B;RPL23;ENPP2;EIF4A3;ERCC2;RIOK2;WDR12;PQBP1;RPL37A;WBP11;PES1;GEMIN2;NUP133;FTSJ1;RPL38;PUS7;XPO1;WBP4;RPS6;RRP1B;RPS27A;RPL23A;TFIP11;TRNT1;RPS25;RPS27;RRP36;BCAS2;PSMB4;RPS11;NHP2;RPS20;RPL9;HNRNPA0;UPF3A;DDX1;RBM5;RPLP2;TSEN54;RPL37;NXF1;RPL14;GTF2H3;SEH1L;HNRNPH1;RPS4X;MPHOSPH6;DUS2;RPL11;RPS24;POLR2D;RPS9;HSPB1;NOB1;RPL36;DIMT1;UBA52;ZBTB8OS;UBB;PSMC2;PSMA3;PRPF6;COLEC12;RPS3A;PSMB2;RPL35;RPL4;SRSF5;POLR2G;RPL32;SNRPD2;PSMD5;MPHOSPH10;TRMT10C;HNRNPU;PSMD7;GNL3;RPL27A;CNOT6;NDC1;RPL3;PHF5A;SRSF3;PSMD14;RPS16;PSMA5;EIF4A2;RPL30;WDR3;RPL36AL;PRCC;HNRNPR;RPL21;GTPBP3;POM121;RPL7
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.38709640918500554,0.6474854154251386,0.8961038961038961,1.0,1.0,3/9,17.86%,TNFRSF11B;TNFRSF1B;TNFRSF1A
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,0.42729923315680673,0.6471832433139586,0.9295774647887324,1.0,1.0,1/6,9.72%,GLUL
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.2831294040908246,-0.6471259447489487,0.9259259259259259,1.0,1.0,4/15,12.08%,CEP97;CHMP2B;CCSAP;HSPA1A
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2938380426018102,0.646784135331049,0.9696969696969697,1.0,1.0,35/165,26.05%,GPM6B;LRGUK;TRAF2;ANK3;BAIAP2L1;BSN;PKP2;NLGN3;NLGN1;WASF1;DARS1;PPID;VCPIP1;PARD3;VMP1;PICALM;TOGARAM1;WNT5A;SPTBN1;FANCA;RHOH;DLG4;RTN3;NLGN4X;KNTC1;NAPG;RHOU;HFE;RTN4;SYCE2;REPS2;RIMS1;PPARGC1A;PTK2B;PARVB
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.4099286845857945,-0.6467659573730944,0.8275862068965517,1.0,1.0,2/5,25.57%,TIRAP;CYBA
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.36448900894434677,0.6464567849901716,0.8840579710144928,1.0,1.0,4/11,20.90%,FRMD5;SPOCK3;SPINT2;CCDC125
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.3096093499359987,0.6464538817145673,0.978494623655914,1.0,1.0,15/53,24.35%,RPS27A;PSMB4;RBX1;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.3710522837646911,0.6463381136849129,0.9625,1.0,1.0,2/19,5.17%,RPA2;TDG
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3495038306674856,0.6461926809337205,0.8961038961038961,1.0,1.0,3/23,15.56%,VPS11;BRCA1;ESR1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.37664626153522796,0.6461237465340905,0.9078947368421053,1.0,1.0,5/11,22.61%,FCGR2B;LRFN5;NR1D1;CX3CL1;SYT11
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.2464091734431757,-0.6460355832765894,1.0,1.0,1.0,10/47,17.60%,MATK;TGFB1;SRC;EGFR;TGFA;AKT1;PTPN12;CBL;PRKCA;DGKD
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4311836929381382,0.6459988469407748,0.859375,1.0,1.0,2/5,24.50%,TMSB10;TWF1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.35614779484332826,0.6459936756482177,0.9629629629629629,1.0,1.0,5/20,27.75%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,KEGG_2021_Human__ABC transporters,0.3391209545398577,0.645740832043857,0.9506172839506173,1.0,1.0,7/27,25.81%,ABCA2;ABCA1;ABCA5;ABCB4;ABCG1;CFTR;ABCC8
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.2955001383784339,-0.6457313858122654,0.9166666666666666,1.0,1.0,3/17,11.53%,TGFB1;APH1A;HM13
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.3662995745163718,-0.6451703165402,0.9090909090909091,1.0,1.0,3/7,13.42%,ITPA;NT5C;GPX1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.30826444704398903,0.6450968633641947,0.9787234042553191,1.0,1.0,10/73,16.34%,TGFB2;ARF6;STXBP5L;APBB3;SNAP25;RAPGEF3;PPID;DISP1;TMED10;CACNA1A
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.38354026681925735,0.6449848758036477,0.8970588235294118,1.0,1.0,1/8,11.60%,SGIP1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.3444950770569094,-0.6445805851042391,0.9310344827586207,1.0,1.0,3/8,19.39%,GRK2;PDE4D;SRI
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.30531528509499434,0.6445782068412675,0.9782608695652174,1.0,1.0,1/79,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.30531528509499434,0.6445782068412675,0.9782608695652174,1.0,1.0,1/79,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.4165940210032242,0.6444401537046744,0.9193548387096774,1.0,1.0,3/6,29.61%,CD300A;SLAMF8;HMOX1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.3263224879110492,0.6443087848108504,0.9230769230769231,1.0,1.0,11/46,22.36%,DTL;PLK2;NSF;APC2;WNT5A;HECW2;TNF;CDKN1B;DDB1;HACE1;BARD1
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.32550977190214736,0.6439428437557679,0.9583333333333334,1.0,1.0,7/38,18.81%,RPS27A;NOD2;RIPK2;NKIRAS1;APP;UBA52;UBB
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3054686129778724,0.6434820416615605,0.9782608695652174,1.0,1.0,18/67,26.67%,MAT2A;BOK;GSDMD;ADCY8;POLQ;SPAST;TMEM120B;PYCARD;ALAD;AQP11;ECT2;SLC9A1;PDCD6IP;NACC2;KCNC2;OPA1;CPSF6;PRMT1
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.2957295368569811,0.643382860277242,0.9791666666666666,1.0,1.0,25/126,26.67%,FKBP5;H2BC11;KCNH8;KANK1;XPO1;IGF1R;KDM1A;PPID;GNAI1;KDM4B;ESR1;POLR2D;CDK9;FOS;UHMK1;CDKN1B;POLR2G;GNB5;JUN;FOXO3;GREB1;GTF2A1;ZDHHC7;HSP90AB1;PRMT1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.3056200963751089,-0.6432840808483676,0.9285714285714286,1.0,1.0,6/24,11.55%,RHOG;P2RY12;NCKAP1L;PLEK;CYFIP1;GSN
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.31236223028397786,0.6432477580084375,0.9782608695652174,1.0,1.0,6/84,9.93%,H2BC11;MASTL;SMC4;NUP133;NCAPH2;LMNB1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.39742611595434113,0.6431184410891116,0.9054054054054054,1.0,1.0,1/8,10.25%,OGA
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.35090277422555816,0.642956908379117,0.9210526315789473,1.0,1.0,3/20,14.17%,CARMIL1;ARHGEF4;ABLIM3
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.31021695906245594,0.6428414268159907,0.9176470588235294,1.0,1.0,11/57,22.86%,TGFB2;PTPRK;RPS27A;PARD3;SMAD1;UBA52;UBB;FOS;SMAD5;APPL1;JUN
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.3161550165551357,-0.6427292496742775,0.9090909090909091,1.0,1.0,4/14,16.60%,TP53;EP400;UBN1;HMGA1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.3960329671110085,-0.642688146340087,0.8918918918918919,1.0,1.0,1/6,9.60%,AGO1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.3768282273501974,-0.6426585037516749,0.9117647058823529,1.0,1.0,1/5,3.49%,CORO1B
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.305521892934594,-0.6425986469311938,0.88,1.0,1.0,4/17,13.82%,BCKDHB;IVD;SLC25A44;ACADSB
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.32249574893087496,-0.6419631698079562,0.9032258064516129,1.0,1.0,4/10,14.93%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),0.374692411256062,0.6418423603756348,0.9090909090909091,1.0,1.0,4/12,21.98%,CEMIP;CEMIP2;SLC9A1;CHP1
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,-0.32777053333121925,-0.6417249160015166,0.8888888888888888,1.0,1.0,2/11,11.08%,AGO1;CNOT6L
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.3516582269456094,-0.641511164861007,0.8235294117647058,1.0,1.0,2/6,14.29%,HSPA1A;SLC15A3
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.44986650127927075,0.6414367925098695,0.9117647058823529,1.0,1.0,2/5,31.12%,PTPRN2;PTPRN
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.3427831523468058,-0.6413253111653926,0.9310344827586207,1.0,1.0,1/12,1.31%,NPC2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.3052503338642737,0.6411677522327708,0.9347826086956522,1.0,1.0,7/43,18.84%,NRG1;VEGFA;ZSWIM4;NRG4;ROCK1;FES;NRG2
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.32646285574470896,-0.6408240266758296,0.8666666666666667,1.0,1.0,2/8,10.03%,LIMA1;PLEK
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.3272792223279768,-0.6407043609877576,0.8928571428571429,1.0,1.0,1/13,11.76%,KPNA6
prerank,KEGG_2021_Human__IL-17 signaling pathway,0.32171146368812137,0.6405412158659132,0.9659090909090909,1.0,1.0,14/44,29.20%,MAPK4;TRAF2;MAPK10;CASP3;FOS;TNF;HSP90B1;JUN;TRADD;TRAF3IP2;HSP90AB1;USP25;ANAPC5;MAPK6
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.3437507720537861,0.6400704333959802,0.9058823529411765,1.0,1.0,7/24,18.81%,RPS27A;TRIM25;RFC4;POLE2;USP43;UBA52;UBB
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.3896645068747977,0.6399586800139722,0.9333333333333333,1.0,1.0,2/9,24.01%,VCPIP1;VRK1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.35332992166457844,0.6397713399623638,0.9113924050632911,1.0,1.0,1/23,1.28%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.32707659237736386,0.6396075185223487,0.9438202247191011,1.0,1.0,3/36,3.87%,IL15;TFRC;ANXA1
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.39355945094122596,0.6395701265994663,0.9090909090909091,1.0,1.0,1/7,17.68%,ERCC6
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.3408517976820727,0.6392524999585875,0.9634146341463414,1.0,1.0,5/21,18.81%,SH3GL3;RPS27A;SH3GL2;UBA52;UBB
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.3164914853374028,0.638928604717788,1.0,1.0,1.0,18/94,22.86%,ACVR2A;PIAS4;BMPR1B;VEGFA;CAV3;CALM3;TXN;THBD;MAPK10;ITGAV;GSTP1;TNFRSF1A;PRKAA2;FOS;TNF;HSP90B1;GSTM3;JUN
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.3183029299013244,0.63860824869614,0.9574468085106383,1.0,1.0,15/49,30.19%,H2BC11;RPS27A;RPS6KA2;IGFBP7;UBA52;UBB;FOS;CDKN1B;JUN;RPS6KA3;FZR1;UBE2D1;ANAPC5;ANAPC7;H3-3B
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.29512623847308594,0.6378974666619283,0.9789473684210527,1.0,1.0,14/65,24.06%,FZD6;CELSR2;PSMB4;PRICKLE1;MAGI2;WNT5A;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.30897188174343804,0.6376949910107665,1.0,1.0,1.0,8/76,17.22%,DOCK1;VEGFA;SHC2;WASF1;PRR5;ITGAV;ROCK1;HSPB1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.30252010529488915,0.637476468100607,0.9782608695652174,1.0,1.0,1/80,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3200291002108179,0.6372255168134165,0.9655172413793104,1.0,1.0,5/46,12.42%,AGT;SPRY1;ERRFI1;RNF126;SH3GL2
prerank,KEGG_2021_Human__Viral myocarditis,0.3102973565457791,0.6372162966834365,0.9294117647058824,1.0,1.0,6/43,18.16%,DMD;LAMA2;CD55;CYCS;CASP3;SGCD
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.4483760053454088,0.6370265518749431,0.9491525423728814,1.0,1.0,1/5,14.57%,SFXN3
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.36664887428272974,0.637020141603597,0.9135802469135802,1.0,1.0,5/17,25.67%,SLC11A1;SLC41A2;SLC39A14;SLC11A2;SLC39A6
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.39659910932430265,0.6369164607548145,0.9594594594594594,1.0,1.0,2/8,19.08%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.3005930557737581,0.6366805537633903,0.9893617021276596,1.0,1.0,7/57,16.85%,WDR74;RBFOX2;DNA2;HNRNPA0;DDX1;HNRNPH1;POLR2D
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.2465454006160243,-0.6366534731680926,1.0,1.0,1.0,9/37,20.53%,ACTB;GATAD2B;RNF8;CECR2;RBBP4;ZNHIT1;ACTR8;CHD4;INO80
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.27270688156372475,-0.6366057451448028,0.9523809523809523,1.0,1.0,5/19,18.72%,CTC1;SRC;TERF2;EXOSC10;ERCC4
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,0.39705644180386845,0.6362023486835998,0.9452054794520548,1.0,1.0,3/8,18.81%,RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.35622481717320825,0.6360442087279838,0.95,1.0,1.0,5/19,27.75%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.3839630515844677,-0.6358805401090231,0.8214285714285714,1.0,1.0,2/6,11.55%,DAB2IP;GSN
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.3722322697709702,0.6357479145889378,0.9166666666666666,1.0,1.0,3/12,22.53%,ROCK1;SLC9A1;PTGER4
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.39352192874115083,0.6356625038929847,0.927536231884058,1.0,1.0,3/8,31.34%,ATP2A2;ATP2B4;ATP2B1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3912848330771808,0.6356435193772074,0.9629629629629629,1.0,1.0,3/10,31.90%,LRRK2;OPA1;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.40019480682688957,0.6355901669576799,0.8490566037735849,1.0,1.0,3/6,29.50%,ROCK1;LRPAP1;LRP1
prerank,Reactome_2022__Cross-presentation Of Particulate Exogenous Antigens (Phagosomes) R-HSA-1236973,-0.38436128716230417,-0.635502970996246,0.8214285714285714,1.0,1.0,1/7,5.54%,ITGB5
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.33677648879231736,-0.6354322144837375,0.9310344827586207,1.0,1.0,1/11,0.93%,TICAM1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),-0.37540294384817546,-0.6354148110574819,0.9705882352941176,1.0,1.0,3/6,22.54%,LPL;TIRAP;CD74
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.32765511868154207,0.6353917561756763,0.9340659340659341,1.0,1.0,5/27,13.00%,AMY2B;PDIA2;PLTP;ZDHHC9;SOD2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.35122196046293025,0.6353689294947881,0.96,1.0,1.0,1/19,8.86%,ID2
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.3014538306211276,0.6352510006339189,1.0,1.0,1.0,1/72,0.35%,CLEC4E
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.383553616173976,0.634938085642937,0.9206349206349206,1.0,1.0,1/6,21.82%,TRMT10C
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,0.3958356668495447,0.6346926815312606,0.8571428571428571,1.0,1.0,2/8,27.89%,EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.3068821784594007,0.6343667391727287,0.9662921348314607,1.0,1.0,10/46,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;UBXN2B;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.44087023504720146,0.634351638980785,0.9230769230769231,1.0,1.0,1/6,5.77%,IL7
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,0.30437741221828546,0.634249743823489,0.9690721649484536,1.0,1.0,8/79,11.30%,CLEC12A;CD163;FCGR2B;FGR;C5AR1;FCGR2C;CD93;FGL2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.3582198696474559,0.633792022162674,0.9135802469135802,1.0,1.0,3/16,9.57%,ANKUB1;ATP5MK;CCDC39
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.33014221018101947,0.6336258934478797,0.9545454545454546,1.0,1.0,5/33,16.31%,PPP2R5A;NSMF;CALM3;PPP1R15A;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.4217314015590775,0.6335983070999691,0.9420289855072463,1.0,1.0,1/6,12.87%,BRCA1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.33309150824612455,0.6331249416698439,0.9662921348314607,1.0,1.0,10/36,23.75%,RPS27A;NOD2;RIPK2;MAPK10;MAP3K13;UBA52;UBB;PTGER4;GPS1;GPS2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.3162910823875674,-0.6328345575672538,0.9310344827586207,1.0,1.0,1/9,5.30%,MKKS
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.324582041749133,0.6325469976317264,0.9666666666666667,1.0,1.0,10/43,21.92%,ROBO2;NSMF;PAX8;GHR;SRA1;NR4A3;KLF9;ATP1A2;RDX;TRIM24
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3153802909843147,-0.6324548606085508,0.9090909090909091,1.0,1.0,3/7,16.29%,NCKAP1L;IKBKB;NUAK1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.29315877777522076,0.6324428013386146,0.9795918367346939,1.0,1.0,27/120,24.06%,IL1RAPL1;MAP3K8;GSDMD;RPS27A;NOD2;PSMB4;RBX1;RIPK2;NKIRAS1;PELI1;IL18;APP;PTPN9;UBA52;UBB;PSMC2;PSMA3;PTPN5;PSMB2;PTPN20;IRAK3;PSMD5;PSMD7;MAP3K3;CASP1;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.299763056883793,0.6322308075389506,0.9888888888888889,1.0,1.0,13/47,31.27%,ARIH2;RBX1;RNF126;PELI1;SYVN1;ZNRF1;HACE1;UBE2D2;UBR5;UBE2D1;KBTBD6;RNF6;UBE2R2
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3271826866675279,0.6319938025844577,0.9135802469135802,1.0,1.0,6/23,24.15%,MAPT;IRS2;NPRL2;CDKN1B;HNRNPU;EIF4A2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.4035125819430366,0.6315254273427529,0.9298245614035088,1.0,1.0,1/5,21.58%,FLOT2
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3312624349112719,0.6313869113007354,0.9879518072289156,1.0,1.0,2/27,8.25%,GEMIN2;XPO1
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.3078254673154407,-0.6313666922732126,0.9444444444444444,1.0,1.0,3/16,11.55%,PFN1;SSH3;GSN
prerank,KEGG_2021_Human__Apoptosis,0.30123076410753985,0.6313289395111769,0.9595959595959596,1.0,1.0,13/106,15.15%,TUBA4A;GADD45B;TUBA1A;TRAF2;EIF2AK3;SEPTIN4;BOK;MCL1;LMNB1;SPTAN1;CYCS;MAPK10;CASP3
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.3621835009185922,-0.6311521007589608,0.9090909090909091,1.0,1.0,4/9,13.10%,RIPOR2;TREM2;TYROBP;CD53
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,-0.33618654988158336,-0.6311234925170942,0.9444444444444444,1.0,1.0,2/13,8.55%,ICAM1;TLR3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.39497389846846387,0.6302046165740777,0.9333333333333333,1.0,1.0,3/8,20.20%,SH3D19;TNFRSF1B;TNF
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.309199201705177,0.6300747154191451,0.9662921348314607,1.0,1.0,13/62,16.36%,SLC24A2;GRIN2A;TRPC4;SLC24A1;NALCN;RYR3;PMPCA;PKD1;GRIN2B;ATP2A2;SLC24A3;CACNA1A;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3788214406999718,0.6299487241303029,0.9230769230769231,1.0,1.0,2/12,18.11%,KDM1A;TAF9B
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.27738451340500675,-0.6297616922064363,0.9655172413793104,1.0,1.0,3/21,13.87%,BBS10;TBC1D32;DISC1
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,0.3911567475635339,0.6295276928781777,0.9411764705882353,1.0,1.0,2/10,15.61%,PAICS;PFAS
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3516958447457788,0.6295135653150801,0.9102564102564102,1.0,1.0,3/17,15.39%,PTPRK;SORBS1;THY1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),0.4151139815324999,0.6294388705340443,0.8955223880597015,1.0,1.0,2/5,24.96%,DDX3X;RSAD2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),0.4151139815324999,0.6294388705340443,0.8955223880597015,1.0,1.0,2/5,24.96%,DDX3X;RSAD2
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.301145612048821,0.6294325417458783,1.0,1.0,1.0,16/70,22.66%,CADM1;INF2;NDRG2;ID2;CD93;PDE4DIP;THBD;PPA1;TMEM14A;DUSP10;BCL6;CSRP1;SLC24A4;SLAMF8;VAV3;CPNE3
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.3945961154102074,0.6291467676726111,0.8902439024390244,1.0,1.0,2/10,20.27%,LIPE;STS
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.3835521471642561,0.6289473386337335,0.9090909090909091,1.0,1.0,2/7,22.61%,PNKD;SYT11
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.29283615878259156,0.6289197452464808,0.9896907216494846,1.0,1.0,20/92,24.35%,PPP2R3B;RPS27A;PSMB4;POLE2;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;PSMB2;RBL2;CDKN1B;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.3126396039752372,0.6284284081477932,0.9885057471264368,1.0,1.0,3/50,5.04%,TGFB2;IL15;VEGFA
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.2830134297585787,0.6283967607142078,0.96875,1.0,1.0,15/89,24.06%,FZD6;GNAO1;CELSR2;PSMB4;PRICKLE1;WNT5A;PLCB1;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.30031396837435126,0.6280870934068032,1.0,1.0,1.0,16/70,27.20%,NEK11;ERCC2;PSMB4;DBF4;PSMC2;PSMA3;PSMB2;CDKN1B;DDB1;PSMD5;PSMD7;PSMD14;PSMA5;ATP2B4;FZR1;UBE2D1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.3358234023994607,-0.6280344823288418,0.9285714285714286,1.0,1.0,2/8,11.82%,MKKS;TASOR
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3294431696188001,-0.6280180469709428,0.9666666666666667,1.0,1.0,3/9,23.57%,AKAP8L;AKAP8;MTHFR
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.30753994925918493,0.6279508698560344,0.9431818181818182,1.0,1.0,7/32,25.74%,RBPJ;DTX3;SORBS2;NOTCH2;STAT1;DTX2;TRAF7
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.38835640089707424,0.6278280556359839,0.8695652173913043,1.0,1.0,2/7,14.58%,AMDHD2;ALDH1A1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.3122116189382629,0.6276737905900049,0.967391304347826,1.0,1.0,13/51,21.28%,ERCC2;RPS27A;RBX1;RFC4;GTF2H3;POLE2;POLR2D;ERCC6;UVSSA;UBA52;UBB;DDB1;POLR2G
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.3420110974383394,0.6273210223035616,0.9204545454545454,1.0,1.0,6/25,15.66%,SEMA3A;NSMF;SEMA6A;CAMK2B;CTNNA2;PHACTR1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.43815521253846745,0.6270306541884029,0.9444444444444444,1.0,1.0,1/5,8.46%,FN1
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.374040469741298,-0.6270236147998918,1.0,1.0,1.0,1/6,3.49%,CORO1B
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.29566250528216603,0.6269551331984442,0.9545454545454546,1.0,1.0,3/52,9.26%,H2BC11;MFNG;RBPJ
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.3996280903706198,0.6267562225656723,0.9253731343283582,1.0,1.0,3/9,29.84%,TIMELESS;SPIDR;BLM
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.23028728722123162,-0.6266919111475904,1.0,1.0,1.0,17/57,22.47%,IDE;GZMB;RSPRY1;CAPN2;SOCS6;NGLY1;HM13;CTSZ;CHFR;CASP8;CTSH;ZRANB1;VPS4B;CTSC;UBC;ATE1;PRKN
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.3725505702959148,-0.6266493212728118,0.9210526315789473,1.0,1.0,1/5,11.69%,SLC25A33
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,0.3689110517279762,0.6259767669510727,0.9166666666666666,1.0,1.0,2/10,10.74%,ADGRE1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,0.3689110517279762,0.6259767669510727,0.9166666666666666,1.0,1.0,2/10,10.74%,ADGRE1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,0.3689110517279762,0.6259767669510727,0.9166666666666666,1.0,1.0,2/10,10.74%,ADGRE1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,0.3689110517279762,0.6259767669510727,0.9166666666666666,1.0,1.0,2/10,10.74%,ADGRE1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,0.3689110517279762,0.6259767669510727,0.9166666666666666,1.0,1.0,2/10,10.74%,ADGRE1;PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.3774372040697614,0.6258595021192471,0.9342105263157895,1.0,1.0,4/9,21.27%,VEGFA;KDM1A;SMARCD3;CX3CL1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3170952129105057,0.6255395733148111,0.9560439560439561,1.0,1.0,8/33,24.61%,ABCA2;ABCA1;IRS2;PNPLA8;PRKAA2;ABCB4;ABCG1;DDX3X
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,0.3053908174230235,0.6255162921633272,1.0,1.0,1.0,8/73,13.83%,CD163;AMY2B;RGS1;F13A1;CD93;FGL2;HCLS1;CD300A
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.3026152803613013,0.6255091314075045,0.9775280898876404,1.0,1.0,12/46,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.31766867523382686,-0.6253893735720943,0.9259259259259259,1.0,1.0,3/9,13.44%,FYN;REST;STK26
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.3921353240672696,0.625098977736634,0.8970588235294118,1.0,1.0,2/5,29.50%,DDRGK1;LRP1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.3488980616765174,0.6250895797672713,0.9315068493150684,1.0,1.0,2/17,13.85%,SNX10;HOOK3
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.37057975168629725,0.6250417012768885,0.9523809523809523,1.0,1.0,4/15,19.36%,RPS27A;UBA52;UBB;AP2A2
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.4051034324005169,0.6248844303470162,0.9436619718309859,1.0,1.0,1/8,9.85%,WASF1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2868928203688118,0.6248328203508114,0.99,1.0,1.0,26/168,21.95%,NFE2L3;NFIX;ERCC2;NR4A2;NOCT;MTERF1;PAX8;POLR1C;DEAF1;DRAP1;POLR3H;GTF2H3;NELFB;CEBPD;KLF13;POLR2D;TFAM;ERCC6;TAF9B;CDK9;TAF7;POLRMT;POLR2G;TEFM;TRIM24;EAF1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,0.3135607896136707,0.6246313502319517,0.9887640449438202,1.0,1.0,10/59,15.99%,CD163;TNS1;F13A1;PDK4;MAFB;CD93;FLT1;THBD;ALDH1A1;LDB2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.36353173905956226,0.6245596425077442,0.8840579710144928,1.0,1.0,2/10,12.66%,CLASP2;SPAST
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.37561359794245064,-0.6243164119710142,0.8387096774193549,1.0,1.0,1/5,7.51%,TGFB1
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,0.388763314957732,0.6241075495085191,0.9315068493150684,1.0,1.0,3/7,20.78%,TNF;SELL;IL7R
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.3653601734550202,0.6240259355796552,0.8974358974358975,1.0,1.0,1/10,7.34%,KDM3A
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.3540655115963275,0.6237694526351589,0.9545454545454546,1.0,1.0,3/15,11.93%,CD55;TRIM5;SASH1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.41202474880168277,0.6236416145240399,0.9384615384615385,1.0,1.0,3/5,30.47%,IMPACT;DDX3X;EIF4G1
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,0.37533573934603764,0.6234912926678843,0.9125,1.0,1.0,3/15,10.46%,FCGR2B;C5AR1;FCGR2C
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.34867421043742614,-0.6230072296532878,0.8571428571428571,1.0,1.0,7/7,65.16%,AKT1;GCH1;HSP90AA1;CALM1;PTS;DHFR;QDPR
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.3209318610508453,0.6228586328805259,0.9772727272727273,1.0,1.0,2/40,5.25%,WDR5;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.2999255884978594,0.6227043115527652,0.96875,1.0,1.0,14/65,20.74%,DAPK1;TRIM5;BNIP3L;PLK2;BNIP3;PINK1;ROCK1;NPRL2;PRKAA2;SESN1;TRIM65;FBXO7;LRRK2;TRIM14
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.30967017153410675,0.6223216377277971,0.9886363636363636,1.0,1.0,13/47,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;TACC3;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.30318435343139993,0.6218793978320185,0.963855421686747,1.0,1.0,8/37,24.61%,HSPA5;TFIP11;IMPACT;AIDA;NOP53;PTGER4;JAM3;DDX3X
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.40411968131880693,0.621773108388888,0.9558823529411765,1.0,1.0,3/7,34.23%,SOD1;TOX;TESPA1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.32809086829034706,-0.6211654634824199,0.8888888888888888,1.0,1.0,3/10,21.84%,APH1A;ADAM10;PSEN1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.29726381249352807,0.6209689983572957,0.9666666666666667,1.0,1.0,14/69,24.06%,FBXL7;FBXL2;PSMB4;RBX1;FBXO27;FBXL13;PSMC2;FBXL5;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.3035437295288201,-0.6209575892435678,0.896551724137931,1.0,1.0,1/11,7.54%,CGAS
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.4371722805023074,0.620465249653049,0.9666666666666667,1.0,1.0,2/5,27.21%,MTMR9;MTMR4
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.33249650470473624,0.6203651441654683,0.9666666666666667,1.0,1.0,10/32,23.25%,ERCC2;RPS27A;RBX1;RFC4;GTF2H3;POLE2;UBA52;UBB;DDB1;RPA3
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,-0.3526729161388396,-0.6202825473317343,0.88,1.0,1.0,8/8,64.76%,CHEK2;YWHAE;YWHAG;YWHAB;YWHAZ;YWHAQ;YWHAH;REXO2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.3597905935995947,-0.6200744249875026,0.9166666666666666,1.0,1.0,6/6,64.05%,WWP2;PPIF;CTTNBP2NL;NDFIP2;SNCA;NDFIP1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,0.3072968677608178,0.619850633676914,0.9666666666666667,1.0,1.0,6/63,13.83%,CLEC12A;CR1;FGR;C5AR1;FGL2;CD300A
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,0.3072968677608178,0.619850633676914,0.9666666666666667,1.0,1.0,6/63,13.83%,CLEC12A;CR1;FGR;C5AR1;FGL2;CD300A
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3565483281918189,0.6197874504395295,0.9864864864864865,1.0,1.0,7/20,24.61%,ANXA1;CCND3;PLCB1;RGCC;RDX;CDK10;DDX3X
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.349442035422895,-0.6197101877430119,0.9310344827586207,1.0,1.0,1/9,2.58%,PLA2G4C
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.3759371958095016,0.619694519118829,0.9538461538461539,1.0,1.0,1/10,11.60%,SGIP1
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.31261984700402473,0.6195699983162236,0.9647058823529412,1.0,1.0,9/34,23.49%,CASP5;PDE2A;BNIP3;PIEZO2;TNFRSF1A;SLC9A1;PTGER4;CASP1;TLR5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3586466639247825,0.6195058800019592,0.9066666666666666,1.0,1.0,2/14,11.02%,FANCB;POLQ
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.24084509808771726,-0.6193559907388367,1.0,1.0,1.0,5/53,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.2830306721668321,-0.6191456952588829,1.0,1.0,1.0,2/12,10.62%,PDGFD;ABL1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.3386538299130141,-0.618308229138077,0.8571428571428571,1.0,1.0,8/8,66.17%,BUB3;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.2350037171790156,-0.617936269134177,1.0,1.0,1.0,5/54,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.2953556940651778,0.6179340113434492,0.9894736842105263,1.0,1.0,13/90,13.83%,CLEC12A;SLC11A1;GPNMB;FCGR2B;SIRPB2;TRIM25;FGR;C5AR1;FCGR2C;FGL2;MPP1;TNFRSF1B;CD300A
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.32893832872339634,0.617754406484951,0.9404761904761905,1.0,1.0,5/26,19.08%,RUVBL2;RAPGEF3;BRCA1;CTBP1;TAF7
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.33705523814433636,-0.6173489480704948,0.8333333333333334,1.0,1.0,2/8,9.99%,VPS37B;CHMP2B
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,0.411827488086867,0.6172097652937182,0.9583333333333334,1.0,1.0,2/6,11.37%,TYSND1;AGPS
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,0.3666678647314052,0.6169957370658925,0.9305555555555556,1.0,1.0,2/9,23.60%,FASN;TRADD
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,0.3666678647314052,0.6169957370658925,0.9305555555555556,1.0,1.0,2/9,23.60%,FASN;TRADD
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.34819641138368673,0.6166726072169558,0.926829268292683,1.0,1.0,4/15,30.09%,FZR1;UBE2D1;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.3932391249698827,0.6166675239257048,0.9,1.0,1.0,2/6,29.77%,MEAF6;ING4
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,0.295495266258294,0.6166606010573124,0.9789473684210527,1.0,1.0,11/84,16.48%,CLEC12A;CR1;SLC11A1;FCGR2B;FGR;C5AR1;FCGR2C;TNFRSF1B;CD300A;RASGRP4;LRRC25
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,0.295495266258294,0.6166606010573124,0.9789473684210527,1.0,1.0,11/84,16.48%,CLEC12A;CR1;SLC11A1;FCGR2B;FGR;C5AR1;FCGR2C;TNFRSF1B;CD300A;RASGRP4;LRRC25
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.27418006651796784,0.6166575988805358,1.0,1.0,1.0,118/690,24.15%,CLEC4E;CRISPLD2;ALDH3B1;NDUFA2;CLEC12A;CR1;PLAC8;PRKCE;SLC2A3;DOCK1;CHI3L1;SLC11A1;MAP3K8;POLR3F;KCNH8;CD55;DGAT1;GNS;ACTR1B;ATOX1;PDZD2;MYO10;SNAP25;GSDMD;DNM3;RPS27A;TRIM25;FGR;TXNIP;WASF1;MGAM;CKAP4;C5AR1;CD93;SPTAN1;DNM1;NOD2;ARSA;PSMB4;FGL2;RPS6KA2;DYNC1H1;RIPK2;TNFRSF1B;NFASC;SNAP29;PKM;ACP3;LRRC7;POLR3H;CD300A;HOOK3;NKIRAS1;MAGT1;ENPP4;UBE2M;PYCARD;AIM2;SDCBP;MAPK10;PELI1;LTA4H;RASGRP4;ITGAV;TXK;IQGAP1;TEC;ROCK1;PLD3;HSPA1B;APP;GSTP1;PIK3R4;FTH1;ALAD;UBA52;PRDX4;UBB;PSMC2;PSMA3;AP2A2;FOS;SYNGR1;ATP6V0B;SURF4;PGM1;PSMB2;SELL;DUSP6;CPNE2;ECSIT;ATG5;IRAK3;PSMD5;HSP90B1;ATP6V1B2;EEF1A1;PSMD7;VAV3;STAT6;CPNE3;GSDME;JUN;GAA;FPR1;CASP1;ATP6V0E2;DSN1;TLR5;UBE2D2;ARHGAP9;PRKACB;PSMD14;ATP6V1D;TRIM56;ILF2;PSMA5;CCT8
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.3590306510174787,-0.6165421722440636,0.925,1.0,1.0,6/6,64.12%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.3590306510174787,-0.6165421722440636,0.925,1.0,1.0,6/6,64.12%,RAB32;AP3D1;AP1M1;AP1G1;RAB38;CD63
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.2923961033754162,-0.6163127890438523,0.9642857142857143,1.0,1.0,3/13,11.43%,PLA2G4C;PLA2G12A;PLB1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.3498769465097648,-0.61595248248473,0.8666666666666667,1.0,1.0,2/5,8.79%,FYN;SRC
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.35278716358419426,0.6158288829067122,0.9404761904761905,1.0,1.0,1/16,3.93%,SLC1A2
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.28542259844692647,0.6157671725445241,0.9680851063829787,1.0,1.0,9/78,17.16%,CLDN18;CLDN20;RAPGEF3;CD99L2;GNAI1;CTNNA2;THY1;TXK;ROCK1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3060448171483559,0.6156963642252842,0.989247311827957,1.0,1.0,11/52,20.20%,AZI2;TRAF2;RPS27A;RIPK2;NKIRAS1;ROCK1;TNFRSF1A;UBA52;PRDX4;UBB;TNF
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.3226489477199107,0.6155122985339188,0.975,1.0,1.0,7/24,28.64%,SEC24C;MCFD2;GRIA1;CNIH1;F8;TMED2;MIA3
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.3309763589766454,-0.6152216583320045,0.9090909090909091,1.0,1.0,1/7,9.22%,HLA-E
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.3211001596195844,-0.6150595607777049,0.9259259259259259,1.0,1.0,4/12,14.93%,MTLN;LPL;NR1H3;MLXIPL
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.32757350565343063,0.614730877079075,0.9358974358974359,1.0,1.0,3/24,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.33290152900156056,0.6140037276862468,0.9104477611940298,1.0,1.0,1/13,8.38%,CAV3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.31603291865043165,0.6139970235956574,0.9135802469135802,1.0,1.0,3/28,14.88%,ERCC2;POLR1C;GTF2H3
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.2916975730058316,0.6136932559563467,0.978021978021978,1.0,1.0,3/56,7.94%,GPM6A;ANLN;NLGN1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.31968774923774557,0.6136832143224237,0.9647058823529412,1.0,1.0,5/37,15.76%,NUP133;PGAM1;HIF1A;PRKAG2;SEH1L
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.2883079756074452,0.613662605934743,1.0,1.0,1.0,26/132,23.58%,NDUFA2;MAP3K8;KCNH8;GSDMD;DNM3;RPS27A;DNM1;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;PIK3R4;UBA52;UBB;FOS;DUSP6;ECSIT;IRAK3;HSP90B1;GSDME;JUN;TLR5;UBE2D2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.3490919232043349,0.6136152680716614,0.96,1.0,1.0,1/14,5.77%,IL7
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.2982055032948112,-0.613556026429217,1.0,1.0,1.0,1/11,5.30%,MKKS
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.31789009522243084,-0.6135008053644417,0.875,1.0,1.0,3/9,21.07%,SRC;MED1;NR3C1
prerank,KEGG_2021_Human__RNA transport,0.2814228857800845,0.6134444284065561,0.9897959183673469,1.0,1.0,12/128,15.76%,EEF1A2;EIF4A3;GEMIN2;NUP133;XPO1;TRNT1;EIF3E;NMD3;UPF3A;EIF2B2;NXF1;SEH1L
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.3077676718824841,0.6134208770108976,0.9629629629629629,1.0,1.0,7/31,28.80%,POLR3F;RIPK2;TRIM56;DDX3X;TLR2;IRF1;RIOK3
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3459671663565577,0.6132209729415892,0.9305555555555556,1.0,1.0,4/13,31.76%,NSF;AP1AR;KIF16B;ECE1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.2479994267304238,-0.6131832529251324,1.0,1.0,1.0,10/31,21.77%,TGFB1;SRC;EGFR;TGFA;AKT1;CBL;DGKD;RPS6KA5;SLC30A10;GAREM1
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.41651395915843303,0.6128992783152061,0.8387096774193549,1.0,1.0,3/5,36.85%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.29672094209007055,0.6128369819918175,0.9782608695652174,1.0,1.0,10/60,21.71%,ZDHHC15;VPS37C;PARD3;ZDHHC9;SDCBP;PEX3;NACA;AQP11;SRPRA;SRP19
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.2929488934400759,0.6127085252006349,0.9897959183673469,1.0,1.0,23/115,24.09%,HSPA5;PDK4;EIF2AK3;NIM1K;MFSD2A;IMPACT;PRKAG2;SEH1L;NUAK2;NPRL2;PIK3R4;PRKAA2;SESN1;PPARA;ATP6V0B;CPEB4;LRRK2;ATG5;ATP6V1B2;ATP6V0E2;ATP6V1D;FOXO3;BRSK1
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,0.32108575700688746,0.6126668469975389,0.9647058823529412,1.0,1.0,2/37,6.24%,PIAS4;NUP133
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.42050800846476066,0.6124856927749011,0.9705882352941176,1.0,1.0,1/5,17.42%,SLC25A4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.43513884256126933,0.6124343115395313,0.9558823529411765,1.0,1.0,1/5,15.02%,CPEB2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.37403065686341624,0.6123547485247217,0.9634146341463414,1.0,1.0,6/12,30.59%,MID1IP1;NR4A3;PPARA;PPARGC1A;LPGAT1;NR1H2
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.2994400234067265,0.6123300944391126,0.9555555555555556,1.0,1.0,12/44,24.08%,H2BC11;ERC2;LMNB1;APP;SUZ12;EZH2;CDC25B;CDK5R1;GSDME;JUN;TRADD;FOXO3
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.3454950318519108,0.6120476984708723,0.925,1.0,1.0,7/23,25.27%,ARSA;SUMF2;SUMF1;STS;F8;ARSK;GGCX
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.35625980264716295,0.6119305421730042,0.8933333333333333,1.0,1.0,2/12,21.83%,CRLF1;STAT1
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.3636319769020845,0.6107702569355478,0.9508196721311475,1.0,1.0,2/10,11.74%,PUS7;NHP2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.39221675721288113,0.6107189633555691,0.8873239436619719,1.0,1.0,1/6,13.26%,PINK1
prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.27887857350388845,0.6106980062278949,1.0,1.0,1.0,5/146,5.44%,SAP30;VIM;GADD45B;ENTPD3;TRAF2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.3026188658746954,-0.6106931411851161,0.9393939393939394,1.0,1.0,5/11,28.15%,ACO2;IDH3B;IDH3G;IDH3A;IREB2
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.28279128183737834,0.6104751253381739,0.9893617021276596,1.0,1.0,13/71,24.06%,NDUFA2;SEC61B;RPS27A;PSMB4;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.32601066342852436,0.6104686432410006,0.963855421686747,1.0,1.0,2/32,6.24%,PIAS4;NUP133
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.34193529768110803,0.6100332836345068,0.987012987012987,1.0,1.0,5/21,17.76%,PPP2R5A;NSMF;CALM3;CNEP1R1;MTMR9
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.29948245620017583,0.6095872013347108,0.9666666666666667,1.0,1.0,2/49,7.92%,FAAH;ACAT1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.3317847791198581,-0.6094788128202688,0.967741935483871,1.0,1.0,10/10,66.86%,TERF2;TPP1;TNKS;XRCC5;ATRX;POT1;BRCA2;TNKS2;TERF2IP;ATR
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.4168660334395605,0.6089382185212904,0.9538461538461539,1.0,1.0,3/6,31.05%,HPRT1;PNP;NT5C2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.3674468565187143,0.6084288656614882,0.9066666666666666,1.0,1.0,2/8,17.93%,PLXNB1;PLXNC1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.2267577037646934,-0.6083201438064575,1.0,1.0,1.0,9/61,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.3383971572860922,0.6083107513765073,0.9294117647058824,1.0,1.0,7/26,25.69%,KCNH8;RPS6KA2;MAPK10;FOS;DUSP6;JUN;RPS6KA3
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.3275286448889903,0.6081044984172114,0.9555555555555556,1.0,1.0,8/25,25.85%,DNM3;DNM1;RPS6KA2;SH3GL2;AP2A2;RDX;RPS6KA3;AP2S1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.3534248026365292,0.6079449468793532,0.9516129032258065,1.0,1.0,1/12,6.69%,OVOL2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.325142439614569,0.6076835519440328,0.9342105263157895,1.0,1.0,1/23,0.81%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.3724039929458751,0.6075987673782541,0.8947368421052632,1.0,1.0,3/9,21.19%,E2F7;DBF4;WIZ
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.3854116832588982,0.6071479720386136,0.9428571428571428,1.0,1.0,3/7,28.85%,PRKRA;AGO4;DICER1
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,-0.32553622698868434,-0.6071096695412757,0.875,1.0,1.0,7/7,67.47%,MMAB;MTRR;LMBRD1;ABCD4;MMADHC;MTR;MMUT
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2813517775822445,0.6070212833927016,1.0,1.0,1.0,18/104,24.06%,VIM;CARHSP1;PCBP4;XPO1;RPS27A;PSMB4;HSPB1;UBA52;UBB;PSMC2;ZC3HAV1;PSMA3;SAMD4A;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.34562718171720197,0.6069497013688293,0.9761904761904762,1.0,1.0,2/17,20.22%,PINK1;FBXO7
prerank,KEGG_2021_Human__Propanoate metabolism,0.30922791394255633,0.606397722422638,0.974025974025974,1.0,1.0,3/29,11.64%,ACSS3;ACAT1;ALDH6A1
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.3275700124238844,-0.6061183918953613,0.9375,1.0,1.0,3/8,19.02%,HM13;SEC11C;SPCS1
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,0.36952248045595937,0.6060523257068765,1.0,1.0,1.0,2/10,36.85%,PARP9;PARP10
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.2983610109792352,0.605677074806118,0.989247311827957,1.0,1.0,16/63,23.67%,ERCC2;COPS5;RPS27A;RBX1;RFC4;GTF2H3;POLE2;POLR2D;ERCC6;UVSSA;UBA52;UBB;DDB1;POLR2G;RPA3;GPS1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.26484426959041507,-0.6054070895556013,0.9545454545454546,1.0,1.0,1/17,3.26%,GANC
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.2669659107552643,-0.6052496453611328,1.0,1.0,1.0,2/17,10.21%,BAHD1;POLE3
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.36421445736080393,0.6050378572888552,0.9420289855072463,1.0,1.0,3/7,29.57%,NMNAT2;KYNU;HAAO
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3396655842357378,0.605023831215436,0.9642857142857143,1.0,1.0,4/18,18.04%,SOX4;RUVBL2;BRCA1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.36741384685151235,0.6042353651202955,0.9027777777777778,1.0,1.0,1/12,5.76%,GRM3
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.23450987312296326,-0.6039347230961201,1.0,1.0,1.0,5/56,8.38%,PSMB3;PSME3;PSMC4;PSMD12;PSME4
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.28939547358030393,0.6038475737909099,0.9789473684210527,1.0,1.0,10/65,15.83%,VIM;HMGB2;PRKCE;PDE4B;PDCD1LG2;NOD2;TNFRSF1B;PYCARD;WNT5A;IL18
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.3122908218590277,-0.6025213031631305,0.9142857142857143,1.0,1.0,4/8,19.87%,AKAP8L;SAP30BP;SPHK2;AKAP8
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.39883282334063896,0.6024851069256066,0.9166666666666666,1.0,1.0,1/6,12.87%,BRCA1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.34941161234526935,0.6023749678735233,0.96,1.0,1.0,3/13,14.36%,GINS1;MCMDC2;RFC4
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.23887046933552947,-0.6021989640656407,1.0,1.0,1.0,9/54,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.23887046933552947,-0.6021989640656407,1.0,1.0,1.0,9/54,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.23887046933552947,-0.6021989640656407,1.0,1.0,1.0,9/54,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.23887046933552947,-0.6021989640656407,1.0,1.0,1.0,9/54,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.29630491265626857,0.6020351196196388,0.9770114942528736,1.0,1.0,9/43,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;VRK1;CHMP7;POM121
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.29630491265626857,0.6020351196196388,0.9770114942528736,1.0,1.0,9/43,25.06%,NUP133;RCC1;SPAST;REEP3;SEH1L;NDC1;VRK1;CHMP7;POM121
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.3222151852427657,0.6012717164917615,0.9390243902439024,1.0,1.0,6/22,23.84%,RPS27A;BRCA1;UBA52;UBB;BARD1;PSMD14
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.290469448960625,0.6010243617696787,0.9655172413793104,1.0,1.0,10/42,29.17%,POLR3F;RIPK2;PYCARD;PTPRS;TRIM56;DDX3X;TLR2;IRF1;RIOK3;RELB
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.28565805828774554,0.6008378482295159,0.9772727272727273,1.0,1.0,12/58,21.28%,EIF2AK3;RPS6KB2;IMPACT;EIF3E;DDX1;EIF2B2;POLR2D;HSPB1;MIF4GD;UHMK1;ATF3;POLR2G
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,-0.2441355271382274,-0.6007397392358715,1.0,1.0,1.0,2/28,3.54%,SELPLG;ELK3
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.3667281689209978,0.5997180356365582,0.9130434782608695,1.0,1.0,2/9,10.17%,MFSD2A;ALK
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.23188812245246143,-0.5993441721447783,1.0,1.0,1.0,9/31,21.12%,ACTR10;GALNT1;DCTN6;CAPZB;CAPZA1;DCTN5;DYNC1LI2;DYNC1LI1;ACTR1A
prerank,KEGG_2021_Human__Fatty acid elongation,0.3367634657727615,0.5991959575898829,0.9518072289156626,1.0,1.0,2/17,14.11%,ELOVL4;HSD17B12
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.3536218279761086,-0.5990838797842472,0.8571428571428571,1.0,1.0,2/6,11.64%,P2RY12;OPHN1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.33664727175256526,0.5990166248833121,0.9418604651162791,1.0,1.0,5/18,17.45%,TXN;TXNIP;PYCARD;IL18;APP
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.33316973264104704,0.5989246381025778,0.9879518072289156,1.0,1.0,2/21,7.92%,HMGB2;BHLHE40
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.34470572841130753,0.5985569430513173,0.975,1.0,1.0,1/13,9.03%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.3069413179542314,0.5984764937749095,0.9651162790697675,1.0,1.0,9/31,25.73%,RYR2;DNAJB2;VMP1;ATP1B3;ATP1B2;HNRNPU;UHRF1;DNAJC9;DYNLL1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.33683866073241187,-0.5984618963192335,0.9393939393939394,1.0,1.0,3/10,21.37%,ZKSCAN3;TERF2;SLC30A10
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.31640754632904655,0.5979660601362304,0.9651162790697675,1.0,1.0,13/34,30.18%,VBP1;FMN2;PFDN4;ITGAV;ROCK1;IRAK3;FLOT2;BANP;LILRB2;HSP90AB1;SNX12;PRNP;PFDN2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.27637763212765415,0.59731314489611,1.0,1.0,1.0,13/63,24.06%,FZD6;CELSR2;PSMB4;PRICKLE1;WNT5A;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.33676743793278163,-0.5972848979595928,0.8928571428571429,1.0,1.0,7/7,66.35%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.33676743793278163,-0.5972848979595928,0.8928571428571429,1.0,1.0,7/7,66.35%,TERF2;TERF1;ATRX;POT1;H3-3A;DAXX;TERF2IP
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.33119102894191865,0.5964385166422487,0.9230769230769231,1.0,1.0,2/16,7.92%,ACOT13;ACAT1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.33119102894191865,0.5964385166422487,0.9230769230769231,1.0,1.0,2/16,7.92%,ACOT13;ACAT1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.3335597074004778,0.5963081387282831,0.9722222222222222,1.0,1.0,4/17,25.13%,ACAT1;ALDH6A1;AUH;ECHS1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.3335597074004778,0.5963081387282831,0.9722222222222222,1.0,1.0,4/17,25.13%,ACAT1;ALDH6A1;AUH;ECHS1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.33520301016417786,0.5962612386885288,0.9342105263157895,1.0,1.0,4/13,26.64%,KANK1;CCDC125;TNFAIP1;KCTD13
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.2977754942563916,0.5960271932961398,0.9659090909090909,1.0,1.0,11/43,26.53%,TIMM13;FLVCR1;TOMM20;BNIP3;TMEM14A;SLC25A4;FBXO7;MFN2;TOMM40;TIMM22;SLC25A24
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,0.3548432466438388,0.5957366503557628,0.9452054794520548,1.0,1.0,1/8,15.39%,THY1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.336691816051377,0.5950391875572303,0.9102564102564102,1.0,1.0,6/15,36.79%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.336691816051377,0.5950391875572303,0.9102564102564102,1.0,1.0,6/15,36.79%,POLR2D;POLR2G;POLR2A;TERF2IP;POLR2H;DAXX
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.3023792464368809,0.5949823413448234,0.9777777777777777,1.0,1.0,5/36,18.20%,H2BC11;PIAS4;BRCA1;POLL;LRIF1
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.32809631367842373,0.5949735138433117,0.9487179487179487,1.0,1.0,5/17,31.44%,EIF4A2;EIF3A;EIF3D;EIF4G1;DHX29
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.2831665045259742,0.5947972325962362,0.9782608695652174,1.0,1.0,13/50,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PRKACB;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.28701748458484666,-0.5945317647685523,0.9166666666666666,1.0,1.0,10/10,71.33%,ANAPC4;CUL3;NSMCE2;ANAPC11;CDC16;RB1;CDC27;CDC23;ANAPC7;ANAPC5
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.3449003714961162,-0.5945272638309865,0.8787878787878788,1.0,1.0,5/5,65.53%,TMEM167A;RAB11B;TRAPPC11;TMEM167B;RAB3A
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.295806207589101,0.594304938875596,0.9493670886075949,1.0,1.0,1/37,2.98%,H2BC11
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,0.3445170133453202,0.5941868702221004,0.9315068493150684,1.0,1.0,3/9,29.13%,SLC25A28;ISCU;SLC25A37
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.31437567644014053,0.5940605081493128,0.9487179487179487,1.0,1.0,4/19,23.36%,PTPN9;PTPN5;PTPN20;CASP1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.34063207190107947,0.5938384322767839,0.9625,1.0,1.0,1/19,2.98%,H2BC11
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.3570016564850471,-0.5936401459640054,0.9523809523809523,1.0,1.0,3/6,17.75%,SVIP;SGTA;USP14
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,0.3943685959840453,0.5934148595510328,0.9104477611940298,1.0,1.0,2/6,25.69%,RPS6KA2;RPS6KA3
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.3601378568876669,-0.5929690495713319,0.9714285714285714,1.0,1.0,1/6,1.38%,NPR2
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.2948858955481951,0.5928736113732274,1.0,1.0,1.0,8/52,17.56%,ANXA1;FCGR2B;CASP5;FGR;NOD2;WNT5A;BCL6;FOXP1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.2840463652436785,0.5928553301366419,0.9772727272727273,1.0,1.0,13/50,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PRKACB;PSMD14;PSMA5
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.2840463652436785,0.5928553301366419,0.9772727272727273,1.0,1.0,13/50,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PRKACB;PSMD14;PSMA5
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.28314592085954066,0.5927590826450243,1.0,1.0,1.0,19/114,21.01%,NDUFA2;MAP3K8;KCNH8;DNM3;RPS27A;DNM1;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;PELI1;APP;UBA52;UBB;FOS;DUSP6;ECSIT;IRAK3
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.28798526271244496,0.5925252791038675,1.0,1.0,1.0,16/57,25.81%,ABCA1;RPS27A;PSMB4;ERLIN1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;ABCB4;PSMD7;PSMD14;PSMA5;CFTR;ABCC8
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.36796375932382186,0.5922507664872754,0.8939393939393939,1.0,1.0,2/8,15.83%,PYCARD;IL18
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.2982124708862739,-0.5918641991786614,0.9354838709677419,1.0,1.0,3/13,21.23%,ZDHHC2;CENATAC;CHEK2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.3303149421586943,0.5915133842008432,0.9452054794520548,1.0,1.0,1/13,11.38%,PPP2R2B
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.36565029885111744,-0.5909471073122665,0.9705882352941176,1.0,1.0,1/6,3.45%,ACTB
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.34411852174714364,0.5908950087659455,0.9342105263157895,1.0,1.0,2/12,12.86%,CHURC1-FNTB;ZDHHC9
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.33141142039123245,0.590817341479242,0.9538461538461539,1.0,1.0,6/13,32.99%,EPHA4;PTPRS;RTN4RL1;GIT1;AJAP1;SERPINE1
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.3133113496860074,0.5906716196705778,0.9759036144578314,1.0,1.0,4/25,18.81%,RPS27A;ETS2;UBA52;UBB
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,-0.343120001885594,-0.5905297257290855,0.8611111111111112,1.0,1.0,1/6,7.43%,CBFB
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.37952050513425345,-0.5905051079525835,0.9428571428571428,1.0,1.0,2/5,9.84%,RDH10;DHRS9
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.2754174731027589,-0.5900606183753487,1.0,1.0,1.0,6/50,10.78%,H2BC4;H4C3;C3;H2BC7;HLA-DPA1;FCGR1A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.38041214995014533,0.5899887910868316,0.9384615384615385,1.0,1.0,4/7,24.19%,CNEP1R1;PRKCB;VRK1;NEK9
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.26405641373431654,-0.5895315712134568,1.0,1.0,1.0,1/16,1.62%,ITPA
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3712844657558918,0.5893105962835828,0.9577464788732394,1.0,1.0,2/8,23.17%,MFN2;ATG13
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.39751481353672435,-0.5891031390664444,0.925,1.0,1.0,1/5,8.79%,NFATC3
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,-0.36199968020250195,-0.5888986348332231,0.8809523809523809,1.0,1.0,3/6,9.84%,RDH10;CYP4V2;DHRS9
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.3865723440847217,-0.5888355225124697,1.0,1.0,1.0,1/6,8.79%,NFATC3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.32088758414500357,0.5888143283085889,0.9506172839506173,1.0,1.0,6/21,23.75%,RUNX1T1;WNT5A;TNF;ANKRD26;RORA;GPS2
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.26265144013046715,-0.5886123912489454,0.9523809523809523,1.0,1.0,8/21,19.70%,TAF13;HELB;TTF1;TTF2;GTF2B;TBP;TCEA2;PRIM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,0.36406969866827643,0.5885759004424806,0.9333333333333333,1.0,1.0,1/6,15.39%,THY1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,0.36406969866827643,0.5885759004424806,0.9333333333333333,1.0,1.0,1/6,15.39%,THY1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.28119015978658196,0.5885452339755536,1.0,1.0,1.0,11/61,22.43%,HMGB2;TXN;NMD3;RIPK2;PKD1;RPL11;APP;CLIC2;HIP1R;LRRK2;HFE
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.27051954582934407,0.5879087167642537,1.0,1.0,1.0,24/153,23.72%,ADCY3;CREB5;GNA11;GNAO1;VEGFA;TRAF2;RPS6KB2;CALM3;ADCY8;CYCS;GNAI1;CASP3;ITGAV;PLCB1;ROCK1;TNFRSF1A;GNAQ;TNF;CX3CL1;GNB5;PTGER4;PRKCB;TRADD;PRKACB
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),0.35301996563355487,0.5877837842944927,0.9692307692307692,1.0,1.0,2/10,20.57%,SLC25A21;PIPOX
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),0.35301996563355487,0.5877837842944927,0.9692307692307692,1.0,1.0,2/10,20.57%,SLC25A21;PIPOX
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.3926617908853863,0.587751882633723,0.9482758620689655,1.0,1.0,2/5,33.30%,SLC12A5;SLC12A2
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,0.39264932889929327,0.5876253799711505,0.9411764705882353,1.0,1.0,2/5,36.54%,HSD17B4;ACOX3
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.37259951126184,0.587235553752295,0.9571428571428572,1.0,1.0,4/9,34.18%,CFL1;TWF1;MICAL2;DSTN
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.3075046890671287,0.5870861012846131,0.9880952380952381,1.0,1.0,3/25,20.17%,RBPJ;TBL1XR1;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.33772590691436977,-0.5862180871617003,0.90625,1.0,1.0,2/5,22.47%,EIF2AK4;PRKN
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.3463921071590411,0.5860068444119186,1.0,1.0,1.0,4/10,31.63%,APP;PRKCSH;S100B;AGER
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,0.35697442583441535,0.5857664294364546,0.922077922077922,1.0,1.0,1/7,15.39%,THY1
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,0.35697442583441535,0.5857664294364546,0.922077922077922,1.0,1.0,1/7,15.39%,THY1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.2599279090877806,-0.5854762331646508,0.9523809523809523,1.0,1.0,2/11,13.39%,SLC37A1;SLC37A4
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.2599279090877806,-0.5854762331646508,0.9523809523809523,1.0,1.0,2/11,13.39%,SLC37A1;SLC37A4
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,0.3178458493990268,0.5851914539792101,0.974025974025974,1.0,1.0,2/15,21.83%,RBPJ;STAT1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.3496263458775498,0.5850228130781832,0.975609756097561,1.0,1.0,5/12,34.31%,LRRK2;MFN2;MTM1;MARK1;ATCAY
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.36468957273210667,0.5848926606346145,0.9130434782608695,1.0,1.0,2/9,21.03%,ACAT1;PDHB
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.30181825867645523,0.5844037678843754,0.9880952380952381,1.0,1.0,9/38,26.10%,NLRP12;NOD2;SASH1;APP;TNF;PDCD4;TRADD;DDX3X;TLR2
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.3336797031708263,-0.584294360592344,0.896551724137931,1.0,1.0,5/6,31.59%,RCC2;SMC5;NUMA1;SMC6;SIRT2
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.2866563909117666,0.5841653476712246,1.0,1.0,1.0,7/58,15.95%,CLEC12A;EMILIN2;TLDC2;TNFRSF1B;CD300A;PYCARD;RASGRP4
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.3797757221740704,0.584075713987541,0.9384615384615385,1.0,1.0,1/7,10.79%,IMPACT
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,0.3070869773219224,0.5839193191371733,0.9411764705882353,1.0,1.0,1/27,2.98%,H2BC11
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.34566894392158454,0.5829725822260601,0.9583333333333334,1.0,1.0,3/9,31.18%,PMPCA;IMMP2L;PMPCB
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3022516272770421,0.5825768912731566,0.9767441860465116,1.0,1.0,5/40,21.98%,SOX4;CAMLG;HSPA1B;GTPBP4;CHP1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.329483081362252,0.5823725826484618,0.9333333333333333,1.0,1.0,3/15,26.36%,PTN;ZNF706;TAF6L
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.31417255110591813,0.5821455116658825,0.9550561797752809,1.0,1.0,4/27,18.81%,MAP3K8;RPS27A;UBA52;UBB
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.2766655225908284,-0.5820921531548926,1.0,1.0,1.0,4/17,11.43%,PLA2G4C;PLA2G12A;NR1H3;PLB1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.3207710446943367,0.5816803194921056,0.963855421686747,1.0,1.0,2/19,13.86%,POLR3F;ZNF143
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,0.353305263214458,0.5812720243111187,0.953125,1.0,1.0,2/9,20.57%,SLC25A21;PIPOX
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.2728301309131373,0.5810260738528036,1.0,1.0,1.0,14/76,24.06%,ENPP2;XPO1;RPS27A;PSMB4;HSPB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3531116514109564,0.5806895468546266,0.975609756097561,1.0,1.0,3/10,33.49%,RASGRF1;PRNP;PJA2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3150759219103029,0.5803812353639609,0.9506172839506173,1.0,1.0,7/25,24.39%,CAV3;RNF139;PSMC2;ATP5IF1;MAGEF1;PTEN;DDRGK1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.3531094302825546,-0.5799076473112474,0.9722222222222222,1.0,1.0,2/6,12.18%,CSF1R;CHCHD10
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.28122152310495474,0.5798589751725773,1.0,1.0,1.0,24/67,32.35%,RPS27A;PSMB4;RBX1;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;ORC3;PSMD14;PSMA5;MCM3;FZR1;UBE2D1;ANAPC5;MCM6;ANAPC7;GMNN;PSMB8;PSMD8;PSMA4
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.3303105774843815,0.5798551013211657,0.9605263157894737,1.0,1.0,2/16,11.93%,TRAF2;SASH1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.3052558181272878,0.5794712084088386,0.9772727272727273,1.0,1.0,4/39,11.27%,CACNB2;ANK2;CAV3;CAMK2B
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,0.36085688543821204,0.5789302795342526,0.9402985074626866,1.0,1.0,2/7,15.39%,ALCAM;THY1
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.29931017916345776,0.5788109642125677,0.9629629629629629,1.0,1.0,8/28,20.27%,ARSA;GALC;UGT8;UGCG;SUMF2;SUMF1;GBA3;STS
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.2176182529239953,-0.5787278835415729,1.0,1.0,1.0,8/53,15.38%,BFAR;RNF187;DDB2;RNF19B;RNF8;SH3RF3;RNF157;RNF11
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.2668046117642856,-0.5783625065656258,0.8947368421052632,1.0,1.0,3/15,15.49%,STOML2;MIGA1;FIS1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.33955508907796966,0.5779262293892806,0.9733333333333334,1.0,1.0,2/11,15.83%,CD55;IL18
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.3068482566315577,-0.5776160970322677,0.9393939393939394,1.0,1.0,4/10,14.16%,CTC1;BCAR3;EGFR;KAT7
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.272220344711051,-0.5774783927627323,0.9545454545454546,1.0,1.0,13/13,72.82%,ANAPC4;BUB3;CDC26;ANAPC11;CDC16;ANAPC16;UBE2E1;ANAPC1;CDC27;CDC23;ANAPC7;ANAPC5;UBE2D1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.3309716414556317,0.5774339194458042,0.9733333333333334,1.0,1.0,5/15,29.90%,CCDC39;NDRG4;BBS7;SETDB2;MICAL2
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.295777027027027,-0.5767729432402252,1.0,1.0,1.0,9/9,70.45%,REST;HDAC2;SIRT2;RCOR1;HDAC1;HDAC3;HDAC4;HDAC9;SMARCAD1
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.3116357027523259,0.576642375939495,0.9880952380952381,1.0,1.0,9/24,39.40%,PRKAG2;PRKAA2;PRKAB2;STK11;RRAGD;STRADB;TSC2;MTOR;LAMTOR2
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.3219069315233863,0.5757679804180877,0.9436619718309859,1.0,1.0,6/12,34.36%,TRPC4;TRPM7;TRPC1;MCOLN1;TRPM3;TRPC5
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.3005139639601671,0.5756468212112772,1.0,1.0,1.0,4/23,18.81%,RPS27A;SPTBN1;UBA52;UBB
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.3063947409376693,0.5754917882139745,0.9431818181818182,1.0,1.0,7/30,18.81%,RPS27A;TRIM25;RFC4;POLE2;USP43;UBA52;UBB
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.3181608977527152,0.5752426044967167,0.95,1.0,1.0,3/15,28.85%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.38131184012088276,0.5748499320201953,0.967741935483871,1.0,1.0,3/5,39.02%,ATG2B;ULK1;ATG2A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.2994460768191847,0.5747486173858036,0.963855421686747,1.0,1.0,3/25,11.99%,PPP2R5B;PHLPP1;MAGI2
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.3575325490568802,-0.574315277575396,0.8666666666666667,1.0,1.0,2/5,13.01%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.3193335046611392,0.5741692306305961,0.963855421686747,1.0,1.0,2/19,15.82%,EIF2AK3;DHX33
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.3112515331720084,0.5735254132771325,0.9642857142857143,1.0,1.0,5/25,18.81%,XPO1;RPS27A;PPP1R15A;UBA52;UBB
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,-0.23372414733491853,-0.5735192337956315,1.0,1.0,1.0,8/34,19.21%,STAM2;SRC;PKN1;SRGAP2;NCK1;ARHGAP31;CDC42;ARHGAP30
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.34845092454186155,0.5734253842769192,0.9852941176470589,1.0,1.0,5/9,24.19%,CNEP1R1;DCTN1;PRKCB;VRK1;NEK9
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.2750778587853755,0.5734035326474327,0.9896907216494846,1.0,1.0,16/69,22.42%,EPHA3;NGEF;DNM1;EPHA7;KALRN;EPHA4;EPHA6;ITSN1;EPHA5;GRIN2B;SDCBP;ROCK1;AP2A2;CLTCL1;MYL6;VAV3
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.3744316138295489,0.5732368889899045,0.9230769230769231,1.0,1.0,1/5,15.59%,PDK3
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2608739772549082,0.5713619693582277,1.0,1.0,1.0,40/257,22.12%,CLIP3;TBC1D8;NAPA;ARF6;TBC1D13;NUP133;AKAP6;RAB20;NLGN1;XPO1;RANBP3L;TBC1D15;PRICKLE1;HEATR3;FAM53C;NSF;TNPO2;PKD1;CDC37;RANBP17;TMED10;BAG3;RPL11;SNX17;STXBP2;SCG5;RAB21;STX2;TECPR2;SRPRA;SURF4;TBC1D2;STX19;NAPG;TBC1D14;IPO7;APPL1;CHP1;RAB5A;CTTN
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.22604340507170745,-0.5711302529560256,1.0,1.0,1.0,9/59,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.3477464662840461,0.5710787523316284,0.9767441860465116,1.0,1.0,4/12,20.20%,VEGFA;ROCK1;TNFRSF1A;TNF
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,-0.30591216216216216,-0.570249789107112,0.9705882352941176,1.0,1.0,9/9,69.44%,NLRC3;IFI16;STING1;XRCC5;TBK1;IRF3;MRE11;XRCC6;PRKDC
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.2604536606027339,0.5696524716920528,1.0,1.0,1.0,22/248,17.24%,TBRG4;EIF4A3;ERCC2;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;RBM5;RBM4B;MFAP1;GTF2H3;WDR83;HNRNPH1;POLR2D;SART3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.3588308676674049,0.5690280846062594,0.9014084507042254,1.0,1.0,1/7,13.85%,HOOK3
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.2554230454950731,-0.5687400815053192,1.0,1.0,1.0,2/15,11.79%,CH25H;OSBPL6
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.2960688788114266,-0.5684373490961568,0.9444444444444444,1.0,1.0,4/11,19.65%,EIF4EBP1;EIF2AK4;RBM4;FMR1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.26804354963366117,0.5681722320918879,1.0,1.0,1.0,18/77,24.25%,ABCA2;RPS27A;PSMB4;ABCA5;PEX3;ERLIN1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;ABCB4;PSMD7;ABCG1;PSMD14;PSMA5;CFTR
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.32656791297025245,-0.567590547931244,0.8648648648648649,1.0,1.0,4/7,20.15%,PDE3A;RNF157;PDE4D;MGRN1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3541072306749351,0.5668536411993773,1.0,1.0,1.0,1/10,8.90%,BOK
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.3301725512603053,0.5667868985950046,0.9620253164556962,1.0,1.0,4/14,30.09%,FZR1;UBE2D1;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.32198108944737347,-0.5663677602898611,1.0,1.0,1.0,4/9,22.31%,NCKAP1L;DOCK10;PPP2R3C;MEF2C
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.22896200882253068,-0.5663260159898096,1.0,1.0,1.0,9/58,15.17%,PSMB3;PSME3;PSMC4;PSMD12;PSME4;PSMA1;ANAPC4;BUB3;PSMA7
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),-0.3298429319371728,-0.5661149333104754,0.9130434782608695,1.0,1.0,7/7,67.04%,ZFP36L1;MR1;PTPRC;ZFP36L2;RABL3;LIG4;ADAM17
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3530589482819562,0.5660412669603129,0.9710144927536232,1.0,1.0,2/9,17.76%,MFSD2A;MTMR9
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,0.3507727947550437,0.5658623885604531,0.9701492537313433,1.0,1.0,4/10,26.10%,PDCD1LG2;THBD;MRC1;TLR2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.2728767335151347,0.5656859172048473,0.9893617021276596,1.0,1.0,4/54,12.78%,NLRP12;NOD2;SASH1;UACA
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.2996345183148509,-0.5654279850632452,0.9032258064516129,1.0,1.0,1/10,2.95%,ST6GALNAC3
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.29066609926446935,-0.5651916778361515,0.9615384615384616,1.0,1.0,2/8,13.71%,C3;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.29559807637375063,0.5648909699992968,0.9767441860465116,1.0,1.0,6/26,18.85%,RUVBL2;KDM1A;BRCA1;CTBP1;SART3;CDK9
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.3935244915658293,0.564295140668158,0.9538461538461539,1.0,1.0,1/5,20.68%,LRRK2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.2883986968349819,0.5633408679320876,0.9759036144578314,1.0,1.0,4/27,20.29%,MAPT;UXT;UBB;DYNC1I1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.3853978019539328,0.5631498630710832,0.9558823529411765,1.0,1.0,1/5,8.14%,ROBO1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.33918521380719496,0.5630834053572005,0.9743589743589743,1.0,1.0,3/12,24.61%,CPEB2;ATF3;DDX3X
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.31249550464170683,0.5629663775105088,0.9583333333333334,1.0,1.0,1/17,9.50%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.286397825608656,0.5628261780169227,0.9888888888888889,1.0,1.0,12/39,33.67%,FANCB;POLQ;POLR2D;POLR2G;MAGEF1;H1-0;UBQLN4;BLM;RIF1;POLR2A;ZRANB3;TERF2IP
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.2755195345418983,0.562393542171632,0.9891304347826086,1.0,1.0,13/48,24.06%,RPS27A;PSMB4;PRICKLE1;WNT5A;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.3550013671315019,0.5623073326027102,0.95,1.0,1.0,1/5,12.70%,TMEM39A
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.3277186840093034,0.5618009338804292,0.9565217391304348,1.0,1.0,1/13,9.50%,KDM1A
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.2728477369852716,0.5617310481326928,1.0,1.0,1.0,12/47,24.06%,RPS27A;PSMB4;RBX1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.2583179115433264,0.5615730597748069,0.98989898989899,1.0,1.0,24/157,26.31%,EIF4A3;PQBP1;WBP11;WBP4;TFIP11;BCAS2;HNRNPA0;RBM5;HNRNPH1;POLR2D;PRPF6;COLEC12;SRSF5;POLR2G;SNRPD2;HNRNPU;PHF5A;SRSF3;PRCC;HNRNPR;ELAVL2;LSM5;SRSF9;CPSF6
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.3112380954241086,0.5604104140853089,0.9868421052631579,1.0,1.0,1/16,3.87%,ANXA1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.3287495610087967,-0.5603163549977127,1.0,1.0,1.0,2/6,13.98%,SMOX;SMS
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.3182183033630107,0.560226275046209,0.958904109589041,1.0,1.0,2/12,23.75%,TBL1XR1;GPS2
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,0.3689220026985218,0.5582186680406765,0.9178082191780822,1.0,1.0,1/5,21.82%,TRMT10C
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.35832018435119795,0.5569384729179597,0.9841269841269841,1.0,1.0,3/7,33.60%,DUSP10;DUSP1;CYLD
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.35990450065709156,0.5569160865033975,0.974025974025974,1.0,1.0,3/10,17.20%,ASPH;PLOD1;EGLN3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.32643733912604533,0.5569077338485278,0.963855421686747,1.0,1.0,4/13,15.51%,OVOL2;ID2;GNAI1;PIEZO2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.26888683571139843,0.5562904324037073,0.9888888888888889,1.0,1.0,14/51,24.35%,RPS27A;PSMB4;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.36342743681788026,0.5560955730966212,0.9178082191780822,1.0,1.0,1/5,23.73%,SLX4
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.269533718190773,0.555987062487303,1.0,1.0,1.0,11/44,28.79%,NGEF;ARHGEF4;KALRN;ITSN1;FGD4;ECT2;VAV3;GNA13;MAGED1;ARHGEF17;ARHGEF38
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.2632784357420675,0.5555936906988369,1.0,1.0,1.0,35/109,28.45%,SEC61B;TIMM13;RPS27A;TYSND1;AGPS;TOMM20;PMPCA;SERP1;CAMLG;GRPEL1;PEX3;ATP5F1A;ZNF260;UBE2J2;SLC25A4;APP;CHCHD3;UBA52;HSPD1;UBB;ATP5MC1;CHCHD7;PIPOX;COQ2;UBE2D2;TOMM40;TIMM22;PEX10;VAPA;BAG6;HSPA9;UBE2D1;HSD17B4;HMGCL;COA6
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.2566405550708706,-0.5548295281012237,1.0,1.0,1.0,3/23,11.56%,CHUK;IKBKB;BIRC2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2536341615170637,0.5548244669644665,1.0,1.0,1.0,34/208,26.18%,EIF4A3;PQBP1;WBP11;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;RBM5;RBM4B;MFAP1;WDR83;HNRNPH1;POLR2D;SART3;PRPF6;SRSF5;POLR2G;SNRPD2;HNRNPU;SFPQ;PHF5A;HNRNPH3;SRSF3;PRCC;HNRNPR;BUD13;ELAVL2;SYNCRIP;LSM5;SRSF9
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.2580780592425959,0.5545563804236505,1.0,1.0,1.0,30/88,32.35%,H2BC11;RPS27A;PSMB4;POLE2;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3;FZR1;UBE2D1;ANAPC5;MCM6;ANAPC7;H3-3B;POLA1;GMNN;H2BC9;PSMB8;PSMD8;PSMA4
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.27111939641807714,0.5542410511586899,1.0,1.0,1.0,20/79,29.96%,SUV39H2;HCFC1;RUVBL2;KDM4B;ACTR5;SMARCD3;ESR1;ERCC6;SMARCC1;KDM5B;KDM6B;SMARCD2;SATB2;SMARCA5;JARID2;TAF6L;KDM6A;SMARCAD1;ACTL6A;KDM5C
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.23179968723557698,-0.5539296342162301,1.0,1.0,1.0,4/25,9.99%,STAM2;VTA1;VPS37B;CHMP2B
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.33375077080539783,0.5537875156793152,0.972972972972973,1.0,1.0,1/14,6.84%,SPIRE2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.34844741729659534,0.5535399867652675,1.0,1.0,1.0,2/7,22.64%,CPT1A;TMLHE
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3779232781365981,0.5535112834039848,0.9696969696969697,1.0,1.0,2/5,17.63%,ACP3;SLC39A14
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.37149137974044877,0.5534938666663257,0.9545454545454546,1.0,1.0,1/5,11.75%,SLC35A1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.3401165857938321,0.5533338694668177,0.9393939393939394,1.0,1.0,1/8,15.82%,UGCG
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.32553347728626914,0.5531207921738315,0.9770114942528736,1.0,1.0,4/18,21.71%,ARF6;ROCK1;TNF;FHOD3
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.2630517009903905,0.5529215849320682,1.0,1.0,1.0,17/70,24.06%,FZD6;RPS27A;PSMB4;PRICKLE1;WNT5A;UBA52;UBB;PSMC2;PSMA3;AP2A2;PSMB2;PSMD5;PSMD7;PRKCB;RORA;PSMD14;PSMA5
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,0.28043981794666206,0.5527501439939414,1.0,1.0,1.0,5/32,16.31%,RUVBL2;DNA2;NHP2;RFC4;SHQ1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.3345153664302601,-0.552659395717055,0.9032258064516129,1.0,1.0,5/5,66.57%,STX4;TAPBP;CALR;SEC22B;TAP1
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.23548554948439898,-0.552519400918303,1.0,1.0,1.0,4/24,9.99%,STAM2;VTA1;VPS37B;CHMP2B
prerank,KEGG_2021_Human__Lysosome,0.2605066947344797,0.5518354586512771,1.0,1.0,1.0,7/95,11.86%,GLA;SLC11A1;AP3B2;GNS;ABCA2;ARSA;GALC
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.25482710844338696,0.5517038993554861,1.0,1.0,1.0,10/191,9.50%,SAP30;WDR5;H2BC11;ARID5B;SUV39H2;KDM3A;HCFC1;RUVBL2;YEATS2;KDM1A
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.3072446173317672,0.5516356339577686,1.0,1.0,1.0,14/32,34.29%,DGKB;DGKG;DDHD1;PLD1;GPAT4;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;GNPAT;AGPAT3;PLA2G4A;AGPAT5
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.282659324798178,0.5515672984455806,0.9886363636363636,1.0,1.0,6/27,17.45%,SEC61B;EMC7;SERP1;CAMLG;UBE2J2;APP
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.2690715552927262,-0.5511121843219635,1.0,1.0,1.0,12/12,73.13%,ZFP36;ZFP36L1;DHX36;TOB1;ZFP36L2;TNRC6B;AGO2;CNOT1;PABPC1;CPEB3;TNRC6C;CNOT7
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.2690715552927262,-0.5511121843219635,1.0,1.0,1.0,12/12,73.13%,ZFP36;ZFP36L1;DHX36;TOB1;ZFP36L2;TNRC6B;AGO2;CNOT1;PABPC1;CPEB3;TNRC6C;CNOT7
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.26060338167108277,-0.5510453198397186,1.0,1.0,1.0,2/14,12.21%,IPPK;PIH1D1
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3088228414327909,0.5509649273842321,0.9876543209876543,1.0,1.0,14/31,34.29%,DGKB;DGKG;DDHD1;PLD1;GPAT4;LPCAT4;DGKE;DGKZ;LPCAT1;DGKQ;GNPAT;AGPAT3;PLA2G4A;AGPAT5
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.2674405820744262,0.5508780900960909,1.0,1.0,1.0,13/57,24.06%,PREX2;RPS27A;PSMB4;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PTEN;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.3567112106703055,0.5508104455117715,0.9714285714285714,1.0,1.0,2/6,22.43%,CD300A;HFE
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,0.3333999798320406,0.550703690715382,0.9459459459459459,1.0,1.0,3/11,22.97%,MBOAT2;PNPLA8;LPCAT4
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3333999798320406,0.550703690715382,0.9459459459459459,1.0,1.0,3/11,22.97%,MBOAT2;PNPLA8;LPCAT4
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),-0.3329102937716155,-0.5503884208325776,0.9393939393939394,1.0,1.0,1/6,9.90%,SLC35G1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.318002828370002,-0.5503588171483894,1.0,1.0,1.0,4/12,16.25%,SLC7A8;SFXN2;SLC7A1;SLC47A1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.33679500168861876,-0.5503074623325261,1.0,1.0,1.0,5/5,66.34%,TRIP11;TBC1D23;WDR11;FAM91A1;C17ORF75
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.3559101577259287,-0.5501651284475825,0.8857142857142857,1.0,1.0,3/5,25.96%,EXOSC9;EXOSC8;EXOSC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.3559101577259287,-0.5501651284475825,0.8857142857142857,1.0,1.0,3/5,25.96%,EXOSC9;EXOSC8;EXOSC2
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),-0.3149404284688827,-0.550066428280059,1.0,1.0,1.0,2/6,15.54%,ENG;PTCH1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.31982438365417093,-0.5500051958649481,0.9032258064516129,1.0,1.0,5/5,68.04%,PGGT1B;RABGGTB;PTAR1;FNTA;CHM
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.2861113978620386,0.549679071176813,1.0,1.0,1.0,3/34,18.04%,RPS6;PRKAG2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.30014783806451173,0.5484005494361389,0.9876543209876543,1.0,1.0,6/20,23.39%,DYNC1H1;HSPA1B;GPSM2;HNRNPU;CHMP5;PDCD6IP
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.2415773986572676,-0.5482771997073851,1.0,1.0,1.0,7/15,22.52%,SLC37A1;DHRS9;SORL1;SYTL2;SLC17A5;OSBPL7;PLEKHA6
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.31323681616844534,-0.5478979869208372,0.967741935483871,1.0,1.0,1/8,10.31%,BTK
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.2705045362663371,0.5478404014384212,1.0,1.0,1.0,7/55,16.85%,H2BC11;RUVBL2;DNA2;NHP2;RFC4;SHQ1;POLR2D
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,0.34702205483355597,0.5471660953278802,0.9473684210526315,1.0,1.0,3/8,30.03%,CYP46A1;HSD17B4;SLC27A5
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2486530594112325,0.5467816013747064,1.0,1.0,1.0,39/200,26.04%,CLSPN;TRAF2;MINDY1;COPS5;HIF1A;HCFC1;RPS27A;PSMB4;USP35;OTUD7B;TOMM20;VCPIP1;BRCA1;ACTR5;USP38;ESR1;SMAD1;TAF9B;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;OTUD1;TNIP1;PSMD5;PSMD7;BARD1;USP48;USP5;PTEN;PSMD14;PSMA5;CFTR;USP11;SUDS3;CCP110;ATXN7L3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.33501770644790535,0.5463438282677889,0.9242424242424242,1.0,1.0,4/6,33.46%,GFPT1;CSGALNACT1;EXTL2;GNE
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.2999463364804331,0.5460427866775328,0.974025974025974,1.0,1.0,6/28,15.86%,FAM162A;BNIP3;PINK1;PRELID1;PYCARD;CIDEB
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.27748341237470353,0.5457721674012821,0.9886363636363636,1.0,1.0,9/47,27.16%,PIAS4;NUP133;SEH1L;KIAA1586;BCL11A;NDC1;POM121;SAE1;NUP58
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,-0.349002756628263,-0.5455562104934472,1.0,1.0,1.0,1/5,11.50%,MECP2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.31220408386750453,0.5451998419440227,0.9714285714285714,1.0,1.0,4/11,25.12%,HSPB1;SOD1;ATP1B2;TF
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.3772386488700488,0.5443918490450825,0.9545454545454546,1.0,1.0,2/5,28.60%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.3772386488700488,0.5443918490450825,0.9545454545454546,1.0,1.0,2/5,28.60%,HSPA1B;HSBP1L1
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,0.3342606263588217,0.5437984862689565,0.9836065573770492,1.0,1.0,1/10,9.28%,IRS2
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.3452378956046751,0.5434218997907204,0.9444444444444444,1.0,1.0,2/9,18.25%,ERLIN1;SOD1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.2759082735298121,0.5428045460848214,0.9864864864864865,1.0,1.0,5/19,30.08%,SAMD4A;CNOT6;PAN2;CNOT7;CNOT8
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.20964451190035904,-0.5426877611971718,1.0,1.0,1.0,9/45,20.42%,ACTB;SMARCD1;EP300;ZMIZ1;POLR1F;HMGA1;TBP;SPHK2;ATAD2B
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.24481006621955662,-0.5424980202152239,0.9411764705882353,1.0,1.0,5/19,21.29%,HSCB;ABCB7;MMS19;CIAO2B;NFU1
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.2548808368371855,0.5423812151528983,1.0,1.0,1.0,20/85,24.35%,DNA2;RPS27A;GINS1;PSMB4;RBX1;RFC4;POLE2;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.30713602455928335,0.5417197317748604,0.9746835443037974,1.0,1.0,5/22,20.93%,PINK1;ICA1L;FES;LRRK2;LEPR
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.2939056749103104,0.5409846692086424,0.987012987012987,1.0,1.0,1/20,3.84%,GPC5
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.25221188976310116,-0.5407260828664764,1.0,1.0,1.0,1/11,6.86%,CDAN1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.24117535850839317,-0.5407189249421456,0.9629629629629629,1.0,1.0,6/16,23.50%,SERPINB6;TRPV4;WNK3;LRRC8D;CAB39;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.32231301628911296,-0.5399522242378098,1.0,1.0,1.0,1/6,13.04%,PRDM11
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.29867151358453836,0.5396861772179091,0.96,1.0,1.0,3/14,21.81%,NREP;SOD1;RTN4RL1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.33408671470494866,0.539389852128398,0.9682539682539683,1.0,1.0,2/8,29.71%,CDK9;CTR9
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),0.34206462389200776,0.5391134066213875,0.9848484848484849,1.0,1.0,1/5,21.03%,PDHB
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.34430587594199896,-0.5385822707162481,0.9655172413793104,1.0,1.0,1/5,6.81%,JMJD6
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.3444393006036288,0.5384064570092555,0.9866666666666667,1.0,1.0,2/6,27.62%,MAPK8IP1;IRF1
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.35479662403519174,0.5382292687169704,0.9701492537313433,1.0,1.0,4/9,23.76%,RPS27A;UBA52;UBB;PTEN
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.32725399078869744,0.5381705619557522,0.971830985915493,1.0,1.0,2/11,16.31%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.3580633955781335,0.5380650792459619,0.967741935483871,1.0,1.0,1/7,16.17%,PCSK6
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.286734454373194,-0.537784357073309,0.9583333333333334,1.0,1.0,3/8,19.03%,DR1;GTF2B;TBP
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.28562859406984076,0.5373208442179797,0.9868421052631579,1.0,1.0,2/23,17.56%,KDM1A;FOXP1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.3144995818845163,0.5372682571344058,0.9634146341463414,1.0,1.0,3/20,23.00%,SIRT5;SIRT3;LYPLAL1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3193046281728975,0.5372661075906948,0.9850746268656716,1.0,1.0,2/8,20.17%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.27702535489055,-0.537181043139352,0.9629629629629629,1.0,1.0,4/11,20.48%,ABCC4;SLC19A1;LRRC8D;SLC25A17
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.2815360953878554,0.5369687570480992,1.0,1.0,1.0,3/27,20.44%,CSKMT;EZH2;EEF1AKMT1
prerank,KEGG_2021_Human__Spliceosome,0.25223563494021645,0.5362497859620035,1.0,1.0,1.0,20/111,29.66%,EIF4A3;PQBP1;WBP11;ZMAT2;BCAS2;HSPA1B;HSPA2;PRPF6;SRSF5;SNRPD2;HNRNPU;PHF5A;SRSF3;LSM5;SRSF9;LSM3;HSPA8;SNU13;SNRNP70;PRPF40B
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,0.34255943735434824,0.53620471680389,0.9861111111111112,1.0,1.0,2/10,23.39%,ANTXR2;PDCD6IP
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.24540947589243223,0.5361818693125078,1.0,1.0,1.0,41/148,28.76%,GDPD1;MBOAT2;INPP4B;DGAT1;MTMR7;MFSD2A;SELENOI;OSBPL10;SLC44A5;PEMT;PNPLA8;ETNPPL;PLD3;DDHD1;PIK3R4;MTMR9;CHPT1;PNPLA7;SLC44A1;OSBPL5;CDS2;GPAT4;RAB5A;GPD2;PLEKHA3;CPNE3;LPCAT4;PTEN;MBOAT7;MTM1;PCTP;PRKCSH;PGS1;MTMR4;LPGAT1;LPCAT1;OSBPL8;PLEKHA8;PIP5K1A;FIG4;AGK
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.27525927349663093,0.5358552913107618,1.0,1.0,1.0,8/30,25.73%,DYNC2LI1;IFT74;KIF3A;IFT122;DYNC2H1;SSX2IP;IFT81;DYNLL1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.3271122534123887,0.5358354487409153,0.9558823529411765,1.0,1.0,3/7,36.72%,RIPOR1;COPG1;STK25
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,0.3425162401319072,0.5356282180713795,0.971830985915493,1.0,1.0,1/7,11.71%,SGCE
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,-0.30063746152738374,-0.534626823939914,0.9354838709677419,1.0,1.0,3/7,26.57%,CAMKK2;CAMKK1;RNASE1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3038208885151425,0.5339033201572518,0.9705882352941176,1.0,1.0,3/12,20.68%,HERPUD1;SYVN1;LRRK2
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.24889195942340916,0.5333553304782692,1.0,1.0,1.0,22/102,24.35%,H2BC11;DNA2;RPS27A;GINS1;PSMB4;RBX1;RFC4;POLE2;ORC6;UBA52;DBF4;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;RPA3;ORC3;PSMD14;PSMA5;MCM3
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,-0.32548125633232017,-0.5329943131271203,0.9473684210526315,1.0,1.0,5/5,67.47%,MMAB;MTRR;MMADHC;MTR;MMUT
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.3228251421164388,-0.5327738187483398,0.9428571428571428,1.0,1.0,1/7,9.60%,AGO1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.26751102880241684,0.5327010346377321,0.9882352941176471,1.0,1.0,4/28,28.08%,CAMK2B;TBL1XR1;GPS2;AGO4
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.34287865564308107,0.5322040738195242,0.961038961038961,1.0,1.0,2/6,26.85%,NOTCH2;FBN1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.29653414366886244,0.5321668998444936,0.9651162790697675,1.0,1.0,6/20,22.04%,TRIM25;SRA1;BRCA1;ESR1;TRIM24;GSTM3
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.3332702659037341,0.5321462975319367,0.9875,1.0,1.0,2/10,16.31%,MFSD2A;CNEP1R1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.25111786865753244,-0.5318297612561358,1.0,1.0,1.0,5/17,18.82%,NR1H3;TREM2;NFKBIA;PTCH1;PPARG
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.27738993600522843,-0.5310699537786789,0.9629629629629629,1.0,1.0,4/10,20.48%,ABCC4;SLC19A1;LRRC8D;SLC25A17
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,-0.3171549539017755,-0.531046228951281,0.9714285714285714,0.9997111483213247,1.0,3/7,19.62%,SRC;ATG12;CSNK2A2
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.323526757630027,0.5305492891954192,0.9863013698630136,1.0,1.0,3/11,28.85%,PRKRA;AGO4;DICER1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.27341061059918287,-0.5303405988955737,1.0,0.9994336713709144,1.0,2/12,18.63%,HLCS;PARP2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.25593907995221915,0.5303176646317114,1.0,1.0,1.0,9/41,27.66%,OGA;STT3B;FBXO27;NR1D1;DDB1;TRIM24;CLPX;BAG6;HSPA8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.30172753027021154,0.5298918938624589,0.9577464788732394,1.0,1.0,1/13,11.28%,TENT4B
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.3138754299982955,0.5296823342990258,0.9726027397260274,1.0,1.0,4/13,21.38%,RRP1B;CPEB2;LRRK2;RDX
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.24263427560567244,0.5296756813873951,1.0,1.0,1.0,46/132,33.07%,INPP4B;MTMR7;DGKB;MFSD2A;SELENOI;SLC44A5;DGKG;PEMT;ETNPPL;DDHD1;PIK3R4;MTMR9;CHPT1;SLC44A1;PLD1;CDS2;GPAT4;RAB5A;PLEKHA3;CPNE3;LPCAT4;DGKE;PTEN;MBOAT7;DGKZ;MTM1;PCTP;PGS1;MTMR4;LPCAT1;PLEKHA8;PIP5K1A;FIG4;AGK;DGKQ;PLEKHA4;SYNJ2;PIK3CA;GNPAT;SACM1L;PIK3CB;MTMR6;CDIPT;PIP5K1B;AGPAT3;STARD7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.30344087390962904,-0.5291189678010597,0.9696969696969697,0.9993944249001658,1.0,2/8,10.32%,DAB2IP;TREM2
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.3145815466734694,-0.5290547357353393,0.9772727272727273,0.9989566704024511,1.0,1/6,8.65%,ALOX5
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.329494978291701,0.5284881440018141,0.9850746268656716,1.0,1.0,4/6,37.06%,SEC14L1;RIOK3;C1QBP;DHX58
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.3046288101759712,0.5283067473013063,0.971830985915493,1.0,1.0,4/13,26.13%,ABCA2;SPTBN1;APPL1;ZDHHC7
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.2463711337867711,0.5274343106151903,1.0,1.0,1.0,16/99,24.06%,CLEC4E;RPS27A;PSMB4;UBE2M;PYCARD;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;UBE2D2;PRKACB;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.2772299793294861,-0.5268793051326104,1.0,0.999161846596936,1.0,2/11,20.26%,DVL2;LRP6
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.3324416354595208,0.5266704520571203,0.96875,1.0,1.0,4/7,31.12%,MTHFD1;KYNU;HAAO;GOT1
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.2557915800708218,0.5263991485556342,1.0,1.0,1.0,17/92,24.72%,BNIP3L;PRKAG2;BNIP3;PINK1;CASP3;NRBP2;PRKAA2;SESN1;CDK5R1;ATP6V0B;UCHL1;LRRK2;ATP6V1B2;ATG13;ATP6V0E2;ATP6V1D;VPS26B
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.2624013837357633,0.52617926389769,0.9878048780487805,1.0,1.0,3/30,16.92%,SPTAN1;IQGAP1;SPTBN1
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,0.25887699818294,0.5254455329857811,1.0,1.0,1.0,11/46,28.31%,NUP133;TRNT1;DDX1;TSEN54;SEH1L;ZBTB8OS;COLEC12;NDC1;POM121;NUP58;RTRAF
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.2883015851583855,0.5248592267109171,1.0,1.0,1.0,4/13,32.37%,IFNLR1;C1QBP;DHX9;TRAF3IP1
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.3102974644818377,0.5235116867209846,1.0,1.0,1.0,2/19,11.55%,KCNH8;RPS6KA2
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.243600811822912,0.522267758835765,1.0,1.0,1.0,4/62,11.64%,ITPKC;INPP4B;MTMR7;ALDH6A1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.3555078987364017,0.5220907374190653,0.9672131147540983,1.0,1.0,1/6,17.51%,KLF7
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.32788394748362676,0.5219783183899614,0.9436619718309859,1.0,1.0,1/7,21.86%,HNRNPU
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.24568239793762972,-0.5217773370962286,1.0,1.0,1.0,5/18,21.29%,HSCB;ABCB7;MMS19;CIAO2B;NFU1
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.24593311559017025,0.5212827025048523,1.0,1.0,1.0,12/59,28.31%,PDZD2;RPS27A;TRIM25;NKIRAS1;APP;UBA52;UBB;ATG5;UBE2D2;HSP90AB1;UBE2D1;TAX1BP1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.31219263173546896,0.5203332508375348,1.0,1.0,1.0,1/9,13.83%,CD300A
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.23784400030701316,0.5190026864687863,1.0,1.0,1.0,24/164,26.31%,EIF4A3;PQBP1;WBP11;WBP4;TFIP11;BCAS2;HNRNPA0;RBM5;HNRNPH1;POLR2D;PRPF6;COLEC12;SRSF5;POLR2G;SNRPD2;HNRNPU;PHF5A;SRSF3;PRCC;HNRNPR;ELAVL2;LSM5;SRSF9;CPSF6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.2646815505350071,-0.5187825099419479,1.0,1.0,1.0,2/10,16.93%,SRC;DNAJC13
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.34476835124060085,0.5186828795455062,1.0,1.0,1.0,2/6,26.66%,SRM;AMD1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.23969670042659214,0.518015399098333,1.0,1.0,1.0,7/67,18.65%,TDG;BMI1;POLR1C;SMYD5;ERCC6;SUZ12;EZH2
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.2561146846504109,0.5178385441147487,1.0,1.0,1.0,16/58,31.61%,H2BC11;RPS27A;RNF144A;UBE2J2;UBA52;UBB;USP5;UBE2D2;PEX10;UBE2D1;RAD18;CTR9;UBE2L3;PRKDC;UBE2R2;H2BC9
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.2637929135449794,0.5176387665545431,1.0,1.0,1.0,6/44,18.81%,H2BC11;RPS27A;RNF144A;UBE2J2;UBA52;UBB
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.2521531448373341,0.5168377109690944,1.0,1.0,1.0,13/89,20.53%,MAP3K8;KCNH8;RPS27A;NOD2;RPS6KA2;RIPK2;NKIRAS1;MAPK10;APP;UBA52;UBB;FOS;DUSP6
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.30382462536336785,0.5165189043689652,0.9714285714285714,1.0,1.0,1/11,11.55%,RPS6KA2
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.23087257253022028,0.5145553642655882,1.0,1.0,1.0,44/173,32.46%,ENC1;KCTD2;TRIM9;PSMB4;RBX1;RNF126;RNF139;PELI1;SYVN1;TBL1XR1;UBXN2B;HECW2;PSMC2;ZNRF1;PSMA3;PSMB2;NR1D1;SPSB3;UCHL1;DDB1;PSMD5;PSMD7;HACE1;FEM1C;PSMD14;PSMA5;TNFAIP1;BAG6;KCTD13;CTNNB1;FEM1B;NSFL1C;MAEA;KBTBD6;FBXL17;RBCK1;PRPF19;SPOPL;PLAA;UBE3D;PSMB8;PSMD8;PSMA4;CLOCK
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.25323394203423677,0.5142497625608162,1.0,1.0,1.0,17/88,23.67%,ERCC2;COPS5;RPS27A;RBX1;RFC4;GTF2H3;ACTR5;POLE2;POLR2D;ERCC6;UVSSA;UBA52;UBB;DDB1;POLR2G;RPA3;GPS1
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.25106520090705975,0.5140858894777415,1.0,1.0,1.0,13/51,24.25%,RPS27A;PSMB4;ERLIN1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5;CFTR
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.3160775764091759,0.5138173305198964,0.9863013698630136,1.0,1.0,3/8,29.17%,PYCARD;PTPRS;RELB
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.2826457590530237,0.5135541975388551,1.0,1.0,1.0,3/21,17.45%,TRIM25;NKIRAS1;APP
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,0.3251457306451226,0.5132152334019484,0.9866666666666667,1.0,1.0,5/8,46.00%,RBBP8;RAD52;MRE11;PARP1;BRCA2
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.2820402251568735,0.5129447941817583,0.9875,1.0,1.0,1/20,8.87%,RPS6
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.2341871563482999,0.5125654046802853,1.0,1.0,1.0,37/203,25.80%,H2BC11;CLSPN;HIF1A;HCFC1;RPS27A;TRIM25;NOD2;PSMB4;OTUD7B;RIPK2;TOMM20;POLG2;VCPIP1;BRCA1;ACTR5;ESR1;SMAD1;TAF9B;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;TNIP1;PSMD5;PSMD7;BARD1;USP48;USP5;PTEN;PSMD14;PSMA5;CFTR;USP11;SUDS3;CCP110
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.3189853529993071,0.5123491020856836,0.9726027397260274,1.0,1.0,3/7,27.29%,RDX;PRKACB;TTN
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.28962218736670936,0.5123159412393263,0.9879518072289156,1.0,1.0,7/24,28.03%,STXBP5L;DISP1;TNF;CHP1;PTPN1;HSPA8;SNX12
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.3075444596188581,0.5119750706345936,1.0,1.0,1.0,4/17,26.52%,PKD1;EXOC5;RAB11A;PTGES2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.32241970949891496,-0.5117813494634693,0.96875,1.0,1.0,1/5,13.04%,PRDM11
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,0.2284890222858096,0.511144903957534,1.0,1.0,1.0,452/3680,20.33%,SOCS3;GPR18;DDIT4;NAMPT;SH3BP5;SPON1;ZNF382;SPARC;MDH1;ARAF;PLIN2;NDUFA2;ZNF793;TUBA4A;DTL;VIM;CKS2;PCDH9;RPL23;CFAP36;CCPG1;HMGB2;TLE1;PLAC8;NMRAL1;CCDC152;IDI1;EIF4A3;ZBTB16;CKMT2;PPP1R9A;TAMALIN;GADD45B;MANF;SMIM19;NAA38;SLC2A3;TALDO1;NUDT4;MXRA7;GLIPR2;NR4A2;AMZ2;TMEM161A;MFNG;AGT;NGDN;NR4A1;ATAD3A;SCAF1;NAPA;RNASEH2C;PQBP1;ARF6;SLF1;NDUFB9;WDR74;CLSPN;MEI1;SLC4A10;VBP1;ENC1;RGS1;TTBK2;C21ORF91;CLEC2B;SRGN;MAP3K8;RPA2;DALRD3;MASTL;MRPL33;RPL37A;PTPRK;ARID5B;BROX;TDG;IER5;HSPA5;WBP11;RXRB;CRELD2;ERMP1;PPP2R5A;TCF7;CDKN2AIP;ANTKMT;CD55;TRNAU1AP;SMC4;SEC61B;RBM3;CARHSP1;ETFB;RPS6KB2;ACTR1B;LTB4R;NUP133;IMP3;PGAM1;MVD;HINT1;NCAPH2;SFMBT1;BAALC;ATOX1;RPL38;SPIRE2;RCC1;CA2;EMC7;COPS5;MPG;SIPA1L1;HERPUD1;PIGQ;VPS11;AGTPBP1;SDF2L1;TIMM13;ACAT1;BHLHE40;FOSL2;SLCO3A1;SPRY1;PAICS;FAM184A;SUGP2;SCD5;CALM3;SBDS;DNAJC7;SVIL;NBEAL1;ITGAE;PDE1C;ID2;RPS6;RPL7L1;TSC22D3;GSDMD;NARF;ATAD2;IRS2;COX7A2;RPS27A;KDM1A;MCL1;RPL23A;ARIH2;IFITM3;TFIP11;FGR;ZMAT2;TXNIP;CELF2;SRA1;LMNB1;AKR1B1;GFOD1;BZW1;FAM162A;RPS25;DARS1;MGAT1;NDUFA3;PER1;RPS27;OSBPL10;SPTAN1;SH3D19;FAM50A;TYSND1;BCAS2;PDE4B;PRR5;CRTC3;STT3B;CRYL1;PSMB4;UBALD2;RBX1;GABPB1;SAAL1;CTHRC1;DCAF6;NDUFS8;AGPS;GPR65;CLASP2;DNAJB2;UCKL1;GAN;RPS11;PPID;NHP2;HCLS1;GALC;RNF126;DYNC1H1;PIK3IP1;TMEM50A;RPS20;COX7C;EIF3E;NMD3;CCNC;RPL9;OTUD7B;NFKBIZ;CMPK1;HNRNPA0;UPF3A;GPI;CYCS;EPHA4;DDX1;TOMM20;RBM5;PRPS1;FAM53C;RPLP2;TNFRSF1B;PMPCA;SNX10;NR4A3;BRCA1;LINGO2;DRAP1;SNAP29;TSEN54;EEF1B2;GOLGA8B;DRG2;RPS18;LANCL2;MPHOSPH9;PKM;CENPK;PPA1;RNF139;PRELID1;MRPL43;SERP1;INSIG1;DMGDH;MRPL20;C3ORF38;RPL37;NSMCE1;KDM4B;YAF2;CALCOCO2;SCAMP3;AUP1;HOOK3;PPP1R15A;TMEM120B;UNC13C;MFAP1;BCAS1;AHNAK;HSD17B12;GNAL;TRIM26;MAGT1;TSPYL1;FDFT1;CDC37;UHRF2;NXF1;TMEM134;UBE2M;ABCA5;RPL14;DNAJB9;CAMLG;SDCBP;OCIAD1;DUSP10;CDC37L1;NDUFB6;CDADC1;HMGCS1;NELFB;MRPL14;KIF11;GRPEL1;HEMK1;CASP3;USP38;WDR83;DTX3;TXNDC15;DCK;ZNF292;TMED10;CFL1;KLHL28;MLF2;UXT;GGNBP2;PDK3;PEMT;PFDN4;AKIRIN1;KLHL6;HNRNPH1;CIDEB;PREPL;CEBPD;MRPL27;RPS4X;LDB2;TTC33;UQCRFS1;ZNF260;KLF13;CCND3;SUMF2;ATP1B3;CTBP1;COMMD8;PNPLA8;TCP1;EML2;GBP2;RPL11;ARAP2;UQCRC1;LITAF;CARNMT1;TXK;CXXC1;SNX17;KCNIP4;SMAP2;ENOSF1;RPS24;SND1;NACA;POLR2D;TRAPPC6B;IQGAP1;SPTBN1;PRKD3;PLCB1;RPS9;ODF2L;CISD1;ROCK1;TFAM;ARHGDIA;NOB1;UBE2J2;ARRDC2;NPRL2;MRPL19;CACYBP;DDHD1;GSTP1;FOXP1;RGCC;RPL36;PCMTD1;FANCL;PTPN9;MTMR9;TPGS1;MORF4L2;PLXNC1;SSR3;KLHDC4;DCTN1;SLC16A3;ADH5;PCED1B;STXBP2;RNF149;MPC2;ABRACL;SOD1;FTH1;CHCHD3;GTPBP4;HPRT1;SESN1;TMEM175;LAPTM4A;UBA52;HSPD1;GUK1;SUZ12;SMARCC1;ZBTB8OS;EZH2;ELL2;DBF4;HACL1;UBB;PSMC2;ZC3HAV1;GRIK4;RHOH;PRPF39;TMSB10;CDC25B;SLC66A3;ZNRF1;TAF7;TRIM65;CD151;MIF4GD;RAB21;FIBP;PSMA3;VPS51;TBC1D31;ZNF684;FOS;SLC38A10;SRPRA;SUN2;DUSP16;TRPM7;PHTF1;PRPF6;CTDSP1;KDM6B;PGM2L1;NCAM1;RFC1;HIP1R;MRPL3;RPS3A;PGK1;SURF4;SLC3A2;CYC1;KMT5C;CTPS1;OSBPL5;AK5;PGM1;FBXO7;ENO1;PSMB2;SSH2;CDS2;GNL1;NR1D1;COX4I1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.26545485089583715,0.511033579658566,0.9761904761904762,1.0,1.0,7/32,21.36%,IFITM3;NELFB;POLR2D;CDK9;TRIM14;POLR2G;HEXIM1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.27516814579008253,-0.5106379863199977,1.0,1.0,1.0,3/11,16.60%,SSBP1;RECQL;HMGA1
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.24204728201117381,0.5101254842021529,1.0,1.0,1.0,26/77,32.35%,H2BC11;RPS27A;PSMB4;ORC6;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;ORC3;PSMD14;PSMA5;MCM3;FZR1;UBE2D1;ANAPC5;MCM6;ANAPC7;H3-3B;GMNN;H2BC9;PSMB8;PSMD8;PSMA4
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.28660734409907057,0.5100755683267663,0.987012987012987,1.0,1.0,3/16,20.58%,RUVBL2;MORF4L2;MEAF6
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.31516302889424114,0.5094728838255567,0.9701492537313433,1.0,1.0,3/9,23.42%,PLD3;SORT1;ADGRB3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.29693885329122854,0.5086223637926411,1.0,1.0,1.0,4/13,32.04%,PRKRA;AGO4;DICER1;DHX9
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.2364128352794324,-0.5078039755675484,1.0,1.0,1.0,2/13,12.98%,WIPI1;ATG12
prerank,KEGG_2021_Human__Lysine degradation,0.25197188469008364,0.5073944771814544,1.0,1.0,1.0,11/52,27.00%,SUV39H2;COLGALT2;ACAT1;PLOD1;EZH2;KMT5C;PIPOX;TMLHE;ECHS1;DOT1L;SETDB2
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.28812084948933103,0.5061879850059586,0.9866666666666667,1.0,1.0,3/16,23.39%,XRCC3;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.2699370373775094,0.5056179576605915,0.9883720930232558,1.0,1.0,4/29,20.94%,BNIP3;PINK1;FBXO7;ATG5
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,0.27150946252517144,0.5046884324089903,1.0,1.0,1.0,6/27,24.91%,VPS37C;RPS27A;UBA52;UBB;CHMP5;CHMP7
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.2555166210185262,0.5044915469816642,1.0,1.0,1.0,10/67,18.81%,ERCC2;COPS5;RPS27A;RBX1;RFC4;GTF2H3;ACTR5;POLE2;UBA52;UBB
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.24320517984584764,0.5041691771686417,1.0,1.0,1.0,15/73,24.06%,HCFC1;RPS27A;PSMB4;ACTR5;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;PSMD5;PSMD7;BARD1;PSMD14;PSMA5
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.3309952625054912,0.5024600351005474,0.9714285714285714,1.0,1.0,2/5,27.81%,ATP1A2;ANXA6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2779545977544532,0.5017404778412292,1.0,1.0,1.0,8/24,24.61%,ANXA1;CCND3;PLCB1;RGCC;EZH2;RDX;DDRGK1;DDX3X
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.2608404725023139,0.5015899255211055,1.0,1.0,1.0,8/24,34.11%,OTUD7B;OTUD1;PSMD14;USP25;UIMC1;OTUD7A;CYLD;BABAM2
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,0.3262488644895766,0.5012849115828656,0.9827586206896551,1.0,1.0,1/6,15.44%,POLE2
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.2559101380826869,-0.49978106270082207,1.0,1.0,1.0,4/8,23.72%,RNF8;RNF168;MSH6;MSH2
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.28031012267269706,0.49954987095870823,0.9868421052631579,1.0,1.0,4/13,31.06%,NOP53;ZCCHC3;SEC14L1;C1QBP
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3047091236691558,0.49938938626088086,0.984375,1.0,1.0,2/9,24.61%,DHX33;DDX3X
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.26103666454114544,-0.4991414478304207,1.0,1.0,1.0,1/7,10.62%,ABL1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.26103666454114544,-0.4991414478304207,1.0,1.0,1.0,1/7,10.62%,ABL1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.2965301898860257,0.4990891226013647,1.0,1.0,1.0,1/10,11.78%,SOX6
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.2386214295727741,0.4987891659869654,1.0,1.0,1.0,12/47,24.06%,RPS27A;PSMB4;HSPB1;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.23860703784919132,-0.4987741378839349,1.0,1.0,1.0,2/18,11.79%,CH25H;OSBPL6
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.3145974591696277,-0.49847550637873517,1.0,1.0,1.0,1/6,7.61%,ARFIP1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.23781646487121166,0.49840662734269714,1.0,1.0,1.0,9/62,20.71%,MRPL33;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.24549013297271413,0.49809080294001323,1.0,1.0,1.0,9/58,23.88%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.32576570948217665,0.49757458677160193,1.0,1.0,1.0,2/6,29.84%,SLX4;BLM
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.2386948350518434,-0.4975137692294658,1.0,1.0,1.0,1/21,1.50%,INPP5K
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.24531086413977818,0.49723064563476466,1.0,1.0,1.0,9/59,23.88%,EIF2AK3;IMPACT;SEH1L;NPRL2;SESN1;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.33607983583476764,0.496961693771577,0.9852941176470589,1.0,1.0,1/7,17.56%,FOXP1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.26453819172344256,0.4965736284771066,1.0,1.0,1.0,4/25,18.65%,BMI1;SMYD5;SUZ12;EZH2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.32219833403400866,0.49631342233356085,0.971830985915493,1.0,1.0,2/5,32.10%,MAN1A1;EDEM3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.2973064257367221,-0.495794463130117,0.9354838709677419,1.0,1.0,6/6,70.29%,AKT1;RHEB;GSK3B;RFX3;CLOCK;FOXO1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.26445248819644884,0.4938194252387095,1.0,1.0,1.0,3/29,24.39%,RETREG1;VRK1;DDRGK1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.29433756683204637,-0.49342882913429786,0.9736842105263158,1.0,1.0,2/5,16.68%,PKN1;PRKCA
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.2888722466856988,-0.49319517235059424,0.9642857142857143,1.0,1.0,2/7,13.73%,EIF5A;PTTG1IP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.28841842151940034,0.4928757276790883,0.9868421052631579,1.0,1.0,2/11,19.91%,HOOK3;TBCCD1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.33180143046360194,0.4924743024652755,0.9710144927536232,1.0,1.0,1/5,9.91%,MFSD2A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.223999514652504,0.4922675191264779,1.0,1.0,1.0,36/226,26.18%,EIF4A3;PQBP1;WBP11;GEMIN2;DBR1;SRSF12;WBP4;TFIP11;ZMAT2;NOVA1;BCAS2;HNRNPA0;DDX1;RBM5;RBM4B;MFAP1;WDR83;HNRNPH1;POLR2D;SART3;PRPF6;SRSF5;POLR2G;SNRPD2;HNRNPU;SFPQ;PHF5A;HNRNPH3;SRSF3;PRCC;HNRNPR;BUD13;ELAVL2;SYNCRIP;LSM5;SRSF9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.2793014673981254,0.49216767270648365,0.9866666666666667,1.0,1.0,1/16,8.08%,CSKMT
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),0.3211053974887207,0.4910785186361127,0.9855072463768116,1.0,1.0,2/5,29.76%,SETDB2;MEGF8
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.32183804639970054,0.4901955192088879,0.9857142857142858,1.0,1.0,2/6,25.69%,BCLAF1;RPS6KA3
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,0.25211767646375816,0.49015585735764233,0.9876543209876543,1.0,1.0,8/26,33.76%,ACOT13;DBI;ECHS1;PCTP;ACSM3;ACADM;MMUT;MECR
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,0.3121541519961441,0.4891148623338007,0.987012987012987,1.0,1.0,2/7,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.23210668885525032,0.4880467001711596,1.0,1.0,1.0,9/66,20.71%,MRPL33;MRPL43;MRPL20;MRPL14;MRPL55;MRPL27;MRPL19;MRPL3;MRPS14
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),0.34001201291394795,0.48716491346156654,0.9863013698630136,1.0,1.0,2/5,20.20%,ROCK1;TNF
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.28712528245842195,0.48708079132310217,1.0,1.0,1.0,2/12,15.47%,CPLX1;MCTP1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.34560279413518336,0.48702375654593677,1.0,1.0,1.0,1/5,23.75%,GPS2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.28047108637830254,-0.48663530954532525,1.0,1.0,1.0,1/7,9.60%,AGO1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.29502203569460955,0.4844843816383802,0.9841269841269841,1.0,1.0,2/7,19.64%,DMGDH;SLC44A1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.30091511780648167,-0.48306760098777024,0.9615384615384616,1.0,1.0,2/5,22.43%,CHCHD10;KCNK1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.27362255435206895,0.48190495965431024,0.9722222222222222,1.0,1.0,3/11,24.91%,CHMP5;PDCD6IP;CHMP7
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,0.3103595327744942,0.4810435205846627,1.0,1.0,1.0,2/8,21.00%,ACACB;SLC5A6
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.23606216103729247,0.47924375364814414,1.0,1.0,1.0,18/53,32.35%,RPS27A;PSMB4;UBA52;UBB;PSMC2;PSMA3;PSMB2;PSMD5;PSMD7;PSMD14;PSMA5;FZR1;UBE2D1;ANAPC5;ANAPC7;PSMB8;PSMD8;PSMA4
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.3469035088370424,0.4788266809829554,0.9861111111111112,1.0,1.0,3/5,28.59%,KIF3A;FYCO1;KIF13A
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.28529566709126014,0.47778175164268627,0.972972972972973,1.0,1.0,1/9,22.52%,SORT1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.28068794700487165,0.47757268524314583,1.0,1.0,1.0,6/15,33.13%,NR4A3;MFN2;JUN;MEF2D;GJA1;BMPR1A
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.28453225261735904,-0.47667282203735273,1.0,1.0,1.0,5/5,71.57%,SURF1;COX18;CYBA;COX10;COA6
prerank,KEGG_2021_Human__Asthma,-0.24062347679807955,-0.47528422431580797,1.0,1.0,1.0,2/12,16.92%,HLA-DPA1;HLA-DRB5
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.2679004301179957,0.4751422459990335,1.0,1.0,1.0,9/19,29.60%,B4GALT5;GK;GCNT1;ALG11;TNIP1;GK5;LARGE1;TKT;SCCPDH
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.24082977810548856,-0.4750466538084761,0.9655172413793104,1.0,1.0,3/8,19.87%,AKAP8L;SAP30BP;AKAP8
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,0.29740223357076445,0.4750217263844886,0.9746835443037974,1.0,1.0,1/9,15.06%,WNT5A
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",0.2810808200634589,0.47465625987946897,1.0,1.0,1.0,2/9,23.72%,PFKFB4;PRKACB
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.3253203774298893,0.4737484606161943,0.9863013698630136,1.0,1.0,1/6,20.58%,MEAF6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.2627690306922442,-0.47352779383241744,1.0,1.0,1.0,3/8,19.66%,HLCS;PCCB;MCCC1
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.3230200165408682,0.4733854022186866,1.0,1.0,1.0,2/6,20.20%,ITGAV;TNF
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.26106045254981425,-0.47272770265813846,1.0,1.0,1.0,5/5,73.91%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.26106045254981425,-0.47272770265813846,1.0,1.0,1.0,5/5,73.91%,TIRAP;RELA;CD14;MAPK14;TLR2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.29805423759246436,0.4727041068086178,1.0,1.0,1.0,2/9,23.36%,HSPA1B;CASP1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.25479911281630063,0.4721026880383573,0.9859154929577465,1.0,1.0,4/21,30.96%,AUP1;BAG6;FBXL17;ZER1
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.2704551211686228,-0.46920977396736796,1.0,1.0,1.0,6/6,72.98%,CD81;PECAM1;CD9;CXCR4;XBP1;PRDM1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.2143463566428502,0.46909777511533357,1.0,1.0,1.0,35/210,24.25%,CLSPN;TRAF2;COPS5;HIF1A;HCFC1;RPS27A;PSMB4;USP35;OTUD7B;TOMM20;VCPIP1;BRCA1;ACTR5;USP38;ESR1;SMAD1;TAF9B;UBA52;UBB;PSMC2;PSMA3;PSMB2;UCHL1;OTUD1;TNIP1;PSMD5;PSMD7;BARD1;USP48;USP5;GPS1;PTEN;PSMD14;PSMA5;CFTR
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.28448238867141545,0.46909380319410876,0.9859154929577465,1.0,1.0,5/11,30.16%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.28448238867141545,0.46909380319410876,0.9859154929577465,1.0,1.0,5/11,30.16%,SMARCD3;SMARCC1;SMARCD2;ARID2;SET
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.2818043603221238,0.4683813293660127,0.987012987012987,1.0,1.0,3/12,30.09%,UBE2D1;ANAPC5;ANAPC7
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2924069592859749,-0.46752195803465296,1.0,1.0,1.0,1/6,7.62%,PLA2G12A
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.25561350734525434,0.46746354593226264,1.0,1.0,1.0,7/22,31.30%,PLTP;ABCA5;ABCB4;GPS2;LRP1;NR1H2;ABCA3
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.28579299996510166,0.46551790479165733,1.0,1.0,1.0,1/10,10.42%,C5AR1
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.2944993347646782,-0.46523886712641227,1.0,1.0,1.0,2/6,22.85%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.2944993347646782,-0.46523886712641227,1.0,1.0,1.0,2/6,22.85%,ANK1;LIN7B
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.28998592009226365,-0.4647503501970484,1.0,1.0,1.0,1/5,12.66%,MAML1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.26938017226819794,-0.4641154947441755,1.0,1.0,1.0,7/7,73.09%,SORL1;RAB11B;INPP5F;ARHGAP1;EIPR1;ACTN2;ATP9A
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.28841607565011823,-0.4617290762567306,1.0,1.0,1.0,5/5,71.18%,TRPV4;CAB39;STK39;SLC12A5;MYLK
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,0.23698746891141784,0.46078982770073323,1.0,1.0,1.0,4/25,24.20%,OSBPL10;ARG2;CRYBG1;TRAF3IP2
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.24984882175773337,0.45961860123147985,1.0,1.0,1.0,6/22,29.55%,NHP2;SHQ1;RFC1;HSP90AB1;DKC1;STN1
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.20641936313584716,-0.4586529968296908,1.0,1.0,1.0,3/22,14.21%,TRIB3;PKN1;AKT1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.23295298870862086,0.4580982876378575,0.9879518072289156,1.0,1.0,2/28,15.56%,KDM1A;ESR1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.29311767948817796,0.45759394467709935,1.0,1.0,1.0,1/6,21.38%,RDX
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.26106045254981425,-0.4566567879072552,1.0,1.0,1.0,5/5,73.91%,TIRAP;CD36;TLR1;CD14;TLR2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.25686347552778926,0.4562466583405771,1.0,1.0,1.0,2/11,30.41%,GNL3;RAD21
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.2726736027532921,0.456029684436818,1.0,1.0,1.0,3/8,33.08%,UBXN2B;NSFL1C;BICD1
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.26755337984523836,0.45594567372267913,1.0,1.0,1.0,3/10,35.96%,RBL2;TFDP2;TFDP1
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.2746538331644715,-0.45400987096272083,1.0,1.0,1.0,5/5,72.55%,MTMR2;LAPTM5;ITCH;DTX3L;PTPN1
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,-0.2955220985934191,-0.4530445572627448,0.9428571428571428,1.0,1.0,1/5,7.62%,PLA2G12A
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.24111601962846363,0.45257488545455454,1.0,1.0,1.0,7/32,29.74%,BNIP3;PINK1;FBXO7;ATG5;ATG13;MAP1LC3A;ATG2B
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,0.20579935633868418,0.4505772385899862,1.0,1.0,1.0,32/207,27.66%,EIF4A3;PQBP1;WBP11;NUP133;WBP4;TFIP11;BCAS2;HNRNPA0;RBM5;NXF1;SEH1L;HNRNPH1;POLR2D;PRPF6;COLEC12;SRSF5;POLR2G;SNRPD2;HNRNPU;NDC1;PHF5A;SRSF3;PRCC;HNRNPR;POM121;ELAVL2;LSM5;SRSF9;CPSF6;NUP58;LSM3;HSPA8
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.20756518036227,-0.450186699835644,1.0,1.0,1.0,4/18,18.69%,PEX16;ABCD3;FIS1;PEX2
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.3143917654010179,0.44981427152572323,1.0,1.0,1.0,3/5,37.33%,MACROH2A1;MTF2;OGT
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,0.27737540671227284,0.4491945510353911,1.0,1.0,1.0,5/8,41.67%,PCSK6;MBTPS1;PCSK5;MBTPS2;LMF2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.2689969604863222,-0.44832088245614987,1.0,1.0,1.0,5/5,73.12%,UFD1;NPLOC4;DHX58;C1QBP;SEC14L1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.2675377804447925,0.4480344345812266,1.0,1.0,1.0,2/10,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.2675377804447925,0.4480344345812266,1.0,1.0,1.0,2/10,21.93%,COQ6;COQ2
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,0.2516838515710913,0.4479564058052145,1.0,1.0,1.0,6/15,29.61%,TXNIP;PYCARD;APP;CASP1;HSP90AB1;HMOX1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.2914615929653939,0.4458870071178624,1.0,1.0,1.0,2/7,24.74%,MTHFD1;ADI1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.2754593298910206,0.44572131289529704,0.9841269841269841,1.0,1.0,3/6,32.37%,MICB;C1QBP;TRAF3IP1
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.20650612589776088,-0.43939638919123475,1.0,1.0,1.0,14/14,79.38%,TYMS;RBBP4;LIN54;RBL1;LIN52;E2F4;HDAC1;LIN9;E2F6;DHFR;TFDP1;TFDP2;POLA1;RBL2
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.25983994042445746,0.4389157497261965,1.0,1.0,1.0,2/11,21.93%,COQ6;COQ2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.219619283451636,-0.43515683638912567,1.0,1.0,1.0,2/12,18.25%,PJVK;ACBD5
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.2735726161446465,0.4346203110706812,1.0,1.0,1.0,4/10,30.59%,PCSK6;SORT1;HDAC9;NR1H2
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.23175801854246447,-0.43345282974317334,1.0,1.0,1.0,1/9,11.58%,ADRM1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.25746410962513955,0.42935064112261195,0.9866666666666667,1.0,1.0,2/11,21.38%,KLF9;RDX
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.2342358910055421,0.42740638972952544,1.0,1.0,1.0,7/23,32.67%,POLR3H;SNAPC3;ICE2;SNAPC4;CRCP;GTF3C6;ELL
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.2151670949454886,0.4273739819930215,1.0,1.0,1.0,10/35,33.16%,DNA2;GTPBP4;ORC3;ATAD5;WAPL;STN1;BLM;GMNN;DHX9;ATR
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.2527204047449474,0.4271731253819416,1.0,1.0,1.0,4/11,27.81%,KCNB2;ENO1;ATP1A2;ANXA6
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.24572135434555295,0.4244694657420814,1.0,1.0,1.0,1/11,9.71%,TFIP11
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.2294747148347178,0.41851569690988727,0.9863013698630136,1.0,1.0,3/13,24.91%,CHMP5;PDCD6IP;CHMP7
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.28708197867977314,0.4158903683215757,1.0,1.0,1.0,2/5,23.61%,SERINC5;ZCCHC3
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.26123940327551565,-0.4061363965468027,1.0,1.0,1.0,2/5,21.06%,CHMP2A;VPS4B
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.23315241790088848,-0.40540096456592917,1.0,1.0,1.0,2/9,15.95%,SRC;CBL
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.26045376432328937,0.4047023173126554,1.0,1.0,1.0,3/10,35.25%,FOXO3;FOXO1;REXO2
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.2747745524775609,0.4031183625663867,0.9857142857142858,1.0,1.0,1/5,20.20%,TNF
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,0.2266842901052422,0.40227564891982753,1.0,1.0,1.0,5/17,35.45%,POLR2D;POLR2G;POLR2A;TDRD1;POLR2H
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.289387916761,0.40089679916350357,1.0,1.0,1.0,1/5,20.69%,CNTN2
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.27258446282575255,0.400555023150467,1.0,1.0,1.0,3/5,36.07%,ATP8A2;ATP8A1;SCARB2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.2591264251550535,0.39641384758826415,1.0,1.0,1.0,2/5,33.82%,NASP;CHAF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.2591264251550535,0.39641384758826415,1.0,1.0,1.0,2/5,33.82%,NASP;CHAF1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.251969691454173,0.39565197138285985,1.0,0.9999604243635821,1.0,2/6,27.94%,PPARA;OSBPL8
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.2055916884872033,-0.3903948811908855,1.0,1.0,1.0,10/10,79.47%,BUB3;RCC2;ZW10;MIS12;IK;KNL1;CHAMP1;MTBP;ZWILCH;CENPT
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,-0.2616808650057038,-0.3852068288820533,1.0,1.0,1.0,1/6,13.23%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.2616808650057038,-0.3852068288820533,1.0,1.0,1.0,1/6,13.23%,SYK
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.2616808650057038,-0.3852068288820533,1.0,1.0,1.0,1/6,13.23%,SYK
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.2285925552727766,0.3834140314555029,1.0,1.0,1.0,3/10,30.22%,TAF7;GTF2A2;TAF1B
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.23333425983036749,0.3827872296692043,1.0,0.9999350850358424,1.0,2/11,22.91%,TMCC2;ABCG1
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.20784818107169917,0.3800832464613845,1.0,0.99980793562875,1.0,4/21,26.78%,CDC37;TWF1;HSP90AB1;PHIP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.2015037332057146,0.3465550876103526,1.0,0.9999548820918668,1.0,6/14,38.06%,AP1AR;SORT1;KIF16B;MON2;VPS13C;RAB14
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.21290739768944938,-0.3423146084481145,1.0,0.9999937133804411,1.0,2/7,19.63%,TASL;GRN
